,project_id,fiscal_year,report_title,principal_investigator,supervisor,research_org,lab_staff_within_org,extramural_collab,collab_other_NCI,collab_other_NIH,publications,url
0,BC004496-39,"October 01, 2015 -  September 30, 2016",Chromosomal Proteins and Chromosomal Functions,Michael  Bustin; PhD|IRP Faculty Profile,NULL,"Protein Section, NCI",NULL,"Vasily  Studitsky (Department of Pharmacology, University of Medicine and Dentistry of New Jersey)|Eran  Meshorer (Hebrew University)|Jefferey  Hayes (University of Rochester medical Center)",Joost J Oppenheim; MD (Cancer Inflammation Program),David  Landsman; PhD (NLM),"1. Deng T, Zhu ZI, Zhang S, Postnikov Y, Huang D, Horsch M, Furusawa T, Beckers J, Rozman J, Klingenspor M, Amarie O, Graw J, Rathkolb B, Wolf E, Adler T, Busch DH, Gailus-Durner V, Fuchs H, Hrabě de Angelis M, van der Velde A, Tessarollo L, Ovcherenko I, Landsman D, Bustin M (2015). Functional compensation among HMGN variants modulates the DNase I hypersensitive sites at enhancers. Genome Res  25, 1295-308.   https://doi.org/10.1101/gr.192229.115|2. Furusawa T, Rochman M, Taher L, Dimitriadis EK, Nagashima K, Anderson S, Bustin M (2015). Chromatin decompaction by the nucleosomal binding protein HMGN5 impairs nuclear sturdiness. Nat Commun  6, 6138.   https://doi.org/10.1038/ncomms7138|3. Garfinkel BP, Arad S, Le PT, Bustin M, Rosen CJ, Gabet Y, Orly J (2015). Proportionate Dwarfism in Mice Lacking Heterochromatin Protein 1 Binding Protein 3 (HP1BP3) Is Associated With Alterations in the Endocrine IGF-1 Pathway. Endocrinology  156, 4558-70.   https://doi.org/10.1210/en.2015-1668|4. Postnikov YV, Bustin M (2016). Functional interplay between histone H1 and HMG proteins in chromatin. Biochim Biophys Acta  1859, 462-7.   https://doi.org/10.1016/j.bbagrm.2015.10.006",https://intramural.nih.gov/search/searchview.taf?ipid=93619
1,BC004504-44,"October 01, 2015 -  September 30, 2016",Interacting Signaling Pathways that Initiate Squamous Cell Carcinogenesis,Stuart H Yuspa; MD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Elise Suzanne Fraser|Jee Hyun Kim|Laurie Gayle Kostecka|Alicia Pingjian Chang Mizes|Joanna  Anders|Christophe  Cataisson|Show all 11,NULL,Giorgio  Trinchieri (Cancer Inflammation Program),Maria Irene Morasso; PhD (NIAMS) |Wendy  Weinberg (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93620
2,BC004517-40,"October 01, 2015 -  September 30, 2016",DNA Repair in Human Cancer-Prone Genetic Diseases,Kenneth H Kraemer; MD|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",Raina Jewel Rebecca Bembry|Paul Faik Hanona|Melissa Ann Levoska|Sikandar  Khan|Ryusuke  Ono; MD|John  Digiovanna|Show all 7,"Steffen  Emmert|Vera  Price (Univ of California, SF)|Hanoch  Slor (Tel Aviv Univ Med School)|Alain  Sarasin|Allen  Lehmann (Genome Damage and Stability Centre, Univ of Sussex)|N G  Jaspers (Genetics, Erasmus Univ)|Show all 12","Margaret Anne Tucker (Human Genetics Program)|Alisa  Goldstein; PhD (Genetic Epidemiology Branch)|Michael  Bustin; PhD (Protein Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Mark  Raffeld; MD (Laboratory of Pathology)|Chyi-Chia Richard Lee (Laboratory of Pathology)","Nicholas  Patronas; MD (CC) |Vilhelm A Bohr; MD, PhD (NIA) |Brian Patrick Brooks; MD, PhD (NEI) |Melissa A Merideth (NHGRI) |Carmen Crowell Brewer; PhD (NIDCD) |Andrew J Griffith; MD, PhD (NIDCD)","1. Heller ER, Khan SG, Kuschal C, Tamura D, DiGiovanna JJ, Kraemer KH (2015). Mutations in the TTDN1 gene are associated with a distinct trichothiodystrophy phenotype. J Invest Dermatol  135, 734-741.   https://doi.org/10.1038/jid.2014.440|2. Kuschal C, Khan SG, Enk B, DiGiovanna JJ, Kraemer KH (2015). Readthrough of stop codons by use of aminoglycosides in cells from xeroderma pigmentosum group C patients. Exp Dermatol  24, 296-7.   https://doi.org/10.1111/exd.12655",https://intramural.nih.gov/search/searchview.taf?ipid=93621
3,BC005093-38,"October 01, 2015 -  September 30, 2016",Growth-Differentiation Factors in Organogenesis,Alan O Perantoni; PhD,NULL,"Cancer and Developmental Biology Laboratory, NCI",Michael David Hall|Nirmala D Sharma|Michael Joseph Valdez|Kangsun  Yun|Susan  Mackem; MD,Harold  Lovvorn (Vanderbilt University)|Ryuichi  Nishnakamura (Kumamoto University - Institute of Molecular Embryology and Genetics),Terence P Yamaguchi; PhD (Cell Signaling in Vertebrate Development Section)|Mark B Lewandoski (Genetics of Vertebrate Development Section)|Nadya I Tarasova; PhD (Cancer Inflammation Program)|James  Lautenberger; PhD (Office of the Director)|George  Nelson (Office of the Director),NULL,"1. Tanigawa S, Sharma N, Hall MD, Nishinakamura R, Perantoni AO (2015). Preferential Propagation of Competent SIX2+ Nephronic Progenitors by LIF/ROCKi Treatment of the Metanephric Mesenchyme. Stem Cell Reports  5, 435-47.   https://doi.org/10.1016/j.stemcr.2015.07.015",https://intramural.nih.gov/search/searchview.taf?ipid=93622
4,BC005177-36,"October 01, 2015 -  September 30, 2016",Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA,Miriam Christine Poirier; PhD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",NULL,Daniel  Martineau (University of Montreal at St. Hyacinthe)|John  Wise,Qing  Lan (Occupational and Environmental Epidemiology Branch)|Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)|Daniel C Edelman (Cancer Genetics Branch),Esther Jo Asaki (CIT),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93624
5,BC005268-29,"October 01, 2015 -  September 30, 2016",Mechanism of Meiotic Recombination,Michael Joseph Lichten; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Jasvinder  Singh; PhD|Hardeep  Kaur; PhD|Seyoun  Kim|Darpan Kaustuv Medhi|John Paul Tsu Ouyang,NULL,NULL,NULL,"1. Kaur H, De Muyt A, Lichten M (2015). Top3-Rmi1 DNA single-strand decatenase is integral to the formation and resolution of meiotic recombination intermediates. Mol Cell  57, 583-594.   https://doi.org/10.1016/j.molcel.2015.01.020|2. Lichten M (2015). Molecular biology. Putting the breaks on meiosis. Science  350, 913.   https://doi.org/10.1126/science.aad5404",https://intramural.nih.gov/search/searchview.taf?ipid=93626
6,BC005270-35,"October 01, 2015 -  September 30, 2016",Molecular Mechanism of Action of Phorbol Ester,Peter  Blumberg; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Adelle  Abramovitz|Agnes  Czikora|Brienna Kyle Alwell Herold|Noemi  Kedei|Jessica S Kelsey|Larry V Pearce|Show all 12,"James  Stone (Dept. of Cardiology, University of Alberta)|Chaya  Brodie (Henry Ford Hospital)|Gary  Keck (Dept. of Chemistry, University of Utah)|Daniel J Lundberg|Marie  Comin (National Institute of Industrial Technology)|Jeewoo  Lee (Seoul National Univeristy)|Show all 14",Victor  Marquez; PhD (Chemical Biology Laboratory)|Megan L Peach (Chemical Biology Laboratory)|Lisa Marie Jenkins (Pigment Cell Biology Section),Kenton J Swartz; PhD (NINDS),"1. Ann J, Jung A, Kim MY, Kim HM, Ryu H, Kim S, Kang DW, Hong S, Cui M, Choi S, Blumberg PM, Frank-Foltyn R, Bahrenberg G, Stockhausen H, Christoph T, Lee J (2015). Structure activity relationships of benzyl C-region analogs of 2-(3-fluoro-4-methylsulfonamidophenyl)propanamides as potent TRPV1 antagonists. Bioorg Med Chem  23, 6844-54.   https://doi.org/10.1016/j.bmc.2015.10.001|2. Ann J, Yoon S, Baek J, Kim DH, Lewin NE, Hill CS, Blumberg PM, Lee J (2015). Design and synthesis of protein kinase C epsilon selective diacylglycerol lactones (DAG-lactones). Eur J Med Chem  90, 332-41.   https://doi.org/10.1016/j.ejmech.2014.11.025|3. Blumberg PM (2015). To not be hot when TRPV1 is not. Temperature (Austin)  2, 166-7.   https://doi.org/10.1080/23328940.2015.1048045|4. Czifra G, Szöllősi A, Nagy Z, Boros M, Juhász I, Kiss A, Erdődi F, Szabó T, Kovács I, Török M, Kovács L, Blumberg PM, Bíró T (2015). Protein kinase Cδ promotes proliferation and induces malignant transformation in skeletal muscle. J Cell Mol Med  19, 396-407.   https://doi.org/10.1111/jcmm.12452|5. Feng Z, Pearce LV, Xu X, Yang X, Yang P, Blumberg PM, Xie XQ (2015). Structural insight into tetrameric hTRPV1 from homology modeling, molecular docking, molecular dynamics simulation, virtual screening, and bioassay validations. J Chem Inf Model  55, 572-88.   https://doi.org/10.1021/ci5007189|6. Kedei N, Kraft MB, Keck GE, Herald CL, Melody N, Pettit GR, Blumberg PM (2015). Neristatin 1 provides critical insight into bryostatin 1 structure-function relationships. J Nat Prod  78, 896-900.   https://doi.org/10.1021/acs.jnatprod.5b00094|7. Lee HK, Finniss S, Cazacu S, Xiang C, Poisson LM, Blumberg PM, Brodie C (2015). RasGRP3 regulates the migration of glioma cells via interaction with Arp3. Oncotarget  6, 1850-64.   https://doi.org/10.18632/oncotarget.2575|8. Ryu H, Seo S, Lee JY, Ha TH, Lee S, Jung A, Ann J, Kim SE, Yoon S, Hong M, Blumberg PM, Frank-Foltyn R, Bahrenberg G, Schiene K, Stockhausen H, Christoph T, Frormann S, Lee J (2015). Pyridine C-region analogs of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonists. Eur J Med Chem  93, 101-8.   https://doi.org/10.1016/j.ejmech.2015.02.001|9. Tran PT, Kim HS, Ann J, Kim SE, Kim C, Hong M, Hoang VH, Ngo VT, Hong S, Cui M, Choi S, Blumberg PM, Frank-Foltyn R, Bahrenberg G, Stockhausen H, Christoph T, Lee J (2015). α-Substituted 2-(3-fluoro-4-methylsulfonamidophenyl)acetamides as potent TRPV1 antagonists. Bioorg Med Chem Lett  25, 2326-30.   https://doi.org/10.1016/j.bmcl.2015.04.024",https://intramural.nih.gov/search/searchview.taf?ipid=93627
7,BC005271-25,"October 01, 2015 -  September 30, 2016",Gene Regulation and Function: The B-ZIP Proteins,Charles  Vinson; PhD|IRP Faculty Profile,NULL,"Nucleic Acids Section, NCI",NULL,Tim  Hughes (University of Toronto)|Matthew T Weirauch (University of Toronto)|John  Stamatoyannopoulos (University of Washington)|Andrew  Smith (University of Southern California)|Jussi  Taipale (Karolinska Institute),Frank Jess Gonzalez; PhD (Laboratory of Metabolism)|Shioko  Kimura; PhD (Endocrinology Section)|Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|Michael  Bustin; PhD (Protein Section)|Peter C Fitzgerald (Office of the Director),Ann  Dean; PhD (NIDDK) |Kai  Ge; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93628
8,BC005445-32,"October 01, 2015 -  September 30, 2016",Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer,Stuart H Yuspa; MD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Heba Khair Al Khamici|Elise Suzanne Fraser|Joanna  Anders|Brandi Lynn Carofino; PhD|Christophe  Cataisson|Luowei  Li|Show all 7,NULL,Giorgio  Trinchieri (Cancer Inflammation Program)|Christina M Annunziata (Womens Malignancies Branch)|Rosandra N Kaplan (Pediatric Oncology Branch),Maria Irene Morasso; PhD (NIAMS) |Wendy  Weinberg (OD),"1. Mascia F, Schloemann D, Cataisson C, McKinnon K, Krymskaya L, Wolcott K, Yuspa S (2016) Cell autonomous or systemic EGFR blockade alters the immune-environment in squamous cell carcinomas. International Journal of Cancer, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=93629
9,BC005450-33,"October 01, 2015 -  September 30, 2016",Chromatin Structure and Gene Expression,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Songjoon  Baek|Miroslav  Dundr|Saori  Fujiwara|Ido  Goldstein; PhD|Mary  Hawkins|Thomas A Johnson|Show all 13,Susanne  Mandrup (University of Southern Denmark)|Dan  Theodorescu (University of Colorado)|Lars  Grontved,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Sheueyann  Cheng; PhD (Gene Regulation Section)|Michael L Nickerson (Laboratory Translational Genomics)|Peter A Pinto; MD (Urologic Oncology Branch)|Peter L Choyke; MD (Molecular Imaging Program)","Rafael Cristian Casellas; PhD (NIAMS) |Jay H Chung; MD, PhD (NHLBI) |David Johannes Clark; PhD (NICHD)","1. Goldstein I, Hager GL (2015). Transcriptional and Chromatin Regulation during Fasting - The Genomic Era. Trends Endocrinol Metab  26, 699-710.   https://doi.org/10.1016/j.tem.2015.09.005|2. Grøntved L, Waterfall JJ, Kim DW, Baek S, Sung MH, Zhao L, Park JW, Nielsen R, Walker RL, Zhu YJ, Meltzer PS, Hager GL, Cheng SY (2015). Transcriptional activation by the thyroid hormone receptor through ligand-dependent receptor recruitment and chromatin remodelling. Nat Commun  6, 7048.   https://doi.org/10.1038/ncomms8048|3. Sawyer I, Hager G, Dundr M (2016) Cajal bodies influence genome conformation. RNA Biology, in press.|4. Sawyer I, Sturgill D, Sung M, Hager G, Dundr M (2016) Understanding the role of nuclear bodies in genome organization and function. Bioessays, in press.|5. Sung MH, Baek S, Hager GL (2016). Genome-wide footprinting: ready for prime time? Nat Methods  13, 222-228.   https://doi.org/10.1038/nmeth.3766|6. Swinstead E, Presman D, Paakinaho V, Hager G (2016) The dynamics of chromatin programming. Bioessays, in press.|7. Swinstead EE, Miranda TB, Paakinaho V, Baek S, Goldstein I, Hawkins M, Karpova TS, Ball D, Mazza D, Lavis LD, Grimm JB, Morisaki T, Grøntved L, Presman DM, Hager GL (2016). Steroid Receptors Reprogram FoxA1 Occupancy through Dynamic Chromatin Transitions. Cell  165, 593-605.   https://doi.org/10.1016/j.cell.2016.02.067|8. Tesikova M, Dezitter X, Nenseth HZ, Klokk TI, Mueller F, Hager GL, Saatcioglu F (2016). Divergent Binding and Transactivation by Two Related Steroid Receptors at the Same Response Element. J Biol Chem  291, 11899-910.   https://doi.org/10.1074/jbc.M115.684480|9. Thompson B, Varticovski L, Baek S, Hager GL (2016). Genome-Wide Chromatin Landscape Transitions Identify Novel Pathways in Early Commitment to Osteoblast Differentiation. PLoS One  11, e0148619.   https://doi.org/10.1371/journal.pone.0148619",https://intramural.nih.gov/search/searchview.taf?ipid=93630
10,BC005522-29,"October 01, 2015 -  September 30, 2016",Thyroid Stem-Progenitor Cells,Shioko  Kimura; PhD|IRP Faculty Profile,NULL,"Endocrinology Section, NCI",Manabu  Iwadate|Yoshinori  Takizawa|Shigetoshi  Yokoyama,NULL,"Sheueyann  Cheng; PhD (Gene Regulation Section)|Snorri S. Thorgeirsson; MD, PhD (Laboratory of Human Carcinogenesis)","Jerrold M Ward; DVM, PhD (NIAID)","1. Hayase S, Sasaki Y, Matsubara T, Seo D, Miyakoshi M, Murata T, Ozaki T, Kakudo K, Kumamoto K, Ylaya K, Cheng SY, Thorgeirsson SS, Hewitt SM, Ward JM, Kimura S (2015). Expression of stanniocalcin 1 in thyroid side population cells and thyroid cancer cells. Thyroid  25, 425-36.   https://doi.org/10.1089/thy.2014.0464|2. Zou M, Baitei EY, Al-Rijjal RA, Parhar RS, Al-Mohanna FA, Kimura S, Pritchard C, BinEssa H, Alanazi AA, Alzahrani AS, Akhtar M, Assiri AM, Meyer BF, Shi Y (2015). KRAS(G12D)-mediated oncogenic transformation of thyroid follicular cells requires long-term TSH stimulation and is regulated by SPRY1. Lab Invest  95, 1269-77.   https://doi.org/10.1038/labinvest.2015.90",https://intramural.nih.gov/search/searchview.taf?ipid=93631
11,BC005562-29,"October 01, 2015 -  September 30, 2016",Xenobiotic receptors,Frank Jess Gonzalez; PhD|IRP Faculty Profile,NULL,"Laboratory of Metabolism, NCI",NULL,"Jeffrey  Peters (NCI)|Toshifumi  Aoyama (Department of Metabolic Regulation, Shinshu University, Institute on Aging and Adaptation)|Jeffrey  Idle (University of Bern)|Andrew  Patterson (Pennsylvania State University)|Yatrik  Shah|Kalipada  Pahan; PhD (Department of Neurological Sciences, Rush University Medical Center)|Show all 12",Curtis  Harris; MD (Laboratory of Human Carcinogenesis),"Oksana  Gavrilova; PhD (NIDDK) |Bin  Gao; MD, PhD (NIAAA)","1. Cicchini C, de Nonno V, Battistelli C, Cozzolino AM, De Santis Puzzonia M, Ciafrè SA, Brocker C, Gonzalez FJ, Amicone L, Tripodi M (2015). Epigenetic control of EMT/MET dynamics: HNF4α impacts DNMT3s through miRs-29. Biochim Biophys Acta  1849, 919-29.   https://doi.org/10.1016/j.bbagrm.2015.05.005|2. Contreras AV, Rangel-Escareño C, Torres N, Alemán-Escondrillas G, Ortiz V, Noriega LG, Torre-Villalvazo I, Granados O, Velázquez-Villegas LA, Tobon-Cornejo S, González-Hirschfeld D, Recillas-Targa F, Tejero-Barrera E, Gonzalez FJ, Tovar AR (2015). PPARα via HNF4α regulates the expression of genes encoding hepatic amino acid catabolizing enzymes to maintain metabolic homeostasis. Genes Nutr  10, 452.   https://doi.org/10.1007/s12263-014-0452-0|3. Corbett GT, Gonzalez FJ, Pahan K (2015). Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP. Proc Natl Acad Sci U S A  112, 8445-50.   https://doi.org/10.1073/pnas.1504890112|4. Elentner A, Ortner D, Clausen B, Gonzalez FJ, Fernández-Salguero PM, Schmuth M, Dubrac S (2015). Skin response to a carcinogen involves the xenobiotic receptor pregnane X receptor. Exp Dermatol  24, 835-40.   https://doi.org/10.1111/exd.12766|5. Ghosh A, Jana M, Modi K, Gonzalez FJ, Sims KB, Berry-Kravis E, Pahan K (2015). Activation of peroxisome proliferator-activated receptor α induces lysosomal biogenesis in brain cells: implications for lysosomal storage disorders. J Biol Chem  290, 10309-24.   https://doi.org/10.1074/jbc.M114.610659|6. Gonzalez FJ, Jiang C, Bisson WH, Patterson AD (2015). Inhibition of farnesoid X receptor signaling shows beneficial effects in human obesity. J Hepatol  62, 1234-6.   https://doi.org/10.1016/j.jhep.2015.02.043|7. Gu X, Song Y, Chai Y, Lu F, Gonzalez FJ, Fan G, Qi Y (2015). GC-MS metabolomics on PPARα-dependent exacerbation of colitis. Mol Biosyst  11, 1329-37.   https://doi.org/10.1039/c5mb00048c|8. Jiang C, Xie C, Li F, Zhang L, Nichols RG, Krausz KW, Cai J, Qi Y, Fang ZZ, Takahashi S, Tanaka N, Desai D, Amin SG, Albert I, Patterson AD, Gonzalez FJ (2015). Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease. J Clin Invest  125, 386-402.   https://doi.org/10.1172/JCI76738|9. Komatsu M, Kimura T, Yazaki M, Tanaka N, Yang Y, Nakajima T, Horiuchi A, Fang ZZ, Joshita S, Matsumoto A, Umemura T, Tanaka E, Gonzalez FJ, Ikeda S, Aoyama T (2015). Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPARα. Biochim Biophys Acta  1852, 473-81.   https://doi.org/10.1016/j.bbadis.2014.12.011|10. Liu HX, Hu Y, French SW, Gonzalez FJ, Wan YJ (2015). Forced expression of fibroblast growth factor 21 reverses the sustained impairment of liver regeneration in hPPARα(PAC) mice due to dysregulated bile acid synthesis. Oncotarget  6, 9686-700.   https://doi.org/10.18632/oncotarget.3531|11. Liu X, Cao YF, Ran RX, Dong PP, Gonzalez FJ, Wu X, Huang T, Chen JX, Fu ZW, Li RS, Liu YZ, Sun HZ, Fang ZZ (2016). New insights into the risk of phthalates: Inhibition of UDP-glucuronosyltransferases. Chemosphere  144, 1966-72.   https://doi.org/10.1016/j.chemosphere.2015.10.076|12. Matsuo S, Ogawa M, Muckenthaler MU, Mizui Y, Sasaki S, Fujimura T, Takizawa M, Ariga N, Ozaki H, Sakaguchi M, Gonzalez FJ, Inoue Y (2015). Hepatocyte Nuclear Factor 4α Controls Iron Metabolism and Regulates Transferrin Receptor 2 in Mouse Liver. J Biol Chem  290, 30855-65.   https://doi.org/10.1074/jbc.M115.694414|13. Nagaya T, Tanaka N, Kimura T, Kitabatake H, Fujimori N, Komatsu M, Horiuchi A, Yamaura T, Umemura T, Sano K, Gonzalez FJ, Aoyama T, Tanaka E (2015). Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy. BBA Clin  3, 168-74.   https://doi.org/10.1016/j.bbacli.2015.02.001|14. Peters JM, Gonzalez FJ, Müller R (2015). Establishing the Role of PPARβ/δ in Carcinogenesis. Trends Endocrinol Metab  26, 595-607.   https://doi.org/10.1016/j.tem.2015.09.004|15. Peters JM, Yao PL, Gonzalez FJ (2015). Targeting Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ) for Cancer Chemoprevention. Curr Pharmacol Rep  1, 121-128.   https://doi.org/10.1007/s40495-015-0026-x|16. Pillai R, Paglialunga S, Hoang M, Cousteils K, Prentice KJ, Bombardier E, Huang M, Gonzalez FJ, Tupling AR, Wheeler MB, Joseph JW (2015). Deletion of ARNT/HIF1β in pancreatic beta cells does not impair glucose homeostasis in mice, but is associated with defective glucose sensing ex vivo. Diabetologia  58, 2832-42.   https://doi.org/10.1007/s00125-015-3768-4|17. Pingili AK, Kara M, Khan NS, Estes AM, Lin Z, Li W, Gonzalez FJ, Malik KU (2015). 6β-hydroxytestosterone, a cytochrome P450 1B1 metabolite of testosterone, contributes to angiotensin II-induced hypertension and its pathogenesis in male mice. Hypertension  65, 1279-87.   https://doi.org/10.1161/HYPERTENSIONAHA.115.05396|18. Roy A, Jana M, Kundu M, Corbett GT, Rangaswamy SB, Mishra RK, Luan CH, Gonzalez FJ, Pahan K (2015). HMG-CoA Reductase Inhibitors Bind to PPARα to Upregulate Neurotrophin Expression in the Brain and Improve Memory in Mice. Cell Metab  22, 253-65.   https://doi.org/10.1016/j.cmet.2015.05.022|19. Spruiell K, Gyamfi AA, Yeyeodu ST, Richardson RM, Gonzalez FJ, Gyamfi MA (2015). Pregnane X Receptor-Humanized Mice Recapitulate Gender Differences in Ethanol Metabolism but Not Hepatotoxicity. J Pharmacol Exp Ther  354, 459-70.   https://doi.org/10.1124/jpet.115.224295|20. Tanaka N, Takahashi S, Matsubara T, Jiang C, Sakamoto W, Chanturiya T, Teng R, Gavrilova O, Gonzalez FJ (2015). Adipocyte-specific disruption of fat-specific protein 27 causes hepatosteatosis and insulin resistance in high-fat diet-fed mice. J Biol Chem  290, 3092-105.   https://doi.org/10.1074/jbc.M114.605980|21. Tanaka N, Takahashi S, Zhang Y, Krausz KW, Smith PB, Patterson AD, Gonzalez FJ (2015). Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet. Biochim Biophys Acta  1852, 1242-52.   https://doi.org/10.1016/j.bbadis.2015.02.012|22. Wang R, Gu X, Dai W, Ye J, Lu F, Chai Y, Fan G, Gonzalez FJ, Duan G, Qi Y (2016). A lipidomics investigation into the intervention of celastrol in experimental colitis. Mol Biosyst  12, 1436-44.   https://doi.org/10.1039/c5mb00864f|23. Yanagiba Y, Suzuki T, Suda M, Hojo R, Gonzalez FJ, Nakajima T, Wang RS (2016). Cytochrome P450 2E1 is responsible for the initiation of 1,2-dichloropropane-induced liver damage. Toxicol Ind Health  32, 1589-97.   https://doi.org/10.1177/0748233714568801|24. Yao PL, Chen L, Hess RA, Müller R, Gonzalez FJ, Peters JM (2015). Peroxisome Proliferator-activated Receptor-D (PPARD) Coordinates Mouse Spermatogenesis by Modulating Extracellular Signal-regulated Kinase (ERK)-dependent Signaling. J Biol Chem  290, 23416-31.   https://doi.org/10.1074/jbc.M115.664508|25. Yao PL, Chen LP, Dobrzański TP, Phillips DA, Zhu B, Kang BH, Gonzalez FJ, Peters JM (2015). Inhibition of testicular embryonal carcinoma cell tumorigenicity by peroxisome proliferator-activated receptor-β/δ- and retinoic acid receptor-dependent mechanisms. Oncotarget  6, 36319-37.   https://doi.org/10.18632/oncotarget.5415|26. Yu T, Wang Y, Zhang H, Johnson CH, Jiang Y, Li X, Wu Z, Liu T, Krausz KW, Yu A, Gonzalez FJ, Huang M, Bi H (2016). Metabolomics reveals mycoplasma contamination interferes with the metabolism of PANC-1 cells. Anal Bioanal Chem  408, 4267-73.   https://doi.org/10.1007/s00216-016-9525-9|27. Zhang L, Nichols RG, Correll J, Murray IA, Tanaka N, Smith PB, Hubbard TD, Sebastian A, Albert I, Hatzakis E, Gonzalez FJ, Perdew GH, Patterson AD (2015). Persistent Organic Pollutants Modify Gut Microbiota-Host Metabolic Homeostasis in Mice Through Aryl Hydrocarbon Receptor Activation. Environ Health Perspect  123, 679-88.   https://doi.org/10.1289/ehp.1409055",https://intramural.nih.gov/search/searchview.taf?ipid=93632
12,BC005597-27,"October 01, 2015 -  September 30, 2016",Biochemistry of Energy-Dependent (Intracellular) Protein Degradation,Michael  Maurizi; PhD|IRP Faculty Profile,NULL,"Biochemistry of Proteins Section, NCI",NULL,"Carolyn  Suzuki (Biochemistry and Molecular Biology, University of Medicine and Dentistry of New Jersey)|Sung Gyun Kang; PhD|Joaquin  Ortega (McMaster University Health Sciences Centre)|Anuradha  Janakiraman (The City College of CUNY)|Alfred  Goldberg (Department Cell Biology, Harvard University Medical School)",NULL,Grzegorz  Piszczek; PhD (NHLBI),"1. Zhang Y, Maurizi MR (2016). Mitochondrial ClpP activity is required for cisplatin resistance in human cells. Biochim Biophys Acta  1862, 252-64.   https://doi.org/10.1016/j.bbadis.2015.12.005",https://intramural.nih.gov/search/searchview.taf?ipid=93633
13,BC005598-27,"October 01, 2015 -  September 30, 2016",Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells,Michael Marc Gottesman; MD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Carol O Cardarelli|Dominique H Cossari|Lyn Ann J Mickley|Hanna Alexandrovna Kozlowski|Orit  Lavi; PhD|Doron  Levy; PhD|Show all 10,NULL,"Di S Xia; PhD, MS, BS (Crystallography Section)|Suresh V Ambudkar; PhD (Transport Biochemistry Section)",Robert  Innis; MD (NIMH),"1. Basseville A, Hall M, Chau C, Robey R, Gottesman M, Figg W, Bates S (2016) The ABCG2 multidrug transporter, in ABC Transporters - 40 Years On. , pp. 195-226.|2. Fung K, Hunt R, KimchiSarfaty C, Gottesman M (2016) Genetic polymorphisms of P glycoprotein:  echoes of silence, in ABC Transporters - 40 Years On. , pp. 105-134.|3. Gottesman MM, Pastan IH (2015). The Role of Multidrug Resistance Efflux Pumps in Cancer: Revisiting a JNCI Publication Exploring Expression of the MDR1 (P-glycoprotein) Gene. J Natl Cancer Inst  107.   https://doi.org/10.1093/jnci/djv222|4. Greene JM, Levy D, Herrada SP, Gottesman MM, Lavi O (2016). Mathematical Modeling Reveals That Changes to Local Cell Density Dynamically Modulate Baseline Variations in Cell Growth and Drug Response. Cancer Res  76, 2882-90.   https://doi.org/10.1158/0008-5472.CAN-15-3232|5. Kumar JS, Miller Jenkins LM, Gottesman MM, Hall MD (2016). The Drug Excipient Cyclodextrin Interacts With d-Luciferin and Interferes With Bioluminescence Imaging. Mol Imaging  15.   https://doi.org/10.1177/1536012115625225|6. Pluchino KM, Esposito D, Moen JK, Hall MD, Madigan JP, Shukla S, Procter LV, Wall VE, Schneider TD, Pringle I, Ambudkar SV, Gill DR, Hyde SC, Gottesman MM (2015). Identification of a Cryptic Bacterial Promoter in Mouse (mdr1a) P-Glycoprotein cDNA. PLoS One  10, e0136396.   https://doi.org/10.1371/journal.pone.0136396|7. Pluchino KM, Hall MD, Moen JK, Chufan EE, Fetsch PA, Shukla S, Gill DR, Hyde SC, Xia D, Ambudkar SV, Gottesman MM (2016). Human-Mouse Chimeras with Normal Expression and Function Reveal That Major Domain Swapping Is Tolerated by P-Glycoprotein (ABCB1). Biochemistry  55, 1010-23.   https://doi.org/10.1021/acs.biochem.5b01064|8. Souza PS, Madigan JP, Gillet JP, Kapoor K, Ambudkar SV, Maia RC, Gottesman MM, Fung KL (2015). Expression of the multidrug transporter P-glycoprotein is inversely related to that of apoptosis-associated endogenous TRAIL. Exp Cell Res  336, 318-28.   https://doi.org/10.1016/j.yexcr.2015.06.005|9. Weidner LD, Zoghbi SS, Lu S, Shukla S, Ambudkar SV, Pike VW, Mulder J, Gottesman MM, Innis RB, Hall MD (2015). The Inhibitor Ko143 Is Not Specific for ABCG2. J Pharmacol Exp Ther  354, 384-93.   https://doi.org/10.1124/jpet.115.225482|10. Zheng M, Zhang H, Dill DL, Clark JD, Tu S, Yablonovitch AL, Tan MH, Zhang R, Rujescu D, Wu M, Tessarollo L, Vieira W, Gottesman MM, Deng S, Eberlin LS, Zare RN, Billard JM, Gillet JP, Li JB, Peltz G (2015). The role of Abcb5 alleles in susceptibility to haloperidol-induced toxicity in mice and humans. PLoS Med  12, e1001782.   https://doi.org/10.1371/journal.pmed.1001782",https://intramural.nih.gov/search/searchview.taf?ipid=93634
14,BC005599-26,"October 01, 2015 -  September 30, 2016","Tumor Suppressor Protein, p53",Ettore  Appella; MD|IRP Faculty Profile,NULL,"Chemical Immunology Section, NCI",Subrata  Debnath; PhD|Yantenew  Gete|Sharlyn  Mazur; PhD|Harichandra Dnyaneshwar Tagad; PhD,NULL,Stewart  Durell (Laboratory of Cell Biology)|Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology),Frederick P Dyda; PhD (NIDDK),"1. Tong Q, Cui G, Botuyan MV, Rothbart SB, Hayashi R, Musselman CA, Singh N, Appella E, Strahl BD, Mer G, Kutateladze TG (2015). Structural plasticity of methyllysine recognition by the tandem tudor domain of 53BP1. Structure  23, 312-21.   https://doi.org/10.1016/j.str.2014.11.013|2. Tong Q, Mazur SJ, Rincon-Arano H, Rothbart SB, Kuznetsov DM, Cui G, Liu WH, Gete Y, Klein BJ, Jenkins L, Mer G, Kutateladze AG, Strahl BD, Groudine M, Appella E, Kutateladze TG (2015). An acetyl-methyl switch drives a conformational change in p53. Structure  23, 322-31.   https://doi.org/10.1016/j.str.2014.12.010|3. Zhang Z, Liu L, Gomez-Casal R, Wang X, Hayashi R, Appella E, Kopelovich L, DeLeo AB (2016). Targeting cancer stem cells with p53 modulators. Oncotarget  7, 45079-45093.   https://doi.org/10.18632/oncotarget.8650",https://intramural.nih.gov/search/searchview.taf?ipid=93635
15,BC005645-27,"October 01, 2015 -  September 30, 2016",T-cell Transformation by Oncoviruses,Genoveffa  Franchini; MD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",NULL,"Vincenzo  Ciminale (Department of Oncology and Surgical Sciences, University of Padova)|Christophe  Nicot (-, University of Kansas Medical Center)",NULL,Steven J Jacobson; PhD (NINDS) |Klaus  Strebel; PhD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93636
16,BC005708-25,"October 01, 2015 -  September 30, 2016","Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers",Frank Jess Gonzalez; PhD|IRP Faculty Profile,NULL,"Laboratory of Metabolism, NCI",NULL,"Jeffrey  Peters (NCI)|Toshifumi  Aoyama (Department of Metabolic Regulation, Shinshu University, Institute on Aging and Adaptation)|Jeffrey  Idle (University of Bern)|Andrew  Patterson (Pennsylvania State University)|Yatrik  Shah|Kalipada  Pahan; PhD (Department of Neurological Sciences, Rush University Medical Center)|Show all 12",Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Electron  Kebebew; MD (Endocrine Oncology Branch)|Shioko  Kimura; PhD (Endocrinology Section)|James B Mitchell; PhD (Radiation Biology Branch),Oksana  Gavrilova; PhD (NIDDK),"1. Cao GY, Xu W, Yang XW, Gonzalez FJ, Li F (2015). New neolignans from the seeds of Myristica fragrans that inhibit nitric oxide production. Food Chem  173, 231-7.   https://doi.org/10.1016/j.foodchem.2014.09.170|2. Eldridge MA, Lerchner W, Saunders RC, Kaneko H, Krausz KW, Gonzalez FJ, Ji B, Higuchi M, Minamimoto T, Richmond BJ (2016). Chemogenetic disconnection of monkey orbitofrontal and rhinal cortex reversibly disrupts reward value. Nat Neurosci  19, 37-9.   https://doi.org/10.1038/nn.4192|3. Fan X, Chen P, Jiang Y, Wang Y, Tan H, Zeng H, Wang Y, Qu A, Gonzalez FJ, Huang M, Bi H (2015). Therapeutic efficacy of Wuzhi tablet (Schisandra sphenanthera Extract) on acetaminophen-induced hepatotoxicity through a mechanism distinct from N-acetylcysteine. Drug Metab Dispos  43, 317-24.   https://doi.org/10.1124/dmd.114.062067|4. Fang ZZ, Tosh DK, Tanaka N, Wang H, Krausz KW, O'Connor R, Jacobson KA, Gonzalez FJ (2015). Metabolic mapping of A3 adenosine receptor agonist MRS5980. Biochem Pharmacol  97, 215-23.   https://doi.org/10.1016/j.bcp.2015.07.007|5. Gu X, Song Y, Chai Y, Lu F, Gonzalez FJ, Fan G, Qi Y (2015). GC-MS metabolomics on PPARα-dependent exacerbation of colitis. Mol Biosyst  11, 1329-37.   https://doi.org/10.1039/c5mb00048c|6. Guo B, Fang Z, Yang L, Xiao L, Xia Y, Gonzalez FJ, Zhu L, Cao Y, Ge G, Yang L, Sun H (2015). Tissue and species differences in the glucuronidation of glabridin with UDP-glucuronosyltransferases. Chem Biol Interact  231, 90-7.   https://doi.org/10.1016/j.cbi.2015.03.001|7. Jennings BL, Moore JA, Pingili AK, Estes AM, Fang XR, Kanu A, Gonzalez FJ, Malik KU (2015). Disruption of the cytochrome P-450 1B1 gene exacerbates renal dysfunction and damage associated with angiotensin II-induced hypertension in female mice. Am J Physiol Renal Physiol  308, F981-92.   https://doi.org/10.1152/ajprenal.00597.2014|8. Jiang Y, Fan X, Wang Y, Chen P, Zeng H, Tan H, Gonzalez FJ, Huang M, Bi H (2015). Schisandrol B protects against acetaminophen-induced hepatotoxicity by inhibition of CYP-mediated bioactivation and regulation of liver regeneration. Toxicol Sci  143, 107-15.   https://doi.org/10.1093/toxsci/kfu216|9. Li F, Yang XW, Krausz KW, Nichols RG, Xu W, Patterson AD, Gonzalez FJ (2015). Modulation of colon cancer by nutmeg. J Proteome Res  14, 1937-46.   https://doi.org/10.1021/pr5013152|10. Mak TD, Tyburski JB, Krausz KW, Kalinich JF, Gonzalez FJ, Fornace AJ (2015). Exposure to ionizing radiation reveals global dose- and time-dependent changes in the urinary metabolome of rat. Metabolomics  11, 1082-1094.   https://doi.org/10.1007/s11306-014-0765-4|11. Manna SK, Golla S, Golla JP, Tanaka N, Cai Y, Takahashi S, Krausz KW, Matsubara T, Korboukh I, Gonzalez FJ (2015) St. Johns Wort Attenuates Colorectal Carcinogenesis in Mice through Suppression of Inflammatory Signaling. Cancer Prev Res (Phila) 8:786-95|12. Manna SK, Thompson MD, Gonzalez FJ (2015). Application of mass spectrometry-based metabolomics in identification of early noninvasive biomarkers of alcohol-induced liver disease using mouse model. Adv Exp Med Biol  815, 217-38.   https://doi.org/10.1007/978-3-319-09614-8_13|13. Song JH, Cui L, An LB, Li WT, Fang ZZ, Zhang YY, Dong PP, Wu X, Wang LX, Gonzalez FJ, Sun XY, Zhao DW (2015) Inhibition of UDP-Glucuronosyltransferases (UGTs) Activity by constituents of Schisandra chinensis. Phytother Res 29:1658-64|14. Teranishi Y, Matsubara T, Krausz KW, Le TT, Gonzalez FJ, Yoshizato K, Ikeda K, Kawada N (2015). Involvement of hepatic stellate cell cytoglobin in acute hepatocyte damage through the regulation of CYP2E1-mediated xenobiotic metabolism. Lab Invest  95, 515-24.   https://doi.org/10.1038/labinvest.2015.29|15. Wang L, Lingappan K, Jiang W, Couroucli XI, Welty SE, Shivanna B, Barrios R, Wang G, Firoze Khan M, Gonzalez FJ, Jackson Roberts L, Moorthy B (2015) Disruption of cytochrome P4501A2 in mice leads to increased susceptibility to hyperoxic lung injury. Free Radic Biol Med 82:147-59|16. Yanagiba Y, Suzuki T, Suda M, Hojo R, Gonzalez FJ, Nakajima T, Wang RS (2016). Cytochrome P450 2E1 is responsible for the initiation of 1,2-dichloropropane-induced liver damage. Toxicol Ind Health  32, 1589-97.   https://doi.org/10.1177/0748233714568801|17. Zhang L, Nichols RG, Correll J, Murray IA, Tanaka N, Smith PB, Hubbard TD, Sebastian A, Albert I, Hatzakis E, Gonzalez FJ, Perdew GH, Patterson AD (2015). Persistent Organic Pollutants Modify Gut Microbiota-Host Metabolic Homeostasis in Mice Through Aryl Hydrocarbon Receptor Activation. Environ Health Perspect  123, 679-88.   https://doi.org/10.1289/ehp.1409055",https://intramural.nih.gov/search/searchview.taf?ipid=93638
17,BC005740-24,"October 01, 2015 -  September 30, 2016",Transgenic Models for Breast Cancer,Jeffrey E Green; MD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Aleksandra M Michalowska|Lalage  Wakefield; PhD|Kent W Hunter; PhD,Alfonso  Calvo (University of Pamplona)|Tamaro  Hudson (Howard University),Dolph Lee Hatfield; PhD (Mouse Cancer Genetics Program)|Frank Jess Gonzalez; PhD (Laboratory of Metabolism)|Young S Kim (Nutritional Science Research Group),NULL,"1. Min DJ, He S, Green JE (2016). Birinapant (TL32711) Improves Responses to GEM/AZD7762 Combination Therapy in Triple-negative Breast Cancer Cell Lines. Anticancer Res  36, 2649-57.|2. Thompson MD, Grubbs CJ, Bode AM, Reid JM, McGovern R, Bernard PS, Stijleman IJ, Green JE, Bennett C, Juliana MM, Moeinpour F, Steele VE, Lubet RA (2015). Lack of effect of metformin on mammary carcinogenesis in nondiabetic rat and mouse models. Cancer Prev Res (Phila)  8, 231-9.   https://doi.org/10.1158/1940-6207.CAPR-14-0181-T",https://intramural.nih.gov/search/searchview.taf?ipid=93639
18,BC005785-22,"October 01, 2015 -  September 30, 2016",TGF-betas in breast cancer progression,Lalage  Wakefield; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Nellie  Moshkovich; BS|Binwu  Tang|Joshua Michaek Zent,Stanley  Podlasek (Johns Hopkins Pathology at Suburban Hospital)|John  Condeelis (Albert Einstein College of Medicine)|Maja  Oktay (Albert Einstein College of Medicine),Dominic  Esposito; PhD (Office Of The Director)|Curtis  Henrich (Molecular Targets Laboratory)|James  McMahon; PhD (Molecular Targets Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93640
19,BC005793-22,"October 01, 2015 -  September 30, 2016",Mechanism of viral hepatitis-mediated hepatocarcinogenesis,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI",Anuradha Samantha Budhu|Marshonna J Forgues,NULL,Curtis  Harris; MD (Laboratory of Human Carcinogenesis),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93641
20,BC006150-35,"October 01, 2015 -  September 30, 2016","DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs",Yves  Pommier; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Keli  Agama|Muthana  Al Abo|Michael Khodadad Azimi|Allison  Burrell|Tiffany L Heacock|Shar-Yin Naomi Huang|Show all 20,"Mark  Cushman (Medicinal Chemistry, Purdue University)|William  Gmeiner (PHARMACOLOGY, WAKE FOREST UNIVERSITY)|William  Jorgensen (CHEMISTRY, Yale University)|Christopher  Self (Provide Pharma)|Gary  Olson (Provid Pharma)|Yuk  Sham (University of Minnesota)|Show all 16","Robert  Shoemaker (Chemopreventive Agent Development Research Group)|Joseph E Tomaszewski (Office of the Director)|David S Waugh; PhD (Protein Engineering Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Beverly Ann Teicher (Molecular Pharmocology Branch)|Terrence R Burke; PhD (Chemical Biology Laboratory)","Christopher P Austin; AB, MD (NCATS) |Weidong  Wang; PhD (NIA)","1. Dillon LW, Kumar P, Shibata Y, Wang YH, Willcox S, Griffith JD, Pommier Y, Takeda S, Dutta A (2015). Production of Extrachromosomal MicroDNAs Is Linked to Mismatch Repair Pathways and Transcriptional Activity. Cell Rep  11, 1749-59.   https://doi.org/10.1016/j.celrep.2015.05.020|2. Hirota K, Yoshikiyo K, Guilbaud G, Tsurimoto T, Murai J, Tsuda M, Phillips LG, Narita T, Nishihara K, Kobayashi K, Yamada K, Nakamura J, Pommier Y, Lehmann A, Sale JE, Takeda S (2015). The POLD3 subunit of DNA polymerase δ can promote translesion synthesis independently of DNA polymerase ζ. Nucleic Acids Res  43, 1671-83.   https://doi.org/10.1093/nar/gkv023|3. Jandu H, Aluzaite K, Fogh L, Thrane SW, Noer JB, Proszek J, Do KN, Hansen SN, Damsgaard B, Nielsen SL, Stougaard M, Knudsen BR, Moreira J, Hamerlik P, Gajjar M, Smid M, Martens J, Foekens J, Pommier Y, Brünner N, Schrohl AS, Stenvang J (2016). Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines. BMC Cancer  16, 34.   https://doi.org/10.1186/s12885-016-2071-1|4. Jensen NF, Agama K, Roy A, Smith DH, Pfister TD, Rømer MU, Zhang HL, Doroshow JH, Knudsen BR, Stenvang J, Brünner N, Pommier Y (2016). Characterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutations. J Exp Clin Cancer Res  35, 56.   https://doi.org/10.1186/s13046-016-0335-x|5. Jossé R, Zhang YW, Giroux V, Ghosh AK, Luo J, Pommier Y (2015). Activation of RAF1 (c-RAF) by the Marine Alkaloid Lasonolide A Induces Rapid Premature Chromosome Condensation. Mar Drugs  13, 3625-39.   https://doi.org/10.3390/md13063625",https://intramural.nih.gov/search/searchview.taf?ipid=93643
21,BC006161-33,"October 01, 2015 -  September 30, 2016",DNA Topoisomerases as nuclear and mitochondrial targets of Anticancer Drugs,Yves  Pommier; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Keli  Agama|Muthana  Al Abo|Michael Khodadad Azimi|Andrea Simone Baechler|Allison  Burrell|Valentina  Factor|Show all 17,"Mark  Cushman (Medicinal Chemistry, Purdue University)|Takehiro  Yasukawa (University College of London)",Melinda  Hollingshead (Biological Testing Branch)|Joseph E Tomaszewski (Office of the Director),"Keir Cajal Neuman; BA, PhD (NHLBI)","1. Gmeiner WH, Gearhart PJ, Pommier Y, Nakamura J (2016). F10 cytotoxicity via topoisomerase I cleavage complex repair consistent with a unique mechanism for thymineless death. Future Oncol  12, 2183-8.   https://doi.org/10.2217/fon-2016-0127|2. Huang SY, Ghosh S, Pommier Y (2015). Topoisomerase I alone is sufficient to produce short DNA deletions and can also reverse nicks at ribonucleotide sites. J Biol Chem  290, 14068-76.   https://doi.org/10.1074/jbc.M115.653345|3. Jensen NF, Agama K, Roy A, Smith DH, Pfister TD, Rømer MU, Zhang HL, Doroshow JH, Knudsen BR, Stenvang J, Brünner N, Pommier Y (2016). Characterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutations. J Exp Clin Cancer Res  35, 56.   https://doi.org/10.1186/s13046-016-0335-x|4. Kummar S, Chen A, Gutierrez M, Pfister TD, Wang L, Redon C, Bonner WM, Yutzy W, Zhang Y, Kinders RJ, Ji J, Allen D, Covey JM, Eiseman JL, Holleran JL, Beumer JH, Rubinstein L, Collins J, Tomaszewski J, Parchment R, Pommier Y, Doroshow JH (2016). Clinical and pharmacologic evaluation of two dosing schedules of indotecan (LMP400), a novel indenoisoquinoline, in patients with advanced solid tumors. Cancer Chemother Pharmacol  78, 73-81.   https://doi.org/10.1007/s00280-016-2998-6|5. Seol Y, Zhang H, Agama K, Lorence N, Pommier Y, Neuman KC (2015). Single-Molecule Supercoil Relaxation Assay as a Screening Tool to Determine the Mechanism and Efficacy of Human Topoisomerase IB Inhibitors. Mol Cancer Ther  14, 2552-9.   https://doi.org/10.1158/1535-7163.MCT-15-0454|6. Shamanna RA, Lu H, Croteau DL, Arora A, Agarwal D, Ball G, Aleskandarany MA, Ellis IO, Pommier Y, Madhusudan S, Bohr VA (2016). Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer. Oncotarget  7, 13269-84.   https://doi.org/10.18632/oncotarget.7906|7. Yu LM, Zhang XR, Li XB, Yang Y, Wei HY, He XX, Gu LQ, Huang ZS, Pommier Y, An LK (2015). Synthesis and biological evaluation of 6-substituted indolizinoquinolinediones as catalytic DNA topoisomerase I inhibitors. Eur J Med Chem  101, 525-33.   https://doi.org/10.1016/j.ejmech.2015.07.007",https://intramural.nih.gov/search/searchview.taf?ipid=93644
22,BC006198-27,"October 01, 2015 -  September 30, 2016",Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents,Terrence R Burke; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",David Thomas Hymel; PhD|Trung Xuan Nguyen|Kohei  Tsuji|Xue Zhi  Zhao|James A Kelley; PhD,"Robert  Ulrich (Molecular Immunology, USAMRIID)|Michael  Yaffe (Massachusetts Institute of Technology)|Christoph  Rader; PhD",David S Waugh; PhD (Protein Engineering Section)|Kyung  Lee; PhD (Chemistry Section),NULL,"1. Jang J, Burke T, Hymel D (2016) Peptidomimetics targeting the polo-box of polo-like kinase 1. J Emerging Invest, in press.|2. Qian WJ, Burke TR (2015). Mitsunobu mischief: neighbor-directed histidine N(τ)-alkylation provides access to peptides containing selectively functionalized imidazolium heterocycles. Org Biomol Chem  13, 4221-5.   https://doi.org/10.1039/c5ob00171d|3. Walseng E, Nelson CG, Qi J, Nanna AR, Roush WR, Goswami RK, Sinha SC, Burke TR, Rader C (2016). Chemically Programmed Bispecific Antibodies in Diabody Format. J Biol Chem  291, 19661-73.   https://doi.org/10.1074/jbc.M116.745588",https://intramural.nih.gov/search/searchview.taf?ipid=93645
23,BC007333-25,"October 01, 2015 -  September 30, 2016",Pharmacology of HIV Viral DNA  Retroviral Integrases,Yves  Pommier; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Evgeny Anatolyevich Kiselev; PhD|Christophe R Marchand|Ann  Orr,"Roberto  Di Santo (Univerty of Roma ""La Sapienza"")|Yuk  Sham (University of Minnesota)|ZhengQuiang  Wang (University of Minnesota)|A. Jun  Komano (AIDS Research Center)|Peter  Cherepanov (Imperial College London)|Seth A Cohen",Stephen H Hughes; PhD (Retroviral Replication Laboratory)|Terrence R Burke; PhD (Chemical Biology Laboratory)|Xue Zhi  Zhao (Chemical Biology Laboratory),NULL,"1. Sari O, Roy V, Métifiot M, Marchand C, Pommier Y, Bourg S, Bonnet P, Schinazi RF, Agrofoglio LA (2015). Synthesis of dihydropyrimidine α,γ-diketobutanoic acid derivatives targeting HIV integrase. Eur J Med Chem  104, 127-38.   https://doi.org/10.1016/j.ejmech.2015.09.015",https://intramural.nih.gov/search/searchview.taf?ipid=93646
24,BC007363-22,"October 01, 2015 -  September 30, 2016",Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs,Terrence R Burke; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Hannah Louise Peters|Xue Zhi  Zhao,Peter  Cherepanov (Imperial College London)|Arnold  Edward (Rutgers University),Stephen H Hughes; PhD (Retroviral Replication Laboratory)|William D Figg; PharmD (Genitourinary Malignancies Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93647
25,BC007365-22,"October 01, 2015 -  September 30, 2016",Regulation of ADP-ribosylation factor,"Paul A Randazzo; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI","Sofia Alexandra Girald Berlingeri|Xiaoying  Jian; PhD|Ruibai  Luo|Neeladri Sekhar Roy; PhD|Roberto  Weigert; MSc Chemistry, PhD",Richard  Kahn (Emory University)|Elizabeth  Sztul (University of Alabama),"Ira  Daar; PhD (Cancer and Developmental Biology Laboratory)|Robert Andrew Byrd (Structural Biophysics Laboratory)|Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)|Di S Xia; PhD, MS, BS (Crystallography Section)|Marielle Elizabeth Yohe (Pediatric Oncology Branch)",J Silvio  Gutkind; PhD (NIDCR) |James  Gruschus; PhD (NHLBI) |James Robert Sellers; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93648
26,BC008382-33,"October 01, 2015 -  September 30, 2016",Computational Approaches for RNA StructureFunction Determination,Bruce Allen Shapiro; PhD|IRP Faculty Profile,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",Eckart  Bindewald|Noah Jacob Hoffman|Kazimierz Wojcieck Kasprzak|Hugo Murua Martinez; PhD|Johann Karl Borefka Miller|Rishabh  Sharan|Show all 7,"Anne  Simon (Cell Biology and Molecular Genetics, University of Maryland)|R  Padmanabhan (Department of Microbiology and Immunology, Geogetown University School of Medicine)|Hugo  Martinez (Consultant, SAIC)|Hanan  Samet (University of Maryland)|Jason  Wang (New Jersey Institute of Technology)|Jonathan  Dinman (University of Maryland)|Show all 8",Stuart F J Le Grice; PhD (Basic Research Laboratory)|Thomas A Misteli; PhD (Laboratory of Receptor Biology and Gene Expression)|Gisela Esta Sterneck; PhD (Laboratory of Cell and Developmental Signaling),NULL,"1. Shapiro BA, Le Grice SF (2016). Advances in RNA structure determination. Methods  103, 1-3.   https://doi.org/10.1016/j.ymeth.2016.06.006|2. Song Y, Hua L, Shapiro BA, Wang JT (2015). Effective alignment of RNA pseudoknot structures using partition function posterior log-odds scores. BMC Bioinformatics  16, 39.   https://doi.org/10.1186/s12859-015-0464-9",https://intramural.nih.gov/search/searchview.taf?ipid=93649
27,BC008710-39,"October 01, 2015 -  September 30, 2016",Molecular Chaperones and DNA Replication,Sue H Wickner; PhD|IRP Faculty Profile,NULL,"DNA Molecular Biology Section, NCI",Duyania M Cephas|Erin Elizabeth Doody|Shannon M Doyle|Joel R Hoskins|Andrea Nicole Kravats,NULL,Leonard  Neckers; PhD (Urologic Oncology Branch)|Susan  Gottesman; PhD (Biochemical Genetics Section),Daniel C Masison; PhD (NIDDK),"1. Doyle S, Kravats A, McKenney S (2016) Structure and mechanism of AAA+ chaperones, in Series in Structural Biology: Structure and action of Molecular Chaperones. , pp. 205-250.",https://intramural.nih.gov/search/searchview.taf?ipid=93615
28,BC008714-39,"October 01, 2015 -  September 30, 2016",Bacterial Functions Involved in Cell Growth Control,Susan  Gottesman; PhD|IRP Faculty Profile,NULL,"Biochemical Genetics Section, NCI",Jiandong  Chen|Francois  De Mets|Kumari  Kavita|Nadim  Majdalani|Ashley S Parker|Erin Ashley Wall,"Maude  Guillier|Sarah  Woodson (Department of Biophysics, Johns Hopkins University)|Evgeny  Nudler (New York University School of Medicine, HHMI)",NULL,"Gisela  Storz; PhD (NICHD) |Stephen H Leppla; PhD (NIAID) |Susan K Buchanan (NIDDK) |Karen Moore Frank; MD, PhD (CC) |Yasmine  Belkaid; PhD (NIAID)","1. Battesti A, Majdalani N, Gottesman S (2015). Stress sigma factor RpoS degradation and translation are sensitive to the state of central metabolism. Proc Natl Acad Sci U S A  112, 5159-64.   https://doi.org/10.1073/pnas.1504639112|2. Gottesman S, Storz G (2015). RNA reflections: converging on Hfq. RNA  21, 511-2.   https://doi.org/10.1261/rna.050047.115|3. Panja S, Santiago-Frangos A, Schu DJ, Gottesman S, Woodson SA (2015). Acidic Residues in the Hfq Chaperone Increase the Selectivity of sRNA Binding and Annealing. J Mol Biol  427, 3491-3500.   https://doi.org/10.1016/j.jmb.2015.07.010|4. Schu DJ, Zhang A, Gottesman S, Storz G (2015). Alternative Hfq-sRNA interaction modes dictate alternative mRNA recognition. EMBO J  34, 2557-73.   https://doi.org/10.15252/embj.201591569|5. Vrentas C, Ghirlando R, Keefer A, Hu Z, Tomczak A, Gittis AG, Murthi A, Garboczi DN, Gottesman S, Leppla SH (2015). Hfqs in Bacillus anthracis: Role of protein sequence variation in the structure and function of proteins in the Hfq family. Protein Sci  24, 1808-19.   https://doi.org/10.1002/pro.2773",https://intramural.nih.gov/search/searchview.taf?ipid=93650
29,BC008751-36,"October 01, 2015 -  September 30, 2016",Regulation of Gene Transcription,Sankar  Adhya; PhD|IRP Faculty Profile,NULL,"Developmental Genetics Section, NCI",NULL,Szabolcs  Semsey|Michal  Hammel (Lawrence Berkeley National Laboratory),Victor  Zhurkin; PhD (Laboratory of Cell Biology)|David  Levens; PhD (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93651
30,BC008752-36,"October 01, 2015 -  September 30, 2016",Thyroid Hormone Nuclear Receptors in Health and Disease,Sheueyann  Cheng; PhD|IRP Faculty Profile,NULL,"Gene Regulation Section, NCI",Cho Rong  Han|Minkyung  Kang|Sunmi  Park|Mark Cauthen Willingham|Li  Zhao|Xuguang  Zhu,"G.R.  Williams (Imperial College London, Imperial College London)|Anthony  Hollenberg (Harvard University)|Anneke  Alkemade (University of Amsterdam Medical Center)|James  Lechleiter (University of Texas Health Science Center at San Antonio)|Susan  Bonner-Weir (Harvard Medical School)|Gregory  Brent (VA Greater Los Angeles Healthcare System)|Show all 10","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)",Douglas  Forrest; PhD (NIDDK) |Yun-Bo  Shi; PhD (NICHD),"1. Park J, Cheng S (2015) Activation of PI3K by thyroid hormone nuclear receptors, in SH Domains: Structure, mechanism and application. , pp. 91-110.|2. Lee MH, Lee JU, Joung KH, Kim YK, Ryu MJ, Lee SE, Kim SJ, Chung HK, Choi MJ, Chang JY, Lee SH, Kweon GR, Kim HJ, Kim KS, Kim SM, Jo YS, Park J, Cheng SY, Shong M (2015). Thyroid dysfunction associated with follicular cell steatosis in obese male mice and humans. Endocrinology  156, 1181-93.   https://doi.org/10.1210/en.2014-1670|3. Park JW, Zhao L, Willingham M, Cheng SY (2015). Oncogenic mutations of thyroid hormone receptor β. Oncotarget  6, 8115-31.   https://doi.org/10.18632/oncotarget.3466|4. Zhu X, Kim DW, Zhao L, Willingham MC, Cheng SY (2016). SAHA-induced loss of tumor suppressor Pten gene promotes thyroid carcinogenesis in a mouse model. Endocr Relat Cancer  23, 521-33.   https://doi.org/10.1530/ERC-16-0103",https://intramural.nih.gov/search/searchview.taf?ipid=93652
31,BC008753-34,"October 01, 2015 -  September 30, 2016",Immunotoxin Therapy of Solid and Hematopoietic Tumors:  Preclinical Studies,Ira H Pastan; MD|IRP Faculty Profile,NULL,"Molecular Biology Section, NCI",Selamawit A Addissie|Richard A Beers|Tapan K Bera|Gilad  Kaplan|Emily Mertens King|Fred  Lee|Show all 16,"DARELL  BIGNER (Duke University Medical Center, Dept. of Pathology)|JOHN  SAMPSON (Div of Neurosurgery, Duke University Medical Center, Div. of Neurosurgery)|Satoshi  Nagata (Sanford Research/USD)|Ulrich  Brinkmann (NCI)|Taiji  Matsusaka (Tokyo Medical & Dental University)|Itai  Benhar (Tel Aviv University)|Show all 12","David J Fitzgerald; PhD (Biotherapy Section)|Byungkook  Lee; PhD (Laboratory of Molecular Biology)|Mitchell  Ho (Laboratory of Molecular Biology)|Oleg Y Chertov (Office Of The Director)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)",NULL,"1. Ali-Rahmani F, FitzGerald DJ, Martin S, Patel P, Prunotto M, Ormanoglu P, Thomas C, Pastan I (2016). Anticancer Effects of Mesothelin-Targeted Immunotoxin Therapy Are Regulated by Tyrosine Kinase DDR1. Cancer Res  76, 1560-8.   https://doi.org/10.1158/0008-5472.CAN-15-2401|2. Hollevoet K, Mason-Osann E, Müller F, Pastan I (2015). Methylation-associated partial down-regulation of mesothelin causes resistance to anti-mesothelin immunotoxins in a pancreatic cancer cell line. PLoS One  10, e0122462.   https://doi.org/10.1371/journal.pone.0122462|3. Lee JH, Kim H, Yao Z, Lee SJ, Szajek LP, Grasso L, Pastan I, Paik CH (2015). Tumor and organ uptake of (64)Cu-labeled MORAb-009 (amatuximab), an anti-mesothelin antibody, by PET imaging and biodistribution studies. Nucl Med Biol  42, 880-6.   https://doi.org/10.1016/j.nucmedbio.2015.07.008|4. Lindenberg L, Thomas A, Adler S, Mena E, Kurdziel K, Maltzman J, Wallin B, Hoffman K, Pastan I, Paik CH, Choyke P, Hassan R (2015). Safety and biodistribution of 111In-amatuximab in patients with mesothelin expressing cancers using single photon emission computed tomography-computed tomography (SPECT-CT) imaging. Oncotarget  6, 4496-504.   https://doi.org/10.18632/oncotarget.2883|5. Müller N, Michen S, Tietze S, Töpfer K, Schulte A, Lamszus K, Schmitz M, Schackert G, Pastan I, Temme A (2015). Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma. J Immunother  38, 197-210.   https://doi.org/10.1097/CJI.0000000000000082|6. Manning ML, Mason-Osann E, Onda M, Pastan I (2015). Bortezomib reduces pre-existing antibodies to recombinant immunotoxins in mice. J Immunol  194, 1695-701.   https://doi.org/10.4049/jimmunol.1402324|7. Mason-Osann E, Hollevoet K, Niederfellner G, Pastan I (2015). Quantification of recombinant immunotoxin delivery to solid tumors allows for direct comparison of in vivo and in vitro results. Sci Rep  5, 10832.   https://doi.org/10.1038/srep10832|8. Mazor R, Tai CH, Lee B, Pastan I (2015). Poor correlation between T-cell activation assays and HLA-DR binding prediction algorithms in an immunogenic fragment of Pseudomonas exotoxin A. J Immunol Methods  425, 10-20.   https://doi.org/10.1016/j.jim.2015.06.003|9. Mazor R, Zhang J, Xiang L, Addissie S, Awuah P, Beers R, Hassan R, Pastan I (2015). Recombinant Immunotoxin with T-cell Epitope Mutations That Greatly Reduce Immunogenicity for Treatment of Mesothelin-Expressing Tumors. Mol Cancer Ther  14, 2789-96.   https://doi.org/10.1158/1535-7163.MCT-15-0532|10. Pasetto M, Antignani A, Ormanoglu P, Buehler E, Guha R, Pastan I, Martin SE, FitzGerald DJ (2015). Whole-genome RNAi screen highlights components of the endoplasmic reticulum/Golgi as a source of resistance to immunotoxin-mediated cytotoxicity. Proc Natl Acad Sci U S A  112, E1135-42.   https://doi.org/10.1073/pnas.1501958112|11. Shah NN, Stevenson MS, Yuan CM, Richards K, Delbrook C, Kreitman RJ, Pastan I, Wayne AS (2015). Characterization of CD22 expression in acute lymphoblastic leukemia. Pediatr Blood Cancer  62, 964-9.   https://doi.org/10.1002/pbc.25410|12. Stahl S, da Silva Mateus Seidl AR, Ducret A, Kux van Geijtenbeek S, Michel S, Racek T, Birzele F, Haas AK, Rueger R, Gerg M, Niederfellner G, Pastan I, Brinkmann U (2015). Loss of diphthamide pre-activates NF-κB and death receptor pathways and renders MCF7 cells hypersensitive to tumor necrosis factor. Proc Natl Acad Sci U S A  112, 10732-7.   https://doi.org/10.1073/pnas.1512863112",https://intramural.nih.gov/search/searchview.taf?ipid=93653
32,BC008756-29,"October 01, 2015 -  September 30, 2016",Genetically Engineered Mouse Models to Study RTK Function in Melanoma,Glenn  Merlino; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Chi-Ping  Day|Kerrie Leanne Marie|Helen Thompson Michael|Eva Eugenia Perez Guijarro|Jennifer D Rieker|Yanlin  Yu,"Edward  De Fabo (GWU)|Hitoshi  Takagi (First Dept of Internal Medicien, Gunma University School of Medicine)|Thomas  Tuting (Dermatology, University of Bonn)|Dot  Bennett (St. George's Hospital Medical School)|Scott  Lowe (Cold Spring Harbor Laboratory)|Norman  Sharpless (University of North Carolina)|Show all 12","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Giorgio  Trinchieri (Cancer Inflammation Program)|Margaret Anne Tucker (Human Genetics Program)|Howard A Young; PhD (Cancer Inflammation Program)|Sean Richard Davis; MD, PhD (Cancer Genetics Branch)|Curtis  Henrich (Molecular Targets Laboratory)",Heinz  Arnheiter; MD (NINDS) |J Silvio  Gutkind; PhD (NIDCR) |William James Pavan; PhD (NHGRI),"1. Damsky W, Micevic G, Meeth K, Muthusamy V, Curley DP, Santhanakrishnan M, Erdelyi I, Platt JT, Huang L, Theodosakis N, Zaidi MR, Tighe S, Davies MA, Dankort D, McMahon M, Merlino G, Bardeesy N, Bosenberg M (2015). mTORC1 activation blocks BrafV600E-induced growth arrest but is insufficient for melanoma formation. Cancer Cell  27, 41-56.   https://doi.org/10.1016/j.ccell.2014.11.014|2. Farthing HM, Marie KL, Merlino G (2015). Buckle up! Transposon mutagenesis can differentiate melanoma drivers from their many passengers. Pigment Cell Melanoma Res  28, 646-7.   https://doi.org/10.1111/pcmr.12416|3. Merlino G, Herlyn M, Fisher DE, Bastian BC, Flaherty KT, Davies MA, Wargo JA, Curiel-Lewandrowski C, Weber MJ, Leachman SA, Soengas MS, McMahon M, Harbour JW, Swetter SM, Aplin AE, Atkins MB, Bosenberg MW, Dummer R, Gershenwald JE, Halpern AC, Herlyn D, Karakousis GC, Kirkwood JM, Krauthammer M, Lo RS, et al. [17 more authors] (2016). The state of melanoma: challenges and opportunities. Pigment Cell Melanoma Res  29, 404-16.   https://doi.org/10.1111/pcmr.12475|4. Shakhova O, Cheng P, Mishra PJ, Zingg D, Schaefer SM, Debbache J, Häusel J, Matter C, Guo T, Davis S, Meltzer P, Mihic-Probst D, Moch H, Wegner M, Merlino G, Levesque MP, Dummer R, Santoro R, Cinelli P, Sommer L (2015). Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma. PLoS Genet  11, e1004877.   https://doi.org/10.1371/journal.pgen.1004877",https://intramural.nih.gov/search/searchview.taf?ipid=93654
33,BC008757-29,"October 01, 2015 -  September 30, 2016",Bio-Therapies for the Treatment of Cancer,David J Fitzgerald; PhD|IRP Faculty Profile,NULL,"Biotherapy Section, NCI","Antonella  Antignani; BS, PhD|Max Robert Krause|Robert J Sarnovsky|Nathan C Simon",NULL,"Ira H Pastan; MD (Molecular Biology Section)|Peter C Fitzgerald (Office of the Director)|Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Mitchell  Ho (Laboratory of Molecular Biology)|Christine Campo Alewine (Laboratory of Molecular Biology)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)",Craig Joseph Thomas (NCATS) |Massimo Giulio Gadina; PhD (NIAMS),"1. Simon N, Fitzgerald D (2016) Immunotoxin Therapies for the Treatment of Epidermal Growth Factor Receptor-Dependent Cancers Toxins 8:137",https://intramural.nih.gov/search/searchview.taf?ipid=93655
34,BC008905-35,"October 01, 2015 -  September 30, 2016",Tumor gene expression in vitro and in vivo,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",NULL,Steven J Carr|Igor  Barsukov (University of Liverpool),NULL,NULL,"1. Grossman RL, Heath AP, Ferretti V, Varmus HE, Lowy DR, Kibbe WA, Staudt LM (2016). Toward a Shared Vision for Cancer Genomic Data. N Engl J Med  375, 1109-12.   https://doi.org/10.1056/NEJMp1607591|2. Lowy D, Singer D, DePinho R, Simon GC, Soon-Shiong P (2016). Cancer moonshot countdown. Nat Biotechnol  34, 596-9.   https://doi.org/10.1038/nbt.3616",https://intramural.nih.gov/search/searchview.taf?ipid=93656
35,BC009003-34,"October 01, 2015 -  September 30, 2016",The Role of Cripto in the Pathogenesis of Breast and Colon Cancer,David  Salomon; PhD,NULL,"Mouse Cancer Genetics Program, NCI",NULL,"Gabriella  Minchiotti (CNR, Institute of Genetics)|Masaharu  Seno (Biotechnology, Okayama University)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93657
36,BC009052-27,"October 01, 2015 -  September 30, 2016",Papillomavirus Virion Proteins and Vaccines,John  Schiller; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Carla Vanessa Correia Cerqueira|Nicolas  Cuburu; PhD|Patricia  Day; PhD|Ri Na Kim|Rhonda C Kines|Yuk Ying S Pang|Show all 7,Denise  Nardelli-Haefliger (Centre Hospitalier Universitaire Vaudois)|Richard  Roden (Johns Hopkins University)|Bryce  Chackerian (University of New Mexico)|Elisabet  de los Pinos (Aura Biosciences Inc.)|Ali  Salanti (University of Copenhagen)|Gert  Scheper (Crucell/Johnson&Johnson),Ligia  Pinto (Infection & Immunoepidemiology Branch)|Genoveffa  Franchini; MD (Vaccine Branch)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Aimee Rebecca Kreimer (Infection & Immunoepidemiology Branch),"Barney S Graham; MD, PhD (NIAID) |Jeffrey  Cohen; MD (NIAID) |Alan T Remaley; MD, PhD (NHLBI)","1. Çuburu N, Wang K, Goodman KN, Pang YY, Thompson CD, Lowy DR, Cohen JI, Schiller JT (2015). Topical herpes simplex virus 2 (HSV-2) vaccination with human papillomavirus vectors expressing gB/gD ectodomains induces genital-tissue-resident memory CD8+ T cells and reduces genital disease and viral shedding after HSV-2 challenge. J Virol  89, 83-96.   https://doi.org/10.1128/JVI.02380-14|2. Beachler DC, Kreimer AR, Schiffman M, Herrero R, Wacholder S, Rodriguez AC, Lowy DR, Porras C, Schiller JT, Quint W, Jimenez S, Safaeian M, Struijk L, Schussler J, Hildesheim A, Gonzalez P, Costa Rica HPV Vaccine Trial (CVT) Group (2016). Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection. J Natl Cancer Inst  108.   https://doi.org/10.1093/jnci/djv302|3. Cerqueira C, Pang YY, Day PM, Thompson CD, Buck CB, Lowy DR, Schiller JT (2016). A Cell-Free Assembly System for Generating Infectious Human Papillomavirus 16 Capsids Implicates a Size Discrimination Mechanism for Preferential Viral Genome Packaging. J Virol  90, 1096-107.   https://doi.org/10.1128/JVI.02497-15|4. Correia-Pinto JF, Csaba N, Schiller JT, Alonso MJ (2015). Chitosan-Poly (I:C)-PADRE Based Nanoparticles as Delivery Vehicles for Synthetic Peptide Vaccines. Vaccines (Basel)  3, 730-50.   https://doi.org/10.3390/vaccines3030730|5. Crossey E, Amar MJA, Sampson M, Peabody J, Schiller JT, Chackerian B, Remaley AT (2015). A cholesterol-lowering VLP vaccine that targets PCSK9. Vaccine  33, 5747-5755.   https://doi.org/10.1016/j.vaccine.2015.09.044|6. Day PM, Thompson CD, Lowy DR, Schiller JT (2015). The HPV16 and MusPV1 papillomaviruses initially interact with distinct host components on the basement membrane. Virology  481, 79-94.   https://doi.org/10.1016/j.virol.2015.02.021|7. Day PM, Thompson CD, Pang YY, Lowy DR, Schiller JT (2015). Involvement of Nucleophosmin (NPM1/B23) in Assembly of Infectious HPV16 Capsids. Papillomavirus Res  1, 74-89.   https://doi.org/10.1016/j.pvr.2015.06.005|8. Fernández-Romero JA, Deal C, Herold BC, Schiller J, Patton D, Zydowsky T, Romano J, Petro CD, Narasimhan M (2015). Multipurpose prevention technologies: the future of HIV and STI protection. Trends Microbiol  23, 429-436.   https://doi.org/10.1016/j.tim.2015.02.006|9. Gonzalez P, Hildesheim A, Herrero R, Katki H, Wacholder S, Porras C, Safaeian M, Jimenez S, Darragh TM, Cortes B, Befano B, Schiffman M, Carvajal L, Palefsky J, Schiller J, Ocampo R, Schussler J, Lowy D, Guillen D, Stoler MH, Quint W, Morales J, Avila C, Rodriguez AC, Kreimer AR, Costa Rica HPV Vaccine Trial (CVT) Group (2015). Rationale and design of a long term follow-up study of women who did and did not receive HPV 16/18 vaccination in Guanacaste, Costa Rica. Vaccine  33, 2141-51.   https://doi.org/10.1016/j.vaccine.2015.03.015|10. Hildesheim A, Gonzalez P, Kreimer AR, Wacholder S, Schussler J, Rodriguez AC, Porras C, Schiffman M, Sidawy M, Schiller JT, Lowy DR, Herrero R, Costa Rica HPV Vaccine Trial (CVT) Group (2016). Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment. Am J Obstet Gynecol  215, 212.e1-212.e15.   https://doi.org/10.1016/j.ajog.2016.02.021|11. Kines RC, Cerio RJ, Roberts JN, Thompson CD, de Los Pinos E, Lowy DR, Schiller JT (2016). Human papillomavirus capsids preferentially bind and infect tumor cells. Int J Cancer  138, 901-11.   https://doi.org/10.1002/ijc.29823|12. Kines RC, Zarnitsyn V, Johnson TR, Pang YY, Corbett KS, Nicewonger JD, Gangopadhyay A, Chen M, Liu J, Prausnitz MR, Schiller JT, Graham BS (2015). Vaccination with human papillomavirus pseudovirus-encapsidated plasmids targeted to skin using microneedles. PLoS One  10, e0120797.   https://doi.org/10.1371/journal.pone.0120797|13. Panagiotou OA, Befano BL, Gonzalez P, Rodríguez AC, Herrero R, Schiller JT, Kreimer AR, Schiffman M, Hildesheim A, Wilcox AJ, Wacholder S, Costa Rica HPV Vaccine Trial (CVT) Group (see end of manuscript for full list of investigators) (2015). Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial. BMJ  351, h4358.   https://doi.org/10.1136/bmj.h4358|14. Schiller JT, Lowy DR (2015). Raising expectations for subunit vaccine. J Infect Dis  211, 1373-5.   https://doi.org/10.1093/infdis/jiu648|15. Schiller JT, Lowy DR (2015). Reply to Nalin. J Infect Dis  212, 2021-2.   https://doi.org/10.1093/infdis/jiv394",https://intramural.nih.gov/search/searchview.taf?ipid=93658
37,BC009265-34,"October 01, 2015 -  September 30, 2016",Analysis of the T Cell Repertoire,Richard J Hodes; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Steven Edward Bowen|Luis Emanuel Rivera Hiraldo|Joy A Williams|Karen  Hathcock,"Ferenc  Livak (School of Medicine, University of Maryland)|Gail  Bishop (University of Iowa)|Yousuke  Takahama (Tokushima)",NULL,NULL,"1. Chiang YJ, Hodes RJ (2016). T-cell development is regulated by the coordinated function of proximal and distal Lck promoters active at different developmental stages. Eur J Immunol  46, 2401-2408.   https://doi.org/10.1002/eji.201646440",https://intramural.nih.gov/search/searchview.taf?ipid=93660
38,BC009273-29,"October 01, 2015 -  September 30, 2016",T Cell Differentiation and Repertoire Selection,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Dinah  Singer; PhD|Jung-Hyun  Park,"Naomi  Taylor|Batu M Erman|Deitmar  Kappes (Immunology, Fox Chase Cancer Center)|Wilfried  Ellmeier (Immunology, University of Vienna)|Sophia D Sarafova (NCI)|Ed  Palmer (University of Basel)|Show all 7","Remy J Bosselut; MD, PhD (Laboratory of Immune Cell Biology)|Carl  Wu; PhD (Laboratory Of Biochemistry & Molecular Biology)","Paul E Love; MD, PhD (NICHD)","1. Kimura M, Thomas J, Tai X, Guinter T, Shinzawa M, Etzensperger R, Li Z, Love P, Nakayama T, Singer A (2016) Timing and duration of MHC-I positive selection signals in the thymus reveal a novel compensatory signaling mechanism that prevents lineage fate errors. Nature Immunology, in press.|2. Pobezinsky LA, Etzensperger R, Jeurling S, Alag A, Kadakia T, McCaughtry TM, Kimura MY, Sharrow SO, Guinter TI, Feigenbaum L, Singer A (2015). Let-7 microRNAs target the lineage-specific transcription factor PLZF to regulate terminal NKT cell differentiation and effector function. Nat Immunol  16, 517-24.   https://doi.org/10.1038/ni.3146|3. Takada K, Van Laethem F, Xing Y, Akane K, Suzuki H, Murata S, Tanaka K, Jameson SC, Singer A, Takahama Y (2015). TCR affinity for thymoproteasome-dependent positively selecting peptides conditions antigen responsiveness in CD8(+) T cells. Nat Immunol  16, 1069-76.   https://doi.org/10.1038/ni.3237",https://intramural.nih.gov/search/searchview.taf?ipid=93661
39,BC009279-31,"October 01, 2015 -  September 30, 2016",Regulation of Expression of MHC Class I Genes,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",John A Campbell|Oliver James Hendy|Susan  Sharrow,NULL,Daniel Robert Larson; PhD (Laboratory of Receptor Biology and Gene Expression),NULL,"1. Devaiah BN, Case-Borden C, Gegonne A, Hsu CH, Chen Q, Meerzaman D, Dey A, Ozato K, Singer DS (2016). BRD4 is a histone acetyltransferase that evicts nucleosomes from chromatin. Nat Struct Mol Biol  23, 540-8.   https://doi.org/10.1038/nsmb.3228",https://intramural.nih.gov/search/searchview.taf?ipid=93662
40,BC009281-30,"October 01, 2015 -  September 30, 2016",Receptor Mediated T and B Cell Activation,Richard J Hodes; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Michael Patrick Breen|Yungping  Chiang|Masashi  Watanabe,NULL,NULL,"Ronald N Germain; MD, PhD (NIAID)","1. Chiang Y, Hodes R (2016) T- cell development  is regulated by the coordinated function of proximal and distal Lck promoters active at different developmental stages. European Journal of Immunology, in press.|2. Chiang YJ, Hodes RJ (2015). Regulation of T cell development by c-Cbl: essential role of Lck. Int Immunol  27, 245-51.   https://doi.org/10.1093/intimm/dxu105",https://intramural.nih.gov/search/searchview.taf?ipid=93663
41,BC009283-32,"October 01, 2015 -  September 30, 2016",Consequences of chronic Interferon-gamma expression on the host,Howard A Young; PhD|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Emmanuella Osei Asante|Heekyong  Bae|Marlee Ann Dinterman|Nkolika Chisom Egbukichi|John Maxwell Fenimore|Andrew Loc Nguyen|Show all 11,Monika  Wolkers (Sanquin)|M  Gershwin (University of Califernia at Davis)|Zia  Rahman (Penn State Univ. College of Medicine)|Ram  Savan|STEFANIE  VOGEL (UNIV. OF MARYLAND SCHOOL OF MEDICINE),Jonathan  Keller; PhD (Mouse Cancer Genetics Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93664
42,BC009285-30,"October 01, 2015 -  September 30, 2016",Responses of MHC Class I Genes to Exogeneous Stimuli,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",John A Campbell|Oliver James Hendy|Susan  Sharrow,NULL,Daniel Robert Larson; PhD (Laboratory of Receptor Biology and Gene Expression),NULL,"1. Devaiah BN, Case-Borden C, Gegonne A, Hsu CH, Chen Q, Meerzaman D, Dey A, Ozato K, Singer DS (2016). BRD4 is a histone acetyltransferase that evicts nucleosomes from chromatin. Nat Struct Mol Biol  23, 540-8.   https://doi.org/10.1038/nsmb.3228",https://intramural.nih.gov/search/searchview.taf?ipid=93665
43,BC009287-32,"October 01, 2015 -  September 30, 2016",Cytokines and T Cell Development,Scott K Durum; PhD|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Caroline Elizabeth Salter|Sarah Delia Cramer|Julie  Hixon|Wenqing  Li|Gisele Olinto Libanio Rodrigues; MS|Emilee Rose Senkevitch|Show all 7,Joao  Barata (U.Lisbon)|Richard  Hotchkiss (Wash U)|Scott  Walsh (University of Maryland),NULL,NULL,"1. Andrews C, McLean MH, Durum SK (2016). Interleukin-27 as a Novel Therapy for Inflammatory Bowel Disease: A Critical Review of the Literature. Inflamm Bowel Dis  22, 2255-64.   https://doi.org/10.1097/MIB.0000000000000818|2. Robinette ML, Fuchs A, Cortez VS, Lee JS, Wang Y, Durum SK, Gilfillan S, Colonna M, Immunological Genome Consortium (2015). Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets. Nat Immunol  16, 306-17.   https://doi.org/10.1038/ni.3094|3. Shen W, Hixon JA, McLean MH, Li WQ, Durum SK (2015). IL-22-Expressing Murine Lymphocytes Display Plasticity and Pathogenicity in Reporter Mice. Front Immunol  6, 662.   https://doi.org/10.3389/fimmu.2015.00662",https://intramural.nih.gov/search/searchview.taf?ipid=93666
44,BC009369-26,"October 01, 2015 -  September 30, 2016",Studies of Receptor Interactions and Effects of Alarmins,Joost J Oppenheim; MD|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Zhen  Han; PhD|Madelyn Moyer Hurwitz|Shuo  Liu|Yingjie No Nie|Anna Lee  Trivett|De  Yang|Show all 8,Feng  Wei|Arthur  Friedlander (USAMRIID)|Richard  Jewell (University of Maryland)|Oystein  Rekdal (Lytix Biopharma)|W  Wu (University of Maryland)|Ning  Zhang (Tianjin Medical University),Michael  Bustin; PhD (Protein Section)|Joseph John Barchi (Chemical Biology Laboratory)|Bruce Allen Shapiro; PhD (Gene Regulation and Chromosome Biology Laboratory),NULL,"1. Chen X, Willette-Brown J, Wu X, Hu Y, Howard OM, Hu Y, Oppenheim JJ (2015). IKKα is required for the homeostasis of regulatory T cells and for the expansion of both regulatory and effector CD4 T cells. FASEB J  29, 443-54.   https://doi.org/10.1096/fj.14-259564|2. Nie Y, Yang D, Oppenheim JJ (2016). Alarmins and Antitumor Immunity. Clin Ther  38, 1042-53.   https://doi.org/10.1016/j.clinthera.2016.03.021",https://intramural.nih.gov/search/searchview.taf?ipid=93667
45,BC009392-24,"October 01, 2015 -  September 30, 2016",Determining the Fate of Transmembrane Proteins,Allan M Weissman; MD|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Christopher Edward Smith|Meredith Boyle Metzger; PhD|Jessica Lee Scales|Yien-Che  Tsai,Michael  Glickman (Technion)|Joseph  Roitelman,Xinhua  Ji; PhD (Biomolecular Structure Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93609
46,BC009404-22,"October 01, 2015 -  September 30, 2016",Regulation of MHC Class II Trafficking in Antigen Presenting Cells,Paul A Roche; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Joanna Marta Bandola-Simon; PhD|Kyung Jin  Cho|Karis  Faust|Sunil  Kaul|Hei Jung  Kim|Lei  Lei|Show all 7,"Lisa  Denzin (Immunology Program, Sloan-Kettering Institute)|Satoshi  Ishido (Riken Center for Allergy and Immunology)|Laura  Santambrogio (Memorial Sloan Kettering)|James  Drake (NCI)|Laurence  Eisenlohr (University of Pennsylvania)|J  Blander (Icahn School of Medicine at Mount Sinai)",NULL,NULL,"1. Liu Z, Roche PA (2015). Macropinocytosis in phagocytes: regulation of MHC class-II-restricted antigen presentation in dendritic cells. Front Physiol  6, 1.   https://doi.org/10.3389/fphys.2015.00001|2. Mittal SK, Roche PA (2015). Suppression of antigen presentation by IL-10. Curr Opin Immunol  34, 22-7.   https://doi.org/10.1016/j.coi.2014.12.009|3. Roche PA, Cresswell P (2016). Antigen Processing and Presentation Mechanisms in Myeloid Cells. Microbiol Spectr  4.   https://doi.org/10.1128/microbiolspec.MCHD-0008-2015|4. Roche PA, Furuta K (2015). The ins and outs of MHC class II-mediated antigen processing and presentation. Nat Rev Immunol  15, 203-16.   https://doi.org/10.1038/nri3818",https://intramural.nih.gov/search/searchview.taf?ipid=93668
47,BC009405-22,"October 01, 2015 -  September 30, 2016",Regulation of Lymphocyte Proliferation and Replicative Capacity,Richard J Hodes; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Yungping  Chiang|Karen  Hathcock,NULL,Karl Thomas Ried; MD (Cancer Genetics Branch)|Louis  Staudt; MD (Lymphoid Malignancies Branch),Herbert Carpenter Morse; MD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93669
48,BC010001-21,"October 01, 2015 -  September 30, 2016",Molecular-Cellular Regulation of Hematopoiesis,Jonathan  Keller; PhD,NULL,"Mouse Cancer Genetics Program, NCI",Stephen Joseph Gadomski; BS|Kimberly D Klarmann|Shweta  Singh; PhD|Lei  Sun|Lino  Tessarollo|Kathrin  Muegge; MD,NULL,"Laura  Schmidt (Urologic Oncology Branch)|Serguei V Kozlov (Office of the Director)|Pengnian Charles Lin; PhD (Cancer Inflammation Program)|Jairaj K Acharya; MBBS, PhD (Cancer and Developmental Biology Laboratory)|Shyam K Sharan (Genetics of Cancer Susceptibility Section)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93670
49,BC010006-21,"October 01, 2015 -  September 30, 2016",Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways,Ira  Daar; PhD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Laura Olivia Knapik|Moonsup  Lee|Jian  Sun; PhD|Jaeho  Yoon; PhD,NULL,NULL,NULL,"1. Gaur S, Mandelbaum M, Herold M, Majumdar HD, Neilson KM, Maynard TM, Mood K, Daar IO, Moody SA (2016). Neural transcription factors bias cleavage stage blastomeres to give rise to neural ectoderm. Genesis  54, 334-49.   https://doi.org/10.1002/dvg.22943",https://intramural.nih.gov/search/searchview.taf?ipid=93671
50,BC010008-21,"October 01, 2015 -  September 30, 2016",The Genetics of Susceptibility to Mouse Plasma Cell Tumors,Beverly  Mock; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Adrian  Eiden|Zaw Hlyan Phyo|Patricia Ann Wiley|Shuling  Zhang; MD, PhD|Robert Mark Simpson; DVM, PhD",NULL,NULL,"Rafael Cristian Casellas; PhD (NIAMS) |Toren  Finkel; MD, PhD (NHLBI)","1. Eiden AM, Zhang S, Gary JM, Simmons JK, Mock BA (2016). Molecular Pathways: Increased Susceptibility to Infection Is a Complication of mTOR Inhibitor Use in Cancer Therapy. Clin Cancer Res  22, 277-83.   https://doi.org/10.1158/1078-0432.CCR-14-3239",https://intramural.nih.gov/search/searchview.taf?ipid=93672
51,BC010012-21,"October 01, 2015 -  September 30, 2016",Mechanisms of Immune-mediated Tumor Cell Destruction,Thomas Joseph Sayers; PhD,NULL,"Cancer Inflammation Program, NCI",Alan  Brooks|Poonam  Tewary,"William  Murphy (University of Nevada)|Hideo  Yagita (Immunology, Juntendo University)",NULL,NULL,"1. Pellom ST, Dudimah DF, Thounaojam MC, Sayers TJ, Shanker A (2015). Modulatory effects of bortezomib on host immune cell functions. Immunotherapy  7, 1011-22.   https://doi.org/10.2217/imt.15.66|2. Shanker A, Pellom ST, Dudimah DF, Thounaojam MC, de Kluyver RL, Brooks AD, Yagita H, McVicar DW, Murphy WJ, Longo DL, Sayers TJ (2015). Bortezomib Improves Adoptive T-cell Therapy by Sensitizing Cancer Cells to FasL Cytotoxicity. Cancer Res  75, 5260-72.   https://doi.org/10.1158/0008-5472.CAN-15-0794",https://intramural.nih.gov/search/searchview.taf?ipid=93673
52,BC010013-21,"October 01, 2015 -  September 30, 2016",Molecular Studies of Cellular Cytotoxicity,Stephen K Anderson; PhD,NULL,"Cancer Inflammation Program, NCI",Luke Li Cai|Jenna Kelly Johnson|Hong-Chuan  Li|Luis G Rodriguez|Paul  Wright|Giorgio  Trinchieri|Show all 7,"Jeffrey  Miller (University of Minnesota Cancer Center)|Andrew  Makrigiannis (ICRM)|Kerry  Campbell (Immunobiology, Fox Chase Cancer Institute)|William  Murphy (UC Davis)|Savan  Ram (University of Washington)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93674
53,BC010014-21,"October 01, 2015 -  September 30, 2016",Epigenetic control during embryogenesis,Kathrin  Muegge; MD,NULL,"Mouse Cancer Genetics Program, NCI",NULL,NULL,Robert M Leighty (Office Of The Director)|Carl E Mcintosh (Office of the Director),NULL,"1. Han Y, Gao S, Muegge K, Zhang W, Zhou B (2015). Advanced Applications of RNA Sequencing and Challenges. Bioinform Biol Insights  9, 29-46.   https://doi.org/10.4137/BBI.S28991|2. Jiang Y, Yan B, Lai W, Shi Y, Xiao D, Jia J, Liu S, Li H, Lu J, Li Z, Chen L, Chen X, Sun L, Muegge K, Cao Y, Tao Y (2015). Repression of Hox genes by LMP1 in nasopharyngeal carcinoma and modulation of glycolytic pathway genes by HoxC8. Oncogene  34, 6079-91.   https://doi.org/10.1038/onc.2015.53|3. Ren J, Briones V, Barbour S, Yu W, Han Y, Terashima M, Muegge K (2015). The ATP binding site of the chromatin remodeling homolog Lsh is required for nucleosome density and de novo DNA methylation at repeat sequences. Nucleic Acids Res  43, 1444-55.   https://doi.org/10.1093/nar/gku1371|4. Terashima M, Barbour S, Ren J, Yu W, Han Y, Muegge K (2015). Effect of high fat diet on paternal sperm histone distribution and male offspring liver gene expression. Epigenetics  10, 861-71.   https://doi.org/10.1080/15592294.2015.1075691",https://intramural.nih.gov/search/searchview.taf?ipid=93675
54,BC010015-21,"October 01, 2015 -  September 30, 2016",The Role of Cellular Receptors Involved in Inflammation and Tumor Progression,"Ji Ming  Wang; MD, PhD|IRP Faculty Profile",NULL,"Cancer Inflammation Program, NCI",NULL,"Xiuwu  Bian (Southwest Hospital, Institute of Pathology)|Chunfu  Wu (Medicinal Chemistry, Shenyang Pharmaceutical University)|Yingying  Le (Immunology, Institute for Nutritional Sciences)",NULL,NULL,"1. Chen K, Wang JM, Yuan R, Yi X, Li L, Gong W, Yang T, Li L, Su S (2016). Tissue-resident dendritic cells and diseases involving dendritic cell malfunction. Int Immunopharmacol  34, 1-15.   https://doi.org/10.1016/j.intimp.2016.02.007|2. Li L, Chen K, Xiang Y, Yoshimura T, Su S, Zhu J, Bian XW, Wang JM (2016). New development in studies of formyl-peptide receptors: critical roles in host defense. J Leukoc Biol  99, 425-35.   https://doi.org/10.1189/jlb.2RI0815-354RR",https://intramural.nih.gov/search/searchview.taf?ipid=93676
55,BC010017-21,"October 01, 2015 -  September 30, 2016","Use of Bacteriophages to Prevent, Diagnose, and Treat Diseases",Sankar  Adhya; PhD|IRP Faculty Profile,NULL,"Developmental Genetics Section, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93677
56,BC010020-21,"October 01, 2015 -  September 30, 2016",Clinical Trials with Immunotoxins,Ira H Pastan; MD|IRP Faculty Profile,NULL,"Molecular Biology Section, NCI",Barbara  Debrah|Sonya C Duke|Timonthy R McNickle,"DARELL  BIGNER (Duke University Medical Center, Dept. of Pathology)|JOHN  SAMPSON (Div of Neurosurgery, Duke University Medical Center, Div. of Neurosurgery)|Alan S Wayne; MD","Christine Campo Alewine (Laboratory of Molecular Biology)|Raffit  Hassan (Thoracic & Oncologic Surgery Branch)|Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93678
57,BC010021-21,"October 01, 2015 -  September 30, 2016",Biology of Mammary Gland Development and Tumorigenesis,Gilbert  Smith; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Corinne A Boulanger-Espeut|Andrea Lynn George; PhD|Sonia Menin Rosenfield,"Cathrin  Brisken (ISREC/EPFL)|John P. Lydon; PhD (Department of Molecular and Cellular Biology, Baylor College of Medicine)|Nelson  Horseman (Univ. Cinn.)|Robert D Bruno|Pepper  Schedin (University of Colorado)|Brian  Booth",NULL,NULL,"1. Blanding W, Feltracco J, Rosenfield S, Park J, Smith G, Booth B (2015) Characterization in Vitro and in Vivo of Clonogenic Cells from Heterogeneous Cell Populations. SRL Stem Cell Res 001-0010|2. Boulanger CA, Rosenfield SM, George AL, Smith GH (2015). Hormone signaling requirements for the conversion of non-mammary mouse cells to mammary cell fate(s) in vivo. J Mammary Gland Biol Neoplasia  20, 93-101.   https://doi.org/10.1007/s10911-015-9343-2|3. George A, Smith G (2016) Mammary Epithelial Cell Lineage Analysis via the Lyons Hypothesis Intl.J Stem Cell Res Therapy 3:018",https://intramural.nih.gov/search/searchview.taf?ipid=93679
58,BC010022-21,"October 01, 2015 -  September 30, 2016",Genetics of Complex Diseases and Health Disparities,Cheryl Ann Winkler,NULL,"Basic Research Laboratory, NCI",Elizabeth  Binns-Roemer|Saloni Jignesh Dalal|Victor A David|Sophie Mh Limou,Gregory D Kirk|Etienne  Pays (Universite Libre de Bruxelles)|Mohammed  Atta (Johns Hopkins University)|Rajendra  Bhimma (University of KwaZulu-Natal)|Michael  Lipkowitz (Georgetown University)|Rakhi  Naik (Johns Hopkins University)|Show all 9,Mark  Purdue (Occupational and Environmental Epidemiology Branch)|Jonathan Nicholas Hofmann (Occupational and Environmental Epidemiology Branch)|George  Nelson (Office of the Director)|Stephen J Lockett; PhD (Office Of The Director)|Randall C Johnson (Office Of The Director),Jeffrey Burnett Kopp; MD (NIDDK),"1. Chen TK, Choi MJ, Kao WH, Astor BC, Scialla JJ, Appel LJ, Li L, Lipkowitz MS, Wolf M, Parekh RS, Winkler CA, Estrella MM, Crews DC (2015). Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression. Clin J Am Soc Nephrol  10, 2128-35.   https://doi.org/10.2215/CJN.05220515|2. Hoy WE, Hughson MD, Kopp JB, Mott SA, Bertram JF, Winkler CA (2015). APOL1 Risk Alleles Are Associated with Exaggerated Age-Related Changes in Glomerular Number and Volume in African-American Adults: An Autopsy Study. J Am Soc Nephrol  26, 3179-89.   https://doi.org/10.1681/ASN.2014080768|3. Iyengar SK, Sedor JR, Freedman BI, Kao WH, Kretzler M, Keller BJ, Abboud HE, Adler SG, Best LG, Bowden DW, Burlock A, Chen YD, Cole SA, Comeau ME, Curtis JM, Divers J, Drechsler C, Duggirala R, Elston RC, Guo X, Huang H, Hoffmann MM, Howard BV, Ipp E, Kimmel PL, Family Investigation of Nephropathy and Diabetes (FIND), et al. [34 more authors] (2015). Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND). PLoS Genet  11, e1005352.   https://doi.org/10.1371/journal.pgen.1005352|4. Kopp JB, Winkler CA, Zhao X, Radeva MK, Gassman JJ, D'Agati VD, Nast CC, Wei C, Reiser J, Guay-Woodford LM, Pollak MR, Hildebrandt F, Moxey-Mims M, Gipson DS, Trachtman H, Friedman AL, Kaskel FJ, FSGS-CT Study Consortium (2015). Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical Trial. J Am Soc Nephrol  26, 1443-8.   https://doi.org/10.1681/ASN.2013111242|5. Osafo C, Raji YR, Olanrewaju T, Mamven M, Arogundade F, Ajayi S, Ulasi I, Salako B, Plange-Rhule J, Mengistu Y, Mc'Ligeyo SO, Moturi G, Winkler CA, Moxey-Mims MM, Rasooly RS, Kimmel P, Adu D, Ojo A, Parekh RS, H3Africa Kidney Disease Research Network (2016). Genomic approaches to the burden of kidney disease in Sub-Saharan Africa: the Human Heredity and Health in Africa (H3Africa) Kidney Disease Research Network. Kidney Int  90, 2-5.   https://doi.org/10.1016/j.kint.2015.12.059|6. Peralta CA, Bibbins-Domingo K, Vittinghoff E, Lin F, Fornage M, Kopp JB, Winkler CA (2016). APOL1 Genotype and Race Differences in Incident Albuminuria and Renal Function Decline. J Am Soc Nephrol  27, 887-93.   https://doi.org/10.1681/ASN.2015020124|7. Pino-Yanes M, Gignoux CR, Galanter JM, Levin AM, Campbell CD, Eng C, Huntsman S, Nishimura KK, Gourraud PA, Mohajeri K, O'Roak BJ, Hu D, Mathias RA, Nguyen EA, Roth LA, Padhukasahasram B, Moreno-Estrada A, Sandoval K, Winkler CA, Lurmann F, Davis A, Farber HJ, Meade K, Avila PC, Serebrisky D, et al. [25 more authors] (2015). Genome-wide association study and admixture mapping reveal new loci associated with total IgE levels in Latinos. J Allergy Clin Immunol  135, 1502-10.   https://doi.org/10.1016/j.jaci.2014.10.033|8. Pino-Yanes M, Thakur N, Gignoux CR, Galanter JM, Roth LA, Eng C, Nishimura KK, Oh SS, Vora H, Huntsman S, Nguyen EA, Hu D, Drake KA, Conti DV, Moreno-Estrada A, Sandoval K, Winkler CA, Borrell LN, Lurmann F, Islam TS, Davis A, Farber HJ, Meade K, Avila PC, Serebrisky D, et al. [15 more authors] (2015). Genetic ancestry influences asthma susceptibility and lung function among Latinos. J Allergy Clin Immunol  135, 228-35.   https://doi.org/10.1016/j.jaci.2014.07.053|9. Purswani MU, Patel K, Winkler CA, Spector SA, Hazra R, Seage GR, Mofenson L, Karalius B, Scott GB, Van Dyke RB, Kopp JB, Pediatric HIVAIDS Cohort Study (2016). Brief Report: APOL1 Renal Risk Variants Are Associated With Chronic Kidney Disease in Children and Youth With Perinatal HIV Infection. J Acquir Immune Defic Syndr  73, 63-8.   https://doi.org/10.1097/QAI.0000000000001010",https://intramural.nih.gov/search/searchview.taf?ipid=93680
59,BC010027-22,"October 01, 2015 -  September 30, 2016",Function of Steroid Receptors in Subcellular Compartments,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Songjoon  Baek|Thomas A Johnson|Rodney Louis Schiltz; PhD|Diana  Stavreva|Lyuba  Varticovski,Stafford  Lightman (University of Bristol)|Jorma  Palvimo (Univ of Eastern Finland),NULL,"Carson C Chow; BASc, PhD (NIDDK)","1. Stavreva DA, Hager GL (2015). Chromatin structure and gene regulation: a dynamic view of enhancer function. Nucleus  6, 442-8.   https://doi.org/10.1080/19491034.2015.1107689|2. Stavreva DA, Varticovski L, Levkova L, George AA, Davis L, Pegoraro G, Blazer V, Iwanowicz L, Hager GL (2016). Novel cell-based assay for detection of thyroid receptor beta-interacting environmental contaminants. Toxicology  368-369, 69-79.   https://doi.org/10.1016/j.tox.2016.08.012",https://intramural.nih.gov/search/searchview.taf?ipid=93681
60,BC010030-21,"October 01, 2015 -  September 30, 2016",Biochemical Analysis of Multidrug Resistance-linked Transport Proteins,Suresh V Ambudkar; PhD|IRP Faculty Profile,NULL,"Transport Biochemistry Section, NCI",Biebele  Abel|Eduardo Emilio Chufan; PhD|John E Golin|Aerfa  Mobin; PhD|Megumi  Obara; MD|Ivannie  Ortiz Rivera|Show all 9,"Rajendra  Prasad (Jawaharlal Nehru University)|Zhe-Sheng  Chen (Pharmaceutical Sciences, St. John's University)|Liwu  Fu (Sun Yat-Sen University)|Tanaji  Tallele (St. Johns University)|Maria  Baer (Medicine, Roswell Park Cancer Institute)|Michael  Mayer (University of Michigan)","Di S Xia; PhD, MS, BS (Crystallography Section)|Michael Marc Gottesman; MD (Laboratory of Cell Biology)|Stewart  Durell (Laboratory of Cell Biology)|Sriram  Subramaniam; PhD (Laboratory of Cell Biology)",NULL,"1. Anreddy N, Patel A, Zhang YK, Wang YJ, Shukla S, Kathawala RJ, Kumar P, Gupta P, Ambudkar SV, Wurpel JN, Chen ZS, Guo H (2015). A-803467, a tetrodotoxin-resistant sodium channel blocker, modulates ABCG2-mediated MDR in vitro and in vivo. Oncotarget  6, 39276-91.   https://doi.org/10.18632/oncotarget.5747|2. Frank GA, Shukla S, Rao P, Borgnia MJ, Bartesaghi A, Merk A, Mobin A, Esser L, Earl LA, Gottesman MM, Xia D, Ambudkar SV, Subramaniam S (2016). Cryo-EM Analysis of the Conformational Landscape of Human P-glycoprotein (ABCB1) During its Catalytic Cycle. Mol Pharmacol  90, 35-41.   https://doi.org/10.1124/mol.116.104190|3. Katayama K, Kapoor K, Ohnuma S, Patel A, Swaim W, Ambudkar IS, Ambudkar SV (2015). Revealing the fate of cell surface human P-glycoprotein (ABCB1): The lysosomal degradation pathway. Biochim Biophys Acta  1853, 2361-70.   https://doi.org/10.1016/j.bbamcr.2015.06.001|4. Weidner LD, Zoghbi SS, Lu S, Shukla S, Ambudkar SV, Pike VW, Mulder J, Gottesman MM, Innis RB, Hall MD (2015). The Inhibitor Ko143 Is Not Specific for ABCG2. J Pharmacol Exp Ther  354, 384-93.   https://doi.org/10.1124/jpet.115.225482",https://intramural.nih.gov/search/searchview.taf?ipid=93682
61,BC010277-19,"October 01, 2015 -  September 30, 2016",Mechanisms of Chromosome Maintenance in Bacteria,Dhruba K Chattoraj; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Yawen  Bai; PhD,NULL,Peter C Fitzgerald (Office of the Director)|Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory)|Kumaran S Ramamurthi (Laboratory of Molecular Biology),Aravind L Iyer; PhD (NLM) |Rodolfo  Ghirlando; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93683
62,BC010278-19,"October 01, 2015 -  September 30, 2016",Imaging cellular assemblies with three-dimensional electron microscopy,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Andrei Radu Florescu|Lisa M. Hartnell|Lesley Ann Earl; PhD|Madhvi Jayalakshmi Venkatesh,Chris  Szakal (NIST)|Michael  Phaneuf (Fibics Inc.),Jeffrey D Lifson; MD (Office Of The Director)|Kumaran S Ramamurthi (Laboratory of Molecular Biology),Donald F Bliss (NLM) |Terry S Yoo; PhD (NLM) |Robert S Balaban; PhD (NHLBI) |Luigi  Ferrucci; MD (NIA),"1. Matthies D, Dalmas O, Borgnia MJ, Dominik PK, Merk A, Rao P, Reddy BG, Islam S, Bartesaghi A, Perozo E, Subramaniam S (2016). Cryo-EM Structures of the Magnesium Channel CorA Reveal Symmetry Break upon Gating. Cell  164, 747-56.   https://doi.org/10.1016/j.cell.2015.12.055|2. Merk A, Bartesaghi A, Banerjee S, Falconieri V, Rao P, Davis MI, Pragani R, Boxer MB, Earl LA, Milne JLS, Subramaniam S (2016). Breaking Cryo-EM Resolution Barriers to Facilitate Drug Discovery. Cell  165, 1698-1707.   https://doi.org/10.1016/j.cell.2016.05.040|3. Subramaniam S, Earl LA, Falconieri V, Milne JL, Egelman EH (2016). Resolution advances in cryo-EM enable application to drug discovery. Curr Opin Struct Biol  41, 194-202.   https://doi.org/10.1016/j.sbi.2016.07.009",https://intramural.nih.gov/search/searchview.taf?ipid=93684
63,BC010283-19,"October 01, 2015 -  September 30, 2016",DNA repair,Andre A Nussenzweig; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genome Integrity, NCI",Maria Elsa  Callen Moreu|Arnab  Ray Chaudhuri|Hua Tang  Chen|Andres  Canela Rodriguez|Nicholas Franklin Sciascia; BS|Kenta  Shinoda|Show all 11,"Barry P. Sleckman; MD, PhD (Department of Pathology and Immunology, Washington University School of Medicine)|Jeremy A Daniel|Martin  Digweed (Institute of Medical and Human Genetics, Charité)|Steven  Narod (University of Toronto)|Michel  Nussenzweig (Rockefeller University)|James  Turner (University College London)|Show all 7","Shyam K Sharan (Genetics of Cancer Susceptibility Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",Kai  Ge; PhD (NIDDK),"1. Canela A, Sridharan S, Sciascia N, Tubbs A, Meltzer P, Sleckman BP, Nussenzweig A (2016). DNA Breaks and End Resection Measured Genome-wide by End Sequencing. Mol Cell  63, 898-911.   https://doi.org/10.1016/j.molcel.2016.06.034|2. Canela Rodriguez A, Sciascia N, Tubbs A, Paul M, Sleckman B, Nussenzweig A (2016) DNA breaks and end-resection measured genome wide by end sequencing (END-seq) Molecular Cell in Press|3. Cloutier JM, Mahadevaiah SK, ElInati E, Nussenzweig A, Tóth A, Turner JM (2015). Histone H2AFX Links Meiotic Chromosome Asynapsis to Prophase I Oocyte Loss in Mammals. PLoS Genet  11, e1005462.   https://doi.org/10.1371/journal.pgen.1005462|4. Ding X, Ray Chaudhuri A, Callen E, Pang Y, Biswas K, Klarmann K, Martin B, Burkett S, Cleveland L, Stauffer S, Sullivan T, Dewan A, Marks H, Buehler E, Akagi K, Martin S, Keller J, Nussenzweig A, Sharan S (2016) Synthetic viability by BRCA2 and PARP1ARTD1 deficiencies Nature Comm In Press|5. Iqbal J, Nussenzweig A, Lubinski J, Byrski T, Eisen A, Bordeleau L, Tung NM, Manoukian S, Phelan CM, Sun P, Narod SA, Hereditary Breast Cancer Research Group (2016). The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study. Br J Cancer  114, 1160-4.   https://doi.org/10.1038/bjc.2016.58|6. Ray Chaudhuri A, Callen E, Ding X, Gogola E, Duarte AA, Lee JE, Wong N, Lafarga V, Calvo JA, Panzarino NJ, John S, Day A, Crespo AV, Shen B, Starnes LM, de Ruiter JR, Daniel JA, Konstantinopoulos PA, Cortez D, Cantor SB, Fernandez-Capetillo O, Ge K, Jonkers J, Rottenberg S, Sharan SK, et al. [1 more author] (2016). Replication fork stability confers chemoresistance in BRCA-deficient cells. Nature  535, 382-7.   https://doi.org/10.1038/nature18325|7. Robbiani DF, Deroubaix S, Feldhahn N, Oliveira TY, Callen E, Wang Q, Jankovic M, Silva IT, Rommel PC, Bosque D, Eisenreich T, Nussenzweig A, Nussenzweig MC (2015). Plasmodium Infection Promotes Genomic Instability and AID-Dependent B Cell Lymphoma. Cell  162, 727-37.   https://doi.org/10.1016/j.cell.2015.07.019|8. Salewsky B, Hildebrand G, Rothe S, Parplys AC, Radszewski J, Kieslich M, Wessendorf P, Krenzlin H, Borgmann K, Nussenzweig A, Sperling K, Digweed M (2016) Directed Alternative Splicing in Nijmegen Breakage Syndrome: Proof of Principle Concerning Its Therapeutical Application. Mol Ther 24:117-24|9. Starnes LM, Su D, Pikkupeura LM, Weinert BT, Santos MA, Mund A, Soria R, Cho YW, Pozdnyakova I, Kubec Højfeldt M, Vala A, Yang W, López-Méndez B, Lee JE, Peng W, Yuan J, Ge K, Montoya G, Nussenzweig A, Choudhary C, Daniel JA (2016). A PTIP-PA1 subcomplex promotes transcription for IgH class switching independently from the associated MLL3/MLL4 methyltransferase complex. Genes Dev  30, 149-63.   https://doi.org/10.1101/gad.268797.115",https://intramural.nih.gov/search/searchview.taf?ipid=93685
64,BC010292-19,"October 01, 2015 -  September 30, 2016",Enzymes and Substrates of the Ubiquitin Conjugating System,Allan M Weissman; MD|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Sam G Giannakoulias|Jennifer B Mariano|Christopher Edward Smith|Yien-Che  Tsai|Mei  Yang; MD,"Karen H Vousden|David  Fushman (Biochemistry, University of Maryland)",Robert Andrew Byrd (Structural Biophysics Laboratory)|Xinhua  Ji; PhD (Biomolecular Structure Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93610
65,BC010297-19,"October 01, 2015 -  September 30, 2016",Identification of Genetic Factors Associated with Infectious Diseases,Cheryl Ann Winkler,NULL,"Basic Research Laboratory, NCI",Ping  An; PhD|Elizabeth  Binns-Roemer|Victor A David|Sophie Mh Limou|Efe  Sezgin|Lily Meredith Widdup|Show all 7,Gregory D Kirk|William  Wester (Vanderbilt University School of Medicine)|Rajendra  Bhimma (University of KwaZulu-Natal)|Saraladevi  Naicker (University of the Witwatersrand),James Jerome Goedert; MD (Hormonal and Reproductive Epidemiology Branch),Jeffrey Burnett Kopp; MD (NIDDK),"1. Limou S, Taverner AM, Winkler CA (2016). Ferret: a user-friendly Java tool to extract data from the 1000 Genomes Project. Bioinformatics  32, 2224-6.   https://doi.org/10.1093/bioinformatics/btw147|2. Madlala P, Singh R, An P, Werner L, Mlisana K, Abdool Karim SS, Winkler CA, Ndungʼu T (2016). Association of Polymorphisms in the Regulatory Region of the Cyclophilin a Gene (PPIA) with Gene Expression and HIV/AIDS Disease Progression. J Acquir Immune Defic Syndr  72, 465-73.   https://doi.org/10.1097/QAI.0000000000001028",https://intramural.nih.gov/search/searchview.taf?ipid=93686
66,BC010298-19,"October 01, 2015 -  September 30, 2016",Growth Regulation Section,Ira H Pastan; MD|IRP Faculty Profile,NULL,"Molecular Biology Section, NCI",Tapan K Bera,NULL,Christine Campo Alewine (Laboratory of Molecular Biology),NULL,"1. Awuah P, Bera TK, Folivi M, Chertov O, Pastan I (2016). Reduced Shedding of Surface Mesothelin Improves Efficacy of Mesothelin-Targeting Recombinant Immunotoxins. Mol Cancer Ther  15, 1648-55.   https://doi.org/10.1158/1535-7163.MCT-15-0863|2. Hara S, Kobayashi N, Sakamoto K, Ueno T, Manabe S, Takashima Y, Hamada J, Pastan I, Fukamizu A, Matsusaka T, Nagata M (2015). Podocyte injury-driven lipid peroxidation accelerates the infiltration of glomerular foam cells in focal segmental glomerulosclerosis. Am J Pathol  185, 2118-31.   https://doi.org/10.1016/j.ajpath.2015.04.007|3. Hollevoet K, Mason-Osann E, Müller F, Pastan I (2015). Methylation-associated partial down-regulation of mesothelin causes resistance to anti-mesothelin immunotoxins in a pancreatic cancer cell line. PLoS One  10, e0122462.   https://doi.org/10.1371/journal.pone.0122462|4. Illei PB, Alewine C, Zahurak M, Cowan ML, Montgomery E, Hassan R, Xiang L, Pastan I, Kelly RJ (2016). Mesothelin Expression in Advanced Gastroesophageal Cancer Represents a Novel Target for Immunotherapy. Appl Immunohistochem Mol Morphol  24, 246-52.   https://doi.org/10.1097/PAI.0000000000000292|5. Kobayashi N, Ueno T, Ohashi K, Yamashita H, Takahashi Y, Sakamoto K, Manabe S, Hara S, Takashima Y, Dan T, Pastan I, Miyata T, Kurihara H, Matsusaka T, Reiser J, Nagata M (2015). Podocyte injury-driven intracapillary plasminogen activator inhibitor type 1 accelerates podocyte loss via uPAR-mediated β1-integrin endocytosis. Am J Physiol Renal Physiol  308, F614-26.   https://doi.org/10.1152/ajprenal.00616.2014|6. Müller N, Michen S, Tietze S, Töpfer K, Schulte A, Lamszus K, Schmitz M, Schackert G, Pastan I, Temme A (2015). Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma. J Immunother  38, 197-210.   https://doi.org/10.1097/CJI.0000000000000082|7. Okabe M, Miyazaki Y, Niimura F, Pastan I, Nishiyama A, Yokoo T, Ichikawa I, Matsusaka T (2015). Unilateral ureteral obstruction attenuates intrarenal angiotensin II generation induced by podocyte injury. Am J Physiol Renal Physiol  308, F932-7.   https://doi.org/10.1152/ajprenal.00444.2014|8. Shah NN, Stevenson MS, Yuan CM, Richards K, Delbrook C, Kreitman RJ, Pastan I, Wayne AS (2015). Characterization of CD22 expression in acute lymphoblastic leukemia. Pediatr Blood Cancer  62, 964-9.   https://doi.org/10.1002/pbc.25410|9. Stahl S, da Silva Mateus Seidl AR, Ducret A, Kux van Geijtenbeek S, Michel S, Racek T, Birzele F, Haas AK, Rueger R, Gerg M, Niederfellner G, Pastan I, Brinkmann U (2015). Loss of diphthamide pre-activates NF-κB and death receptor pathways and renders MCF7 cells hypersensitive to tumor necrosis factor. Proc Natl Acad Sci U S A  112, 10732-7.   https://doi.org/10.1073/pnas.1512863112",https://intramural.nih.gov/search/searchview.taf?ipid=93687
67,BC010300-19,"October 01, 2015 -  September 30, 2016",Signal Transduction of Paired Inhibitory Receptors of NK Cells and Macrophages,Daniel  McVicar; PhD|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",NULL,"Valance  Washington (Anatomy and Cell biology, Universidad Central del Caribe)|Mary  Nakamura (Laboratoire d'Hematologie, UCSF)|James  Finke (Cleveland Clinic)|Philip  Taylor (Cardiff University)|Selinda Jane Orr",Stefan  Ambs (Laboratory of Human Carcinogenesis)|William Marston Linehan; MD (Urologic Oncology Branch),"Pamela Lee Schwartzberg; MD, PhD (NHGRI) |Suk See De Ravin; MD, PhD (NIAID) |Doug B Kuhns; PhD (NIAID) |Leslie Glenn Biesecker; MD (NHGRI)","1. Baseler WA, Davies LC, Quigley L, Ridnour LA, Weiss JM, Hussain SP, Wink DA, McVicar DW (2016). Autocrine IL-10 functions as a rheostat for M1 macrophage glycolytic commitment by tuning nitric oxide production. Redox Biol  10, 12-23.   https://doi.org/10.1016/j.redox.2016.09.005|2. Ma C, Kesarwala AH, Eggert T, Medina-Echeverz J, Kleiner DE, Jin P, Stroncek DF, Terabe M, Kapoor V, ElGindi M, Han M, Thornton AM, Zhang H, Egger M, Luo J, Felsher DW, McVicar DW, Weber A, Heikenwalder M, Greten TF (2016). NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis. Nature  531, 253-7.   https://doi.org/10.1038/nature16969|3. Shanker A, Pellom ST, Dudimah DF, Thounaojam MC, de Kluyver RL, Brooks AD, Yagita H, McVicar DW, Murphy WJ, Longo DL, Sayers TJ (2015). Bortezomib Improves Adoptive T-cell Therapy by Sensitizing Cancer Cells to FasL Cytotoxicity. Cancer Res  75, 5260-72.   https://doi.org/10.1158/0008-5472.CAN-15-0794|4. Thomas DD, Heinecke JL, Ridnour LA, Cheng RY, Kesarwala AH, Switzer CH, McVicar DW, Roberts DD, Glynn S, Fukuto JM, Wink DA, Miranda KM (2015). Signaling and stress: The redox landscape in NOS2 biology. Free Radic Biol Med  87, 204-25.   https://doi.org/10.1016/j.freeradbiomed.2015.06.002",https://intramural.nih.gov/search/searchview.taf?ipid=93688
68,BC010301-19,"October 01, 2015 -  September 30, 2016",Development of Recombinant Toxins to Treat Hematologic Malignancies,"Robert J Kreitman; MD, PhD|IRP Faculty Profile",NULL,"Clinical Immunotherapy Section, NCI",Evgeny  Arons|Barbara  Debrah|Sonya C Duke|Lesley Ann Mathews|Evanna Njeri Nyambura|Katherine S Potocka|Show all 8,Arthur  Frankel (Texas A&M)|Francesco  Forconi (Policlinico le Scotte)|Tadeusz  Robak (University of Lodz)|Martin  Tallman (Memorial Sloan Kettering Cancer Center)|Farhad  Ravandi (MD Anderson)|Michael  Grever (Ohio State Universithy)|Show all 9,"Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Constance M Yuan (Laboratory of Pathology)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Daniel C Edelman (Cancer Genetics Branch)|Ira H Pastan; MD (Molecular Biology Section)|David J Fitzgerald; PhD (Biotherapy Section)",Nicholas  Patronas; MD (CC),"1. Kreitman RJ (2015). Removing a hair of doubt about BRAF targeting. Blood  125, 1199-200.   https://doi.org/10.1182/blood-2014-12-616318|2. Kreitman RJ, Pastan I (2015). Immunoconjugates in the management of hairy cell leukemia. Best Pract Res Clin Haematol  28, 236-45.   https://doi.org/10.1016/j.beha.2015.09.003|3. Kreitman RJ, Stetler-Stevenson M, Jaffe ES, Conlon KC, Steinberg SM, Wilson W, Waldmann TA, Pastan I (2016). Complete Remissions of Adult T-cell Leukemia with Anti-CD25 Recombinant Immunotoxin LMB-2 and Chemotherapy to Block Immunogenicity. Clin Cancer Res  22, 310-8.   https://doi.org/10.1158/1078-0432.CCR-15-1412|4. Satishkumar S, Vuram PK, Relangi SS, Gurram V, Zhou H, Kreitman RJ, Montemayor MM, Yang L, Kaliyaperumal M, Sharma S, Pottabathini N, Lakshman MK (2015). Cladribine Analogues via O⁶-(Benzotriazolyl) Derivatives of Guanine Nucleosides. Molecules  20, 18437-63.   https://doi.org/10.3390/molecules201018437",https://intramural.nih.gov/search/searchview.taf?ipid=93689
69,BC010304-18,"October 01, 2015 -  September 30, 2016",Biochemical Basis of T Cell Activation,Lawrence Elliot Samelson; MD|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Lakshmi  Balagopalan|Ana Maria Dios Esponera|Sunmee  Huh|Wenmei  Li; PhD|Asit Kumar Manna; PhD|Katherine Marie McIntire|Show all 9,Arpita  Upadhyaya (University of Maryland/Maryland Nanocenter)|Wolfgang  Losert (University of Maryland),Ettore  Appella; MD (Chemical Immunology Section)|Nicholas Phillip Restifo; MD (Surgery Branch),"Peter W Schuck; PhD (NIBIB) |Paul E Love; MD, PhD (NICHD)","1. Guittard G, Kortum RL, Balagopalan L, Çuburu N, Nguyen P, Sommers CL, Samelson LE (2015). Absence of both Sos-1 and Sos-2 in peripheral CD4(+) T cells leads to PI3K pathway activation and defects in migration. Eur J Immunol  45, 2389-95.   https://doi.org/10.1002/eji.201445226|2. Hui KL, Balagopalan L, Samelson LE, Upadhyaya A (2015). Cytoskeletal forces during signaling activation in Jurkat T-cells. Mol Biol Cell  26, 685-95.   https://doi.org/10.1091/mbc.E14-03-0830|3. Palmer DC, Guittard GC, Franco Z, Crompton JG, Eil RL, Patel SJ, Ji Y, Van Panhuys N, Klebanoff CA, Sukumar M, Clever D, Chichura A, Roychoudhuri R, Varma R, Wang E, Gattinoni L, Marincola FM, Balagopalan L, Samelson LE, Restifo NP (2015). Cish actively silences TCR signaling in CD8+ T cells to maintain tumor tolerance. J Exp Med  212, 2095-113.   https://doi.org/10.1084/jem.20150304|4. Rodriguez-Peña AB, Gomez-Rodriguez J, Kortum RL, Palmer DC, Yu Z, Guittard GC, Wohlfert EA, Silver PB, Misplon JA, Sommers CL, Feigenbaum L, Epstein SL, Caspi RR, Belkaid Y, Restifo NP, Samelson LE, Balagopalan L (2015). Enhanced T-cell activation and differentiation in lymphocytes from transgenic mice expressing ubiquitination-resistant 2KR LAT molecules. Gene Ther  22, 781-92.   https://doi.org/10.1038/gt.2015.48|5. Rouquette-Jazdanian AK, Kortum RL, Li W, Merrill RK, Nguyen PH, Samelson LE, Sommers CL (2015). miR-155 Controls Lymphoproliferation in LAT Mutant Mice by Restraining T-Cell Apoptosis via SHIP-1/mTOR and PAK1/FOXO3/BIM Pathways. PLoS One  10, e0131823.   https://doi.org/10.1371/journal.pone.0131823",https://intramural.nih.gov/search/searchview.taf?ipid=93690
70,BC010307-17,"October 01, 2015 -  September 30, 2016",Molecular Mechanisms Regulating Mouse Mammary Gland and Human Breast Tumor Cells,Gisela Esta Sterneck; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Balamurugan  Kuppusamy|Shikha  Sharan|Waheed Saadiya Sehareen|Namratha  Sheshadri,Carlos  Caldas (Cancer Research UK Cambridge Research Institute)|Snehalata Anil Pawar|Fiona  Yull (Vanderbilt University)|Goran  Landberg (Paterson Institute for Cancer Research)|Savitri  Krishnamurthy (The University of Texas MD Anderson Cancer Center)|Naoto  Ueno (National Institute for Basic Biology)|Show all 7,Philip Jeffrey Tofilon (Radiation Oncology Branch),NULL,"1. Mendoza-Villanueva D, Balamurugan K, Ali HR, Kim SR, Sharan S, Johnson RC, Merchant AS, Caldas C, Landberg G, Sterneck E (2016). The C/EBPδ protein is stabilized by estrogen receptor α activity, inhibits SNAI2 expression and associates with good prognosis in breast cancer. Oncogene  35, 6166-6176.   https://doi.org/10.1038/onc.2016.156",https://intramural.nih.gov/search/searchview.taf?ipid=93617
71,BC010308-18,"October 01, 2015 -  September 30, 2016",In vivo Imaging Analysis of Steroid-Nuclear Receptor Function,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Mary  Hawkins|Ville Juhani Paakinaho; PhD|Diego Martin Presman; PhD|Rodney Louis Schiltz; PhD|Diana  Stavreva|Lyuba  Varticovski,Luke  Iwanowicz (USGS-BRD)|Adali  Pecci (Ciudad Universitaria)|Michael  Collins (Center for Natural Capital)|Luke  Lavis; PhD (Howard Hughes Medical Institute/JFRC),"Mary Helen Ward; MS, PhD (Occupational and Environmental Epidemiology Branch)","Christopher P Austin; AB, MD (NCATS)","1. Stavreva DA, Varticovski L, Levkova L, George AA, Davis L, Pegoraro G, Blazer V, Iwanowicz L, Hager GL (2016). Novel cell-based assay for detection of thyroid receptor beta-interacting environmental contaminants. Toxicology  368-369, 69-79.   https://doi.org/10.1016/j.tox.2016.08.012",https://intramural.nih.gov/search/searchview.taf?ipid=93693
72,BC010309-18,"October 01, 2015 -  September 30, 2016",Nuclear Architecture and Disease,Thomas A Misteli; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Emily Anne Deboy|Elizabeth  Finn|Ziad Mohamoud Jowhar|Leonard Pieter Kubben|Stephen A Mabon|Karen J Meaburn|Show all 15,Job  Dekker; PhD (University of Massachusetts)|Dan  Levy (University of Wyoming)|Rick  Young (Whitehead Institute),Stephen J Lockett; PhD (Office Of The Director)|Michael  Bustin; PhD (Protein Section)|Karl Thomas Ried; MD (Cancer Genetics Branch),James  Inglese (NCATS),"1. Burgess RC, Misteli T (2015). Not All DDRs Are Created Equal: Non-Canonical DNA Damage Responses. Cell  162, 944-7.   https://doi.org/10.1016/j.cell.2015.08.006|2. Burman B, Misteli T, Pegoraro G (2015). Quantitative detection of rare interphase chromosome breaks and translocations by high-throughput imaging. Genome Biol  16, 146.   https://doi.org/10.1186/s13059-015-0718-x|3. Burman B, Zhang ZZ, Pegoraro G, Lieb JD, Misteli T (2015). Histone modifications predispose genome regions to breakage and translocation. Genes Dev  29, 1393-402.   https://doi.org/10.1101/gad.262170.115|4. Bustin M, Misteli T (2016). Nongenetic functions of the genome. Science  352, aad6933.   https://doi.org/10.1126/science.aad6933|5. Dekker J, Misteli T (2015). Long-Range Chromatin Interactions. Cold Spring Harb Perspect Biol  7, a019356.   https://doi.org/10.1101/cshperspect.a019356|6. Gonzalez I, Munita R, Agirre E, Dittmer TA, Gysling K, Misteli T, Luco RF (2015). A lncRNA regulates alternative splicing via establishment of a splicing-specific chromatin signature. Nat Struct Mol Biol  22, 370-6.   https://doi.org/10.1038/nsmb.3005|7. Jia L, Sun Z, Wu X, Misteli T, Sharma V (2015). Gene expression analysis upon lncRNA DDSR1 knockdown in human fibroblasts. Genom Data  6, 277-9.   https://doi.org/10.1016/j.gdata.2015.10.017|8. Roukos V, Pegoraro G, Voss TC, Misteli T (2015). Cell cycle staging of individual cells by fluorescence microscopy. Nat Protoc  10, 334-48.   https://doi.org/10.1038/nprot.2015.016|9. Shachar S, Pegoraro G, Misteli T (2015). HIPMap: A High-Throughput Imaging Method for Mapping Spatial Gene Positions. Cold Spring Harb Symp Quant Biol  80, 73-81.   https://doi.org/10.1101/sqb.2015.80.027417|10. Shachar S, Voss TC, Pegoraro G, Sciascia N, Misteli T (2015). Identification of Gene Positioning Factors Using High-Throughput Imaging Mapping. Cell  162, 911-23.   https://doi.org/10.1016/j.cell.2015.07.035",https://intramural.nih.gov/search/searchview.taf?ipid=93694
73,BC010313-18,"October 01, 2015 -  September 30, 2016",Molecular signatures for liver cancer diagnosis and treatment stratification,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI",Chaoran Billie Bian|Anuradha Samantha Budhu|Hien Thi-Thu Dang|Benjamin  Davies|Edward Jamal Duqum|Marshonna J Forgues|Show all 16,"Zhao-You  Tang (Liver Cancer Institute)|Lun-Xiu  Qin (Liver Cancer Institute)|Qinghai  Ye (Liver Cancer Insitute)|Christoffer  Loffredo (Georgetown University)|Mathuros  Ruchirawat (Chulabhorn Research Institute)|Dean  Felsher (Division of Oncology, Stanford University School of Medicine)|Show all 15","Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Snorri S. Thorgeirsson; MD, PhD (Laboratory of Human Carcinogenesis)|James  McMahon; PhD (Molecular Targets Laboratory)|Javed  Khan; MD (Cancer Genetics Branch)|Tim Friedrich Greten (Thoracic & Oncologic Surgery Branch)",NULL,"1. Auslander N, Yizhak K, Weinstock A, Budhu A, Tang W, Wang XW, Ambs S, Ruppin E (2016). A joint analysis of transcriptomic and metabolomic data uncovers enhanced enzyme-metabolite coupling in breast cancer. Sci Rep  6, 29662.   https://doi.org/10.1038/srep29662|2. Fako V, Yu Z, Henrich CJ, Ransom T, Budhu AS, Wang XW (2016). Inhibition of wnt/β-catenin Signaling in Hepatocellular Carcinoma by an Antipsychotic Drug Pimozide. Int J Biol Sci  12, 768-75.   https://doi.org/10.7150/ijbs.14718|3. Greten TF, Wang XW, Korangy F (2015). Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approaches. Gut  64, 842-8.   https://doi.org/10.1136/gutjnl-2014-307990|4. Itzel T, Scholz P, Maass T, Krupp M, Marquardt JU, Strand S, Becker D, Staib F, Binder H, Roessler S, Wang XW, Thorgeirsson S, Müller M, Galle PR, Teufel A (2015). Translating bioinformatics in oncology: guilt-by-profiling analysis and identification of KIF18B and CDCA3 as novel driver genes in carcinogenesis. Bioinformatics  31, 216-24.   https://doi.org/10.1093/bioinformatics/btu586|5. Scarzello AJ, Jiang Q, Back T, Dang H, Hodge D, Hanson C, Subleski J, Weiss JM, Stauffer JK, Chaisaingmongkol J, Rabibhadana S, Ruchirawat M, Ortaldo J, Wang XW, Norris PS, Ware CF, Wiltrout RH (2016). LTβR signalling preferentially accelerates oncogenic AKT-initiated liver tumours. Gut  65, 1765-75.   https://doi.org/10.1136/gutjnl-2014-308810|6. Tao J, Ji J, Li X, Ding N, Wu H, Liu Y, Wang XW, Calvisi DF, Song G, Chen X (2015). Distinct anti-oncogenic effect of various microRNAs in different mouse models of liver cancer. Oncotarget  6, 6977-88.   https://doi.org/10.18632/oncotarget.3166|7. Wang RH, Zhao T, Cui K, Hu G, Chen Q, Chen W, Wang XW, Soto-Gutierrez A, Zhao K, Deng CX (2016). Negative reciprocal regulation between Sirt1 and Per2 modulates the circadian clock and aging. Sci Rep  6, 28633.   https://doi.org/10.1038/srep28633|8. Xue W, Wang X (2015) The search for precision models clinically relevant to human liver cancer Hepatic Oncology 2:315-19",https://intramural.nih.gov/search/searchview.taf?ipid=93696
74,BC010319-18,"October 01, 2015 -  September 30, 2016",Structural Analysis of Biological Membrane Proteins,"Di S Xia; PhD, MS, BS|IRP Faculty Profile",NULL,"Crystallography Section, NCI",Xiaoyun  Bai|Jenica Gabrielle Chandran|Lothar  Esser|Taivan  Odzorig|Wai-Kwan  Tang|Alex  Zhang|Show all 7,NULL,Suresh V Ambudkar; PhD (Transport Biochemistry Section)|Michael Marc Gottesman; MD (Laboratory of Cell Biology),NULL,"1. Esser L, Zhou F, Yu C, Xia D (2015) Structure-function studies of the cytochrome bc1 complex of anoxygenic photosynthetic purple bacteria, in Advances in Photosynthesis and Respiration, in press.|2. Zhou F, Esser L, Yu C, Xia D (2015) Structural and functional studies of the cytochrome bc1 complex from photosynthetic purple bacteria, in Handbook of Photosynthesis, in press.|3. Frank GA, Shukla S, Rao P, Borgnia MJ, Bartesaghi A, Merk A, Mobin A, Esser L, Earl LA, Gottesman MM, Xia D, Ambudkar SV, Subramaniam S (2016). Cryo-EM Analysis of the Conformational Landscape of Human P-glycoprotein (ABCB1) During its Catalytic Cycle. Mol Pharmacol  90, 35-41.   https://doi.org/10.1124/mol.116.104190",https://intramural.nih.gov/search/searchview.taf?ipid=93698
75,BC010326-17,"October 01, 2015 -  September 30, 2016","Biomolecular Structure and Mechanism, Structure-Based Drug Design",Xinhua  Ji; PhD|IRP Faculty Profile,NULL,"Biomolecular Structure Section, NCI",NULL,Honggao  Yan|Jorge  Cruz-Reyes (Texas A&M University)|Sherif  Abou Elela (University of Sherbrooke)|Allen  Nicholson (Temple University),Ding Jun Jin (Gene Regulation and Chromosome Biology Laboratory)|David S Waugh; PhD (Protein Engineering Section)|Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)|Robert Andrew Byrd (Structural Biophysics Laboratory)|Mikhail V Kashlev (Molecular Mechanisms of Transcription Section)|Joseph Edward Tropea (Macromolecular Crystallography Laboratory),NULL,"1. Ji X (2016) Structural insights into cell cycle control by essential GTPase Era. Advances in Biochemistry, in press.|2. Kakar S, Fang X, Lubkowska L, Zhou YN, Shaw GX, Wang YX, Jin DJ, Kashlev M, Ji X (2015). Allosteric Activation of Bacterial Swi2/Snf2 (Switch/Sucrose Non-fermentable) Protein RapA by RNA Polymerase: BIOCHEMICAL AND STRUCTURAL STUDIES. J Biol Chem  290, 23656-69.   https://doi.org/10.1074/jbc.M114.618801|3. Li S, Liang YH, Mariano J, Metzger MB, Stringer DK, Hristova VA, Li J, Randazzo PA, Tsai YC, Ji X, Weissman AM (2015) Insights into Ubiquitination from the Unique Clamp-like Binding of the RING E3 AO7 to the E2 UbcH5B. J Biol Chem 290:30225-39",https://intramural.nih.gov/search/searchview.taf?ipid=93699
76,BC010328-17,"October 01, 2015 -  September 30, 2016",Role of CEBP transcription factors in cell growth and tumorigenesis,Peter F Johnson; PhD|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Sandip  Basu|Srikanta  Basu; PhD|Nancy C Martin|Jacqueline  Salotti; PhD|Karen Lynn Saylor|Jonathan  Keller; PhD,Robert  Smart (North Carolina State University)|Hongwei  Gao (Harvard Medical School)|Warren  Tourtellotte (Northwestern University),Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory)|Maria  Miller (Protein Structure Section)|Deborah K Morrison (Laboratory of Cell and Developmental Signaling)|Ming  Zhou (Nucleic Acids Section),NULL,"1. Salotti J, Sakchaisri K, Tourtellotte WG, Johnson PF (2015). An Arf-Egr-C/EBPβ pathway linked to ras-induced senescence and cancer. Mol Cell Biol  35, 866-83.   https://doi.org/10.1128/MCB.01489-14",https://intramural.nih.gov/search/searchview.taf?ipid=93700
77,BC010329-17,"October 01, 2015 -  September 30, 2016",Regulation of Ras-Dependent Signal Transduction Pathways,Deborah K Morrison|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",NULL,"Robert  Rottapel (University of Toronto)|Channing J Der (Department of Pharmacology, University of North Carolina at Chapel Hill)|Sharon  Campbell (University of North Carolina School of Medicine)|Adrienne  Cox (University of North Carolina School of Medicine)",Udayan  Guha (Thoracic & Oncologic Surgery Branch)|James  McMahon; PhD (Molecular Targets Laboratory)|Matthew T Holderfield (Office Of The Director)|Andrew G Stephen (Office Of The Director),NULL,"1. Kortum RL, Morrison DK (2015). Path Forward for RAF Therapies: Inhibition of Monomers and Dimers. Cancer Cell  28, 279-81.   https://doi.org/10.1016/j.ccell.2015.08.006|2. Zhou B, Ritt DA, Morrison DK, Der CJ, Cox AD (2016). Protein Kinase CK2α Maintains Extracellular Signal-regulated Kinase (ERK) Activity in a CK2α Kinase-independent Manner to Promote Resistance to Inhibitors of RAF and MEK but Not ERK in BRAF Mutant Melanoma. J Biol Chem  291, 17804-15.   https://doi.org/10.1074/jbc.M115.712885",https://intramural.nih.gov/search/searchview.taf?ipid=93701
78,BC010331-17,"October 01, 2015 -  September 30, 2016",Phospholipid and Sphingolipid Signaling in Drosophila,"Jairaj K Acharya; MBBS, PhD|IRP Faculty Profile",NULL,"Cancer and Developmental Biology Laboratory, NCI",NULL,"Pedro  Labarca (Arturo Prat 514, Centro de Estudios Cientificos)|Usha  Acharya (University of Mass. Medical School)|joost  holthuis (University of Utrecht)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93702
79,BC010334-17,"October 01, 2015 -  September 30, 2016",Posttranscriptional control of gene expression,Barbara K Felber|IRP Faculty Profile,NULL,"Vaccine Branch, NCI","Candido  Alicea; PhD|Jenifer L Bear|Cristina  Bergamaschi|Frances Talieh Dayton|Bethany Anne Nagy|George N Pavlakis; MD, PhD",Morten  Thaysen-Andersen (Macquarie University)|David A Zaharoff,Stuart F J Le Grice; PhD (Basic Research Laboratory)|Elena  Chertova (Office Of The Director)|Jeffrey D Lifson; MD (Office Of The Director),NULL,"1. Purzycka KJ, Pilkington GR, Felber BK, Le Grice SF (2015). The ""complex"" RNA post-transcriptional element of a ""simple"" retrovirus. Mob Genet Elements  5, 1-4.   https://doi.org/10.1080/2159256X.2015.1017085",https://intramural.nih.gov/search/searchview.taf?ipid=93703
80,BC010336-17,"October 01, 2015 -  September 30, 2016",Lambda Genetic Networks and Lambda Red-Mediated Recombination,Donald L Court; PhD|IRP Faculty Profile,NULL,"Molecular Control and Genetics Section, NCI",Katherine Ann Cascino|Nina C Costantino|Lynn C Thomason|Gokhan  Tolun; PhD|Anna Isabell Weaver,"Max  Gottesman (Institute of Cancer Research, Columbia University)|Kenon  Murphy (Molecular Genetics and Microbiology, University of Massachusetts Med. School)|William  Margolin (Microbiology and Molecular Genetics, University of Texas Medical School)|Joel  Stavans (Physics of Complex Systems, Weizmann Institute of Science)",Mikhail V Kashlev (Molecular Mechanisms of Transcription Section)|Sankar  Adhya; PhD (Developmental Genetics Section)|Ding Jun Jin (Gene Regulation and Chromosome Biology Laboratory)|Xinhua  Ji; PhD (Biomolecular Structure Section)|David S Waugh; PhD (Protein Engineering Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93704
81,BC010338-17,"October 01, 2015 -  September 30, 2016",The Role of Fgf Signaling in Vertebrate Development,Mark B Lewandoski|IRP Faculty Profile,NULL,"Genetics of Vertebrate Development Section, NCI",Matthew J Anderson|Michael Graham Stanley Boylan|Cynthia M Elder,"Gregg  Duester (Department of OncoDevelopmental Biology, Burnham Institute)|Trevor  Williams (University of Colarado)|Gary C Schoenwolf|Thomas  Schimmang (University of Valladolid)|David M Ornitz; MD (Department of Developmental Biology, Washington University, School of Medicine)",NULL,NULL,"1. Anderson MJ, Southon E, Tessarollo L, Lewandoski M (2016). Fgf3-Fgf4-cis: A new mouse line for studying Fgf functions during mouse development. Genesis  54, 91-8.   https://doi.org/10.1002/dvg.22913|2. Cunningham TJ, Brade T, Sandell LL, Lewandoski M, Trainor PA, Colas A, Mercola M, Duester G (2015). Retinoic Acid Activity in Undifferentiated Neural Progenitors Is Sufficient to Fulfill Its Role in Restricting Fgf8 Expression for Somitogenesis. PLoS One  10, e0137894.   https://doi.org/10.1371/journal.pone.0137894|3. Hung IH, Schoenwolf GC, Lewandoski M, Ornitz DM (2016). A combined series of Fgf9 and Fgf18 mutant alleles identifies unique and redundant roles in skeletal development. Dev Biol  411, 72-84.   https://doi.org/10.1016/j.ydbio.2016.01.008",https://intramural.nih.gov/search/searchview.taf?ipid=93705
82,BC010341-17,"October 01, 2015 -  September 30, 2016",Protein Expression and Purification in the Fast Lane,David S Waugh; PhD|IRP Faculty Profile,NULL,"Protein Engineering Section, NCI",Timothy James Diethrich|Sreedevi  Nallamsetty|Danielle  Needle|Sreejith  Raran Kurussi; PhD,NULL,NULL,NULL,"1. Raran-Kurussi S, Keefe K, Waugh DS (2015). Positional effects of fusion partners on the yield and solubility of MBP fusion proteins. Protein Expr Purif  110, 159-64.   https://doi.org/10.1016/j.pep.2015.03.004|2. Waugh DS (2016). Crystal structures of MBP fusion proteins. Protein Sci  25, 559-71.   https://doi.org/10.1002/pro.2863",https://intramural.nih.gov/search/searchview.taf?ipid=93706
83,BC010345-17,"October 01, 2015 -  September 30, 2016",The Role of Wnt Genes in Vertebrate Development and Cancer,Terence P Yamaguchi; PhD|IRP Faculty Profile,NULL,"Cell Signaling in Vertebrate Development Section, NCI",Ravindra Babu  Chalamalasetty|Robert John Garriock|Akhil  Kapoor|Sara E Parkin,NULL,Mark B Lewandoski (Genetics of Vertebrate Development Section),NULL,"1. Ajima R, Bisson JA, Helt JC, Nakaya MA, Habas R, Tessarollo L, He X, Morrisey EE, Yamaguchi TP, Cohen ED (2015). DAAM1 and DAAM2 are co-required for myocardial maturation and sarcomere assembly. Dev Biol  408, 126-39.   https://doi.org/10.1016/j.ydbio.2015.10.003|2. Cunningham TJ, Kumar S, Yamaguchi TP, Duester G (2015). Wnt8a and Wnt3a cooperate in the axial stem cell niche to promote mammalian body axis extension. Dev Dyn  244, 797-807.   https://doi.org/10.1002/dvdy.24275|3. Garriock RJ, Chalamalasetty RB, Kennedy MW, Canizales LC, Lewandoski M, Yamaguchi TP (2015). Lineage tracing of neuromesodermal progenitors reveals novel Wnt-dependent roles in trunk progenitor cell maintenance and differentiation. Development  142, 1628-38.   https://doi.org/10.1242/dev.111922|4. Li D, Sinha T, Ajima R, Seo HS, Yamaguchi TP, Wang J (2016). Spatial regulation of cell cohesion by Wnt5a during second heart field progenitor deployment. Dev Biol  412, 18-31.   https://doi.org/10.1016/j.ydbio.2016.02.017|5. Tsukiyama T, Fukui A, Terai S, Fujioka Y, Shinada K, Takahashi H, Yamaguchi TP, Ohba Y, Hatakeyama S (2015). Molecular Role of RNF43 in Canonical and Noncanonical Wnt Signaling. Mol Cell Biol  35, 2007-23.   https://doi.org/10.1128/MCB.00159-15",https://intramural.nih.gov/search/searchview.taf?ipid=93707
84,BC010348-17,"October 01, 2015 -  September 30, 2016",Protein Structure,Alexander  Wlodawer; PhD|IRP Faculty Profile,NULL,"Macromolecular Crystallography Laboratory, NCI",NULL,NULL,Barry R O'Keefe (Molecular Targets Laboratory)|Zbigniew  Dauter (Synchrotron Radiation Research Section),NULL,"1. Jakób M, Lubkowski J, O'Keefe BR, Wlodawer A (2015). Structure of a lectin from the sea mussel Crenomytilus grayanus (CGL). Acta Crystallogr F Struct Biol Commun  71, 1429-36.   https://doi.org/10.1107/S2053230X15019858|2. Jaskolski M, Miller M, Mohana Rao JK, Gustchina A, Wlodawer A (2015). Elucidation of the structure of retroviral proteases: a reminiscence. FEBS J  282, 4059-66.   https://doi.org/10.1111/febs.13397|3. Li M, Gustchina A, Cruz R, Simões M, Curto P, Martinez J, Faro C, Simões I, Wlodawer A (2015). Structure of RC1339/APRc from Rickettsia conorii, a retropepsin-like aspartic protease. Acta Crystallogr D Biol Crystallogr  71, 2109-18.   https://doi.org/10.1107/S1399004715013905|4. Nunes NN, Ferreira RS, Silva-Lucca RA, de Sá LF, de Oliveira AE, Correia MT, Paiva PM, Wlodawer A, Oliva ML (2015). Potential of the Lectin/Inhibitor Isolated from Crataeva tapia Bark (CrataBL) for Controlling Callosobruchus maculatus Larva Development. J Agric Food Chem  63, 10431-6.   https://doi.org/10.1021/acs.jafc.5b03634|5. Pomés A, Chruszcz M, Gustchina A, Minor W, Mueller GA, Pedersen LC, Wlodawer A, Chapman MD (2015). 100 Years later: Celebrating the contributions of x-ray crystallography to allergy and clinical immunology. J Allergy Clin Immunol  136, 29-37.e10.   https://doi.org/10.1016/j.jaci.2015.05.016|6. Pomés A, Chruszcz M, Gustchina A, Wlodawer A (2015). Interfaces between allergen structure and diagnosis: know your epitopes. Curr Allergy Asthma Rep  15, 506.   https://doi.org/10.1007/s11882-014-0506-9|7. Zhou D, Hansen D, Shabalin IG, Gustchina A, Vieira DF, de Brito MV, Araújo AP, Oliva ML, Wlodawer A (2015). Structure of BbKI, a disulfide-free plasma kallikrein inhibitor. Acta Crystallogr F Struct Biol Commun  71, 1055-62.   https://doi.org/10.1107/S2053230X15011127",https://intramural.nih.gov/search/searchview.taf?ipid=93708
85,BC010350-17,"October 01, 2015 -  September 30, 2016",Prevention of AIDS,Barbara K Felber|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Candido  Alicea; PhD|Jenifer L Bear|Cristina  Bergamaschi|Frances Talieh Dayton|Xintao  Hu|Zhongyan  Lu|Show all 13,"Bart  Haynes (Duke Human Vaccine Institute)|Rama  Amara (Emory Vaccine Center)|Dan  Barouch (Harvard University)|Michael  Egan (Profectus Biosciences, Inc.)|John  Eldridge (Wyeth Lederle Vaccines)|Timothy  Fouts (Profectus BioSciences, Inc.)|Show all 16",NULL,Konstantinos  Petrovas (NIAID) |Mario  Roederer; PhD (NIAID),"1. Fouts TR, Bagley K, Prado IJ, Bobb KL, Schwartz JA, Xu R, Zagursky RJ, Egan MA, Eldridge JH, LaBranche CC, Montefiori DC, Le Buanec H, Zagury D, Pal R, Pavlakis GN, Felber BK, Franchini G, Gordon S, Vaccari M, Lewis GK, DeVico AL, Gallo RC (2015). Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection. Proc Natl Acad Sci U S A  112, E992-9.   https://doi.org/10.1073/pnas.1423669112|2. Hulot SL, Korber B, Giorgi EE, Vandergrift N, Saunders KO, Balachandran H, Mach LV, Lifton MA, Pantaleo G, Tartaglia J, Phogat S, Jacobs B, Kibler K, Perdiguero B, Gomez CE, Esteban M, Rosati M, Felber BK, Pavlakis GN, Parks R, Lloyd K, Sutherland L, Scearce R, Letvin NL, Seaman MS, et al. [5 more authors] (2015). Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost. J Virol  89, 6462-80.   https://doi.org/10.1128/JVI.00383-15|3. Li J, Valentin A, Beach RK, Alicea C, Felber BK, Pavlakis GN (2015). DNA is an efficient booster of dendritic cell-based vaccine. Hum Vaccin Immunother  11, 1927-35.   https://doi.org/10.1080/21645515.2015.1020265|4. Mothe B, Hu X, Llano A, Rosati M, Olvera A, Kulkarni V, Valentin A, Alicea C, Pilkington GR, Sardesai NY, Rocafort M, Crespo M, Carrillo J, Marco A, Mullins JI, Dorrell L, Hanke T, Clotet B, Pavlakis GN, Felber BK, Brander C (2015). A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques. J Transl Med  13, 60.   https://doi.org/10.1186/s12967-015-0392-5|5. Shen X, Duffy R, Howington R, Cope A, Sadagopal S, Park H, Pal R, Kwa S, Ding S, Yang OO, Fouda GG, Le Grand R, Bolton D, Esteban M, Phogat S, Roederer M, Amara RR, Picker LJ, Seder RA, McElrath MJ, Barnett S, Permar SR, Shattock R, DeVico AL, Felber BK, et al. [5 more authors] (2015). Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates. J Virol  89, 8643-50.   https://doi.org/10.1128/JVI.03635-14|6. Valentin A, Li J, Rosati M, Kulkarni V, Patel V, Jalah R, Alicea C, Reed S, Sardesai N, Berkower I, Pavlakis GN, Felber BK (2015). Dose-dependent inhibition of Gag cellular immunity by Env in SIV/HIV DNA vaccinated macaques. Hum Vaccin Immunother  11, 2005-11.   https://doi.org/10.1080/21645515.2015.1016671",https://intramural.nih.gov/search/searchview.taf?ipid=93709
86,BC010378-17,"October 01, 2015 -  September 30, 2016",Macromolecular Crystallography Research with Synchrotron Radiation,Zbigniew  Dauter|IRP Faculty Profile,NULL,"Synchrotron Radiation Research Section, NCI",Miroslawa  Dauter|Zhipu  Luo|Sergei V Pletnev|Milosz Jacek Ruszkowski; PhD,"Andrzej  Joachimiak (Biosciences, Argonne Natl. Lab.)|Wladek  Minor|Zbyszek  Otwinowski (Biomedical Sciences, Southwestern Medical School)|Mariusz  Jaskolski (University of  Poznan)|Gerold  Rosenbaum (SER-CAT, Univeresity of Georgia)|Vladislav  Verkhusha; PhD (Albert Einstein College of Medicine, Jack and Pearl Resnick Campus)",Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory),NULL,"1. Czerwinski A, Basava C, Dauter M, Dauter Z (2015). Crystal structure of N-{N-[N-acetyl-(S)-leuc-yl]-(S)-leuc-yl}norleucinal (ALLN), an inhibitor of proteasome. Acta Crystallogr E Crystallogr Commun  71, 254-7.   https://doi.org/10.1107/S2056989015002091|2. Dauter Z (2015). Solving coiled-coil protein structures. IUCrJ  2, 164-5.   https://doi.org/10.1107/S2052252515003486|3. Dauter Z, Wlodawer A (2015). On the accuracy of unit-cell parameters in protein crystallography. Acta Crystallogr D Biol Crystallogr  71, 2217-26.   https://doi.org/10.1107/S1399004715015503|4. Dauter Z, Wlodawer A (2016). Progress in protein crystallography. Protein Pept Lett  23, 201-10.   https://doi.org/10.2174/0929866523666160106153524|5. Liebschner D, Rosenbaum G, Dauter M, Dauter Z (2015). Radiation decay of thaumatin crystals at three X-ray energies. Acta Crystallogr D Biol Crystallogr  71, 772-8.   https://doi.org/10.1107/S1399004715001030|6. Malinska M, Dauter M, Kowiel M, Jaskolski M, Dauter Z (2015). Protonation and geometry of histidine rings. Acta Crystallogr D Biol Crystallogr  71, 1444-54.   https://doi.org/10.1107/S1399004715007816|7. Minor W, Dauter Z, Helliwell JR, Jaskolski M, Wlodawer A (2016). Safeguarding Structural Data Repositories against Bad Apples. Structure  24, 216-20.   https://doi.org/10.1016/j.str.2015.12.010|8. Pletnev VZ, Pletneva NV, Sarkisyan KS, Mishin AS, Lukyanov KA, Goryacheva EA, Ziganshin RH, Dauter Z, Pletnev S (2015). Structure of the green fluorescent protein NowGFP with an anionic tryptophan-based chromophore. Acta Crystallogr D Biol Crystallogr  71, 1699-707.   https://doi.org/10.1107/S1399004715010159|9. Pletneva NV, Pletnev VZ, Sarkisyan KS, Gorbachev DA, Egorov ES, Mishin AS, Lukyanov KA, Dauter Z, Pletnev S (2015). Crystal Structure of Phototoxic Orange Fluorescent Proteins with a Tryptophan-Based Chromophore. PLoS One  10, e0145740.   https://doi.org/10.1371/journal.pone.0145740|10. Ruszkowski M, Nocek B, Forlani G, Dauter Z (2015). The structure of Medicago truncatula δ(1)-pyrroline-5-carboxylate reductase provides new insights into regulation of proline biosynthesis in plants. Front Plant Sci  6, 869.   https://doi.org/10.3389/fpls.2015.00869|11. Shabalin I, Dauter Z, Jaskolski M, Minor W, Wlodawer A (2015). Crystallography and chemistry should always go together: a cautionary tale of protein complexes with cisplatin and carboplatin. Acta Crystallogr D Biol Crystallogr  71, 1965-79.   https://doi.org/10.1107/S139900471500629X|12. Shcherbakova DM, Baloban M, Pletnev S, Malashkevich VN, Xiao H, Dauter Z, Verkhusha VV (2015). Molecular Basis of Spectral Diversity in Near-Infrared Phytochrome-Based Fluorescent Proteins. Chem Biol  22, 1540-1551.   https://doi.org/10.1016/j.chembiol.2015.10.007|13. Sliwiak J, Dauter Z, Kowiel M, McCoy AJ, Read RJ, Jaskolski M (2015). ANS complex of St John's wort PR-10 protein with 28 copies in the asymmetric unit: a fiendish combination of pseudosymmetry with tetartohedral twinning. Acta Crystallogr D Biol Crystallogr  71, 829-43.   https://doi.org/10.1107/S1399004715001388",https://intramural.nih.gov/search/searchview.taf?ipid=93710
87,BC010379-17,"October 01, 2015 -  September 30, 2016",Search for the Structural Basis of Biomacromolecular Function and Activity,Yun Xing M Wang|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",NULL,NULL,Alan  Rein; PhD (Retroviral Replication Laboratory)|Xinhua  Ji; PhD (Biomolecular Structure Section),Adrian Riu Ferre-D'Amare (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93711
88,BC010380-17,"October 01, 2015 -  September 30, 2016",Recombination and Regulation,Jeffrey N Strathern,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93712
89,BC010381-17,"October 01, 2015 -  September 30, 2016",Studies on Silencing,Amar J S Klar; PhD,NULL,"Developmental Genetics Section, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93713
90,BC010385-17,"October 01, 2015 -  September 30, 2016",Studies on mat1 Imprinting,Amar J S Klar; PhD,NULL,"Developmental Genetics Section, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93714
91,BC010387-17,"October 01, 2015 -  September 30, 2016",Functional Analysis of Breast Cancer Susceptibility Genes in Mice,Shyam K Sharan|IRP Faculty Profile,NULL,"Genetics of Cancer Susceptibility Section, NCI",NULL,"Debananda  Pati (Texas Children's Cancer Center, Baylor College of Medicine)|William  Foulkes (McGill University)",Robert Andrew Byrd (Structural Biophysics Laboratory)|Jonathan  Keller; PhD (Mouse Cancer Genetics Program),NULL,"1. Hartford SA, Chittela R, Ding X, Vyas A, Martin B, Burkett S, Haines DC, Southon E, Tessarollo L, Sharan SK (2016). Interaction with PALB2 Is Essential for Maintenance of Genomic Integrity by BRCA2. PLoS Genet  12, e1006236.   https://doi.org/10.1371/journal.pgen.1006236",https://intramural.nih.gov/search/searchview.taf?ipid=93715
92,BC010390-17,"October 01, 2015 -  September 30, 2016",Role of Neurotrophins in the Development of the Mammalian Nervous System,Lino  Tessarollo|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Colleen A Barrick|Jodi L Becker|Gianluca  Fulgenzi|Zhenyi  Hong; PhD|Erkan  Kiris|Mary Ellen  Palko|Show all 8,"Italo  Mocchetti (Pharmacology, Georgetown University)|Juan Carlos  Arevalo (University of Salamanca)|Barbara  Hempstead (Cornell University)",NULL,NULL,"1. Fulgenzi G, Tomassoni-Ardori F, Babini L, Becker J, Barrick C, Puverel S, Tessarollo L (2015). BDNF modulates heart contraction force and  long-term homeostasis through truncated TrkB.T1  receptor activation. J Cell Biol  210, 1003-12.   https://doi.org/10.1083/jcb.201502100|2. Kiris E, Burnett JC, Nuss JE, Wanner LM, Peyser BD, Du HT, Gomba GY, Kota KP, Panchal RG, Gussio R, Kane CD, Tessarollo L, Bavari S (2015). SRC family kinase inhibitors antagonize the toxicity of multiple serotypes of botulinum neurotoxin in human embryonic stem cell-derived motor neurons. Neurotox Res  27, 384-98.   https://doi.org/10.1007/s12640-015-9526-z|3. Kiris E, Nuss JE, Stanford SM, Wanner LM, Cazares L, Maestre MF, Du HT, Gomba GY, Burnett JC, Gussio R, Bottini N, Panchal RG, Kane CD, Tessarollo L, Bavari S (2015). Phosphatase Inhibitors Function as Novel, Broad Spectrum Botulinum Neurotoxin Antagonists in Mouse and Human Embryonic Stem Cell-Derived Motor Neuron-Based Assays. PLoS One  10, e0129264.   https://doi.org/10.1371/journal.pone.0129264",https://intramural.nih.gov/search/searchview.taf?ipid=93716
93,BC010391-17,"October 01, 2015 -  September 30, 2016",Role of Trk Receptors in the Development and Function of Non-neuronal Structures,Lino  Tessarollo|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Colleen A Barrick|Jodi L Becker|Gianluca  Fulgenzi|Mary Ellen  Palko|Francesco  Tomassoni Ardori; PhD,NULL,NULL,NULL,"1. Fulgenzi G, Tomassoni-Ardori F, Babini L, Becker J, Barrick C, Puverel S, Tessarollo L (2015). BDNF modulates heart contraction force and  long-term homeostasis through truncated TrkB.T1  receptor activation. J Cell Biol  210, 1003-12.   https://doi.org/10.1083/jcb.201502100|2. Puverel S, Kiris E, Singh S, Klarmann KD, Coppola V, Keller JR, Tessarollo L (2016). RanBPM (RanBP9) regulates mouse c-Kit receptor level and is essential for normal development of bone marrow progenitor cells. Oncotarget  7, 85109-85123.   https://doi.org/10.18632/oncotarget.13198",https://intramural.nih.gov/search/searchview.taf?ipid=93717
94,BC010411-17,"October 01, 2015 -  September 30, 2016",Initiation of DNA Replication in Mammalian Cells,Mirit I Aladjem; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Haiqing  Fu|Sangmin  Jang|Anna Belle Marks|Christophe  Redon|Koichi  Utani|Yves  Pommier; PhD|Show all 7,"Eric  Bouhassira (hematology, Albert Einstein College of Medicine)|Jean-Marc  Lemaitre (Institute of Functional Genomics)|lizhao  wu (Rutgers New Jersey Medical School Cancer Center)","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Patricia  Steeg; PhD (Womens Malignancies Branch)",Karen P Usdin; PhD (NIDDK),"1. Bartholdy B, Mukhopadhyay R, Lajugie J, Aladjem MI, Bouhassira EE (2015). Allele-specific analysis of DNA replication origins in mammalian cells. Nat Commun  6, 7051.   https://doi.org/10.1038/ncomms8051|2. Fu H, Martin MM, Regairaz M, Huang L, You Y, Lin CM, Ryan M, Kim R, Shimura T, Pommier Y, Aladjem MI (2015). The DNA repair endonuclease Mus81 facilitates fast DNA replication in the absence of exogenous damage. Nat Commun  6, 6746.   https://doi.org/10.1038/ncomms7746|3. Kim R, Smith OK, Wong WC, Ryan AM, Ryan MC, Aladjem MI (2015). ColoWeb: a resource for analysis of colocalization of genomic features. BMC Genomics  16, 142.   https://doi.org/10.1186/s12864-015-1345-3|4. Luna A, McFadden GB, Aladjem MI, Kohn KW (2015). Predicted Role of NAD Utilization in the Control of Circadian Rhythms during DNA Damage Response. PLoS Comput Biol  11, e1004144.   https://doi.org/10.1371/journal.pcbi.1004144",https://intramural.nih.gov/search/searchview.taf?ipid=93718
95,BC010412-17,"October 01, 2015 -  September 30, 2016",Structural Analysis of Macromolecular Complexes by Electron Microscopy,Jacqueline L Milne,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",Sriram  Subramaniam; PhD,NULL,NULL,NULL,"1. Banerjee S, Bartesaghi A, Merk A, Rao P, Bulfer SL, Yan Y, Green N, Mroczkowski B, Neitz RJ, Wipf P, Falconieri V, Deshaies RJ, Milne JL, Huryn D, Arkin M, Subramaniam S (2016). 2.3 Å resolution cryo-EM structure of human p97 and mechanism of allosteric inhibition. Science  351, 871-5.   https://doi.org/10.1126/science.aad7974|2. Bartesaghi A, Merk A, Banerjee S, Matthies D, Wu X, Milne JL, Subramaniam S (2015). 2.2 Å resolution cryo-EM structure of β-galactosidase in complex with a cell-permeant inhibitor. Science  348, 1147-51.   https://doi.org/10.1126/science.aab1576|3. Merk A, Bartesaghi A, Banerjee S, Falconieri V, Rao P, Davis MI, Pragani R, Boxer MB, Earl LA, Milne JLS, Subramaniam S (2016). Breaking Cryo-EM Resolution Barriers to Facilitate Drug Discovery. Cell  165, 1698-1707.   https://doi.org/10.1016/j.cell.2016.05.040",https://intramural.nih.gov/search/searchview.taf?ipid=93719
96,BC010413-16,"October 01, 2015 -  September 30, 2016",Human Artificial Chromosomes for Cancer Research and Functional Genomics,"Vladimir L Larionov; PhD, DSc|IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI",Nikolay V Goncharov|Jung-Hyun  Kim|Hee-Sheung  Lee|Mikhail A Liskovykh|Nikolai S Petrov|Nicole M Bedanova|Show all 7,"Mitsuo  Oshimura (Tottori University)|William  Earnshaw (Laboratory of Cell Biology, Wellcome Trust Centre for Cell Biology)|Hiroshi  Masumoto (NCI)",NULL,NULL,"1. Kim JH, Lee HS, Lee NC, Goncharov NV, Kumeiko V, Masumoto H, Earnshaw WC, Kouprina N, Larionov V (2016). Development of a novel HAC-based ""gain of signal"" quantitative assay for measuring chromosome instability (CIN) in cancer cells. Oncotarget  7, 14841-56.   https://doi.org/10.18632/oncotarget.7854|2. Kouprina N, Larionov V (2016). Transformation-associated recombination (TAR) cloning for genomics studies and synthetic biology. Chromosoma  125, 621-32.   https://doi.org/10.1007/s00412-016-0588-3|3. Lee HS, Lee NC, Kouprina N, Kim JH, Kagansky A, Bates S, Trepel JB, Pommier Y, Sackett D, Larionov V (2016). Effects of Anticancer Drugs on Chromosome Instability and New Clinical Implications for Tumor-Suppressing Therapies. Cancer Res  76, 902-11.   https://doi.org/10.1158/0008-5472.CAN-15-1617|4. Markossian S, Arnaoutov A, Saba NS, Larionov V, Dasso M (2016). Quantitative assessment of chromosome instability induced through chemical disruption of mitotic progression. Cell Cycle  15, 1706-14.   https://doi.org/10.1080/15384101.2016.1175796|5. Ohzeki J, Shono N, Otake K, Martins NM, Kugou K, Kimura H, Nagase T, Larionov V, Earnshaw WC, Masumoto H (2016). KAT7/HBO1/MYST2 Regulates CENP-A Chromatin Assembly by Antagonizing Suv39h1-Mediated Centromere Inactivation. Dev Cell  37, 413-27.   https://doi.org/10.1016/j.devcel.2016.05.006|6. Shono N, Ohzeki J, Otake K, Martins NM, Nagase T, Kimura H, Larionov V, Earnshaw WC, Masumoto H (2015). CENP-C and CENP-I are key connecting factors for kinetochore and CENP-A assembly. J Cell Sci  128, 4572-87.   https://doi.org/10.1242/jcs.180786|7. Yoon SL, Roh YG, Chu IS, Heo J, Kim SI, Chang H, Kang TH, Chung JW, Koh SS, Larionov V, Leem SH (2016) A polymorphic minisatellite region of BORIS regulates gene expression and its rare variants correlate with lung cancer susceptibility. Exp Mol Med 48:e246",https://intramural.nih.gov/search/searchview.taf?ipid=93618
97,BC010418-17,"October 01, 2015 -  September 30, 2016",Signaling Events Regulating Chemotaxis,Carole A Parent; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Song  Chen|Paul W Kriebel|Wolfgang  Losert; PhD|Weiye  Wang,NULL,Daniel Robert Larson; PhD (Laboratory of Receptor Biology and Gene Expression),Alan Robert Kimmel; PhD (NIDDK),"1. Liao XH, Meena NP, Southall N, Liu L, Swaroop M, Zhang AL, Xiang JJ, Parent CA, Zheng W, Kimmel AR (2016). A High-Throughput, Multi-Cell Phenotype Assay for the Identification of Novel Inhibitors of Chemotaxis/Migration. Sci Rep  6, 22273.   https://doi.org/10.1038/srep22273|2. Sun X, Driscoll MK, Guven C, Das S, Parent CA, Fourkas JT, Losert W (2015). Asymmetric nanotopography biases cytoskeletal dynamics and promotes unidirectional cell guidance. Proc Natl Acad Sci U S A  112, 12557-62.   https://doi.org/10.1073/pnas.1502970112",https://intramural.nih.gov/search/searchview.taf?ipid=93720
98,BC010419-17,"October 01, 2015 -  September 30, 2016",Molecular Mechanisms of TGF-beta Signaling Pathway,Ying  Zhang|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Mary E Heller|Liuya  Tang|Veenu  Tripathi; PhD|Xuan  Xu|Kun  Zhu; PhD,NULL,Ming  Zhou (Nucleic Acids Section)|Jing  Huang (Laboratory of Cancer Biology and Genetics)|Lisa Marie Jenkins (Pigment Cell Biology Section)|James  Gao (Office of the Director),"Sushil Gopal Rane; MS, PhD (NIDDK)","1. Zhang Y (2016) Non-Scad Signaling Pathways of the TGF-beta family. Cold Spring Harb Prospect Biol, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=93721
99,BC010425-17,"October 01, 2015 -  September 30, 2016",Strategies for Cancer Immunotherapy Clinical Trials,Jeffrey  Schlom; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Renee Nicole Donahue|Morgan Lee Gargulak|Italia  Grenga|Lauren Marissa Lepone|Kwong Yok Tsang|James W Hodge; PhD|Show all 7,NULL,Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Raffit  Hassan (Thoracic & Oncologic Surgery Branch)|William D Figg; PharmD (Genitourinary Malignancies Branch)|William Laurence Dahut; MD (Genitourinary Malignancies Branch)|Arun  Rajan (Thoracic & Oncologic Surgery Branch)|Peter A Pinto; MD (Urologic Oncology Branch),NULL,"1. Farsaci B, Donahue R, Grenga I, Lepone L, Kim P, Dempsey B, Siebert J, Ibrahim N, Madan R, Heery C, Gulley J, Schlom J (2016) Analyses of pre-therapy peripheral immunoscore and response to vaccine therapy. Cancer Immunology Research, in press.|2. Gulley JL, Marté J, Heery CR, Madan RA, Steinberg SM, Leitman SF, Tsang KY, Schlom J (2015). The impact of leukapheresis on immune-cell number and function in patients with advanced cancer. Cancer Immunol Immunother  64, 1429-35.   https://doi.org/10.1007/s00262-015-1738-9|3. Heery CR, Ibrahim NK, Arlen PM, Mohebtash M, Murray JL, Koenig K, Madan RA, McMahon S, Marté JL, Steinberg SM, Donahue RN, Grenga I, Jochems C, Farsaci B, Folio LR, Schlom J, Gulley JL (2015). Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast Cancer: A Randomized Clinical Trial. JAMA Oncol  1, 1087-95.   https://doi.org/10.1001/jamaoncol.2015.2736|4. Heery CR, Singh BH, Rauckhorst M, Marté JL, Donahue RN, Grenga I, Rodell TC, Dahut W, Arlen PM, Madan RA, Schlom J, Gulley JL (2015). Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury. Cancer Immunol Res  3, 1248-56.   https://doi.org/10.1158/2326-6066.CIR-15-0119|5. Roselli M, Formica V, Cereda V, Jochems C, Richards J, Grenga I, Orlandi A, Ferroni P, Guadagni F, Schlom J (2016) The association of clinical outcome and peripheral T-cell subsets in metastatic colorectal cancer patients receiving first-line FOLFIRI plus bevacizumab therapy. OncoImmunology, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=93722
100,BC010440-15,"October 01, 2015 -  September 30, 2016","Protein Structure, Stability, and Amyloid Formation",Ruth  Nussinov; PhD,NULL,"Cancer Inflammation Program, NCI",Ayse Bahar  Delibas; PhD|Emine  Guven Maiorov; MSC|Hyunbum  Jang|Shuai  Li|Tsung-Jen  Liao|Buyong  Ma|Show all 16,"Turkan  Haliloglu|Ozlem  Keskin (Koc University)|Attila  Gursoy (Computer Science Dept., Koc University)|Haim  Wolfson (Tel Aviv Univ)|Ratnesh  Lal (Medical School, University of Chicago)|Bruce  Kagan (UCLA)|Show all 13",NULL,NULL,"1. Banerjee A, Jang H, Nussinov R, Gaponenko V (2016). The disordered hypervariable region and the folded catalytic domain of oncogenic K-Ras4B partner in phospholipid binding. Curr Opin Struct Biol  36, 10-7.   https://doi.org/10.1016/j.sbi.2015.11.010|2. Baram M, Atsmon-Raz Y, Ma B, Nussinov R, Miller Y (2016). Amylin-Aβ oligomers at atomic resolution using molecular dynamics simulations: a link between Type 2 diabetes and Alzheimer's disease. Phys Chem Chem Phys  18, 2330-8.   https://doi.org/10.1039/c5cp03338a|3. Chavan TS, Jang H, Khavrutskii L, Abraham SJ, Banerjee A, Freed BC, Johannessen L, Tarasov SG, Gaponenko V, Nussinov R, Tarasova NI (2015). High-Affinity Interaction of the K-Ras4B Hypervariable Region with the Ras Active Site. Biophys J  109, 2602-2613.   https://doi.org/10.1016/j.bpj.2015.09.034|4. Chavan TS, Muratcioglu S, Marszalek R, Jang H, Keskin O, Gursoy A, Nussinov R, Gaponenko V (2015). Plasma membrane regulates Ras signaling networks. Cell Logist  5, e1136374.   https://doi.org/10.1080/21592799.2015.1136374|5. Clausen R, Ma B, Nussinov R, Shehu A (2015). Mapping the Conformation Space of Wildtype and Mutant H-Ras with a Memetic, Cellular, and Multiscale Evolutionary Algorithm. PLoS Comput Biol  11, e1004470.   https://doi.org/10.1371/journal.pcbi.1004470|6. Csermely P, Korcsmáros T, Nussinov R (2016). Intracellular and intercellular signaling networks in cancer initiation, development and precision anti-cancer therapy: RAS acts as contextual signaling hub. Semin Cell Dev Biol  58, 55-9.   https://doi.org/10.1016/j.semcdb.2016.07.005|7. Datta SA, Clark PK, Fan L, Ma B, Harvin DP, Sowder RC, Nussinov R, Wang YX, Rein A (2016). Dimerization of the SP1 Region of HIV-1 Gag Induces a Helical Conformation and Association into Helical Bundles: Implications for Particle Assembly. J Virol  90, 1773-87.   https://doi.org/10.1128/JVI.02061-15|8. Guven-Maiorov E, Keskin O, Gursoy A, Nussinov R (2015). A Structural View of Negative Regulation of the Toll-like Receptor-Mediated Inflammatory Pathway. Biophys J  109, 1214-26.   https://doi.org/10.1016/j.bpj.2015.06.048|9. Guven-Maiorov E, Keskin O, Gursoy A, VanWaes C, Chen Z, Tsai CJ, Nussinov R (2015). The Architecture of the TIR Domain Signalosome in the Toll-like Receptor-4 Signaling Pathway. Sci Rep  5, 13128.   https://doi.org/10.1038/srep13128|10. Jang H, Abraham SJ, Chavan TS, Hitchinson B, Khavrutskii L, Tarasova NI, Nussinov R, Gaponenko V (2015). Mechanisms of membrane binding of small GTPase K-Ras4B farnesylated hypervariable region. J Biol Chem  290, 9465-77.   https://doi.org/10.1074/jbc.M114.620724|11. Jang H, Banerjee A, Chavan TS, Lu S, Zhang J, Gaponenko V, Nussinov R (2016). The higher level of complexity of K-Ras4B activation at the membrane. FASEB J  30, 1643-55.   https://doi.org/10.1096/fj.15-279091|12. Lei J, Qi R, Wei G, Nussinov R, Ma B (2016). Self-aggregation and coaggregation of the p53 core fragment with its aggregation gatekeeper variant. Phys Chem Chem Phys  18, 8098-107.   https://doi.org/10.1039/c5cp06538k|13. Lu S, Banerjee A, Jang H, Zhang J, Gaponenko V, Nussinov R (2015). GTP Binding and Oncogenic Mutations May Attenuate Hypervariable Region (HVR)-Catalytic Domain Interactions in Small GTPase K-Ras4B, Exposing the Effector Binding Site. J Biol Chem  290, 28887-900.   https://doi.org/10.1074/jbc.M115.664755|14. Lu S, Jang H, Gu S, Zhang J, Nussinov R (2016). Drugging Ras GTPase: a comprehensive mechanistic and signaling structural view. Chem Soc Rev  45, 4929-52.   https://doi.org/10.1039/c5cs00911a|15. Lu S, Jang H, Nussinov R, Zhang J (2016). The Structural Basis of Oncogenic Mutations G12, G13 and Q61 in Small GTPase K-Ras4B. Sci Rep  6, 21949.   https://doi.org/10.1038/srep21949|16. Ma B, Zhao J, Nussinov R (2016). Conformational selection in amyloid-based immunotherapy: Survey of crystal structures of antibody-amyloid complexes. Biochim Biophys Acta  1860, 2672-81.   https://doi.org/10.1016/j.bbagen.2016.05.040|17. Maximova T, Moffatt R, Ma B, Nussinov R, Shehu A (2016). Principles and Overview of Sampling Methods for Modeling Macromolecular Structure and Dynamics. PLoS Comput Biol  12, e1004619.   https://doi.org/10.1371/journal.pcbi.1004619|18. Muratcioglu S, Chavan TS, Freed BC, Jang H, Khavrutskii L, Freed RN, Dyba MA, Stefanisko K, Tarasov SG, Gursoy A, Keskin O, Tarasova NI, Gaponenko V, Nussinov R (2015). GTP-Dependent K-Ras Dimerization. Structure  23, 1325-35.   https://doi.org/10.1016/j.str.2015.04.019|19. Muratcioglu S, Presman DM, Pooley JR, Grøntved L, Hager GL, Nussinov R, Keskin O, Gursoy A (2015). Structural Modeling of GR Interactions with the SWI/SNF Chromatin Remodeling Complex and C/EBP. Biophys J  109, 1227-39.   https://doi.org/10.1016/j.bpj.2015.06.044|20. Nussinov R, Muratcioglu S, Tsai CJ, Jang H, Gursoy A, Keskin O (2015). The Key Role of Calmodulin in KRAS-Driven Adenocarcinomas. Mol Cancer Res  13, 1265-73.   https://doi.org/10.1158/1541-7786.MCR-15-0165|21. Nussinov R, Tsai CJ, Chakrabarti M, Jang H (2016). A New View of Ras Isoforms in Cancers. Cancer Res  76, 18-23.   https://doi.org/10.1158/0008-5472.CAN-15-1536|22. Wei G, Xi W, Nussinov R, Ma B (2016). Protein Ensembles: How Does Nature Harness Thermodynamic Fluctuations for Life? The Diverse Functional Roles of Conformational Ensembles in the Cell. Chem Rev  116, 6516-51.   https://doi.org/10.1021/acs.chemrev.5b00562|23. Xiao Y, Ma B, McElheny D, Parthasarathy S, Long F, Hoshi M, Nussinov R, Ishii Y (2015). Aβ(1-42) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer's disease. Nat Struct Mol Biol  22, 499-505.   https://doi.org/10.1038/nsmb.2991|24. Xu L, Nussinov R, Ma B (2016). Allosteric stabilization of the amyloid-β peptide hairpin by the fluctuating N-terminal. Chem Commun (Camb)  52, 1733-6.   https://doi.org/10.1039/c5cc08107f|25. Xu L, Nussinov R, Ma B (2016). Coupling of the non-amyloid-component (NAC) domain and the KTK(E/Q)GV repeats stabilize the α-synuclein fibrils. Eur J Med Chem  121, 841-850.   https://doi.org/10.1016/j.ejmech.2016.01.044|26. Xu L, Shan S, Chen Y, Wang X, Nussinov R, Ma B (2015). Coupling of Zinc-Binding and Secondary Structure in Nonfibrillar Aβ40 Peptide Oligomerization. J Chem Inf Model  55, 1218-30.   https://doi.org/10.1021/acs.jcim.5b00063|27. Zhou P, Zhang N, Nussinov R, Ma B (2015). Defining the Domain Arrangement of the Mammalian Target of Rapamycin Complex Component Rictor Protein. J Comput Biol  22, 876-86.   https://doi.org/10.1089/cmb.2015.0103|28. Zhu Y, Ma B, Qi R, Nussinov R, Zhang Q (2016). Temperature-Dependent Conformational Properties of Human Neuronal Calcium Sensor-1 Protein Revealed by All-Atom Simulations. J Phys Chem B  120, 3551-9.   https://doi.org/10.1021/acs.jpcb.5b12299|29. Zhu Y, Yang S, Qi R, Zou Y, Ma B, Nussinov R, Zhang Q (2015). Effects of the C-Terminal Tail on the Conformational Dynamics of Human Neuronal Calcium Sensor-1 Protein. J Phys Chem B  119, 14236-44.   https://doi.org/10.1021/acs.jpcb.5b07962",https://intramural.nih.gov/search/searchview.taf?ipid=93691
101,BC010441-15,"October 01, 2015 -  September 30, 2016",Biomolecular Recognition and Binding Mechanisms,Ruth  Nussinov; PhD,NULL,"Cancer Inflammation Program, NCI",Emine  Guven Maiorov; MSC|Hyunbum  Jang|Tsung-Jen  Liao|Buyong  Ma|Chung  Tsai|Giorgio  Trinchieri|Show all 7,"Turkan  Haliloglu|Ozlem  Keskin (Koc University)|Attila  Gursoy (Computer Science Dept., Koc University)|Haim  Wolfson (Tel Aviv Univ)|Peter  Csermely (Semmelweis University)|Jie  Zheng (University of Akron)|Show all 9",NULL,NULL,"1. 1 Guve, 2 Tsai, 3 Nuss (2016) Pathogen mimicry of host protein-protein interfaces modulates immunity. Semin Cell Dev Biol, in press.|2. Chavan TS, Jang H, Khavrutskii L, Abraham SJ, Banerjee A, Freed BC, Johannessen L, Tarasov SG, Gaponenko V, Nussinov R, Tarasova NI (2015). High-Affinity Interaction of the K-Ras4B Hypervariable Region with the Ras Active Site. Biophys J  109, 2602-2613.   https://doi.org/10.1016/j.bpj.2015.09.034|3. Chavan TS, Muratcioglu S, Marszalek R, Jang H, Keskin O, Gursoy A, Nussinov R, Gaponenko V (2015). Plasma membrane regulates Ras signaling networks. Cell Logist  5, e1136374.   https://doi.org/10.1080/21592799.2015.1136374|4. Clausen R, Ma B, Nussinov R, Shehu A (2015). Mapping the Conformation Space of Wildtype and Mutant H-Ras with a Memetic, Cellular, and Multiscale Evolutionary Algorithm. PLoS Comput Biol  11, e1004470.   https://doi.org/10.1371/journal.pcbi.1004470|5. Datta SA, Clark PK, Fan L, Ma B, Harvin DP, Sowder RC, Nussinov R, Wang YX, Rein A (2016). Dimerization of the SP1 Region of HIV-1 Gag Induces a Helical Conformation and Association into Helical Bundles: Implications for Particle Assembly. J Virol  90, 1773-87.   https://doi.org/10.1128/JVI.02061-15|6. Guven-Maiorov E, Keskin O, Gursoy A, Nussinov R (2015). A Structural View of Negative Regulation of the Toll-like Receptor-Mediated Inflammatory Pathway. Biophys J  109, 1214-26.   https://doi.org/10.1016/j.bpj.2015.06.048|7. Guven-Maiorov E, Keskin O, Gursoy A, VanWaes C, Chen Z, Tsai CJ, Nussinov R (2015). The Architecture of the TIR Domain Signalosome in the Toll-like Receptor-4 Signaling Pathway. Sci Rep  5, 13128.   https://doi.org/10.1038/srep13128|8. Jang H, Abraham SJ, Chavan TS, Hitchinson B, Khavrutskii L, Tarasova NI, Nussinov R, Gaponenko V (2015). Mechanisms of membrane binding of small GTPase K-Ras4B farnesylated hypervariable region. J Biol Chem  290, 9465-77.   https://doi.org/10.1074/jbc.M114.620724|9. Lu S, Banerjee A, Jang H, Zhang J, Gaponenko V, Nussinov R (2015). GTP Binding and Oncogenic Mutations May Attenuate Hypervariable Region (HVR)-Catalytic Domain Interactions in Small GTPase K-Ras4B, Exposing the Effector Binding Site. J Biol Chem  290, 28887-900.   https://doi.org/10.1074/jbc.M115.664755|10. Muratcioglu S, Chavan TS, Freed BC, Jang H, Khavrutskii L, Freed RN, Dyba MA, Stefanisko K, Tarasov SG, Gursoy A, Keskin O, Tarasova NI, Gaponenko V, Nussinov R (2015). GTP-Dependent K-Ras Dimerization. Structure  23, 1325-35.   https://doi.org/10.1016/j.str.2015.04.019|11. Muratcioglu S, Presman DM, Pooley JR, Grøntved L, Hager GL, Nussinov R, Keskin O, Gursoy A (2015). Structural Modeling of GR Interactions with the SWI/SNF Chromatin Remodeling Complex and C/EBP. Biophys J  109, 1227-39.   https://doi.org/10.1016/j.bpj.2015.06.044|12. Nussinov R, Muratcioglu S, Tsai CJ, Jang H, Gursoy A, Keskin O (2015). The Key Role of Calmodulin in KRAS-Driven Adenocarcinomas. Mol Cancer Res  13, 1265-73.   https://doi.org/10.1158/1541-7786.MCR-15-0165|13. Nussinov R, Tsai CJ, Chakrabarti M, Jang H (2016). A New View of Ras Isoforms in Cancers. Cancer Res  76, 18-23.   https://doi.org/10.1158/0008-5472.CAN-15-1536|14. Xiao Y, Ma B, McElheny D, Parthasarathy S, Long F, Hoshi M, Nussinov R, Ishii Y (2015). Aβ(1-42) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer's disease. Nat Struct Mol Biol  22, 499-505.   https://doi.org/10.1038/nsmb.2991|15. Xu L, Shan S, Chen Y, Wang X, Nussinov R, Ma B (2015). Coupling of Zinc-Binding and Secondary Structure in Nonfibrillar Aβ40 Peptide Oligomerization. J Chem Inf Model  55, 1218-30.   https://doi.org/10.1021/acs.jcim.5b00063|16. Zhou P, Zhang N, Nussinov R, Ma B (2015). Defining the Domain Arrangement of the Mammalian Target of Rapamycin Complex Component Rictor Protein. J Comput Biol  22, 876-86.   https://doi.org/10.1089/cmb.2015.0103|17. Zhu Y, Yang S, Qi R, Zou Y, Ma B, Nussinov R, Zhang Q (2015). Effects of the C-Terminal Tail on the Conformational Dynamics of Human Neuronal Calcium Sensor-1 Protein. J Phys Chem B  119, 14236-44.   https://doi.org/10.1021/acs.jpcb.5b07962",https://intramural.nih.gov/search/searchview.taf?ipid=93692
102,BC010442-15,"October 01, 2015 -  September 30, 2016",Method Development: Efficient Computer Vision Based Algorithms,Ruth  Nussinov; PhD,NULL,"Cancer Inflammation Program, NCI",Ayse Bahar  Delibas; PhD|Hyunbum  Jang|Chung  Tsai,"Turkan  Haliloglu|Ozlem  Keskin (Koc University)|Attila  Gursoy (Computer Science Dept., Koc University)|Haim  Wolfson (Tel Aviv Univ)|Jie  Zheng (University of Akron)|Yoshitaka  Ishii|Show all 8",NULL,NULL,"1. Clausen R, Ma B, Nussinov R, Shehu A (2015). Mapping the Conformation Space of Wildtype and Mutant H-Ras with a Memetic, Cellular, and Multiscale Evolutionary Algorithm. PLoS Comput Biol  11, e1004470.   https://doi.org/10.1371/journal.pcbi.1004470|2. Ma B, Zhao J, Nussinov R (2016). Conformational selection in amyloid-based immunotherapy: Survey of crystal structures of antibody-amyloid complexes. Biochim Biophys Acta  1860, 2672-81.   https://doi.org/10.1016/j.bbagen.2016.05.040|3. Maximova T, Moffatt R, Ma B, Nussinov R, Shehu A (2016). Principles and Overview of Sampling Methods for Modeling Macromolecular Structure and Dynamics. PLoS Comput Biol  12, e1004619.   https://doi.org/10.1371/journal.pcbi.1004619|4. Nussinov R, Tsai CJ, Chakrabarti M, Jang H (2016). A New View of Ras Isoforms in Cancers. Cancer Res  76, 18-23.   https://doi.org/10.1158/0008-5472.CAN-15-1536",https://intramural.nih.gov/search/searchview.taf?ipid=93695
103,BC010449-15,"October 01, 2015 -  September 30, 2016",Role of Novel Cytokine-like Molecules Secretoglobin (SCGB) 3A1 and 3A2 in Lung,Shioko  Kimura; PhD|IRP Faculty Profile,NULL,"Endocrinology Section, NCI",Lei  Xu|Shigetoshi  Yokoyama,Reiko  Kurotani|Aprile  Pilon (Therabron Therapeutics),Frank Jess Gonzalez; PhD (Laboratory of Metabolism),"Jerrold M Ward; DVM, PhD (NIAID) |Bin  Gao; MD, PhD (NIAAA)","1. Cai Y, Kimura S (2015). Secretoglobin 3A2 Exhibits Anti-Fibrotic Activity in Bleomycin-Induced Pulmonary Fibrosis Model Mice. PLoS One  10, e0142497.   https://doi.org/10.1371/journal.pone.0142497|2. Cai Y, Yoneda M, Tomita T, Kurotani R, Okamoto M, Kido T, Abe H, Mitzner W, Guha A, Kimura S (2015) Transgenically-expressed secretoglobin 3A2 accelerates resolution of bleomycin-induced pulmonary fibrosis in mice. BMC Pulm Med 15:72|3. Kurotani R, Shima R, Miyano Y, Sakahara S, Matsumoto Y, Shibata Y, Abe H, Kimura S (2015). SCGB3A2 Inhibits Acrolein-Induced Apoptosis through Decreased p53 Phosphorylation. Acta Histochem Cytochem  48, 61-8.   https://doi.org/10.1267/ahc.14065|4. Xu MJ, Cai Y, Wang H, Altamirano J, Chang B, Bertola A, Odena G, Lu J, Tanaka N, Matsusue K, Matsubara T, Mukhopadhyay P, Kimura S, Pacher P, Gonzalez FJ, Bataller R, Gao B (2015). Fat-Specific Protein 27/CIDEC Promotes Development of Alcoholic Steatohepatitis in Mice and Humans. Gastroenterology  149, 1030-41.e6.   https://doi.org/10.1053/j.gastro.2015.06.009|5. Yoneda M, Molinolo AA, Ward JM, Kimura S, Goodlad RA (2015). A Simple Device to Rapidly Prepare Whole Mounts of the Mouse Intestine. J Vis Exp   e53042  https://doi.org/10.3791/53042",https://intramural.nih.gov/search/searchview.taf?ipid=93723
104,BC010451-15,"October 01, 2015 -  September 30, 2016",Carbohydrate Antigen-bearing Nanoparticles for Antitumor Therapy,Joseph John Barchi|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Shailesh Gulabrao Ambre; PhD|Jennifer Rose Marshall|M A Siddiqui|Jeffrey  Gildersleeve,NULL,NULL,NULL,"1. Ambre S, Barchi J (2015) Carbohydrate Nanotechnology and its Applications for the Treatment of Cancer, in Carbohydrate Nanotechnology. , pp. 335-368.|2. Biswas S, Medina SH, Barchi JJ (2015). Synthesis and cell-selective antitumor properties of amino acid conjugated tumor-associated carbohydrate antigen-coated gold nanoparticles. Carbohydr Res  405, 93-101.   https://doi.org/10.1016/j.carres.2014.11.002",https://intramural.nih.gov/search/searchview.taf?ipid=93787
105,BC010453-15,"October 01, 2015 -  September 30, 2016",Identify SNPs and Polymorphisms Involved in the Development of Prostate Cancer,William D Figg; PharmD|IRP Faculty Profile,NULL,"Genitourinary Malignancies Branch, NCI",Cindy Huong-Bich Chau|Douglas K Price|Edel Marie McCrea,Alan  Kristal (Fred Hutchinson Cancer Research Center)|Ian Abban Thompson; MD|Robin  Leach (UT Health Science Center San Antonio)|Phyllis  Goodman (Fred Hutchinson Cancer Research Center)|Ashraful  Hoque (MD Anderson Cancer Center)|Marian  Neuhouser (Fred Hutchinson Cancer Research Center)|Show all 10,Howard  Parnes (Prostate and Urologic Cancer Research Group),NULL,"1. Chau CH, Price DK, Till C, Goodman PJ, Chen X, Leach RJ, Johnson-Pais TL, Hsing AW, Hoque A, Tangen CM, Chu L, Parnes HL, Schenk JM, Reichardt JK, Thompson IM, Figg WD (2015). Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention Trial. PLoS One  10, e0126672.   https://doi.org/10.1371/journal.pone.0126672|2. Figg WD, Thompson IM (2015). Effect of 5α-Reductase Inhibitor Use on Mortality From Prostate Cancer. JAMA Oncol  1, 321-2.   https://doi.org/10.1001/jamaoncol.2015.0408|3. Goey AK, Figg WD (2016). UGT genotyping in belinostat dosing. Pharmacol Res  105, 22-7.   https://doi.org/10.1016/j.phrs.2016.01.002|4. Goey AK, Sissung TM, Peer CJ, Figg WD (2016). Pharmacogenomics and histone deacetylase inhibitors. Pharmacogenomics  17, 1807-1815.   https://doi.org/10.2217/pgs-2016-0113|5. Hoque A, Yao S, Till C, Kristal AR, Goodman PJ, Hsing AW, Tangen CM, Platz EA, Stanczyk FZ, Reichardt JK, vanBokhoven A, Neuhouser ML, Santella RM, Figg WD, Price DK, Parnes HL, Lippman SM, Ambrosone CB, Thompson IM (2015). Effect of finasteride on serum androstenedione and risk of prostate cancer within the prostate cancer prevention trial: differential effect on high- and low-grade disease. Urology  85, 616-20.   https://doi.org/10.1016/j.urology.2014.11.024|6. Leibrand CR, Price DK, Figg WD (2016). Androgen receptor splice variant 7 (AR-V7) and drug efficacy in castration-resistant prostate cancer: Biomarker for treatment selection exclusion or inclusion? Cancer Biol Ther  17, 467-9.   https://doi.org/10.1080/15384047.2016.1156274|7. McCrea E, Sissung T, Chau C, Price D, Figg W (2016) Androgen receptor variation affects prostate cancer progression and drug resistance. Pharmacological Research, in press.|8. Polman DJ, Price DK, Figg WD (2015). New bigenic mouse model increases the understanding of genetic synergism in the progression of prostate cancer. Cancer Biol Ther  16, 1702-3.   https://doi.org/10.1080/15384047.2015.1108498|9. Strope JD, Price DK, Figg WD (2016). Building a hit list for the fight against metastatic castration resistant prostate cancer. Cancer Biol Ther  17, 231-2.   https://doi.org/10.1080/15384047.2016.1139270",https://intramural.nih.gov/search/searchview.taf?ipid=93724
106,BC010476-14,"October 01, 2015 -  September 30, 2016",Time Domian Electron Paramagnetic Resonance Imaging,Murali  Krishna; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",James B Mitchell; PhD,Robert  Gillies (Moffitt Cancer Center)|Charles  Hart (Threshold Pharmaceuticals),NULL,Alan Paul Koretsky; PhD (NINDS) |Jeeva P Munasinghe (NINDS) |Thomas J Pohida; MS (CIT),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93734
107,BC010477-14,"October 01, 2015 -  September 30, 2016",Overhauser Enhanced Magnetic Resonance Imaging (OMRI),Murali  Krishna; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",James B Mitchell; PhD,NULL,NULL,Alan Paul Koretsky; PhD (NINDS) |Jeeva P Munasinghe (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93733
108,BC010481-14,"October 01, 2015 -  September 30, 2016",HIV-1 Reverse Transcriptase,Stephen H Hughes; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Paul L Boyer|Patrick K Clark|Linda L Dunn|Andrea L Ferris|Steven J Smith,"Eddy  Arnold; PhD (Chemistry and Chemical Biology, CABM and Rutgers University)|Zandrea  Ambrose (University of Pittsburgh)|Stefan  Sarafianos (Department of Molecular Microbiology & Immunology, University of Missouri School of Medicine)",Gary T Pauly (Chemical Biology Laboratory)|Terrence R Burke; PhD (Chemical Biology Laboratory)|Joel Patrick Schneider; PhD (Chemical Biology Laboratory),Craig Joseph Thomas (NCATS),"1. Boyer PL, Das K, Arnold E, Hughes SH (2015). Analysis of the Zidovudine Resistance Mutations T215Y, M41L, and L210W in HIV-1 Reverse Transcriptase. Antimicrob Agents Chemother  59, 7184-96.   https://doi.org/10.1128/AAC.05069-14|2. Dunn LL, Boyer PL, McWilliams MJ, Smith SJ, Hughes SH (2015). Mutations in human immunodeficiency virus type 1 reverse transcriptase that make it sensitive to degradation by the viral protease in virions are selected against in patients. Virology  484, 127-35.   https://doi.org/10.1016/j.virol.2015.05.020|3. Hughes SH (2015). Reverse Transcription of Retroviruses and LTR Retrotransposons. Microbiol Spectr  3, MDNA3-0027-2014.   https://doi.org/10.1128/microbiolspec.MDNA3-0027-2014|4. Hughes SH, Coffin JM (2016). What Integration Sites Tell Us about HIV Persistence. Cell Host Microbe  19, 588-98.   https://doi.org/10.1016/j.chom.2016.04.010|5. Smith SJ, Pauly GT, Akram A, Melody K, Ambrose Z, Schneider JP, Hughes SH (2016). Rilpivirine and Doravirine Have Complementary Efficacies Against NNRTI-Resistant HIV-1 Mutants. J Acquir Immune Defic Syndr  72, 485-91.   https://doi.org/10.1097/QAI.0000000000001031|6. Smith SJ, Pauly GT, Akram A, Melody K, Rai G, Maloney DJ, Ambrose Z, Thomas CJ, Schneider JT, Hughes SH (2016). Rilpivirine analogs potently inhibit drug-resistant HIV-1 mutants. Retrovirology  13, 11.   https://doi.org/10.1186/s12977-016-0244-2",https://intramural.nih.gov/search/searchview.taf?ipid=93730
109,BC010483-14,"October 01, 2015 -  September 30, 2016",TEM5 Ligand Hunt,Bradley D St Croix,Lino  Tessarollo,"Mouse Cancer Genetics Program, NCI",Guojun  Yu,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93739
110,BC010484-14,"October 01, 2015 -  September 30, 2016",Functional Analysis of TEM5 and TEM8,Bradley D St Croix,Lino  Tessarollo,"Mouse Cancer Genetics Program, NCI",Steven  Seaman|Christopher S Szot|Guojun  Yu,Saurabh  Saha (BioMed Valley Discoveries)|Michelle  Zhang (BioMed Valley Discoveries),"Dimiter Stanchev Dimitrov; PhD (Cancer Inflammation Program)|Nancy J Emenaker (Nutritional Science Research Group)|Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)|Diana C Haines (Office Of The Director)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93740
111,BC010486-14,"October 01, 2015 -  September 30, 2016",Search for New Tumor Endothelial Markers,Bradley D St Croix,Lino  Tessarollo,"Mouse Cancer Genetics Program, NCI",Steven  Seaman,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93741
112,BC010487-14,"October 01, 2015 -  September 30, 2016",The role of CPSF6 in HIV-1 infection,Vineet Narain KewalRamani; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Robert Michael Hutton|Kyeongeun  Lee|Joshua Michael Schwartz|Ryan Michael Shubert|Hyun Jae  Yu|Lu  Zhu,"Alan  Engelman; PhD (Dana-Farber, Harvard University)|Thomas  Hope (Northwestern University)",Stephen H Hughes; PhD (Retroviral Replication Laboratory)|Xiaolin  Wu; PhD (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93731
113,BC010488-14,"October 01, 2015 -  September 30, 2016",HIV-1 passage through the nuclear pore complex,Vineet Narain KewalRamani; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Guangai  Xue; PhD|Hyun Jae  Yu|Lu  Zhu,"Jeremy  Luban (Columbia University)|Stefan  Sarafianos (Department of Molecular Microbiology & Immunology, University of Missouri School of Medicine)",NULL,NULL,"1. Gres AT, Kirby KA, KewalRamani VN, Tanner JJ, Pornillos O, Sarafianos SG (2015). STRUCTURAL VIROLOGY. X-ray crystal structures of native HIV-1 capsid protein reveal conformational variability. Science  349, 99-103.   https://doi.org/10.1126/science.aaa5936",https://intramural.nih.gov/search/searchview.taf?ipid=93732
114,BC010493-14,"October 01, 2015 -  September 30, 2016",High-Resolution Protein and Nucleic Acid Footprinting,Stuart F J Le Grice; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",NULL,"David  Rekosh (Myles Thayler AIDS Institute, University of Virginia)|Marie-Louise  Hammarskjold (University of Virginia)|Marcin  Nowotny (International Institute of Molecular and Cell Biology)|John  Tavis (Saint Louis University)|Nicolas  Sluis-Cremer; PhD (Department of Medicine, University of Pittsburgh)",Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory)|John Stephen Schneekloth (Chemical Biology Laboratory),NULL,"1. Brinson RG, Miller JT, Kahn JD, Le Grice SF, Marino JP (2016). Applying Thymine Isostere 2,4-Difluoro-5-Methylbenzene as a NMR Assignment Tool and Probe of Homopyrimidine/Homopurine Tract Structural Dynamics. Methods Enzymol  566, 89-110.   https://doi.org/10.1016/bs.mie.2015.05.009|2. Rausch JW, Sztuba-Solinska J, Lusvarghi S, Le Grice SF (2016). Novel Biochemical Tools for Probing HIV RNA Structure. Methods Mol Biol  1354, 91-117.   https://doi.org/10.1007/978-1-4939-3046-3_7",https://intramural.nih.gov/search/searchview.taf?ipid=93736
115,BC010494-14,"October 01, 2015 -  September 30, 2016",HIV-1 RNase H  as  a Therapeutic Target,Stuart F J Le Grice; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",NULL,"Graziella  Tocco (University of Cagliari)|John  Tavis (Saint Louis University)|Nicolas  Sluis-Cremer; PhD (Department of Medicine, University of Pittsburgh)|Ryan  Murelli (Brooklyn College)|Angela Maria Gronenborn; PhD (Department of Structural Biology, University of Pittsburgh)",John A Beutler (Molecular Targets Laboratory)|Barry R O'Keefe (Molecular Targets Laboratory),NULL,"1. Corona A, Desantis J, Massari S, Distinto S, Masaoka T, Sabatini S, Esposito F, Manfroni G, Maccioni E, Cecchetti V, Pannecouque C, Le Grice SF, Tramontano E, Tabarrini O (2016). Studies on Cycloheptathiophene-3-carboxamide Derivatives as Allosteric HIV-1 Ribonuclease H Inhibitors. ChemMedChem  11, 1709-20.   https://doi.org/10.1002/cmdc.201600015|2. Lu G, Lomonosova E, Cheng X, Moran E, Mayers M, Le Grice S, Mecxk C, Hirsch D, D'Erasmo M, Suyabatmaz D, Murelli R, Tavis J (2015) Hydroxylated Troplones Inhibit Hepatitis B Virus Replication by Blocking the Viral Ribonuclease H Activity Antiviral Agents and Chemotherapy 59:1070-1079",https://intramural.nih.gov/search/searchview.taf?ipid=93735
116,BC010499-14,"October 01, 2015 -  September 30, 2016",Maryland Prostate Cancer Case-Control Study,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Tiffany Marie Howe|Cheryl Jacobs Smith; PhD|Wei  Tang; PhD|Margaret Saira Pichardo,"Chris  Loffredo (Cancer Genetics and Epidemiology Program, Georgetown University)|Arun  Sreekumar (Baylor College of Medicine)|Sharon  Glynn|Rick  Kittles (University of Illinois at Chicago)|Nagireddy  Putluri (Baylor College of Medicine)",Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics)|Michael Blaise Cook (Hormonal and Reproductive Epidemiology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93725
117,BC010504-14,"October 01, 2015 -  September 30, 2016","Understanding Retroviral Reverse Transcription, Recombination, and Replication",Wei-Shau  Hu; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Yang  Liu; PhD|Olga A Nikolaitchik|Jonathan Mark Olivares Rawson|Steven Fernandes Dos Santos|Chijioke Nkemjika Umunnakwe|Vinay K Pathak; PhD,NULL,Brandon Frank Keele (Office Of The Director),NULL,"1. Nikolaitchik O, Keele B, Gorelick R, Alvord WG, Mazurov D, Pathak VK, Hu WS (2015). High recombination potential of subtype A HIV-1. Virology  484, 334-40.   https://doi.org/10.1016/j.virol.2015.06.025|2. Shunaeva A, Potashnikova D, Pichugin A, Mishina A, Filatov A, Nikolaitchik O, Hu WS, Mazurov D (2015). Improvement of HIV-1 and Human T Cell Lymphotropic Virus Type 1 Replication-Dependent Vectors via Optimization of Reporter Gene Reconstitution and Modification with Intronic Short Hairpin RNA. J Virol  89, 10591-601.   https://doi.org/10.1128/JVI.01940-15",https://intramural.nih.gov/search/searchview.taf?ipid=93729
118,BC010506-14,"October 01, 2015 -  September 30, 2016","Defining Mechanisms of HIV-1 RNA Trafficking, Virus Assembly,  Virion Structure",Wei-Shau  Hu; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Jianbo  Chen|Yang  Liu; PhD|Olga A Nikolaitchik|Sheikh Abdul Rahman|Jonathan Mark Olivares Rawson|Steven Fernandes Dos Santos|Show all 10,David  Grnwald (Technical University of Delft)|Dmitriy  Mazurov (Institute of Immunology)|WE  Moerner (Stanford University)|John  Briggs (European Molecular Biology Laboratory),Eric O Freed; PhD (HIV Drug Resistance Program)|Robert  Gorelick (Office Of The Director)|Stephen J Lockett; PhD (Office Of The Director)|Daniel Robert Larson; PhD (Laboratory of Receptor Biology and Gene Expression)|Jiji  Chen (Office of the Director),NULL,"1. Sardo L, Hatch SC, Chen J, Nikolaitchik O, Burdick RC, Chen D, Westlake CJ, Lockett S, Pathak VK, Hu WS (2015). Dynamics of HIV-1 RNA Near the Plasma Membrane during Virus Assembly. J Virol  89, 10832-40.   https://doi.org/10.1128/JVI.01146-15",https://intramural.nih.gov/search/searchview.taf?ipid=93728
119,BC010511-14,"October 01, 2015 -  September 30, 2016",Retrovirus Assembly and Maturation,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Laura Elizabeth Baker|Siddhartha  Datta; PhD|Demetria P Harvin|Joseph Emanuele Manzi|Diborah Mengistu Yimer|Wei-Shau  Hu; PhD,"Susan  Krueger (National Institute of Standards and Technology)|Mark  Yeager|Bogdan  Dragnea (University of Indiana)|Adam  Zlotnick; PhD (Biochemistry and Molecular Biology, University of Oklahoma)|Volker  Vogt (Cornell University)|Susan R Ross|Show all 15",Raul Eduardo Cachau (Office Of The Director)|Yun Xing M Wang (Structural Biophysics Laboratory)|Robert Andrew Byrd (Structural Biophysics Laboratory)|Kunio  Nagashima (Office Of The Director)|Thorkell  Andresson (Office Of The Director)|Ruth  Nussinov; PhD (Cancer Inflammation Program),Peter W Schuck; PhD (NIBIB),"1. O'Carroll I, Rein A (2016) Viral nucleic acids, in Encyclopedia of Cell Biology. , pp. 517-524.|2. Dick RA, Datta SA, Nanda H, Fang X, Wen Y, Barros M, Wang YX, Rein A, Vogt VM (2015). Hydrodynamic and Membrane Binding Properties of Purified Rous Sarcoma Virus Gag Protein. J Virol  89, 10371-82.   https://doi.org/10.1128/JVI.01628-15",https://intramural.nih.gov/search/searchview.taf?ipid=93737
120,BC010512-14,"October 01, 2015 -  September 30, 2016",Interactions of Retroviral Proteins with Nucleic Acids,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Laura Elizabeth Baker|Mauricio  Comas Garcia; PhD|Siddhartha  Datta; PhD|Demetria P Harvin|Joseph Emanuele Manzi|Diborah Mengistu Yimer|Show all 7,Kevin  Weeks (University of North Carolina)|Karin  Musier-Forsyth (Ohio State University),"Sean Richard Davis; MD, PhD (Cancer Genetics Branch)|Stephen J Lockett; PhD (Office Of The Director)",Rajat  Varma; PhD (NIAID) |Peter W Schuck; PhD (NIBIB) |John Robert Hogg (NHLBI),"1. O'Carroll I, Rein A (2016) Viral nucleic acids, in Encyclopedia of Cell Biology. , pp. 517-524.",https://intramural.nih.gov/search/searchview.taf?ipid=93738
121,BC010516-14,"October 01, 2015 -  September 30, 2016",Gated Optical Detectors-Dose Guided Radiotherapy,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93744
122,BC010518-14,"October 01, 2015 -  September 30, 2016",Role of BMP and FGF signaling during limb development,Mark B Lewandoski|IRP Faculty Profile,NULL,"Genetics of Vertebrate Development Section, NCI",Matthew J Anderson|Cynthia M Elder|Maria  Kaltcheva,"Brian  Harfe; PhD (Molecular Genetics and Microbiology, University of Florida)|Trevor  Williams (University of Colarado)",Susan  Mackem; MD (Cancer and Developmental Biology Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93747
123,BC010523-14,"October 01, 2015 -  September 30, 2016",RNAi and Epigenetic Control of Higher-Order Chromatin Assembly,Shivinder Singh Grewal|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",NULL,NULL,Peter C Fitzgerald (Office of the Director)|Ming  Zhou (Nucleic Acids Section),NULL,"1. Chalamcharla VR, Folco HD, Dhakshnamoorthy J, Grewal SI (2015). Conserved factor Dhp1/Rat1/Xrn2 triggers premature transcription termination and nucleates heterochromatin to promote gene silencing. Proc Natl Acad Sci U S A  112, 15548-55.   https://doi.org/10.1073/pnas.1522127112|2. Sugiyama T, Thillainadesan G, Chalamcharla VR, Meng Z, Balachandran V, Dhakshnamoorthy J, Zhou M, Grewal SIS (2016). Enhancer of Rudimentary Cooperates with Conserved RNA-Processing Factors to Promote Meiotic mRNA Decay and Facultative Heterochromatin Assembly. Mol Cell  61, 747-759.   https://doi.org/10.1016/j.molcel.2016.01.029|3. Zofall M, Smith DR, Mizuguchi T, Dhakshnamoorthy J, Grewal SIS (2016). Taz1-Shelterin Promotes Facultative Heterochromatin Assembly at Chromosome-Internal Sites Containing Late Replication Origins. Mol Cell  62, 862-874.   https://doi.org/10.1016/j.molcel.2016.04.034",https://intramural.nih.gov/search/searchview.taf?ipid=93611
124,BC010524-14,"October 01, 2015 -  September 30, 2016",HIV Integrase Modeling and Computer-Aided Inhibitor and Microbicide Development,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Chenzhong  Liao|Megan L Peach,"Vladimir  Poroikov (Lab. of Structure-Function Based Drug Design, Russian Academy of Medical Sciences)|Karen  Buckheit (ImQuest Biosciences)|Chenzhong  Liao",Stephen H Hughes; PhD (Retroviral Replication Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93745
125,BC010525-14,"October 01, 2015 -  September 30, 2016",Immune Reconstitution,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Francis  Flomerfelt; PhD|Hye Kyung  Kim|Philip J Lucas; PhD,NULL,Alfred  Singer; MD (Experimental Immunology Branch)|Richard J Hodes; MD (Experimental Immunology Branch)|Jung-Hyun  Park (Experimental Immunology Branch)|Joy A Williams (Lymphocyte Development Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93727
126,BC010538-14,"October 01, 2015 -  September 30, 2016",Molecular Analysis of Breast Cancer Metastasis to the Brain,Patricia  Steeg; PhD|IRP Faculty Profile,NULL,"Womens Malignancies Branch, NCI",Brunilde M Gril|Emily  Hua|Anurag Narasimha Paranjape|Ladawn Tiffany Reed,"Andreas  Stark (University of Schleswig-Holstein Medical Center)|Quentin  Smith; PhD (Dept. of Pharmacy, Texas Technical University)|Paul  Lockman (Texas Tech University)|Jacek  Jassem (Medical University of Gdansk)|Renata  Duchnowska (Military Institute of Medicine,)|Priscilla  Brastianos (MGH)|Show all 8",Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Deedee Kay Smart (Radiation Oncology Branch)|Joel Patrick Schneider; PhD (Chemical Biology Laboratory),NULL,"1. Duchnowska R, Jassem J, Goswami CP, Dundar M, Gökmen-Polar Y, Li L, Woditschka S, Biernat W, Sosińska-Mielcarek K, Czartoryska-Arłukowicz B, Radecka B, Tomasevic Z, Stępniak P, Wojdan K, Sledge GW, Steeg PS, Badve S (2015). Predicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patients. J Neurooncol  122, 205-16.   https://doi.org/10.1007/s11060-014-1704-y|2. Moon YW, Rao G, Kim JJ, Shim HS, Park KS, An SS, Kim B, Steeg PS, Sarfaraz S, Changwoo Lee L, Voeller D, Choi EY, Luo J, Palmieri D, Chung HC, Kim JH, Wang Y, Giaccone G (2015). LAMC2 enhances the metastatic potential of lung adenocarcinoma. Cell Death Differ  22, 1341-52.   https://doi.org/10.1038/cdd.2014.228|3. Zhang L, Zhang S, Yao J, Lowery FJ, Zhang Q, Huang WC, Li P, Li M, Wang X, Zhang C, Wang H, Ellis K, Cheerathodi M, McCarty JH, Palmieri D, Saunus J, Lakhani S, Huang S, Sahin AA, Aldape KD, Steeg PS, Yu D (2015). Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature  527, 100-104.   https://doi.org/10.1038/nature15376",https://intramural.nih.gov/search/searchview.taf?ipid=93742
127,BC010547-14,"October 01, 2015 -  September 30, 2016",Development of Drugs That Target Prostate Cancer,William D Figg; PharmD|IRP Faculty Profile,NULL,"Genitourinary Malignancies Branch, NCI","Cindy Huong-Bich Chau|Edel Marie McCrea|Douglas K Price|James L Gulley; MD, PhD|William Laurence Dahut; MD|Ravi  Madan|Show all 7",NULL,"Howard  Parnes (Prostate and Urologic Cancer Research Group)|Jane Beth Trepel (Developmental Therapeutics Branch)|Kevin  Gardner; MD, PhD (Cancer Genetics Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)",Fatima Hafiz Karzai; MD (NIMHD),"1. Fernandez EV, Reece KM, Ley AM, Troutman SM, Sissung TM, Price DK, Chau CH, Figg WD (2015). Dual targeting of the androgen receptor and hypoxia-inducible factor 1α pathways synergistically inhibits castration-resistant prostate cancer cells. Mol Pharmacol  87, 1006-12.   https://doi.org/10.1124/mol.114.097477|2. Figg WD, Thompson IM (2015). Effect of 5α-Reductase Inhibitor Use on Mortality From Prostate Cancer. JAMA Oncol  1, 321-2.   https://doi.org/10.1001/jamaoncol.2015.0408|3. Karzai FH, Madan RA, Figg WD (2015). Beyond PSA: managing modern therapeutic options in metastatic castration-resistant prostate cancer. South Med J  108, 224-8.   https://doi.org/10.14423/SMJ.0000000000000266|4. Madan RA, Gulley JL (2015). (R)Evolutionary therapy: the potential of immunotherapy to fulfill the promise of personalized cancer treatment. J Natl Cancer Inst  107, 347.   https://doi.org/10.1093/jnci/dju347|5. Madan RA, Karzai FH, Ning YM, Adesunloye BA, Huang X, Harold N, Couvillon A, Chun G, Cordes L, Sissung T, Beedie SL, Dawson NA, Theoret MR, McLeod DG, Rosner I, Trepel JB, Lee MJ, Tomita Y, Lee S, Chen C, Steinberg SM, Arlen PM, Gulley JL, Figg WD, Dahut WL (2016). Phase II trial of docetaxel, bevacizumab, lenalidomide and prednisone in patients with metastatic castration-resistant prostate cancer. BJU Int  118, 590-7.   https://doi.org/10.1111/bju.13412|6. McCrea E, Sissung T, Chau C, Price D, Figg W (2016) Androgen receptor variation affects prostate cancer progression and drug resistance. Pharmacological Research, in press.|7. Polman DJ, Price DK, Figg WD (2015). New bigenic mouse model increases the understanding of genetic synergism in the progression of prostate cancer. Cancer Biol Ther  16, 1702-3.   https://doi.org/10.1080/15384047.2015.1108498|8. Schmidt KT, Chau CH, Price DK, Figg WD (2016). Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment. J Clin Pharmacol  56, 1484-1499.   https://doi.org/10.1002/jcph.765|9. Sissung TM, Deeken J, Leibrand CR, Price DK, Ehrlich S, Steinberg SM, Liewehr DJ, Dahut W, Figg WD (2016). Identification of novel SNPs associated with risk and prognosis in patients with castration-resistant prostate cancer. Pharmacogenomics  17, 1979-1986.   https://doi.org/10.2217/pgs-2016-0134|10. Strauss J, Alewine C, Figg WD, Duffy A (2016). Targeting the microenvironment of pancreatic cancer: overcoming treatment barriers and improving local immune responses. Clin Transl Oncol  18, 653-9.   https://doi.org/10.1007/s12094-015-1459-8|11. Strauss J, Figg WD (2016). Using Epigenetic Therapy to Overcome Chemotherapy Resistance. Anticancer Res  36, 1-4.",https://intramural.nih.gov/search/searchview.taf?ipid=93726
128,BC010549-14,"October 01, 2015 -  September 30, 2016",Zebrafish Models of Cancer,Dennis D Hickstein|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,NULL,"Paul P. Liu; MD, PhD (NHGRI)","1. Shive HR, West RR, Embree LJ, Sexton JM, Hickstein DD (2015). Expression of KRASG12V in Zebrafish Gills Induces Hyperplasia and CXCL8-Associated Inflammation. Zebrafish  12, 221-9.   https://doi.org/10.1089/zeb.2014.1038",https://intramural.nih.gov/search/searchview.taf?ipid=93612
129,BC010566-13,"October 01, 2015 -  September 30, 2016",Tumor and Metastasis Biology,Lee Jay Helman; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,"Aykut  Uren (Georgetown University Medical Center)|Cheryl  London (Center for Comparative Medicine, University Of California)|Richard  Gorlick (Laboratory of Cellular Carcinogenesis and Tumor Promotion, Albert Einstein College of Medicine)|Timothy  Fan (Veterinary Clinical Medicine, University of Illinois)|Danny  Welch (Department of Pathology, University of Alabama, Birmingham)","Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics)|Stuart H Yuspa; MD (Laboratory of Cancer Biology and Genetics)|Jeffrey E Green; MD (Laboratory of Cancer Biology and Genetics)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Patricia  Steeg; PhD (Womens Malignancies Branch)",NULL,"1. Vo KT, Edwards JV, Epling CL, Sinclair E, Hawkins DS, Grier HE, Janeway KA, Barnette P, McIlvaine E, Krailo MD, Barkauskas DA, Matthay KK, Womer RB, Gorlick RG, Lessnick SL, Mackall CL, DuBois SG (2016). Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group. Clin Cancer Res  22, 3643-50.   https://doi.org/10.1158/1078-0432.CCR-15-2516",https://intramural.nih.gov/search/searchview.taf?ipid=93759
130,BC010578-13,"October 01, 2015 -  September 30, 2016",Targeting TEMs in Preclinical Tumor Models,Bradley D St Croix,Lino  Tessarollo,"Mouse Cancer Genetics Program, NCI",Steven  Seaman|Guojun  Yu|Christopher S Szot,Saurabh  Saha (BioMed Valley Discoveries)|Michelle  Zhang (BioMed Valley Discoveries),Dimiter Stanchev Dimitrov; PhD (Cancer Inflammation Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93614
131,BC010579-13,"October 01, 2015 -  September 30, 2016",Papillomavirus Virion Proteins and Vaccines,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",John  Schiller; PhD|Christopher  Buck,NULL,Lauren V Wood; MD (Vaccine Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Ligia  Pinto (Infection & Immunoepidemiology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93760
132,BC010580-13,"October 01, 2015 -  September 30, 2016",Phase II Trial of PEG-Intron in Children with Diffuse Pontine Gliomas,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Pamela  Wolters|Nalini M Jayaprakash,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93748
133,BC010595-13,"October 01, 2015 -  September 30, 2016",Structure and Function of Vif and APOBEC3 (A3) Proteins,Vinay K Pathak; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Krista A Delviks-Frankenberry|Belete Ayele Desimmie|Adam G Ketchum|Michael David Nekorchuk; PhD|Dongfei  Qi|Wei-Shau  Hu; PhD,"Kei  Sato (Kyoto University)|Stefan  Sarafianos (Department of Molecular Microbiology & Immunology, University of Missouri School of Medicine)|Yong  Xiong (Yale University)|Hiroshi  Matsuo; PhD (STRUCTURAL BIOPHYSICS LABORATORY)|Eric  Barklis (University of Oregon)",Mary  Kearney (Host Virus Interaction Branch)|Jeffrey D Lifson; MD (Office Of The Director)|Frank  Maldarelli (Host Virus Interaction Branch),NULL,"1. Chen J, Rahman SA, Nikolaitchik OA, Grunwald D, Sardo L, Burdick RC, Plisov S, Liang E, Tai S, Pathak VK, Hu WS (2016). HIV-1 RNA genome dimerizes on the plasma membrane in the presence of Gag protein. Proc Natl Acad Sci U S A  113, E201-8.   https://doi.org/10.1073/pnas.1518572113|2. Chikaev AN, Bakulina AY, Burdick RC, Karpenko LI, Pathak VK, Ilyichev AA (2015). Selection of peptide mimics of HIV-1 epitope recognized by neutralizing antibody VRC01. PLoS One  10, e0120847.   https://doi.org/10.1371/journal.pone.0120847|3. Delviks-Frankenberry KA, Nikolaitchik OA, Burdick RC, Gorelick RJ, Keele BF, Hu WS, Pathak VK (2016). Minimal Contribution of APOBEC3-Induced G-to-A Hypermutation to HIV-1 Recombination and Genetic Variation. PLoS Pathog  12, e1005646.   https://doi.org/10.1371/journal.ppat.1005646|4. Sardo L, Hatch SC, Chen J, Nikolaitchik O, Burdick RC, Chen D, Westlake CJ, Lockett S, Pathak VK, Hu WS (2015). Dynamics of HIV-1 RNA Near the Plasma Membrane during Virus Assembly. J Virol  89, 10832-40.   https://doi.org/10.1128/JVI.01146-15",https://intramural.nih.gov/search/searchview.taf?ipid=93762
134,BC010598-13,"October 01, 2015 -  September 30, 2016",Human Immune Responses to Tumor Antigens for Cancer Immunotherapy,Jeffrey  Schlom; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Renee Nicole Donahue|Morgan Lee Gargulak|Italia  Grenga|Lauren Marissa Lepone|Sarah Renee Tritsch|Kwong Yok Tsang|Show all 8,NULL,Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Raffit  Hassan (Thoracic & Oncologic Surgery Branch)|William D Figg; PharmD (Genitourinary Malignancies Branch)|William Laurence Dahut; MD (Genitourinary Malignancies Branch)|Arun  Rajan (Thoracic & Oncologic Surgery Branch)|Peter A Pinto; MD (Urologic Oncology Branch),NULL,"1. Tsang K, Jochems C, Schlom J (2015) Insights on peptide vaccines in cancer immunotherapy, in New Developments in T Cell-based Anticancer Immunotherapies, in press.|2. Boyerinas B, Jochems C, Fantini M, Heery CR, Gulley JL, Tsang KY, Schlom J (2015). Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti-PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells. Cancer Immunol Res  3, 1148-1157.   https://doi.org/10.1158/2326-6066.CIR-15-0059|3. Farsaci B, Donahue R, Grenga I, Lepone L, Kim P, Dempsey B, Siebert J, Ibrahim N, Madan R, Heery C, Gulley J, Schlom J (2016) Analyses of pre-therapy peripheral immunoscore and response to vaccine therapy. Cancer Immunology Research, in press.|4. Heery CR, Ibrahim NK, Arlen PM, Mohebtash M, Murray JL, Koenig K, Madan RA, McMahon S, Marté JL, Steinberg SM, Donahue RN, Grenga I, Jochems C, Farsaci B, Folio LR, Schlom J, Gulley JL (2015). Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast Cancer: A Randomized Clinical Trial. JAMA Oncol  1, 1087-95.   https://doi.org/10.1001/jamaoncol.2015.2736|5. Heery CR, Madan RA, Stein MN, Stadler WM, Di Paola RS, Rauckhorst M, Steinberg SM, Marté JL, Chen CC, Grenga I, Donahue RN, Jochems C, Dahut WL, Schlom J, Gulley JL (2016). Samarium-153-EDTMP (Quadramet®) with or without vaccine in metastatic castration-resistant prostate cancer: A randomized Phase 2 trial. Oncotarget  7, 69014-69023.   https://doi.org/10.18632/oncotarget.10883|6. Heery CR, Singh BH, Rauckhorst M, Marté JL, Donahue RN, Grenga I, Rodell TC, Dahut W, Arlen PM, Madan RA, Schlom J, Gulley JL (2015). Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury. Cancer Immunol Res  3, 1248-56.   https://doi.org/10.1158/2326-6066.CIR-15-0119|7. Lepone L, Donahue R, Grenga I, Metenou S, Richards J, Heery C, Gulley J (2016) Analyses of 123 peripheral human immune cell subsets: defining differences with age and between healthy donors and cancer patients not detected in analysis of standard immune cell types J Circ Biomark 5. doi: 10.5772/62322.",https://intramural.nih.gov/search/searchview.taf?ipid=93613
135,BC010600-13,"October 01, 2015 -  September 30, 2016",Study of AAA proteins by X-ray protein crystallography,"Di S Xia; PhD, MS, BS|IRP Faculty Profile",NULL,"Crystallography Section, NCI",Whitney  Jin|Wai-Kwan  Tang,NULL,Michael  Maurizi; PhD (Biochemistry of Proteins Section),Yihong  Ye (NIDDK),"1. Xia D, Ye Y (2015). In Search of a Cure for Proteostasis-Addicted Cancer: A AAA Target Revealed. Cancer Cell  28, 550-552.   https://doi.org/10.1016/j.ccell.2015.10.006",https://intramural.nih.gov/search/searchview.taf?ipid=93749
136,BC010607-13,"October 01, 2015 -  September 30, 2016",Ras-mediated signals in human epithelial cell transformation and metastasis,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Simeng  Wang|Juanjuan  Yin,Yennien  Liu (Taipei Medical University)|Eva  Corey (University of Washington),Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program),Alan Paul Koretsky; PhD (NINDS),"1. Liu YN, Yin J, Barrett B, Sheppard-Tillman H, Li D, Casey OM, Fang L, Hynes PG, Ameri AH, Kelly K (2015) Loss of Androgen-Regulated MicroRNA 1 Activates SRC and Promotes Prostate Cancer Bone Metastasis. Mol Cell Biol 35:1940-51",https://intramural.nih.gov/search/searchview.taf?ipid=93758
137,BC010624-13,"October 01, 2015 -  September 30, 2016",The Molecular Profile of Prostate Tumors in African-American Men,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Tiffany Marie Howe|Symone Victoria Jordan|Wei  Tang; PhD|Cheryl Jacobs Smith; PhD,"Chris  Loffredo (Cancer Genetics and Epidemiology Program, Georgetown University)|Arun  Sreekumar (Baylor College of Medicine)|Sharon  Glynn|Rick  Kittles (University of Illinois at Chicago)|Nagireddy  Putluri (Baylor College of Medicine)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93765
138,BC010627-13,"October 01, 2015 -  September 30, 2016",Clinical Pharmacogenetics,William D Figg; PharmD|IRP Faculty Profile,NULL,"Office Of The Clinical Director, NCI",Sheryl A Gere|Andrew Kiem Goey|Alesia J Holly|Ariel Morgan Ley|Cody John Peer|Keith Thomas Schmidt|Show all 8,C  Landgren (Memorial Sloan Kettering Cancer Center)|Susan  Bates; MD (NCI),Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Heidi H Kong (Dermatology Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|James Halpern Doroshow (Developmental Therapeutics Branch)|Jung-Min  Lee (Womens Malignancies Branch),NULL,"1. Akshintala S, Marcus L, Warren KE, Murphy RF, Sissung TM, Srivastava A, Goodspeed WJ, Goodwin A, Brewer CC, Zalewski C, King KA, Kim A, Figg WD, Widemann BC (2015). Phase 1 trial and pharmacokinetic study of the oral platinum analog satraplatin in children and young adults with refractory solid tumors including brain tumors. Pediatr Blood Cancer  62, 603-10.   https://doi.org/10.1002/pbc.25344|2. Goey AK, Figg WD (2016). UGT genotyping in belinostat dosing. Pharmacol Res  105, 22-7.   https://doi.org/10.1016/j.phrs.2016.01.002|3. Goey AK, Sissung TM, Peer CJ, Trepel JB, Lee MJ, Tomita Y, Ehrlich S, Bryla C, Balasubramaniam S, Piekarz R, Steinberg SM, Bates SE, Figg WD (2016). Effects of UGT1A1 genotype on the pharmacokinetics, pharmacodynamics, and toxicities of belinostat administered by 48-hour continuous infusion in patients with cancer. J Clin Pharmacol  56, 461-73.   https://doi.org/10.1002/jcph.625|4. McCrea E, Sissung T, Chau C, Price D, Figg W (2016) Androgen receptor variation affects prostate cancer progression and drug resistance. Pharmacological Research, in press.|5. Peer CJ, Goey AK, Sissung TM, Erlich S, Lee MJ, Tomita Y, Trepel JB, Piekarz R, Balasubramaniam S, Bates SE, Figg WD (2016). UGT1A1 genotype-dependent dose adjustment of belinostat in patients with advanced cancers using population pharmacokinetic modeling and simulation. J Clin Pharmacol  56, 450-60.   https://doi.org/10.1002/jcph.627",https://intramural.nih.gov/search/searchview.taf?ipid=93754
139,BC010632-13,"October 01, 2015 -  September 30, 2016",Transcription Regulation in E. coli and H. pylori,Ding Jun Jin,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI","Carmen  Mata Martin; PhD|Zhe  Sun|Yan Ning H Zhou|Thomas Dana Schneider; PhD|Zhi Ming  Zheng; MD, PhD",NULL,Xinhua  Ji; PhD (Biomolecular Structure Section)|Mikhail V Kashlev (Molecular Mechanisms of Transcription Section)|Donald L Court; PhD (Molecular Control and Genetics Section)|Stephen J Lockett; PhD (Office Of The Director)|Charles  Rabkin (Infection & Immunoepidemiology Branch),NULL,"1. Jin D, Cagliero C, Izard J, Martin C, Zhou Y (2016) The distribution and spatial organization of RNA polymerase in Escherichia coli: growth rate regulation and stress responses, in Stress and Environmental Regulation of Gene Expression and Adaptation in Bacteria, Edited by Frans J De Bruijn, 2 Volume Set. , pp. 48-63.|2. Jin DJ, Cagliero C, Martin CM, Izard J, Zhou YN (2015). The dynamic nature and territory of transcriptional machinery in the bacterial chromosome. Front Microbiol  6, 497.   https://doi.org/10.3389/fmicb.2015.00497",https://intramural.nih.gov/search/searchview.taf?ipid=93757
140,BC010646-13,"October 01, 2015 -  September 30, 2016",Chromatin Remodeling Proteins,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Songjoon  Baek|Mary  Hawkins|Ville Juhani Paakinaho; PhD|Diego Martin Presman; PhD|Rodney Louis Schiltz; PhD,NULL,NULL,NULL,"1. Salomon-Kent R, Marom R, John S, Dundr M, Schiltz LR, Gutierrez J, Workman J, Benayahu D, Hager GL (2015). New Face for Chromatin-Related Mesenchymal Modulator: n-CHD9 Localizes to Nucleoli and Interacts With Ribosomal Genes. J Cell Physiol  230, 2270-80.   https://doi.org/10.1002/jcp.24960",https://intramural.nih.gov/search/searchview.taf?ipid=93756
141,BC010649-12,"October 01, 2015 -  September 30, 2016",Immunotherapy Strategies for Uveal Melanoma,Udai S Kammula,NULL,"Surgery Branch, NCI",NULL,"J  Harbour (Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine)|Richard  Carvajal (Memorial Sloan-Kettering Cancer Center)",Mark  Raffeld; MD (Laboratory of Pathology)|Eric Alan Stahlberg (Center For Biomedical Informatics & Information Technology),NULL,"1. Rothermel LD, Sabesan AC, Stephens DJ, Chandran SS, Paria BC, Srivastava AK, Somerville R, Wunderlich JR, Lee CC, Xi L, Pham TH, Raffeld M, Jailwala P, Kasoji M, Kammula US (2016). Identification of an Immunogenic Subset of Metastatic Uveal Melanoma. Clin Cancer Res  22, 2237-49.   https://doi.org/10.1158/1078-0432.CCR-15-2294",https://intramural.nih.gov/search/searchview.taf?ipid=93778
142,BC010654-12,"October 01, 2015 -  September 30, 2016",Lymphatic Imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",NULL,NULL,Peter A Pinto; MD (Urologic Oncology Branch)|Jacob D Estes (Office Of The Director),NULL,"1. Bouchelouche K, Turkbey B, Choyke PL (2016). PSMA PET and Radionuclide Therapy in Prostate Cancer. Semin Nucl Med  46, 522-535.   https://doi.org/10.1053/j.semnuclmed.2016.07.006|2. Hao XP, Lucero CM, Turkbey B, Bernardo ML, Morcock DR, Deleage C, Trubey CM, Smedley J, Klatt NR, Giavedoni LD, Kristoff J, Xu A, Del Prete GQ, Keele BF, Rao SS, Alvord WG, Choyke PL, Lifson JD, Brenchley JM, Apetrei C, Pandrea I, Estes JD (2015). Experimental colitis in SIV-uninfected rhesus macaques recapitulates important features of pathogenic SIV infection. Nat Commun  6, 8020.   https://doi.org/10.1038/ncomms9020|3. Sankineni S, Brown AM, Fascelli M, Law YM, Pinto PA, Choyke PL, Turkbey B (2015). Lymph node staging in prostate cancer. Curr Urol Rep  16, 30.   https://doi.org/10.1007/s11934-015-0505-y|4. Sankineni S, Smedley J, Bernardo M, Brown AM, Johnson L, Muller B, Griffiths GL, Kobayashi H, Rais-Bahrami S, Pinto PA, Wood BJ, Keele B, Choyke PL, Turkbey B (2016). Ferumoxytol as an intraprostatic MR contrast agent for lymph node mapping of the prostate: a feasibility study in non-human primates. Acta Radiol  57, 1396-1401.   https://doi.org/10.1177/0284185115586023",https://intramural.nih.gov/search/searchview.taf?ipid=93772
143,BC010655-12,"October 01, 2015 -  September 30, 2016",Prostate Cancer Imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",NULL,Anwar  Padhani (Mt Vernon Hospital)|Jeff  Weinreb (Yale New Haven Hospital)|Francois  Cornud (Hopital Neckers)|Art  Rastinehed (Long Island Jewish Hospital)|Martin G Pomper|Jelle  Barentsz (Nijmegen University)|Show all 8,William Marston Linehan; MD (Urologic Oncology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch)|Bradford J Wood; MD (Office of the Director)|Aradhana  Kaushal (Radiation Oncology Branch)|Maria  Merino; PhD (Laboratory of Pathology),"Ronald M Summers; MD, PhD (CC)","1. Özcan A, Türkbey B, Choyke PL, Akin O, Aras Ö, Mun SK (2015). Interactive Feature Space Explorer© for multi-modal magnetic resonance imaging. Magn Reson Imaging  33, 804-15.   https://doi.org/10.1016/j.mri.2015.03.007|2. Agarwal HK, Mertan FV, Sankineni S, Bernardo M, Senegas J, Keupp J, Daar D, Merino M, Wood BJ, Pinto PA, Choyke PL, Turkbey B (2017). Optimal high b-value for diffusion weighted MRI in diagnosing high risk prostate cancers in the peripheral zone. J Magn Reson Imaging  45, 125-131.   https://doi.org/10.1002/jmri.25353|3. Barrett T, Turkbey B, Choyke PL (2015). PI-RADS version 2: what you need to know. Clin Radiol  70, 1165-76.   https://doi.org/10.1016/j.crad.2015.06.093|4. Berman RM, Brown AM, Chang SD, Sankineni S, Kadakia M, Wood BJ, Pinto PA, Choyke PL, Turkbey B (2016). DCE MRI of prostate cancer. Abdom Radiol (NY)  41, 844-53.   https://doi.org/10.1007/s00261-015-0589-3|5. Bouchelouche K, Turkbey B, Choyke PL (2016). PSMA PET and Radionuclide Therapy in Prostate Cancer. Semin Nucl Med  46, 522-535.   https://doi.org/10.1053/j.semnuclmed.2016.07.006|6. Buerger C, Sénégas J, Kabus S, Carolus H, Schulz H, Agarwal H, Turkbey B, Choyke PL, Renisch S (2015). Comparing nonrigid registration techniques for motion corrected MR prostate diffusion imaging. Med Phys  42, 69-80.   https://doi.org/10.1118/1.4903262|7. Fascelli M, George AK, Frye T, Turkbey B, Choyke PL, Pinto PA (2015). The role of MRI in active surveillance for prostate cancer. Curr Urol Rep  16, 42.   https://doi.org/10.1007/s11934-015-0507-9|8. Giesel FL, Fiedler H, Stefanova M, Sterzing F, Rius M, Kopka K, Moltz JH, Afshar-Oromieh A, Choyke PL, Haberkorn U, Kratochwil C (2015). PSMA PET/CT with Glu-urea-Lys-(Ahx)-[⁶⁸Ga(HBED-CC)] versus 3D CT volumetric lymph node assessment in recurrent prostate cancer. Eur J Nucl Med Mol Imaging  42, 1794-800.   https://doi.org/10.1007/s00259-015-3106-6|9. Imani F, Zhuang B, Tahmasebi A, Kwak JT, Xu S, Agarwal H, Bharat S, Uniyal N, Turkbey IB, Choyke P, Pinto P, Wood B, Moradi M, Mousavi P, Abolmaesumi P (2015). Augmenting MRI-transrectal ultrasound-guided prostate biopsy with temporal ultrasound data: a clinical feasibility study. Int J Comput Assist Radiol Surg  10, 727-35.   https://doi.org/10.1007/s11548-015-1184-3|10. Koo PJ, Kwak JJ, Pokharel S, Choyke PL (2015). Novel Imaging of Prostate Cancer with MRI, MRI/US, and PET. Curr Oncol Rep  17, 56.   https://doi.org/10.1007/s11912-015-0480-y|11. Kwak JT, Xu S, Wood BJ, Turkbey B, Choyke PL, Pinto PA, Wang S, Summers RM (2015). Automated prostate cancer detection using T2-weighted and high-b-value diffusion-weighted magnetic resonance imaging. Med Phys  42, 2368-78.   https://doi.org/10.1118/1.4918318|12. Mertan FV, Berman R, Szajek K, Pinto PA, Choyke PL, Turkbey B (2016). Evaluating the Role of mpMRI in Prostate Cancer Assessment. Expert Rev Med Devices  13, 129-41.   https://doi.org/10.1586/17434440.2016.1134311|13. Peng Y, Shen D, Liao S, Turkbey B, Rais-Bahrami S, Wood B, Karademir I, Antic T, Yousef A, Jiang Y, Pinto PA, Choyke PL, Oto A (2015). MRI-based prostate volume-adjusted prostate-specific antigen in the diagnosis of prostate cancer. J Magn Reson Imaging  42, 1733-9.   https://doi.org/10.1002/jmri.24944|14. Rastinehad AR, Waingankar N, Turkbey B, Yaskiv O, Sonstegard AM, Fakhoury M, Olsson CA, Siegel DN, Choyke PL, Ben-Levi E, Villani R (2015). Comparison of Multiparametric MRI Scoring Systems and the Impact on Cancer Detection in Patients Undergoing MR US Fusion Guided Prostate Biopsies. PLoS One  10, e0143404.   https://doi.org/10.1371/journal.pone.0143404|15. Sankineni S, Brown AM, Fascelli M, Law YM, Pinto PA, Choyke PL, Turkbey B (2015). Lymph node staging in prostate cancer. Curr Urol Rep  16, 30.   https://doi.org/10.1007/s11934-015-0505-y|16. Sankineni S, Smedley J, Bernardo M, Brown AM, Johnson L, Muller B, Griffiths GL, Kobayashi H, Rais-Bahrami S, Pinto PA, Wood BJ, Keele B, Choyke PL, Turkbey B (2016). Ferumoxytol as an intraprostatic MR contrast agent for lymph node mapping of the prostate: a feasibility study in non-human primates. Acta Radiol  57, 1396-1401.   https://doi.org/10.1177/0284185115586023|17. Siddiqui MM, Rais-Bahrami S, Turkbey B, George AK, Rothwax J, Shakir N, Okoro C, Raskolnikov D, Parnes HL, Linehan WM, Merino MJ, Simon RM, Choyke PL, Wood BJ, Pinto PA (2015). Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA  313, 390-7.   https://doi.org/10.1001/jama.2014.17942|18. Siddiqui MM, Truong H, Rais-Bahrami S, Stamatakis L, Logan J, Walton-Diaz A, Turkbey B, Choyke PL, Wood BJ, Simon RM, Pinto PA (2015). Clinical implications of a multiparametric magnetic resonance imaging based nomogram applied to prostate cancer active surveillance. J Urol  193, 1943-1949.   https://doi.org/10.1016/j.juro.2015.01.088|19. Turkbey B, Choyke PL (2015). PIRADS 2.0: what is new? Diagn Interv Radiol  21, 382-4.   https://doi.org/10.5152/dir.2015.15099",https://intramural.nih.gov/search/searchview.taf?ipid=93773
144,BC010656-12,"October 01, 2015 -  September 30, 2016",Growth Factor Imaging and Photoimmunotherapy,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",NULL,NULL,William Marston Linehan; MD (Urologic Oncology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch)|Donald P Bottaro; PhD (Urologic Oncology Branch),NULL,"1. Kishimoto S, Bernardo M, Saito K, Koyasu S, Mitchell JB, Choyke PL, Krishna MC (2015). Evaluation of oxygen dependence on in vitro and in vivo cytotoxicity of photoimmunotherapy using IR-700-antibody conjugates. Free Radic Biol Med  85, 24-32.   https://doi.org/10.1016/j.freeradbiomed.2015.03.038|2. Kobayashi H, Choyke PL (2016). Super enhanced permeability and retention (SUPR) effects in tumors following near infrared photoimmunotherapy. Nanoscale  8, 12504-9.   https://doi.org/10.1039/c5nr05552k|3. Watanabe R, Hanaoka H, Sato K, Nagaya T, Harada T, Mitsunaga M, Kim I, Paik CH, Wu AM, Choyke PL, Kobayashi H (2015). Photoimmunotherapy targeting prostate-specific membrane antigen: are antibody fragments as effective as antibodies? J Nucl Med  56, 140-4.   https://doi.org/10.2967/jnumed.114.149526",https://intramural.nih.gov/search/searchview.taf?ipid=93774
145,BC010657-12,"October 01, 2015 -  September 30, 2016",Cellular In vivo Imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",NULL,NULL,Christian S Hinrichs (Experimental Transplantation and Immunology Branch),Joshua  Farber; MD (NIAID) |Richard  Childs; MD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93775
146,BC010661-12,"October 01, 2015 -  September 30, 2016",Vaccine and Drug Combination Therapy for Human Cancers,James W Hodge; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Jeffrey  Schlom; PhD,NULL,NULL,NULL,"1. Boehm A, Donahue R, Hodge J (2015) The B7-1 costimulatory molecule, in Cancer Therapeutic Targets, in press.|2. Gameiro SR, Malamas AS, Bernstein MB, Tsang KY, Vassantachart A, Sahoo N, Tailor R, Pidikiti R, Guha CP, Hahn SM, Krishnan S, Hodge JW (2016). Tumor Cells Surviving Exposure to Proton or Photon Radiation Share a Common Immunogenic Modulation Signature, Rendering Them More Sensitive to T Cell-Mediated Killing. Int J Radiat Oncol Biol Phys  95, 120-30.   https://doi.org/10.1016/j.ijrobp.2016.02.022|3. Garg AD, Galluzzi L, Apetoh L, Baert T, Birge RB, Bravo-San Pedro JM, Breckpot K, Brough D, Chaurio R, Cirone M, Coosemans A, Coulie PG, De Ruysscher D, Dini L, de Witte P, Dudek-Peric AM, Faggioni A, Fucikova J, Gaipl US, Golab J, Gougeon ML, Hamblin MR, Hemminki A, Herrmann M, Hodge JW, et al. [27 more authors] (2015). Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death. Front Immunol  6, 588.   https://doi.org/10.3389/fimmu.2015.00588|4. Grenga I, Kwilas AR, Donahue RN, Farsaci B, Hodge JW (2015). Inhibition of the angiopoietin/Tie2 axis induces immunogenic modulation, which sensitizes human tumor cells to immune attack. J Immunother Cancer  3, 52.   https://doi.org/10.1186/s40425-015-0096-7|5. Kwilas A, Donahue R, Tsang K, Hodge J (2015) Immune consequences of tyrosine kinase inhibitors that synergize with cancer immunotherapy. Can Cell Microenviron, in press.|6. Kwilas A, Gameiro S, Kim P, Malamas A, Hodge J (2015) Improving clinical benefit for prostate cancer patients through the combination of androgen deprivation and immjnotherapy. OncoImmunology, in press.|7. Kwilas AR, Ardiani A, Dirmeier U, Wottawah C, Schlom J, Hodge JW (2015). A poxviral-based cancer vaccine the transcription factor twist inhibits primary tumor growth and metastases in a model of metastatic breast cancer and improves survival in a spontaneous prostate cancer model. Oncotarget  6, 28194-210.   https://doi.org/10.18632/oncotarget.4442|8. Kwilas AR, Donahue RN, Tsang KY, Hodge JW (2015). Immune consequences of tyrosine kinase inhibitors that synergize with cancer immunotherapy. Cancer Cell Microenviron  2.   https://doi.org/10.14800/ccm.677|9. Kwilas AR, Gameiro SR, Kim PS, Malamas AS, Hodge JW (2015). Improving clinical benefit for prostate cancer patients through the combination of androgen deprivation and immunotherapy. Oncoimmunology  4, e1009303.   https://doi.org/10.1080/2162402X.2015.1009303",https://intramural.nih.gov/search/searchview.taf?ipid=93786
147,BC010666-12,"October 01, 2015 -  September 30, 2016",Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines,"James L Gulley; MD, PhD|IRP Faculty Profile",NULL,"Genitourinary Malignancies Branch, NCI",Amy Rosenberg Hankin|Julius Yehuda Strauss; MD|William Laurence Dahut; MD|Ravi  Madan,"Robert  DiPaola (The Cancer Institute of New Jersey)|John  Marshall|William  Carson (Molecular Virology, Immunology and Medical Genetics, Ohio State University)|Douglas  McNeel (University of Wisconsin)|Paul  Chaplin (Bavarian Nordic, Inc.)|Alex  Franzusoff (Research and Development, GlobeImmune)",William Marston Linehan; MD (Urologic Oncology Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Peter A Pinto; MD (Urologic Oncology Branch)|Claudia Mercedes Palena (Laboratory of Tumor Immunology and Biology)|Peter L Choyke; MD (Molecular Imaging Program)|Raffit  Hassan (Thoracic & Oncologic Surgery Branch),NULL,"1. Land SR, Warren GW, Crafts JL, Hatsukami DK, Ostroff JS, Willis GB, Chollette VY, Mitchell SA, Folz JN, Gulley JL, Szabo E, Brandon TH, Duffy SA, Toll BA (2016) Cognitive testing of tobacco use items for administration to patients with cancer and cancer survivors in clinical research. Cancer 122:1728-34|2. Lepone L, Donahue R, Grenga I, Metenou S, Richards J, Heery C, Madan R, Gulley J, Schlom J (2016) Analyses of 123 peripheral human immune cell subsets: defining differences with age and between healthy donors and cancer patients not detected in analysis of standard immune cell types J Circ Biomark 5:1-20|3. Lu D, Graf R, Harvey M, Madan R, Heery C, Marte J, Beasley S, Tsang K, Krupa R, Louw J, Wahl J, Bales N, Landers M, Marrinucci D, Schlom J, Gulley J, Dittamore R (2015) Detection and characterization of circulating tumour cells from frozen peripheral blood mononuclear cells J Circ Biomark 4:4|4. Madan RA, Gulley JL (2015). (R)Evolutionary therapy: the potential of immunotherapy to fulfill the promise of personalized cancer treatment. J Natl Cancer Inst  107, 347.   https://doi.org/10.1093/jnci/dju347|5. Madan RA, Gulley JL (2015). Moving the goal posts in prostate cancer trials. Lancet Oncol  16, 247-9.   https://doi.org/10.1016/S1470-2045(15)70071-9|6. Madan RA, Karzai FH, Ning YM, Adesunloye BA, Huang X, Harold N, Couvillon A, Chun G, Cordes L, Sissung T, Beedie SL, Dawson NA, Theoret MR, McLeod DG, Rosner I, Trepel JB, Lee MJ, Tomita Y, Lee S, Chen C, Steinberg SM, Arlen PM, Gulley JL, Figg WD, Dahut WL (2016). Phase II trial of docetaxel, bevacizumab, lenalidomide and prednisone in patients with metastatic castration-resistant prostate cancer. BJU Int  118, 590-7.   https://doi.org/10.1111/bju.13412|7. Wattenberg M, Fong L, Madan R, Gulley J (2016) Immunotherapy in genitourinary malignancies. Current Opinion in Urology, in press.|8. Wattenberg MM, Fong L, Madan RA, Gulley JL (2016). Immunotherapy in genitourinary malignancies. Curr Opin Urol  26, 501-7.   https://doi.org/10.1097/MOU.0000000000000331",https://intramural.nih.gov/search/searchview.taf?ipid=93785
148,BC010668-12,"October 01, 2015 -  September 30, 2016",Instrumentation for microSPECT and microPET imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",NULL,NULL,NULL,Thomas J Pohida; MS (CIT),"1. Basuli F, Li C, Xu B, Williams M, Wong K, Coble VL, Vasalatiy O, Seidel J, Green MV, Griffiths GL, Choyke PL, Jagoda EM (2015). Synthesis of fluorine-18 radio-labeled serum albumins for PET blood pool imaging. Nucl Med Biol  42, 219-25.   https://doi.org/10.1016/j.nucmedbio.2014.11.011",https://intramural.nih.gov/search/searchview.taf?ipid=93771
149,BC010670-12,"October 01, 2015 -  September 30, 2016",Molecular-Targeted Radiation Therapy,Norman Norman Coleman; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Mansoor Mukhtar Ahmed; PhD|Molykutty J Aryankalayil|Iris Regina Eke; MD|Joel Daniel Levin|Adeola Yetunde Makinde,Emanuel  Petricoin (George Mason University)|Lance  Liotta (George Mason University)|Sylvia  Formenti (NYU),James B Mitchell; PhD (Radiation Biology Branch),NULL,"1. Coleman CN, Higgins GS, Brown JM, Baumann M, Kirsch DG, Willers H, Prasanna PG, Dewhirst MW, Bernhard EJ, Ahmed MM (2016). Improving the Predictive Value of Preclinical Studies in Support of Radiotherapy Clinical Trials. Clin Cancer Res  22, 3138-47.   https://doi.org/10.1158/1078-0432.CCR-16-0069|2. Coleman CN, Sullivan JM, Bader JL, Murrain-Hill P, Koerner JF, Garrett AL, Weinstock DM, Case C, Hrdina C, Adams SA, Whitcomb RC, Graeden E, Shankman R, Lant T, Maidment BW, Hatchett RC (2015). Public health and medical preparedness for a nuclear detonation: the nuclear incident medical enterprise. Health Phys  108, 149-60.   https://doi.org/10.1097/HP.0000000000000249|3. FitzGerald TJ, Bishop-Jodoin M, Followill DS, Galvin J, Knopp MV, Michalski JM, Rosen MA, Bradley JD, Shankar LK, Laurie F, Cicchetti MG, Moni J, Coleman CN, Deye JA, Capala J, Vikram B (2016). Imaging and Data Acquisition in Clinical Trials for Radiation Therapy. Int J Radiat Oncol Biol Phys  94, 404-11.   https://doi.org/10.1016/j.ijrobp.2015.10.028|4. Grover S, Balogun OD, Yamoah K, Groen R, Shah M, Rodin D, Martei Y, Olson AC, Slone JS, Shulman LN, Coleman CN, Hahn SM (2015). Corrigendum: ""Training Global Oncologists: Addressing the Global Cancer Control Problem"". Front Oncol  5, 133.   https://doi.org/10.3389/fonc.2015.00133|5. Grover S, Balogun OD, Yamoah K, Groen R, Shah M, Rodin D, Olson AC, Slone JS, Shulman LN, Coleman CN, Hahn SM (2015) Training global oncologists: addressing the global cancer control problem. Front Oncol 5:80|6. Petereit DG, Coleman CN (2015). Editorial: ""global challenges in radiation oncology"". Front Oncol  5, 103.   https://doi.org/10.3389/fonc.2015.00103|7. Prasanna PG, Narayanan D, Hallett K, Bernhard EJ, Ahmed MM, Evans G, Vikram B, Weingarten M, Coleman CN (2015). Radioprotectors and Radiomitigators for Improving Radiation Therapy: The Small Business Innovation Research (SBIR) Gateway for Accelerating Clinical Translation. Radiat Res  184, 235-48.   https://doi.org/10.1667/RR14186.1|8. Stone HB, Bernhard EJ, Coleman CN, Deye J, Capala J, Mitchell JB, Brown JM (2016). Preclinical Data on Efficacy of 10 Drug-Radiation Combinations: Evaluations, Concerns, and Recommendations. Transl Oncol  9, 46-56.   https://doi.org/10.1016/j.tranon.2016.01.002",https://intramural.nih.gov/search/searchview.taf?ipid=93764
150,BC010671-12,"October 01, 2015 -  September 30, 2016",Genetic Analysis of T-cell Differentiation,"Remy J Bosselut; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Immune Cell Biology, NCI",Andrea Christine Bohrer|Laura Beth Chopp|Thomas  Ciucci|Yayi  Gao|Jia  Nie|Melanie S Vacchio; PhD|Show all 7,"Albert  Bendelac (University of Chicago)|Marc  Jenkins|Wilfried  Ellmeier (Immunology, University of Vienna)|Matthias Martin Gaida|Ari  Melnick (Cornell University)|Georg  Hollander (University of Oxford)","Charles  Vinson; PhD (Nucleic Acids Section)|Michael  Bustin; PhD (Protein Section)|Avinash  Bhandoola; MD, PhD (Laboratory Of Genome Integrity)","Paul E Love; MD, PhD (NICHD) |Yasmine  Belkaid; PhD (NIAID) |John J O'Shea; MD (NIAMS) |Dorian  McGavern (NINDS) |B. J. Fowlkes; PhD (NIAID) |Michael  Grigg; PhD (NIAID)","1. Dobenecker MW, Kim JK, Marcello J, Fang TC, Prinjha R, Bosselut R, Tarakhovsky A (2015). Coupling of T cell receptor specificity to natural killer T cell development by bivalent histone H3 methylation. J Exp Med  212, 297-306.   https://doi.org/10.1084/jem.20141499|2. Manna S, Kim JK, Baugé C, Cam M, Zhao Y, Shetty J, Vacchio MS, Castro E, Tran B, Tessarollo L, Bosselut R (2015). Histone H3 Lysine 27 demethylases Jmjd3 and Utx are required for T-cell differentiation. Nat Commun  6, 8152.   https://doi.org/10.1038/ncomms9152",https://intramural.nih.gov/search/searchview.taf?ipid=93763
151,BC010675-12,"October 01, 2015 -  September 30, 2016",Development of a Carbohydrate Microarray,Jeffrey  Gildersleeve|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Sarah Victoria Durbin|David W Farnsworth|Li  Xia|Ruslan  Gibadullin|Joseph John Barchi,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93777
152,BC010677-12,"October 01, 2015 -  September 30, 2016",NADPH Oxidase 1: A Novel Target for Colon Cancer Therapy,James Halpern Doroshow|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI","Guojian  Jiang; MD|Agnes  Juhasz|Jiamo  Lu; MD, MPH, MHS",NULL,NULL,NULL,"1. Hayes P, Dhillon S, O'Neill K, Thoeni C, Hui KY, Elkadri A, Guo CH, Kovacic L, Aviello G, Alvarez LA, Griffiths AM, Snapper SB, Brant SR, Doroshow JH, Silverberg MS, Peter I, McGovern DP, Cho J, Brumell JH, Uhlig HH, Bourke B, Muise AA, Knaus UG (2015). Defects in NADPH Oxidase Genes NOX1 and DUOX2 in Very Early Onset Inflammatory Bowel Disease. Cell Mol Gastroenterol Hepatol  1, 489-502.   https://doi.org/10.1016/j.jcmgh.2015.06.005",https://intramural.nih.gov/search/searchview.taf?ipid=93776
153,BC010681-12,"October 01, 2015 -  September 30, 2016",Development of inhibitors targeting Plk1 polo-box domain,Kyung  Lee; PhD|IRP Faculty Profile,NULL,"Chemistry Section, NCI",Brandon Jia-Wei Chu|Wonchull  Kang|Eunhye  Lee|Jung Eun  Park|In Young  Lee|Chang Uk  Lee,Michael  Yaffe (Massachusetts Institute of Technology)|Bo  Kim (Korea Research Institute of Bioscience and Biotechnology)|Jeong Kyu Bang,Stuart H Yuspa; MD (Laboratory of Cancer Biology and Genetics)|Terrence R Burke; PhD (Chemical Biology Laboratory),NULL,"1. Jia JL, Han YH, Kim HC, Ahn M, Kwon JW, Luo Y, Gunasekaran P, Lee SJ, Lee KS, Kyu Bang J, Kim NH, Namgoong S (2015). Structural basis for recognition of Emi2 by Polo-like kinase 1 and development of peptidomimetics blocking oocyte maturation and fertilization. Sci Rep  5, 14626.   https://doi.org/10.1038/srep14626|2. Lee KS, Burke TR, Park JE, Bang JK, Lee E (2015). Recent Advances and New Strategies in Targeting Plk1 for Anticancer Therapy. Trends Pharmacol Sci  36, 858-877.   https://doi.org/10.1016/j.tips.2015.08.013|3. Park JE, Kim TS, Kim BY, Lee KS (2015). Selective blockade of cancer cell proliferation and anchorage-independent growth by Plk1 activity-dependent suicidal inhibition of its polo-box domain. Cell Cycle  14, 3624-34.   https://doi.org/10.1080/15384101.2015.1104435|4. Qian WJ, Park JE, Grant R, Lai CC, Kelley JA, Yaffe MB, Lee KS, Burke TR (2015). Neighbor-directed histidine N (τ)-alkylation: A route to imidazolium-containing phosphopeptide macrocycles. Biopolymers  104, 663-73.   https://doi.org/10.1002/bip.22698",https://intramural.nih.gov/search/searchview.taf?ipid=93782
154,BC010683-12,"October 01, 2015 -  September 30, 2016",Role of FH loss in development of HLRCC heriditary kidney cancer,Leonard  Neckers; PhD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",William Marston Linehan; MD,YunJin  Jung (Pusan National University)|Sunil  Sudarshan,NULL,NULL,"1. Khiati S, Baechler SA, Factor VM, Zhang H, Huang SY, Dalla Rosa I, Sourbier C, Neckers L, Thorgeirsson SS, Pommier Y (2015). Lack of mitochondrial topoisomerase I (TOP1mt) impairs liver regeneration. Proc Natl Acad Sci U S A  112, 11282-7.   https://doi.org/10.1073/pnas.1511016112|2. Sourbier C, Scroggins BT, Mannes PZ, Liao PJ, Siems K, Wolf D, Beutler JA, Linehan WM, Neckers L (2015). Tonantzitlolone cytotoxicity toward renal cancer cells is PKCθ- and HSF1-dependent. Oncotarget  6, 29963-74.   https://doi.org/10.18632/oncotarget.4676",https://intramural.nih.gov/search/searchview.taf?ipid=93784
155,BC010692-12,"October 01, 2015 -  September 30, 2016",Significance of Marrow Karyotypes in Inherited Bone Marrow Failure Syndromes,Diane Carol Arthur; MD,Frederic Glenn Barr,"Laboratory of Pathology, NCI",NULL,NULL,Blanche P Alter (Clinical Genetics Branch)|Neelam K Giri; MD (Clinical Genetics Branch)|Sharon Ann Savage (Clinical Genetics Branch),Irina  Maric; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93766
156,BC010696-12,"October 01, 2015 -  September 30, 2016",Study of Hereditary Renal and Other Familial Syndromes,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",David D Roberts; PhD,NULL,"Peter A Pinto; MD (Urologic Oncology Branch)|Electron  Kebebew; MD (Endocrine Oncology Branch)|William Marston Linehan; MD (Urologic Oncology Branch)|Ramaprasad  Srinivasan; MD, PhD (Urologic Oncology Branch)","Karel  Pacak; MD, PhD (NICHD)","1. Karageorgiadis AS, Papadakis GZ, Biro J, Keil MF, Lyssikatos C, Quezado MM, Merino M, Schrump DS, Kebebew E, Patronas NJ, Hunter MK, Alwazeer MR, Karaviti LP, Balazs AE, Lodish MB, Stratakis CA (2015). Ectopic adrenocorticotropic hormone and corticotropin-releasing hormone co-secreting tumors in children and adolescents causing cushing syndrome: a diagnostic dilemma and how to solve it. J Clin Endocrinol Metab  100, 141-8.   https://doi.org/10.1210/jc.2014-2945|2. Lang M, Vocke CD, Merino MJ, Schmidt LS, Linehan WM (2015). Mitochondrial DNA mutations distinguish bilateral multifocal renal oncocytomas from familial Birt-Hogg-Dubé tumors. Mod Pathol  28, 1458-69.   https://doi.org/10.1038/modpathol.2015.101|3. Zilbermint M, Xekouki P, Faucz FR, Berthon A, Gkourogianni A, Schernthaner-Reiter MH, Batsis M, Sinaii N, Quezado MM, Merino M, Hodes A, Abraham SB, Libé R, Assié G, Espiard S, Drougat L, Ragazzon B, Davis A, Gebreab SY, Neff R, Kebebew E, Bertherat J, Lodish MB, Stratakis CA (2015). Primary Aldosteronism and ARMC5 Variants. J Clin Endocrinol Metab  100, E900-9.   https://doi.org/10.1210/jc.2014-4167",https://intramural.nih.gov/search/searchview.taf?ipid=93783
157,BC010701-11,"October 01, 2015 -  September 30, 2016",Human Monoclonal Antibodies Against Cancer,Dimiter Stanchev Dimitrov; PhD,NULL,"Cancer Inflammation Program, NCI",Jennifer Dorcas Hwang|Weizao  Chen|Yang  Feng|Dontcho Videv Jelev; PhD|Wei  Li; PhD|Yanping  Wang|Show all 10,Michel  Sadelain (Memorial Sloan-Kettering Cancer Institute)|Philip  Low (Perdue University)|Kurt  Ghelsen (RCT)|Nancy  Ip (Hong University of Science and Technology)|David  Miao (Concortis)|Qi  Zhao (Institute of Biomedicine and Biotechnology)|Show all 10,Ira H Pastan; MD (Molecular Biology Section)|Mitchell  Ho (Laboratory of Molecular Biology)|Bradley D St Croix (Mouse Cancer Genetics Program),NULL,"1. Lynn RC, Poussin M, Kalota A, Feng Y, Low PS, Dimitrov DS, Powell DJ (2015). Targeting of folate receptor β on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cells. Blood  125, 3466-76.   https://doi.org/10.1182/blood-2014-11-612721|2. Shen J, Putt KS, Visscher DW, Murphy L, Cohen C, Singhal S, Sandusky G, Feng Y, Dimitrov DS, Low PS (2015). Assessment of folate receptor-β expression in human neoplastic tissues. Oncotarget  6, 14700-9.   https://doi.org/10.18632/oncotarget.3739|3. Ying T, Wang Y, Feng Y, Prabakaran P, Gong R, Wang L, Crowder K, Dimitrov DS (2015). Engineered antibody domains with significantly increased transcytosis and half-life in macaques mediated by FcRn. MAbs  7, 922-30.   https://doi.org/10.1080/19420862.2015.1067353|4. Zhao Q, Tran H, Dimitrov DS, Cheung NK (2015). A dual-specific anti-IGF-1/IGF-2 human monoclonal antibody alone and in combination with temsirolimus for therapy of neuroblastoma. Int J Cancer  137, 2243-52.   https://doi.org/10.1002/ijc.29588",https://intramural.nih.gov/search/searchview.taf?ipid=93788
158,BC010707-11,"October 01, 2015 -  September 30, 2016",Role of T Regulatory Cell Suppression in Autoimmunity and Cancer,Joost J Oppenheim; MD|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Xin  Chen|Yingjie No Nie|Anna Lee  Trivett|De  Yang|Haiyun  Xin,Xin  Chen (University of Macao)|Benoit  Salomon (Universite Pierre et Marie Curi),NULL,NULL,"1. Zaragoza B, Chen X, Oppenheim JJ, Baeyens A, Gregoire S, Chader D, Gorochov G, Miyara M, Salomon BL (2016). Suppressive activity of human regulatory T cells is maintained in the presence of TNF. Nat Med  22, 16-7.   https://doi.org/10.1038/nm.4019",https://intramural.nih.gov/search/searchview.taf?ipid=93790
159,BC010709-11,"October 01, 2015 -  September 30, 2016",Exploratory Study of Biologic and Pathophysiologic Effects of Radiation Therapy,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Sonja Kashell Crandon; RN|Terran D Stubbs|Pamela  Wolters,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch)|Deborah E Citrin (Radiation Oncology Branch)|Aradhana  Kaushal (Radiation Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93804
160,BC010717-11,"October 01, 2015 -  September 30, 2016",Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,NULL,Louis  Staudt; MD (Lymphoid Malignancies Branch)|Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93805
161,BC010719-11,"October 01, 2015 -  September 30, 2016",Randomized Phase II study of borteozmib-EPOCH-R in Mantle cell lymphoma,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,NULL,Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),"Adrian U Wiestner; MD, PhD (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93806
162,BC010725-11,"October 01, 2015 -  September 30, 2016",Role of Formylpeptide Receptors in Host Defense,"Ji Ming  Wang; MD, PhD|IRP Faculty Profile",NULL,"Cancer Inflammation Program, NCI",NULL,"Xiuwu  Bian (Southwest Hospital, Institute of Pathology)|Gert  Schmid-Schonbein (Whitaker Institute, UC San Diego)|Chunfu  Wu (Medicinal Chemistry, Shenyang Pharmaceutical University)|Yingying  Le (Immunology, Institute for Nutritional Sciences)",NULL,"Ronald N Germain; MD, PhD (NIAID) |Yasmine  Belkaid; PhD (NIAID)","1. Song C, Wang Q, Song C, Lockett SJ, Colburn NH, Li CC, Wang JM, Rogers TJ (2015). Nucleocytoplasmic shuttling of valosin-containing protein (VCP/p97) regulated by its N domain and C-terminal region. Biochim Biophys Acta  1853, 222-32.   https://doi.org/10.1016/j.bbamcr.2014.10.019|2. Yoshimura T, Liu M, Chen X, Li L, Wang JM (2015). Crosstalk between Tumor Cells and Macrophages in Stroma Renders Tumor Cells as the Primary Source of MCP-1/CCL2 in Lewis Lung Carcinoma. Front Immunol  6, 332.   https://doi.org/10.3389/fimmu.2015.00332",https://intramural.nih.gov/search/searchview.taf?ipid=93796
163,BC010728-11,"October 01, 2015 -  September 30, 2016",Phase III Study of R-CHOP v DA-EPOCH-R with microarray,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,"Myron  Czuczman (Oncology, Roswell Park Cancer Institute)|Bruce Allan Chabner|Andrew  Zelenetz (Medicine, MSKCC)|Bruce  Cheson (NCI)",Louis  Staudt; MD (Lymphoid Malignancies Branch)|Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93807
164,BC010735-11,"October 01, 2015 -  September 30, 2016",Structural studies of fimbriae of enterotoxigenic E. coli (ETEC),"Di S Xia; PhD, MS, BS|IRP Faculty Profile",NULL,"Crystallography Section, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93797
165,BC010736-11,"October 01, 2015 -  September 30, 2016",Unraveling the function of CD276,Bradley D St Croix,Lino  Tessarollo,"Mouse Cancer Genetics Program, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93803
166,BC010738-11,"October 01, 2015 -  September 30, 2016","Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging",Steven X Hou|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Catharine Hannah Dietrich|Qinglan  Ge|Khushbu  Jain|Hanhan  Liu|Hyunhee  Shin|Shree Ram  Singh|Show all 7,NULL,NULL,NULL,"1. Liu Y, Singh SR, Zeng X, Zhao J, Hou SX (2015). The Nuclear Matrix Protein Megator Regulates Stem Cell Asymmetric Division through the Mitotic Checkpoint Complex in Drosophila Testes. PLoS Genet  11, e1005750.   https://doi.org/10.1371/journal.pgen.1005750|2. Zeng X, Hou SX (2015). Enteroendocrine cells are generated from stem cells through a distinct progenitor in the adult Drosophila posterior midgut. Development  142, 644-53.   https://doi.org/10.1242/dev.113357",https://intramural.nih.gov/search/searchview.taf?ipid=93800
167,BC010740-11,"October 01, 2015 -  September 30, 2016",Carbohydrate Microarray Profiling of Glycan-Binding Antibodies and Lectins,Jeffrey  Gildersleeve|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Ali Ahmed Aslam|Natalie Rose Flanagan|Ruslan  Gibadullin|Aza  Shiao|Eric Russell Sterner|Li  Xia|Show all 8,"Lara  Mahal (Chemistry, University of Texas at Austin)|Mai  Xu; PhD|Lynn  Morris (National Institute for Communicable Diseases)|Hanping  Feng (University of Maryland)|James  Fleckenstein (Washington University School of Medicine, St. Louis)|Paul  Lampe (Fred Hutchinson Cancer Research Center)",Jacek Tadeusz Lubkowski (Macromolecular Crystallography Laboratory)|Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93799
168,BC010747-11,"October 01, 2015 -  September 30, 2016",Characterization of the Expression and Ligands of KIR3DS1,Daniel  McVicar; PhD|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Jeffrey J Subleski|Stephen K Anderson; PhD,"Andrew  Brooks (University of Melbourne)|Jamie  Rossjohn (Dept. of Biochemistry & Molecular Biology, Monash University)|David  Price (Cardiff University)|Alain  Rook (University of Pennsylvania)|Simon  Kollnberger (University of Oxford)",NULL,"Suk See De Ravin; MD, PhD (NIAID) |Michael  Ward; MD (NIAMS) |Robert A Colbert; MD, PhD (NIAMS)","1. O'Connor GM, Vivian JP, Gostick E, Pymm P, Lafont BA, Price DA, Rossjohn J, Brooks AG, McVicar DW (2015). Peptide-Dependent Recognition of HLA-B*57:01 by KIR3DS1. J Virol  89, 5213-21.   https://doi.org/10.1128/JVI.03586-14",https://intramural.nih.gov/search/searchview.taf?ipid=93789
169,BC010749-11,"October 01, 2015 -  September 30, 2016",DNA Vaccines,"George N Pavlakis; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI",Rachel Elizabeth Kelly Beach|Bhabadeb S Chowdhury; PhD|Ashli Nicole Earl|Jinyao  Li; PhD|Eirini  Moysi; PhD|Bethany Anne Nagy|Show all 12,"David C Montefiori; PhD (Department of Surgery, NIAID)|James  Mullins; PhD (Microbiology, University of Washington)|Michael  Egan (Profectus Biosciences, Inc.)|John  Eldridge (Wyeth Lederle Vaccines)|Timothy  Fouts (Profectus BioSciences, Inc.)|Robert  Gallo; MD (Institute of Human Virology, Maryland University)|Show all 21",NULL,NULL,"1. Fouts TR, Bagley K, Prado IJ, Bobb KL, Schwartz JA, Xu R, Zagursky RJ, Egan MA, Eldridge JH, LaBranche CC, Montefiori DC, Le Buanec H, Zagury D, Pal R, Pavlakis GN, Felber BK, Franchini G, Gordon S, Vaccari M, Lewis GK, DeVico AL, Gallo RC (2015). Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection. Proc Natl Acad Sci U S A  112, E992-9.   https://doi.org/10.1073/pnas.1423669112|2. Hulot SL, Korber B, Giorgi EE, Vandergrift N, Saunders KO, Balachandran H, Mach LV, Lifton MA, Pantaleo G, Tartaglia J, Phogat S, Jacobs B, Kibler K, Perdiguero B, Gomez CE, Esteban M, Rosati M, Felber BK, Pavlakis GN, Parks R, Lloyd K, Sutherland L, Scearce R, Letvin NL, Seaman MS, et al. [5 more authors] (2015). Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost. J Virol  89, 6462-80.   https://doi.org/10.1128/JVI.00383-15|3. Li J, Valentin A, Beach RK, Alicea C, Felber BK, Pavlakis GN (2015). DNA is an efficient booster of dendritic cell-based vaccine. Hum Vaccin Immunother  11, 1927-35.   https://doi.org/10.1080/21645515.2015.1020265|4. Mothe B, Hu X, Llano A, Rosati M, Olvera A, Kulkarni V, Valentin A, Alicea C, Pilkington GR, Sardesai NY, Rocafort M, Crespo M, Carrillo J, Marco A, Mullins JI, Dorrell L, Hanke T, Clotet B, Pavlakis GN, Felber BK, Brander C (2015). A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques. J Transl Med  13, 60.   https://doi.org/10.1186/s12967-015-0392-5|5. Shen X, Duffy R, Howington R, Cope A, Sadagopal S, Park H, Pal R, Kwa S, Ding S, Yang OO, Fouda GG, Le Grand R, Bolton D, Esteban M, Phogat S, Roederer M, Amara RR, Picker LJ, Seder RA, McElrath MJ, Barnett S, Permar SR, Shattock R, DeVico AL, Felber BK, et al. [5 more authors] (2015). Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates. J Virol  89, 8643-50.   https://doi.org/10.1128/JVI.03635-14|6. Valentin A, Li J, Rosati M, Kulkarni V, Patel V, Jalah R, Alicea C, Reed S, Sardesai N, Berkower I, Pavlakis GN, Felber BK (2015). Dose-dependent inhibition of Gag cellular immunity by Env in SIV/HIV DNA vaccinated macaques. Hum Vaccin Immunother  11, 2005-11.   https://doi.org/10.1080/21645515.2015.1016671",https://intramural.nih.gov/search/searchview.taf?ipid=93791
170,BC010750-11,"October 01, 2015 -  September 30, 2016",Cytokines in AIDS and Cancer Immunotherapy,"George N Pavlakis; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI",Rachel Elizabeth Kelly Beach|Bhabadeb S Chowdhury; PhD|Konstantinos  Dimas; MD|Swagata  Kar|Jinyao  Li; PhD|Eirini  Moysi; PhD|Show all 13,John  Eldridge (Wyeth Lederle Vaccines)|Karen  Gaensler (University of California)|Peter  Katsikis (Drexel University College of Medicine)|Rafick-Pierre  Sekaly (Centre de Recherche du Centre Hospitalier de l'Universite de Montreal)|Morten  Thaysen-Andersen (Macquarie University)|David A Zaharoff,"Jeffrey D Lifson; MD (Office Of The Director)|Elena  Chertova (Office Of The Director)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)|Kevin Charles Conlon (Lymphoid Malignancies Branch)",Konstantinos  Petrovas (NIAID) |Richard A Koup; MD (NIAID) |Mario  Roederer; PhD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93792
171,BC010759-11,"October 01, 2015 -  September 30, 2016",Functional Genomics of Sarcoma,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Sean Richard Davis; MD, PhD|Kathryn Elizabeth Driest|Corbin D Ester|Arthur A Glatfelter; MS|Heiko  Horn; PhD|Yuan  Jiang; MD|Show all 12","Heinrich  Kovar (St. Anna's Children's Hospital)|Richard  Gorlick (Laboratory of Cellular Carcinogenesis and Tumor Promotion, Albert Einstein College of Medicine)|Ching  Lau (Ped Heme/Onc, Texas Children's Hospital)|Ashok  Venkitaraman (University of Cambridge)",Sharon Ann Savage (Clinical Genetics Branch)|Lee Jay Helman; MD (Pediatric Oncology Branch)|Lisa  Mirabello (Genetic Epidemiology Branch),NULL,"1. Gindin Y, Jiang Y, Francis P, Walker RL, Abaan OD, Zhu YJ, Meltzer PS (2015). miR-23a impairs bone differentiation in osteosarcoma via down-regulation of GJA1. Front Genet  6, 233.   https://doi.org/10.3389/fgene.2015.00233|2. Isakoff MS, Bielack SS, Meltzer P, Gorlick R (2015). Osteosarcoma: Current Treatment and a Collaborative Pathway to Success. J Clin Oncol  33, 3029-35.   https://doi.org/10.1200/JCO.2014.59.4895|3. Mirabello L, Koster R, Moriarity BS, Spector LG, Meltzer PS, Gary J, Machiela MJ, Pankratz N, Panagiotou OA, Largaespada D, Wang Z, Gastier-Foster JM, Gorlick R, Khanna C, de Toledo SR, Petrilli AS, Patiño-Garcia A, Sierrasesúmaga L, Lecanda F, Andrulis IL, Wunder JS, Gokgoz N, Serra M, Hattinger C, Picci P, et al. [27 more authors] (2015). A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma. Cancer Discov  5, 920-31.   https://doi.org/10.1158/2159-8290.CD-15-0125|4. Ren L, Mendoza A, Zhu J, Briggs JW, Halsey C, Hong ES, Burkett SS, Morrow J, Lizardo MM, Osborne T, Li SQ, Luu HH, Meltzer P, Khanna C (2015). Characterization of the metastatic phenotype of a panel of established osteosarcoma cells. Oncotarget  6, 29469-81.   https://doi.org/10.18632/oncotarget.5177|5. Saxena N, Maio N, Crooks DR, Ricketts CJ, Yang Y, Wei MH, Fan TW, Lane AN, Sourbier C, Singh A, Killian JK, Meltzer PS, Vocke CD, Rouault TA, Linehan WM (2016). SDHB-Deficient Cancers: The Role of Mutations That  Impair Iron Sulfur Cluster Delivery. J Natl Cancer Inst  108.   https://doi.org/10.1093/jnci/djv287|6. Schwentner R, Papamarkou T, Kauer MO, Stathopoulos V, Yang F, Bilke S, Meltzer PS, Girolami M, Kovar H (2015). EWS-FLI1 employs an E2F switch to drive target gene expression. Nucleic Acids Res  43, 2780-9.   https://doi.org/10.1093/nar/gkv123|7. Sun W, Chatterjee B, Wang Y, Stevenson HS, Edelman DC, Meltzer PS, Barr FG (2015). Distinct methylation profiles characterize fusion-positive and fusion-negative rhabdomyosarcoma. Mod Pathol  28, 1214-24.   https://doi.org/10.1038/modpathol.2015.82",https://intramural.nih.gov/search/searchview.taf?ipid=93801
172,BC010763-11,"October 01, 2015 -  September 30, 2016",Building on the success of the adoptive immunotherapy of cancer,Nicholas Phillip Restifo; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI",Arash D Eidizadeh|Devikala  Gurusamy|S M Rafiqul  Islam; PhD|Douglas  Palmer|Shashankkumar Jitendra Patel; MS|Madhusudhanan  Sukumar|Show all 16,Paul  Antony (Univeristy of Maryland)|Vincenzo  Bronte,Giorgio  Trinchieri (Cancer Inflammation Program),NULL,"1. Apetoh L, Smyth MJ, Drake CG, Abastado JP, Apte RN, Ayyoub M, Blay JY, Bonneville M, Butterfield LH, Caignard A, Castelli C, Cavallo F, Celis E, Chen L, Colombo MP, Comin-Anduix B, Coukos G, Dhodapkar MV, Dranoff G, Frazer IH, Fridman WH, Gabrilovich DI, Gilboa E, Gnjatic S, Jäger D, et al. [34 more authors] (2015). Consensus nomenclature for CD8(+) T cell phenotypes in cancer. Oncoimmunology  4, e998538.|2. Beane JD, Lee G, Zheng Z, Mendel M, Abate-Daga D, Bharathan M, Black M, Gandhi N, Yu Z, Chandran S, Giedlin M, Ando D, Miller J, Paschon D, Guschin D, Rebar EJ, Reik A, Holmes MC, Gregory PD, Restifo NP, Rosenberg SA, Morgan RA, Feldman SA (2015). Clinical Scale Zinc Finger Nuclease-mediated Gene Editing of PD-1 in Tumor Infiltrating Lymphocytes for the Treatment of Metastatic Melanoma. Mol Ther  23, 1380-1390.   https://doi.org/10.1038/mt.2015.71|3. Crompton JG, Sukumar M, Roychoudhuri R, Clever D, Gros A, Eil RL, Tran E, Hanada K, Yu Z, Palmer DC, Kerkar SP, Michalek RD, Upham T, Leonardi A, Acquavella N, Wang E, Marincola FM, Gattinoni L, Muranski P, Sundrud MS, Klebanoff CA, Rosenberg SA, Fearon DT, Restifo NP (2015). Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics. Cancer Res  75, 296-305.   https://doi.org/10.1158/0008-5472.CAN-14-2277|4. Khor B, Gagnon JD, Goel G, Roche MI, Conway KL, Tran K, Aldrich LN, Sundberg TB, Paterson AM, Mordecai S, Dombkowski D, Schirmer M, Tan PH, Bhan AK, Roychoudhuri R, Restifo NP, O'Shea JJ, Medoff BD, Shamji AF, Schreiber SL, Sharpe AH, Shaw SY, Xavier RJ (2015). The kinase DYRK1A reciprocally regulates the differentiation of Th17 and regulatory T cells. Elife  4.   https://doi.org/10.7554/eLife.05920|5. Rodriguez-Peña AB, Gomez-Rodriguez J, Kortum RL, Palmer DC, Yu Z, Guittard GC, Wohlfert EA, Silver PB, Misplon JA, Sommers CL, Feigenbaum L, Epstein SL, Caspi RR, Belkaid Y, Restifo NP, Samelson LE, Balagopalan L (2015). Enhanced T-cell activation and differentiation in lymphocytes from transgenic mice expressing ubiquitination-resistant 2KR LAT molecules. Gene Ther  22, 781-92.   https://doi.org/10.1038/gt.2015.48|6. Rosenberg SA, Restifo NP (2015). Adoptive cell transfer as personalized immunotherapy for human cancer. Science  348, 62-8.   https://doi.org/10.1126/science.aaa4967|7. Roychoudhuri R, Lefebvre F, Honda M, Pan L, Ji Y, Klebanoff CA, Nichols CN, Fourati S, Hegazy AN, Goulet JP, Gattinoni L, Nabel GJ, Gilliet M, Cameron M, Restifo NP, Sékaly RP, Flatz L (2015). Transcriptional profiles reveal a stepwise developmental program of memory CD8(+) T cell differentiation. Vaccine  33, 914-23.   https://doi.org/10.1016/j.vaccine.2014.10.007|8. Vahedi G, Kanno Y, Furumoto Y, Jiang K, Parker SC, Erdos MR, Davis SR, Roychoudhuri R, Restifo NP, Gadina M, Tang Z, Ruan Y, Collins FS, Sartorelli V, O'Shea JJ (2015). Super-enhancers delineate disease-associated regulatory nodes in T cells. Nature  520, 558-62.   https://doi.org/10.1038/nature14154|9. Ya Z, Hailemichael Y, Overwijk W, Restifo NP (2015). Mouse model for pre-clinical study of human cancer immunotherapy. Curr Protoc Immunol  108, 20.1.1-20.1.43.   https://doi.org/10.1002/0471142735.im2001s108|10. Zhang L, Morgan RA, Beane JD, Zheng Z, Dudley ME, Kassim SH, Nahvi AV, Ngo LT, Sherry RM, Phan GQ, Hughes MS, Kammula US, Feldman SA, Toomey MA, Kerkar SP, Restifo NP, Yang JC, Rosenberg SA (2015). Tumor-infiltrating lymphocytes genetically engineered with an inducible gene encoding interleukin-12 for the immunotherapy of metastatic melanoma. Clin Cancer Res  21, 2278-88.   https://doi.org/10.1158/1078-0432.CCR-14-2085",https://intramural.nih.gov/search/searchview.taf?ipid=93802
173,BC010766-10,"October 01, 2015 -  September 30, 2016",High Throughput Isolation of Antigen Specific T-cells for Cancer Therapy,Udai S Kammula,NULL,"Surgery Branch, NCI",NULL,NULL,Mark  Raffeld; MD (Laboratory of Pathology)|Eric Alan Stahlberg (Center For Biomedical Informatics & Information Technology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93853
174,BC010770-10,"October 01, 2015 -  September 30, 2016",Genotoxicity and mitochondrial toxicity of antiretroviral NRTI and PI drugs,Miriam Christine Poirier; PhD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",NULL,"Maria  Rugeles (Immunovirology, Unversidad de Antioquia)|Vernon  Walker (University of Vermont)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93855
175,BC010773-10,"October 01, 2015 -  September 30, 2016",Interactions of APOBEC3 Proteins with Murine Leukemia Viruses,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Yadvinder Singh Ahi|Laura Elizabeth Baker|Siddhartha  Datta; PhD|Demetria P Harvin|Joseph Emanuele Manzi|Diborah Mengistu Yimer|Show all 7,"John  Coffin (Tufts University)|Susan R Ross|Hung  Fan (University of California, Irvine)|Patric  Jern (Tufts University)|Mark  Williams (Northeastern University)",Xinhua  Ji; PhD (Biomolecular Structure Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93854
176,BC010774-10,"October 01, 2015 -  September 30, 2016",T Cell Alternative p38 Activation Pathway,Jonathan D Ashwell; MD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Muhammad Shamsul Alam|Bei  Dong|June  Guha; PhD,Al  Fornace (Georgetown University)|Matthias Martin Gaida,Ettore  Appella; MD (Chemical Immunology Section),NULL,"1. Alam MS, Gaida MM, Bergmann F, Lasitschka F, Giese T, Giese NA, Hackert T, Hinz U, Hussain SP, Kozlov SV, Ashwell JD (2015). Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression. Nat Med  21, 1337-43.   https://doi.org/10.1038/nm.3957",https://intramural.nih.gov/search/searchview.taf?ipid=93808
177,BC010778-10,"October 01, 2015 -  September 30, 2016",HIV-1 Maturation,Eric O Freed; PhD|IRP Faculty Profile,NULL,"HIV Drug Resistance Program, NCI",Sherimay  Ablan|Justin Allan Kaplan|Nishani  Kuruppu|Emiko  Urano; PhD|Ariana Lee Gitzen|Phuong Nhat Pham,Tatyana  Polenova; PhD (University of Delaware)|Feng  Li; PhD|Ritu  Gaur|Carl  Wild (Panacos Pharmaceuticals)|-  Hetero Drugs (Hetero Research Foundation)|Owen  Pornillos (University of Virginia),Alan  Rein; PhD (Retroviral Replication Laboratory)|Joel Patrick Schneider; PhD (Chemical Biology Laboratory),Alasdair C Steven; PhD (NIAMS),"1. Freed EO (2015). HIV-1 assembly, release and maturation. Nat Rev Microbiol  13, 484-96.   https://doi.org/10.1038/nrmicro3490",https://intramural.nih.gov/search/searchview.taf?ipid=93815
178,BC010782-10,"October 01, 2015 -  September 30, 2016",Study of the Roles of SDF1 and CXCR4 in Hematopoiesis,Giovanna  Tosato; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI","Michael Joseph Diprima|Taekyu  Ha|Shinichiro  Hasegawa; MD, PhD|Hyeong Il  Kwak|Hidetaka  Ohnuki|Lisa Beth Ritchey|Show all 9","Frederick  Wang (Harvard Univ)|James  Stone (Dept. of Cardiology, University of Alberta)|Maria  Cid (Univ. of Barcelona Medical School)|Catherine  Porcher (Oxford Univ)|Shushang  Wang (Univ. Texas Southwestern Med Center)|Elena  Pasquale (Burnham Inst)","Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|David  Levens; PhD (Laboratory of Pathology)|Roberto  Weigert; MSc Chemistry, PhD (Laboratory of Cellular and Molecular Biology)|Ira  Daar; PhD (Cancer and Developmental Biology Laboratory)",Yosuke  Mukoyama; PhD (NHLBI),"1. Chen II, Caprioli A, Ohnuki H, Kwak H, Porcher C, Tosato G (2016). EphrinB2 regulates the emergence of a hemogenic endothelium from the aorta. Sci Rep  6, 27195.   https://doi.org/10.1038/srep27195|2. Salvucci O, Ohnuki H, Maric D, Hou X, Li X, Yoon SO, Segarra M, Eberhart CG, Acker-Palmer A, Tosato G (2015). EphrinB2 controls vessel pruning through STAT1-JNK3 signalling. Nat Commun  6, 6576.   https://doi.org/10.1038/ncomms7576",https://intramural.nih.gov/search/searchview.taf?ipid=93821
179,BC010783-10,"October 01, 2015 -  September 30, 2016","Inflammation, Macrophage Differentiation, and Cancer",Zhenggang  Liu; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Moran  Choe|Swati Suresh Choksi|Jonathan  Jang|Qing  Xu; MD,"Xuemin  Zhang|Brian  Rowan (School of Medicine, Tulane University)",NULL,Chengyu  Liu; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93822
180,BC010788-10,"October 01, 2015 -  September 30, 2016",Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma,Carol J Thiele|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Fidelia  Acevedo|Deblina  Banerjee|Amanda Kathryn Ciardiello|Norris Lio Lam|Zhihui  Liu|Veronica  Veschi|Show all 7,"Jinhua  Zhang (Hematology, 2nd China Medical School)|John  Maris (Pharmacology, Children's Hospital of Philadelphia)|Anna  Philpott (Cambridge)|Chesler  Louis (The Royal Marsden NHS Foundation Trust)",NULL,Yosuke  Mukoyama; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93823
181,BC010789-10,"October 01, 2015 -  September 30, 2016",Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma,Carol J Thiele|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Fidelia  Acevedo|Norris Lio Lam|Zhihui  Liu|Seiichi  Odate|Veronica  Veschi|Vivian  Wang,"David  Kaplan (Hospital for Sick Kids)|Jinhua  Zhang (Hematology, 2nd China Medical School)",Seth M Steinberg; PhD (Biostatistics and Data Management Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93824
182,BC010791-10,"October 01, 2015 -  September 30, 2016","Effects of genetic polymorphism in MHC, KIR, and related loci on human disease","Mary  Carrington; MS, PhD",NULL,"Cancer Inflammation Program, NCI",Marjan  Akdag|Richard  Apps; PhD|Arman A Bashirova|Fuh-Mei  Duh|Xiaojiang  Gao|Maureen P Martin|Show all 10,"Amalio  Telenti (University Hospital of Lausanne)|Howard  Strickler (Albert Einstein College of Medicine)|Chloe  Thio (University Medicine, Johns Hopkins University)|David  Thomas (Johns Hopkins University)|Michael  Knowles (Cystic Fibrosis Pulmonary Research and Treatment Center, University of North Carolina at Chapel Hill)|Bruce  Walker (Harvard Medical School)|Show all 21",Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|James Jerome Goedert; MD (Hormonal and Reproductive Epidemiology Branch),Daniel C Douek; MD (NIAID),"1. Adland E, Paioni P, Thobakgale C, Laker L, Mori L, Muenchhoff M, Csala A, Clapson M, Flynn J, Novelli V, Hurst J, Naidoo V, Shapiro R, Huang KH, Frater J, Prendergast A, Prado JG, Ndung'u T, Walker BD, Carrington M, Jooste P, Goulder PJ (2015). Discordant Impact of HLA on Viral Replicative Capacity and Disease Progression in Pediatric and Adult HIV Infection. PLoS Pathog  11, e1004954.   https://doi.org/10.1371/journal.ppat.1004954|2. Augusto DG, O'Connor GM, Lobo-Alves SC, Bass S, Martin MP, Carrington M, McVicar DW, Petzl-Erler ML (2015). Pemphigus is associated with KIR3DL2 expression levels and provides evidence that KIR3DL2 may bind HLA-A3 and A11 in vivo. Eur J Immunol  45, 2052-60.   https://doi.org/10.1002/eji.201445324|3. Goyette P, Boucher G, Mallon D, Ellinghaus E, Jostins L, Huang H, Ripke S, Gusareva ES, Annese V, Hauser SL, Oksenberg JR, Thomsen I, Leslie S, International Inflammatory Bowel Disease Genetics Consortium, Australia and New Zealand IBDGC, Belgium IBD Genetics Consortium, Italian Group for IBD Genetic Consortium, NIDDK Inflammatory Bowel Disease Genetics Consortium, United Kingdom IBDGC, Wellcome Trust Case Control Consortium, Quebec IBD Genetics Consortium, Daly MJ, Van Steen K, Duerr RH, Barrett JC, McGovern DP, Schumm LP, Traherne JA, Carrington MN, Kosmoliaptsis V, Karlsen TH, Franke A, Rioux JD (2015). High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis. Nat Genet  47, 172-9.   https://doi.org/10.1038/ng.3176|4. Hölzemer A, Thobakgale CF, Jimenez Cruz CA, Garcia-Beltran WF, Carlson JM, van Teijlingen NH, Mann JK, Jaggernath M, Kang SG, Körner C, Chung AW, Schafer JL, Evans DT, Alter G, Walker BD, Goulder PJ, Carrington M, Hartmann P, Pertel T, Zhou R, Ndung'u T, Altfeld M (2015). Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South Africa. PLoS Med  12, e1001900; discussion e1001900.   https://doi.org/10.1371/journal.pmed.1001900|5. McLaren PJ, Carrington M (2015). The impact of host genetic variation on infection with HIV-1. Nat Immunol  16, 577-83.   https://doi.org/10.1038/ni.3147|6. McLaren PJ, Coulonges C, Bartha I, Lenz TL, Deutsch AJ, Bashirova A, Buchbinder S, Carrington MN, Cossarizza A, Dalmau J, De Luca A, Goedert JJ, Gurdasani D, Haas DW, Herbeck JT, Johnson EO, Kirk GD, Lambotte O, Luo M, Mallal S, van Manen D, Martinez-Picado J, Meyer L, Miro JM, Mullins JI, et al. [16 more authors] (2015). Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load. Proc Natl Acad Sci U S A  112, 14658-63.   https://doi.org/10.1073/pnas.1514867112|7. Olesen R, Vigano S, Rasmussen TA, Søgaard OS, Ouyang Z, Buzon M, Bashirova A, Carrington M, Palmer S, Brinkmann CR, Yu XG, Østergaard L, Tolstrup M, Lichterfeld M (2015). Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat. J Virol  89, 10176-89.   https://doi.org/10.1128/JVI.01484-15|8. Reusing SB, Manser AR, Enczmann J, Mulder A, Claas FH, Carrington M, Fischer JC, Borkhardt A, Babor F, Uhrberg M (2016). Selective downregulation of HLA-C and HLA-E in childhood acute lymphoblastic leukaemia. Br J Haematol  174, 477-80.   https://doi.org/10.1111/bjh.13777|9. Ruibal P, Oestereich L, Lüdtke A, Becker-Ziaja B, Wozniak DM, Kerber R, Korva M, Cabeza-Cabrerizo M, Bore JA, Koundouno FR, Duraffour S, Weller R, Thorenz A, Cimini E, Viola D, Agrati C, Repits J, Afrough B, Cowley LA, Ngabo D, Hinzmann J, Mertens M, Vitoriano I, Logue CH, Boettcher JP, et al. [62 more authors] (2016). Unique human immune signature of Ebola virus disease in Guinea. Nature  533, 100-4.   https://doi.org/10.1038/nature17949",https://intramural.nih.gov/search/searchview.taf?ipid=93813
183,BC010792-10,"October 01, 2015 -  September 30, 2016",Molecular genetics and population studies of the KIR and HLA gene complexes,"Mary  Carrington; MS, PhD",NULL,"Cancer Inflammation Program, NCI",Marjan  Akdag|Richard  Apps; PhD|Arman A Bashirova|Fuh-Mei  Duh|Xiaojiang  Gao|Maureen P Martin|Show all 11,John  Trowsdale (University of Cambridge)|Richard  Single (University of Vermont)|Kenneth  Kidd (Yale University)|Bruce  Walker (Harvard Medical School)|Judith  Kidd (Yale University)|Daniel  Geraghty (Fred Hutchinson Cancer Research Center)|Show all 7,NULL,NULL,"1. Apps R, Meng Z, Del Prete GQ, Lifson JD, Zhou M, Carrington M (2015). Relative expression levels of the HLA class-I proteins in normal and HIV-infected cells. J Immunol  194, 3594-600.   https://doi.org/10.4049/jimmunol.1403234|2. Ruibal P, Oestereich L, Lüdtke A, Becker-Ziaja B, Wozniak DM, Kerber R, Korva M, Cabeza-Cabrerizo M, Bore JA, Koundouno FR, Duraffour S, Weller R, Thorenz A, Cimini E, Viola D, Agrati C, Repits J, Afrough B, Cowley LA, Ngabo D, Hinzmann J, Mertens M, Vitoriano I, Logue CH, Boettcher JP, et al. [62 more authors] (2016). Unique human immune signature of Ebola virus disease in Guinea. Nature  533, 100-4.   https://doi.org/10.1038/nature17949",https://intramural.nih.gov/search/searchview.taf?ipid=93812
184,BC010793-10,"October 01, 2015 -  September 30, 2016","Role of inflammation, innate resistance, and immunity in carcinogenesis",Giorgio  Trinchieri|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Jonathan Harold Badger|Sharon A Bargo|Ren Ming  Dai|Amiran  Dzutsev; PhD|Rosalba  Salcedo|Loretta R Smith|Show all 14,"Xiaojing  Ma (Microbiology and Immunology, Weill Medical College)|Mario  Colombo (Experimental Oncology, National Institute of Surgery and Cure of Tumors)|Uzma  Hasan (Infections and Cancer Biology, International Agency for Research on Cancer (IARC-WHO))|Sergei A. Nedospasov; PhD, DSc|Dominique  Kaiserlian (U404, INSERM)|Sergey  Grivennikov (Fox Chase Cancer Center)",Li  Yang; PhD (Laboratory of Cancer Biology and Genetics),Alan  Sher; PhD (NIAID) |Yasmine  Belkaid; PhD (NIAID),"1. Bodogai M, Moritoh K, Lee-Chang C, Hollander CM, Sherman-Baust CA, Wersto RP, Araki Y, Miyoshi I, Yang L, Trinchieri G, Biragyn A (2015). Immunosuppressive and Prometastatic Functions of Myeloid-Derived Suppressive Cells Rely upon Education from Tumor-Associated B Cells. Cancer Res  75, 3456-65.   https://doi.org/10.1158/0008-5472.CAN-14-3077|2. de Matos-Neto EM, Lima JD, de Pereira WO, Figuerêdo RG, Riccardi DM, Radloff K, das Neves RX, Camargo RG, Maximiano LF, Tokeshi F, Otoch JP, Goldszmid R, Câmara NO, Trinchieri G, de Alcântara PS, Seelaender M (2015). Systemic Inflammation in Cachexia - Is Tumor Cytokine Expression Profile the Culprit? Front Immunol  6, 629.   https://doi.org/10.3389/fimmu.2015.00629|3. Levay A, Brenneman R, Hoinka J, Sant D, Cardone M, Trinchieri G, Przytycka TM, Berezhnoy A (2015). Identifying high-affinity aptamer ligands with defined cross-reactivity using high-throughput guided systematic evolution of ligands by exponential enrichment. Nucleic Acids Res  43, e82.   https://doi.org/10.1093/nar/gkv534|4. Perez-Chanona E, Trinchieri G (2016). The role of microbiota in cancer therapy. Curr Opin Immunol  39, 75-81.   https://doi.org/10.1016/j.coi.2016.01.003|5. Ridnour LA, Cheng RY, Weiss JM, Kaur S, Soto-Pantoja DR, Basudhar D, Heinecke JL, Stewart CA, DeGraff W, Sowers AL, Thetford A, Kesarwala AH, Roberts DD, Young HA, Mitchell JB, Trinchieri G, Wiltrout RH, Wink DA (2015). NOS Inhibition Modulates Immune Polarization and Improves Radiation-Induced Tumor Growth Delay. Cancer Res  75, 2788-99.   https://doi.org/10.1158/0008-5472.CAN-14-3011|6. Trinchieri G (2015). Cancer Immunity: Lessons From Infectious Diseases. J Infect Dis  212 Suppl 1, S67-73.   https://doi.org/10.1093/infdis/jiv070",https://intramural.nih.gov/search/searchview.taf?ipid=93825
185,BC010795-10,"October 01, 2015 -  September 30, 2016",Mechanisms of transcription fidelity in prokaryotes and eukaryotes,Mikhail V Kashlev|IRP Faculty Profile,NULL,"Molecular Mechanisms of Transcription Section, NCI",Omar Carlos Herrera Asmat; MSC|Masahiko  Imashimizu|Maria L Kireeva|Lucyna E Lubkowska|Gayane  Matevosyan,"Zachary  Burton (Department of Biochemistry and Molecular Biology, Michigan State University)|Carlos  Bustamante (University of California - Berkeley)|Michelle  Wang (Cornell University)|Charles  Turnbough (Unversity of Alabama)|Max  Gottesman (Institute of Cancer Research, Columbia University)",Donald L Court; PhD (Molecular Control and Genetics Section)|Bruce Allen Shapiro; PhD (Gene Regulation and Chromosome Biology Laboratory),NULL,"1. Imashimizu M, Takahashi H, Oshima T, McIntosh C, Bubunenko M, Court DL, Kashlev M (2015). Visualizing translocation dynamics and nascent transcript errors in paused RNA polymerases in vivo. Genome Biol  16, 98.   https://doi.org/10.1186/s13059-015-0666-5|2. Penno C, Sharma V, Coakley A, O'Connell Motherway M, van Sinderen D, Lubkowska L, Kireeva ML, Kashlev M, Baranov PV, Atkins JF (2015). Productive mRNA stem loop-mediated transcriptional slippage: Crucial features in common with intrinsic terminators. Proc Natl Acad Sci U S A  112, E1984-93.   https://doi.org/10.1073/pnas.1418384112",https://intramural.nih.gov/search/searchview.taf?ipid=93826
186,BC010801-10,"October 01, 2015 -  September 30, 2016",Therapy for NF1-Related Tumors and other Genetic Tumor Predisposition Syndromes,Brigitte  Widemann; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Andrea Maria Baldwin|Diana Louise Bradford|Eva  Dombi|Andrea Michelle Gross; MD|Kara Suzanne Heisey|Christine Sarah Higham|Show all 10,"John  Perentesis (Pediatric Oncology, Cincinnati Children's Hospital)|Bruce  Korf (University of Alabama)|Regina  Jakacki (Neuropathology, Children's Hospital of Pittsburgh)|Victor  Mautner (Genetics, Hamburg University)|Nancy  Ratner (Division of Experimental Hematology, Children's Hospital Medical Center)|Ludwine  Messiaen; PhD (Dept of Genetics, University of Alabama)|Show all 9","Douglas Russell Stewart; BA, MD (Clinical Genetics Branch)|Karlyne M Reilly; BS, PhD (Office of the Director)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Abby  Sandler (Office Of The Director)","Nicholas  Patronas; MD (CC) |Constantine Argyrios Stratakis; MD, DSc (NICHD) |Jeffrey M Solomon; BS, MS, PhD (CC) |Scott Mitchell Paul; MD (CC) |Edmond Joseph Fitzgibbon; MD (NEI) |Clara Chi Chen; MD (CC)","1. Avery R, Katowitz J, Fisher M, Heidary G, Dombi E, Packer R, Widemann B (2016) OrbitalPeri-Orbital Plexiform Neurofibromas in Children with Neurofibromatosis type 1: Multi-disciplinary Recommendations for Care. Ophthalmology, in press.|2. Cung W, Freedman LA, Khan NE, Romberg E, Gardner PJ, Bassim CW, Baldwin AM, Widemann BC, Stewart DR (2015). Cephalometry in adults and children with neurofibromatosis type 1: Implications for the pathogenesis of sphenoid wing dysplasia and the ""NF1 facies"". Eur J Med Genet  58, 584-90.   https://doi.org/10.1016/j.ejmg.2015.09.001|3. Jakacki R, Dombi E, Steinberg S, Goldman S, Kieran M, Ullrich N, Pollack I, Goodwin A, Manley P, Fangusaro J, Allen R, Widemann B (2016) Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromas. Neuro-Oncology, in press.|4. Martin S, Wolters PL, Toledo-Tamula MA, Schmitt SN, Baldwin A, Starosta A, Gillespie A, Widemann B (2016). Acceptance and commitment therapy in youth with neurofibromatosis type 1 (NF1) and chronic pain and their parents: A pilot study of feasibility and preliminary efficacy. Am J Med Genet A  170, 1462-70.   https://doi.org/10.1002/ajmg.a.37623|5. Widemann B (2016) Recommendations of the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration. Neurology, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=93828
187,BC010802-10,"October 01, 2015 -  September 30, 2016",Tumor stem cells and metastatic outcomes in mouse models of prostate cancer,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Supreet  Agarwal|Aian Neil Seno Alilin|Michael Louis Beshiri; PhD|Dmitry Nicholas Grigoryev|Keith Henry Jansson|Lechen  Li|Show all 9,George  Petrovics (CPDR/ USUHS)|Eva  Corey (University of Washington)|Joshua  Lang (University of Wisconsin)|Yennien  Liu (Taipei Medical University)|Heather  Tillman (St. Jude Children's Research Hospital),"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Peter A Pinto; MD (Urologic Oncology Branch)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|William Laurence Dahut; MD (Genitourinary Malignancies Branch)|Peter L Choyke; MD (Molecular Imaging Program)",NULL,"1. Agarwal S, Hynes PG, Tillman HS, Lake R, Abou-Kheir WG, Fang L, Casey OM, Ameri AH, Martin PL, Yin JJ, Iaquinta PJ, Karthaus WR, Clevers HC, Sawyers CL, Kelly K (2015). Identification of Different Classes of Luminal Progenitor Cells within Prostate Tumors. Cell Rep  13, 2147-58.   https://doi.org/10.1016/j.celrep.2015.10.077",https://intramural.nih.gov/search/searchview.taf?ipid=93829
188,BC010806-10,"October 01, 2015 -  September 30, 2016",Developing Novel Therapies for Neuroblastoma and Rhabdomyosarcoma,Javed  Khan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",NULL,"John  Maris (Pharmacology, Children's Hospital of Philadelphia)|David  Azorsa (NHGRI)",Carol J Thiele (Pediatric Oncology Branch)|Lee Jay Helman; MD (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93830
189,BC010808-10,"October 01, 2015 -  September 30, 2016",Chromatin structure and dynamics,Yawen  Bai; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Carl  Wu; PhD,NULL,NULL,Rodolfo  Ghirlando; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93810
190,BC010814-10,"October 01, 2015 -  September 30, 2016",Elucidating the Regulation of HIV RNA Functions and Genome Packaging,Wei-Shau  Hu; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Jianbo  Chen|Yang  Liu; PhD|Olga A Nikolaitchik|Sheikh Abdul Rahman|Jonathan Mark Olivares Rawson|Steven Fernandes Dos Santos|Show all 9,"David  Grnwald (Technical University of Delft)|Dmitriy  Mazurov (Institute of Immunology)|WE  Moerner (Stanford University)|Jeffrey  Chao (Friedrich Miescher Institute for Biomedical Research)|Kevin  Weeks (University of North Carolina, Chapel Hill)",Stephen J Lockett; PhD (Office Of The Director)|Daniel Robert Larson; PhD (Laboratory of Receptor Biology and Gene Expression)|Brandon Frank Keele (Office Of The Director)|Robert  Gorelick (Office Of The Director),Madhu A Lal (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93831
191,BC010816-10,"October 01, 2015 -  September 30, 2016","Immunotherapy for  Malignant Mesothelioma, Lung Cancer and Thymic Malignancies",Raffit  Hassan|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",NULL,NULL,Ira H Pastan; MD (Molecular Biology Section)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Peter L Choyke; MD (Molecular Imaging Program)|Daniel H Fowler (Experimental Transplantation and Immunology Branch)|Mark  Raffeld; MD (Laboratory of Pathology)|Markku Martti Miettinen (Laboratory of Pathology),NULL,"1. Khanna S, Thomas A, Abate-Daga D, Zhang J, Morrow B, Steinberg SM, Orlandi A, Ferroni P, Schlom J, Guadagni F, Hassan R (2016). Malignant Mesothelioma Effusions Are Infiltrated by CD3+ T Cells Highly Expressing PD-L1 and the PD-L1+ Tumor Cells within These Effusions Are Susceptible to ADCC by the Anti-PD-L1 Antibody Avelumab. J Thorac Oncol  11, 1993-2005.   https://doi.org/10.1016/j.jtho.2016.07.033|2. Zhang J, Khanna S, Jiang Q, Alewine C, Miettinen M, Pastan I, Hassan R (2017). Efficacy of Anti-mesothelin Immunotoxin RG7787 plus Nab-Paclitaxel against Mesothelioma Patient-Derived Xenografts and Mesothelin as a Biomarker of Tumor Response. Clin Cancer Res  23, 1564-1574.   https://doi.org/10.1158/1078-0432.CCR-16-1667",https://intramural.nih.gov/search/searchview.taf?ipid=93832
192,BC010819-10,"October 01, 2015 -  September 30, 2016",HIV-1 Genetic Variation in Infected Individuals,Frank  Maldarelli|IRP Faculty Profile,NULL,"Host Virus Interaction Branch, NCI",Zehava  Grossman; PhD|Shawn A Hill|Junko  Hattori|Mary  Kearney,John W Mellors|Zandrea  Ambrose (University of Pittsburgh)|Michael  Jordan (Tufts University)|James Coston Brooks|John  Coffin (Tufts University),Paul L Boyer (Retroviral Replication Laboratory)|Eric O Freed; PhD (HIV Drug Resistance Program)|Wei-Shau  Hu; PhD (Retroviral Replication Laboratory)|Stephen H Hughes; PhD (Retroviral Replication Laboratory)|Vinay K Pathak; PhD (Retroviral Replication Laboratory),"Henry  Masur; MD (CC) |Shyamasundaran  Kottilil; MD, PhD (NIAID) |Caryn G Morse; MD (CC) |H. Clifford  Lane; MD (NIAID) |Joann  Mican; MD (NIAID) |Joseph A Kovacs; MD (CC)","1. Asher I, Guri KM, Elbirt D, Bezalel SR, Maldarelli F, Mor O, Grossman Z, Sthoeger ZM (2016). Characteristics and Outcome of Patients Diagnosed With HIV at Older Age. Medicine (Baltimore)  95, e2327.   https://doi.org/10.1097/MD.0000000000002327|2. Grossman Z, Avidor B, Mor Z, Chowers M, Levy I, Shahar E, Riesenberg K, Sthoeger Z, Maayan S, Shao W, Lorber M, Olstein-Pops K, Elbirt D, Elinav H, Asher I, Averbuch D, Istomin V, Gottesman BS, Kedem E, Girshengorn S, Kra-Oz Z, Shemer Avni Y, Radian Sade S, Turner D, Maldarelli F (2015). A Population-Structured HIV Epidemic in Israel: Roles of Risk and Ethnicity. PLoS One  10, e0135061.   https://doi.org/10.1371/journal.pone.0135061|3. Kassaye SG, Grossman Z, Balamane M, Johnston-White B, Liu C, Kumar P, Young M, Sneller MC, Sereti I, Dewar R, Rehm C, Meyer W, Shafer R, Katzenstein D, Maldarelli F (2016). Transmitted HIV Drug Resistance Is High and Longstanding in Metropolitan Washington, DC. Clin Infect Dis  63, 836-843.   https://doi.org/10.1093/cid/ciw382|4. Mikula JM, Manion MM, Maldarelli F, Suarez LM, Norman-Wheeler JF, Ober AG, Dewar RL, Kopp JB, Lane HC, Pau AK (2016). Tenofovir alafenamide as part of a salvage regimen in a patient with multi-drug resistant HIV and tenofovir-DF-associated renal tubulopathy. Antivir Ther  21, 553-558.   https://doi.org/10.3851/IMP3040",https://intramural.nih.gov/search/searchview.taf?ipid=93833
193,BC010822-10,"October 01, 2015 -  September 30, 2016",Molecular Determinants of Chromosome Transmission and Cell Cycle Regulation,Munira A Basrai; PhD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Natasha  Caplen|Karl Thomas Ried; MD,"Grant  Hartzog (MCD Biology, Univ. of California, Santa Cruz)|Richard  Baker (Univ. of Massachusetts, Amherst)|Maitreya  Dunham (Genome Sciences, Univ of Washington,)|Charles  Boone (NCI)|Dan  Foltz (Univ. of VA)|Melissa  Gardner (Univ of Minnesota)|Show all 9",Tatiana  Karpova (Laboratory of Receptor Biology and Gene Expression),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93811
194,BC010824-10,"October 01, 2015 -  September 30, 2016",Molecular structures of membrane protein assemblies,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Alberto  Bartesaghi|Sagar  Chittori|Doreen  Matthies|Prashant Arkalgud Rao|Madhvi Jayalakshmi Venkatesh|Lesley Ann Earl; PhD|Show all 8,"Guillermo  Sapiro (Electrical Engineering, Uinversity of Minnesota)|Frank  McCormick (UCSF School of Medicine)|Eduardo  Perozo (University of Chicago)|Stephen  Sligar (University of Illinois at Urbana-Champaign)",Suresh V Ambudkar; PhD (Transport Biochemistry Section),"Bernard R Brooks; PhD (NHLBI) |Mark Lee Mayer; BSc, PhD (NINDS)","1. 1 Meye, 2 Chit, 3 Merk, 4 Rao, 5 Han, 6 Serp, 7 Maye, 8 Subr (2016) Structural basis of kainate subtype glutamate receptor desensitization. Nature, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=93834
195,BC010825-10,"October 01, 2015 -  September 30, 2016",HIV neutralization and mechanisms of cellular entry,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Kira Ann Podolsky|Erin E Tran|Lesley Ann Earl; PhD|Soojay  Banerjee; PhD|Alberto  Bartesaghi,"Guillermo  Sapiro (Electrical Engineering, Uinversity of Minnesota)|Judith  White (University of Virginia)",Jeffrey D Lifson; MD (Office Of The Director)|Eric O Freed; PhD (HIV Drug Resistance Program)|Oleg  Kuybeda; PhD (Office of the Director)|Vinay K Pathak; PhD (Retroviral Replication Laboratory),"Donald F Bliss (NLM) |G. Marius  Clore; PhD, MD (NIDDK)","1. Frank GA, Narayan K, Bess JW, Del Prete GQ, Wu X, Moran A, Hartnell LM, Earl LA, Lifson JD, Subramaniam S (2015). Maturation of the HIV-1 core by a non-diffusional phase transition. Nat Commun  6, 5854.   https://doi.org/10.1038/ncomms6854|2. Moulaei T, Alexandre KB, Shenoy SR, Meyerson JR, Krumpe LR, Constantine B, Wilson J, Buckheit RW, McMahon JB, Subramaniam S, Wlodawer A, O'Keefe BR (2015). Griffithsin tandemers: flexible and potent lectin inhibitors of the human immunodeficiency virus. Retrovirology  12, 6.   https://doi.org/10.1186/s12977-014-0127-3",https://intramural.nih.gov/search/searchview.taf?ipid=93835
196,BC010826-10,"October 01, 2015 -  September 30, 2016",Technology Development for 3D Electron Microscopy,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Soojay  Banerjee; PhD|Alberto  Bartesaghi|Joseph Edgar Darling|Jean-Philippe  Demers|Lesley Ann Earl; PhD|Veronica Marie Falconieri|Show all 9,"Guillermo  Sapiro (Electrical Engineering, Uinversity of Minnesota)|Chris  Szakal (NIST)|Michael  Phaneuf (Fibics Inc.)|Frank  McCormick (UCSF School of Medicine)|Michael  Rossman (Purdue University)|Miljan  Simonovic (University of Illinois at Chicago)|Show all 8",Suresh V Ambudkar; PhD (Transport Biochemistry Section)|Kumaran S Ramamurthi (Laboratory of Molecular Biology)|Oleg  Kuybeda; PhD (Office of the Director),"Bernard R Brooks; PhD (NHLBI) |Terry S Yoo; PhD (NLM) |G. Marius  Clore; PhD, MD (NIDDK) |Xiongwu  Wu; PhD (NHLBI)","1. Bartesaghi A, Merk A, Banerjee S, Matthies D, Wu X, Milne JL, Subramaniam S (2015). 2.2 Å resolution cryo-EM structure of β-galactosidase in complex with a cell-permeant inhibitor. Science  348, 1147-51.   https://doi.org/10.1126/science.aab1576|2. Stuart D, Subramaniam S, Abrescia N (2016) The democratization of cryo-EM. Nature Methods, in press.|3. Subramaniam S, Earl L, Falconieri V, Milne J, Egelman E (2016) Resolution advances in cryo-EM enable application to drug discovery. Current Opinion in Structural Biology, in press.|4. Subramaniam S, Kühlbrandt W, Henderson R (2016). CryoEM at IUCrJ: a new era. IUCrJ  3, 3-7.   https://doi.org/10.1107/S2052252515023738",https://intramural.nih.gov/search/searchview.taf?ipid=93836
197,BC010827-10,"October 01, 2015 -  September 30, 2016",Structural Studies of Metabolic Enzymes and Their Regulation,Jacqueline L Milne,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",Sriram  Subramaniam; PhD,NULL,NULL,NULL,"1. Borgnia MJ, Banerjee S, Merk A, Matthies D, Bartesaghi A, Rao P, Pierson J, Earl LA, Falconieri V, Subramaniam S, Milne JL (2016). Using Cryo-EM to Map Small Ligands on Dynamic Metabolic Enzymes: Studies with Glutamate Dehydrogenase. Mol Pharmacol  89, 645-51.   https://doi.org/10.1124/mol.116.103382|2. Subramaniam S, Earl L, Falconieri V, Milne J, Egelman E (2016) Resolution advances in cryo-EM enable application to drug discovery. Current Opin Struct Biol, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=93837
198,BC010830-10,"October 01, 2015 -  September 30, 2016",Mechanisms of non-classical multidrug resistance in cancer,Michael Marc Gottesman; MD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Carol O Cardarelli|Lyn Ann J Mickley|Orit  Lavi; PhD|Doron  Levy; PhD|James Patrick Madigan|Christian M Mustroph|Show all 12,Doron  Levy (University of Maryland)|Bates  Susan (Columbia University),NULL,Kevin G Chen; MD (NINDS) |Thomas J Pohida; MS (CIT) |Robert  Innis; MD (NIMH),"1. Chang KE, Wei BR, Madigan JP, Hall MD, Simpson RM, Zhuang Z, Gottesman MM (2015). The protein phosphatase 2A inhibitor LB100 sensitizes ovarian carcinoma cells to cisplatin-mediated cytotoxicity. Mol Cancer Ther  14, 90-100.   https://doi.org/10.1158/1535-7163.MCT-14-0496|2. Jagodinsky JC, Sulima A, Cao Y, Poprawski JE, Blackman BN, Lloyd JR, Swenson RE, Gottesman MM, Hall MD (2015). Evaluation of fluorophore-tethered platinum complexes to monitor the fate of cisplatin analogs. J Biol Inorg Chem  20, 1081-95.   https://doi.org/10.1007/s00775-015-1290-2|3. Kumar JS, Miller Jenkins LM, Gottesman MM, Hall MD (2016). The Drug Excipient Cyclodextrin Interacts With d-Luciferin and Interferes With Bioluminescence Imaging. Mol Imaging  15.   https://doi.org/10.1177/1536012115625225|4. Liow JS, Zoghbi SS, Hu S, Hall MD, Hines CS, Shetty HU, Araneta MD, Page EM, Pike VW, Kreisl WC, Herscovitch P, Gottesman MM, Theodore WH, Innis RB (2016). (18)F-FCWAY, a serotonin 1A receptor radioligand, is a substrate for efflux transport at the human blood-brain barrier. Neuroimage  138, 134-140.   https://doi.org/10.1016/j.neuroimage.2016.05.045|5. Stukova M, Hall MD, Tsotsoros SD, Madigan JP, Farrell NP, Gottesman MM (2015). Reduced accumulation of platinum drugs is not observed in drug-resistant ovarian cancer cell lines derived from cisplatin-treated patients. J Inorg Biochem  149, 45-8.   https://doi.org/10.1016/j.jinorgbio.2015.05.003|6. Tanner K, Gottesman MM (2015). Beyond 3D culture models of cancer. Sci Transl Med  7, 283ps9.   https://doi.org/10.1126/scitranslmed.3009367",https://intramural.nih.gov/search/searchview.taf?ipid=93838
199,BC010832-10,"October 01, 2015 -  September 30, 2016",Fundamentals of Ligand-Protein Interactions,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Megan L Peach,Wolf-Dietrich  Ihlenfeldt (Xemistry GmbH)|Ulf  Ryde (Lund University)|Alberto  Podjarny (IGBMC),Raul Eduardo Cachau (Office Of The Director)|Igor  Topol (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93839
200,BC010833-10,"October 01, 2015 -  September 30, 2016",Identification and functional characterization of colorectal cancer genes,Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Markus Alexander Brown|Bernard N Chen|Wei-Dong  Chen|Chi Chung  Cheng|Damrong M Wangsa|Darawalee  Wangsa|Show all 7,"Michael  Ghadimi (Surgery, U. of Goettingen)|Daniel Paul Rosenberg|Jens  Habermann",NULL,NULL,"1. Camps J, Erdos MR, Ried T (2015). The role of lamin B1 for the maintenance of nuclear structure and function. Nucleus  6, 8-14.   https://doi.org/10.1080/19491034.2014.1003510|2. Chen H, Chen J, Muir LA, Ronquist S, Meixner W, Ljungman M, Ried T, Smale S, Rajapakse I (2015). Functional organization of the human 4D Nucleome. Proc Natl Acad Sci U S A  112, 8002-7.   https://doi.org/10.1073/pnas.1505822112|3. Chen H, Comment N, Chen J, Ronquist S, Hero A, Ried T, Rajapakse I (2015). Chromosome conformation of human fibroblasts grown in 3-dimensional spheroids. Nucleus  6, 55-65.   https://doi.org/10.1080/19491034.2014.1003745|4. Nicholson JM, Macedo JC, Mattingly AJ, Wangsa D, Camps J, Lima V, Gomes AM, Dória S, Ried T, Logarinho E, Cimini D (2015). Chromosome mis-segregation and cytokinesis failure in trisomic human cells. Elife  4.   https://doi.org/10.7554/eLife.05068|5. Zepeda-Mendoza CJ, Mukhopadhyay S, Wong ES, Harder N, Splinter E, de Wit E, Eckersley-Maslin MA, Ried T, Eils R, Rohr K, Mills A, de Laat W, Flicek P, Sengupta AM, Spector DL (2015). Quantitative analysis of chromatin interaction changes upon a 4.3 Mb deletion at mouse 4E2. BMC Genomics  16, 982.   https://doi.org/10.1186/s12864-015-2137-5",https://intramural.nih.gov/search/searchview.taf?ipid=93840
201,BC010834-10,"October 01, 2015 -  September 30, 2016","Identifying Diagnostic Markers for Cervical, Breast, and Prostate Cancer",Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Bernard N Chen|Chi Chung  Cheng|Kerstin  Heselmeyer|Irianna Marie Torres|Damrong M Wangsa|Darawalee  Wangsa|Show all 8,Gert  Auer|Timo  Gaiser|Philipp  Stroebel (Georg August University GÃ¶ttingen),NULL,Alejandro Alberto Schaffer; PhD (NLM),"1. Chowdhury SA, Gertz EM, Wangsa D, Heselmeyer-Haddad K, Ried T, Schäffer AA, Schwartz R (2015). Inferring models of multiscale copy number evolution for single-tumor phylogenetics. Bioinformatics  31, i258-67.   https://doi.org/10.1093/bioinformatics/btv233|2. Hathcock KS, Padilla-Nash HM, Camps J, Shin DM, Triner D, Shaffer AL, Maul RW, Steinberg SM, Gearhart PJ, Staudt LM, Morse HC, Ried T, Hodes RJ (2015). ATM deficiency promotes development of murine B-cell lymphomas that resemble diffuse large B-cell lymphoma in humans. Blood  126, 2291-301.   https://doi.org/10.1182/blood-2015-06-654749|3. Wangsa D, Chowdhury SA, Ryott M, Gertz EM, Elmberger G, Auer G, Åvall Lundqvist E, Küffer S, Ströbel P, Schäffer AA, Schwartz R, Munck-Wikland E, Ried T, Heselmeyer-Haddad K (2016). Phylogenetic analysis of multiple FISH markers in oral tongue squamous cell carcinoma suggests that a diverse distribution of copy number changes is associated with poor prognosis. Int J Cancer  138, 98-109.   https://doi.org/10.1002/ijc.29691",https://intramural.nih.gov/search/searchview.taf?ipid=93841
202,BC010835-10,"October 01, 2015 -  September 30, 2016",Colorectal Cancer Transcriptome: Effects of Genomic Instability and Aneuploidy,Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Bernard N Chen|Georg  Emons|Yue  Hu|Damrong M Wangsa|Darawalee  Wangsa,"Michael  Ghadimi (Surgery, U. of Goettingen)|Thomas  Cremer (University of Munich)|Jens  Habermann|Timo  Gaiser",NULL,Danny L Sackett; PhD (NICHD),"1. Camps J, Erdos MR, Ried T (2015). The role of lamin B1 for the maintenance of nuclear structure and function. Nucleus  6, 8-14.   https://doi.org/10.1080/19491034.2014.1003510|2. Chen H, Chen J, Muir LA, Ronquist S, Meixner W, Ljungman M, Ried T, Smale S, Rajapakse I (2015). Functional organization of the human 4D Nucleome. Proc Natl Acad Sci U S A  112, 8002-7.   https://doi.org/10.1073/pnas.1505822112|3. Chen H, Comment N, Chen J, Ronquist S, Hero A, Ried T, Rajapakse I (2015). Chromosome conformation of human fibroblasts grown in 3-dimensional spheroids. Nucleus  6, 55-65.   https://doi.org/10.1080/19491034.2014.1003745|4. Nicholson JM, Macedo JC, Mattingly AJ, Wangsa D, Camps J, Lima V, Gomes AM, Dória S, Ried T, Logarinho E, Cimini D (2015). Chromosome mis-segregation and cytokinesis failure in trisomic human cells. Elife  4.   https://doi.org/10.7554/eLife.05068|5. Zepeda-Mendoza CJ, Mukhopadhyay S, Wong ES, Harder N, Splinter E, de Wit E, Eckersley-Maslin MA, Ried T, Eils R, Rohr K, Mills A, de Laat W, Flicek P, Sengupta AM, Spector DL (2015). Quantitative analysis of chromatin interaction changes upon a 4.3 Mb deletion at mouse 4E2. BMC Genomics  16, 982.   https://doi.org/10.1186/s12864-015-2137-5",https://intramural.nih.gov/search/searchview.taf?ipid=93842
203,BC010837-10,"October 01, 2015 -  September 30, 2016",Prediction of Therapy Response in Colorectal Cancer,Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Bernard N Chen|Chi Chung  Cheng|Georg  Emons|Ruediger  Meyer|Damrong M Wangsa|Darawalee  Wangsa|Show all 7,"Michael  Ghadimi (Surgery, U. of Goettingen)|Indika  Rajapakse (University of Michigan)",NULL,NULL,"1. Camps J, Erdos MR, Ried T (2015). The role of lamin B1 for the maintenance of nuclear structure and function. Nucleus  6, 8-14.   https://doi.org/10.1080/19491034.2014.1003510|2. Chen H, Chen J, Muir LA, Ronquist S, Meixner W, Ljungman M, Ried T, Smale S, Rajapakse I (2015). Functional organization of the human 4D Nucleome. Proc Natl Acad Sci U S A  112, 8002-7.   https://doi.org/10.1073/pnas.1505822112|3. Chen H, Comment N, Chen J, Ronquist S, Hero A, Ried T, Rajapakse I (2015). Chromosome conformation of human fibroblasts grown in 3-dimensional spheroids. Nucleus  6, 55-65.   https://doi.org/10.1080/19491034.2014.1003745|4. Zepeda-Mendoza CJ, Mukhopadhyay S, Wong ES, Harder N, Splinter E, de Wit E, Eckersley-Maslin MA, Ried T, Eils R, Rohr K, Mills A, de Laat W, Flicek P, Sengupta AM, Spector DL (2015). Quantitative analysis of chromatin interaction changes upon a 4.3 Mb deletion at mouse 4E2. BMC Genomics  16, 982.   https://doi.org/10.1186/s12864-015-2137-5",https://intramural.nih.gov/search/searchview.taf?ipid=93844
204,BC010844-10,"October 01, 2015 -  September 30, 2016",DNA Folding in Chromatin and Interaction with Transcription Factors,Victor  Zhurkin; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",NULL,"Wilma  Olson (Wright-Rieman Laboratories, Rutgers University)|Sergei  Grigoryev (Pennsylvania State University College of Medicine)|Feng  Cui (Rochester Institute of Technology)",NULL,David Johannes Clark; PhD (NICHD),"1. Cole HA, Cui F, Ocampo J, Burke TL, Nikitina T, Nagarajavel V, Kotomura N, Zhurkin VB, Clark DJ (2016). Novel nucleosomal particles containing core histones and linker DNA but no histone H1. Nucleic Acids Res  44, 573-81.   https://doi.org/10.1093/nar/gkv943|2. Norouzi D, Katebi A, Cui F, Zhurkin V (2015) Topological diversity of chromatin fibers: Interplay between nucleosome repeat length, DNA linking number and the level of transcription. AIMS Biophysics 2:613-629|3. Norouzi D, Zhurkin VB (2015). Topological polymorphism of the two-start chromatin fiber. Biophys J  108, 2591-2600.   https://doi.org/10.1016/j.bpj.2015.04.015|4. Shaytan AK, Armeev GA, Goncearenco A, Zhurkin VB, Landsman D, Panchenko AR (2016). Coupling between Histone Conformations and DNA Geometry in Nucleosomes on a Microsecond Timescale: Atomistic Insights into Nucleosome Functions. J Mol Biol  428, 221-237.   https://doi.org/10.1016/j.jmb.2015.12.004|5. Shaytan AK, Armeev GA, Goncearenco A, Zhurkin VB, Landsman D, Panchenko AR (2016). Trajectories of microsecond molecular dynamics simulations of nucleosomes and nucleosome core particles. Data Brief  7, 1678-81.   https://doi.org/10.1016/j.dib.2016.04.073",https://intramural.nih.gov/search/searchview.taf?ipid=93846
205,BC010845-10,"October 01, 2015 -  September 30, 2016",p53-induced Regulation of Transcription in the Chromatin Context,Victor  Zhurkin; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",NULL,Sergei  Grigoryev (Pennsylvania State University College of Medicine)|Feng  Cui,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93820
206,BC010846-10,"October 01, 2015 -  September 30, 2016",Mechanisms of Transcriptional Control by p300,"Kevin  Gardner; MD, PhD",NULL,"Cancer Genetics Branch, NCI","Jung Shin  Byun|Jee-Hye  Shin; PhD|Paul S Meltzer; MD, PhD|Ashish Kumar Lal","Juliet  Daniel (McMaster University)|Olufunmilayo  Olopade (University of Chicago)|Eytan  Ruppin; MD/PhD (Department of Computer Science, University of Maryland)|Michael  Thirman (Medicine, University of Chicago)|Melissa  Troester (University of North Carolina at Chape)|Clayton  Yates (Tuskegee University)","Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics)|Maxwell P Lee; PhD (Laboratory of Cancer Biology and Genetics)|Maria  Merino; PhD (Laboratory of Pathology)|Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)",Dan L Longo; MD (NIA),"1. Fufa TD, Byun JS, Wakano C, Fernandez AG, Pise-Masison CA, Gardner K (2015). The Tax oncogene enhances ELL incorporation into p300 and P-TEFb containing protein complexes to activate transcription. Biochem Biophys Res Commun  465, 5-11.   https://doi.org/10.1016/j.bbrc.2015.07.072",https://intramural.nih.gov/search/searchview.taf?ipid=93818
207,BC010847-10,"October 01, 2015 -  September 30, 2016",Molecular linkages between epigenetic regulation and metabolism in breast cancer,"Kevin  Gardner; MD, PhD",NULL,"Cancer Genetics Branch, NCI","Paul S Meltzer; MD, PhD",NULL,Maria  Merino; PhD (Laboratory of Pathology)|David D Roberts; PhD (Laboratory of Pathology)|Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)|Maxwell P Lee; PhD (Laboratory of Cancer Biology and Genetics),Dan L Longo; MD (NIA),"1. De Luca P, Dalton GN, Scalise GD, Moiola CP, Porretti J, Massillo C, Kordon E, Gardner K, Zalazar F, Flumian C, Todaro L, Vazquez ES, Meiss R, De Siervi A (2016). CtBP1 associates metabolic syndrome and breast carcinogenesis targeting multiple miRNAs. Oncotarget  7, 18798-811.   https://doi.org/10.18632/oncotarget.7711",https://intramural.nih.gov/search/searchview.taf?ipid=93819
208,BC010850-10,"October 01, 2015 -  September 30, 2016",Mechanisms of Normal Tissue Toxicity,Deborah E Citrin|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Eunjoo Serena Chung|Ayla Oksuz White|Su Im Chung; PhD|Erica E Schott,NULL,James B Mitchell; PhD (Radiation Biology Branch),Thomas Anthony Wynn; PhD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93847
209,BC010852-10,"October 01, 2015 -  September 30, 2016",Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides,"Dennis M Klinman; MD, PhD|IRP Faculty Profile",NULL,"Cancer Inflammation Program, NCI",Joost J Oppenheim; MD|Giorgio  Trinchieri|Howard A Young; PhD,"Ihsan  Gursel|Jay  Hooper (USAMRIID)|Yoshiaki  Ishigatsubo; MD, PhD (Yokohama City Univ Medical School)|Sven  Klaschik|Imtiaz  Mawji (Bioensemble, LTD)|Masuhiro  Takahashi (Niigata University)|Show all 9","Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)",Igal  Gery; PhD (NEI) |Danielle A Springer; VMD (NHLBI),"1. Bayik D, Gursel I, Klinman DM (2016). Structure, mechanism and therapeutic utility of immunosuppressive oligonucleotides. Pharmacol Res  105, 216-25.   https://doi.org/10.1016/j.phrs.2015.11.010|2. Klinman DM (2015). Therapeutic implications of orally delivered immunomodulatory oligonucleotides. Mol Ther  23, 222-3.   https://doi.org/10.1038/mt.2014.251|3. Sato T, Shimosato T, Ueda A, Ishigatsubo Y, Klinman DM (2015). Intrapulmonary Delivery of CpG Microparticles Eliminates Lung Tumors. Mol Cancer Ther  14, 2198-205.   https://doi.org/10.1158/1535-7163.MCT-15-0401|4. Shirota H, Tross D, Klinman DM (2015). CpG Oligonucleotides as Cancer Vaccine Adjuvants. Vaccines (Basel)  3, 390-407.   https://doi.org/10.3390/vaccines3020390|5. Wang J, Shirota Y, Bayik D, Shirota H, Tross D, Gulley JL, Wood LV, Berzofsky JA, Klinman DM (2015). Effect of TLR agonists on the differentiation and function of human monocytic myeloid-derived suppressor cells. J Immunol  194, 4215-21.   https://doi.org/10.4049/jimmunol.1402004",https://intramural.nih.gov/search/searchview.taf?ipid=93851
210,BC010853-10,"October 01, 2015 -  September 30, 2016",Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide,"Dennis M Klinman; MD, PhD|IRP Faculty Profile",NULL,"Cancer Inflammation Program, NCI",Joost J Oppenheim; MD|Giorgio  Trinchieri,Sven  Klaschik|Takashi  Sato,NULL,Igal  Gery; PhD (NEI) |John M Hallenbeck; MD (NINDS),"1. Klinman DM (2015). Therapeutic implications of orally delivered immunomodulatory oligonucleotides. Mol Ther  23, 222-3.   https://doi.org/10.1038/mt.2014.251|2. Klinman DM, Sato T, Shimosato T (2016). Use of nanoparticles to deliver immunomodulatory oligonucleotides. Wiley Interdiscip Rev Nanomed Nanobiotechnol  8, 631-7.   https://doi.org/10.1002/wnan.1382|3. Wandu WS, Tan C, Ogbeifun O, Vistica BP, Shi G, Hinshaw SJ, Xie C, Chen X, Klinman DM, Cai H, Gery I (2015). Leucine-Rich Repeat Kinase 2 (Lrrk2) Deficiency Diminishes the Development of Experimental Autoimmune Uveitis (EAU) and the Adaptive Immune Response. PLoS One  10, e0128906.   https://doi.org/10.1371/journal.pone.0128906|4. Zhao J, Mou Y, Bernstock JD, Klimanis D, Wang S, Spatz M, Maric D, Johnson K, Klinman DM, Li X, Li X, Hallenbeck JM (2015). Synthetic Oligodeoxynucleotides Containing Multiple Telemeric TTAGGG Motifs Suppress Inflammasome Activity in Macrophages Subjected to Oxygen and Glucose Deprivation and Reduce Ischemic Brain Injury in Stroke-Prone Spontaneously Hypertensive Rats. PLoS One  10, e0140772.   https://doi.org/10.1371/journal.pone.0140772",https://intramural.nih.gov/search/searchview.taf?ipid=93852
211,BC010870-09,"October 01, 2015 -  September 30, 2016",Hematopoietic Stem Cell Transplant for GATA2 Deficiency,Dennis D Hickstein|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Lisa J Embree|Matthew Launer Fuchs|Laura M Tuschong|Robert R West,NULL,NULL,Steven M Holland; MD (NIAID),"1. Ganapathi KA, Townsley DM, Hsu AP, Arthur DC, Zerbe CS, Cuellar-Rodriguez J, Hickstein DD, Rosenzweig SD, Braylan RC, Young NS, Holland SM, Calvo KR (2015). GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia. Blood  125, 56-70.   https://doi.org/10.1182/blood-2014-06-580340",https://intramural.nih.gov/search/searchview.taf?ipid=93892
212,BC010871-09,"October 01, 2015 -  September 30, 2016",Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis,Glenn  Merlino; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Yanlin  Yu,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Melinda  Hollingshead (Biological Testing Branch)",NULL,"1. Balakumaran A, Mishra PJ, Pawelczyk E, Yoshizawa S, Sworder BJ, Cherman N, Kuznetsov SA, Bianco P, Giri N, Savage SA, Merlino G, Dumitriu B, Dunbar CE, Young NS, Alter BP, Robey PG (2015). Bone marrow skeletal stem/progenitor cell defects in dyskeratosis congenita and telomere biology disorders. Blood  125, 793-802.   https://doi.org/10.1182/blood-2014-06-566810|2. Sworder BJ, Yoshizawa S, Mishra PJ, Cherman N, Kuznetsov SA, Merlino G, Balakumaran A, Robey PG (2015). Molecular profile of clonal strains of human skeletal stem/progenitor cells with different potencies. Stem Cell Res  14, 297-306.   https://doi.org/10.1016/j.scr.2015.02.005",https://intramural.nih.gov/search/searchview.taf?ipid=93976
213,BC010872-09,"October 01, 2015 -  September 30, 2016",High throughput screen for small molecule inhibitors of Ran regulated functions,Petr  Kalab; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93950
214,BC010876-09,"October 01, 2015 -  September 30, 2016",The role of cancer stem cells in liver cancer heterogeneity and subtypes,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI","Anuradha Samantha Budhu|Edward Jamal Duqum|Marshonna J Forgues|Valerie Fako Miller|Takamitsu  Sasaki|Atsushi  Takai; MD, PhD|Show all 7",Zhao-You  Tang (Liver Cancer Institute)|Lun-Xiu  Qin (Liver Cancer Institute)|Qinghai  Ye (Liver Cancer Insitute)|Takahiro  Uenishi (Osaka City University)|Hui-Chuan  Sun (Liver Cancer Institute)|Lola  Reid (University of North Carolina)|Show all 8,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Snorri S. Thorgeirsson; MD, PhD (Laboratory of Human Carcinogenesis)|Mitchell  Ho (Laboratory of Molecular Biology)|James  McMahon; PhD (Molecular Targets Laboratory)|Javed  Khan; MD (Cancer Genetics Branch)",NULL,"1. Bian C, Wang X (2015) Targeting heterogeneity in hepatocellular carcinoma Oncology News 10:15-16|2. Li L, Liu Y, Guo Y, Liu B, Zhao Y, Li P, Song F, Zheng H, Yu J, Song T, Niu R, Li Q, Wang XW, Zhang W, Chen K (2015). Regulatory MiR-148a-ACVR1/BMP circuit defines a cancer stem cell-like aggressive subtype of hepatocellular carcinoma. Hepatology  61, 574-84.   https://doi.org/10.1002/hep.27543",https://intramural.nih.gov/search/searchview.taf?ipid=93936
215,BC010877-09,"October 01, 2015 -  September 30, 2016",The identification of human hepatocellular carcinoma metastasis genes,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI",Anuradha Samantha Budhu|Marshonna J Forgues|Zhipeng  Yu,Zhao-You  Tang (Liver Cancer Institute)|Lun-Xiu  Qin (Liver Cancer Institute)|Qinghai  Ye (Liver Cancer Insitute)|Hui-Chuan  Sun (Liver Cancer Institute),NULL,NULL,"1. 1 Ye, 2 Zhu, 3 Zhan, 4 Qin, 5 Lu, 6 Lin, 7 Guo, 8 Zhan, 9 Lin, 10 Roes, 11 Forg, 12 Jia, 13 Lu, 14 Zhan, 15 Lian, 16 Xie, 17 Dong, 18 Tang, 19 Wang, 20 Qin (2016) GOLM1 modulates EGFRRTK cell-surface recycling to drive hepatocellular carcinoma metastasis Cancer Cell In Press|2. Lee YK, Jee BA, Kwon SM, Yoon YS, Xu WG, Wang HJ, Wang XW, Thorgeirsson SS, Lee JS, Woo HG, Yoon G (2015). Identification of a mitochondrial defect gene signature reveals NUPR1 as a key regulator of liver cancer progression. Hepatology  62, 1174-89.   https://doi.org/10.1002/hep.27976",https://intramural.nih.gov/search/searchview.taf?ipid=93935
216,BC010881-09,"October 01, 2015 -  September 30, 2016",Development of TGF-beta antagonists for cancer therapy,Lalage  Wakefield; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Kathleen C Flanders; PhD|Yu-an  Yang|Liu  Ying|Jinqiu  Chen|Kent W Hunter; PhD|Maxwell P Lee; PhD|Show all 7,"Amer  Mirza (XOMA (US) LLC)|Peter  Watson (Pathology, University of Manitoba)","Stephen M Hewitt; MD, PhD (Laboratory of Pathology)",NULL,"1. Chen JQ, Wakefield LM, Goldstein DJ (2015). Capillary nano-immunoassays: advancing quantitative proteomics analysis, biomarker assessment, and molecular diagnostics. J Transl Med  13, 182.   https://doi.org/10.1186/s12967-015-0537-6|2. Flanders KC, Yang YA, Herrmann M, Chen J, Mendoza N, Mirza AM, Wakefield LM (2016). Quantitation of TGF-β proteins in mouse tissues shows reciprocal changes in TGF-β1 and TGF-β3 in normal vs neoplastic mammary epithelium. Oncotarget  7, 38164-38179.   https://doi.org/10.18632/oncotarget.9416|3. Sato M, Matsubara T, Adachi J, Hashimoto Y, Fukamizu K, Kishida M, Yang YA, Wakefield LM, Tomonaga T (2015). Differential Proteome Analysis Identifies TGF-β-Related Pro-Metastatic Proteins in a 4T1 Murine Breast Cancer Model. PLoS One  10, e0126483.   https://doi.org/10.1371/journal.pone.0126483",https://intramural.nih.gov/search/searchview.taf?ipid=93933
217,BC010885-09,"October 01, 2015 -  September 30, 2016",Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies,Robert  Yarchoan; MD|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI",Ashley Itohan Aisabor|Rebecca Grace Beasley|David A Davis; MD|Prabha  Shrestha; PhD|Shewit  Tekeste; PhD|Coralie  Viollet-Djelassi|Show all 9,"Rolf  Renne (Case Western Reserave University, Cleveland, OH)|Jiannis  Ragoussis (McGill University)|Francesco  Pezzella (University of Oxford)|Martin  Reczko (Institute of Molecular Oncology)|Jerome  Zeldis (Celgene Corporation)","Denise  Whitby (Office Of The Director)|Stefania  Pittaluga (Laboratory of Pathology)|Christopher  Buck (Laboratory of Cellular Oncology)|Giovanna  Tosato; PhD (Laboratory of Cellular Oncology)|Elaine S Jaffe; MD (Laboratory of Pathology)|Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)",Paul T Wingfield; PhD (NIAMS),"1. Davis DA, Naiman NE, Wang V, Shrestha P, Haque M, Hu D, Anagho HA, Carey RF, Davidoff KS, Yarchoan R (2015) Identification of Caspase Cleavage Sites in KSHV Latency-Associated Nuclear Antigen and Their Effects on Caspase-Related Host Defense Responses. PLoS Pathog 11:e1005064|2. Hu D, Wang V, Yang M, Abdullah S, Davis DA, Uldrick TS, Polizzotto MN, Veeranna RP, Pittaluga S, Tosato G, Yarchoan R (2016). Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interleukin-6 by X-Box Binding Protein 1. J Virol  90, 368-78.   https://doi.org/10.1128/JVI.01192-15|3. Polizzotto MN, Uldrick TS, Wyvill KM, Aleman K, Marshall V, Wang V, Whitby D, Pittaluga S, Jaffe ES, Millo C, Tosato G, Little RF, Steinberg SM, Sereti I, Yarchoan R (2016). Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS). Clin Infect Dis  62, 730-738.   https://doi.org/10.1093/cid/civ996|4. Viollet C, Davis DA, Reczko M, Ziegelbauer JM, Pezzella F, Ragoussis J, Yarchoan R (2015). Next-Generation Sequencing Analysis Reveals Differential Expression Profiles of MiRNA-mRNA Target Pairs in KSHV-Infected Cells. PLoS One  10, e0126439.   https://doi.org/10.1371/journal.pone.0126439|5. Yarchoan R (2015) HIV and KSHV-Related Cancers: Diseases at the Crossroads of Virology, Immunology, and Cell Biology Microbe 10:157-162",https://intramural.nih.gov/search/searchview.taf?ipid=93944
218,BC010886-09,"October 01, 2015 -  September 30, 2016",Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Daniel K Lee,NULL,Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93856
219,BC010887-09,"October 01, 2015 -  September 30, 2016",Novel Markers for Disease Outcome in Breast Cancer,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Tiffany Marie Howe|Symone Victoria Jordan|Daniel K Lee|Prachi  Mishra|Cheryl Jacobs Smith; PhD|Wei  Tang; PhD,Arun  Sreekumar (Baylor College of Medicine)|Olufunmilayo  Olopade (University of Chicago)|Ruppin  Eytan (University of Maryland)|Nagireddy  Putluri (Baylor College of Medicine)|Clayton  Yates (Tuskegee University),"David Anderson Wink (Cancer Inflammation Program)|Kevin  Gardner; MD, PhD (Cancer Genetics Branch)|Ashish Kumar Lal (Cancer Genetics Branch)",NULL,"1. Bhowmik SK, Ramirez-Peña E, Arnold JM, Putluri V, Sphyris N, Michailidis G, Putluri N, Ambs S, Sreekumar A, Mani SA (2015). EMT-induced metabolite signature identifies poor clinical outcome. Oncotarget  6, 42651-60.   https://doi.org/10.18632/oncotarget.4765|2. Mishra P, Ambs S (2015). Metabolic Signatures of Human Breast Cancer. Mol Cell Oncol  2.   https://doi.org/10.4161/23723556.2014.992217",https://intramural.nih.gov/search/searchview.taf?ipid=93857
220,BC010888-09,"October 01, 2015 -  September 30, 2016",Clinical Trials of Patients with AIDS-Related Malignancies,Robert  Yarchoan; MD|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI",Victoria Y Wang|Joseph M Ziegelbauer,Mac  Cheever (Fred Hutchinson Cancer Research Center)|Jerry  Zeldis (Celgene Corporation)|Michelle A Rudek,Denise  Whitby (Office Of The Director)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Stefania  Pittaluga (Laboratory of Pathology)|Giovanna  Tosato; PhD (Laboratory of Cellular Oncology)|William D Figg; PharmD (Genitourinary Malignancies Branch)|Elaine S Jaffe; MD (Laboratory of Pathology),Amir Hossein Gandjbakhche; PhD (NICHD) |Irina  Maric; MD (CC) |Irini  Sereti; MD (NIAID) |Corina M Millo; MD (CC),"1. Uldrick T, Yarchoan R (2015) Hematology and Oncology in Patients with HIV Infection, in Goldman's Cecil Medicine. , pp. 2322-8.|2. Yarchoan R, Uldrick T, Polizzotto M, Little R (2015) AIDS-Related Malignancies, in Cancer:  Principles and Practice of Oncology, 10th Edition. , pp. 1780-1793.|3. Bhutani M, Polizzotto MN, Uldrick TS, Yarchoan R (2015). Kaposi sarcoma-associated herpesvirus-associated malignancies: epidemiology, pathogenesis, and advances in treatment. Semin Oncol  42, 223-46.   https://doi.org/10.1053/j.seminoncol.2014.12.027|4. Polizzotto MN, Millo C, Uldrick TS, Aleman K, Whatley M, Wyvill KM, O'Mahony D, Marshall V, Whitby D, Maass-Moreno R, Steinberg SM, Little RF, Yarchoan R (2015). 18F-fluorodeoxyglucose Positron Emission Tomography in Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease: Correlation With Activity, Severity, Inflammatory and Virologic Parameters. J Infect Dis  212, 1250-60.   https://doi.org/10.1093/infdis/jiv204|5. Polizzotto MN, Uldrick TS, Wyvill KM, Aleman K, Marshall V, Wang V, Whitby D, Pittaluga S, Jaffe ES, Millo C, Tosato G, Little RF, Steinberg SM, Sereti I, Yarchoan R (2016). Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS). Clin Infect Dis  62, 730-738.   https://doi.org/10.1093/cid/civ996|6. Yarchoan R (2015) HIV and KSHV-Related Cancers: Diseases at the Crossroads of Virology, Immunology, and Cell Biology Microbe 10:157-162",https://intramural.nih.gov/search/searchview.taf?ipid=93943
221,BC010891-09,"October 01, 2015 -  September 30, 2016",Development of new antibody-based cancer therapies,Mitchell  Ho|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Hejiao  Bian|Holly E Holden|Haiying  Fu|Ying  Fu|Nan  Li|Yifan  Zhang,NULL,"Ira H Pastan; MD (Molecular Biology Section)|Xin Wei Wang; PhD (Molecular Genetics and Carcinogenesis Section)|Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)|Dimiter Stanchev Dimitrov; PhD (Cancer Inflammation Program)|Hisataka  Kobayashi (Molecular Imaging Program)",NULL,"1. Gao W, Kim H, Ho M (2015). Human Monoclonal Antibody Targeting the Heparan Sulfate Chains of Glypican-3 Inhibits HGF-Mediated Migration and Motility of Hepatocellular Carcinoma Cells. PLoS One  10, e0137664.   https://doi.org/10.1371/journal.pone.0137664|2. Gao W, Tang Z, Zhang YF, Feng M, Qian M, Dimitrov DS, Ho M (2015). Immunotoxin targeting glypican-3 regresses liver cancer via dual inhibition of Wnt signalling and protein synthesis. Nat Commun  6, 6536.   https://doi.org/10.1038/ncomms7536|3. Wang C, Gao W, Feng M, Pastan I, Ho M (2017). Construction of an immunotoxin, HN3-mPE24, targeting glypican-3 for liver cancer therapy. Oncotarget  8, 32450-32460.   https://doi.org/10.18632/oncotarget.10592|4. Zhang YF, Phung Y, Gao W, Kawa S, Hassan R, Pastan I, Ho M (2015). New high affinity monoclonal antibodies recognize non-overlapping epitopes on mesothelin for monitoring and treating mesothelioma. Sci Rep  5, 9928.   https://doi.org/10.1038/srep09928",https://intramural.nih.gov/search/searchview.taf?ipid=93893
222,BC010898-09,"October 01, 2015 -  September 30, 2016",Redox Mechanism Process of Angiogenesis and Wound Healing,David Anderson Wink|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Howard A Young; PhD,NULL,Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Stefan  Ambs (Laboratory of Human Carcinogenesis)|David D Roberts; PhD (Laboratory of Pathology)|Murali  Krishna; PhD (Radiation Biology Branch)|Robert  Wiltrout; PhD (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93940
223,BC010899-09,"October 01, 2015 -  September 30, 2016",Inflammation and cancer treatment,David Anderson Wink|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Howard A Young; PhD|Giorgio  Trinchieri,"Bruce  King (Department of Chemistry, Wake Forest University)|Micheal  Vitek (Neurology, Duke Uniuversity Medical School)",James B Mitchell; PhD (Radiation Biology Branch)|David D Roberts; PhD (Laboratory of Pathology)|Murali  Krishna; PhD (Radiation Biology Branch)|Robert  Wiltrout; PhD (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93941
224,BC010914-09,"October 01, 2015 -  September 30, 2016",Gene Expression Profiling and Clinical Characterization of Phototoxicity,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93956
225,BC010938-09,"October 01, 2015 -  September 30, 2016",Studies of Skin Microflora in Healthy Individuals and Atopic Dermatitis Patients,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",Jay Hyun  Jo; PhD|Elizabeth Alexandra Kennedy|Sheila E Phang|Valentina Shobhana Pillai; CRNP|Keisuke  Nagao,NULL,NULL,"Julia A Segre; PhD (NHGRI) |Hirsh David Komarow; MD (NIAID) |Alexandra  Freeman (NIAID) |Steven M Holland; MD (NIAID) |Yasmine  Belkaid; PhD (NIAID) |Niki  Moutsopoulos; DDS, PhD (NIDCR)","1. Cuellar-Rodriguez J, Freeman AF, Grossman J, Su H, Parta M, Murdock H, Shah N, Bollard C, Kong HH, Moutsopoulos N, Stone K, Gea-Banacloche J, Holland SM, Hickstein DD (2015). Matched related and unrelated donor hematopoietic stem cell transplantation for DOCK8 deficiency. Biol Blood Marrow Transplant  21, 1037-45.   https://doi.org/10.1016/j.bbmt.2015.01.022|2. Jo JH, Kennedy EA, Kong HH (2016). Research Techniques Made Simple: Bacterial 16S Ribosomal RNA Gene Sequencing in Cutaneous Research. J Invest Dermatol  136, e23-e27.   https://doi.org/10.1016/j.jid.2016.01.005|3. Kobayashi T, Glatz M, Horiuchi K, Kawasaki H, Akiyama H, Kaplan DH, Kong HH, Amagai M, Nagao K (2015). Dysbiosis and Staphylococcus aureus Colonization Drives Inflammation in Atopic Dermatitis. Immunity  42, 756-66.   https://doi.org/10.1016/j.immuni.2015.03.014|4. Kong HH (2016). Details Matter: Designing Skin Microbiome Studies. J Invest Dermatol  136, 900-902.   https://doi.org/10.1016/j.jid.2016.03.004|5. Naik S, Bouladoux N, Linehan JL, Han SJ, Harrison OJ, Wilhelm C, Conlan S, Himmelfarb S, Byrd AL, Deming C, Quinones M, Brenchley JM, Kong HH, Tussiwand R, Murphy KM, Merad M, Segre JA, Belkaid Y (2015). Commensal-dendritic-cell interaction specifies a unique protective skin immune signature. Nature  520, 104-8.   https://doi.org/10.1038/nature14052|6. Oh J, Byrd AL, Park M, NISC Comparative Sequencing Program, Kong HH, Segre JA (2016). Temporal Stability of the Human Skin Microbiome. Cell  165, 854-66.   https://doi.org/10.1016/j.cell.2016.04.008|7. Tsai YC, Conlan S, Deming C, NISC Comparative Sequencing Program, Segre JA, Kong HH, Korlach J, Oh J (2016). Resolving the Complexity of Human Skin Metagenomes Using Single-Molecule Sequencing. MBio  7, e01948-15.   https://doi.org/10.1128/mBio.01948-15|8. Waldor MK, Tyson G, Borenstein E, Ochman H, Moeller A, Finlay BB, Kong HH, Gordon JI, Nelson KE, Dabbagh K, Smith H (2015). Where next for microbiome research? PLoS Biol  13, e1002050.   https://doi.org/10.1371/journal.pbio.1002050",https://intramural.nih.gov/search/searchview.taf?ipid=93957
226,BC010940-09,"October 01, 2015 -  September 30, 2016",Cutaneous Adverse Drug Reactions,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",Edward W Cowen,NULL,"Ramaprasad  Srinivasan; MD, PhD (Urologic Oncology Branch)|William Marston Linehan; MD (Urologic Oncology Branch)|William Laurence Dahut; MD (Genitourinary Malignancies Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93955
227,BC010944-09,"October 01, 2015 -  September 30, 2016",Strategies for Cancer Immunotherapy Development:  Preclinical Studies,Jeffrey  Schlom; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Rika  Fujii|Sofia Ribeiro Gameiro|Duane Howard Hamilton|Peter Sungwhan Kim; PhD|Karin Marie Knudson|Michelle Renee Padget|Show all 12,"Mario  Roselli (Oncology, Tor Vergata)|Fiorella  Guadagni (Pathology, Regina Elena Cancer Institute)|Frank E Jones; PhD (Tulane School of Medicine)|Paul  Chaplin (Bavarian Nordic, Inc.)",NULL,NULL,"1. Boyerinas B, Jochems C, Fantini M, Heery CR, Gulley JL, Tsang KY, Schlom J (2015). Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti-PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells. Cancer Immunol Res  3, 1148-1157.   https://doi.org/10.1158/2326-6066.CIR-15-0059|2. Fujii R, Friedman ER, Richards J, Tsang KY, Heery CR, Schlom J, Hodge JW (2016). Enhanced killing of chordoma cells by antibody-dependent cell-mediated cytotoxicity employing the novel anti-PD-L1 antibody avelumab. Oncotarget  7, 33498-511.   https://doi.org/10.18632/oncotarget.9256|3. Gabitzsch ES, Tsang KY, Palena C, David JM, Fantini M, Kwilas A, Rice AE, Latchman Y, Hodge JW, Gulley JL, Madan RA, Heery CR, Balint JP, Jones FR, Schlom J (2015). The generation and analyses of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic. Oncotarget  6, 31344-59.   https://doi.org/10.18632/oncotarget.5181|4. Grenga I, Donahue RN, Lepone LM, Richards J, Schlom J (2016). A fully human IgG1 anti-PD-L1 MAb in an in vitro assay enhances antigen-specific T-cell responses. Clin Transl Immunology  5, e83.   https://doi.org/10.1038/cti.2016.27|5. Hamilton DH, Fernando RI, Schlom J, Palena C (2015). Aberrant expression of the embryonic transcription factor brachyury in human tumors detected with a novel rabbit monoclonal antibody. Oncotarget  6, 4853-62.   https://doi.org/10.18632/oncotarget.3086|6. Jochems C, Fantini M, Fernando RI, Kwilas AR, Donahue RN, Lepone LM, Grenga I, Kim YS, Brechbiel MW, Gulley JL, Madan RA, Heery CR, Hodge JW, Newton R, Schlom J, Tsang KY (2016). The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells. Oncotarget  7, 37762-37772.   https://doi.org/10.18632/oncotarget.9326|7. Kim PS, Kwilas AR, Xu W, Alter S, Jeng EK, Wong HC, Schlom J, Hodge JW (2016). IL-15 superagonist/IL-15RαSushi-Fc fusion complex (IL-15SA/IL-15RαSu-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas. Oncotarget  7, 16130-45.   https://doi.org/10.18632/oncotarget.7470|8. Kwilas AR, Ardiani A, Dirmeier U, Wottawah C, Schlom J, Hodge JW (2015). A poxviral-based cancer vaccine the transcription factor twist inhibits primary tumor growth and metastases in a model of metastatic breast cancer and improves survival in a spontaneous prostate cancer model. Oncotarget  6, 28194-210.   https://doi.org/10.18632/oncotarget.4442",https://intramural.nih.gov/search/searchview.taf?ipid=93903
228,BC010945-09,"October 01, 2015 -  September 30, 2016",Clinical trials employing cancer vaccine combination therapies,"James L Gulley; MD, PhD|IRP Faculty Profile",NULL,"Genitourinary Malignancies Branch, NCI",Amy Rosenberg Hankin|Julius Yehuda Strauss; MD|William Laurence Dahut; MD|Ravi  Madan,"Robert  DiPaola (The Cancer Institute of New Jersey)|William  Carson (Molecular Virology, Immunology and Medical Genetics, Ohio State University)|Nuhad  Ibrahim (MD Anderson Cancer Center)|Douglas  McNeel (University of Wisconsin)|Walter  Stadler (University of Chicago)|Paul  Chaplin (Bavarian Nordic, Inc.)",William Marston Linehan; MD (Urologic Oncology Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Aradhana  Kaushal (Radiation Oncology Branch)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch),NULL,"1. Apolo AB, Lindenberg L, Shih JH, Mena E, Kim JW, Park JC, Alikhani A, McKinney YY, Weaver J, Turkbey B, Parnes HL, Wood LV, Madan RA, Gulley JL, Dahut WL, Kurdziel KA, Choyke PL (2016). Prospective Study Evaluating Na18F PET/CT in Predicting Clinical Outcomes and Survival in Advanced Prostate Cancer. J Nucl Med  57, 886-92.   https://doi.org/10.2967/jnumed.115.166512|2. Heery CR, Madan RA, Stein MN, Stadler WM, Di Paola RS, Rauckhorst M, Steinberg SM, Marté JL, Chen CC, Grenga I, Donahue RN, Jochems C, Dahut WL, Schlom J, Gulley JL (2016). Samarium-153-EDTMP (Quadramet®) with or without vaccine in metastatic castration-resistant prostate cancer: A randomized Phase 2 trial. Oncotarget  7, 69014-69023.   https://doi.org/10.18632/oncotarget.10883|3. Madan RA, Karzai FH, Ning YM, Adesunloye BA, Huang X, Harold N, Couvillon A, Chun G, Cordes L, Sissung T, Beedie SL, Dawson NA, Theoret MR, McLeod DG, Rosner I, Trepel JB, Lee MJ, Tomita Y, Lee S, Chen C, Steinberg SM, Arlen PM, Gulley JL, Figg WD, Dahut WL (2016). Phase II trial of docetaxel, bevacizumab, lenalidomide and prednisone in patients with metastatic castration-resistant prostate cancer. BJU Int  118, 590-7.   https://doi.org/10.1111/bju.13412|4. McNeel DG, Chen YH, Gulley JL, Dwyer AJ, Madan RA, Carducci MA, DiPaola RS (2015). Randomized phase II trial of docetaxel with or without PSA-TRICOM vaccine in patients with castrate-resistant metastatic prostate cancer: A trial of the ECOG-ACRIN cancer research group (E1809). Hum Vaccin Immunother  11, 2469-74.   https://doi.org/10.1080/21645515.2015.1062190|5. Strauss J, Madan RA, Gulley JL (2016). Considerations for the combination of anticancer vaccines and immune checkpoint inhibitors. Expert Opin Biol Ther  16, 895-901.   https://doi.org/10.1517/14712598.2016.1170805",https://intramural.nih.gov/search/searchview.taf?ipid=93889
229,BC010946-09,"October 01, 2015 -  September 30, 2016",Protection against Radiation-Induced Carcinogenesis,James B Mitchell; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Rajani  Choudhuri|John Andrew Cook; PhD|Sarwat  Naz; PhD|Anastasia L Sowers|Murali  Krishna; PhD,NULL,Frank Jess Gonzalez; PhD (Laboratory of Metabolism),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93977
230,BC010956-09,"October 01, 2015 -  September 30, 2016",EpCAM (CD326) Function in Epithelial Cell Biology and Immunophysiology,Mark  Udey; MD,NULL,"Dermatology Branch, NCI",Gaku  Nakato|Xu  Feng; PhD|Michael C Lu|Chuanjin  Wu,"Daniel M Kaplan|Frank  Costanti (Columbia University Medical Center)|Nicholas  Greene (Institute of Child Health, UCL)",NULL,Maria Irene Morasso; PhD (NIAMS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93930
231,BC010957-09,"October 01, 2015 -  September 30, 2016",Transplant Models,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Catherine Virginia Bare|Francis  Flomerfelt; PhD|Hye Kyung  Kim|Philip J Lucas; PhD|Ruifeng  Teng|Jiun  Wang|Show all 7,NULL,NULL,Michael  Eckhaus; DVM (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93887
232,BC010958-09,"October 01, 2015 -  September 30, 2016","Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion",Ira  Daar; PhD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Yoo-Seok  Hwang|Laura Olivia Knapik|Moonsup  Lee|Jaeho  Yoon; PhD,NULL,Deborah K Morrison (Laboratory of Cell and Developmental Signaling),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93873
233,BC010959-09,"October 01, 2015 -  September 30, 2016",Relationship between DNA damage detection and signaling,Andre A Nussenzweig; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genome Integrity, NCI",Maria Elsa  Callen Moreu|Arnab  Ray Chaudhuri|Hua Tang  Chen|Andres  Canela Rodriguez|Nicholas Franklin Sciascia; BS|Kenta  Shinoda|Show all 11,"Jeremy A Daniel|Martin  Digweed (Institute of Medical and Human Genetics, Charité)|Steven  Narod (University of Toronto)|Michel  Nussenzweig (Rockefeller University)|Barry P. Sleckman; MD, PhD (Department of Pathology and Immunology, Washington University School of Medicine)|James  Turner (University College London)|Show all 7","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Shyam K Sharan (Genetics of Cancer Susceptibility Section)",Kai  Ge; PhD (NIDDK),"1. Canela A, Sridharan S, Sciascia N, Tubbs A, Meltzer P, Sleckman BP, Nussenzweig A (2016). DNA Breaks and End Resection Measured Genome-wide by End Sequencing. Mol Cell  63, 898-911.   https://doi.org/10.1016/j.molcel.2016.06.034|2. Canela Rodriguez A, Sciascia N, Tubbs A, Paul M, Sleckman B, Nussenzweig A (2016) DNA breaks and end-resection measured genome wide by end sequencing (END-seq) Molecular Cell in Press|3. Cloutier JM, Mahadevaiah SK, ElInati E, Nussenzweig A, Tóth A, Turner JM (2015). Histone H2AFX Links Meiotic Chromosome Asynapsis to Prophase I Oocyte Loss in Mammals. PLoS Genet  11, e1005462.   https://doi.org/10.1371/journal.pgen.1005462|4. Ding X, Ray Chaudhuri A, Callen E, Pang Y, Biswas K, Klarmann K, Martin B, Burkett S, Cleveland L, Stauffer S, Sullivan T, Dewan A, Marks H, Buehler E, Akagi K, Martin S, Keller J, Nussenzweig A, Sharan S (2016) Synthetic viability by BRCA2 and PARP1ARTD1 deficiencies Nature Comm In Press|5. Iqbal J, Nussenzweig A, Lubinski J, Byrski T, Eisen A, Bordeleau L, Tung NM, Manoukian S, Phelan CM, Sun P, Narod SA, Hereditary Breast Cancer Research Group (2016). The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study. Br J Cancer  114, 1160-4.   https://doi.org/10.1038/bjc.2016.58|6. Ray Chaudhuri A, Callen E, Ding X, Gogola E, Duarte AA, Lee JE, Wong N, Lafarga V, Calvo JA, Panzarino NJ, John S, Day A, Crespo AV, Shen B, Starnes LM, de Ruiter JR, Daniel JA, Konstantinopoulos PA, Cortez D, Cantor SB, Fernandez-Capetillo O, Ge K, Jonkers J, Rottenberg S, Sharan SK, et al. [1 more author] (2016). Replication fork stability confers chemoresistance in BRCA-deficient cells. Nature  535, 382-7.   https://doi.org/10.1038/nature18325|7. Robbiani DF, Deroubaix S, Feldhahn N, Oliveira TY, Callen E, Wang Q, Jankovic M, Silva IT, Rommel PC, Bosque D, Eisenreich T, Nussenzweig A, Nussenzweig MC (2015). Plasmodium Infection Promotes Genomic Instability and AID-Dependent B Cell Lymphoma. Cell  162, 727-37.   https://doi.org/10.1016/j.cell.2015.07.019|8. Salewsky B, Hildebrand G, Rothe S, Parplys AC, Radszewski J, Kieslich M, Wessendorf P, Krenzlin H, Borgmann K, Nussenzweig A, Sperling K, Digweed M (2016) Directed Alternative Splicing in Nijmegen Breakage Syndrome: Proof of Principle Concerning Its Therapeutical Application. Mol Ther 24:117-24|9. Starnes LM, Su D, Pikkupeura LM, Weinert BT, Santos MA, Mund A, Soria R, Cho YW, Pozdnyakova I, Kubec Højfeldt M, Vala A, Yang W, López-Méndez B, Lee JE, Peng W, Yuan J, Ge K, Montoya G, Nussenzweig A, Choudhary C, Daniel JA (2016). A PTIP-PA1 subcomplex promotes transcription for IgH class switching independently from the associated MLL3/MLL4 methyltransferase complex. Genes Dev  30, 149-63.   https://doi.org/10.1101/gad.268797.115|10. Zong D, Chaudhuri AR, Nussenzweig A (2016). More end resection is not merrier. Nat Struct Mol Biol  23, 699-701.   https://doi.org/10.1038/nsmb.3274",https://intramural.nih.gov/search/searchview.taf?ipid=93984
234,BC010960-09,"October 01, 2015 -  September 30, 2016",ETIB Clinical Trials,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Daniele N Avila|Judy Liliana Baruffaldi|Jennifer Amy Mann|Sarfraz A Memon|Andrew James Uhlman|Jennifer Sproul Wilder,"Andrew  Pecora (Cancer Center, Hackensack University)|Robert  Korngold (Cancer Center, Hackensack University)|Scott  Rowley (Hackensack University)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93888
235,BC010970-09,"October 01, 2015 -  September 30, 2016",The connection of innate and adaptive anti-cancer immunity,John  Greiner; PhD,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI",Lajuan  Chase|Garland M Davis|Bertina L Gibbs|Yves Maurice Morillon; PhD|Amanda Jayne Lyon; PhD|Claudia Mercedes Palena|Show all 8,"Paul  Chaplin (Bavarian Nordic, Inc.)|Zhen  Su (EMD Serono-Merck)",NULL,NULL,"1. Vandeveer AJ, Fallon JK, Tighe R, Sabzevari H, Schlom J, Greiner JW (2016). Systemic Immunotherapy of Non-Muscle Invasive Mouse Bladder Cancer with Avelumab, an Anti-PD-L1 Immune Checkpoint Inhibitor. Cancer Immunol Res  4, 452-62.   https://doi.org/10.1158/2326-6066.CIR-15-0176",https://intramural.nih.gov/search/searchview.taf?ipid=93885
236,BC010972-09,"October 01, 2015 -  September 30, 2016",Identification of human tumor-associated antigens,Kwong Yok Tsang,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI",Titas Kumar Bera|Massimo Na Fantini; PhD|Romaine Ingrid Fernando|Caroline Mikaela Maria Jochems; PhD|Claudia Mercedes Palena|James W Hodge; PhD|Show all 7,"Mario  Roselli (Oncology, Tor Vergata)|Fiorella  Guadagni (Pathology, Regina Elena Cancer Institute)|Frank E Jones; PhD (Tulane School of Medicine)|Paul  Chaplin (Bavarian Nordic, Inc.)","James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Ravi  Madan (Genitourinary Malignancies Branch)",NULL,"1. Tsang K, Jochems C, Schlom J (2015) Insights on peptide vaccines in cancer immunotherapy, in New Developments in T Cell-Based Anticancer Immunotherapies, in press.|2. Gabitzsch ES, Tsang KY, Palena C, David JM, Fantini M, Kwilas A, Rice AE, Latchman Y, Hodge JW, Gulley JL, Madan RA, Heery CR, Balint JP, Jones FR, Schlom J (2015). The generation and analyses of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic. Oncotarget  6, 31344-59.   https://doi.org/10.18632/oncotarget.5181|3. Lu D, Graf R, Harvey M, Madan R, Heery C, Marte J, Beasley S, Tsang K, Krupa R, Louw J, Wahl J, Bales N, Landers M, Marrinucci D, Schlom J, Gulley J, Dittamore R (2015) Detection and characterization of circulating tumor cells from frozen peripheral blood mononuclear cells. J Circ Biomark, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=93928
237,BC010973-09,"October 01, 2015 -  September 30, 2016",Analyses of human T regulatory cells,Kwong Yok Tsang,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI",Titas Kumar Bera|Massimo Na Fantini; PhD|Romaine Ingrid Fernando|Caroline Mikaela Maria Jochems; PhD|Claudia Mercedes Palena|James W Hodge; PhD|Show all 7,"Mario  Roselli (Oncology, Tor Vergata)|Fiorella  Guadagni (Pathology, Regina Elena Cancer Institute)|Paul  Chaplin (Bavarian Nordic, Inc.)","James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Ravi  Madan (Genitourinary Malignancies Branch)",NULL,"1. Tsang K, Jochems C, Schlom J (2015) Insights on peptide vaccines in cancer immunotherapy, in New Developments in T Cell-Based Anticancer Immunotherapies, in press.|2. 1 Gull, 2 Mart, 3 Heer, 4 Mada, 5 Stei, 6 Leit, 7 Tsan, 8 Schl (2015) The impact of leukapheresis on immune cell number and function in patients with advanced  cancer. Cancer Immunol Immunother, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=93929
238,BC010975-09,"October 01, 2015 -  September 30, 2016",Vaccine and radiation for the therapy of human cancers,James W Hodge; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Jeffrey  Schlom; PhD,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch),NULL,"1. Garg AD, Galluzzi L, Apetoh L, Baert T, Birge RB, Bravo-San Pedro JM, Breckpot K, Brough D, Chaurio R, Cirone M, Coosemans A, Coulie PG, De Ruysscher D, Dini L, de Witte P, Dudek-Peric AM, Faggioni A, Fucikova J, Gaipl US, Golab J, Gougeon ML, Hamblin MR, Hemminki A, Herrmann M, Hodge JW, et al. [27 more authors] (2015). Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death. Front Immunol  6, 588.   https://doi.org/10.3389/fimmu.2015.00588|2. Garnett-Benson C, Hodge JW, Gameiro SR (2015). Combination regimens of radiation therapy and therapeutic cancer vaccines: mechanisms and opportunities. Semin Radiat Oncol  25, 46-53.   https://doi.org/10.1016/j.semradonc.2014.07.002",https://intramural.nih.gov/search/searchview.taf?ipid=93945
239,BC010976-09,"October 01, 2015 -  September 30, 2016",Role of MFG-E8 in Tumor Biology and Immunophysiology,Mark  Udey; MD,NULL,"Dermatology Branch, NCI",Michael C Lu,Nicholas  Marsh-Armstrong (Johns Hopkins University)|Harvey  Florman (Universty of Massachusetts Medical School)|George  Hajishengallis (University of Pennsylvanis School of Dental Medicine)|Seiichiro  Motegi (Gunma University School of Medicine)|Martina  Rauner (Technical University),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93931
240,BC010977-09,"October 01, 2015 -  September 30, 2016",Cbl Proteins as Regulators of Tyrosine Kinase Signaling,"Stanley  Lipkowitz; MD, PhD|IRP Faculty Profile",NULL,"Womens Malignancies Branch, NCI",Mariya Sergeyevna Liyasova; PhD|Ke  Ma|Marion M Nau|Donna M Voeller,Marcus Ramsay Clark|Jian  Zhang (University of Chicago),"Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)|Paul A Randazzo; MD, PhD (Laboratory of Cellular and Molecular Biology)|Anand S Merchant (Office of the Director)|Barry R O'Keefe (Molecular Targets Laboratory)",Anna  Panchenko; PhD (NLM),"1. Li M, Kales S, Ma K, Shoemaker B, CrespoBarreto J, Cangelosi A, Lipkowitz S, Panchenko A (2015) Protein stability-activity tradeoff in cancer: mutations affect different and multiple stages of Cbl ubiquitin ligase activation cycle. Cancer Research, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=93967
241,BC010982-09,"October 01, 2015 -  September 30, 2016",Collaborative Pathways that Lead to Leukemia,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Yang-Jo  Chung|Liat Hava Goldberg-Cooks|Subhadip  Kundu|Mianmian  Yin|Paul S Meltzer; MD, PhD",Trang  Hoang (U. Montreal)|Steven  Nimer (MSKCC)|Donald  Small (Johns Hopkins University School of Medicine),Terry J Fry (Pediatric Oncology Branch),NULL,"1. Cui Y, Onozawa M, Garber HR, Samsel L, Wang Z, McCoy JP, Burkett S, Wu X, Aplan PD, Mackall CL (2015). Thymic expression of a T-cell receptor targeting a tumor-associated antigen coexpressed in the thymus induces T-ALL. Blood  125, 2958-67.   https://doi.org/10.1182/blood-2014-10-609271|2. Fry TJ, Aplan PD (2015). A robust in vivo model for B cell precursor acute lymphoblastic leukemia. J Clin Invest  125, 3427-9.   https://doi.org/10.1172/JCI83799",https://intramural.nih.gov/search/searchview.taf?ipid=93859
242,BC010983-09,"October 01, 2015 -  September 30, 2016",Pre-clinical Studies of Therapy for Myelodysplastic Syndrome,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Yang-Jo  Chung|Ghanwa Naveed Khawaja,Steven  Nimer (MSKCC)|JP  Issa (MD Anderson)|Chris  Slape (Monash University),Terry J Fry (Pediatric Oncology Branch),NULL,"1. Ma HS, Greenblatt SM, Shirley CM, Duffield AS, Bruner JK, Li L, Nguyen B, Jung E, Aplan PD, Ghiaur G, Jones RJ, Small D (2016). All-trans retinoic acid synergizes with FLT3 inhibition to eliminate FLT3/ITD+ leukemia stem cells in vitro and in vivo. Blood  127, 2867-78.   https://doi.org/10.1182/blood-2015-05-646786",https://intramural.nih.gov/search/searchview.taf?ipid=93860
243,BC010984-09,"October 01, 2015 -  September 30, 2016",Adoptive Cell Transfer Immunotherapy of Cancer,"Steven Aaron Rosenberg; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Mojgan  Ahmadzadeh|Drew Caldwell Deniger; PhD|Jared Joseph Gartner|Alena - Gros; PhD|Sadia  Ilyas|Lucas Aaron McDuffie; MD|Show all 17,NULL,James N Kochenderfer (Experimental Transplantation and Immunology Branch)|Mark Richard Gilbert; MD (Neuro-Oncology Branch),NULL,"1. Arafeh R, Qutob N, Emmanuel R, Keren-Paz A, Madore J, Elkahloun A, Wilmott JS, Gartner JJ, Di Pizio A, Winograd-Katz S, Sindiri S, Rotkopf R, Dutton-Regester K, Johansson P, Pritchard AL, Waddell N, Hill VK, Lin JC, Hevroni Y, Rosenberg SA, Khan J, Ben-Dor S, Niv MY, Ulitsky I, Mann GJ, et al. [3 more authors] (2015). Recurrent inactivating RASA2 mutations in melanoma. Nat Genet  47, 1408-10.   https://doi.org/10.1038/ng.3427|2. Cohen CJ, Gartner JJ, Horovitz-Fried M, Shamalov K, Trebska-McGowan K, Bliskovsky VV, Parkhurst MR, Ankri C, Prickett TD, Crystal JS, Li YF, El-Gamil M, Rosenberg SA, Robbins PF (2015). Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes. J Clin Invest  125, 3981-91.   https://doi.org/10.1172/JCI82416|3. Conlon KC, Lugli E, Welles HC, Rosenberg SA, Fojo AT, Morris JC, Fleisher TA, Dubois SP, Perera LP, Stewart DM, Goldman CK, Bryant BR, Decker JM, Chen J, Worthy TA, Figg WD, Peer CJ, Sneller MC, Lane HC, Yovandich JL, Creekmore SP, Roederer M, Waldmann TA (2015). Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer. J Clin Oncol  33, 74-82.   https://doi.org/10.1200/JCO.2014.57.3329|4. Crompton JG, Sukumar M, Roychoudhuri R, Clever D, Gros A, Eil RL, Tran E, Hanada K, Yu Z, Palmer DC, Kerkar SP, Michalek RD, Upham T, Leonardi A, Acquavella N, Wang E, Marincola FM, Gattinoni L, Muranski P, Sundrud MS, Klebanoff CA, Rosenberg SA, Fearon DT, Restifo NP (2015). Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics. Cancer Res  75, 296-305.   https://doi.org/10.1158/0008-5472.CAN-14-2277|5. Feldman SA, Assadipour Y, Kriley I, Goff SL, Rosenberg SA (2015). Adoptive Cell Therapy--Tumor-Infiltrating Lymphocytes, T-Cell Receptors, and Chimeric Antigen Receptors. Semin Oncol  42, 626-39.   https://doi.org/10.1053/j.seminoncol.2015.05.005|6. Jaigirdar A, Rosenberg SA, Parkhurst M (2016). A High-avidity WT1-reactive T-Cell Receptor Mediates Recognition of Peptide and Processed Antigen but not Naturally Occurring WT1-positive Tumor Cells. J Immunother  39, 105-16.   https://doi.org/10.1097/CJI.0000000000000116|7. Klebanoff CA, Rosenberg SA, Restifo NP (2016). Prospects for gene-engineered T cell immunotherapy for solid cancers. Nat Med  22, 26-36.   https://doi.org/10.1038/nm.4015|8. Klebanoff CA, Scott CD, Leonardi AJ, Yamamoto TN, Cruz AC, Ouyang C, Ramaswamy M, Roychoudhuri R, Ji Y, Eil RL, Sukumar M, Crompton JG, Palmer DC, Borman ZA, Clever D, Thomas SK, Patel S, Yu Z, Muranski P, Liu H, Wang E, Marincola FM, Gros A, Gattinoni L, Rosenberg SA, et al. [2 more authors] (2016). Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapy. J Clin Invest  126, 318-34.   https://doi.org/10.1172/JCI81217|9. Pasetto A, Gros A, Robbins PF, Deniger DC, Prickett TD, Matus-Nicodemos R, Douek DC, Howie B, Robins H, Parkhurst MR, Gartner J, Trebska-McGowan K, Crystal JS, Rosenberg SA (2016). Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh Tumor. Cancer Immunol Res  4, 734-43.   https://doi.org/10.1158/2326-6066.CIR-16-0001|10. Rosenberg SA (2015). CCR 20th Anniversary Commentary: Autologous T Cells-The Ultimate Personalized Drug for the Immunotherapy of Human Cancer. Clin Cancer Res  21, 5409-11.   https://doi.org/10.1158/1078-0432.CCR-14-3131|11. Rosenberg SA, Restifo NP (2015). Adoptive cell transfer as personalized immunotherapy for human cancer. Science  348, 62-8.   https://doi.org/10.1126/science.aaa4967|12. Topalian SL, Wolchok JD, Chan TA, Mellman I, Palucka K, Banchereau J, Rosenberg SA, Dane Wittrup K (2015). Immunotherapy: The path to win the war on cancer? Cell  161, 185-6.   https://doi.org/10.1016/j.cell.2015.03.045|13. Tran E, Robbins PF, Lu YC, Prickett TD, Gartner JJ, Jia L, Pasetto A, Zheng Z, Ray S, Groh EM, Kriley IR, Rosenberg SA (2016). T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer. N Engl J Med  375, 2255-2262.   https://doi.org/10.1056/NEJMoa1609279|14. Yang JC, Rosenberg SA (2016). Adoptive T-Cell Therapy for Cancer. Adv Immunol  130, 279-94.   https://doi.org/10.1016/bs.ai.2015.12.006",https://intramural.nih.gov/search/searchview.taf?ipid=93901
244,BC010985-09,"October 01, 2015 -  September 30, 2016",Gene therapy of cancer,"Steven Aaron Rosenberg; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Drew Caldwell Deniger; PhD|Alena - Gros; PhD|Sadia  Ilyas|Yong-Chen  Lu; PhD|Lucas Aaron McDuffie; MD|Lien T Ngo|Show all 18,NULL,NULL,NULL,"1. Beane JD, Lee G, Zheng Z, Mendel M, Abate-Daga D, Bharathan M, Black M, Gandhi N, Yu Z, Chandran S, Giedlin M, Ando D, Miller J, Paschon D, Guschin D, Rebar EJ, Reik A, Holmes MC, Gregory PD, Restifo NP, Rosenberg SA, Morgan RA, Feldman SA (2015). Clinical Scale Zinc Finger Nuclease-mediated Gene Editing of PD-1 in Tumor Infiltrating Lymphocytes for the Treatment of Metastatic Melanoma. Mol Ther  23, 1380-1390.   https://doi.org/10.1038/mt.2015.71|2. Feldman SA, Assadipour Y, Kriley I, Goff SL, Rosenberg SA (2015). Adoptive Cell Therapy--Tumor-Infiltrating Lymphocytes, T-Cell Receptors, and Chimeric Antigen Receptors. Semin Oncol  42, 626-39.   https://doi.org/10.1053/j.seminoncol.2015.05.005|3. Kalaora S, Barnea E, Merhavi-Shoham E, Qutob N, Teer JK, Shimony N, Schachter J, Rosenberg SA, Besser MJ, Admon A, Samuels Y (2016). Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens. Oncotarget  7, 5110-7.   https://doi.org/10.18632/oncotarget.6960|4. Klebanoff CA, Rosenberg SA, Restifo NP (2016). Prospects for gene-engineered T cell immunotherapy for solid cancers. Nat Med  22, 26-36.   https://doi.org/10.1038/nm.4015|5. Liu L, Patel B, Ghanem MH, Bundoc V, Zheng Z, Morgan RA, Rosenberg SA, Dey B, Berger EA (2015). Novel CD4-Based Bispecific Chimeric Antigen Receptor Designed for Enhanced Anti-HIV Potency and Absence of HIV Entry Receptor Activity. J Virol  89, 6685-94.   https://doi.org/10.1128/JVI.00474-15|6. Zhang L, Morgan RA, Beane JD, Zheng Z, Dudley ME, Kassim SH, Nahvi AV, Ngo LT, Sherry RM, Phan GQ, Hughes MS, Kammula US, Feldman SA, Toomey MA, Kerkar SP, Restifo NP, Yang JC, Rosenberg SA (2015). Tumor-infiltrating lymphocytes genetically engineered with an inducible gene encoding interleukin-12 for the immunotherapy of metastatic melanoma. Clin Cancer Res  21, 2278-88.   https://doi.org/10.1158/1078-0432.CCR-14-2085",https://intramural.nih.gov/search/searchview.taf?ipid=93900
245,BC010992-09,"October 01, 2015 -  September 30, 2016",Fidelity of Transcription,Jeffrey N Strathern,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",Ding Jun Jin,"Zachory  Burton (Biochemistry and Molecular Biology, Michigan State University)|Maria  Kilfoil (U Mass Amherst)|Marc  Vermulst (GENOME RECOMBINATION & REGULATION SECTION)",Stephen H Hughes; PhD (Retroviral Replication Laboratory)|Mikhail V Kashlev (Molecular Mechanisms of Transcription Section)|Donald L Court; PhD (Molecular Control and Genetics Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93924
246,BC010998-09,"October 01, 2015 -  September 30, 2016",Identification of Novel Mutations In Pediatric Cancers,Javed  Khan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Paul S Meltzer; MD, PhD","John  Maris (Pharmacology, Children's Hospital of Philadelphia)|Daniel  Catchpoole (The Children's Hospital at Westmead)|Robert  Seeger (Division of Pediatric Hematology-Oncology, Children's Hospital of Los Angeles)|David  Azorsa (NHGRI)|Stephen  Skapek (The University of Chicago)|Douglas  Hawkins (Pediatric Oncology, Children's Hosp. of Seattle)|Show all 7",Carol J Thiele (Pediatric Oncology Branch)|Lee Jay Helman; MD (Pediatric Oncology Branch),James G Taylor; MD (NHLBI),"1. Chang W, Brohl AS, Patidar R, Sindiri S, Shern JF, Wei JS, Song YK, Yohe ME, Gryder B, Zhang S, Calzone KA, Shivaprasad N, Wen X, Badgett TC, Miettinen M, Hartman KR, League-Pascual JC, Trahair TN, Widemann BC, Merchant MS, Kaplan RN, Lin JC, Khan J (2016). MultiDimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A Report from the Center for Cancer Research. Clin Cancer Res  22, 3810-20.   https://doi.org/10.1158/1078-0432.CCR-15-2717|2. Chen J, Hackett CS, Zhang S, Song YK, Bell RJ, Molinaro AM, Quigley DA, Balmain A, Song JS, Costello JF, Gustafson WC, Van Dyke T, Kwok PY, Khan J, Weiss WA (2015). The genetics of splicing in neuroblastoma. Cancer Discov  5, 380-95.   https://doi.org/10.1158/2159-8290.CD-14-0892|3. Chen L, Shern JF, Wei JS, Yohe ME, Song YK, Hurd L, Liao H, Catchpoole D, Skapek SX, Barr FG, Hawkins DS, Khan J (2015). Clonality and evolutionary history of rhabdomyosarcoma. PLoS Genet  11, e1005075.   https://doi.org/10.1371/journal.pgen.1005075|4. Gooskens SL, Gadd S, Guidry Auvil JM, Gerhard DS, Khan J, Patidar R, Meerzaman D, Chen QR, Hsu CH, Yan C, Nguyen C, Hu Y, Mullighan CG, Ma J, Jennings LJ, de Krijger RR, van den Heuvel-Eibrink MM, Smith MA, Ross N, Gastier-Foster JM, Perlman EJ (2015). TCF21 hypermethylation in genetically quiescent clear cell sarcoma of the kidney. Oncotarget  6, 15828-41.   https://doi.org/10.18632/oncotarget.4682|5. Russell MR, Penikis A, Oldridge DA, Alvarez-Dominguez JR, McDaniel L, Diamond M, Padovan O, Raman P, Li Y, Wei JS, Zhang S, Gnanchandran J, Seeger R, Asgharzadeh S, Khan J, Diskin SJ, Maris JM, Cole KA (2015). CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus. Cancer Res  75, 3155-66.   https://doi.org/10.1158/0008-5472.CAN-14-3613",https://intramural.nih.gov/search/searchview.taf?ipid=93953
247,BC010999-09,"October 01, 2015 -  September 30, 2016","Targeting FGFR4,  RAS, and  PAX3-FOXO1 gene in Rhabdomyosarcoma",Javed  Khan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",NULL,NULL,Terry J Fry (Pediatric Oncology Branch)|Mitchell  Ho (Laboratory of Molecular Biology),James G Taylor; MD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93954
248,BC011002-09,"October 01, 2015 -  September 30, 2016",Bioinformatics: Systems Biology of Pediatric Cancers,Javed  Khan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Hsien-Chao  Chou|Berkley Eric Gryder|Igor Borisovich Kuznetsov|Rajesh  Patidar|Sivasish  Sindiri|Manoj  Tyagi; PhD|Show all 8,"John  Maris (Pharmacology, Children's Hospital of Philadelphia)|Jason  Shohet (Baylor College of Medicine)|Jeffrey  Trent (TGen)",NULL,NULL,"1. Bogen D, Wei JS, Azorsa DO, Ormanoglu P, Buehler E, Guha R, Keller JM, Mathews Griner LA, Ferrer M, Song YK, Liao H, Mendoza A, Gryder BE, Sindri S, He J, Wen X, Zhang S, Shern JF, Yohe ME, Taschner-Mandl S, Shohet JM, Thomas CJ, Martin SE, Ambros PF, Khan J (2015). Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma. Oncotarget  6, 35247-62.   https://doi.org/10.18632/oncotarget.6208|2. Chang W, Brohl AS, Patidar R, Sindiri S, Shern JF, Wei JS, Song YK, Yohe ME, Gryder B, Zhang S, Calzone KA, Shivaprasad N, Wen X, Badgett TC, Miettinen M, Hartman KR, League-Pascual JC, Trahair TN, Widemann BC, Merchant MS, Kaplan RN, Lin JC, Khan J (2016). MultiDimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A Report from the Center for Cancer Research. Clin Cancer Res  22, 3810-20.   https://doi.org/10.1158/1078-0432.CCR-15-2717|3. Chen J, Hackett CS, Zhang S, Song YK, Bell RJ, Molinaro AM, Quigley DA, Balmain A, Song JS, Costello JF, Gustafson WC, Van Dyke T, Kwok PY, Khan J, Weiss WA (2015). The genetics of splicing in neuroblastoma. Cancer Discov  5, 380-95.   https://doi.org/10.1158/2159-8290.CD-14-0892|4. Chen L, Shern JF, Wei JS, Yohe ME, Song YK, Hurd L, Liao H, Catchpoole D, Skapek SX, Barr FG, Hawkins DS, Khan J (2015). Clonality and evolutionary history of rhabdomyosarcoma. PLoS Genet  11, e1005075.   https://doi.org/10.1371/journal.pgen.1005075|5. Ji J, Zheng X, Forgues M, Yamashita T, Wauthier EL, Reid LM, Wen X, Song Y, Wei JS, Khan J, Thorgeirsson SS, Wang XW (2015). Identification of microRNAs specific for epithelial cell adhesion molecule-positive tumor cells in hepatocellular carcinoma. Hepatology  62, 829-40.   https://doi.org/10.1002/hep.27886|6. McKinnon T, Venier R, Dickson BC, Kabaroff L, Alkema M, Chen L, Shern JF, Yohe ME, Khan J, Gladdy RA (2015). Kras activation in p53-deficient myoblasts results in high-grade sarcoma formation with impaired myogenic differentiation. Oncotarget  6, 14220-32.   https://doi.org/10.18632/oncotarget.3856|7. Oldridge DA, Wood AC, Weichert-Leahey N, Crimmins I, Sussman R, Winter C, McDaniel LD, Diamond M, Hart LS, Zhu S, Durbin AD, Abraham BJ, Anders L, Tian L, Zhang S, Wei JS, Khan J, Bramlett K, Rahman N, Capasso M, Iolascon A, Gerhard DS, Guidry Auvil JM, Young RA, Hakonarson H, et al. [3 more authors] (2015). Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism. Nature  528, 418-21.   https://doi.org/10.1038/nature15540|8. Shern JF, Yohe ME, Khan J (2015). Pediatric Rhabdomyosarcoma. Crit Rev Oncog  20, 227-43.   https://doi.org/10.1615/critrevoncog.2015013800|9. Zhang S, Wei JS, Li SQ, Badgett TC, Song YK, Agarwal S, Coarfa C, Tolman C, Hurd L, Liao H, He J, Wen X, Liu Z, Thiele CJ, Westermann F, Asgharzadeh S, Seeger RC, Maris JM, Guidry Auvil JM, Smith MA, Kolaczyk ED, Shohet J, Khan J (2016). MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastoma. Cancer Lett  371, 214-24.   https://doi.org/10.1016/j.canlet.2015.11.045",https://intramural.nih.gov/search/searchview.taf?ipid=93952
249,BC011006-09,"October 01, 2015 -  September 30, 2016",Molecular diagnosis and outcome prediction in lymphoma,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI","Da Wei  Huang|Roland  Schmitz|Weihong  Xu|Yandan  Yang; PhD|Wyndham H Wilson; MD, PhD|Kieron Michael Dunleavy|Show all 7",John  Chan (Univ. of Nebraska Medical Center)|Elias  Campo (University of Barcelona)|Randy  Gascoyne (British Columbia Cancer Center)|Erlend  Smeland (Norwegian Radium Hospital)|Lisa  Rimsza (University of Arizona Cancer Center)|Joseph  Connors (British Columbia Cancer Agency)|Show all 8,Elaine S Jaffe; MD (Laboratory of Pathology)|George W Wright (Computational & Systems Biology Branch)|Stefania  Pittaluga (Laboratory of Pathology),John I Powell (CIT),"1. Iqbal J, Shen Y, Huang X, Liu Y, Wake L, Liu C, Deffenbacher K, Lachel CM, Wang C, Rohr J, Guo S, Smith LM, Wright G, Bhagavathi S, Dybkaer K, Fu K, Greiner TC, Vose JM, Jaffe E, Rimsza L, Rosenwald A, Ott G, Delabie J, Campo E, Braziel RM, et al. [8 more authors] (2015). Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma. Blood  125, 1137-45.   https://doi.org/10.1182/blood-2014-04-566778|2. Malecka A, Tierens A, Østlie I, Schmitz R, Trøen G, Spetalen S, Staudt LM, Smeland E, Holte H, Delabie J (2015). Primary diffuse large B-cell lymphoma associated with clonally-related monoclonal B lymphocytosis indicates a common precursor cell. Haematologica  100, e415-8.   https://doi.org/10.3324/haematol.2015.126656|3. Scott DW, Mottok A, Ennishi D, Wright GW, Farinha P, Ben-Neriah S, Kridel R, Barry GS, Hother C, Abrisqueta P, Boyle M, Meissner B, Telenius A, Savage KJ, Sehn LH, Slack GW, Steidl C, Staudt LM, Connors JM, Rimsza LM, Gascoyne RD (2015). Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies. J Clin Oncol  33, 2848-56.   https://doi.org/10.1200/JCO.2014.60.2383|4. Wang C, McKeithan TW, Gong Q, Zhang W, Bouska A, Rosenwald A, Gascoyne RD, Wu X, Wang J, Muhammad Z, Jiang B, Rohr J, Cannon A, Steidl C, Fu K, Li Y, Hung S, Weisenburger DD, Greiner TC, Smith L, Ott G, Rogan EG, Staudt LM, Vose J, Iqbal J, et al. [1 more author] (2015). IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma. Blood  126, 1741-52.   https://doi.org/10.1182/blood-2015-05-644591",https://intramural.nih.gov/search/searchview.taf?ipid=93917
250,BC011007-09,"October 01, 2015 -  September 30, 2016",RNA interference-based screens for molecular targets in cancer,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Emmanuel B Bachy|Da Wei  Huang|James Daniel Phelan|Sandrine Anne Roulland|Daniel E Webster|Yandan  Yang; PhD|Show all 7,NULL,George W Wright (Computational & Systems Biology Branch),John I Powell (CIT),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93918
251,BC011008-09,"October 01, 2015 -  September 30, 2016",Oncogenic mechanisms and molecular targets in lymphoma,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Da Wei  Huang|Priscilla Ninette Kelly; PhD|Roland  Schmitz|Arthur L Shaffer|Weihong  Xu|Hee Min  Yoo|Show all 12,John  Chan (Univ. of Nebraska Medical Center)|Elias  Campo (University of Barcelona)|Randy  Gascoyne (British Columbia Cancer Center)|Erlend  Smeland (Norwegian Radium Hospital)|Lisa  Rimsza (University of Arizona Cancer Center)|Joseph  Connors (British Columbia Cancer Agency)|Show all 8,Elaine S Jaffe; MD (Laboratory of Pathology)|George W Wright (Computational & Systems Biology Branch)|Stefania  Pittaluga (Laboratory of Pathology),John I Powell (CIT),"1. Hodson DJ, Shaffer AL, Xiao W, Wright GW, Schmitz R, Phelan JD, Yang Y, Webster DE, Rui L, Kohlhammer H, Nakagawa M, Waldmann TA, Staudt LM (2016). Regulation of normal B-cell differentiation and malignant B-cell survival by OCT2. Proc Natl Acad Sci U S A  113, E2039-46.   https://doi.org/10.1073/pnas.1600557113|2. Kelly PN, Romero DL, Yang Y, Shaffer AL, Chaudhary D, Robinson S, Miao W, Rui L, Westlin WF, Kapeller R, Staudt LM (2015). Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy. J Exp Med  212, 2189-201.   https://doi.org/10.1084/jem.20151074|3. Yang Y, Staudt LM (2015). Protein ubiquitination in lymphoid malignancies. Immunol Rev  263, 240-56.   https://doi.org/10.1111/imr.12247|4. Young RM, Shaffer AL, Phelan JD, Staudt LM (2015). B-cell receptor signaling in diffuse large B-cell lymphoma. Semin Hematol  52, 77-85.   https://doi.org/10.1053/j.seminhematol.2015.01.008|5. Young RM, Wu T, Schmitz R, Dawood M, Xiao W, Phelan JD, Xu W, Menard L, Meffre E, Chan WC, Jaffe ES, Gascoyne RD, Campo E, Rosenwald A, Ott G, Delabie J, Rimsza LM, Staudt LM (2015). Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens. Proc Natl Acad Sci U S A  112, 13447-54.   https://doi.org/10.1073/pnas.1514944112",https://intramural.nih.gov/search/searchview.taf?ipid=93915
252,BC011010-09,"October 01, 2015 -  September 30, 2016",Oncogenic mechanisms and molecular targets in myeloma,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Ryan Matthew Young,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93916
253,BC011011-09,"October 01, 2015 -  September 30, 2016",The genome-wide function of supercoiling and alternative DNA conformations,David  Levens; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Laura  Baranello|Fedor Edmundovich Kouzine|Zuqin  Nie; PhD|Suzanne Laurie Sanford|Lipeng  Wu|Ying  Zheng,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",Keji  Zhao; PhD (NHLBI) |Rafael Cristian Casellas; PhD (NIAMS) |Teresa M Przytycka (NLM),"1. Baranello L, Wojtowicz D, Cui K, Devaiah BN, Chung HJ, Chan-Salis KY, Guha R, Wilson K, Zhang X, Zhang H, Piotrowski J, Thomas CJ, Singer DS, Pugh BF, Pommier Y, Przytycka TM, Kouzine F, Lewis BA, Zhao K, Levens D (2016). RNA Polymerase II Regulates Topoisomerase 1 Activity to Favor Efficient Transcription. Cell  165, 357-71.   https://doi.org/10.1016/j.cell.2016.02.036|2. Przytycka TM, Levens D (2015). Shapely DNA attracts the right partner. Proc Natl Acad Sci U S A  112, 4516-7.   https://doi.org/10.1073/pnas.1503951112",https://intramural.nih.gov/search/searchview.taf?ipid=93961
254,BC011028-09,"October 01, 2015 -  September 30, 2016",Clinical Studies of the Molecular Genetic Basis of Kidney Cancer,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Leonard  Neckers; PhD|Donald P Bottaro; PhD,NULL,Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)|Bradford J Wood; MD (Office of the Director),"Emily Y Chew; MD (NEI) |Karel  Pacak; MD, PhD (NICHD) |Pamela  Stratton; MD (NINDS)","1. C R, LS S, WM L (2016) The Genetic Basis of Cancer of the Kidney, in Genetic Diseases of the Kidney, in press.|2. M B, LS S, WM L (2016) Hereditary Renal Cell Carcinoma - Molecular Features and Updates, in Hereditary Renal Cell Carcinoma, in press.|3. Moch H, Bonsib S, Delahunt B, Eble J, Egevad L, Grignon D, Linehan W, Reuter V, Srigley J, Sulser T, Ran P (2016) Clear Cell renal cell carcinoma, in World Health Organization Classification of Tumours. , pp. 18-21.|4. Sourbier C, Srinivasan R, Linehan W (2015) Metabolism and oxidative stress response pathways in kidney cancer: a tale of chance and necessity, in ASCO Educational Book. , pp. 220-225.|5. Srinivasan R, Linehan W (2016) Treatment of Advanced Renal Cell Carcinoma, in Campbell-Walsh Urology, 11th ed. , pp. 259-262.|6. 1 Hunt, 2 Wu, 3 Elde, 4 Butm, 5 Chew, 6 Line, 7 Oldf, 8 Lons (2015) Biologic and Clinical Impact of Hemangioblastoma-Associated Peritumoral Cysts in Von Hippel-Lindau Disease. J Neurosurg, in press.|7. 1 Sour, 2 Scro, 3 Mann, 4 Liao, 5 Siem, 6 Wolf, 7 Beut, 8 Line, 9 Neck (2015) Tonantzitlolone cytotoxicity toward renal cancer cells is PKC- and HSF1-dependent Oncotarget Advance online pub:1-12|8. Baba M, Toyama H, Sun L, Takubo K, Suh HC, Hasumi H, Nakamura-Ishizu A, Hasumi Y, Klarmann KD, Nakagata N, Schmidt LS, Linehan WM, Suda T, Keller JR (2016). Loss of Folliculin Disrupts Hematopoietic Stem Cell Quiescence and Homeostasis Resulting in Bone Marrow Failure. Stem Cells  34, 1068-82.   https://doi.org/10.1002/stem.2293|9. Cherkasova E, Scrivani C, Doh S, Weisman Q, Takahashi Y, Harashima N, Yokoyama H, Srinivasan R, Linehan WM, Lerman MI, Childs RW (2016). Detection of an Immunogenic HERV-E Envelope with Selective Expression in Clear Cell Kidney Cancer. Cancer Res  76, 2177-85.   https://doi.org/10.1158/0008-5472.CAN-15-3139|10. Hankins RA, Walton-Diaz A, Truong H, Shih J, Bratslavsky G, Pinto PA, Marston Linehan W, Metwalli AR (2016). Renal functional outcomes after robotic multiplex partial nephrectomy: the National Cancer Institute experience with robotic partial nephrectomy for 3 or more tumors in a single kidney. Int Urol Nephrol  48, 1817-1821.   https://doi.org/10.1007/s11255-016-1392-y|11. Hasumi H, Baba M, Hasumi Y, Lang M, Huang Y, Oh HF, Matsuo M, Merino MJ, Yao M, Ito Y, Furuya M, Iribe Y, Kodama T, Southon E, Tessarollo L, Nagashima K, Haines DC, Linehan WM, Schmidt LS (2015). Folliculin-interacting proteins Fnip1 and Fnip2 play critical roles in kidney tumor suppression in cooperation with Flcn. Proc Natl Acad Sci U S A  112, E1624-31.   https://doi.org/10.1073/pnas.1419502112|12. LS S, WM L (2016) Principles and Management of Familial Renal Cell Carcinoma. BJUI Knowledge, in press.|13. M W, D D, A B, D C, D L, C P, B P, P H, A S, W A, T H, S L, D B, LS S, WM L, G B, M M (2016) The FNIP co-chaperones decelerate the Hsp90 chaperone cycle and enhance drug binding. Nature, in press.|14. Martucci VL, Lorenzo ZG, Weintraub M, del Rivero J, Ling A, Merino M, Siddiqui M, Shuch B, Vourganti S, Linehan WM, Agarwal PK, Pacak K (2015). Association of urinary bladder paragangliomas with germline mutations in the SDHB and VHL genes. Urol Oncol  33, 167.e13-20.   https://doi.org/10.1016/j.urolonc.2014.11.017|15. R E, SK V, D C, CA K, M S, JH P, DC P, A G, TN Y, SJ P, GC G, ZX Y, V C, K O, DS S, WM L, R R, NP R (2016) Ionic immune suppression within the tumour microenvironment limits T cell effector function. Nature, in press.|16. Ricketts CJ, Linehan WM (2015). Gender Specific Mutation Incidence and Survival Associations in Clear Cell Renal Cell Carcinoma (CCRCC). PLoS One  10, e0140257.   https://doi.org/10.1371/journal.pone.0140257|17. S F, WM L (2016) Hypoxia-inducible factor 2a mutation-related paragangliomas classify as discrete pseudohypoxic sub-cluster. Neoplasia, in press.|18. Scelo G, Hofmann JN, Banks RE, Bigot P, Bhatt RS, Cancel-Tassin G, Chew SK, Creighton CJ, Cussenot O, Davis IJ, Escudier B, Frayling TM, Häggström C, Hildebrandt MA, Holcatova I, Johansson M, Linehan WM, McDermott DF, Nathanson KL, Ogawa S, Perlman EJ, Purdue MP, Stattin P, Swanton C, Vasudev NS, et al. [4 more authors] (2016). International cancer seminars: a focus on kidney cancer. Ann Oncol  27, 1382-5.   https://doi.org/10.1093/annonc/mdw186|19. Schmidt LS, Linehan WM (2016). Genetic predisposition to kidney cancer. Semin Oncol  43, 566-574.   https://doi.org/10.1053/j.seminoncol.2016.09.001|20. Sidana A, Kadakia M, Friend JC, Krane LS, Su D, Merino MJ, Srinivasan R (2017). Determinants and prognostic implications of malignant ascites in metastatic papillary renal cancer. Urol Oncol  35, 114.e9-114.e14.   https://doi.org/10.1016/j.urolonc.2016.10.023|21. Sidana A, Walton-Diaz A, Truong H, Siddiqui MM, Miao N, Shih J, Mannes A, Bratslavsky G, Linehan WM, Metwalli AR (2016). Postoperative elevation in creatine kinase and its impact on renal function in patients undergoing complex partial nephrectomy. Int Urol Nephrol  48, 1047-1053.   https://doi.org/10.1007/s11255-016-1284-1|22. Srinivasan R, Ricketts CJ, Sourbier C, Linehan WM (2015). New strategies in renal cell carcinoma: targeting the genetic and metabolic basis of disease. Clin Cancer Res  21, 10-7.   https://doi.org/10.1158/1078-0432.CCR-13-2993",https://intramural.nih.gov/search/searchview.taf?ipid=93965
255,BC011032-09,"October 01, 2015 -  September 30, 2016",Post-translational modifications of Hsp90 that impact drug efficacy,Leonard  Neckers; PhD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",NULL,"Brian  Blagg (Chemistry, University of Kansas)|David  Toft (Cell Biology, Mayo Clinic)|Larry  Karnitz (Mayo Clinic)|Robert  Cotter (Johns Hopkins University)|Neal  Rosen (Medicine, Memorial Sloan Kettering Cancer Center)|Nicolas  Winssinger (University of Strassbourg)|Show all 11",NULL,NULL,"1. Calderwood SK, Neckers L (2016). Hsp90 in Cancer: Transcriptional Roles in the Nucleus. Adv Cancer Res  129, 89-106.   https://doi.org/10.1016/bs.acr.2015.08.002|2. Lu Y, Xu W, Ji J, Feng D, Sourbier C, Yang Y, Qu J, Zeng Z, Wang C, Chang X, Chen Y, Mishra A, Xu M, Lee MJ, Lee S, Trepel J, Linehan WM, Wang X, Yang Y, Neckers L (2015). Alternative splicing of the cell fate determinant Numb in hepatocellular carcinoma. Hepatology  62, 1122-31.   https://doi.org/10.1002/hep.27923|3. Prince TL, Kijima T, Tatokoro M, Lee S, Tsutsumi S, Yim K, Rivas C, Alarcon S, Schwartz H, Khamit-Kush K, Scroggins BT, Beebe K, Trepel JB, Neckers L (2015). Client Proteins and Small Molecule Inhibitors Display Distinct Binding Preferences for Constitutive and Stress-Induced HSP90 Isoforms and Their Conformationally Restricted Mutants. PLoS One  10, e0141786.   https://doi.org/10.1371/journal.pone.0141786|4. Sattin S, Tao J, Vettoretti G, Moroni E, Pennati M, Lopergolo A, Morelli L, Bugatti A, Zuehlke A, Moses M, Prince T, Kijima T, Beebe K, Rusnati M, Neckers L, Zaffaroni N, Agard DA, Bernardi A, Colombo G (2015). Activation of Hsp90 Enzymatic Activity and Conformational Dynamics through Rationally Designed Allosteric Ligands. Chemistry  21, 13598-608.   https://doi.org/10.1002/chem.201502211|5. Schwartz H, Scroggins B, Zuehlke A, Kijima T, Beebe K, Mishra A, Neckers L, Prince T (2015). Combined HSP90 and kinase inhibitor therapy: Insights from The Cancer Genome Atlas. Cell Stress Chaperones  20, 729-41.   https://doi.org/10.1007/s12192-015-0604-1|6. Zuehlke AD, Beebe K, Neckers L, Prince T (2015). Regulation and function of the human HSP90AA1 gene. Gene  570, 8-16.   https://doi.org/10.1016/j.gene.2015.06.018|7. Zuehlke AD, Neckers L (2016). Clients Place Unique Functional Constraints on Hsp90. Trends Biochem Sci  41, 562-564.   https://doi.org/10.1016/j.tibs.2016.05.011",https://intramural.nih.gov/search/searchview.taf?ipid=93983
256,BC011033-09,"October 01, 2015 -  September 30, 2016",Mechanisms of MHC Class II Association with Plasma Membrane Microdomains,Paul A Roche; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Karis  Faust|Sunil  Kaul,Satoshi  Ishido (Riken Center for Allergy and Immunology)|James  Drake (NCI),NULL,NULL,"1. Roche PA, Furuta K (2015). The ins and outs of MHC class II-mediated antigen processing and presentation. Nat Rev Immunol  15, 203-16.   https://doi.org/10.1038/nri3818",https://intramural.nih.gov/search/searchview.taf?ipid=93899
257,BC011035-09,"October 01, 2015 -  September 30, 2016",Regulation of Exocytosis from Immune Cells,Paul A Roche; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Karis  Faust|Sunil  Kaul,NULL,Lino  Tessarollo (Mouse Cancer Genetics Program),Katherine Walton Roche; PhD (NINDS),"1. Kaul S, Mittal SK, Feigenbaum L, Kruhlak MJ, Roche PA (2015). Expression of the SNARE protein SNAP-23 is essential for cell survival. PLoS One  10, e0118311.   https://doi.org/10.1371/journal.pone.0118311|2. Ren B, Azzegagh Z, Jaramillo AM, Zhu Y, Pardo-Saganta A, Bagirzadeh R, Flores JR, Han W, Tang YJ, Tu J, Alanis DM, Evans CM, Guindani M, Roche PA, Rajagopal J, Chen J, Davis CW, Tuvim MJ, Dickey BF (2015). SNAP23 is selectively expressed in airway secretory cells and mediates baseline and stimulated mucin secretion. Biosci Rep  35.   https://doi.org/10.1042/BSR20150004",https://intramural.nih.gov/search/searchview.taf?ipid=93898
258,BC011038-09,"October 01, 2015 -  September 30, 2016",Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Leonard  Neckers; PhD|Donald P Bottaro; PhD,NULL,Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)|Bradford J Wood; MD (Office of the Director),"Emily Y Chew; MD (NEI) |Karel  Pacak; MD, PhD (NICHD) |Pamela  Stratton; MD (NINDS)","1. C R, LS S, WM L (2016) The Genetic Basis of Cancer of the Kidney, in Genetic Diseases of the Kidney, in press.|2. M B, LS S, WM L (2016) Hereditary Renal Cell Carcinoma - Molecular Features and Updates, in Hereditary Renal Cell Carcinoma, in press.|3. Moch H, Bonsib S, Delahunt B, Eble J, Egevad L, Grignon D, Linehan W, Reuter V, Srigley J, Sulser T, Ran P (2016) Clear Cell renal cell carcinoma, in World Health Organization Classification of Tumours. , pp. 18-21.|4. Srinivasan R, Linehan W (2016) Treatment of Advanced Renal Cell Carcinoma, in Campbell-Walsh Urology, 11th ed. , pp. 259-262.|5. 1 Hunt, 2 Wu, 3 Elde, 4 Butm, 5 Chew, 6 Line, 7 Oldf, 8 Lons (2015) Biologic and Clinical Impact of Hemangioblastoma-Associated Peritumoral Cysts in Von Hippel-Lindau Disease. J Neurosurg, in press.|6. Cherkasova E, Scrivani C, Doh S, Weisman Q, Takahashi Y, Harashima N, Yokoyama H, Srinivasan R, Linehan WM, Lerman MI, Childs RW (2016). Detection of an Immunogenic HERV-E Envelope with Selective Expression in Clear Cell Kidney Cancer. Cancer Res  76, 2177-85.   https://doi.org/10.1158/0008-5472.CAN-15-3139|7. LS S, WM L (2016) Principles and Management of Familial Renal Cell Carcinoma. BJUI Knowledge, in press.|8. Martucci VL, Lorenzo ZG, Weintraub M, del Rivero J, Ling A, Merino M, Siddiqui M, Shuch B, Vourganti S, Linehan WM, Agarwal PK, Pacak K (2015). Association of urinary bladder paragangliomas with germline mutations in the SDHB and VHL genes. Urol Oncol  33, 167.e13-20.   https://doi.org/10.1016/j.urolonc.2014.11.017|9. Ricketts CJ, Linehan WM (2015). Gender Specific Mutation Incidence and Survival Associations in Clear Cell Renal Cell Carcinoma (CCRCC). PLoS One  10, e0140257.   https://doi.org/10.1371/journal.pone.0140257|10. Scelo G, Hofmann JN, Banks RE, Bigot P, Bhatt RS, Cancel-Tassin G, Chew SK, Creighton CJ, Cussenot O, Davis IJ, Escudier B, Frayling TM, Häggström C, Hildebrandt MA, Holcatova I, Johansson M, Linehan WM, McDermott DF, Nathanson KL, Ogawa S, Perlman EJ, Purdue MP, Stattin P, Swanton C, Vasudev NS, et al. [4 more authors] (2016). International cancer seminars: a focus on kidney cancer. Ann Oncol  27, 1382-5.   https://doi.org/10.1093/annonc/mdw186|11. Schmidt LS, Linehan WM (2016). Genetic predisposition to kidney cancer. Semin Oncol  43, 566-574.   https://doi.org/10.1053/j.seminoncol.2016.09.001|12. Sidana A, Walton-Diaz A, Truong H, Siddiqui MM, Miao N, Shih J, Mannes A, Bratslavsky G, Linehan WM, Metwalli AR (2016). Postoperative elevation in creatine kinase and its impact on renal function in patients undergoing complex partial nephrectomy. Int Urol Nephrol  48, 1047-1053.   https://doi.org/10.1007/s11255-016-1284-1|13. Srinivasan R, Ricketts CJ, Sourbier C, Linehan WM (2015). New strategies in renal cell carcinoma: targeting the genetic and metabolic basis of disease. Clin Cancer Res  21, 10-7.   https://doi.org/10.1158/1078-0432.CCR-13-2993",https://intramural.nih.gov/search/searchview.taf?ipid=93966
259,BC011043-09,"October 01, 2015 -  September 30, 2016",Molecular Therapeutics of Kidney Cancer:  MET Gene and BHD Gene,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Leonard  Neckers; PhD|Donald P Bottaro; PhD,NULL,Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)|Jonathan  Keller; PhD (Mouse Cancer Genetics Program),NULL,"1. C R, LS S, WM L (2016) The Genetic Basis of Cancer of the Kidney, in Genetic Diseases of the Kidney, in press.|2. M B, LS S, WM L (2016) Hereditary Renal Cell Carcinoma - Molecular Features and Updates, in Hereditary Renal Cell Carcinoma, in press.|3. Moch H, Bonsib S, Delahunt B, Eble J, Egevad L, Grignon D, Linehan W, Reuter V, Srigley J, Sulser T, Ran P (2016) Clear Cell renal cell carcinoma, in World Health Organization Classification of Tumours. , pp. 18-21.|4. Sourbier C, Srinivasan R, Linehan W (2015) Metabolism and oxidative stress response pathways in kidney cancer: a tale of chance and necessity, in ASCO Educational Book. , pp. 220-225.|5. Baba M, Toyama H, Sun L, Takubo K, Suh HC, Hasumi H, Nakamura-Ishizu A, Hasumi Y, Klarmann KD, Nakagata N, Schmidt LS, Linehan WM, Suda T, Keller JR (2016). Loss of Folliculin Disrupts Hematopoietic Stem Cell Quiescence and Homeostasis Resulting in Bone Marrow Failure. Stem Cells  34, 1068-82.   https://doi.org/10.1002/stem.2293|6. Hasumi H, Baba M, Hasumi Y, Lang M, Huang Y, Oh HF, Matsuo M, Merino MJ, Yao M, Ito Y, Furuya M, Iribe Y, Kodama T, Southon E, Tessarollo L, Nagashima K, Haines DC, Linehan WM, Schmidt LS (2015). Folliculin-interacting proteins Fnip1 and Fnip2 play critical roles in kidney tumor suppression in cooperation with Flcn. Proc Natl Acad Sci U S A  112, E1624-31.   https://doi.org/10.1073/pnas.1419502112|7. LS S, WM L (2016) Principles and Management of Familial Renal Cell Carcinoma. BJUI Knowledge, in press.|8. M W, D D, A B, D C, D L, C P, B P, P H, A S, W A, T H, S L, D B, LS S, WM L, G B, M M (2016) The FNIP co-chaperones decelerate the Hsp90 chaperone cycle and enhance drug binding. Nature, in press.|9. Scelo G, Hofmann JN, Banks RE, Bigot P, Bhatt RS, Cancel-Tassin G, Chew SK, Creighton CJ, Cussenot O, Davis IJ, Escudier B, Frayling TM, Häggström C, Hildebrandt MA, Holcatova I, Johansson M, Linehan WM, McDermott DF, Nathanson KL, Ogawa S, Perlman EJ, Purdue MP, Stattin P, Swanton C, Vasudev NS, et al. [4 more authors] (2016). International cancer seminars: a focus on kidney cancer. Ann Oncol  27, 1382-5.   https://doi.org/10.1093/annonc/mdw186|10. Schmidt LS, Linehan WM (2015). Molecular genetics and clinical features of Birt-Hogg-Dubé syndrome. Nat Rev Urol  12, 558-69.   https://doi.org/10.1038/nrurol.2015.206|11. Srinivasan R, Ricketts CJ, Sourbier C, Linehan WM (2015). New strategies in renal cell carcinoma: targeting the genetic and metabolic basis of disease. Clin Cancer Res  21, 10-7.   https://doi.org/10.1158/1078-0432.CCR-13-2993",https://intramural.nih.gov/search/searchview.taf?ipid=93962
260,BC011053-09,"October 01, 2015 -  September 30, 2016",TMPRSS2-ERG chromosomal translocations and prostate cancer,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Aian Neil Seno Alilin|Hong  Pan; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93951
261,BC011054-09,"October 01, 2015 -  September 30, 2016",Nuclear Factor-kappaB in Ovarian Cancer,Christina M Annunziata|IRP Faculty Profile,NULL,"Womens Malignancies Branch, NCI",Anna Maartje Aalbers|Carrie D House|Kristen Parrish Zeligs; MD,NULL,Natasha  Caplen (Cancer Genetics Branch)|George W Wright (Computational & Systems Biology Branch),Craig Joseph Thomas (NCATS),"1. House CD, Hernandez L, Annunziata CM (2015). In vitro enrichment of ovarian cancer tumor-initiating cells. J Vis Exp  .  https://doi.org/10.3791/52446|2. Kim MK, James J, Annunziata CM (2015). Topotecan synergizes with CHEK1 (CHK1) inhibitor to induce apoptosis in ovarian cancer cells. BMC Cancer  15, 196.   https://doi.org/10.1186/s12885-015-1231-z",https://intramural.nih.gov/search/searchview.taf?ipid=93858
262,BC011055-09,"October 01, 2015 -  September 30, 2016",Serum Antibody Profiling with a Carbohydrate Microarray,Jeffrey  Gildersleeve|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Tiffany Rose Bellomo|Sarah Victoria Durbin|Li  Xia,Xuefei  Huang (Michigan State University)|Lynn  Morris (National Institute for Communicable Diseases)|Elizabeth M Jaffee|Julie  Lucas (MRI Global),"Lisa  Mcshane (Biostatistics Branch)|Marjorie  Robert-Guroff; PhD (Vaccine Branch)|Maria Teresa Pia Landi; MD, PhD (Genetic Epidemiology Branch)|James W Hodge; PhD (Laboratory of Tumor Immunology and Biology)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)",NULL,"1. Muthana SM, Gulley JL, Hodge JW, Schlom J, Gildersleeve JC (2015). ABO blood type correlates with survival on prostate cancer vaccine therapy. Oncotarget  6, 32244-56.   https://doi.org/10.18632/oncotarget.4993|2. Muthana SM, Xia L, Campbell CT, Zhang Y, Gildersleeve JC (2015). Competition between serum IgG, IgM, and IgA anti-glycan antibodies. PLoS One  10, e0119298.   https://doi.org/10.1371/journal.pone.0119298|3. Yin Z, Chowdhury S, McKay C, Baniel C, Wright WS, Bentley P, Kaczanowska K, Gildersleeve JC, Finn MG, BenMohamed L, Huang X (2015). Significant Impact of Immunogen Design on the Diversity of Antibodies Generated by Carbohydrate-Based Anticancer Vaccine. ACS Chem Biol  10, 2364-72.   https://doi.org/10.1021/acschembio.5b00406",https://intramural.nih.gov/search/searchview.taf?ipid=93884
263,BC011056-09,"October 01, 2015 -  September 30, 2016",Promoting tumor cell apoptosis by death ligands,Thomas Joseph Sayers; PhD,NULL,"Cancer Inflammation Program, NCI",Alan  Brooks|Poonam  Tewary,"William  Murphy (University of Nevada)|Hideo  Yagita (Immunology, Juntendo University)|Avi  Ashkenazi (Genentech, Inc.)|Robert  Rees (John van Geest Cancer Centre)|Neil  Cross (Sheffield Hallam University)|AA Leslie  Gunatilaka (University of Arizona)",James  McMahon; PhD (Molecular Targets Laboratory)|Kirk R Gustafson; PhD (Molecular Targets Laboratory)|Curtis  Henrich (Molecular Targets Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93902
264,BC011058-09,"October 01, 2015 -  September 30, 2016",Development of a Vaccine for HIV-AIDS: Humoral Immunity,Marjorie  Robert-Guroff; PhD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Thorsten  Demberg|Cameron Laine Fisher|Sabrina  Helmold Hait|Tanya N Hoang|Erin Danielle Huiting; BA|Leia Kaye Miller; PhD|Show all 16,"Susan  Barnett (Chiron Corporation)|Ruth  Ruprecht (Dana Farber Cancer Institute)|Robert  Gallo; MD (Institute of Human Virology, Maryland University)|Timothy  Fouts (Profectus BioSciences, Inc.)|David C Montefiori; PhD (Department of Surgery, NIAID)|Joseph  Mattapallil (Uniformed Services University)|Show all 10",David J Venzon; PhD (Biostatistics and Data Management Section)|Jacob D Estes (Office Of The Director),NULL,"1. 1 Demb, 2 Moha, 3 Musi, 4 Broc, 5 McKi, 6 Venz, 7 Robe (2015) Loss of marginal zone B-cells in SHIV-SF162P4 challenged rhesus macaques despite control of viremia to low or undetectable levels in chronic infection Virology 484:323-333|2. Demberg T, Robert-Guroff M (2015) B-cells and the use of non-human primates for evaluation of HIV vaccine candidates. Current HIV Research 13:462-478|3. Musich T, Demberg T, Morgan IL, Estes JD, Franchini G, Robert-Guroff M (2015). Purification and functional characterization of mucosal IgA from vaccinated and SIV-infected rhesus macaques. Clin Immunol  158, 127-39.   https://doi.org/10.1016/j.clim.2015.03.020|4. Shytaj IL, Nickel G, Arts E, Farrell N, Biffoni M, Pal R, Chung HK, LaBranche C, Montefiori D, Vargas-Inchaustegui D, Robert-Guroff M, Lewis MG, Sacha JB, Palamara AT, Savarino A (2015). Two-Year Follow-Up of Macaques Developing Intermittent Control of the Human Immunodeficiency Virus Homolog Simian Immunodeficiency Virus SIVmac251 in the Chronic Phase of Infection. J Virol  89, 7521-35.   https://doi.org/10.1128/JVI.00396-15|5. Tuero I, Mohanram V, Musich T, Miller L, Vargas-Inchaustegui DA, Demberg T, Venzon D, Kalisz I, Kalyanaraman VS, Pal R, Ferrari MG, LaBranche C, Montefiori DC, Rao M, Vaccari M, Franchini G, Barnett SW, Robert-Guroff M (2015). Mucosal B Cells Are Associated with Delayed SIV Acquisition in Vaccinated Female but Not Male Rhesus Macaques Following SIVmac251 Rectal Challenge. PLoS Pathog  11, e1005101.   https://doi.org/10.1371/journal.ppat.1005101",https://intramural.nih.gov/search/searchview.taf?ipid=93896
265,BC011061-09,"October 01, 2015 -  September 30, 2016",Computational and Experimental RNA Nanobiology,Bruce Allen Shapiro; PhD|IRP Faculty Profile,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",Seth Gregory Abels|Kirill Andreevich Afonin|Nathan Baker Bartlett|Eckart  Bindewald|Jules Matthew Chabot|Catherine Rose Cyril|Show all 18,"Hugo  Martinez (Consultant, SAIC)|Luc  Jaeger (University of California Santa Barbara)|Roderick  Melnik (M2Net Laboratory, Wilfrid Laurier University)|Robert L Jernigan; PhD (NCI)|Hanan  Samet (University of Maryland)|Wah  Chiu|Show all 16",Marina A Dobrovolskaia (Office Cancer Nanotechnology Research)|Eric O Freed; PhD (HIV Drug Resistance Program)|Mikhail V Kashlev (Molecular Mechanisms of Transcription Section)|Joel Patrick Schneider; PhD (Chemical Biology Laboratory)|Vineet Narain KewalRamani; PhD (Basic Research Laboratory)|Stephen J Lockett; PhD (Office Of The Director),NULL,"1. Afonin KA, Bindewald E, Kireeva M, Shapiro BA (2015). Computational and experimental studies of reassociating RNA/DNA hybrids containing split functionalities. Methods Enzymol  553, 313-34.   https://doi.org/10.1016/bs.mie.2014.10.058|2. Afonin KA, Schultz D, Jaeger L, Gwinn E, Shapiro BA (2015). Silver nanoclusters for RNA nanotechnology: steps towards visualization and tracking of RNA nanoparticle assemblies. Methods Mol Biol  1297, 59-66.   https://doi.org/10.1007/978-1-4939-2562-9_4|3. Afonin KA, Viard M, Tedbury P, Bindewald E, Parlea L, Howington M, Valdman M, Johns-Boehme A, Brainerd C, Freed EO, Shapiro BA (2016). The Use of Minimal RNA Toeholds to Trigger the Activation of Multiple Functionalities. Nano Lett  16, 1746-53.   https://doi.org/10.1021/acs.nanolett.5b04676|4. Dao B, Viard M, Martins A, Kasprzak W, Shapiro B, Afonin K (2015) Triggering RNAi with multifunctional RNA nanoparticles and their delivery DNA and RNA Nanotechnology 2:27-38|5. Gupta K, Mattingly SJ, Knipp RJ, Afonin KA, Viard M, Bergman JT, Stepler M, Nantz MH, Puri A, Shapiro BA (2015) Oxime ether lipids containing hydroxylated head groups are more superior siRNA delivery agents than their nonhydroxylated counterparts. Nanomedicine (Lond) 10:2805-18|6. Halman J, Satterwhite E, Smollett J, Bindewald E, Parlea L, Viard M, Zakrevsky P, Kasprzak W, Afonin K, Shapiro B (2016) Triggerable RNA nanodevices RNA and Disease 3:1-4|7. Tannir Z, Afonin K, Shapiro B (2015) RNA and DNA nanoparticles for triggering RNA interference RNA and Disease 1-4|8. Zarkrevsky P, Bindewald E, Shapiro B (2016) RNA Toehold Interactions Initiate Conditional Gene Silencing DNA and RNA Nanotechnology 3:11-13",https://intramural.nih.gov/search/searchview.taf?ipid=93905
266,BC011062-09,"October 01, 2015 -  September 30, 2016",Development of a Vaccine for HIV-AIDS: Cellular Immunity,Marjorie  Robert-Guroff; PhD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Sabrina  Helmold Hait|Tanya N Hoang|Leia Kaye Miller; PhD|Thomas Anthony Musich; PhD|Iskra  Tuero; PhD|Diego Antonio Vargas-Inchaustegui; PhD|Show all 11,Susan  Barnett (Chiron Corporation)|Qingsheng  Li (University of Nebraska Lincoln),David J Venzon; PhD (Biostatistics and Data Management Section)|Tatiana  Karpova (Laboratory of Receptor Biology and Gene Expression),NULL,"1. 1 Moni, 2 Liya, 3 Dost, 4 Park, 5 Grub, 6 Lipi, 7 McKi, 8 Brow, 9 Hirs, 10 Vacc, 11 Gord, 12 Pegu, 13 Feni, 14 Flis, 15 Grze, 16 Dabr, 17 Robe, 18 Silv, 19 Stev, 20 McCu, 21 Fran (2015) Glucocorticoid Treatment at Moderate Doses of SIVmac251-Infected Rhesus Macaques Decreases the Frequency of Circulating CD14(+)CD16(++) Monocytes But Does Not Alter the Tissue Virus Reservoir AIDS Res Hum Retroviruses 31:115-126|2. Musich T, Robert-Guroff M (2016). New developments in an old strategy: heterologous vector primes and envelope protein boosts in HIV vaccine design. Expert Rev Vaccines  15, 1015-27.   https://doi.org/10.1586/14760584.2016.1158108|3. Tuero I, Mohanram V, Musich T, Miller L, VargasInchaustegui D, Demberg T, Venzon D, Kalisz I, Kalyanaraman V, Pal R, Ferrari M, LaBranche C, Montefiori D, Rao M, Vaccari M, Franchini G, Barnett S, Robert-Guroff M (2015) Mucosal B cells are associated with delayed SIV acquisition in vaccinated female but not male rhesus macaques following SIVmac251 rectal challenge. PLoS Pathogens 11:e1005010|4. Vargas-Inchaustegui DA, Demers A, Shaw JM, Kang G, Ball D, Tuero I, Musich T, Mohanram V, Demberg T, Karpova TS, Li Q, Robert-Guroff M (2016). Vaccine Induction of Lymph Node-Resident Simian Immunodeficiency Virus Env-Specific T Follicular Helper Cells in Rhesus Macaques. J Immunol  196, 1700-10.   https://doi.org/10.4049/jimmunol.1502137|5. Vargas-Inchaustegui DA, Xiao P, Demberg T, Pal R, Robert-Guroff M (2015). Therapeutic envelope vaccination in combination with antiretroviral therapy temporarily rescues SIV-specific CD4⁺ T-cell-dependent natural killer cell effector responses in chronically infected rhesus macaques. Immunology  145, 288-99.   https://doi.org/10.1111/imm.12447",https://intramural.nih.gov/search/searchview.taf?ipid=93897
267,BC011063-09,"October 01, 2015 -  September 30, 2016",Development of a Vaccine for HIV-AIDS: Translation to the Clinic,Marjorie  Robert-Guroff; PhD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Thorsten  Demberg|Sabrina  Helmold Hait|Tanya N Hoang|Erin Danielle Huiting; BA|Leia Kaye Miller; PhD|Thomas Anthony Musich; PhD|Show all 9,NULL,Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Brandon Frank Keele (Office Of The Director),Mark  Connors; MD (NIAID),"1. Thomas M, Nyanhete T, Tuero I, Venzon D, Robert-Guroff M (2016) Beyond Oncolytics: E1B55K-deleted aenovirus as a vaccine delivery vector PLoS One 11:e0158505",https://intramural.nih.gov/search/searchview.taf?ipid=93895
268,BC011064-09,"October 01, 2015 -  September 30, 2016",A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1,Beverly  Mock; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Ke  Zhang|Shuling  Zhang; MD, PhD",NULL,NULL,Rafael Cristian Casellas; PhD (NIAMS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93980
269,BC011065-09,"October 01, 2015 -  September 30, 2016","Preclinical Testing of HDAC, mTOR and MYC Inhibitors",Beverly  Mock; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Snehal Mahendra Gaikwad|Elena Christina Leon|John K Simmons|Nicholas Jeremy Watson|Ke  Zhang|Shuling  Zhang; MD, PhD|Show all 7",NULL,Ola Anders Landgren (Lymphoid Malignancies Branch)|John Stephen Schneekloth (Chemical Biology Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93981
270,BC011070-09,"October 01, 2015 -  September 30, 2016",Hematopathology Diagnosis,Elaine S Jaffe; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Tapan Mahendra Bhavsar|Theresa M Davies Hill|Nancy Ellen Diener|Michael Edward Kallen|Froilan Tolentino Orille|Maryknoll Mawanay Palisoc|Show all 14,NULL,"Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Thomas S Uldrick (HIV and AIDS Malignancy Branch)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Kieron Michael Dunleavy (Lymphoid Malignancies Branch)",Jeffrey  Cohen; MD (NIAID),"1. Bates SE, Eisch R, Ling A, Rosing D, Turner M, Pittaluga S, Prince HM, Kirschbaum MH, Allen SL, Zain J, Geskin LJ, Joske D, Popplewell L, Cowen EW, Jaffe ES, Nichols J, Kennedy S, Steinberg SM, Liewehr DJ, Showe LC, Steakley C, Wright J, Fojo T, Litman T, Piekarz RL (2015). Romidepsin in peripheral and cutaneous T-cell lymphoma: mechanistic implications from clinical and correlative data. Br J Haematol  170, 96-109.   https://doi.org/10.1111/bjh.13400|2. Brown RJ, Chan JL, Jaffe ES, Cochran E, DePaoli AM, Gautier JF, Goujard C, Vigouroux C, Gorden P (2016). Lymphoma in acquired generalized lipodystrophy. Leuk Lymphoma  57, 45-50.   https://doi.org/10.3109/10428194.2015.1040015|3. Cohen JI, Niemela JE, Stoddard JL, Pittaluga S, Heslop H, Jaffe ES, Dowdell K (2015). Late-onset severe chronic active EBV in a patient for five years with mutations in STXBP2 (MUNC18-2) and PRF1 (perforin 1). J Clin Immunol  35, 445-8.   https://doi.org/10.1007/s10875-015-0168-y|4. Ganapathi KA, Jobanputra V, Iwamoto F, Jain P, Chen J, Cascione L, Nahum O, Levy B, Xie Y, Khattar P, Hoehn D, Bertoni F, Murty VV, Pittaluga S, Jaffe ES, Alobeid B, Mansukhani MM, Bhagat G (2016). The genetic landscape of dural marginal zone lymphomas. Oncotarget  7, 43052-43061.   https://doi.org/10.18632/oncotarget.9678|5. Gong S, Auer I, Duggal R, Pittaluga S, Raffeld M, Jaffe ES (2015). Epstein-Barr virus-associated inflammatory pseudotumor presenting as a colonic mass. Hum Pathol  46, 1956-61.   https://doi.org/10.1016/j.humpath.2015.08.011|6. Jain S, Chen J, Nicolae A, Wang H, Shin DM, Adkins EB, Sproule TJ, Leeth CM, Sakai T, Kovalchuk AL, Raffeld M, Ward JM, Rehg JE, Waldmann TA, Jaffe ES, Roopenian DC, Morse HC (2015). IL-21-driven neoplasms in SJL mice mimic some key features of human angioimmunoblastic T-cell lymphoma. Am J Pathol  185, 3102-14.   https://doi.org/10.1016/j.ajpath.2015.07.021|7. Kanemitsu M, John D, Lim A, Jaffe ES, Aoki J (2015). Clonal Epstein-Barr virus-positive mucocutaneous ulcer mimicking a mature B-cell lymphoma in a patient with mycophenolate-induced immune suppression. Leuk Lymphoma  56, 1908-10.   https://doi.org/10.3109/10428194.2014.982646|8. Kendrick S, Tus K, Wright G, Jaffe ES, Rosenwald A, Campo E, Chan WC, Connors JM, Braziel RM, Ott G, Delabie J, Cook JR, Weisenburger DD, Greiner TC, Fu K, Staudt LM, Gascoyne RD, Scott DW, Rimsza LM (2016). Diffuse large B-cell lymphoma cell-of-origin classification using the Lymph2Cx assay in the context of BCL2 and MYC expression status. Leuk Lymphoma  57, 717-20.   https://doi.org/10.3109/10428194.2015.1072767|9. King RL, Dao LN, McPhail ED, Jaffe ES, Said J, Swerdlow SH, Sattler CA, Ketterling RP, Sidhu JS, Hsi ED, Karikehalli S, Jiang L, Gibson SE, Ondrejka SL, Nicolae A, Macon WR, Dasari S, Parrilla Castellar E, Feldman AL (2016). Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements. Am J Surg Pathol  40, 36-43.   https://doi.org/10.1097/PAS.0000000000000500|10. Laurent C, Fabiani B, Do C, Tchernonog E, Cartron G, Gravelle P, Amara N, Malot S, Palisoc MM, Copie-Bergman C, Glehen AT, Copin MC, Brousset P, Pittaluga S, Jaffe ES, Coppo P (2016). Immune-checkpoint expression in Epstein-Barr virus positive and negative plasmablastic lymphoma: a clinical and pathological study in 82 patients. Haematologica  101, 976-84.   https://doi.org/10.3324/haematol.2016.141978|11. Lee YS, Filie A, Arthur D, Fojo AT, Jaffe ES (2015). Breast implant-associated anaplastic large cell lymphoma in a patient with Li-Fraumeni syndrome. Histopathology  67, 925-7.   https://doi.org/10.1111/his.12737|12. Marx A, Chan JK, Coindre JM, Detterbeck F, Girard N, Harris NL, Jaffe ES, Kurrer MO, Marom EM, Moreira AL, Mukai K, Orazi A, Ströbel P (2015). The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes. J Thorac Oncol  10, 1383-95.   https://doi.org/10.1097/JTO.0000000000000654|13. Menon MP, Nicolae A, Meeker H, Raffeld M, Xi L, Jegalian AG, Miller DC, Pittaluga S, Jaffe ES (2015). Primary CNS T-cell Lymphomas: A Clinical, Morphologic, Immunophenotypic, and Molecular Analysis. Am J Surg Pathol  39, 1719-1729.   https://doi.org/10.1097/PAS.0000000000000503|14. Nicolae A, Pittaluga S, Abdullah S, Steinberg SM, Pham TA, Davies-Hill T, Xi L, Raffeld M, Jaffe ES (2015). EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment. Blood  126, 863-72.   https://doi.org/10.1182/blood-2015-02-630632|15. Roschewski M, Dunleavy K, Pittaluga S, Moorhead M, Pepin F, Kong K, Shovlin M, Jaffe ES, Staudt LM, Lai C, Steinberg SM, Chen CC, Zheng J, Willis TD, Faham M, Wilson WH (2015). Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study. Lancet Oncol  16, 541-9.   https://doi.org/10.1016/S1470-2045(15)70106-3|16. Xiao W, Chen WW, Sorbara L, Davies-Hill T, Pittaluga S, Raffeld M, Jaffe ES (2016). Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion. Hum Pathol  55, 108-116.   https://doi.org/10.1016/j.humpath.2016.04.019|17. Xie Y, Pittaluga S, Jaffe ES (2015). The histological classification of diffuse large B-cell lymphomas. Semin Hematol  52, 57-66.   https://doi.org/10.1053/j.seminhematol.2015.01.006",https://intramural.nih.gov/search/searchview.taf?ipid=93948
271,BC011076-09,"October 01, 2015 -  September 30, 2016",Roles of NADPH Oxidase 5 and Dual Oxidase 2 in Cancer,James Halpern Doroshow|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI","Smitha  Antony|Guojian  Jiang; MD|Jiamo  Lu; MD, MPH, MHS|Jennifer Lynn Meitzler|Yongzhong  Wu",NULL,NULL,NULL,"1. Hayes P, Dhillon S, O'Neill K, Thoeni C, Hui KY, Elkadri A, Guo CH, Kovacic L, Aviello G, Alvarez LA, Griffiths AM, Snapper SB, Brant SR, Doroshow JH, Silverberg MS, Peter I, McGovern DP, Cho J, Brumell JH, Uhlig HH, Bourke B, Muise AA, Knaus UG (2015). Defects in NADPH Oxidase Genes NOX1 and DUOX2 in Very Early Onset Inflammatory Bowel Disease. Cell Mol Gastroenterol Hepatol  1, 489-502.   https://doi.org/10.1016/j.jcmgh.2015.06.005",https://intramural.nih.gov/search/searchview.taf?ipid=93874
272,BC011078-09,"October 01, 2015 -  September 30, 2016",Phase 0-1 Clinical Trials,James Halpern Doroshow|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Agnes  Juhasz|Robert S Meehan|William M Bonner; PhD|Yves  Pommier; PhD,Edward  Newman (City of Hope Comprehensive Cancer Center)|Shivaani  Kummar (Stanford University School of Medicine),Ralph  Parchment (Office of the Director)|Peter L Choyke; MD (Molecular Imaging Program),NULL,"1. Do K, Doroshow J, Kummar S, Pommier Y (2015) Topoisomerase-Interacting Agents, in Cancer: Principles and Practice of Oncology. , pp. 218-227.|2. Doroshow J (2016) Approach to the patient with cancer, in Cecil-Goldman Textbook of Medicine. , pp. 1206-1222.|3. Doroshow J (2016) Malignant tumors of bone, sarcomas, and other soft tissue neoplasms, in Cecil-Goldman Textbook of Medicine. , pp. 1370-1373.|4. Kummar S, Doroshow J (2015) Phase 0 Clinical Trials, in Phase 1 Cancer Clinical Trials--A Practical Guide. , pp. 44-56.|5. Do K, Cao L, Kang Z, Turkbey B, Lindenberg ML, Larkins E, Holkova B, Steinberg SM, Raffeld M, Peer CJ, Figg WD, Eugeni M, Jacobs P, Choyke P, Wright JJ, Doroshow JH, Kummar S (2015). A Phase II Study of Sorafenib Combined With Cetuximab in EGFR-Expressing, KRAS-Mutated Metastatic Colorectal Cancer. Clin Colorectal Cancer  14, 154-61.   https://doi.org/10.1016/j.clcc.2015.02.007|6. Do K, Wilsker D, Ji J, Zlott J, Freshwater T, Kinders RJ, Collins J, Chen AP, Doroshow JH, Kummar S (2015). Phase I Study of Single-Agent AZD1775 (MK-1775), a Wee1 Kinase Inhibitor, in Patients With Refractory Solid Tumors. J Clin Oncol  33, 3409-15.   https://doi.org/10.1200/JCO.2014.60.4009|7. FerryGalow K, Makhlouf H, Wilsker D, Lawrence S, Pfister T, Marrero A, Bigelow K, Yutzy W, Ji J, Butcher D, Gouker B, Kummar S, Chen A, Kinders R, Parchment R, Doroshow J (2016) The root causes of pharmacodynamic assay failure. Sem Oncol, in press.|8. Holleran JL, Beumer JH, McCormick DL, Johnson WD, Newman EM, Doroshow JH, Kummar S, Covey JM, Davis M, Eiseman JL (2015). Oral and intravenous pharmacokinetics of 5-fluoro-2'-deoxycytidine and THU in cynomolgus monkeys and humans. Cancer Chemother Pharmacol  76, 803-11.   https://doi.org/10.1007/s00280-015-2857-x|9. Kummar S, Do K, O'SullivanCoyne G, Chen A, Ji J, Rubenstein L, Doroshow J (2016) Establishing proof of mechanism: assessing target modulation in early-phase clinical trials. Sem Oncol, in press.|10. Kummar S, Oza AM, Fleming GF, Sullivan DM, Gandara DR, Naughton MJ, Villalona-Calero MA, Morgan RJ, Szabo PM, Youn A, Chen AP, Ji J, Allen DE, Lih CJ, Mehaffey MG, Walsh WD, McGregor PM, Steinberg SM, Williams PM, Kinders RJ, Conley BA, Simon RM, Doroshow JH (2015). Randomized Trial of Oral Cyclophosphamide and Veliparib in High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers, or BRCA-Mutant Ovarian Cancer. Clin Cancer Res  21, 1574-82.   https://doi.org/10.1158/1078-0432.CCR-14-2565|11. Kummar S, Williams PM, Lih CJ, Polley EC, Chen AP, Rubinstein LV, Zhao Y, Simon RM, Conley BA, Doroshow JH (2015) Application of molecular profiling in clinical trials for advanced metastatic cancers. J Natl Cancer Inst 107:|12. Morgan RJ, Synold TW, Longmate JA, Quinn DI, Gandara D, Lenz HJ, Ruel C, Xi B, Lewis MD, Colevas AD, Doroshow J, Newman EM (2015). Pharmacodynamics (PD) and pharmacokinetics (PK) of E7389 (eribulin, halichondrin B analog) during a phase I trial in patients with advanced solid tumors: a California Cancer Consortium trial. Cancer Chemother Pharmacol  76, 897-907.   https://doi.org/10.1007/s00280-015-2868-7|13. Newman EM, Morgan RJ, Kummar S, Beumer JH, Blanchard MS, Ruel C, El-Khoueiry AB, Carroll MI, Hou JM, Li C, Lenz HJ, Eiseman JL, Doroshow JH (2015). A phase I, pharmacokinetic, and pharmacodynamic evaluation of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine, administered with tetrahydrouridine. Cancer Chemother Pharmacol  75, 537-46.   https://doi.org/10.1007/s00280-014-2674-7|14. Nguyen D, Rubinstein L, Takebe N, Miele L, Tomaszewski JE, Ivy P, Doroshow JH, Yang SX (2015). Notch1 phenotype and clinical stage progression in non-small cell lung cancer. J Hematol Oncol  8, 9.   https://doi.org/10.1186/s13045-014-0104-2|15. Parchment R, Doroshow J (2016) Pharmacodynamic endpoints as clinical trial objectives to answer important questions in oncology drug development. Sem Oncol, in press.|16. Parchment R, Doroshow J (2016) Theory and practice of clinical pharmacodynamics. Sem Oncol, in press.|17. Parchment R, Voth A, Doroshow J, Berzofsky J (2016) Immuno-pharmacodynamics for evaluating mechanism of action and developing immunotherapy combinations. Sem Oncol, in press.|18. Parchment RE, Doroshow JH (2016). Pharmacodynamic endpoints as clinical trial objectives to answer important questions in oncology drug development. Semin Oncol  43, 514-25.   https://doi.org/10.1053/j.seminoncol.2016.07.002|19. Zhao Y, Polley EC, Li MC, Lih CJ, Palmisano A, Sims DJ, Rubinstein LV, Conley BA, Chen AP, Williams PM, Kummar S, Doroshow JH, Simon RM (2015). GeneMed: An Informatics Hub for the Coordination of Next-Generation Sequencing Studies that Support Precision Oncology Clinical Trials. Cancer Inform  14, 45-55.   https://doi.org/10.4137/CIN.S17282",https://intramural.nih.gov/search/searchview.taf?ipid=93875
273,BC011081-09,"October 01, 2015 -  September 30, 2016",Prostate Section,Peter A Pinto; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Donald P Bottaro; PhD|Leonard  Neckers; PhD,NULL,Peter L Choyke; MD (Molecular Imaging Program)|Bradford J Wood; MD (Office of the Director)|Maria  Merino; PhD (Laboratory of Pathology)|Stefan  Ambs (Laboratory of Human Carcinogenesis)|Aradhana  Kaushal (Radiation Oncology Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93988
274,BC011084-09,"October 01, 2015 -  September 30, 2016",Cellular functions of Ran GTPase,Petr  Kalab; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93949
275,BC011090-09,"October 01, 2015 -  September 30, 2016",Molecular biology of human polyomaviruses,Christopher  Buck|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Eileen Michelle Geoghegan|Diana  Pastrana|Alberto  Peretti; PhD|Michael Joseph Tisza|Nicole Lynne Welch,John  Doorbar (National Institute for Medical Research)|Thilo  Stehle (International Max Planck Research School)|Jianxin  You (U Penn)|Ellen  Cahir-McFarland (Biogen)|Paola  Cinque (San Raffaele Milan),NULL,Alison Anne McBride; PhD (NIAID) |Pawel J Muranski (NHLBI),"1. Buck CB (2016). Exposing the Molecular Machinery of BK Polyomavirus. Structure  24, 495.   https://doi.org/10.1016/j.str.2016.03.011|2. Ho J, Jedrych JJ, Feng H, Natalie AA, Grandinetti L, Mirvish E, Crespo MM, Yadav D, Fasanella KE, Proksell S, Kuan SF, Pastrana DV, Buck CB, Shuda Y, Moore PS, Chang Y (2015). Human polyomavirus 7-associated pruritic rash and viremia in transplant recipients. J Infect Dis  211, 1560-5.   https://doi.org/10.1093/infdis/jiu524|3. Ray U, Cinque P, Gerevini S, Longo V, Lazzarin A, Schippling S, Martin R, Buck CB, Pastrana DV (2015). JC polyomavirus mutants escape antibody-mediated neutralization. Sci Transl Med  7, 306ra151.   https://doi.org/10.1126/scitranslmed.aab1720|4. Siebrasse EA, Pastrana DV, Nguyen NL, Wang A, Roth MJ, Holland SM, Freeman AF, McDyer J, Buck CB, Wang D (2015). WU polyomavirus in respiratory epithelial cells from lung transplant patient with Job syndrome. Emerg Infect Dis  21, 103-6.   https://doi.org/10.3201/eid2101.140855",https://intramural.nih.gov/search/searchview.taf?ipid=93865
276,BC011091-09,"October 01, 2015 -  September 30, 2016",Cancer Genomics Technology Development,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Sean Richard Davis; MD, PhD|Arthur A Glatfelter; MS|Heiko  Horn; PhD|Yuan  Jiang; MD|John E Lueders|Joshua James Waterfall|Show all 13",NULL,Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|Sharon Ann Savage (Clinical Genetics Branch)|Xin Wei Wang; PhD (Molecular Genetics and Carcinogenesis Section)|James Halpern Doroshow (Developmental Therapeutics Branch)|Katherine Elizabeth Warren; MD (Pediatric Oncology Branch),Leslie Glenn Biesecker; MD (NHGRI),"1. Arons E, Zhou H, Edelman DC, Gomez A, Steinberg SM, Petersen D, Wang Y, Meltzer PS, Kreitman RJ (2015). Impact of telomere length on survival in classic and variant hairy cell leukemia. Leuk Res  39, 1360-6.   https://doi.org/10.1016/j.leukres.2015.09.015|2. Figueroa JD, Yang H, Garcia-Closas M, Davis S, Meltzer P, Lissowska J, Horne HN, Sherman ME, Lee M (2015). Integrated analysis of DNA methylation, immunohistochemistry and mRNA expression, data identifies a methylation expression index (MEI) robustly associated with survival of ER-positive breast cancer patients. Breast Cancer Res Treat  150, 457-466.   https://doi.org/10.1007/s10549-015-3314-6|3. Gara SK, Wang Y, Patel D, Liu-Chittenden Y, Jain M, Boufraqech M, Zhang L, Meltzer PS, Kebebew E (2015). Integrated genome-wide analysis of genomic changes and gene regulation in human adrenocortical tissue samples. Nucleic Acids Res  43, 9327-39.   https://doi.org/10.1093/nar/gkv908|4. Grøntved L, Waterfall JJ, Kim DW, Baek S, Sung MH, Zhao L, Park JW, Nielsen R, Walker RL, Zhu YJ, Meltzer PS, Hager GL, Cheng SY (2015). Transcriptional activation by the thyroid hormone receptor through ligand-dependent receptor recruitment and chromatin remodelling. Nat Commun  6, 7048.   https://doi.org/10.1038/ncomms8048|5. Lopez-Chavez A, Thomas A, Rajan A, Raffeld M, Morrow B, Kelly R, Carter CA, Guha U, Killian K, Lau CC, Abdullaev Z, Xi L, Pack S, Meltzer PS, Corless CL, Sandler A, Beadling C, Warrick A, Liewehr DJ, Steinberg SM, Berman A, Doyle A, Szabo E, Wang Y, Giaccone G (2015). Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial. J Clin Oncol  33, 1000-7.   https://doi.org/10.1200/JCO.2014.58.2007|6. Neychev V, Steinberg SM, Cottle-Delisle C, Merkel R, Nilubol N, Yao J, Meltzer P, Pacak K, Marx S, Kebebew E (2015). Mutation-targeted therapy with sunitinib or everolimus in patients with advanced low-grade or intermediate-grade neuroendocrine tumours of the gastrointestinal tract and pancreas with or without cytoreductive surgery: protocol for a phase II clinical trial. BMJ Open  5, e008248.   https://doi.org/10.1136/bmjopen-2015-008248|7. Saxena N, Maio N, Crooks DR, Ricketts CJ, Yang Y, Wei MH, Fan TW, Lane AN, Sourbier C, Singh A, Killian JK, Meltzer PS, Vocke CD, Rouault TA, Linehan WM (2016). SDHB-Deficient Cancers: The Role of Mutations That  Impair Iron Sulfur Cluster Delivery. J Natl Cancer Inst  108.   https://doi.org/10.1093/jnci/djv287|8. Shakhova O, Cheng P, Mishra PJ, Zingg D, Schaefer SM, Debbache J, Häusel J, Matter C, Guo T, Davis S, Meltzer P, Mihic-Probst D, Moch H, Wegner M, Merlino G, Levesque MP, Dummer R, Santoro R, Cinelli P, Sommer L (2015). Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma. PLoS Genet  11, e1004877.   https://doi.org/10.1371/journal.pgen.1004877|9. Sun W, Chatterjee B, Wang Y, Stevenson HS, Edelman DC, Meltzer PS, Barr FG (2015). Distinct methylation profiles characterize fusion-positive and fusion-negative rhabdomyosarcoma. Mod Pathol  28, 1214-24.   https://doi.org/10.1038/modpathol.2015.82|10. Thomas A, Rajan A, Berman A, Tomita Y, Brzezniak C, Lee MJ, Lee S, Ling A, Spittler AJ, Carter CA, Guha U, Wang Y, Szabo E, Meltzer P, Steinberg SM, Trepel JB, Loehrer PJ, Giaccone G (2015). Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial. Lancet Oncol  16, 177-86.   https://doi.org/10.1016/S1470-2045(14)71181-7|11. Torabi K, Miró R, Fernández-Jiménez N, Quintanilla I, Ramos L, Prat E, del Rey J, Pujol N, Killian JK, Meltzer PS, Fernández PL, Ried T, Lozano JJ, Camps J, Ponsa I (2015). Patterns of somatic uniparental disomy identify novel tumor suppressor genes in colorectal cancer. Carcinogenesis  36, 1103-10.   https://doi.org/10.1093/carcin/bgv115|12. Yang XR, Killian JK, Hammond S, Burke LS, Bennett H, Wang Y, Davis SR, Strong LC, Neglia J, Stovall M, Weathers RE, Robison LL, Bhatia S, Mabuchi K, Inskip PD, Meltzer P (2015). Characterization of genomic alterations in radiation-associated breast cancer among childhood cancer survivors, using comparative genomic hybridization (CGH) arrays. PLoS One  10, e0116078.   https://doi.org/10.1371/journal.pone.0116078",https://intramural.nih.gov/search/searchview.taf?ipid=93975
277,BC011095-09,"October 01, 2015 -  September 30, 2016",Hypoxia and Tyrosine Kinase Signaling Integration in Urologic Cancers,Donald P Bottaro; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI","Dinuka Mihirani de Silva; PhD|Young Hwan Lee|Mitchell Kai-Sern Ng|Cara Elizabeth Wright|Ramaprasad  Srinivasan; MD, PhD|Leonard  Neckers; PhD|Show all 7",Ching-Shih  Chen (The Ohio State University)|Paul  Dent (Virginia Commonwealth University)|Jean-Baptiste  Lattouf|Brian M Shuch,"Tawnya Carlene McKee; BA, PhD (Diagnostic Biomarkers and Technology Branch)",NULL,"1. Xie Z, Lee YH, Boeke M, Jilaveanu LB, Liu Z, Bottaro DP, Kluger HM, Shuch B (2016). MET Inhibition in Clear Cell Renal Cell Carcinoma. J Cancer  7, 1205-14.   https://doi.org/10.7150/jca.14604",https://intramural.nih.gov/search/searchview.taf?ipid=93862
278,BC011105-09,"October 01, 2015 -  September 30, 2016",Study of HIV Protease Dimerization (PD) and Identification of PD Inhibitors,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI",Hiromi  Aoki|Manabu  Aoki; PhD|Haydar  Bulut; PhD|Simon  Chang|Debananda  Das; PhD|Ravikiran S Yedidi|Show all 8,"Arun  Ghosh|Masayuki  Amano (Kumamoto University School of Medicine)|Irene  Weber (Department of Biology, Georgia State University)|Hiroanori  Hayashi (Kumamoto University School of Medicine)",NULL,NULL,"1. Amano M, Tojo Y, Salcedo-Gómez PM, Parham GL, Nyalapatla PR, Das D, Ghosh AK, Mitsuya H (2015). A novel tricyclic ligand-containing nonpeptidic HIV-1 protease inhibitor, GRL-0739, effectively inhibits the replication of multidrug-resistant HIV-1 variants and has a desirable central nervous system penetration property in vitro. Antimicrob Agents Chemother  59, 2625-35.   https://doi.org/10.1128/AAC.04757-14|2. Ghosh AK, Martyr CD, Kassekert LA, Nyalapatla PR, Steffey M, Agniswamy J, Wang YF, Weber IT, Amano M, Mitsuya H (2015) Design, synthesis, biological evaluation and X-ray structural studies of HIV-1 protease inhibitors containing substituted fused-tetrahydropyranyl tetrahydrofuran as P2-ligands. Org Biomol Chem 13:11607-21|3. Ghosh AK, Martyr CD, Osswald HL, Sheri VR, Kassekert LA, Chen S, Agniswamy J, Wang YF, Hayashi H, Aoki M, Weber IT, Mitsuya H (2015). Design of HIV-1 Protease Inhibitors with Amino-bis-tetrahydrofuran Derivatives as P2-Ligands to Enhance Backbone-Binding Interactions: Synthesis, Biological Evaluation, and Protein-Ligand X-ray Studies. J Med Chem  58, 6994-7006.   https://doi.org/10.1021/acs.jmedchem.5b00900|4. Ghosh AK, Takayama J, Kassekert LA, Ella-Menye JR, Yashchuk S, Agniswamy J, Wang YF, Aoki M, Amano M, Weber IT, Mitsuya H (2015). Structure-based design, synthesis, X-ray studies, and biological evaluation of novel HIV-1 protease inhibitors containing isophthalamide-derived P2-ligands. Bioorg Med Chem Lett  25, 4903-4909.   https://doi.org/10.1016/j.bmcl.2015.05.052|5. Ghosh AK, Yashchuk S, Mizuno A, Chakraborty N, Agniswamy J, Wang YF, Aoki M, Gomez PM, Amano M, Weber IT, Mitsuya H (2015). Design of gem-difluoro-bis-tetrahydrofuran as P2 ligand for HIV-1 protease inhibitors to improve brain penetration: synthesis, X-ray studies, and biological evaluation. ChemMedChem  10, 107-15.   https://doi.org/10.1002/cmdc.201402358|6. Ghosh AK, Yu X, Osswald HL, Agniswamy J, Wang YF, Amano M, Weber IT, Mitsuya H (2015). Structure-based design of potent HIV-1 protease inhibitors with modified P1-biphenyl ligands: synthesis, biological evaluation, and enzyme-inhibitor X-ray structural studies. J Med Chem  58, 5334-43.   https://doi.org/10.1021/acs.jmedchem.5b00676",https://intramural.nih.gov/search/searchview.taf?ipid=93978
279,BC011106-09,"October 01, 2015 -  September 30, 2016",Specification of T cell function during development,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",NULL,"Batu M Erman|Wilfried  Ellmeier (Immunology, University of Vienna)|Sophia D Sarafova (NCI)","Remy J Bosselut; MD, PhD (Laboratory of Immune Cell Biology)","Paul E Love; MD, PhD (NICHD)","1. Kimura M, Thomas J, Tai X, Guinter T, Shinzawa M, Etzensperger R, Li Z, Love P, Nakayama T, Singer A (2016) Timing and duration of MHC-I positive selection signals in the thymus reveal a novel compensatory signaling mechanism that prevents lineage fate errors. Nature Immunology, in press.|2. Pobezinsky LA, Etzensperger R, Jeurling S, Alag A, Kadakia T, McCaughtry TM, Kimura MY, Sharrow SO, Guinter TI, Feigenbaum L, Singer A (2015). Let-7 microRNAs target the lineage-specific transcription factor PLZF to regulate terminal NKT cell differentiation and effector function. Nat Immunol  16, 517-24.   https://doi.org/10.1038/ni.3146|3. Takada K, Van Laethem F, Xing Y, Akane K, Suzuki H, Murata S, Tanaka K, Jameson SC, Singer A, Takahama Y (2015). TCR affinity for thymoproteasome-dependent positively selecting peptides conditions antigen responsiveness in CD8(+) T cells. Nat Immunol  16, 1069-76.   https://doi.org/10.1038/ni.3237",https://intramural.nih.gov/search/searchview.taf?ipid=93913
280,BC011107-09,"October 01, 2015 -  September 30, 2016",Role of Protein Scaffolds in RTK-Ras-dependent Signal Transduction,Deborah K Morrison|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Christopher John Westlake; PhD,Rueben  Shaw (Salk Institute)|Robert  Rottapel (University of Toronto),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93982
281,BC011109-09,"October 01, 2015 -  September 30, 2016",Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI",Simon  Chang|Debananda  Das; PhD|Kenji  Maeda,NULL,NULL,NULL,"1. Das D, Maeda K, Hayashi Y, Gavande N, Desai DV, Chang SB, Ghosh AK, Mitsuya H (2015). Insights into the mechanism of inhibition of CXCR4: identification of Piperidinylethanamine analogs as anti-HIV-1 inhibitors. Antimicrob Agents Chemother  59, 1895-904.   https://doi.org/10.1128/AAC.04654-14",https://intramural.nih.gov/search/searchview.taf?ipid=93979
282,BC011111-09,"October 01, 2015 -  September 30, 2016",Cytokine signaling in developing thymocytes and T cells,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Jung-Hyun  Park,NULL,NULL,NULL,"1. Kimura M, Thomas J, Tai X, Guinter T, Shinzawa M, Etzensperger R, Li Z, Love P, Nakayama T, Singer A (2016) Timing and duration of MHC-I positive selection signals in the thymus reveal a novel compensatory signaling mechanism that prevents lineage fate errors. Nature Immunology, in press.|2. Pobezinsky LA, Etzensperger R, Jeurling S, Alag A, Kadakia T, McCaughtry TM, Kimura MY, Sharrow SO, Guinter TI, Feigenbaum L, Singer A (2015). Let-7 microRNAs target the lineage-specific transcription factor PLZF to regulate terminal NKT cell differentiation and effector function. Nat Immunol  16, 517-24.   https://doi.org/10.1038/ni.3146|3. Takada K, Van Laethem F, Xing Y, Akane K, Suzuki H, Murata S, Tanaka K, Jameson SC, Singer A, Takahama Y (2015). TCR affinity for thymoproteasome-dependent positively selecting peptides conditions antigen responsiveness in CD8(+) T cells. Nat Immunol  16, 1069-76.   https://doi.org/10.1038/ni.3237",https://intramural.nih.gov/search/searchview.taf?ipid=93914
283,BC011112-09,"October 01, 2015 -  September 30, 2016",Development and function of regulatory T cells,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Dinah  Singer; PhD,NULL,NULL,NULL,"1. Kimura M, Thomas J, Tai X, Guinter T, Shinzawa M, Etzensperger R, Li Z, Love P, Nakayama T, Singer A (2016) Timing and duration of MHC-I positive selection signals in the thymus reveal a novel compensatory signaling mechanism that prevents lineage fate errors. Nature Immunology, in press.|2. Pobezinsky LA, Etzensperger R, Jeurling S, Alag A, Kadakia T, McCaughtry TM, Kimura MY, Sharrow SO, Guinter TI, Feigenbaum L, Singer A (2015). Let-7 microRNAs target the lineage-specific transcription factor PLZF to regulate terminal NKT cell differentiation and effector function. Nat Immunol  16, 517-24.   https://doi.org/10.1038/ni.3146|3. Takada K, Van Laethem F, Xing Y, Akane K, Suzuki H, Murata S, Tanaka K, Jameson SC, Singer A, Takahama Y (2015). TCR affinity for thymoproteasome-dependent positively selecting peptides conditions antigen responsiveness in CD8(+) T cells. Nat Immunol  16, 1069-76.   https://doi.org/10.1038/ni.3237",https://intramural.nih.gov/search/searchview.taf?ipid=93910
284,BC011113-09,"October 01, 2015 -  September 30, 2016",T cell survival,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Jung-Hyun  Park,NULL,NULL,NULL,"1. Kimura M, Thomas J, Tai X, Guinter T, Shinzawa M, Etzensperger R, Li Z, Love P, Nakayama T, Singer A (2016) Timing and duration of MHC-I positive selection signals in the thymus reveal a novel compensatory signaling mechanism that prevents lineage fate errors. Nature Immunology, in press.|2. Pobezinsky LA, Etzensperger R, Jeurling S, Alag A, Kadakia T, McCaughtry TM, Kimura MY, Sharrow SO, Guinter TI, Feigenbaum L, Singer A (2015). Let-7 microRNAs target the lineage-specific transcription factor PLZF to regulate terminal NKT cell differentiation and effector function. Nat Immunol  16, 517-24.   https://doi.org/10.1038/ni.3146|3. Takada K, Van Laethem F, Xing Y, Akane K, Suzuki H, Murata S, Tanaka K, Jameson SC, Singer A, Takahama Y (2015). TCR affinity for thymoproteasome-dependent positively selecting peptides conditions antigen responsiveness in CD8(+) T cells. Nat Immunol  16, 1069-76.   https://doi.org/10.1038/ni.3237",https://intramural.nih.gov/search/searchview.taf?ipid=93911
285,BC011114-09,"October 01, 2015 -  September 30, 2016",Role of microRNAs in T cell development,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",NULL,NULL,NULL,"Paul E Love; MD, PhD (NICHD)","1. Kimura M, Thomas J, Tai X, Guinter T, Shinzawa M, Etzensperger R, Li Z, Love P, Nakayama T, Singer A (2016) Timing and duration of MHC-I positive selection signals in the thymus reveal a novel compensatory signaling mechanism that prevents lineage fate errors. Nature Immunology, in press.|2. Pobezinsky LA, Etzensperger R, Jeurling S, Alag A, Kadakia T, McCaughtry TM, Kimura MY, Sharrow SO, Guinter TI, Feigenbaum L, Singer A (2015). Let-7 microRNAs target the lineage-specific transcription factor PLZF to regulate terminal NKT cell differentiation and effector function. Nat Immunol  16, 517-24.   https://doi.org/10.1038/ni.3146|3. Takada K, Van Laethem F, Xing Y, Akane K, Suzuki H, Murata S, Tanaka K, Jameson SC, Singer A, Takahama Y (2015). TCR affinity for thymoproteasome-dependent positively selecting peptides conditions antigen responsiveness in CD8(+) T cells. Nat Immunol  16, 1069-76.   https://doi.org/10.1038/ni.3237",https://intramural.nih.gov/search/searchview.taf?ipid=93912
286,BC011115-09,"October 01, 2015 -  September 30, 2016",Epigenetic Mechanisms of Gene Expression in Thoracic Malignancies,David  Schrump; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI","Colleen Donahue Bond|Eden Christine Payabyab; MD|Emily Reardon Peroutka|Mahadev  Rao|Vivek  Shukla; BSc, MSc|Sichuan  Xi|Show all 10","Nasser  Altorki (Thoracic Surgery, Cornell University Medical Center)|Xinmin  Li (Functional Genomics, University of Chicago)|Raphael  Bueno (Brigham and Women's Hosp)|David  Beer (Thoracic Surgery, University of Michigan)","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Curtis  Harris; MD (Laboratory of Human Carcinogenesis)",NULL,"1. Xi S, Inchauste S, Guo H, Shan J, Xiao Z, Xu H, Miettenen M, Zhang MR, Hong JA, Raiji MT, Altorki NK, Casson AG, Beer DG, Robles AI, Bowman ED, Harris CC, Steinberg SM, Schrump DS (2015). Cigarette smoke mediates epigenetic repression of miR-217 during esophageal adenocarcinogenesis. Oncogene  34, 5548-59.   https://doi.org/10.1038/onc.2015.10",https://intramural.nih.gov/search/searchview.taf?ipid=93904
287,BC011116-09,"October 01, 2015 -  September 30, 2016",MHC-independent T cells,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Jung-Hyun  Park,Batu M Erman|Gunter  Bernhardt (Hannover Medical School),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93908
288,BC011117-09,"October 01, 2015 -  September 30, 2016",T cell receptor regulation of cytokine signaling,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",NULL,NULL,NULL,NULL,"1. Kimura M, Thomas J, Tai X, Guinter T, Shinzawa M, Etzensperger R, Li Z, Love P, Nakayama T, Singer A (2016) Timing and duration of MHC-I positive selection signals in the thymus reveal a novel compensatory signaling mechanism that prevents lineage fate errors. Nature Immunology, in press.|2. Pobezinsky LA, Etzensperger R, Jeurling S, Alag A, Kadakia T, McCaughtry TM, Kimura MY, Sharrow SO, Guinter TI, Feigenbaum L, Singer A (2015). Let-7 microRNAs target the lineage-specific transcription factor PLZF to regulate terminal NKT cell differentiation and effector function. Nat Immunol  16, 517-24.   https://doi.org/10.1038/ni.3146|3. Takada K, Van Laethem F, Xing Y, Akane K, Suzuki H, Murata S, Tanaka K, Jameson SC, Singer A, Takahama Y (2015). TCR affinity for thymoproteasome-dependent positively selecting peptides conditions antigen responsiveness in CD8(+) T cells. Nat Immunol  16, 1069-76.   https://doi.org/10.1038/ni.3237",https://intramural.nih.gov/search/searchview.taf?ipid=93909
289,BC011118-09,"October 01, 2015 -  September 30, 2016",Role of Shh in developmental patterning and growth of digit skeleton,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao|Drew Vincent Canning|Jianjian  Zhu,"Steve  Vokes (U. Texas, Austin)|Brian  Harfe; PhD (Molecular Genetics and Microbiology, University of Florida)",Stephen J Lockett; PhD (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93972
290,BC011119-09,"October 01, 2015 -  September 30, 2016",Hoxd and Gli3-Hoxd interaction roles in Hedgehog regulated digit morphogenesis,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao|Drew Vincent Canning|Bau Lin Huang|Anna Marie Trofka|Jianjian  Zhu,"John  Rasweiler (SUNY Downstate)|Makoto  Taketo (Orthopedics, Kyoto University)|Steve  Vokes (U. Texas, Austin)|Maurizio  Pacifici (Univ. Pennsylvania School of Medicine)|Dagmar  Iber (ETH Zurich)|Marian  Ros; PhD (Universidad de Cantabria)","Christopher John Westlake; PhD (Laboratory of Cell and Developmental Signaling)|Sean Richard Davis; MD, PhD (Cancer Genetics Branch)|Mark B Lewandoski (Genetics of Vertebrate Development Section)|Martin John Schnermann; PhD (Chemical Biology Laboratory)","Richa  Agarwala; BTech, MS, PhD (NLM)","1. Huang B, Trofka A, Furusawa A, Norrie J, Rabinowitz A, Vokes S, Taketo M, Zakany J, Mackem S (2016) An interdigit signaling center instructs coordinate phalanx-joint formation governed by 5Hoxd-Gli3 antagonism. Nature Communications, in press.|2. Huang BL, Mackem S (2015). Tamoxifen-dependent, inducible Bmp2CreER drives selective recombinase activity in early interdigital mesenchyme and digit collateral ligaments. PLoS One  10, e0123325.   https://doi.org/10.1371/journal.pone.0123325",https://intramural.nih.gov/search/searchview.taf?ipid=93973
291,BC011120-09,"October 01, 2015 -  September 30, 2016",Genome-wide target analysis of Shh-activated transcription network in limb bud,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao|Bau Lin Huang|Anna Marie Trofka,NULL,"Sean Richard Davis; MD, PhD (Cancer Genetics Branch)","Richa  Agarwala; BTech, MS, PhD (NLM)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93970
292,BC011121-09,"October 01, 2015 -  September 30, 2016",Role of Brachyury in regulating notochord development and neoplasia,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao|Jianjian  Zhu,NULL,Claudia Mercedes Palena (Laboratory of Tumor Immunology and Biology)|Terence P Yamaguchi; PhD (Cell Signaling in Vertebrate Development Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93971
293,BC011124-09,"October 01, 2015 -  September 30, 2016",Oncogenic Met Signaling in Urologic Malignancies,Donald P Bottaro; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI",Fabiola  Cecchi|Dinuka Mihirani de Silva; PhD|Young Hwan Lee|Arpita Avijit Roy; PhD|Cara Elizabeth Wright|Cathy  Vocke; PhD|Show all 11,"Angela  Coxon (Amgen)|Regina  Day (NCI)|Irmgard  Irminger (Clinical Development, University Hospitals Geneva HUG)|Anne-Marie  Martin (GlaxoSmithKline)|Freidmann  Muller (Curacyte AG)|Andreas  van de Locht (Department of Pathology, Curacyte AG)|Show all 15","Maria  Merino; PhD (Laboratory of Pathology)|Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)|Peter L Choyke; MD (Molecular Imaging Program)|Robert Andrew Byrd (Structural Biophysics Laboratory)|Melinda  Hollingshead (Biological Testing Branch)|Gary Leonard Griffiths; BSc, PhD (Molecular Imaging Program)",Rolf Eric Swenson; PhD (NHLBI),"1. Cecchi F, Lee Y, Peruzzi B, Lattouf J, Bottaro D (2015) The Role of Hepatocyte Growth Factor Pathway Signaling in Renal Cell Carcinoma, in Renal Cell Carcinoma: Molecular Targets and Clinical Applications. , pp. 303-318.|2. Chen F, Zhang Y, Şenbabaoğlu Y, Ciriello G, Yang L, Reznik E, Shuch B, Micevic G, De Velasco G, Shinbrot E, Noble MS, Lu Y, Covington KR, Xi L, Drummond JA, Muzny D, Kang H, Lee J, Tamboli P, Reuter V, Shelley CS, Kaipparettu BA, Bottaro DP, Godwin AK, Gibbs RA, et al. [15 more authors] (2016). Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma. Cell Rep  14, 2476-89.   https://doi.org/10.1016/j.celrep.2016.02.024|3. Kaye DR, Pinto PA, Cecchi F, Reilly J, Semerjian A, Rabe DC, Gupta G, Choyke PL, Bottaro DP (2016). Tumor and Plasma Met Levels in Non-Metastatic Prostate Cancer. PLoS One  11, e0157130.   https://doi.org/10.1371/journal.pone.0157130",https://intramural.nih.gov/search/searchview.taf?ipid=93864
294,BC011126-09,"October 01, 2015 -  September 30, 2016",Preventive Vaccines for HIV,Genoveffa  Franchini; MD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Marjorie  Robert-Guroff; PhD,"Donald  Forthal (School of Medicine, Univ of CA)|Eckhard  Podack (Department of Microbiology, University of Miami)|Chris  Miller; MS|Guido  Ferrari (Duke University)|Rafick  Sekaly; PhD (Vaccine & Gene Therapy Institute)|Georgia Doris Tomaras; PhD|Show all 7",Christopher  Buck (Laboratory of Cellular Oncology),Nancy R Miller (NIAID) |Vanessa  Hirsch (NIAID) |Mario  Roederer; PhD (NIAID) |Daniel C Douek; MD (NIAID) |Richard A Koup; MD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93883
295,BC011131-09,"October 01, 2015 -  September 30, 2016",Investigation of Protein-Protein Interactions in the ERAD Ubiquitylation Pathway,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Fa-An  Chao|Jess R Li,NULL,Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93867
296,BC011132-09,"October 01, 2015 -  September 30, 2016",Methods Development,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Fa-An  Chao|Jess R Li|Cameron Lynn McGlone|Yun Xing M Wang,NULL,NULL,Nico  Tjandra; PhD (NHLBI),"1. Opina A, Strickland M, Lee Y, Tjandra N, Byrd R, Swenson R, Vasalatiy O (2016) Analysis of the isomer ratios of polymethylated-DOTA complexes and the implications on protein structural studies Dalton Transactions 45:4673-4687|2. Sun S, Gill M, Li Y, Huang M, Byrd RA (2015). Efficient and generalized processing of multidimensional NUS NMR data: the NESTA algorithm and comparison of regularization terms. J Biomol NMR  62, 105-117.   https://doi.org/10.1007/s10858-015-9923-x",https://intramural.nih.gov/search/searchview.taf?ipid=93866
297,BC011150-08,"October 01, 2015 -  September 30, 2016",Chronic Inflammation and Carcinogenesis,Scott K Durum; PhD|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Caroline Elizabeth Salter|Sarah Barclay Heaps|Julie  Hixon|Wenqing  Li|Erika Danielle Olney|Emilee Rose Senkevitch|Show all 8,NULL,NULL,Sandip  Datta (NIAID),"1. Aprelikova O, Tomlinson CC, Hoenerhoff M, Hixon JA, Durum SK, Qiu TH, He S, Burkett S, Liu ZY, Swanson SM, Green JE (2016). Development and Preclinical Application of an Immunocompetent Transplant Model of Basal Breast Cancer with Lung, Liver and Brain Metastases. PLoS One  11, e0155262.   https://doi.org/10.1371/journal.pone.0155262|2. Cramer SD, Aplan PD, Durum SK (2016). Therapeutic targeting of IL-7Rα signaling pathways in ALL treatment. Blood  128, 473-8.   https://doi.org/10.1182/blood-2016-03-679209|3. Robinette ML, Fuchs A, Cortez VS, Lee JS, Wang Y, Durum SK, Gilfillan S, Colonna M, Immunological Genome Consortium (2015). Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets. Nat Immunol  16, 306-17.   https://doi.org/10.1038/ni.3094|4. Shen W, Hixon JA, McLean MH, Li WQ, Durum SK (2015). IL-22-Expressing Murine Lymphocytes Display Plasticity and Pathogenicity in Reporter Mice. Front Immunol  6, 662.   https://doi.org/10.3389/fimmu.2015.00662",https://intramural.nih.gov/search/searchview.taf?ipid=94004
298,BC011152-08,"October 01, 2015 -  September 30, 2016",Regulation of human dendritic cell activation,Giorgio  Trinchieri|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Jonathan Harold Badger|Sharon A Bargo|Ren Ming  Dai|Amiran  Dzutsev; PhD|Loretta R Smith|Rodrigo  Xavier Das Neves|Show all 7,"Xiaojing  Ma (Microbiology and Immunology, Weill Medical College)|Uzma  Hasan (Infections and Cancer Biology, International Agency for Research on Cancer (IARC-WHO))|Franca  Gerosa (Pathology/Immunology, University of Verona)",NULL,Alan  Sher; PhD (NIAID),"1. Askenase MH, Han SJ, Byrd AL, Morais da Fonseca D, Bouladoux N, Wilhelm C, Konkel JE, Hand TW, Lacerda-Queiroz N, Su XZ, Trinchieri G, Grainger JR, Belkaid Y (2015). Bone-Marrow-Resident NK Cells Prime Monocytes for Regulatory Function during Infection. Immunity  42, 1130-42.   https://doi.org/10.1016/j.immuni.2015.05.011|2. Goldszmid RS, Dzutsev A, Viaud S, Zitvogel L, Restifo NP, Trinchieri G (2015). Microbiota modulation of myeloid cells in cancer therapy. Cancer Immunol Res  3, 103-9.   https://doi.org/10.1158/2326-6066.CIR-14-0225|3. Levay A, Brenneman R, Hoinka J, Sant D, Cardone M, Trinchieri G, Przytycka TM, Berezhnoy A (2015). Identifying high-affinity aptamer ligands with defined cross-reactivity using high-throughput guided systematic evolution of ligands by exponential enrichment. Nucleic Acids Res  43, e82.   https://doi.org/10.1093/nar/gkv534|4. Trinchieri G (2015). Cancer Immunity: Lessons From Infectious Diseases. J Infect Dis  212 Suppl 1, S67-73.   https://doi.org/10.1093/infdis/jiv070",https://intramural.nih.gov/search/searchview.taf?ipid=94035
299,BC011153-08,"October 01, 2015 -  September 30, 2016",Role of mouse microbiome in cancer and inflammation,Giorgio  Trinchieri|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Jonathan Harold Badger|Sharon A Bargo|Amiran  Dzutsev; PhD|Soumen  Roy; PhD|Rosalba  Salcedo|Loretta R Smith|Show all 10,"Sergei A. Nedospasov; PhD, DSc|Marilia  Seelaender (University of Sao Paulo)",NULL,"Yasmine  Belkaid; PhD (NIAID) |Karen Moore Frank; MD, PhD (CC)","1. Askenase MH, Han SJ, Byrd AL, Morais da Fonseca D, Bouladoux N, Wilhelm C, Konkel JE, Hand TW, Lacerda-Queiroz N, Su XZ, Trinchieri G, Grainger JR, Belkaid Y (2015). Bone-Marrow-Resident NK Cells Prime Monocytes for Regulatory Function during Infection. Immunity  42, 1130-42.   https://doi.org/10.1016/j.immuni.2015.05.011|2. Fonseca DM, Hand TW, Han SJ, Gerner MY, Glatman Zaretsky A, Byrd AL, Harrison OJ, Ortiz AM, Quinones M, Trinchieri G, Brenchley JM, Brodsky IE, Germain RN, Randolph GJ, Belkaid Y (2015). Microbiota-Dependent Sequelae of Acute Infection Compromise Tissue-Specific Immunity. Cell  163, 354-66.   https://doi.org/10.1016/j.cell.2015.08.030|3. Goldszmid RS, Dzutsev A, Viaud S, Zitvogel L, Restifo NP, Trinchieri G (2015). Microbiota modulation of myeloid cells in cancer therapy. Cancer Immunol Res  3, 103-9.   https://doi.org/10.1158/2326-6066.CIR-14-0225|4. Trinchieri G (2015). Cancer Immunity: Lessons From Infectious Diseases. J Infect Dis  212 Suppl 1, S67-73.   https://doi.org/10.1093/infdis/jiv070",https://intramural.nih.gov/search/searchview.taf?ipid=94034
300,BC011154-08,"October 01, 2015 -  September 30, 2016",Biological Functions of Chromosomal Proteins,Michael  Bustin; PhD|IRP Faculty Profile,NULL,"Protein Section, NCI","Tao  Deng|Takashi  Furusawa|Bing  He|Yuri  Postnikov; MD, PhD|Shaofei  Zhang",Eran  Meshorer (Hebrew University)|Andrew  Lane (U. of Louisville),Joost J Oppenheim; MD (Cancer Inflammation Program),NULL,"1. Furusawa T, Rochman M, Taher L, Dimitriadis EK, Nagashima K, Anderson S, Bustin M (2015). Chromatin decompaction by the nucleosomal binding protein HMGN5 impairs nuclear sturdiness. Nat Commun  6, 6138.   https://doi.org/10.1038/ncomms7138|2. Garfinkel BP, Arad S, Le PT, Bustin M, Rosen CJ, Gabet Y, Orly J (2015). Proportionate Dwarfism in Mice Lacking Heterochromatin Protein 1 Binding Protein 3 (HP1BP3) Is Associated With Alterations in the Endocrine IGF-1 Pathway. Endocrinology  156, 4558-70.   https://doi.org/10.1210/en.2015-1668|3. Garfinkel BP, Melamed-Book N, Anuka E, Bustin M, Orly J (2015). HP1BP3 is a novel histone H1 related protein with essential roles in viability and growth. Nucleic Acids Res  43, 2074-90.   https://doi.org/10.1093/nar/gkv089|4. Moretti F, Rolando C, Winker M, Ivanek R, Rodriguez J, Von Kriegsheim A, Taylor V, Bustin M, Pertz O (2015). Growth Cone Localization of the mRNA Encoding the Chromatin Regulator HMGN5 Modulates Neurite Outgrowth. Mol Cell Biol  35, 2035-50.   https://doi.org/10.1128/MCB.00133-15",https://intramural.nih.gov/search/searchview.taf?ipid=93996
301,BC011155-08,"October 01, 2015 -  September 30, 2016",Antibody-based therapeutics and vaccines against AIDS,Dimiter Stanchev Dimitrov; PhD,NULL,"Cancer Inflammation Program, NCI",Weizao  Chen|Yang  Feng|Wei  Li; PhD|Zhongyu  Zhu,"Christopher  Broder (Uniformed Services University of the Health Sciences)|Shibo  Jiang (Virology, New York Blood Center)|Barton  Haynes (Duke University)|MeiYun  Zhang (University of Hong Kong)|Rui  Gong; PhD|Yuxian  He (Chinese Academy of Medical Sciences)",Sriram  Subramaniam; PhD (Laboratory of Cell Biology),Peter D Kwong; PhD (NIAID),"1. Chen W, Li W, Ying T, Wang Y, Feng Y, Dimitrov DS (2015). Germlining of the HIV-1 broadly neutralizing antibody domain m36. Antiviral Res  116, 62-6.   https://doi.org/10.1016/j.antiviral.2015.02.001|2. Puligujja P, Balkundi SS, Kendrick LM, Baldridge HM, Hilaire JR, Bade AN, Dash PK, Zhang G, Poluektova LY, Gorantla S, Liu XM, Ying T, Feng Y, Wang Y, Dimitrov DS, McMillan JM, Gendelman HE (2015). Pharmacodynamics of long-acting folic acid-receptor targeted ritonavir-boosted atazanavir nanoformulations. Biomaterials  41, 141-50.   https://doi.org/10.1016/j.biomaterials.2014.11.012|3. Yang Z, Li J, Liu Q, Yuan T, Zhang Y, Chen LQ, Lou Q, Sun Z, Ying H, Xu J, Dimitrov DS, Zhang MY (2015). Identification of Non-HIV Immunogens That Bind to Germline b12 Predecessors and Prime for Elicitation of Cross-clade Neutralizing HIV-1 Antibodies. PLoS One  10, e0126428.   https://doi.org/10.1371/journal.pone.0126428",https://intramural.nih.gov/search/searchview.taf?ipid=94003
302,BC011156-08,"October 01, 2015 -  September 30, 2016",Antibody therapeutics against biodefense-related diseases,Dimiter Stanchev Dimitrov; PhD,NULL,"Cancer Inflammation Program, NCI",Yang  Feng|Zhongyu  Zhu,"Christopher  Broder (Uniformed Services University of the Health Sciences)|Shibo  Jiang (Virology, New York Blood Center)|Linfa  Wang (Duke-NUS Graduate Medical School)|Tianlei  Ying",NULL,NULL,"1. Dimitrov DS, Jiang S, Ying T, Tseng CT, Zhang L, Yuen KY (2015). No evidence for a superior platform to develop therapeutic antibodies rapidly in response to MERS-CoV and other emerging viruses. Proc Natl Acad Sci U S A  112, E5115.   https://doi.org/10.1073/pnas.1513441112|2. Ying T, Prabakaran P, Du L, Shi W, Feng Y, Wang Y, Wang L, Li W, Jiang S, Dimitrov DS, Zhou T (2015). Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody. Nat Commun  6, 8223.   https://doi.org/10.1038/ncomms9223",https://intramural.nih.gov/search/searchview.taf?ipid=94002
303,BC011158-08,"October 01, 2015 -  September 30, 2016",The roles of p53 in embryonic stem cells,Jing  Huang|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Shunlin  Jiang|Mangmang  Li,NULL,Jianxin  Shi (Biostatistics Branch),NULL,"1. Li M, Gou H, Tripathi BK, Huang J, Jiang S, Dubois W, Waybright T, Lei M, Shi J, Zhou M, Huang J (2015). An Apela RNA-Containing Negative Feedback Loop Regulates p53-Mediated Apoptosis in Embryonic Stem Cells. Cell Stem Cell  16, 669-83.   https://doi.org/10.1016/j.stem.2015.04.002",https://intramural.nih.gov/search/searchview.taf?ipid=94013
304,BC011162-08,"October 01, 2015 -  September 30, 2016",Integrative Molecular Profiling of Human Pancreatic Cancer,Syed Perwez  Hussain|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI",Limin  Wang; PhD|Peijun  He|Shouhui  Yang; PhD,"Jochen  Gaedcke|Carlo  Croce (Ohio State University Cancer Center)|Anirban  Maitra (Johns Hopkins University School of Medicine)|Frank  Bergmann (University of Heidelberg)|Katsuhiko  Yanaga (Jikei University School of Medicine)|Michael  Ghadimi (Surgery, U. of Goettingen)|Show all 8",David Anderson Wink (Cancer Inflammation Program)|Karl Thomas Ried; MD (Cancer Genetics Branch),NULL,"1. Hussain SP (2016). Pancreatic Cancer: Current Progress and Future Challenges. Int J Biol Sci  12, 270-2.   https://doi.org/10.7150/ijbs.14950",https://intramural.nih.gov/search/searchview.taf?ipid=94014
305,BC011163-08,"October 01, 2015 -  September 30, 2016",Host immature myeloid cells in tumor suppressor or promoter roles of TGFbeta,Li  Yang; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Olga  Aprelikova; PhD|Mary  Hollander|Hiroki  Ishii|Jae Young  So,NULL,Giorgio  Trinchieri (Cancer Inflammation Program)|Pengnian Charles Lin; PhD (Cancer Inflammation Program)|Ashish Kumar Lal (Cancer Genetics Branch),NULL,"1. Yan HH, Jiang J, Pang Y, Achyut BR, Lizardo M, Liang X, Hunter K, Khanna C, Hollander C, Yang L (2015). CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ. Cancer Res  75, 5283-98.   https://doi.org/10.1158/0008-5472.CAN-15-2282-T",https://intramural.nih.gov/search/searchview.taf?ipid=94039
306,BC011165-08,"October 01, 2015 -  September 30, 2016",Role of inflammation in epigenetic alterations of metastatic cancer cells,Li  Yang; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Olga  Aprelikova; PhD|Jae Young  So|Xiang  Wang|Zhiguang  Xiao|Maxwell P Lee; PhD,NULL,Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Karl Thomas Ried; MD (Cancer Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94040
307,BC011167-08,"October 01, 2015 -  September 30, 2016",A novel preclinical model of spontaneous metastasis,Glenn  Merlino; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Chi-Ping  Day|Rachel J Marchalik|Eva Eugenia Perez Guijarro|Jennifer D Rieker,"Martin  McMahon (University of Californial at San Francisco)|Marcus  Bosenberg (Yale University)|Keith  Flaherty (Harvard Medical School)|Norman  Sharpless (University of North Carolina)|Thomas  Tuting (Dermatology, University of Bonn)|Jennifer A Wargo|Show all 7",Melinda  Hollingshead (Biological Testing Branch)|Dominic  Esposito; PhD (Office Of The Director)|Nicholas Phillip Restifo; MD (Surgery Branch),NULL,"1. Day CP, Merlino G, Van Dyke T (2015). Preclinical mouse cancer models: a maze of opportunities and challenges. Cell  163, 39-53.   https://doi.org/10.1016/j.cell.2015.08.068",https://intramural.nih.gov/search/searchview.taf?ipid=94023
308,BC011168-08,"October 01, 2015 -  September 30, 2016",Physiological and pathological functions of E3 ubiquitin ligases Smurfs,Ying  Zhang|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",NULL,Beth  Levine; MD (UT Southwestern Medical Center)|Steven  Cheng (Nanjing Medical University),Xin Wei Wang; PhD (Molecular Genetics and Carcinogenesis Section),Chengyu  Liu; PhD (NHLBI),"1. Zhao X, Parpart S, Takai A, Roessler S, Budhu A, Yu Z, Blank M, Zhang YE, Jia HL, Ye QH, Qin LX, Tang ZY, Thorgeirsson SS, Wang XW (2015). Integrative genomics identifies YY1AP1 as an oncogenic driver in EpCAM(+) AFP(+) hepatocellular carcinoma. Oncogene  34, 5095-104.   https://doi.org/10.1038/onc.2014.438",https://intramural.nih.gov/search/searchview.taf?ipid=94041
309,BC011176-08,"October 01, 2015 -  September 30, 2016",Functions of KSHV microRNAs,Joseph M Ziegelbauer|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI",Christine  Happel; PhD|Dhivya  Ramalingam|Anna  Serquina|Thomas S Uldrick,NULL,"Sean Richard Davis; MD, PhD (Cancer Genetics Branch)","John Lawrence Spouge; MD, PhD (NLM)","1. KiefferKwon P, Happel C, Uldrick T, Ramalingam D, Ziegelbauer J (2015) KSHV microRNAs Repress Tropomyosin 1 and Increase Anchorage-Independent Growth and Endothelial Tube Formation. PLoS One, in press.|2. Ramalingam D, Happel C, Ziegelbauer JM (2015). Kaposi's sarcoma-associated herpesvirus microRNAs repress breakpoint cluster region protein expression, enhance Rac1 activity, and increase in vitro angiogenesis. J Virol  89, 4249-61.   https://doi.org/10.1128/JVI.03687-14|3. Viollet C, Davis DA, Reczko M, Ziegelbauer JM, Pezzella F, Ragoussis J, Yarchoan R (2015). Next-Generation Sequencing Analysis Reveals Differential Expression Profiles of MiRNA-mRNA Target Pairs in KSHV-Infected Cells. PLoS One  10, e0126439.   https://doi.org/10.1371/journal.pone.0126439",https://intramural.nih.gov/search/searchview.taf?ipid=94042
310,BC011177-08,"October 01, 2015 -  September 30, 2016",Botulinum Toxin for Painful Cutaneous Leiomyomas,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",Edward W Cowen,NULL,William Marston Linehan; MD (Urologic Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94019
311,BC011181-08,"October 01, 2015 -  September 30, 2016",Functional Analysis of Human Breast Cancer Susceptibility Gene Variants,Shyam K Sharan|IRP Faculty Profile,NULL,"Genetics of Cancer Susceptibility Section, NCI",NULL,"Debananda  Pati (Texas Children's Cancer Center, Baylor College of Medicine)|William  Foulkes (McGill University)",Robert Andrew Byrd (Structural Biophysics Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94030
312,BC011185-08,"October 01, 2015 -  September 30, 2016",Role of Immune and Inflammation Mediators in Progression of Pancreatic Cancer,Syed Perwez  Hussain|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI",Peijun  He|Shouhui  Yang; PhD|Limin  Wang; PhD,Jochen  Gaedcke|Carlo  Croce (Ohio State University Cancer Center)|Anirban  Maitra (Johns Hopkins University School of Medicine)|Richard  Bucala (Yale University)|Fleming  Jason (MD Anderson Cancer Center)|Diane  Simeone (University of Michigan),David Anderson Wink (Cancer Inflammation Program)|Karl Thomas Ried; MD (Cancer Genetics Branch)|Christine Campo Alewine (Laboratory of Molecular Biology),NULL,"1. Alam MS, Gaida MM, Bergmann F, Lasitschka F, Giese T, Giese NA, Hackert T, Hinz U, Hussain SP, Kozlov SV, Ashwell JD (2015). Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression. Nat Med  21, 1337-43.   https://doi.org/10.1038/nm.3957",https://intramural.nih.gov/search/searchview.taf?ipid=94015
313,BC011187-08,"October 01, 2015 -  September 30, 2016",Sphingolipid Signaling in Mammals,"Jairaj K Acharya; MBBS, PhD|IRP Faculty Profile",NULL,"Cancer and Developmental Biology Laboratory, NCI",Janhavi Nitin Nagwekar,NULL,Lino  Tessarollo (Mouse Cancer Genetics Program)|Shyam K Sharan (Genetics of Cancer Susceptibility Section)|Sarangan  Ravichandran (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93993
314,BC011190-08,"October 01, 2015 -  September 30, 2016",Chemical Biology of Nitroxyl (HNO),David Anderson Wink|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",NULL,"Bruce  King (Department of Chemistry, Wake Forest University)|Jon  Fukuto (UCLA)|Nazerano  Paolocci (Department of Cardiology, Johns Hopkins University Medical School)",James B Mitchell; PhD (Radiation Biology Branch)|Murali  Krishna; PhD (Radiation Biology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94038
315,BC011191-08,"October 01, 2015 -  September 30, 2016",Preclinical Mouse Models of Thyroid Cancer,Sheueyann  Cheng; PhD|IRP Faculty Profile,NULL,"Gene Regulation Section, NCI",Keisuke  Enomoto|Cho Rong  Han|Minkyung  Kang|Sunmi  Park|Mark Cauthen Willingham|Li  Zhao|Show all 7,"Matthew D Ringel; MD (Lab. of Molec. Endocrinol., Washington Hospital Center)|THOMAS  KLONISCH (University of Manitoba)|Young  Jo (Chungnam national University Hospital)","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Electron  Kebebew; MD (Endocrine Oncology Branch)|Shioko  Kimura; PhD (Endocrinology Section)|Kathleen  Kelly; PhD (Laboratory Of Genitourinary Cancer Pathogenesis)",NULL,"1. Zhang LJ, Xiong Y, Nilubol N, He M, Bommareddi S, Zhu X, Jia L, Xiao Z, Park JW, Xu X, Patel D, Willingham MC, Cheng SY, Kebebew E (2015). Testosterone regulates thyroid cancer progression by modifying tumor suppressor genes and tumor immunity. Carcinogenesis  36, 420-8.   https://doi.org/10.1093/carcin/bgv001",https://intramural.nih.gov/search/searchview.taf?ipid=93998
316,BC011197-08,"October 01, 2015 -  September 30, 2016",Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells,Ettore  Appella; MD|IRP Faculty Profile,NULL,"Chemical Immunology Section, NCI",Subrata  Debnath; PhD|Yantenew  Gete|Sharlyn  Mazur; PhD|Harichandra Dnyaneshwar Tagad; PhD,Oleg  Demidov|Barbara  Stecca (Istituto Toscano Tumori Azienda),Stewart  Durell (Laboratory of Cell Biology)|Lisa Marie Jenkins (Pigment Cell Biology Section),Daniel  Appella; PhD (NIDDK) |Frederick P Dyda; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93994
317,BC011202-08,"October 01, 2015 -  September 30, 2016",Mechanism of the initial steps in transcription-coupled DNA repair (TCR),Mikhail V Kashlev|IRP Faculty Profile,NULL,"Molecular Mechanisms of Transcription Section, NCI",NULL,NULL,Xinhua  Ji; PhD (Biomolecular Structure Section)|Yun Xing M Wang (Structural Biophysics Laboratory),Philip John Brooks; PhD (NCATS),"1. Sun B, Pandey M, Inman JT, Yang Y, Kashlev M, Patel SS, Wang MD (2015). T7 replisome directly overcomes DNA damage. Nat Commun  6, 10260.   https://doi.org/10.1038/ncomms10260|2. Walmacq C, Wang L, Chong J, Scibelli K, Lubkowska L, Gnatt A, Brooks PJ, Wang D, Kashlev M (2015). Mechanism of RNA polymerase II bypass of oxidative cyclopurine DNA lesions. Proc Natl Acad Sci U S A  112, E410-9.   https://doi.org/10.1073/pnas.1415186112",https://intramural.nih.gov/search/searchview.taf?ipid=94017
318,BC011203-08,"October 01, 2015 -  September 30, 2016",Proteolysis and Regulation of Bacterial Cell Growth Control,Susan  Gottesman; PhD|IRP Faculty Profile,NULL,"Biochemical Genetics Section, NCI",Sydney  Pimentel|Song  Tong|Arti  Tripathi,Aurelia  Battesti|Alexandra Monica Deaconescu (BIOCHEMISTRY & BIOPHYSICS CENTER),Sue H Wickner; PhD (DNA Molecular Biology Section)|Yan Ning H Zhou (Gene Regulation and Chromosome Biology Laboratory)|Xinhua  Ji; PhD (Biomolecular Structure Section)|Michael  Maurizi; PhD (Biochemistry of Proteins Section)|Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology),NULL,"1. Battesti A, Majdalani N, Gottesman S (2015). Stress sigma factor RpoS degradation and translation are sensitive to the state of central metabolism. Proc Natl Acad Sci U S A  112, 5159-64.   https://doi.org/10.1073/pnas.1504639112",https://intramural.nih.gov/search/searchview.taf?ipid=94007
319,BC011204-08,"October 01, 2015 -  September 30, 2016",Preclinical development of TIMP-2 as a biologic therapy for cancer,"William G Stetler-Stevenson; MD, PhD|IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI",Ananda  Chowdhury; PhD|Sandra  Jensen-Taubman|Sarvesh  Kumar|David  Peeney; PhD|Kevin A Camphausen; MD,Robert G Brinson; PhD|John  Caterina; PhD (NIDR),"Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Joel Patrick Schneider; PhD (Chemical Biology Laboratory)",Rolf Eric Swenson; PhD (NHLBI),"1. Dunn DM, Woodford MR, Truman AW, Jensen SM, Schulman J, Caza T, Remillard TC, Loiselle D, Wolfgeher D, Blagg BS, Franco L, Haystead TA, Daturpalli S, Mayer MP, Trepel JB, Morgan RM, Prodromou C, Kron SJ, Panaretou B, Stetler-Stevenson WG, Landas SK, Neckers L, Bratslavsky G, Bourboulia D, Mollapour M (2015). c-Abl Mediated Tyrosine Phosphorylation of Aha1 Activates Its Co-chaperone Function in Cancer Cells. Cell Rep  12, 1006-18.   https://doi.org/10.1016/j.celrep.2015.07.004|2. Kumar S, Malhotra S, Prasad AK, Van der Eycken EV, Bracke ME, Stetler-Stevenson WG, Parmar VS, Ghosh B (2015). Anti-inflammatory and antioxidant properties of Piper species: a perspective from screening to molecular mechanisms. Curr Top Med Chem  15, 886-93.   https://doi.org/10.2174/1568026615666150220120651|3. Stetler-Stevenson WG (2015). The tumor microenvironment: the connective tissue/tumor cell/host organ system that modulates tumor progression. Connect Tissue Res  56, 343-4.   https://doi.org/10.3109/03008207.2015.1086622|4. Woodford MR, Truman AW, Dunn DM, Jensen SM, Cotran R, Bullard R, Abouelleil M, Beebe K, Wolfgeher D, Wierzbicki S, Post DE, Caza T, Tsutsumi S, Panaretou B, Kron SJ, Trepel JB, Landas S, Prodromou C, Shapiro O, Stetler-Stevenson WG, Bourboulia D, Neckers L, Bratslavsky G, Mollapour M (2016). Mps1 Mediated Phosphorylation of Hsp90 Confers Renal Cell Carcinoma Sensitivity and Selectivity to Hsp90 Inhibitors. Cell Rep  14, 872-884.   https://doi.org/10.1016/j.celrep.2015.12.084",https://intramural.nih.gov/search/searchview.taf?ipid=94033
320,BC011206-08,"October 01, 2015 -  September 30, 2016",Genome wide profiling of histone variants in tumors,Yamini Praful Dalal|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Minh  Bui|Jonathan Douglas Nye|Mary Elizabeth Pitman,NULL,NULL,Aleksandra Urszula Nita-Lazar; PhD (NIAID),"1. Melters DP, Nye J, Zhao H, Dalal Y (2015). Chromatin Dynamics in Vivo: A Game of Musical Chairs. Genes (Basel)  6, 751-76.   https://doi.org/10.3390/genes6030751",https://intramural.nih.gov/search/searchview.taf?ipid=93999
321,BC011207-08,"October 01, 2015 -  September 30, 2016",Analysis of centromere identity and structure in human cells,Yamini Praful Dalal|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Minh  Bui|Swagata  Patnaik|Mary Elizabeth Pitman|Serene Angela Roque|Haiqing  Zhao,"Jennifer  Otteson (Ohio State University)|Garegin  Papaoin (University of Maryland)|Cees  Dekker (Delft University of Technology)|Yuri  Lyubchenko; PhD (Pharmaceutical Sciences, Univ. of Nebraska Medical Center)",NULL,Emilios K Dimitriadis; PhD (NIBIB) |Aleksandra Urszula Nita-Lazar; PhD (NIAID),"1. Winogradoff D, Zhao H, Dalal Y, Papoian GA (2015). Shearing of the CENP-A dimerization interface mediates plasticity in the octameric centromeric nucleosome. Sci Rep  5, 17038.   https://doi.org/10.1038/srep17038",https://intramural.nih.gov/search/searchview.taf?ipid=94000
322,BC011208-08,"October 01, 2015 -  September 30, 2016",Roles of Chromatin-modifying Factors in Epigenetic Control of the Genome,Shivinder Singh Grewal|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",NULL,Job  Dekker; PhD (University of Massachusetts)|Leonid  Mirny (Massachusetts Institute of Technology),Peter C Fitzgerald (Office of the Director)|Ming  Zhou (Nucleic Acids Section),Henry L Levin; PhD (NICHD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94009
323,BC011209-08,"October 01, 2015 -  September 30, 2016",Formation of Centromeres in vivo,Yamini Praful Dalal|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Daniel Patrick Melters|Marin Grace Olson|Mary Elizabeth Pitman|Delphine Chantal Anne Marie Quenet; PhD|David  Sturgill,"Yuri  Lyubchenko; PhD (Pharmaceutical Sciences, Univ. of Nebraska Medical Center)|Garegin  Papaoin (University of Maryland)",Karl Thomas Ried; MD (Cancer Genetics Branch),Aleksandra Urszula Nita-Lazar; PhD (NIAID),"1. Quénet D, Dalal Y (2015). Correction: a long non-coding RNA is required for targeting centromeric protein A to the human centromere. Elife  4.   https://doi.org/10.7554/eLife.07239",https://intramural.nih.gov/search/searchview.taf?ipid=94001
324,BC011211-08,"October 01, 2015 -  September 30, 2016",Subcellular protein localization in B. subtilis,Kumaran S Ramamurthi|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Amanda Rose Decker|Thomas  Delerue|Jailynn A Harke|I-Lin  Wu,"Fang  Tian (Penn State University, College of Medicine)|Kerwyn  Huang (Stanford University)",Sriram  Subramaniam; PhD (Laboratory of Cell Biology),Hari  Shroff; PhD (NIBIB) |Aravind L Iyer; PhD (NLM),"1. Fu R, Gill RL, Kim EY, Briley NE, Tyndall ER, Xu J, Li C, Ramamurthi KS, Flanagan JM, Tian F (2015). Spherical nanoparticle supported lipid bilayers for the structural study of membrane geometry-sensitive molecules. J Am Chem Soc  137, 14031-14034.   https://doi.org/10.1021/jacs.5b08303|2. Gill RL, Castaing JP, Hsin J, Tan IS, Wang X, Huang KC, Tian F, Ramamurthi KS (2015). Structural basis for the geometry-driven localization of a small protein. Proc Natl Acad Sci U S A  112, E1908-15.   https://doi.org/10.1073/pnas.1423868112|3. Tan IS, Weiss CA, Popham DL, Ramamurthi KS (2015). A Quality-Control Mechanism Removes Unfit Cells from a Population of Sporulating Bacteria. Dev Cell  34, 682-93.   https://doi.org/10.1016/j.devcel.2015.08.009|4. Wu IL, Narayan K, Castaing JP, Tian F, Subramaniam S, Ramamurthi KS (2015). A versatile nano display platform from bacterial spore coat proteins. Nat Commun  6, 6777.   https://doi.org/10.1038/ncomms7777",https://intramural.nih.gov/search/searchview.taf?ipid=94029
325,BC011212-08,"October 01, 2015 -  September 30, 2016",Functions of IKK alpha in Skin Homeostasis and Skin Tumorigenesis,Yinling  Hu|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Howard A Young; PhD|Giorgio  Trinchieri,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94012
326,BC011214-08,"October 01, 2015 -  September 30, 2016",Post-Transcriptional Regulation of Interleukin-7 Receptor Expression,Jung-Hyun  Park|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Megan A Luckey|Sujin  Hwang|Davinna Lachelle Ligons|Joo Young  Park|Adam Tully Waickman|Vanja  Lazarevic,Thomas  Hunig (University of Wuerzburg)|Scott  Walsh (University of Maryland)|Batu M Erman|Youngnim  Choi (Seoul National University),NULL,Marta Liliana Catalfamo; PhD (NIAID) |Bibiana  Bielekova; MD (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94027
327,BC011215-08,"October 01, 2015 -  September 30, 2016",Immune Regulatory Roles of Suppressor Of Cytokine Signaling (SOCS) Molecules,Jung-Hyun  Park|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Megan A Luckey|Sujin  Hwang|Davinna Lachelle Ligons|Joo Young  Park|Adam Tully Waickman|Alfred  Singer; MD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94028
328,BC011216-08,"October 01, 2015 -  September 30, 2016",Chemotactic Signals Regulating Human Neutrophil and Breast Metastatic Migration,Carole A Parent; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Song  Chen|Laquaundra Lee Hampton|Rachel Mary Lee|Daniel Lewis Letwin|Wolfgang  Losert; PhD|Ritankar  Majumdar|Show all 10,Wolfgang  Losert (University of Maryland)|Marcus  Cicerone (NIST)|Alessio  Fasano (MassGeneral Hospital),Daniel Robert Larson; PhD (Laboratory of Receptor Biology and Gene Expression),NULL,"1. Lammers KM, Chieppa M, Liu L, Liu S, Omatsu T, Janka-Junttila M, Casolaro V, Reinecker HC, Parent CA, Fasano A (2015). Gliadin Induces Neutrophil Migration via Engagement of the Formyl Peptide Receptor, FPR1. PLoS One  10, e0138338.   https://doi.org/10.1371/journal.pone.0138338|2. Lee R, Stuelten C, Parent C, Losert W (2016) Collective cell migration over long time scales reveals distinct phenotypes Convergent Science Physical Oncology 2:025001",https://intramural.nih.gov/search/searchview.taf?ipid=94026
329,BC011219-08,"October 01, 2015 -  September 30, 2016",Combination Gene Therapy and Th1-Th2 Therapy,Daniel H Fowler,NULL,"Experimental Transplantation and Immunology Branch, NCI",NULL,"Carl  June (University of Penn)|Bruce  Levine (Abramson Family Cancer Research Center, University of Pennsylvania)|Jeffrey A. Medin; PhD (University of Toronto)|Lawrence  Lum (University of Virginia)",Raffit  Hassan (Thoracic & Oncologic Surgery Branch),David F Stroncek; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94005
330,BC011220-08,"October 01, 2015 -  September 30, 2016",Understanding T Cell Rapamycin Resistance,Daniel H Fowler,NULL,"Experimental Transplantation and Immunology Branch, NCI",NULL,"Carl  June (University of Penn)|Bruce  Levine (Abramson Family Cancer Research Center, University of Pennsylvania)",NULL,David F Stroncek; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94006
331,BC011222-08,"October 01, 2015 -  September 30, 2016",CNS sirtuins in radiation-induced vascular permeability and neurodegeneration,Deedee Kay Smart|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Alexandra  Lin,NULL,NULL,NULL,"1. Shukla S, Shankavaram UT, Nguyen P, Stanley BA, Smart DK (2015). Radiation-Induced Alteration of the Brain Proteome: Understanding the Role of the Sirtuin 2 Deacetylase in a Murine Model. J Proteome Res  14, 4104-17.   https://doi.org/10.1021/acs.jproteome.5b00083",https://intramural.nih.gov/search/searchview.taf?ipid=94032
332,BC011223-08,"October 01, 2015 -  September 30, 2016",Regulation of Transcription Initiation and Elongation by O-GlcNAcylation Enzymes,Brian  Lewis,Louis  Staudt; MD,"Lymphoid Malignancies Branch, NCI",NULL,Gerald  Hart (Johns Hopkins University School of Medicine)|Alma  Burlingame (UCSF),Pradman  Qasba; PhD (Basic Research Laboratory),John Allan Hanover; PhD (NIDDK) |Keji  Zhao; PhD (NHLBI),"1. Lewis BA, Burlingame AL, Myers SA (2016). Human RNA Polymerase II Promoter Recruitment in Vitro Is Regulated by O-Linked N-Acetylglucosaminyltransferase (OGT). J Biol Chem  291, 14056-61.   https://doi.org/10.1074/jbc.M115.684365",https://intramural.nih.gov/search/searchview.taf?ipid=94022
333,BC011229-08,"October 01, 2015 -  September 30, 2016",Mechanisms of Tumor Cell Dormancy and Tumor Recurrence,Jeffrey E Green; MD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Aleksandra M Michalowska,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94008
334,BC011232-08,"October 01, 2015 -  September 30, 2016",A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead,Joseph John Barchi|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",NULL,Susan  Keay|Alex  Mackerell Jr (University of Maryland),NULL,Daron  Freedberg (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93995
335,BC011255-07,"October 01, 2015 -  September 30, 2016",Genetic Modifiers of Initiation and Progression of Mammary Cancer,Kent W Hunter; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Md Ruhul Amin|Sarah Kimberly Deasy|Ngoc-Han  Ha|Anjali  Shukla|Karol Zbigniew Szczepanek|Xinyl  Zhu|Show all 8,"Sebastian  Winkler (University of Nottingham)|Yijun  Ruan; PhD (Department of Genetic and Development Biology, Jackson Laboratory for Genomic Medicine)",NULL,Markus  Hafner (NIAMS),"1. Deasy S, Szczepanek K, Hunter K (2015) Targeting metastatic breast cancer; Problems and Potential F1000 Reviews 4:141|2. Hunter K (2015) Inherited polymorphism in metastatic breast cancer incidence and development Journal of Molecular Medicine 93:719-725",https://intramural.nih.gov/search/searchview.taf?ipid=94044
336,BC011264-07,"October 01, 2015 -  September 30, 2016",Glucocorticoids and T cell development and function,Jonathan D Ashwell; MD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Paul  Mittelstadt; PhD|Matthew Donald Taves,NULL,NULL,Dragana  Jankovic; PhD (NIAID),"1. Li CC, Munitic I, Mittelstadt PR, Castro E, Ashwell JD (2015). Suppression of Dendritic Cell-Derived IL-12 by Endogenous Glucocorticoids Is Protective in LPS-Induced Sepsis. PLoS Biol  13, e1002269.   https://doi.org/10.1371/journal.pbio.1002269",https://intramural.nih.gov/search/searchview.taf?ipid=94045
337,BC011267-07,"October 01, 2015 -  September 30, 2016",Preclinical drug development in pancreatic cancer,Udo  Rudloff|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI","Taylor James Aiken|Yansong  Bian; MD, PhD|Dandan  Li|Athina  Zacharia",Duncan  Jodrell (CRUK Cambridge Research Institute)|Jesse  Jaynes (Tuskegee University)|Michael  Baltezor (University of Kansas)|Sui  Huang (Northwestern University)|Clayton  Yates (Tuskegee University),"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Thorkell  Andresson (Office Of The Director)|Serguei V Kozlov (Office of the Director)|Jane Beth Trepel (Developmental Therapeutics Branch)|Sarangan  Ravichandran (Office Of The Director)|Shyam K Sharan (Genetics of Cancer Susceptibility Section)",Craig Joseph Thomas (NCATS) |Xin  Xu (NCATS),"1. Beane JD, Griffin KF, Levy EB, Pandalai P, Wood B, Abi-Jaoudeh N, Beresnev T, Shutack Y, Webb CC, Avital I, Rudloff U (2015). Duodenal ischemia and upper GI bleeding are dose-limiting toxicities of 24-h continuous intra-arterial pancreatic perfusion of gemcitabine following vascular isolation of the pancreatic head: early results from the Regional Chemotherapy in Locally Advanced Pancreatic Cancer (RECLAP) study. Invest New Drugs  33, 109-18.   https://doi.org/10.1007/s10637-014-0157-7|2. Feingold PL, Kwong ML, Sabesan A, Sorber R, Rudloff U (2016). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer and other less common disease histologies: is it time? J Gastrointest Oncol  7, 87-98.   https://doi.org/10.3978/j.issn.2078-6891.2015.098|3. Sorber R, Teper Y, Abisoye-Ogunniyan A, Waterfall JJ, Davis S, Killian JK, Pineda M, Ray S, McCord MR, Pflicke H, Burkett SS, Meltzer PS, Rudloff U (2016). Whole Genome Sequencing of Newly Established Pancreatic Cancer Lines Identifies Novel Somatic Mutation (c.2587G>A) in Axon Guidance Receptor Plexin A1 as Enhancer of Proliferation and Invasion. PLoS One  11, e0149833.   https://doi.org/10.1371/journal.pone.0149833",https://intramural.nih.gov/search/searchview.taf?ipid=94047
338,BC011275-07,"October 01, 2015 -  September 30, 2016",Genomic and genetic studies of endocrine cancers,Electron  Kebebew; MD|IRP Faculty Profile,NULL,"Endocrine Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94048
339,BC011282-07,"October 01, 2015 -  September 30, 2016",RNAi screen for modifiers of homologous recombination,Philipp  Oberdoerffer|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Alex Jordan Kruswick|Jinping  Liu|Andy Dong-Anh Tran; PhD,NULL,Xin Wei Wang; PhD (Molecular Genetics and Carcinogenesis Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94049
340,BC011283-07,"October 01, 2015 -  September 30, 2016","Investigating the link between DNA damage, chromatin and nuclear dysfunction",Philipp  Oberdoerffer|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Kevin  Bachrach|Zacharia  Hosseinipour|Simran  Khurana|Jeongkyu  Kim; PhD|David  Sturgill|Andy Dong-Anh Tran; PhD,NULL,Mirit I Aladjem; PhD (Developmental Therapeutics Branch),Yie  Liu; PhD (NIA),"1. Khurana S, Oberdoerffer P (2015). Replication Stress: A Lifetime of Epigenetic Change. Genes (Basel)  6, 858-77.   https://doi.org/10.3390/genes6030858|2. Kim J, Sturgill D, Tran AD, Sinclair DA, Oberdoerffer P (2016). Controlled DNA double-strand break induction in mice reveals post-damage transcriptome stability. Nucleic Acids Res  44, e64.   https://doi.org/10.1093/nar/gkv1482|3. Oberdoerffer P (2015). Stop relaxing: How DNA damage-induced chromatin compaction may affect epigenetic integrity and disease. Mol Cell Oncol  2, e970952.   https://doi.org/10.4161/23723548.2014.970952",https://intramural.nih.gov/search/searchview.taf?ipid=94050
341,BC011286-07,"October 01, 2015 -  September 30, 2016",Therapeutic targets and novel anticancer agents for endocrine cancers,Electron  Kebebew; MD|IRP Faculty Profile,NULL,"Endocrine Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94052
342,BC011287-07,"October 01, 2015 -  September 30, 2016",Clinical and genetic studies in familial nonmedullary thyroid cancer (FNMTC),Electron  Kebebew; MD|IRP Faculty Profile,NULL,"Endocrine Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94053
343,BC011293-07,"October 01, 2015 -  September 30, 2016",Epigenetic regulation of alternative pre-mRNA splicing,Shalini  Oberdoerffer|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Daniel Alejandro Arango Tamayo|Allissa  Dillman|Gelare  Ghajar-Rahimi|Mariana D Mandler|Kyster Krsna Nanan|Cody Leland Ocheltree|Show all 8,NULL,Jordan Leslie Meier; PhD (Chemical Biology Laboratory)|Kathrin  Muegge; MD (Mouse Cancer Genetics Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94055
344,BC011295-07,"October 01, 2015 -  September 30, 2016",ALL immunobiology and the bone marrow niche,Terry J Fry|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,NULL,Peter D Aplan; MD (Cancer Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94057
345,BC011298-07,"October 01, 2015 -  September 30, 2016",Phase I Trial of Radiation and Lenalidomide in Pediatric Malignant Glioma,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Sonja Kashell Crandon; RN|Terran D Stubbs,"Stewart  Goldman (Pediatric Oncology, Children's Memorial Hospital)|Sean Joseph Hipp|Mark  Atlas (Cohen Children's Medical Center)|Jason  Fangusaro (Lurie Children's Hospital)|Matthias  Karajannis (NYU Langone Medical Center)|Adam  Levy",Kevin A Camphausen; MD (Radiation Oncology Branch)|Deborah E Citrin (Radiation Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94058
346,BC011299-07,"October 01, 2015 -  September 30, 2016",Noninvasive Evaluation of Pediatric CNS Tumors,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,Roger  Packer (CNMC)|Darren  Hargrave (Great ormond Street Hospital for Children)|Gilbert  Vezina (Children's National Medical Center)|Tina  Young Poussaint (Children's Hospital)|Mark  Kieran (Children's Hospital)|Sean Joseph Hipp|Show all 7,NULL,"Nicholas  Patronas; MD (CC) |Eva Halle Baker; MD, PhD (CC) |Peter  Herscovitch; MD (CC)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94059
347,BC011303-07,"October 01, 2015 -  September 30, 2016",Role of the protein SUMOylation pathway in Ras-driven oncogenesis,Ji  Luo|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Haibo  Zhang; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94062
348,BC011304-07,"October 01, 2015 -  September 30, 2016",Methods for mammalian genetic analysis,Ji  Luo|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Abigail  Read|Fehad Jamil Khan|Garmen  Yuen,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94063
349,BC011306-07,"October 01, 2015 -  September 30, 2016",Inhibitors of protein-protein interactions,Nadya I Tarasova; PhD,Giorgio  Trinchieri,"Cancer Inflammation Program, NCI",Victor  Nelson; PhD|Bangalore K Sathyanarayana|Evan Paul Yamaguchi|Joost J Oppenheim; MD|Howard A Young; PhD|Ruth  Nussinov; PhD,Joseph R Kates|Vadim  Gaponenko|Alla  Ivanova|Olga  Timofeeva (Georgetown University)|Mercedes  Gonzalez-Juarrero (Colorado State University)|Anatoly  Drischilo (Georgetown University)|Show all 7,Michael  Dean; PhD (Laboratory Translational Genomics)|Alan O Perantoni; PhD (Cancer and Developmental Biology Laboratory)|Sergey G Tarasov (Structural Biophysics Laboratory)|Marc C Nicklaus (Chemical Biology Laboratory)|Kylie Janice Walters (Structural Biophysics Laboratory),Ola Mae Zack Howard (CSR),"1. Chavan TS, Jang H, Khavrutskii L, Abraham SJ, Banerjee A, Freed BC, Johannessen L, Tarasov SG, Gaponenko V, Nussinov R, Tarasova NI (2015). High-Affinity Interaction of the K-Ras4B Hypervariable Region with the Ras Active Site. Biophys J  109, 2602-2613.   https://doi.org/10.1016/j.bpj.2015.09.034|2. Jang H, Abraham SJ, Chavan TS, Hitchinson B, Khavrutskii L, Tarasova NI, Nussinov R, Gaponenko V (2015). Mechanisms of membrane binding of small GTPase K-Ras4B farnesylated hypervariable region. J Biol Chem  290, 9465-77.   https://doi.org/10.1074/jbc.M114.620724|3. Muratcioglu S, Chavan TS, Freed BC, Jang H, Khavrutskii L, Freed RN, Dyba MA, Stefanisko K, Tarasov SG, Gursoy A, Keskin O, Tarasova NI, Gaponenko V, Nussinov R (2015). GTP-Dependent K-Ras Dimerization. Structure  23, 1325-35.   https://doi.org/10.1016/j.str.2015.04.019",https://intramural.nih.gov/search/searchview.taf?ipid=94064
350,BC011307-07,"October 01, 2015 -  September 30, 2016",Self-assembling protoviral nanoparticles,Nadya I Tarasova; PhD,Giorgio  Trinchieri,"Cancer Inflammation Program, NCI",Lyuba Aleksandrovna Khavrutskii|Karen Marie Stefanisko|Joost J Oppenheim; MD,Joseph R Kates|Vadim  Gaponenko|Mattheas  Majestachak (Loyola University Chicago)|Steven  Ackerman; PhD (University of Illinois at Chicago),Sriram  Subramaniam; PhD (Laboratory of Cell Biology)|Sergey G Tarasov (Structural Biophysics Laboratory)|Raul Eduardo Cachau (Office Of The Director),Ola Mae Zack Howard (CSR),"1. Tripathi A, Vana PG, Chavan TS, Brueggemann LI, Byron KL, Tarasova NI, Volkman BF, Gaponenko V, Majetschak M (2015). Heteromerization of chemokine (C-X-C motif) receptor 4 with α1A/B-adrenergic receptors controls α1-adrenergic receptor function. Proc Natl Acad Sci U S A  112, E1659-68.   https://doi.org/10.1073/pnas.1417564112",https://intramural.nih.gov/search/searchview.taf?ipid=94065
351,BC011311-07,"October 01, 2015 -  September 30, 2016",Identification of genetic interactors of Brca2,Shyam K Sharan|IRP Faculty Profile,NULL,"Genetics of Cancer Susceptibility Section, NCI",NULL,"Debananda  Pati (Texas Children's Cancer Center, Baylor College of Medicine)|William  Foulkes (McGill University)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94068
352,BC011313-07,"October 01, 2015 -  September 30, 2016",Design and Utility of Novel Proteinaceous Biomaterials,Joel Patrick Schneider; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Galit  Fichman|Rebecca Natasha Freed|Poulami  Majumder|Stephen Edward Miller; PhD|Junfeng  Shi|Cem  Sonmez|Show all 8,Darrin  Pochan (University of Delaware)|Scott  Walsh (University of Maryland)|Gerald  Brandacher (Johns Hopkins University)|Eric  Furst (University of Delaware),"Scott K Durum; PhD (Cancer Inflammation Program)|Joost J Oppenheim; MD (Cancer Inflammation Program)|William G Stetler-Stevenson; MD, PhD (Radiation Oncology Branch)",Robert  Tycko; PhD (NIDDK),"1. Lindsey S, Piatt JH, Worthington P, Sönmez C, Satheye S, Schneider JP, Pochan DJ, Langhans SA (2015). Beta Hairpin Peptide Hydrogels as an Injectable Solid Vehicle for Neurotrophic Growth Factor Delivery. Biomacromolecules  16, 2672-83.   https://doi.org/10.1021/acs.biomac.5b00541|2. Micklitsch C, Medina S, Yucel T, NagySmith K, Pochan D, Schneider J (2015) Influence of hydrophobic face amino acids on the hydrogelation of #946;-hairpin peptide amphiphiles Macromolecules 48:1281-1288|3. Nagy-Smith K, Moore E, Schneider J, Tycko R (2015). Molecular structure of monomorphic peptide fibrils within a kinetically trapped hydrogel network. Proc Natl Acad Sci U S A  112, 9816-21.   https://doi.org/10.1073/pnas.1509313112|4. NagySmith K, Schneider J (2016) Peptide Hydrogel Network Electrostatics Govern Release of Encapsulated Proteins J Mat Chem B 4:1999",https://intramural.nih.gov/search/searchview.taf?ipid=94069
353,BC011314-07,"October 01, 2015 -  September 30, 2016",Development of antibacterial agents and materials,Joel Patrick Schneider; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Scott Hammond Medina; PhD|Cem  Sonmez|Stephen Edward Miller; PhD|Robert  Blumenthal; PhD,Gerald  Brandacher (Johns Hopkins University)|Brian  Bush (NIST),NULL,NULL,"1. Medina SH, Schneider JP (2015). Cancer cell surface induced peptide folding allows intracellular translocation of drug. J Control Release  209, 317-26.   https://doi.org/10.1016/j.jconrel.2015.05.267|2. Nagy-Smith K, Moore E, Schneider J, Tycko R (2015). Molecular structure of monomorphic peptide fibrils within a kinetically trapped hydrogel network. Proc Natl Acad Sci U S A  112, 9816-21.   https://doi.org/10.1073/pnas.1509313112|3. NagySmith K, Schneider J (2016) Peptide Hydrogel Network Electrostatics Govern Release of Encapsulated Proteins J Mat Chem B 4:1999",https://intramural.nih.gov/search/searchview.taf?ipid=94070
354,BC011315-07,"October 01, 2015 -  September 30, 2016",Molecular characterization of endometrial cancer,Christina M Annunziata|IRP Faculty Profile,NULL,"Womens Malignancies Branch, NCI",Kristen Paige Bunch,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94071
355,BC011319-07,"October 01, 2015 -  September 30, 2016",Role of FIR in limb morphogenesis,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao|Bau Lin Huang,NULL,David  Levens; PhD (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94073
356,BC011321-07,"October 01, 2015 -  September 30, 2016",Identification and characterization of FGF target genes,Mark B Lewandoski|IRP Faculty Profile,NULL,"Genetics of Vertebrate Development Section, NCI",Matthew J Anderson|Michael Graham Stanley Boylan|Cynthia M Elder|Maria  Kaltcheva|Aaron Christopher Raju,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94074
357,BC011324-07,"October 01, 2015 -  September 30, 2016",Polo-like kinase 1 (Plk1)-dependent centrosome maturation and spindle bipolarity,Kyung  Lee; PhD|IRP Faculty Profile,NULL,"Chemistry Section, NCI",Lingjun  Meng,Kunsoo  Rhee (Seoul National University)|Bo  Kim (Korea Research Institute of Bioscience and Biotechnology)|Raymond L Erikson,NULL,NULL,"1. Lim JM, Lee KS, Woo HA, Kang D, Rhee SG (2015). Control of the pericentrosomal H2O2 level by peroxiredoxin I is critical for mitotic progression. J Cell Biol  210, 23-33.   https://doi.org/10.1083/jcb.201412068|2. Meng L, Park JE, Kim TS, Lee EH, Park SY, Zhou M, Bang JK, Lee KS (2015). Bimodal Interaction of Mammalian Polo-Like Kinase 1 and a Centrosomal Scaffold, Cep192, in the Regulation of Bipolar Spindle Formation. Mol Cell Biol  35, 2626-40.   https://doi.org/10.1128/MCB.00068-15|3. Park CH, Park JE, Kim TS, Kang YH, Soung NK, Zhou M, Kim NH, Bang JK, Lee KS (2015). Mammalian Polo-like kinase 1 (Plk1) promotes proper chromosome segregation by phosphorylating and delocalizing the PBIP1·CENP-Q complex from kinetochores. J Biol Chem  290, 8569-81.   https://doi.org/10.1074/jbc.M114.623546",https://intramural.nih.gov/search/searchview.taf?ipid=94075
358,BC011325-07,"October 01, 2015 -  September 30, 2016",Retrovirus Biology,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Yadvinder Singh Ahi|Demetria P Harvin|Joseph Emanuele Manzi|Diborah Mengistu Yimer|Shu  Zhang|Bowen  Lian,Stephen P Goff|Heinrich  Gottlinger (University of Massachusetts Medical School)|Sara  Sukumar (Johns Hopkins Oncology Center)|Delphine  Muriaux (Centre d'Ã‰tudes d'Agents PathogÃ¨nes et Biotechnologies pour la SantÃ©)|Kenneth  Cornetta (Indiana University)|Rahm  Gummuluru (Boston University)|Show all 8,Yun Xing M Wang (Structural Biophysics Laboratory)|Stephen J Lockett; PhD (Office Of The Director)|Ulrich  Baxa; PhD (Office Of The Director)|Eric O Freed; PhD (HIV Drug Resistance Program)|Thorkell  Andresson (Office Of The Director)|Xinhua  Ji; PhD (Biomolecular Structure Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94076
359,BC011328-07,"October 01, 2015 -  September 30, 2016",Characterization of the Osteosarcoma Genome,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Sean Richard Davis; MD, PhD|Arthur A Glatfelter; MS|Heiko  Horn; PhD|Wayne Rashaan Lawrence|John E Lueders|Robert L Walker; BS|Show all 8",NULL,Sharon Ann Savage (Clinical Genetics Branch)|Lisa  Mirabello (Genetic Epidemiology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94077
360,BC011330-07,"October 01, 2015 -  September 30, 2016",Tumor heterogeneity in breast cancer brain metastasis after brain radiation,Deedee Kay Smart|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Grace  Purec,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94078
361,BC011332-07,"October 01, 2015 -  September 30, 2016",Tumor Microenvironment in Cancer Progression,Rosandra N Kaplan|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Daniel Wirth Beury|Matthew Kent Eason|Wei  Ju|Meera  Murgai|Carol J Thiele|Lee Jay Helman; MD,"Leonard  Wexler (Memorial Sloan Kettering Cancer Center)|Tanya  Trippett (Pediatrics, Memorial Sloan Kettering)|David  Lyden (Weill Cornell Medical Center)|Shahin  Rafii (Weill Cornell Medical Center)|Jackie  Bromberg (Memorial Sloan Kettering Cancer Center)|Shakeel  Modak (Memorial Sloan Kettering Cancer Center)|Show all 7",Javed  Khan; MD (Cancer Genetics Branch),NULL,"1. Murgai M, Giles A, Kaplan R (2015) Physiological, Tumor, and Metastatic Niches: Opportunities and Challenges for Targeting the Tumor Microenvironment, in Critical Reviews in Oncogenesis: The Status of Pediatric Solid Tumors in 2015, in press.|2. Chang W, Brohl AS, Patidar R, Sindiri S, Shern JF, Wei JS, Song YK, Yohe ME, Gryder B, Zhang S, Calzone KA, Shivaprasad N, Wen X, Badgett TC, Miettinen M, Hartman KR, League-Pascual JC, Trahair TN, Widemann BC, Merchant MS, Kaplan RN, Lin JC, Khan J (2016). MultiDimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A Report from the Center for Cancer Research. Clin Cancer Res  22, 3810-20.   https://doi.org/10.1158/1078-0432.CCR-15-2717|3. Giles AJ, Chien CD, Reid CM, Fry TJ, Park DM, Kaplan RN, Gilbert MR (2016). The functional interplay between systemic cancer and the hematopoietic stem cell niche. Pharmacol Ther  168, 53-60.   https://doi.org/10.1016/j.pharmthera.2016.09.006|4. Long AH, Haso WM, Shern JF, Wanhainen KM, Murgai M, Ingaramo M, Smith JP, Walker AJ, Kohler ME, Venkateshwara VR, Kaplan RN, Patterson GH, Fry TJ, Orentas RJ, Mackall CL (2015). 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors. Nat Med  21, 581-90.   https://doi.org/10.1038/nm.3838|5. Papaspyridonos M, Matei I, Huang Y, do Rosario Andre M, Brazier-Mitouart H, Waite JC, Chan AS, Kalter J, Ramos I, Wu Q, Williams C, Wolchok JD, Chapman PB, Peinado H, Anandasabapathy N, Ocean AJ, Kaplan RN, Greenfield JP, Bromberg J, Skokos D, Lyden D (2015). Id1 suppresses anti-tumour immune responses and promotes tumour progression by impairing myeloid cell maturation. Nat Commun  6, 6840.   https://doi.org/10.1038/ncomms7840",https://intramural.nih.gov/search/searchview.taf?ipid=94080
362,BC011333-07,"October 01, 2015 -  September 30, 2016",Neuropsychological outcome measures in patients receiving whole brain radiation,Deedee Kay Smart|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Diane  Rhee,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94081
363,BC011334-07,"October 01, 2015 -  September 30, 2016",Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis,Rosandra N Kaplan|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Daniel Wirth Beury|Wei  Ju|Meera  Murgai|Lee Jay Helman; MD|Katherine Elizabeth Warren; MD|Brigitte  Widemann; MD,"Leonard  Wexler (Memorial Sloan Kettering Cancer Center)|Tanya  Trippett (Pediatrics, Memorial Sloan Kettering)|Jackie  Bromberg (Memorial Sloan Kettering Cancer Center)|Shakeel  Modak (Memorial Sloan Kettering Cancer Center)|Paul  Meyers (Memorial Sloan Kettering Cancer Center)|Peter  Steinherz (Memorial Sloan Kettering Cancer Center)|Show all 7",Javed  Khan; MD (Cancer Genetics Branch)|Sharon Ann Savage (Clinical Genetics Branch),NULL,"1. Murgai M, Giles A, Kaplan R (2015) Physiological, Tumor, and Metastatic Niches: Opportunities and Challenges for Targeting the Tumor Microenvironment, in Critical Reviews in Oncogenesis: The Status of Pediatric Solid Tumors in 2015, in press.|2. Chang W, Brohl AS, Patidar R, Sindiri S, Shern JF, Wei JS, Song YK, Yohe ME, Gryder B, Zhang S, Calzone KA, Shivaprasad N, Wen X, Badgett TC, Miettinen M, Hartman KR, League-Pascual JC, Trahair TN, Widemann BC, Merchant MS, Kaplan RN, Lin JC, Khan J (2016). MultiDimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A Report from the Center for Cancer Research. Clin Cancer Res  22, 3810-20.   https://doi.org/10.1158/1078-0432.CCR-15-2717|3. Giles AJ, Reid CM, Evans JD, Murgai M, Vicioso Y, Highfill SL, Kasai M, Vahdat L, Mackall CL, Lyden D, Wexler L, Kaplan RN (2016). Activation of Hematopoietic Stem/Progenitor Cells Promotes Immunosuppression Within the Pre-metastatic Niche. Cancer Res  76, 1335-47.   https://doi.org/10.1158/0008-5472.CAN-15-0204|4. Papaspyridonos M, Matei I, Huang Y, do Rosario Andre M, Brazier-Mitouart H, Waite JC, Chan AS, Kalter J, Ramos I, Wu Q, Williams C, Wolchok JD, Chapman PB, Peinado H, Anandasabapathy N, Ocean AJ, Kaplan RN, Greenfield JP, Bromberg J, Skokos D, Lyden D (2015). Id1 suppresses anti-tumour immune responses and promotes tumour progression by impairing myeloid cell maturation. Nat Commun  6, 6840.   https://doi.org/10.1038/ncomms7840",https://intramural.nih.gov/search/searchview.taf?ipid=94082
364,BC011336-07,"October 01, 2015 -  September 30, 2016",Tools for Prediction of ADMETox Properties,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",NULL,"Ann  Richard (EPA)|Antony  Williams|Huixiao  Hong (NCI)|Kamel  Mansouri (EPA)|Barry  Bunin (Collaborative Drug Discovery (CDD), Inc.)|Alex  Clark (Molecular Materials Informatics, Inc.)",NULL,"Christopher P Austin; AB, MD (NCATS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94083
365,BC011337-07,"October 01, 2015 -  September 30, 2016",Generation of T-cell receptors recognizing antigens on non-melanoma tumors,"James Chung-Yin Yang; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Nicholas Phillip Restifo; MD,NULL,Samuel A Wells (Medical Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94084
366,BC011340-07,"October 01, 2015 -  September 30, 2016",Preclinical evaluation of novel therapeutics for CNS tumor therapy,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Rafael  Cruz Garcia|Cynthia M Lester mccully|Nalini M Jayaprakash|Robert F Murphy|Srivandana  Akshintala|Brigitte  Widemann; MD,"Jack  Kovach (Lixte)|Paul  Hergenrother (Chemistry, University of Illinois)|Siddarth  Mittra (Stanford)",William D Figg; PharmD (Genitourinary Malignancies Branch)|Cody John Peer (Office Of The Clinical Director),NULL,"1. Cole DE, Lester-McCully CM, Widemann BC, Warren KE (2015). Plasma and cerebrospinal fluid pharmacokinetics of the Akt inhibitor, perifosine, in a non-human primate model. Cancer Chemother Pharmacol  75, 923-8.   https://doi.org/10.1007/s00280-015-2711-1|2. Lester McCully CM, Bacher J, MacAllister RP, Steffen-Smith EA, Saleem K, Thomas ML, Cruz R, Warren KE (2015). Development of a cerebrospinal fluid lateral reservoir model in rhesus monkeys (Macaca mulatta). Comp Med  65, 77-82.|3. MacAllister R, McCully C, Bacher J, Thomas M, Cruz R, Wangari S, Warren K (2016) Development of a minimally invasive lumbar port model for cerebrospinal fluid collection in rhesus monkeys (Macaca mulatta). Comparative Medicine, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=94085
367,BC011343-07,"October 01, 2015 -  September 30, 2016",Clinical protocols for the treatment of gastrointestinal cancer,Tim Friedrich Greten|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",NULL,NULL,Peter L Choyke; MD (Molecular Imaging Program)|Bradford J Wood; MD (Office of the Director)|Liang  Cao (Cancer Genetics Branch)|Douglas K Price (Genitourinary Malignancies Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Sean Fitzgerald Altekruse (Surveillance Systems Branch),NULL,"1. Duffy AG, Makarova-Rusher OV, Ulahannan SV, Rahma OE, Fioravanti S, Walker M, Abdullah S, Raffeld M, Anderson V, Abi-Jaoudeh N, Levy E, Wood BJ, Lee S, Tomita Y, Trepel JB, Steinberg SM, Revenko AS, MacLeod AR, Peer CJ, Figg WD, Greten TF (2016). Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750-an antisense oligonucleotide against eIF4E-in combination with irinotecan in solid tumors and irinotecan-refractory colorectal cancer. Int J Cancer  139, 1648-57.   https://doi.org/10.1002/ijc.30199|2. Duffy AG, Ulahannan SV, Cao L, Rahma OE, Makarova-Rusher OV, Kleiner DE, Fioravanti S, Walker M, Carey S, Yu Y, Venkatesan AM, Turkbey B, Choyke P, Trepel J, Bollen KC, Steinberg SM, Figg WD, Greten TF (2015). A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib. United European Gastroenterol J  3, 453-61.   https://doi.org/10.1177/2050640615583587",https://intramural.nih.gov/search/searchview.taf?ipid=94086
368,BC011344-07,"October 01, 2015 -  September 30, 2016",Immune suppressor mechanisms in patients with GI cancer,Tim Friedrich Greten|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94087
369,BC011345-07,"October 01, 2015 -  September 30, 2016",Analysis of cancer-related immune suppressor mechanisms in mice,Tim Friedrich Greten|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",NULL,"Dean  Felsher (Division of Oncology, Stanford University School of Medicine)|Mathias  Heikenwlder (University of Munich)|Lars  Zender (University of Tubingen)","Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Masaki  Terabe (Vaccine Branch)|Giorgio  Trinchieri (Cancer Inflammation Program)|William G Telford (Experimental Transplantation and Immunology Branch)|Bradford J Wood; MD (Office of the Director)",NULL,"1. Ji J, Eggert T, Budhu A, Forgues M, Takai A, Dang H, Ye Q, Lee JS, Kim JH, Greten TF, Wang XW (2015) Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma. Hepatology 62:481-95",https://intramural.nih.gov/search/searchview.taf?ipid=94088
370,BC011351-07,"October 01, 2015 -  September 30, 2016",Bladder Cancer Program,Andrea Borghese Apolo|IRP Faculty Profile,NULL,"Genitourinary Malignancies Branch, NCI","James L Gulley; MD, PhD",Dean  Bajorin (MSKCC)|Matthew  Galsky (Mount Sinai)|Dan  Theodorescu (University of Colorado)|Jean  Hoffman-Censits (Jefferson University Hospital)|Sumanta  Pal (City of Hope)|Arthur  DeCillis (Exelixis),Maria  Merino; PhD (Laboratory of Pathology)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Donald P Bottaro; PhD (Urologic Oncology Branch)|Mark  Raffeld; MD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program),Les Roger Folio (CC) |Ashkan A Malayeri (CC),"1. Apolo A (2016) The illusion of an ideal biomarker Eur Urol Focus 1 (3):269-71|2. Apolo AB, Burger M (2015). A precision, personalized approach to the management of bladder cancer. Curr Opin Urol  25, 416-7.   https://doi.org/10.1097/MOU.0000000000000195|3. Apolo AB, Vogelzang NJ, Theodorescu D (2015). New and promising strategies in the management of bladder cancer. Am Soc Clin Oncol Educ Book   105-12  https://doi.org/10.14694/EdBook_AM.2015.35.105|4. Fakhrejahani F, Tomita Y, Maj-Hes A, Trepel JB, De Santis M, Apolo AB (2015). Immunotherapies for bladder cancer: a new hope. Curr Opin Urol  25, 586-96.   https://doi.org/10.1097/MOU.0000000000000213|5. Folio LR, Turkbey EB, Steinberg SM, Apolo AB (2015). Viable tumor volume: Volume of interest within segmented metastatic lesions, a pilot study of proposed computed tomography response criteria for urothelial cancer. Eur J Radiol  84, 1708-14.   https://doi.org/10.1016/j.ejrad.2015.05.026|6. Kurtoglu M, Davarpanah NN, Qin R, Powles T, Rosenberg JE, Apolo AB (2015). Elevating the Horizon: Emerging Molecular and Genomic Targets in the Treatment of Advanced Urothelial Carcinoma. Clin Genitourin Cancer  13, 410-20.   https://doi.org/10.1016/j.clgc.2015.02.009|7. Malayeri AA, Pattanayak P, Apolo AB (2015). Imaging muscle-invasive and metastatic urothelial carcinoma. Curr Opin Urol  25, 441-8.   https://doi.org/10.1097/MOU.0000000000000208|8. Zuo RC, Apolo AB, DiGiovanna JJ, Parnes HL, Keen CM, Nanda S, Dahut WL, Cowen EW (2015). Cutaneous adverse effects associated with the tyrosine-kinase inhibitor cabozantinib. JAMA Dermatol  151, 170-7.   https://doi.org/10.1001/jamadermatol.2014.2734",https://intramural.nih.gov/search/searchview.taf?ipid=94089
371,BC011354-07,"October 01, 2015 -  September 30, 2016",BCR Signaling in ABC DLBCL,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,NULL,Louis  Staudt; MD (Lymphoid Malignancies Branch)|Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94091
372,BC011372-06,"October 01, 2015 -  September 30, 2016",Microenvironmental regulation of glioblastoma radiosensitivity,Philip Jeffrey Tofilon|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Barbara Helen Rath|Cindy Rishma Timme|Kevin A Camphausen; MD|Uma  Shankavaram; PhD,NULL,NULL,NULL,"1. 1 Krau, 2 Myre, 3 Chan, 4 Hold, 5 Smit, 6 Shih, 7 Tofi, 8 Fine, 9 Camp (2015) A phase II study of concurrent radiation therapy, temozolomide and the histone deacetylase inhibitor Valproic Acid for newly diagnosed patients with Glioblastoma. Int J Radiat Oncol Biol Phys 92:986-992|2. Rath BH, Wahba A, Camphausen K, Tofilon PJ (2015). Coculture with astrocytes reduces the radiosensitivity of glioblastoma stem-like cells and identifies additional targets for radiosensitization. Cancer Med  4, 1705-16.   https://doi.org/10.1002/cam4.510",https://intramural.nih.gov/search/searchview.taf?ipid=94092
373,BC011373-06,"October 01, 2015 -  September 30, 2016",Radiation-induced translational control of gene expression,Philip Jeffrey Tofilon|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Stacey Lynne Lehman|Marwa Wahba Foreman|Kevin A Camphausen; MD|Uma  Shankavaram; PhD,NULL,NULL,NULL,"1. Wahba A, Rath BH, Bisht K, Camphausen K, Tofilon PJ (2016). Polysome Profiling Links Translational Control to the Radioresponse of Glioblastoma Stem-like Cells. Cancer Res  76, 3078-87.   https://doi.org/10.1158/0008-5472.CAN-15-3050",https://intramural.nih.gov/search/searchview.taf?ipid=94093
374,BC011374-06,"October 01, 2015 -  September 30, 2016",Allotransplant for DOCK8 deficiency,Dennis D Hickstein|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,NULL,"Harry Lewis Malech; MD (NIAID) |Steven M Holland; MD (NIAID) |Helen C Su; MD, PhD (NIAID)","1. Cuellar-Rodriguez J, Freeman AF, Grossman J, Su H, Parta M, Murdock H, Shah N, Bollard C, Kong HH, Moutsopoulos N, Stone K, Gea-Banacloche J, Holland SM, Hickstein DD (2015). Matched related and unrelated donor hematopoietic stem cell transplantation for DOCK8 deficiency. Biol Blood Marrow Transplant  21, 1037-45.   https://doi.org/10.1016/j.bbmt.2015.01.022",https://intramural.nih.gov/search/searchview.taf?ipid=94094
375,BC011378-06,"October 01, 2015 -  September 30, 2016",Studies of amplification in rhabdomyosarcoma,Frederic Glenn Barr|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","Bishwanath  Chatterjee; PhD|Mary Elizabeth Olanich|Stephen M Hewitt; MD, PhD|Svetlana Dmitriyevna Pack; PhD",NULL,Javed  Khan; MD (Cancer Genetics Branch)|John Frederick Shern (Pediatric Oncology Branch),NULL,"1. Womer R, Barr F, Linardic C (2015) Rhabdomyosarcoma, in Nathan  Oskis Hematology and Oncology of Infancy and Childhood, 8th Edition, in press.|2. Olanich ME, Sun W, Hewitt SM, Abdullaev Z, Pack SD, Barr FG (2015). CDK4 Amplification Reduces Sensitivity to CDK4/6 Inhibition in Fusion-Positive Rhabdomyosarcoma. Clin Cancer Res  21, 4947-59.   https://doi.org/10.1158/1078-0432.CCR-14-2955",https://intramural.nih.gov/search/searchview.taf?ipid=94095
376,BC011379-06,"October 01, 2015 -  September 30, 2016",Inhibitor Development Against the Wip1 Phosphatase,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,Ettore  Appella; MD (Chemical Immunology Section)|Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology)|Hanqiao  Feng (Laboratory Of Biochemistry & Molecular Biology),Daniel  Appella; PhD (NIDDK) |Frederick P Dyda; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94096
377,BC011381-06,"October 01, 2015 -  September 30, 2016",Brd4 is an atypical kinase that regulates transcription,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Devaiah Nanjappa Ballachanda|Sabina Izabela Hlavaty|Jie  Mu|Jocelyn D Weissman|Oliver James Hendy,NULL,Laura  Baranello (Laboratory of Pathology)|David  Levens; PhD (Laboratory of Pathology)|Jordan Leslie Meier; PhD (Chemical Biology Laboratory)|Sriram  Subramaniam; PhD (Laboratory of Cell Biology)|Soojay  Banerjee; PhD (Laboratory of Cell Biology),S Stoney  Simons; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94098
378,BC011382-06,"October 01, 2015 -  September 30, 2016",Systems-level analysis of the regulation and function of p53 dynamics,Eric  Batchelor; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Marie Deborah Gaynelle Harton; PhD|Woo Seuk  Koh|Joshua R Porter|Mark  Raffeld; MD,NULL,NULL,NULL,"1. Porter JR, Batchelor E (2015). Using computational modeling and experimental synthetic perturbations to probe biological circuits. Methods Mol Biol  1244, 259-76.   https://doi.org/10.1007/978-1-4939-1878-2_12",https://intramural.nih.gov/search/searchview.taf?ipid=94099
379,BC011383-06,"October 01, 2015 -  September 30, 2016",Transcription and Splicing Dynamics in Single Cells,Daniel Robert Larson; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",NULL,Robert  Singer (Albert Einstein College of Medicine)|Eric  Drier (Mad City Labs)|David  Auble (Univ. Virginia),Dinah  Singer; PhD (Experimental Immunology Branch)|Harold  Varmus; MD (Office Of The Director)|Jordan Leslie Meier; PhD (Chemical Biology Laboratory),"Carson C Chow; BASc, PhD (NIDDK) |Markus  Hafner (NIAMS)","1. Lenstra TL, Coulon A, Chow CC, Larson DR (2015). Single-Molecule Imaging Reveals a Switch between Spurious and Functional ncRNA Transcription. Mol Cell  60, 597-610.   https://doi.org/10.1016/j.molcel.2015.09.028",https://intramural.nih.gov/search/searchview.taf?ipid=94100
380,BC011387-06,"October 01, 2015 -  September 30, 2016",Studies of gene fusions in rhabdomyosarcoma,Frederic Glenn Barr|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Bishwanath  Chatterjee; PhD|Mary Elizabeth Olanich|Puspa Raj Pandey; PhD|Markku Martti Miettinen|Mark  Raffeld; MD,"Douglas  Hawkins (Pediatric Oncology, Children's Hosp. of Seattle)|Stephen  Skapek (The University of Chicago)|Lisa  Teot (Children's Hospital)|Mariusz  Ratajczak (University of Louisville)|Erin  Rudzinski (Oregon Health and Science University)|Julie  Gastier-Foster (Nationwide Children's Hospital)|Show all 10",Javed  Khan; MD (Cancer Genetics Branch)|John Frederick Shern (Pediatric Oncology Branch),NULL,"1. Womer R, Barr F, Linardic C (2015) Rhabdomyosarcoma, in Nathan  Oskis Hematology and Oncology of Infancy and Childhood, 8th Edition, in press.|2. Chen L, Shern JF, Wei JS, Yohe ME, Song YK, Hurd L, Liao H, Catchpoole D, Skapek SX, Barr FG, Hawkins DS, Khan J (2015). Clonality and evolutionary history of rhabdomyosarcoma. PLoS Genet  11, e1005075.   https://doi.org/10.1371/journal.pgen.1005075|3. Olanich ME, Sun W, Hewitt SM, Abdullaev Z, Pack SD, Barr FG (2015). CDK4 Amplification Reduces Sensitivity to CDK4/6 Inhibition in Fusion-Positive Rhabdomyosarcoma. Clin Cancer Res  21, 4947-59.   https://doi.org/10.1158/1078-0432.CCR-14-2955|4. Poniewierska-Baran A, Suszynska M, Sun W, Abdelbaset-Ismail A, Schneider G, Barr FG, Ratajczak MZ (2015). Human rhabdomyosarcoma cells express functional erythropoietin receptor: Potential therapeutic implications. Int J Oncol  47, 1989-97.   https://doi.org/10.3892/ijo.2015.3184|5. Sun W, Chatterjee B, Wang Y, Stevenson H, Edelman D, Meltzer P, Barr F (2015) Distinct methylation profiles characterize fusion-positive and fusion-negative rhabdomyosarcoma. Modern Pathology, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=94102
381,BC011390-06,"October 01, 2015 -  September 30, 2016",Vascular Biology Section,Pengnian Charles Lin; PhD|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Howard A Young; PhD,"Kevin  Peters (Akebia Therapeutics)|Michelle A. Petri; MD (Internal Medicine, Johns Hopkins University)|Dan  Berkowitz; MD (Johns Hopkins School of Medicine)|S  Wang (Adimmune Corporation)",Shyam K Sharan (Genetics of Cancer Susceptibility Section)|Li  Yang; PhD (Laboratory of Cancer Biology and Genetics),Maliha Rizvi Ilias (NIAID),"1. Ghose S, Min Y, Lin PC (2015). δ-Catenin activates Rho GTPase, promotes lymphangiogenesis and growth of tumor metastases. PLoS One  10, e0116338.   https://doi.org/10.1371/journal.pone.0116338|2. Kim S, Song JH, Kim S, Qu P, Martin BK, Sehareen WS, Haines DC, Lin PC, Sharan SK, Chang S (2016). Loss of oncogenic miR-155 in tumor cells promotes tumor growth by enhancing C/EBP-β-mediated MDSC infiltration. Oncotarget  7, 11094-112.   https://doi.org/10.18632/oncotarget.7150",https://intramural.nih.gov/search/searchview.taf?ipid=94103
382,BC011391-06,"October 01, 2015 -  September 30, 2016",Role of IKK alpha in lung cancer development,Yinling  Hu|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI","Howard A Young; PhD|Giorgio  Trinchieri|Dennis M Klinman; MD, PhD",Ellen  Richie (MD Anderson Cancer Center)|Michael W Karin|Xiaoxia  Li (Lerner Research Institute)|Nancy  Jenkins (Houston Methodist Research Institute),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94104
383,BC011393-06,"October 01, 2015 -  September 30, 2016",Development and regulation of stem cell lineages in skin,"Isaac Franklin Brownell; MD, PhD|IRP Faculty Profile",NULL,"Dermatology Branch, NCI",Savannah Thomas Barkdull|Amy B Coxon|Lingling  Miao|Daniel Thomas Thoresen|Ying  Xiao|Keisuke  Nagao|Show all 7,Radhika  Atit (Case Western Reserve University)|Sunny  Wong (University of Michigan),NULL,NULL,"1. Xiao Y, Thoresen DT, Williams JS, Wang C, Perna J, Petrova R, Brownell I (2015). Neural Hedgehog signaling maintains stem cell renewal in the sensory touch dome epithelium. Proc Natl Acad Sci U S A  112, 7195-200.   https://doi.org/10.1073/pnas.1504177112",https://intramural.nih.gov/search/searchview.taf?ipid=94106
384,BC011394-06,"October 01, 2015 -  September 30, 2016",Molecular pathogenesis of Merkel cell carcinoma,"Isaac Franklin Brownell; MD, PhD|IRP Faculty Profile",NULL,"Dermatology Branch, NCI",Tiffany Monique Alexander|Savannah Thomas Barkdull|Amy B Coxon|Tara Beth Gelb|Natasha Tremayne Hill; PhD|Lingling  Miao|Show all 10,"Klaus  Busam (Memorial Sloan-Kettering)|Daniel  Coit (Memorial Sloan-Kettering)|Jedd  Wolchok (Memorial Sloan-Kettering)|Emily Yu-Kuang Chu; MD, PhD|Clayton  Green (Marshfield Clinic)|Bahar  Dasgeb (Memorial Sloan Ketting Cancer Center)|Show all 8","Christopher  Buck (Laboratory of Cellular Oncology)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Chyi-Chia Richard Lee (Laboratory of Pathology)|Claudia Mercedes Palena (Laboratory of Tumor Immunology and Biology)",Jay Robert Knutson; PhD (NHLBI) |Amir Hossein Gandjbakhche; PhD (NICHD) |Matthew David Hall (NCATS) |Madhu A Lal (NCATS),"1. Gaiser MR, Daily K, Hoffmann J, Brune M, Enk A, Brownell I (2015). Evaluating blood levels of neuron specific enolase, chromogranin A, and circulating tumor cells as Merkel cell carcinoma biomarkers. Oncotarget  6, 26472-82.   https://doi.org/10.18632/oncotarget.4500|2. Pulitzer MP, Brannon AR, Berger MF, Louis P, Scott SN, Jungbluth AA, Coit DG, Brownell I, Busam KJ (2015). Cutaneous squamous and neuroendocrine carcinoma: genetically and immunohistochemically different from Merkel cell carcinoma. Mod Pathol  28, 1023-32.   https://doi.org/10.1038/modpathol.2015.60",https://intramural.nih.gov/search/searchview.taf?ipid=94107
385,BC011398-06,"October 01, 2015 -  September 30, 2016",Regulation of Ciliogenesis and Ciliary-related signaling,Christopher John Westlake; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Deborah K Morrison,Andrew  Peden (University of Sheffield)|Esben  Lorentzen (Max Plank Institute for  Biochemistry)|Jeffery  Axelrod (Standford),Kedar  Narayan (Office of the Director)|Sriram  Subramaniam; PhD (Laboratory of Cell Biology),Anand  Swaroop; PhD (NEI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94109
386,BC011405-06,"October 01, 2015 -  September 30, 2016",microRNA Profiling in the Spectrum of Kidney Tumors,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Mark  Raffeld; MD,NULL,"William Marston Linehan; MD (Urologic Oncology Branch)|Ramaprasad  Srinivasan; MD, PhD (Urologic Oncology Branch)","Karel  Pacak; MD, PhD (NICHD)","1. Lang M, Vocke CD, Merino MJ, Schmidt LS, Linehan WM (2015). Mitochondrial DNA mutations distinguish bilateral multifocal renal oncocytomas from familial Birt-Hogg-Dubé tumors. Mod Pathol  28, 1458-69.   https://doi.org/10.1038/modpathol.2015.101",https://intramural.nih.gov/search/searchview.taf?ipid=94110
387,BC011406-06,"October 01, 2015 -  September 30, 2016",miRNA profiling  of prostate cancer in young and older male patients,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",David D Roberts; PhD,NULL,Peter L Choyke; MD (Molecular Imaging Program)|Peter A Pinto; MD (Urologic Oncology Branch)|William Laurence Dahut; MD (Office Of The Clinical Director),NULL,"1. Bi M, Zhao S, Said JW, Merino MJ, Adeniran AJ, Xie Z, Nawaf CB, Choi J, Belldegrun AS, Pantuck AJ, Kluger HM, Bilgüvar K, Lifton RP, Shuch B (2016). Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma. Proc Natl Acad Sci U S A  113, 2170-5.   https://doi.org/10.1073/pnas.1525735113|2. Brown AM, Lindenberg ML, Sankineni S, Shih JH, Johnson LM, Pruthy S, Kurdziel KA, Merino MJ, Wood BJ, Pinto PA, Choyke PL, Turkbey B (2015). Does focal incidental 18F-FDG PET/CT uptake in the prostate have significance? Abdom Imaging  40, 3222-9.   https://doi.org/10.1007/s00261-015-0520-y|3. Logan JK, Rais-Bahrami S, Merino MJ, Pinto PA (2015). Upgrading prostate cancer following proton beam therapy. Urol Ann  7, 262-4.   https://doi.org/10.4103/0974-7796.152944|4. Mertan FV, Greer MD, Borofsky S, Kabakus IM, Merino MJ, Wood BJ, Pinto PA, Choyke PL, Turkbey B (2016). Multiparametric Magnetic Resonance Imaging of Recurrent Prostate Cancer. Top Magn Reson Imaging  25, 139-47.   https://doi.org/10.1097/RMR.0000000000000088|5. Muller BG, Kaushal A, Sankineni S, Lita E, Hoang AN, George AK, Rais-Bahrami S, Kruecker J, Yan P, Xu S, de la Rosette JJ, Merino MJ, Wood BJ, Pinto PA, Choyke PL, Turkbey B (2015). Multiparametric magnetic resonance imaging-transrectal ultrasound fusion-assisted biopsy for the diagnosis of local recurrence after radical prostatectomy. Urol Oncol  33, 425.e1-425.e6.   https://doi.org/10.1016/j.urolonc.2015.05.021|6. Muller BG, Shih JH, Sankineni S, Marko J, Rais-Bahrami S, George AK, de la Rosette JJ, Merino MJ, Wood BJ, Pinto P, Choyke PL, Turkbey B (2015). Prostate Cancer: Interobserver Agreement and Accuracy with the Revised Prostate Imaging Reporting and Data System at Multiparametric MR Imaging. Radiology  277, 741-50.   https://doi.org/10.1148/radiol.2015142818|7. Okoro C, George AK, Siddiqui MM, Rais-Bahrami S, Walton-Diaz A, Shakir NA, Rothwax JT, Raskolnikov D, Stamatakis L, Su D, Turkbey B, Choyke PL, Merino MJ, Parnes HL, Wood BJ, Pinto PA (2015). Magnetic Resonance Imaging/Transrectal Ultrasonography Fusion Prostate Biopsy Significantly Outperforms Systematic 12-Core Biopsy for Prediction of Total Magnetic Resonance Imaging Tumor Volume in Active Surveillance Patients. J Endourol  29, 1115-21.   https://doi.org/10.1089/end.2015.0027|8. Sankineni S, George AK, Brown AM, Rais-Bahrami S, Wood BJ, Merino MJ, Pinto PA, Choyke PL, Turkbey B (2015). Posterior subcapsular prostate cancer: identification with mpMRI and MRI/TRUS fusion-guided biopsy. Abdom Imaging  40, 2557-65.   https://doi.org/10.1007/s00261-015-0426-8|9. Siddiqui MM, George AK, Rubin R, Rais-Bahrami S, Parnes HL, Merino MJ, Simon RM, Turkbey B, Choyke PL, Wood BJ, Pinto PA (2016). Efficiency of Prostate Cancer Diagnosis by MR/Ultrasound Fusion-Guided Biopsy vs Standard Extended-Sextant Biopsy for MR-Visible Lesions. J Natl Cancer Inst  108.   https://doi.org/10.1093/jnci/djw039|10. Siddiqui MM, Rais-Bahrami S, Turkbey B, George AK, Rothwax J, Shakir N, Okoro C, Raskolnikov D, Parnes HL, Linehan WM, Merino MJ, Simon RM, Choyke PL, Wood BJ, Pinto PA (2015). Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA  313, 390-7.   https://doi.org/10.1001/jama.2014.17942|11. Walton Diaz A, Shakir NA, George AK, Rais-Bahrami S, Turkbey B, Rothwax JT, Stamatakis L, Hong CW, Siddiqui MM, Okoro C, Raskolnikov D, Su D, Shih J, Han H, Parnes HL, Merino MJ, Simon RM, Wood BJ, Choyke PL, Pinto PA (2015). Use of serial multiparametric magnetic resonance imaging in the management of patients with prostate cancer on active surveillance. Urol Oncol  33, 202.e1-202.e7.   https://doi.org/10.1016/j.urolonc.2015.01.023",https://intramural.nih.gov/search/searchview.taf?ipid=94111
388,BC011407-06,"October 01, 2015 -  September 30, 2016",Establishment of an International DIPG Registry,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Joshua Norman Baugh,Maryam  Fouladi (Cincinnati Children's Hospital Center)|Dannis  van Vuurden (VU University medical Center)|Darren  Hargrave (Great ormond Street Hospital for Children)|Jacques  Grill (Gustave Roussy Institute)|Chris  Jones (Institute of Cancer Research)|Gilbert  Vezina (Children's National Medical Center)|Show all 8,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94112
389,BC011408-06,"October 01, 2015 -  September 30, 2016",Comparison of substrate specificities of wild type and mutant EGFR kinases,Udayan  Guha|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Tapan Kumar Maity,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94113
390,BC011410-06,"October 01, 2015 -  September 30, 2016",Protein phosphorylation downstream of mutant EGFR kinases,Udayan  Guha|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Tapan Kumar Maity|Abhilash  Venugopalan|Xu  Zhang,"Andrea  Califano; PhD|Teresa  Fan (University of Louisville)|Cathy  Wu (Protein Information Resource, Georgetown University)",NULL,NULL,"1. Maity TK, Venugopalan A, Linnoila I, Cultraro CM, Giannakou A, Nemati R, Zhang X, Webster JD, Ritt D, Ghosal S, Hoschuetzky H, Simpson RM, Biswas R, Politi K, Morrison DK, Varmus HE, Guha U (2015). Loss of MIG6 Accelerates Initiation and Progression of Mutant Epidermal Growth Factor Receptor-Driven Lung Adenocarcinoma. Cancer Discov  5, 534-49.   https://doi.org/10.1158/2159-8290.CD-14-0750|2. Zhang X, Belkina N, Jacob HK, Maity T, Biswas R, Venugopalan A, Shaw PG, Kim MS, Chaerkady R, Pandey A, Guha U (2015). Identifying novel targets of oncogenic EGF receptor signaling in lung cancer through global phosphoproteomics. Proteomics  15, 340-55.   https://doi.org/10.1002/pmic.201400315",https://intramural.nih.gov/search/searchview.taf?ipid=94114
391,BC011412-06,"October 01, 2015 -  September 30, 2016",Role of MIG6 in mutant EGFR-driven lung tumorigenesis,Udayan  Guha|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Constance M Cultraro|Nina Gabrielle Monkash|Abhilash  Venugopalan,NULL,"Robert Mark Simpson; DVM, PhD (Laboratory of Cancer Biology and Genetics)",Xiaoyuan  Chen; PhD (NIBIB),"1. Maity TK, Venugopalan A, Linnoila I, Cultraro CM, Giannakou A, Nemati R, Zhang X, Webster JD, Ritt D, Ghosal S, Hoschuetzky H, Simpson RM, Biswas R, Politi K, Morrison DK, Varmus HE, Guha U (2015). Loss of MIG6 Accelerates Initiation and Progression of Mutant Epidermal Growth Factor Receptor-Driven Lung Adenocarcinoma. Cancer Discov  5, 534-49.   https://doi.org/10.1158/2159-8290.CD-14-0750",https://intramural.nih.gov/search/searchview.taf?ipid=94116
392,BC011413-06,"October 01, 2015 -  September 30, 2016",Autologous T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor,James N Kochenderfer|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Victoria  Shi|Ronald E Gress; MD|Frances  Hakim; PhD,NULL,Stefania  Pittaluga (Laboratory of Pathology),David F Stroncek; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94117
393,BC011414-06,"October 01, 2015 -  September 30, 2016",Identification of potentially active tyrosine kinases in lung cancer,Udayan  Guha|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Tapan Kumar Maity,Marc  Ladanyi (Memorial Sloan-Kettering Cancer Center)|Todd  Golub (Broad Institute of MIT and Harvard),"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94118
394,BC011415-06,"October 01, 2015 -  September 30, 2016",Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor,James N Kochenderfer|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Ronald E Gress; MD|Frances  Hakim; PhD|Luca  Gattinoni,NULL,"Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94119
395,BC011417-06,"October 01, 2015 -  September 30, 2016",New Chimeric Antigen Receptors for Treating Hematologic Malignancies,James N Kochenderfer|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Leah Marie Alabanza|Victoria  Shi|Ronald E Gress; MD|Frances  Hakim; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94120
396,BC011418-06,"October 01, 2015 -  September 30, 2016",Modulating Cancer Stem Cell Signaling in Thoracic Malignancies,David  Schrump; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI","Colleen Donahue Bond|Julie A Hong|Mahadev  Rao|Vivek  Shukla; BSc, MSc|Sichuan  Xi|Mary R Zhang|Show all 8",NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|William D Figg; PharmD (Genitourinary Malignancies Branch)|Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Karl Thomas Ried; MD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94121
397,BC011419-06,"October 01, 2015 -  September 30, 2016",Structural Biology of GTPase Activating Proteins,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Jess R Li|Yifei  Li|Cameron Lynn McGlone,NULL,"Paul A Randazzo; MD, PhD (Laboratory of Cellular and Molecular Biology)|Di S Xia; PhD, MS, BS (Crystallography Section)",NULL,"1. Jian X, Tang WK, Zhai P, Roy NS, Luo R, Gruschus JM, Yohe ME, Chen PW, Li Y, Byrd RA, Xia D, Randazzo PA (2015). Molecular Basis for Cooperative Binding of Anionic Phospholipids to the PH Domain of the Arf GAP ASAP1. Structure  23, 1977-88.   https://doi.org/10.1016/j.str.2015.08.008",https://intramural.nih.gov/search/searchview.taf?ipid=94122
398,BC011422-05,"October 01, 2015 -  September 30, 2016",Role of IKK alpha in lymphoid organ development,Yinling  Hu|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI","Giorgio  Trinchieri|Dennis M Klinman; MD, PhD",Ellen  Richie (MD Anderson Cancer Center)|Michael W Karin|Xiaoxia  Li (Lerner Research Institute)|Florian  Greten (The International Max Planck Research School for Molecular and Cellular Life Sciences),David  Schrump; MD (Thoracic & Oncologic Surgery Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94143
399,BC011423-05,"October 01, 2015 -  September 30, 2016",Epigenetic studies in rhabdomyosarcoma,Frederic Glenn Barr|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Bishwanath  Chatterjee; PhD|Wenyue  Sun,Mariusz  Ratajczak (University of Louisville)|Corinne  Linardic (Duke University),"Javed  Khan; MD (Cancer Genetics Branch)|John Frederick Shern (Pediatric Oncology Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"1. Womer R, Barr F, Linardic C (2015) Rhabdomyosarcoma, in Nathan  Oskis Hematology and Oncology of Infancy and Childhood, 8th Edition, in press.|2. Poniewierska-Baran A, Schneider G, Sun W, Abdelbaset-Ismail A, Barr FG, Ratajczak MZ (2016). Human rhabdomyosarcoma cells express functional pituitary and gonadal sex hormone receptors: Therapeutic implications. Int J Oncol  48, 1815-24.   https://doi.org/10.3892/ijo.2016.3439|3. Poniewierska-Baran A, Suszynska M, Sun W, Abdelbaset-Ismail A, Schneider G, Barr FG, Ratajczak MZ (2015). Human rhabdomyosarcoma cells express functional erythropoietin receptor: Potential therapeutic implications. Int J Oncol  47, 1989-97.   https://doi.org/10.3892/ijo.2015.3184|4. Sun W, Chatterjee B, Wang Y, Stevenson H, Edelman D, Meltzer P, Barr F (2015) Distinct methylation profiles characterize fusion-positive and fusion-negative rhabdomyosarcoma. Modern Pathology, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=94149
400,BC011424-05,"October 01, 2015 -  September 30, 2016",Bone Marrow Stromal Cells as Mitigators of Radiation Injury,Deborah E Citrin|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Nicholas Ryan Boris|Su Im Chung; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94139
401,BC011426-05,"October 01, 2015 -  September 30, 2016",HIV-1 Integrase,Stephen H Hughes; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Andrea L Ferris|Steven J Smith|David  Wells,"Eddy  Arnold; PhD (Chemistry and Chemical Biology, CABM and Rutgers University)|Zandrea  Ambrose (University of Pittsburgh)|Alan  Engelman; PhD (Dana-Farber, Harvard University)|Stefan  Sarafianos (Department of Molecular Microbiology & Immunology, University of Missouri School of Medicine)|Peter  Cherepanov (Imperial College London)|Eric  Poeschla (University of Colorado)|Show all 11",Gary T Pauly (Chemical Biology Laboratory)|Frank  Maldarelli (Host Virus Interaction Branch)|Xiaolin  Wu; PhD (Office Of The Director)|Jeffrey D Lifson; MD (Office Of The Director)|Mary  Kearney (Host Virus Interaction Branch)|Terrence R Burke; PhD (Chemical Biology Laboratory),Henry L Levin; PhD (NICHD) |Daniel C Douek; MD (NIAID),"1. Noh KM, Wang H, Kim HR, Wenderski W, Fang F, Li CH, Dewell S, Hughes SH, Melnick AM, Patel DJ, Li H, Allis CD (2015). Engineering of a Histone-Recognition Domain in Dnmt3a Alters the Epigenetic Landscape and Phenotypic Features of Mouse ESCs. Mol Cell  59, 89-103.   https://doi.org/10.1016/j.molcel.2015.05.017|2. Singh PK, Plumb MR, Ferris AL, Iben JR, Wu X, Fadel HJ, Luke BT, Esnault C, Poeschla EM, Hughes SH, Kvaratskhelia M, Levin HL (2015). LEDGF/p75 interacts with mRNA splicing factors and targets HIV-1 integration to highly spliced genes. Genes Dev  29, 2287-97.   https://doi.org/10.1101/gad.267609.115|3. Skaar JR, Ferris AL, Wu X, Saraf A, Khanna KK, Florens L, Washburn MP, Hughes SH, Pagano M (2015). The Integrator complex controls the termination of transcription at diverse classes of gene targets. Cell Res  25, 288-305.   https://doi.org/10.1038/cr.2015.19",https://intramural.nih.gov/search/searchview.taf?ipid=94123
402,BC011427-05,"October 01, 2015 -  September 30, 2016",Immunohistochemical analysis of tumors,Markku Martti Miettinen|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","Eva Adelina Chavez|Shingo  Inaguma; MD, PhD|Jerzy P Lasota|Zengfeng  Wang; PhD",NULL,NULL,NULL,"1. Miettinen M, McCue PA, Sarlomo-Rikala M, Biernat W, Czapiewski P, Kopczynski J, Thompson LD, Lasota J, Wang Z, Fetsch JF (2015). Sox10--a marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: a systematic analysis of 5134 tumors. Am J Surg Pathol  39, 826-35.   https://doi.org/10.1097/PAS.0000000000000398|2. Miettinen M, Wang Z, Lasota J, Heery C, Schlom J, Palena C (2015). Nuclear Brachyury Expression Is Consistent in Chordoma, Common in Germ Cell Tumors and Small Cell Carcinomas, and Rare in Other Carcinomas and Sarcomas: An Immunohistochemical Study of 5229 Cases. Am J Surg Pathol  39, 1305-12.   https://doi.org/10.1097/PAS.0000000000000462",https://intramural.nih.gov/search/searchview.taf?ipid=94150
403,BC011429-05,"October 01, 2015 -  September 30, 2016",Zbtb family members in lymphocyte differentiation and function,Damian  Kovalovsky; PhD,NULL,"Experimental Immunology Branch, NCI",NULL,NULL,NULL,NULL,"1. Lu Y, Cao X, Zhang X, Kovalovsky D (2015). PLZF Controls the Development of Fetal-Derived IL-17+Vγ6+ γδ T Cells. J Immunol  195, 4273-81.   https://doi.org/10.4049/jimmunol.1500939",https://intramural.nih.gov/search/searchview.taf?ipid=94155
404,BC011431-05,"October 01, 2015 -  September 30, 2016",Role of T-bet in the pathogenesis of experimental autoimmune encephalomyelitis,Vanja  Lazarevic|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",NULL,NULL,NULL,Dorian  McGavern (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94153
405,BC011432-05,"October 01, 2015 -  September 30, 2016",Regulation of T-bet expression in TH17 cells by microRNAs,Vanja  Lazarevic|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94154
406,BC011433-05,"October 01, 2015 -  September 30, 2016",The role of coherent angular motion in adult tissue remodeling,Kandice Danielle Tanner; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Alexus Seniqua Eunique Devine|Colin Dowlin Paul; PhD|Jack Rory Staunton; PhD,NULL,NULL,NULL,"1. Kim J, Staunton JR, Tanner K (2016). Independent Control of Topography for 3D Patterning of the ECM Microenvironment. Adv Mater  28, 132-7.   https://doi.org/10.1002/adma.201503950|2. Kim J, Tanner K (2016). Three-Dimensional Patterning of the ECM Microenvironment Using Magnetic Nanoparticle Self Assembly. Curr Protoc Cell Biol  70, 25.3.1-25.3.14.   https://doi.org/10.1002/0471143030.cb2503s70",https://intramural.nih.gov/search/searchview.taf?ipid=94157
407,BC011436-05,"October 01, 2015 -  September 30, 2016",Retroviral Replication and Interactions with Host Factors,Vinay K Pathak; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Ryan C Burdick|Krista A Delviks-Frankenberry|Sanath Kumar  Janaka|Jayalaxmi  Sastri|Wei-Shau  Hu; PhD,NULL,Sriram  Subramaniam; PhD (Laboratory of Cell Biology),NULL,"1. Nikolaitchik O, Keele B, Gorelick R, Alvord WG, Mazurov D, Pathak VK, Hu WS (2015). High recombination potential of subtype A HIV-1. Virology  484, 334-40.   https://doi.org/10.1016/j.virol.2015.06.025",https://intramural.nih.gov/search/searchview.taf?ipid=94126
408,BC011437-05,"October 01, 2015 -  September 30, 2016",Combinatorial genetic analysis using validated siRNA libraries,Ji  Luo|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Chih-Shia  Lee,Frank  McCormick (UCSF School of Medicine)|Scott  Lowe (Cold Spring Harbor Laboratory),Natasha  Caplen (Cancer Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94145
409,BC011438-05,"October 01, 2015 -  September 30, 2016",Genetic screens for target discovery in cancer,Ji  Luo|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Garmen  Yuen|Haibo  Zhang; PhD|Abigail  Read|Glenn  Merlino; PhD|Li  Yang; PhD,NULL,NULL,J Silvio  Gutkind; PhD (NIDCR),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94146
410,BC011439-05,"October 01, 2015 -  September 30, 2016",Development of Chimeric Antigen Receptors Targeting Multiple Myeloma,James N Kochenderfer|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Leah Marie Alabanza|Victoria  Shi|Ronald E Gress; MD|Frances  Hakim; PhD,NULL,Steven A Feldman (Surgery Branch)|Ira H Pastan; MD (Molecular Biology Section),David F Stroncek; MD (CC) |Irina  Maric; MD (CC),"1. Brudno JN, Kochenderfer JN (2016). Toxicities of chimeric antigen receptor T cells: recognition and management. Blood  127, 3321-30.   https://doi.org/10.1182/blood-2016-04-703751",https://intramural.nih.gov/search/searchview.taf?ipid=94140
411,BC011441-05,"October 01, 2015 -  September 30, 2016",Cell density effects on therapeutic sensitivity,Jayne M Stommel|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Alan Surya Halim|Diane Marie Kambach|Qian  Sun|Kevin A Camphausen; MD,Keith  Ligon (Dana-Farber Cancer Institute)|Cameron  Brennan (Memorial Sloan-Kettering Cancer Center),Natasha  Caplen (Cancer Genetics Branch)|Ettore  Appella; MD (Chemical Immunology Section)|Eric  Batchelor; PhD (Laboratory of Pathology)|Rosandra N Kaplan (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94147
412,BC011443-05,"October 01, 2015 -  September 30, 2016",Single-Molecule Spectroscopy of HIV-1 Replication Complexes,Stuart F J Le Grice; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94125
413,BC011446-05,"October 01, 2015 -  September 30, 2016",The ClpP protease as a therapeutic target in bacterial and mammalian cells,Michael  Maurizi; PhD|IRP Faculty Profile,NULL,"Biochemistry of Proteins Section, NCI",NULL,NULL,NULL,Anton  Simeonov (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94127
414,BC011447-05,"October 01, 2015 -  September 30, 2016",Early Clinical Trials for Children with CNS Tumors,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Terran D Stubbs|Sonja Kashell Crandon; RN|Pamela  Wolters|John Walter Glod,"Susan  Blaney (Baylor University/TCCC)|Roger  Packer (CNMC)|Stewart  Goldman (Pediatric Oncology, Children's Memorial Hospital)|Maryam  Fouladi (Cincinnati Children's Hospital Center)|James  Boyett (St Jude Children's Research Hospital)|Mark  Kieran (Children's Hospital)|Show all 10",Aradhana  Kaushal (Radiation Oncology Branch)|William D Figg; PharmD (Genitourinary Malignancies Branch)|Mark Richard Gilbert; MD (Neuro-Oncology Branch),"Nicholas  Patronas; MD (CC) |Russell R Lonser; MD (NINDS) |Eva Halle Baker; MD, PhD (CC) |John D Heiss; MD (NINDS)","1. Shah NN, Cole DE, Lester-McCully CM, Wayne AS, Warren KE, Widemann BC (2016). Plasma and cerebrospinal fluid pharmacokinetics of vincristine and vincristine sulfate liposomes injection (VSLI, marqibo®) after intravenous administration in Non-human primates. Invest New Drugs  34, 61-5.   https://doi.org/10.1007/s10637-015-0311-x",https://intramural.nih.gov/search/searchview.taf?ipid=94137
415,BC011449-05,"October 01, 2015 -  September 30, 2016",Identification of Inhibitors of Protein Sumoylation,John Stephen Schneekloth|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",William Merton Hewitt|Katherine Hannah Zlotkowski,NULL,Barry R O'Keefe (Molecular Targets Laboratory)|Kirk R Gustafson; PhD (Molecular Targets Laboratory)|David S Waugh; PhD (Protein Engineering Section),NULL,"1. Leyva MJ, Kim YS, Peach ML, Schneekloth JS (2015). Synthetic derivatives of the SUMO consensus sequence provide a basis for improved substrate recognition. Bioorg Med Chem Lett  25, 2146-51.   https://doi.org/10.1016/j.bmcl.2015.03.069|2. Suzawa M, Miranda DA, Ramos KA, Ang KK, Faivre EJ, Wilson CG, Caboni L, Arkin MR, Kim YS, Fletterick RJ, Diaz A, Schneekloth JS, Ingraham HA (2015). A gene-expression screen identifies a non-toxic sumoylation inhibitor that mimics SUMO-less human LRH-1 in liver. Elife  4.   https://doi.org/10.7554/eLife.09003",https://intramural.nih.gov/search/searchview.taf?ipid=94151
416,BC011450-05,"October 01, 2015 -  September 30, 2016",Clinical treatment of advanced Merkel cell carcinoma,"Isaac Franklin Brownell; MD, PhD|IRP Faculty Profile",NULL,"Dermatology Branch, NCI",Heidi H Kong,Klaus  Busam (Memorial Sloan-Kettering)|Daniel  Coit (Memorial Sloan-Kettering)|Jedd  Wolchok (Memorial Sloan-Kettering)|Sandra  D'Angelo (Memorial Sloan-Kettering Cancer Center),"Christopher  Buck (Laboratory of Cellular Oncology)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Christopher Ryan Heery; MD (Laboratory of Tumor Immunology and Biology)",NULL,"1. Cassler NM, Merrill D, Bichakjian CK, Brownell I (2016). Merkel Cell Carcinoma Therapeutic Update. Curr Treat Options Oncol  17, 36.   https://doi.org/10.1007/s11864-016-0409-1|2. Kaufman HL, Russell J, Hamid O, Bhatia S, Terheyden P, D'Angelo SP, Shih KC, Lebbé C, Linette GP, Milella M, Brownell I, Lewis KD, Lorch JH, Chin K, Mahnke L, von Heydebreck A, Cuillerot JM, Nghiem P (2016). Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial. Lancet Oncol  17, 1374-1385.   https://doi.org/10.1016/S1470-2045(16)30364-3",https://intramural.nih.gov/search/searchview.taf?ipid=94148
417,BC011458-05,"October 01, 2015 -  September 30, 2016",Molecular Targeted Photoimmunotherapy for Bladder Cancer,Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Reema Sunil Railkar|Thomas  Sanford,NULL,Hisataka  Kobayashi (Molecular Imaging Program)|Peter L Choyke; MD (Molecular Imaging Program)|John  Schiller; PhD (Laboratory of Cellular Oncology)|Anu  Puri; PhD (Gene Regulation and Chromosome Biology Laboratory)|Mathias  Viard (Gene Regulation and Chromosome Biology Laboratory)|Martin John Schnermann; PhD (Chemical Biology Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94156
418,BC011459-05,"October 01, 2015 -  September 30, 2016",Control of centrosome biogenesis,Jadranka  Loncarek|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Kristina Marie Cronise|Dong  Kong; PhD|Anil Kumar Shukla|Alejandra  Vasquez Limeta; PhD|Allan M Weissman; MD,NULL,NULL,NULL,"1. Shukla A, Kong D, Sharma M, Magidson V, Loncarek J (2015). Plk1 relieves centriole block to reduplication by promoting daughter centriole maturation. Nat Commun  6, 8077.   https://doi.org/10.1038/ncomms9077",https://intramural.nih.gov/search/searchview.taf?ipid=94152
419,BC011460-05,"October 01, 2015 -  September 30, 2016",BKV and JCV vaccine development,Christopher  Buck|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Diana  Pastrana|Alberto  Peretti; PhD,Paola  Cinque (San Raffaele Milan)|Patrick  McTamney,NULL,NULL,"1. Ray U, Cinque P, Gerevini S, Longo V, Lazzarin A, Schippling S, Martin R, Buck CB, Pastrana DV (2015). JC polyomavirus mutants escape antibody-mediated neutralization. Sci Transl Med  7, 306ra151.   https://doi.org/10.1126/scitranslmed.aab1720",https://intramural.nih.gov/search/searchview.taf?ipid=94129
420,BC011461-05,"October 01, 2015 -  September 30, 2016",HIV-1 evasion of cytosolic nucleic acid sensors,Vineet Narain KewalRamani; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Szu-Wei  Huang; PhD|Kyeongeun  Lee|Hyun Jae  Yu|Lu  Zhu,NULL,Bruce Allen Shapiro; PhD (Gene Regulation and Chromosome Biology Laboratory)|Stephen H Hughes; PhD (Retroviral Replication Laboratory),NULL,"1. Afonin KA, Viard M, Kagiampakis I, Case CL, Dobrovolskaia MA, Hofmann J, Vrzak A, Kireeva M, Kasprzak WK, KewalRamani VN, Shapiro BA (2015). Triggering of RNA interference with RNA-RNA, RNA-DNA, and DNA-RNA nanoparticles. ACS Nano  9, 251-9.   https://doi.org/10.1021/nn504508s|2. Gupta K, Afonin KA, Viard M, Herrero V, Kasprzak W, Kagiampakis I, Kim T, Koyfman AY, Puri A, Stepler M, Sappe A, KewalRamani VN, Grinberg S, Linder C, Heldman E, Blumenthal R, Shapiro BA (2015). Bolaamphiphiles as carriers for siRNA delivery: From chemical syntheses to practical applications. J Control Release  213, 142-151.   https://doi.org/10.1016/j.jconrel.2015.06.041",https://intramural.nih.gov/search/searchview.taf?ipid=94124
421,BC011464-05,"October 01, 2015 -  September 30, 2016",Clinical Interventional Studies of HIV Reservoirs,Frank  Maldarelli|IRP Faculty Profile,NULL,"Host Virus Interaction Branch, NCI",Elizabeth M Anderson|Jennifer Marie Bell|Giorgio  Bozzi|Monica Ann Gouzoulis|Shawn A Hill|Camille Marie Lange; PhD|Show all 8,Anuradha  Ganesan (Henry M. Jackson Foundation)|John W Mellors|Deborah  McMahon (University of Pittsburgh)|Erin  Reid (University of California San Diego)|Jantenat  Ananworanich (HIV Netherlands Australia Thailand Research Collaboration (HIV/NAT))|John  Coffin (Tufts University)|Show all 12,"Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Kieron Michael Dunleavy (Lymphoid Malignancies Branch)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Bradford J Wood; MD (Office of the Director)|Robert  Gorelick (Office Of The Director)",Henry  Masur; MD (CC) |Richard T Davey; MD (NIAID) |H. Clifford  Lane; MD (NIAID) |Joann  Mican; MD (NIAID) |Stephen A Migueles; MD (NIAID) |Irini  Sereti; MD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94130
422,BC011465-05,"October 01, 2015 -  September 30, 2016",c-Myc Function,David  Levens; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Laura  Baranello|Fedor Edmundovich Kouzine|Zuqin  Nie; PhD|Suzanne Laurie Sanford|Lipeng  Wu|Ying  Zheng,NULL,NULL,Keji  Zhao; PhD (NHLBI) |Rafael Cristian Casellas; PhD (NIAMS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94128
423,BC011466-05,"October 01, 2015 -  September 30, 2016",HIV Persistence During Suppressive Antiretroviral Therapy,Frank  Maldarelli|IRP Faculty Profile,NULL,"Host Virus Interaction Branch, NCI",Elizabeth M Anderson|Jennifer Marie Bell|Giorgio  Bozzi|Shawn A Hill|Camille Marie Lange; PhD|Sarah Anne Watters|Show all 7,Anuradha  Ganesan (Henry M. Jackson Foundation)|John W Mellors|Deborah  McMahon (University of Pittsburgh)|Jantenat  Ananworanich (HIV Netherlands Australia Thailand Research Collaboration (HIV/NAT))|John  Coffin (Tufts University),Stephen H Hughes; PhD (Retroviral Replication Laboratory)|Vinay K Pathak; PhD (Retroviral Replication Laboratory)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch),Henry  Masur; MD (CC) |Richard T Davey; MD (NIAID) |Michael  Polis; MD (NIAID) |Mark  Connors; MD (NIAID) |H. Clifford  Lane; MD (NIAID) |Joann  Mican; MD (NIAID),"1. Desimmie BA, Burdick RC, Izumi T, Doi H, Shao W, Alvord WG, Sato K, Koyanagi Y, Jones S, Wilson E, Hill S, Maldarelli F, Hu WS, Pathak VK (2016). APOBEC3 proteins can copackage and comutate HIV-1 genomes. Nucleic Acids Res  44, 7848-65.   https://doi.org/10.1093/nar/gkw653|2. Maldarelli F (2016). The role of HIV integration in viral persistence: no more whistling past the proviral graveyard. J Clin Invest  126, 438-47.   https://doi.org/10.1172/JCI80564",https://intramural.nih.gov/search/searchview.taf?ipid=94131
424,BC011469-05,"October 01, 2015 -  September 30, 2016",Building Libraries with Chemical Diversity for Screening,John A Beutler,James  McMahon; PhD,"Molecular Targets Laboratory, NCI",Timothy Leonard Bostaph|Ekaterina  Goncharo|Cheryl L Thomas,John  Porco (Boston University)|Peter  Wipf (University of Pittsburgh)|B.  Shen (Scripps Research Institute)|Sergazy  Adekenov (International Research and Production Holding Phytochemistry)|Darkan  Balpanaov (Biomedpreparat)|Young Ho  Kim|Show all 9,NULL,NULL,"1. Qin T, Iwata T, Ransom TT, Beutler JA, Porco JA (2015). Syntheses of Dimeric Tetrahydroxanthones with Varied Linkages: Investigation of ""Shapeshifting"" Properties. J Am Chem Soc  137, 15225-33.   https://doi.org/10.1021/jacs.5b09825",https://intramural.nih.gov/search/searchview.taf?ipid=94133
425,BC011470-05,"October 01, 2015 -  September 30, 2016",Development of Natural Product Leads as Anticancer Therapeutics,John A Beutler,James  McMahon; PhD,"Molecular Targets Laboratory, NCI",Namki  Cho|Sarah Ann Long|Sett Hmue Naing,"William  Chain (University of Hawaii)|Kathlyn  Parker (Stony Brook University)|Antonio  Echavarren (Institute of Chemical Research of Catalonia)|Ryan  Murelli (Brooklyn College)|David  Wiemer (organic synthesis/molecular target identification, University of Iowa)|David  Beech (University of Leeds School of Medicine)","Stuart F J Le Grice; PhD (Basic Research Laboratory)|Karlyne M Reilly; BS, PhD (Office of the Director)|William Marston Linehan; MD (Urologic Oncology Branch)|Leonard  Neckers; PhD (Urologic Oncology Branch)",Kapil  Bharti; PhD (NEI),"1. D'Erasmo M, Masaoka T, Wilson J, Beutler J, Le Grice S, Murelli R (2016) Traceless solid-phase alpha-hydroxytropolone synthesis. MedChemComm, in press.|2. Masaoka T, Zhao H, Hirsch DR, D'Erasmo MP, Meck C, Varnado B, Gupta A, Meyers MJ, Baines J, Beutler JA, Murelli RP, Tang L, Le Grice SF (2016). Characterization of the C-Terminal Nuclease Domain of Herpes Simplex Virus pUL15 as a Target of Nucleotidyltransferase Inhibitors. Biochemistry  55, 809-19.   https://doi.org/10.1021/acs.biochem.5b01254|3. Murelli R, D'Erasmo M, Hirsch D, Meck C, Masaoka T, Wilson J, Zhang B, Pal R, Gallichio E, Beutler J, Le Grice S (2016) Synthetic alpha-hydroxytropolones as inhibitors of HIV ribonuclease H activity. MedChemComm, in press.|4. Sourbier C, Scroggins BT, Mannes PZ, Liao PJ, Siems K, Wolf D, Beutler JA, Linehan WM, Neckers L (2015). Tonantzitlolone cytotoxicity toward renal cancer cells is PKCθ- and HSF1-dependent. Oncotarget  6, 29963-74.   https://doi.org/10.18632/oncotarget.4676|5. Zhao H, Lin Z, Lynn AY, Varnado B, Beutler JA, Murelli RP, Le Grice SF, Tang L (2015). Two distinct modes of metal ion binding in the nuclease active site of a viral DNA-packaging terminase: insight into the two-metal-ion catalytic mechanism. Nucleic Acids Res  43, 11003-16.   https://doi.org/10.1093/nar/gkv1018",https://intramural.nih.gov/search/searchview.taf?ipid=94134
426,BC011471-05,"October 01, 2015 -  September 30, 2016",Cell-free assay technologies for the identification of active compounds,Barry R O'Keefe,James  McMahon; PhD,"Molecular Targets Laboratory, NCI",Kirk R Gustafson; PhD,NULL,"Jonathan D Ashwell; MD (Laboratory of Immune Cell Biology)|Louis  Staudt; MD (Lymphoid Malignancies Branch)|John Stephen Schneekloth (Chemical Biology Laboratory)|Stanley  Lipkowitz; MD, PhD (Womens Malignancies Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Stuart F J Le Grice; PhD (Basic Research Laboratory)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94135
427,BC011472-05,"October 01, 2015 -  September 30, 2016",Isolation of antiviral proteins from natural product extracts,Barry R O'Keefe,James  McMahon; PhD,"Molecular Targets Laboratory, NCI",NULL,"Kenneth E. Palmer; PhD (Department of Pharmacology and Toxicology, University of Louisville)|Lynn  Morris (National Institute for Communicable Diseases)|Edward  Karamov (Ivanovsky Institute of Virology)|Elibio  Rech (Embrapa, Brasil)|Paul  Christou (Universitat de Lleida)|Robert Walter Buckheit (RETROVIRAL REPLICATION LABORATORY)|Show all 7",Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94136
428,BC011476-04,"October 01, 2015 -  September 30, 2016",Studies of the fate of environmental contaminants in humans and animals,Linda Silber Birnbaum; PhD|IRP Faculty Profile,NULL,"Office of the Director, NCI",Sherry Jones Coulter; BS|Gabriel Arther Knudsen|J Michael Sanders; PhD|Samantha Marie Hall,Marian  Pavuk (CDC)|Arnold  Schecter (NIEHS)|Hoang  Quynh (University of Hanoi)|Steven T Szabo|Michael  Hughes (U.S. Environmental Protection Agency)|Matthew  Lorber (U.S. Environmental Protection Agency),NULL,"Gaylia Jean Harry; PhD (NIEHS) |Stavros  Garantziotis; MD (NIEHS) |Kristina Thayer Chialton; PhD (NIEHS) |Douglas  Bell; PhD (NIEHS) |Suzanne Elizabeth Fenton; MS, PhD (NIEHS) |Shepherd H Schurman; MD (NIEHS)","1. Birnbaum LS, Dutton ND, Cusack C, Mennemeyer ST, Pavuk M (2016). Anniston community health survey: Follow-up and dioxin analyses (ACHS-II)--methods. Environ Sci Pollut Res Int  23, 2014-21.   https://doi.org/10.1007/s11356-015-4684-3|2. Dinse GE, Jusko TA, Whitt IZ, Co CA, Parks CG, Satoh M, Chan EK, Rose KM, Walker NJ, Birnbaum LS, Zeldin DC, Weinberg CR, Miller FW (2016). Associations Between Selected Xenobiotics and Antinuclear Antibodies in the National Health and Nutrition Examination Survey, 1999-2004. Environ Health Perspect  124, 426-36.   https://doi.org/10.1289/ehp.1409345|3. Knudsen GA, Hughes MF, McIntosh KL, Sanders JM, Birnbaum LS (2015). Estimation of tetrabromobisphenol A (TBBPA) percutaneous uptake in humans using the parallelogram method. Toxicol Appl Pharmacol  289, 323-9.   https://doi.org/10.1016/j.taap.2015.09.012",https://intramural.nih.gov/search/searchview.taf?ipid=94200
429,BC011478-04,"October 01, 2015 -  September 30, 2016",Tumor infiltrating lymphocyte therapy for human papillomavirus-positive cancers,Christian S Hinrichs|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Stacey Lynn Doran; MD|Sarah Rachel Helman|Sanja  Stevanovic; PhD,NULL,NULL,NULL,"1. Stevanović S, Draper LM, Langhan MM, Campbell TE, Kwong ML, Wunderlich JR, Dudley ME, Yang JC, Sherry RM, Kammula US, Restifo NP, Rosenberg SA, Hinrichs CS (2015). Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells. J Clin Oncol  33, 1543-50.   https://doi.org/10.1200/JCO.2014.58.9093",https://intramural.nih.gov/search/searchview.taf?ipid=94184
430,BC011479-04,"October 01, 2015 -  September 30, 2016",T-cell receptor gene therapy for human papillomavirus-positive cancers,Christian S Hinrichs|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Tracy Erin Campbell|Stacey Lynn Doran; MD|Benjamin Yongzhu Jin|Sanja  Stevanovic; PhD|Ling  Zhang|Sarah Rachel Helman,NULL,Christina M Annunziata (Womens Malignancies Branch),David F Stroncek; MD (CC),"1. Draper LM, Kwong ML, Gros A, Stevanović S, Tran E, Kerkar S, Raffeld M, Rosenberg SA, Hinrichs CS (2015). Targeting of HPV-16+ Epithelial Cancer Cells by TCR Gene Engineered T Cells Directed against E6. Clin Cancer Res  21, 4431-9.   https://doi.org/10.1158/1078-0432.CCR-14-3341|2. Hinrichs CS (2016). Molecular Pathways: Breaking the Epithelial Cancer Barrier for Chimeric Antigen Receptor and T-cell Receptor Gene Therapy. Clin Cancer Res  22, 1559-64.   https://doi.org/10.1158/1078-0432.CCR-15-1294",https://intramural.nih.gov/search/searchview.taf?ipid=94185
431,BC011480-04,"October 01, 2015 -  September 30, 2016",Programming T Cell Fates for Therapeutic Use,Luca  Gattinoni|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",James N Kochenderfer,"Pedro  Romero; MD (Ludwig Center for Cancer Research, University of Lausanne)|Timothy  Bender (University of Virginia)|Yi  Zhang (Temple University)",Nicholas Phillip Restifo; MD (Surgery Branch)|Terry J Fry (Pediatric Oncology Branch),"David F Stroncek; MD (CC) |Mario  Roederer; PhD (NIAID) |Stefan Adi Muljo; PhD (NIAID) |Toren  Finkel; MD, PhD (NHLBI)","1. Crompton JG, Narayanan M, Cuddapah S, Roychoudhuri R, Ji Y, Yang W, Patel SJ, Sukumar M, Palmer DC, Peng W, Wang E, Marincola FM, Klebanoff CA, Zhao K, Tsang JS, Gattinoni L, Restifo NP (2016). Lineage relationship of CD8(+) T cell subsets is revealed by progressive changes in the epigenetic landscape. Cell Mol Immunol  13, 502-13.   https://doi.org/10.1038/cmi.2015.32|2. Fowler DH, Gattinoni L (2016). T memory stem cell formation: Caveat mTOR. EBioMedicine  4, 3-4.   https://doi.org/10.1016/j.ebiom.2016.02.019|3. Gattinoni L (2015). The dark side of T memory stem cells. Blood  125, 3519-20.   https://doi.org/10.1182/blood-2015-04-640631|4. Ji Y, Gattinoni L (2015). miR-155 releases the brakes on antitumor T cells. Oncoimmunology  4, e1026533.   https://doi.org/10.1080/2162402X.2015.1026533|5. Ji Y, Wrzesinski C, Yu Z, Hu J, Gautam S, Hawk NV, Telford WG, Palmer DC, Franco Z, Sukumar M, Roychoudhuri R, Clever D, Klebanoff CA, Surh CD, Waldmann TA, Restifo NP, Gattinoni L (2015). miR-155 augments CD8+ T-cell antitumor activity in lymphoreplete hosts by enhancing responsiveness to homeostatic γc cytokines. Proc Natl Acad Sci U S A  112, 476-81.   https://doi.org/10.1073/pnas.1422916112|6. Sabatino M, Hu J, Sommariva M, Gautam S, Fellowes V, Hocker JD, Dougherty S, Qin H, Klebanoff CA, Fry TJ, Gress RE, Kochenderfer JN, Stroncek DF, Ji Y, Gattinoni L (2016). Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignancies. Blood  128, 519-28.   https://doi.org/10.1182/blood-2015-11-683847",https://intramural.nih.gov/search/searchview.taf?ipid=94167
432,BC011485-04,"October 01, 2015 -  September 30, 2016",Forkhead-box (FOX) Transcription Factors in the Progression of Pancreatic Cancer,Syed Perwez  Hussain|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI",NULL,NULL,Karl Thomas Ried; MD (Cancer Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94166
433,BC011486-04,"October 01, 2015 -  September 30, 2016",Development of Novel Agents Active against Hepatitis B Virus,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI",Manabu  Aoki; PhD|Debananda  Das; PhD|Nicole  Delino|Yuki  Takamatsu; MD,"Masayuki  Amano (Kumamoto University School of Medicine)|Eiichi  Kodama (Kyoto University)|Stefan  Sarafianos (Department of Molecular Microbiology & Immunology, University of Missouri School of Medicine)|Yasuhito  Tanaka (na)|Sanae  Hayashi (Nagoya City University Graduate School of Medical Sciences)|Shuhei  Imoto (Sojo University)|Show all 10",David J Venzon; PhD (Biostatistics and Data Management Section),NULL,"1. Takamatsu Y, Tanaka Y, Kohgo S, Murakami S, Singh K, Das D, Venzon DJ, Amano M, Higashi-Kuwata N, Aoki M, Delino NS, Hayashi S, Takahashi S, Sukenaga Y, Haraguchi K, Sarafianos SG, Maeda K, Mitsuya H (2015). 4'-modified nucleoside analogs: potent inhibitors active against entecavir-resistant hepatitis B virus. Hepatology  62, 1024-36.   https://doi.org/10.1002/hep.27962",https://intramural.nih.gov/search/searchview.taf?ipid=94160
434,BC011487-04,"October 01, 2015 -  September 30, 2016",Systems-level analysis of the regulation and function of c-Myc,Eric  Batchelor; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Joshua R Porter|David  Levens; PhD|David D Roberts; PhD,NULL,NULL,NULL,"1. Zhou W, Chung YJ, Parrilla Castellar ER, Zheng Y, Chung HJ, Bandle R, Liu J, Tessarollo L, Batchelor E, Aplan PD, Levens D (2016). Far Upstream Element Binding Protein Plays a Crucial Role in Embryonic Development, Hematopoiesis, and Stabilizing Myc Expression Levels. Am J Pathol  186, 701-15.   https://doi.org/10.1016/j.ajpath.2015.10.028",https://intramural.nih.gov/search/searchview.taf?ipid=94187
435,BC011488-04,"October 01, 2015 -  September 30, 2016",Defining and Manipulating Epigenomic Regulators in Endogenous Systems,Jordan Leslie Meier; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Arissa Elene Bavari|Julie Marie Garlick|Rhushikesh Arun Kulkarni; PhD|David Church Montgomery|Jonathan Harold Shrimp|Nicholas Gregory Vlassopoulos|Show all 8,NULL,Shalini  Oberdoerffer (Laboratory of Receptor Biology and Gene Expression)|Carol J Thiele (Pediatric Oncology Branch)|William Marston Linehan; MD (Urologic Oncology Branch),Anton  Simeonov (NCATS) |Ajit  Jadhav (NCATS) |David J Maloney (NCATS),"1. Montgomery DC, Sorum AW, Guasch L, Nicklaus MC, Meier JL (2015). Metabolic Regulation of Histone Acetyltransferases by Endogenous Acyl-CoA Cofactors. Chem Biol  22, 1030-1039.   https://doi.org/10.1016/j.chembiol.2015.06.015|2. Montgomery DC, Sorum AW, Meier JL (2015). Defining the orphan functions of lysine acetyltransferases. ACS Chem Biol  10, 85-94.   https://doi.org/10.1021/cb500853p|3. Zengeya TT, Kulkarni RA, Meier JL (2015). Modular synthesis of cell-permeating 2-ketoglutarate esters. Org Lett  17, 2326-9.   https://doi.org/10.1021/acs.orglett.5b00737",https://intramural.nih.gov/search/searchview.taf?ipid=94196
436,BC011490-04,"October 01, 2015 -  September 30, 2016",Ubiquitin signaling for protein degradation,Kylie Janice Walters|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Sergey G Tarasov,Daniel  Finley (Harvard Medical School)|Richard  Roden (The Johns Hopkins University)|Heran  Darwin (NYU)|Lan  Huang|Engen  John (Northeastern University),Nadya I Tarasova; PhD (Cancer Inflammation Program),NULL,"1. Chen X, Walters KJ (2015). Structural plasticity allows UCH37 to be primed by RPN13 or locked down by INO80G. Mol Cell  57, 767-768.   https://doi.org/10.1016/j.molcel.2015.02.025|2. Lu X, Liu F, Durham SE, Tarasov SG, Walters KJ (2015). A High Affinity hRpn2-Derived Peptide That Displaces Human Rpn13 from Proteasome in 293T Cells. PLoS One  10, e0140518.   https://doi.org/10.1371/journal.pone.0140518",https://intramural.nih.gov/search/searchview.taf?ipid=94197
437,BC011491-04,"October 01, 2015 -  September 30, 2016",Role of kinetochore proteins in chromosome segregation,Alexander Ernest Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Mary Kate  Bonner; PhD|Julian Bernd Haase|Hyunmi Kim Halas; PhD|Jason T Swinderman,NULL,NULL,Nasser M Rusan; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94195
438,BC011492-04,"October 01, 2015 -  September 30, 2016","Biomarkers in Cancer Diagnosis, Prognosis and Therapeutic Outcome",Curtis  Harris; MD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI","Elise Dawn Bowman|Kristen Leigh Greathouse|Majda  Haznadar|Teruhide  Ishigame; PhD, MD|Mohammed A. Khan; PhD|Ezra  Margono|Show all 12","Jun  Yokota (National Cancer Center Research Institute)|Ping  Yang; MD, PhD (Mayo Clinic)|Wataru  Yasui (Hiroshima University)","Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)|Frank Jess Gonzalez; PhD (Laboratory of Metabolism)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"1. Hiyoshi Y, Schetter AJ, Okayama H, Inamura K, Anami K, Nguyen GH, Horikawa I, Hawkes JE, Bowman ED, Leung SY, Harris CC (2015). Increased microRNA-34b and -34c predominantly expressed in stromal tissues is associated with poor prognosis in human colon cancer. PLoS One  10, e0124899.   https://doi.org/10.1371/journal.pone.0124899|2. Hur K, Toiyama Y, Schetter AJ, Okugawa Y, Harris CC, Boland CR, Goel A (2015). Identification of a metastasis-specific MicroRNA signature in human colorectal cancer. J Natl Cancer Inst  107.   https://doi.org/10.1093/jnci/dju492|3. Inamura K, Yamauchi M, Nishihara R, Kim SA, Mima K, Sukawa Y, Li T, Yasunari M, Zhang X, Wu K, Meyerhardt JA, Fuchs CS, Harris CC, Qian ZR, Ogino S (2015). Prognostic significance and molecular features of signet-ring cell and mucinous components in colorectal carcinoma. Ann Surg Oncol  22, 1226-1235.   https://doi.org/10.1245/s10434-014-4159-7|4. Iwakawa R, Kohno T, Totoki Y, Shibata T, Tsuchihara K, Mimaki S, Tsuta K, Narita Y, Nishikawa R, Noguchi M, Harris CC, Robles AI, Yamaguchi R, Imoto S, Miyano S, Totsuka H, Yoshida T, Yokota J (2015). Expression and clinical significance of genes frequently mutated in small cell lung cancers defined by whole exome/RNA sequencing. Carcinogenesis  36, 616-21.   https://doi.org/10.1093/carcin/bgv026|5. Machiela MJ, Zhou W, Sampson JN, Dean MC, Jacobs KB, Black A, Brinton LA, Chang IS, Chen C, Chen C, Chen K, Cook LS, Crous Bou M, De Vivo I, Doherty J, Friedenreich CM, Gaudet MM, Haiman CA, Hankinson SE, Hartge P, Henderson BE, Hong YC, Hosgood HD, Hsiung CA, Hu W, et al. [174 more authors] (2015). Characterization of large structural genetic mosaicism in human autosomes. Am J Hum Genet  96, 487-97.   https://doi.org/10.1016/j.ajhg.2015.01.011|6. Robles AI, Arai E, Mathé EA, Okayama H, Schetter AJ, Brown D, Petersen D, Bowman ED, Noro R, Welsh JA, Edelman DC, Stevenson HS, Wang Y, Tsuchiya N, Kohno T, Skaug V, Mollerup S, Haugen A, Meltzer PS, Yokota J, Kanai Y, Harris CC (2015). An Integrated Prognostic Classifier for Stage I Lung Adenocarcinoma Based on mRNA, microRNA, and DNA Methylation Biomarkers. J Thorac Oncol  10, 1037-48.   https://doi.org/10.1097/JTO.0000000000000560|7. Sun B, Wang Y, Kota K, Shi Y, Motlak S, Makambi K, Loffredo CA, Shields PG, Yang Q, Harris CC, Zheng YL (2015) Telomere length variation: A potential new telomere biomarker for lung cancer risk. Lung Cancer 88:297-303",https://intramural.nih.gov/search/searchview.taf?ipid=94162
439,BC011495-04,"October 01, 2015 -  September 30, 2016",Integrative Molecular Epidemiology of Human Cancer,Curtis  Harris; MD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Elise Dawn Bowman|Mohammed A. Khan; PhD|Akihiko  Miyanaga; MD|Ana  Robles|Elisa A Spillare|Ashley Joy Vargas|Show all 8,NULL,"Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)",NULL,"1. Greathouse KL, Harris CC, Bultman SJ (2015). Dysfunctional families: Clostridium scindens and secondary bile acids inhibit the growth of Clostridium difficile. Cell Metab  21, 9-10.   https://doi.org/10.1016/j.cmet.2014.12.016|2. Mima K, Sukawa Y, Nishihara R, Qian ZR, Yamauchi M, Inamura K, Kim SA, Masuda A, Nowak JA, Nosho K, Kostic AD, Giannakis M, Watanabe H, Bullman S, Milner DA, Harris CC, Giovannucci E, Garraway LA, Freeman GJ, Dranoff G, Chan AT, Garrett WS, Huttenhower C, Fuchs CS, Ogino S (2015). Fusobacterium nucleatum and T Cells in Colorectal Carcinoma. JAMA Oncol  1, 653-61.   https://doi.org/10.1001/jamaoncol.2015.1377|3. Robles AI, Traverso G, Zhang M, Roberts NJ, Khan MA, Joseph C, Lauwers GY, Selaru FM, Popoli M, Pittman ME, Ke X, Hruban RH, Meltzer SJ, Kinzler KW, Vogelstein B, Harris CC, Papadopoulos N (2016). Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers. Gastroenterology  150, 931-43.   https://doi.org/10.1053/j.gastro.2015.12.036",https://intramural.nih.gov/search/searchview.taf?ipid=94163
440,BC011496-04,"October 01, 2015 -  September 30, 2016","p53, Aging, and Cancer",Curtis  Harris; MD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI","Fatima  Alam|Tomer  Cooks|Izumi  Horikawa|Teruhide  Ishigame; PhD, MD|Kazunobu  Isogaya|Delphine  Lissa; PHARMD, PhD|Show all 9",NULL,Ettore  Appella; MD (Chemical Immunology Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94164
441,BC011501-04,"October 01, 2015 -  September 30, 2016",Regulation and functional effects of localized RNAs,Stavroula  Mili|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Vikraant  Kohli|Michael Scott Stueland|Tianhong  Wang|Kyota  Yasuda; PhD,Helim  Aranda-Espinoza (University of Maryland)|James  Shorter (MIT),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94192
442,BC011502-04,"October 01, 2015 -  September 30, 2016",Characterization of Biological Nanoparticle Subsets,"Jennifer Clare Jones; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Zachary Vincent Braig|Bryce William Killingsworth|Aizea  Morales Kastresana|Marjorie  Robert-Guroff; PhD|Jay Arthur Berzofsky; MD, PhD|Katherine M McKinnon|Show all 8",Marty  Bigos (Stanford)|David  Park (Stanford)|Susan  Knox (Stanford)|Vasilis  Toxavidis (Beth Israel Deaconess Medical Center)|Tigges  John (BIDMC)|Sally Penny  Chisholm (MIT)|Show all 8,"William G Telford (Experimental Transplantation and Immunology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Anu  Puri; PhD (Gene Regulation and Chromosome Biology Laboratory)|Aparna Hemant Kesarwala (Radiation Oncology Branch)|Peter L Choyke; MD (Molecular Imaging Program)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)",Marc  Ferrer-Alegre (NCATS),"1. Morales Kastresana A, Jones J (2016) Flow Cytometry for Extracellular Vesicles, in Methods in Molecular Biology: Exosomes and Microvesicles, in press.|2. Danielson KM, Estanislau J, Tigges J, Toxavidis V, Camacho V, Felton EJ, Khoory J, Kreimer S, Ivanov AR, Mantel PY, Jones J, Akuthota P, Das S, Ghiran I (2016). Diurnal Variations of Circulating Extracellular Vesicles Measured by Nano Flow Cytometry. PLoS One  11, e0144678.   https://doi.org/10.1371/journal.pone.0144678|3. Ma C, Kesarwala AH, Eggert T, Medina-Echeverz J, Kleiner DE, Jin P, Stroncek DF, Terabe M, Kapoor V, ElGindi M, Han M, Thornton AM, Zhang H, Egger M, Luo J, Felsher DW, McVicar DW, Weber A, Heikenwalder M, Greten TF (2016). NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis. Nature  531, 253-7.   https://doi.org/10.1038/nature16969",https://intramural.nih.gov/search/searchview.taf?ipid=94193
443,BC011503-04,"October 01, 2015 -  September 30, 2016",Novel Combinations of Radiation and Immunotherapy,"Jennifer Clare Jones; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Aizea  Morales Kastresana|Zachary Vincent Braig|Jay Arthur Berzofsky; MD, PhD|George N Pavlakis; MD, PhD",Gordon  Freeman (Harvard)|Dale  Umetsu (Children's Hospital Boston)|Rosemarie  DeKruyff (Children's Hospital Boston)|Susan  Knox (Stanford),"Kevin A Camphausen; MD (Radiation Oncology Branch)|Tim Friedrich Greten (Thoracic & Oncologic Surgery Branch)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Christopher Ryan Heery; MD (Laboratory of Tumor Immunology and Biology)",NULL,"1. Crittenden M, Kohrt H, Levy R, Jones J, Camphausen K, Dicker A, Demaria S, Formenti S (2015). Current clinical trials testing combinations of immunotherapy and radiation. Semin Radiat Oncol  25, 54-64.   https://doi.org/10.1016/j.semradonc.2014.07.003",https://intramural.nih.gov/search/searchview.taf?ipid=94194
444,BC011504-04,"October 01, 2015 -  September 30, 2016",Study the roles of p53 and p53 mutants in mesenchymal stem cells,Jing  Huang|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Shunlin  Jiang|Min Hwa  Shin|Glenn  Merlino; PhD,NULL,Jianxin  Shi (Biostatistics Branch),Pamela Gehron Robey; PhD (NIDCR) |Chengyu  Liu; PhD (NHLBI),"1. He Y, de Castro LF, Shin MH, Dubois W, Yang HH, Jiang S, Mishra PJ, Ren L, Gou H, Lal A, Khanna C, Merlino G, Lee M, Robey PG, Huang J (2015). p53 loss increases the osteogenic differentiation of bone marrow stromal cells. Stem Cells  33, 1304-19.   https://doi.org/10.1002/stem.1925",https://intramural.nih.gov/search/searchview.taf?ipid=94176
445,BC011505-04,"October 01, 2015 -  September 30, 2016",Characterization of the hematopoietic stem cell lineage,Mark B Lewandoski|IRP Faculty Profile,NULL,"Genetics of Vertebrate Development Section, NCI",Matthew J Anderson|Cynthia M Elder,NULL,Jonathan  Keller; PhD (Mouse Cancer Genetics Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94159
446,BC011506-04,"October 01, 2015 -  September 30, 2016",New Synthetic Approaches to Small Molecules for Imaging,Martin John Schnermann; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Joseph Stephen Capani|Alexander Patrick Gorka|Megan Suzanne Michie|Roger Rauhauser Nani|Roshan Subramanya Rao,NULL,Hisataka  Kobayashi (Molecular Imaging Program)|Kirk R Gustafson; PhD (Molecular Targets Laboratory),NULL,"1. Nani RR, Shaum JB, Gorka AP, Schnermann MJ (2015). Electrophile-integrating Smiles rearrangement provides previously inaccessible C4'-O-alkyl heptamethine cyanine fluorophores. Org Lett  17, 302-5.   https://doi.org/10.1021/ol503398f|2. Patel NJ, Manivannan E, Joshi P, Ohulchanskyy TJ, Nani RR, Schnermann MJ, Pandey RK (2015). Impact of Substituents in Tumor Uptake and Fluorescence Imaging Ability of Near-Infrared Cyanine-like Dyes. Photochem Photobiol  91, 1219-30.   https://doi.org/10.1111/php.12482|3. Sato K, Nagaya T, Nakamura Y, Harada T, Nani RR, Shaum JB, Gorka AP, Kim I, Paik CH, Choyke PL, Schnermann MJ, Kobayashi H (2015). Impact of C4'-O-Alkyl Linker on in Vivo Pharmacokinetics of Near-Infrared Cyanine/Monoclonal Antibody Conjugates. Mol Pharm  12, 3303-11.   https://doi.org/10.1021/acs.molpharmaceut.5b00472",https://intramural.nih.gov/search/searchview.taf?ipid=94191
447,BC011511-04,"October 01, 2015 -  September 30, 2016",Chemical Targeting of Multi-Protein Complexes,Federico  Bernal|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Francisco Antonio Aguilar Alonso; PhD|Amanda Lee Whiting,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94182
448,BC011512-04,"October 01, 2015 -  September 30, 2016",Activatable molecular cancer imaging probe,Hisataka  Kobayashi|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",NULL,Yasuteru  Urano|Marcin  Ptaszek (UMBC)|Yu  Chen (Univ of Maryland)|Neil  Bander (Cornell Univ),Terry Anne Van Dyke (Office of the Director)|Martin John Schnermann; PhD (Chemical Biology Laboratory),NULL,"1. Asanuma D, Sakabe M, Kamiya M, Yamamoto K, Hiratake J, Ogawa M, Kosaka N, Choyke PL, Nagano T, Kobayashi H, Urano Y (2015) Sensitive -galactosidase-targeting fluorescence probe for visualizing small peritoneal metastatic tumours in vivo. Nat Commun 6:6463|2. Nakamura Y, Harada T, Nagaya T, Sato K, Okuyama S, Choyke PL, Kobayashi H (2016). Dynamic fluorescent imaging with the activatable probe, γ-glutamyl hydroxymethyl rhodamine green in the detection of peritoneal cancer metastases: Overcoming the problem of dilution when using a sprayable optical probe. Oncotarget  7, 51124-51137.   https://doi.org/10.18632/oncotarget.9898|3. Sinharay S, Randtke EA, Jones KM, Howison CM, Chambers SK, Kobayashi H, Pagel MD (2017). Noninvasive detection of enzyme activity in tumor models of human ovarian cancer using catalyCEST MRI. Magn Reson Med  77, 2005-2014.   https://doi.org/10.1002/mrm.26278|4. Ueo H, Shinden Y, Tobo T, Gamachi A, Udo M, Komatsu H, Nambara S, Saito T, Ueda M, Hirata H, Sakimura S, Takano Y, Uchi R, Kurashige J, Akiyoshi S, Iguchi T, Eguchi H, Sugimachi K, Kubota Y, Kai Y, Shibuta K, Kijima Y, Yoshinaka H, Natsugoe S, Mori M, et al. [10 more authors] (2015). Rapid intraoperative visualization of breast lesions with γ-glutamyl hydroxymethyl rhodamine green. Sci Rep  5, 12080.   https://doi.org/10.1038/srep12080",https://intramural.nih.gov/search/searchview.taf?ipid=94173
449,BC011513-04,"October 01, 2015 -  September 30, 2016",Cancer-cell specific therapy: photo-immunotherapy,Hisataka  Kobayashi|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",NULL,Mikako  Ogawa|Yu  Chen (Univ of Maryland)|Peter  Marinkovich (Stnford Univ)|Zaver  Bhujwalla (Johns Hopkins)|Toshiyoshi  Fujiwara (Okayama Univ),Mitchell  Ho (Laboratory of Molecular Biology)|Ira H Pastan; MD (Molecular Biology Section)|John  Schiller; PhD (Laboratory of Cellular Oncology)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Martin John Schnermann; PhD (Chemical Biology Laboratory),NULL,"1. Hanaoka H, Nakajima T, Sato K, Watanabe R, Phung Y, Gao W, Harada T, Kim I, Paik CH, Choyke PL, Ho M, Kobayashi H (2015). Photoimmunotherapy of hepatocellular carcinoma-targeting Glypican-3 combined with nanosized albumin-bound paclitaxel. Nanomedicine (Lond)  10, 1139-47.   https://doi.org/10.2217/nnm.14.194|2. Maawy AA, Hiroshima Y, Zhang Y, Garcia-Guzman M, Luiken GA, Kobayashi H, Hoffman RM, Bouvet M (2015). Photoimmunotherapy lowers recurrence after pancreatic cancer surgery in orthotopic nude mouse models. J Surg Res  197, 5-11.   https://doi.org/10.1016/j.jss.2015.02.037|3. Maawy AA, Hiroshima Y, Zhang Y, Heim R, Makings L, Garcia-Guzman M, Luiken GA, Kobayashi H, Hoffman RM, Bouvet M (2015). Near infra-red photoimmunotherapy with anti-CEA-IR700 results in extensive tumor lysis and a significant decrease in tumor burden in orthotopic mouse models of pancreatic cancer. PLoS One  10, e0121989.   https://doi.org/10.1371/journal.pone.0121989|4. Nagaya T, Sato K, Harada T, Nakamura Y, Choyke PL, Kobayashi H (2015). Near Infrared Photoimmunotherapy Targeting EGFR Positive Triple Negative Breast Cancer: Optimizing the Conjugate-Light Regimen. PLoS One  10, e0136829.   https://doi.org/10.1371/journal.pone.0136829|5. Sato K, Nagaya T, Choyke PL, Kobayashi H (2015). Near infrared photoimmunotherapy in the treatment of pleural disseminated NSCLC: preclinical experience. Theranostics  5, 698-709.   https://doi.org/10.7150/thno.11559|6. Sato K, Nagaya T, Mitsunaga M, Choyke PL, Kobayashi H (2015). Near infrared photoimmunotherapy for lung metastases. Cancer Lett  365, 112-21.   https://doi.org/10.1016/j.canlet.2015.05.018|7. Sato K, Nagaya T, Nakamura Y, Harada T, Choyke PL, Kobayashi H (2015). Near infrared photoimmunotherapy prevents lung cancer metastases in a murine model. Oncotarget  6, 19747-58.   https://doi.org/10.18632/oncotarget.3850|8. Sato K, Nakajima T, Choyke PL, Kobayashi H (2015). Selective cell elimination in vitro and in vivo from tissues and tumors using antibodies conjugated with a near infrared phthalocyanine. RSC Adv  5, 25105-25114.   https://doi.org/10.1039/C4RA13835J|9. Watanabe R, Hanaoka H, Sato K, Nagaya T, Harada T, Mitsunaga M, Kim I, Paik CH, Wu AM, Choyke PL, Kobayashi H (2015). Photoimmunotherapy targeting prostate-specific membrane antigen: are antibody fragments as effective as antibodies? J Nucl Med  56, 140-4.   https://doi.org/10.2967/jnumed.114.149526",https://intramural.nih.gov/search/searchview.taf?ipid=94174
450,BC011514-04,"October 01, 2015 -  September 30, 2016",Investigating Pediatric CNS tumor biology,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,"Charles  Eberhart (Pathology, Johns Hopkins University School of Medicine)|Eric H Raabe|Javad  Nazarian (Children's National Medical Center)|Nada  Jabado (McGill University)|Michelle  Monje-Deisseroth (Stanford)","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Martha Maria Nicacio Quezado; MD (Laboratory of Pathology)|Jonathan Keith Killian (Cancer Genetics Branch)",NULL,"1. Ballester L, Aung P, Lai J, Nobrega R, Patrocinio R, Wang Z, Miettinen M, Warren K, Quezado M (2015) Expression of IDH1 mutant protein R132H and SDHB in adult and pediatric gliomas. Int J Neuropath, in press.|2. Grasso CS, Tang Y, Truffaux N, Berlow NE, Liu L, Debily MA, Quist MJ, Davis LE, Huang EC, Woo PJ, Ponnuswami A, Chen S, Johung TB, Sun W, Kogiso M, Du Y, Qi L, Huang Y, Hütt-Cabezas M, Warren KE, Le Dret L, Meltzer PS, Mao H, Quezado M, van Vuurden DG, et al. [15 more authors] (2015). Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nat Med  21, 555-9.   https://doi.org/10.1038/nm.3855|3. Nailor A, Walker DA, Jacques TS, Warren KE, Brem H, Kearns PR, Greenwood J, Penny JI, Pilkington GJ, Carcaboso AM, Fleischhack G, Macarthur D, Slavc I, Meijer L, Gill S, Lowis S, van Vuurden DG, Pearl MS, Clifford SC, Morrissy S, Ivanov DP, Beccaria K, Gilbertson RJ, Straathof K, Green JJ, et al. [3 more authors] (2016). Highlights of Children with Cancer UK's Workshop on Drug Delivery in Paediatric Brain Tumours. Ecancermedicalscience  10, 630.   https://doi.org/10.3332/ecancer.2016.630|4. Taylor IC, Hütt-Cabezas M, Brandt WD, Kambhampati M, Nazarian J, Chang HT, Warren KE, Eberhart CG, Raabe EH (2015). Disrupting NOTCH Slows Diffuse Intrinsic Pontine Glioma Growth, Enhances Radiation Sensitivity, and Shows Combinatorial Efficacy With Bromodomain Inhibition. J Neuropathol Exp Neurol  74, 778-90.   https://doi.org/10.1097/NEN.0000000000000216",https://intramural.nih.gov/search/searchview.taf?ipid=94172
451,BC011518-04,"October 01, 2015 -  September 30, 2016",Molecular basis of centriole duplication,Kyung  Lee; PhD|IRP Faculty Profile,NULL,"Chemistry Section, NCI",Wonchull  Kang|Chang Uk  Lee|Eunhye  Lee|Jung Eun  Park,NULL,Jadranka  Loncarek (Laboratory of Protein Dynamics and Signaling),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94165
452,BC011519-04,"October 01, 2015 -  September 30, 2016",Telomere Biology,Julia Promisel Cooper|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Manasi Sadanand Apte; PhD|Hani  Ebrahimi|Alfonso  Fernandez Alvarez|Haitong  Hou|Hirohisa  Masuda; PhD|Rishi Kumar  Nageshan; PhD|Show all 7,"Nevan  Krogan (Univ of California, San Francisco)|Mark  Winey (Mol. Cell and Dev. Biology, Univ. of Colorado)",NULL,NULL,"1. Fennell A, Fernández-Álvarez A, Tomita K, Cooper JP (2015). Telomeres and centromeres have interchangeable roles in promoting meiotic spindle formation. J Cell Biol  208, 415-28.   https://doi.org/10.1083/jcb.201409058",https://intramural.nih.gov/search/searchview.taf?ipid=94198
453,BC011522-04,"October 01, 2015 -  September 30, 2016",Discovery of kinase targets in chromosome 10 deleted glioma cells,Jayne M Stommel|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Kevin A Camphausen; MD,Keith  Ligon (Dana-Farber Cancer Institute)|Cameron  Brennan (Memorial Sloan-Kettering Cancer Center),Natasha  Caplen (Cancer Genetics Branch)|Eric  Batchelor; PhD (Laboratory of Pathology)|Ji  Luo (Laboratory of Cancer Biology and Genetics)|Rosandra N Kaplan (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94183
454,BC011524-04,"October 01, 2015 -  September 30, 2016",Mechanical regulation of the microenvironmental niche in skin tumorigenesis,Kandice Danielle Tanner; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Alexus Seniqua Eunique Devine|King Leung Fung|Colin Dowlin Paul; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94190
455,BC011525-04,"October 01, 2015 -  September 30, 2016",Leveraging DNA damage repair pathways as therapeutic targets in womens cancers,Jung-Min  Lee|IRP Faculty Profile,NULL,"Womens Malignancies Branch, NCI",Dana-Adriana  Botesteanu|Erin Kathleen Manricks|Takuhei  Yokoyama|Minshu R Yu|Ethan S Brill,NULL,Bradford J Wood; MD (Office of the Director)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|William D Figg; PharmD (Genitourinary Malignancies Branch),NULL,"1. Chiou V, Kohn E, Davarpanah N, Lee J (2015) Novel Therapeutic Strategies For Angiogenesis Inhibition In Recurrent Ovarian Cancer Current Angiogenesis 3(4):179-192|2. Lee JM, Gordon N, Trepel JB, Lee MJ, Yu M, Kohn EC (2015). Development of a multiparameter flow cytometric assay as a potential biomarker for homologous recombination deficiency in women with high-grade serous ovarian cancer. J Transl Med  13, 239.   https://doi.org/10.1186/s12967-015-0604-z|3. Lee JM, Trepel JB, Choyke P, Cao L, Sissung T, Houston N, Yu M, Figg WD, Turkbey IB, Steinberg SM, Lee MJ, Ivy SP, Liu JF, Matulonis UA, Kohn EC (2015). CECs and IL-8 Have Prognostic and Predictive Utility in Patients with Recurrent Platinum-Sensitive Ovarian Cancer: Biomarker Correlates from the Randomized Phase-2 Trial of Olaparib and Cediranib Compared with Olaparib in Recurrent Platinum-Sensitive Ovarian Cancer. Front Oncol  5, 123.   https://doi.org/10.3389/fonc.2015.00123|4. Noonan AM, Bunch KP, Chen JQ, Herrmann MA, Lee JM, Kohn EC, O'Sullivan CC, Jordan E, Houston N, Takebe N, Kinders RJ, Cao L, Peer CJ, Figg WD, Annunziata CM (2016). Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer. Cancer  122, 588-597.   https://doi.org/10.1002/cncr.29783",https://intramural.nih.gov/search/searchview.taf?ipid=94179
456,BC011528-04,"October 01, 2015 -  September 30, 2016","A Randomized, Prospective, Phase II Study to Determine the Efficacy of Bacillus",Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Thomas  Sanford|Rebecca Christine Dolan|Julian  Custer|Yvonne  Wall,Eric  Singer (Rutgers Cancer Institute of New Jersey)|Carla  Beckham (University of Rochester Medical Center),"James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94188
457,BC011529-04,"October 01, 2015 -  September 30, 2016",In-patient hospice and rapid autopsy to interrogate tumor heterogeneity,Udayan  Guha|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Constance M Cultraro|Tapan Kumar Maity|Abhilash  Venugopalan|Xu  Zhang,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Javed  Khan; MD (Cancer Genetics Branch)|David Erwin Kleiner; MD, PhD (Laboratory of Pathology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94186
458,BC011547-03,"October 01, 2015 -  September 30, 2016",Cancer Immunotherapy Clinical Trials,Christopher Ryan Heery; MD,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI",Andrea Danielle Burmeister|Bonnie L Casey|Diana  Martin|Camilo  Pacheco|Chrisa Amanda Bynoe Thomas|John  Greiner; PhD|Show all 9,"Richard  Alexander (University of Maryland Medical Center)|Fiorella  Guadagni (Pathology, Regina Elena Cancer Institute)|Frank E Jones; PhD (Tulane School of Medicine)|Nuhad  Ibrahim (MD Anderson Cancer Center)|H  Lyerly (Office of the Director, Duke Comprehensive Cancer Center)|John  Marshall|Show all 11","Deedee Kay Smart (Radiation Oncology Branch)|William Laurence Dahut; MD (Genitourinary Malignancies Branch)|William D Figg; PharmD (Genitourinary Malignancies Branch)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Raffit  Hassan (Thoracic & Oncologic Surgery Branch)|Ravi  Madan (Genitourinary Malignancies Branch)",NULL,"1. 1 Gull, 2 Mart, 3 Heer, 4 Mada, 5 Stei, 6 Leit, 7 Tsan, 8 Schl (2015) The impact of leukapheresis on immune cell number and function in patients with advanced  cancer. Cancer Immunol Immunother, in press.|2. 1 Miet, 2 Wang, 3 Laso, 4 Heer, 5 Schl, 6 Pale (2015) Nuclear brachyury expression is consistent in chordoma, common in germ cell tumors and small cell carcinomas and rare in other carcinomas and sarcomas. An immunohistochemical study of 5229 cases. Am J Surg Pathol, in press.|3. Fenerty KE, Folio LR, Patronas NJ, Marté JL, Gulley JL, Heery CR (2016). Predicting clinical outcomes in chordoma patients receiving immunotherapy: a comparison between volumetric segmentation and RECIST. BMC Cancer  16, 672.   https://doi.org/10.1186/s12885-016-2699-x|4. Fenerty KE, Patronas NJ, Heery CR, Gulley JL, Folio LR (2016). Resources Required for Semi-Automatic Volumetric Measurements in Metastatic Chordoma: Is Potentially Improved Tumor Burden Assessment Worth the Time Burden? J Digit Imaging  29, 357-64.   https://doi.org/10.1007/s10278-015-9846-9|5. Gulley JL, Marté J, Heery CR, Madan RA, Steinberg SM, Leitman SF, Tsang KY, Schlom J (2015). The impact of leukapheresis on immune-cell number and function in patients with advanced cancer. Cancer Immunol Immunother  64, 1429-35.   https://doi.org/10.1007/s00262-015-1738-9|6. Heery C, Ibrahim N, Arlen P, Mohebtash M, Murray J, Koenig K, Madan R, McMahon S, Marte J, Steinberg S, Donahue R, Grenga I, Jochems C, Farsaci B, Folio L, Schlom J, Gulley J (2015) A phase 2 randomized trial of docetaxel alone or in combination with a therapeutic cancer vaccine (PANVAC) in patients with metastatic breast cancer. JAMA Oncology, in press.|7. Heery CR, Ibrahim NK, Arlen PM, Mohebtash M, Murray JL, Koenig K, Madan RA, McMahon S, Marté JL, Steinberg SM, Donahue RN, Grenga I, Jochems C, Farsaci B, Folio LR, Schlom J, Gulley JL (2015). Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast Cancer: A Randomized Clinical Trial. JAMA Oncol  1, 1087-95.   https://doi.org/10.1001/jamaoncol.2015.2736|8. Heery CR, Madan RA, Stein MN, Stadler WM, Di Paola RS, Rauckhorst M, Steinberg SM, Marté JL, Chen CC, Grenga I, Donahue RN, Jochems C, Dahut WL, Schlom J, Gulley JL (2016). Samarium-153-EDTMP (Quadramet®) with or without vaccine in metastatic castration-resistant prostate cancer: A randomized Phase 2 trial. Oncotarget  7, 69014-69023.   https://doi.org/10.18632/oncotarget.10883|9. Heery CR, Singh BH, Rauckhorst M, Marté JL, Donahue RN, Grenga I, Rodell TC, Dahut W, Arlen PM, Madan RA, Schlom J, Gulley JL (2015). Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury. Cancer Immunol Res  3, 1248-56.   https://doi.org/10.1158/2326-6066.CIR-15-0119|10. Lu D, Graf R, Harvey M, Madan R, Heery C, Marte J, Beasley S, Tsang K, Krupa R, Louw J, Wahl J, Bales N, Landers M, Marrinucci D, Schlom J, Gulley J, Dittamore R (2015) Detection and characterization of circulating tumor cells from frozen peripheral blood mononuclear cells. J Circ Biomark, in press.|11. Rajan A, Kim C, Heery CR, Guha U, Gulley JL (2016). Nivolumab, anti-programmed death-1 (PD-1) monoclonal antibody immunotherapy: Role in advanced cancers. Hum Vaccin Immunother  12, 2219-31.   https://doi.org/10.1080/21645515.2016.1175694",https://intramural.nih.gov/search/searchview.taf?ipid=94234
459,BC011549-03,"October 01, 2015 -  September 30, 2016",Chronic graft-versus-host disease,Edward W Cowen|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",NULL,NULL,"Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)",NULL,"1. Baird K, Comis LE, Joe GO, Steinberg SM, Hakim FT, Rose JJ, Mitchell SA, Pavletic SZ, Figg WD, Yao L, Flanders KC, Takebe N, Sarantopoulos S, Booher S, Cowen EW (2015). Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease. Biol Blood Marrow Transplant  21, 1083-90.   https://doi.org/10.1016/j.bbmt.2015.03.006|2. Bassim CW, Fassil H, Mays JW, Edwards D, Baird K, Steinberg SM, Cowen EW, Naik H, Datiles M, Stratton P, Gress RE, Pavletic SZ (2015). Oral disease profiles in chronic graft versus host disease. J Dent Res  94, 547-54.   https://doi.org/10.1177/0022034515570942|3. Curtis LM, Datiles MB, Steinberg SM, Mitchell SA, Bishop RJ, Cowen EW, Mays J, McCarty JM, Kuzmina Z, Pirsl F, Fowler DH, Gress RE, Pavletic SZ (2015). Predictive models for ocular chronic graft-versus-host disease diagnosis and disease activity in transplant clinical practice. Haematologica  100, 1228-36.   https://doi.org/10.3324/haematol.2015.124131|4. Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, Palmer J, Weisdorf D, Treister NS, Cheng GS, Kerr H, Stratton P, Duarte RF, McDonald GB, Inamoto Y, Vigorito A, Arai S, Datiles MB, Jacobsohn D, Heller T, Kitko CL, Mitchell SA, Martin PJ, Shulman H, Wu RS, et al. [5 more authors] (2015). National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant  21, 389-401.e1.   https://doi.org/10.1016/j.bbmt.2014.12.001|5. Kuzmina Z, Gounden V, Curtis L, Avila D, Rnp TT, Baruffaldi J, Cowen EW, Naik HB, Hasni SA, Mays JW, Mitchell S, Baird K, Steinberg SM, Pavletic SZ (2015). Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria. Am J Hematol  90, 114-9.   https://doi.org/10.1002/ajh.23885",https://intramural.nih.gov/search/searchview.taf?ipid=94230
460,BC011550-03,"October 01, 2015 -  September 30, 2016",Anakinra for neutrophilic pustular skin disease,Edward W Cowen|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",Dominique C Pichard,NULL,NULL,"Alison Anne McBride; PhD (NIAID) |Maria Irene Morasso; PhD (NIAMS) |Nehal N Mehta (NHLBI) |Raphaela  Goldbach-Mansky; MD, MHS (NIAMS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94231
461,BC011551-03,"October 01, 2015 -  September 30, 2016",Structural studies of molecular targets for drug development,David S Waugh; PhD|IRP Faculty Profile,NULL,"Protein Engineering Section, NCI",Rajesh  Gumpena|George T Lountos|Danielle  Needle,"Robert  Ulrich (Molecular Immunology, USAMRIID)|Kamal  Saikh (USAMRIID)",John Stephen Schneekloth (Chemical Biology Laboratory)|Terrence R Burke; PhD (Chemical Biology Laboratory)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Joseph Edward Tropea (Macromolecular Crystallography Laboratory),NULL,"1. Hewitt WM, Lountos GT, Zlotkowski K, Dahlhauser SD, Saunders LB, Needle D, Tropea JE, Zhan C, Wei G, Ma B, Nussinov R, Waugh DS, Schneekloth JS (2016). Insights Into the Allosteric Inhibition of the SUMO E2 Enzyme Ubc9. Angew Chem Int Ed Engl  55, 5703-7.   https://doi.org/10.1002/anie.201511351|2. Lountos GT, Austin BP, Tropea JE, Waugh DS (2015). Structure of human dual-specificity phosphatase 7, a potential cancer drug target. Acta Crystallogr F Struct Biol Commun  71, 650-6.   https://doi.org/10.1107/S2053230X1500504X|3. Lountos GT, Cherry S, Tropea JE, Waugh DS (2015). Structural analysis of human dual-specificity phosphatase 22 complexed with a phosphotyrosine-like substrate. Acta Crystallogr F Struct Biol Commun  71, 199-205.   https://doi.org/10.1107/S2053230X15000217|4. Needle D, Lountos GT, Waugh DS (2015). Structures of the Middle East respiratory syndrome coronavirus 3C-like protease reveal insights into substrate specificity. Acta Crystallogr D Biol Crystallogr  71, 1102-11.   https://doi.org/10.1107/S1399004715003521|5. Olson MA, Lee MS, Kissner TL, Alam S, Waugh DS, Saikh KU (2015). Discovery of small molecule inhibitors of MyD88-dependent signaling pathways using a computational screen. Sci Rep  5, 14246.   https://doi.org/10.1038/srep14246|6. Zhao BM, Keasey SL, Tropea JE, Lountos GT, Dyas BK, Cherry S, Raran-Kurussi S, Waugh DS, Ulrich RG (2015). Phosphotyrosine Substrate Sequence Motifs for Dual Specificity Phosphatases. PLoS One  10, e0134984.   https://doi.org/10.1371/journal.pone.0134984",https://intramural.nih.gov/search/searchview.taf?ipid=94232
462,BC011552-03,"October 01, 2015 -  September 30, 2016",Targeting mechanisms of radiation resistance,Deborah E Citrin|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Shilpa Shantinath Patil; PhD|Erica E Schott|Bradley T Scroggins|Ayla Oksuz White,NULL,Peter L Choyke; MD (Molecular Imaging Program)|Peter A Pinto; MD (Urologic Oncology Branch),NULL,"1. Premo C, Apolo AB, Agarwal PK, Citrin DE (2015). Trimodality therapy in bladder cancer: who, what, and when? Urol Clin North Am  42, 169-80, vii.   https://doi.org/10.1016/j.ucl.2015.02.002",https://intramural.nih.gov/search/searchview.taf?ipid=94229
463,BC011554-03,"October 01, 2015 -  September 30, 2016",Causes and Consequences of Lung Cancer Health Disparities,Brid Mairead Ryan|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Claire Laurie Anne Meaney|Khadijah A Mitchell|Adriana  Zingone; MD|Curtis  Harris; MD,Pine  Sharon (Rutgers Cancer Institute of New Jersey)|Rick  Kittles (University of Arizona Cancer Center)|Keisha  Houston (Centers for Disease Control and Prevention),"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Daniel C Edelman (Cancer Genetics Branch)",Craig Joseph Thomas (NCATS) |Marc  Ferrer-Alegre (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94226
464,BC011555-03,"October 01, 2015 -  September 30, 2016",The Role of Catecholamines in Lung Cancer,Brid Mairead Ryan|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Conor Aidan Bradley|Adriana  Zingone; MD,NULL,NULL,Miguel  Skirzewski Prieto; PhD (NICHD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94227
465,BC011557-03,"October 01, 2015 -  September 30, 2016",Inflammatory Biomarkers of Diagnosis and Prognosis in Early Stage Lung Cancer,Brid Mairead Ryan|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Claire Laurie Anne Meaney|Adriana  Zingone; MD|Curtis  Harris; MD,NULL,"Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)|Anil Kumar Chaturvedi (Infection & Immunoepidemiology Branch)|Bin  Zhu (Biostatistics Branch)",NULL,"1. Pine SR, Mechanic LE, Enewold L, Bowman ED, Ryan BM, Cote ML, Wenzlaff AS, Loffredo CA, Olivo-Marston S, Chaturvedi A, Caporaso NE, Schwartz AG, Harris CC (2016). Differential Serum Cytokine Levels and Risk of Lung Cancer Between African and European Americans. Cancer Epidemiol Biomarkers Prev  25, 488-97.   https://doi.org/10.1158/1055-9965.EPI-15-0378",https://intramural.nih.gov/search/searchview.taf?ipid=94224
466,BC011558-03,"October 01, 2015 -  September 30, 2016",Effects of systemic and topical perturbations on human microbes,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",Iryna Leonidivna Chub|Bathai Ishmael-Elijah Edwards|Jay Hyun  Jo; PhD|Elizabeth Alexandra Kennedy|Valentina Shobhana Pillai; CRNP|Monica Elizabeth Taylor|Show all 8,NULL,"James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Giorgio  Trinchieri (Cancer Inflammation Program)","Julia A Segre; PhD (NHGRI) |Kelly Dean Stone; MD, PhD (NIAID) |Joshua David Milner; MD (NIAID) |Steven M Holland; MD (NIAID) |Yasmine  Belkaid; PhD (NIAID) |Michail S Lionakis (NIAID)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94225
467,BC011559-03,"October 01, 2015 -  September 30, 2016",The role of the tumor biofilm in determining tissue tropism,Kandice Danielle Tanner; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Alexus Seniqua Eunique Devine|King Leung Fung|Colin Dowlin Paul; PhD,NULL,NULL,NULL,"1. Blehm BH, Jiang N, Kotobuki Y, Tanner K (2015). Deconstructing the role of the ECM microenvironment on drug efficacy targeting MAPK signaling in a pre-clinical platform for cutaneous melanoma. Biomaterials  56, 129-39.   https://doi.org/10.1016/j.biomaterials.2015.03.041|2. Tanner K, Gottesman MM (2015). Beyond 3D culture models of cancer. Sci Transl Med  7, 283ps9.   https://doi.org/10.1126/scitranslmed.3009367",https://intramural.nih.gov/search/searchview.taf?ipid=94223
468,BC011561-03,"October 01, 2015 -  September 30, 2016",Exploring mechanisms that govern immune homeostasis in skin,Keisuke  Nagao|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",Benjamin  Voisin|Thomas  Doebel|Kacey Youngkyung Idouchi|Tetsuro  Kobayashi|Sungmin  Sohn|Amanda  Truong|Show all 8,"Daniel M Kaplan|Masayuki  Amagai (Keio University School of Medicine)|Mike  Rosenblum (University of California, San Francisco)",Stefania  Pittaluga (Laboratory of Pathology)|Bao D Quoe  Tran (Cancer Genetics Branch),Warren J Leonard; MD (NHLBI) |Julia A Segre; PhD (NHGRI),"1. Adachi T, Kobayashi T, Sugihara E, Yamada T, Ikuta K, Pittaluga S, Saya H, Amagai M, Nagao K (2015). Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma. Nat Med  21, 1272-9.   https://doi.org/10.1038/nm.3962|2. Kobayashi T, Glatz M, Horiuchi K, Kawasaki H, Akiyama H, Kaplan DH, Kong HH, Amagai M, Nagao K (2015). Dysbiosis and Staphylococcus aureus Colonization Drives Inflammation in Atopic Dermatitis. Immunity  42, 756-66.   https://doi.org/10.1016/j.immuni.2015.03.014|3. Nagao K, Segre JA (2015). ""Bringing Up Baby"" to Tolerate Germs. Immunity  43, 842-4.   https://doi.org/10.1016/j.immuni.2015.10.020|4. Nagao K, Udey MC (2015). Mushrooming insights into skin dendritic cell physiology. Immunity  42, 210-213.   https://doi.org/10.1016/j.immuni.2015.01.025",https://intramural.nih.gov/search/searchview.taf?ipid=94221
469,BC011564-03,"October 01, 2015 -  September 30, 2016",Near-IR Photorelease Chemistry: Discovery and Applications,Martin John Schnermann; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Erin Danielle Anderson; PhD|Alexander Patrick Gorka|Roger Rauhauser Nani|Evan Alexander Schauer|Tsuyoshi  Yamamoto; PhD,NULL,Murali  Krishna; PhD (Radiation Biology Branch)|Hisataka  Kobayashi (Molecular Imaging Program)|Susan  Mackem; MD (Cancer and Developmental Biology Laboratory)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Kirk R Gustafson; PhD (Molecular Targets Laboratory),NULL,"1. Nani RR, Gorka AP, Nagaya T, Kobayashi H, Schnermann MJ (2015). Near-IR Light-Mediated Cleavage of Antibody-Drug Conjugates Using Cyanine Photocages. Angew Chem Int Ed Engl  54, 13635-8.   https://doi.org/10.1002/anie.201507391|2. Nani RR, Kelley JA, Ivanic J, Schnermann MJ (2015). Reactive Species Involved in the Regioselective Photooxidation of Heptamethine Cyanines. Chem Sci  6, 6556-6563.   https://doi.org/10.1039/C5SC02396C",https://intramural.nih.gov/search/searchview.taf?ipid=94222
470,BC011565-03,"October 01, 2015 -  September 30, 2016",Adoptive T cell Therapy for Pediatric Leukemia,Terry J Fry|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,"Boro  Dropulic|Stephen  Grupp (University of Pennsylvania Cancer Center,)|Sarah  Tasian (Children's Hospital of Philadelphia)|Mark  Gilbert (Juno Therapeutics)|David  Hilbert (HGSI, Inc.)",Dimiter Stanchev Dimitrov; PhD (Cancer Inflammation Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94220
471,BC011566-03,"October 01, 2015 -  September 30, 2016","Mechanism, Regulation and Application of miRNA pathway in cancer",Shuo  Gu|IRP Faculty Profile,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",Francesc Xavier  Bofill De Ros|Lisheng  Dai|Angela Christine Dinardo|Katherine  Li|Acong  Yang|Qianze  Zhang|Show all 8,NULL,Mikhail V Kashlev (Molecular Mechanisms of Transcription Section)|Xinhua  Ji; PhD (Biomolecular Structure Section),Markus  Hafner (NIAMS),"1. Dai L, Chen K, Youngren B, Kulina J, Yang A, Guo Z, Li J, Yu P, Gu S (2016) Cytoplasmic Drosha Activity Generated by Alternative Splicing. Nucleic Acids Research, in press.|2. Valdmanis PN, Gu S, Chu K, Jin L, Zhang F, Munding EM, Zhang Y, Huang Y, Kutay H, Ghoshal K, Lisowski L, Kay MA (2016). RNA interference-induced hepatotoxicity results from loss of the first synthesized isoform of microRNA-122 in mice. Nat Med  22, 557-62.   https://doi.org/10.1038/nm.4079",https://intramural.nih.gov/search/searchview.taf?ipid=94217
472,BC011568-03,"October 01, 2015 -  September 30, 2016",Natural Products Discovery and Characterization Through Network Collaborations,Kirk R Gustafson; PhD|IRP Faculty Profile,NULL,"Molecular Targets Laboratory, NCI",Heidi  Bokesch|Laura  Cartner|Susanna Tsz Shan Chan|Richard W Fuller|Ameet Jonathan Singh; PhD,NULL,Thomas Joseph Sayers; PhD (Cancer Inflammation Program)|William D Figg; PharmD (Genitourinary Malignancies Branch)|Martin John Schnermann; PhD (Chemical Biology Laboratory)|David  Covell (Screening Technologies Branch)|Megan L Peach (Chemical Biology Laboratory),NULL,"1. Chan ST, Patel PR, Ransom TR, Henrich CJ, McKee TC, Goey AK, Cook KM, Figg WD, McMahon JB, Schnermann MJ, Gustafson KR (2015). Structural Elucidation and Synthesis of Eudistidine A: An Unusual Polycyclic Marine Alkaloid that Blocks Interaction of the Protein Binding Domains of p300 and HIF-1α. J Am Chem Soc  137, 5569-75.   https://doi.org/10.1021/jacs.5b02156|2. Forcina GC, Castro A, Bokesch HR, Spakowicz DJ, Legaspi ME, Kucera K, Villota S, Narváez-Trujillo A, McMahon JB, Gustafson KR, Strobel SA (2015). Stelliosphaerols A and B, Sesquiterpene-Polyol Conjugates from an Ecuadorian Fungal Endophyte. J Nat Prod  78, 3005-10.   https://doi.org/10.1021/acs.jnatprod.5b00749|3. Henrich CJ, Brooks AD, Erickson KL, Thomas CL, Bokesch HR, Tewary P, Thompson CR, Pompei RJ, Gustafson KR, McMahon JB, Sayers TJ (2015). Withanolide E sensitizes renal carcinoma cells to TRAIL-induced apoptosis by increasing cFLIP degradation. Cell Death Dis  6, e1666.   https://doi.org/10.1038/cddis.2015.38|4. Henrich CJ, Cartner LK, Wilson JA, Fuller RW, Rizzo AE, Reilly KM, McMahon JB, Gustafson KR (2015). Deguelins, Natural Product Modulators of NF1-Defective Astrocytoma Cell Growth Identified by High-Throughput Screening of Partially Purified Natural Product Extracts. J Nat Prod  78, 2776-81.   https://doi.org/10.1021/acs.jnatprod.5b00753|5. Shin HJ, Rashid MA, Cartner LK, Bokesch HR, Wilson JA, McMahon JB, Gustafson KR (2015). Stellettapeptins A and B, HIV-inhibitory cyclic depsipeptides from the marine sponge Stelletta sp. Tetrahedron Lett  56, 4215-4219.   https://doi.org/10.1016/j.tetlet.2015.05.058",https://intramural.nih.gov/search/searchview.taf?ipid=94219
473,BC011575-03,"October 01, 2015 -  September 30, 2016",Modulation of Radiation Response and Metabolism,Aparna Hemant Kesarwala|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Jenna Lee Carter|Monika Kanakadurga Masanam|Natsuko  Miura; PhD|Graham Hart Read,NULL,"James B Mitchell; PhD (Radiation Biology Branch)|David Anderson Wink (Cancer Inflammation Program)|Jennifer Clare Jones; MD, PhD (Vaccine Branch)|Tim Friedrich Greten (Thoracic & Oncologic Surgery Branch)",NULL,"1. Ma C, Kesarwala AH, Eggert T, Medina-Echeverz J, Kleiner DE, Jin P, Stroncek DF, Terabe M, Kapoor V, ElGindi M, Han M, Thornton AM, Zhang H, Egger M, Luo J, Felsher DW, McVicar DW, Weber A, Heikenwalder M, Greten TF (2016). NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis. Nature  531, 253-7.   https://doi.org/10.1038/nature16969",https://intramural.nih.gov/search/searchview.taf?ipid=94211
474,BC011577-03,"October 01, 2015 -  September 30, 2016",Novel Imaging Approaches to Solid Tumors,Aparna Hemant Kesarwala|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Jenna Lee Carter|Natsuko  Miura; PhD|Graham Hart Read,NULL,Murali  Krishna; PhD (Radiation Biology Branch)|James B Mitchell; PhD (Radiation Biology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94212
475,BC011579-03,"October 01, 2015 -  September 30, 2016",Fas-signaling in memory CD8+ T cell differentiation,Christopher Austin Klebanoff,NULL,"Surgery Branch, NCI",Anthony J Leonardi|Tori Nicolle Yamamoto|James N Kochenderfer|Luca  Gattinoni,NULL,Terry J Fry (Pediatric Oncology Branch)|Paul  Robbins (Surgery Branch),"Francesco M. Marincola; MD (CC) |Richard M Siegel; MD, PhD (NIAMS) |Clyde C Mackall (OD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94215
476,BC011583-03,"October 01, 2015 -  September 30, 2016",CD62L+-Derived T cells Transduced With a TCR against NY-ESO-1,Christopher Austin Klebanoff,NULL,"Surgery Branch, NCI",Anthony J Leonardi,NULL,Paul  Robbins (Surgery Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94209
477,BC011584-03,"October 01, 2015 -  September 30, 2016",Clinical trials in womens cancers,Christina M Annunziata|IRP Faculty Profile,NULL,"Womens Malignancies Branch, NCI","Stanley  Lipkowitz; MD, PhD|Jung-Min  Lee",NULL,Jinqiu  Chen (Laboratory of Cancer Biology and Genetics),NULL,"1. Noonan AM, Bunch KP, Chen JQ, Herrmann MA, Lee JM, Kohn EC, O'Sullivan CC, Jordan E, Houston N, Takebe N, Kinders RJ, Cao L, Peer CJ, Figg WD, Annunziata CM (2016). Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer. Cancer  122, 588-597.   https://doi.org/10.1002/cncr.29783",https://intramural.nih.gov/search/searchview.taf?ipid=94207
478,BC011585-03,"October 01, 2015 -  September 30, 2016",Identification of Nucleic Acid Binding Small Molecules,John Stephen Schneekloth|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Stephanie Leigh Alden|Robert Edward Boer|David Raymond Calabrese; PhD|Colleen Marie Connelly|William Merton Hewitt|Thomas Aaron Hilimire|Show all 9,NULL,Barry R O'Keefe (Molecular Targets Laboratory)|Beverly  Mock; PhD (Laboratory of Cancer Biology and Genetics)|Stuart F J Le Grice; PhD (Basic Research Laboratory)|Natasha  Caplen (Cancer Genetics Branch)|Thomas A Misteli; PhD (Office of the Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94208
479,BC011586-03,"October 01, 2015 -  September 30, 2016",T-T interactions between naive and memory CD8+ T cells,Christopher Austin Klebanoff,NULL,"Surgery Branch, NCI",Anthony J Leonardi|Tori Nicolle Yamamoto|Luca  Gattinoni,NULL,NULL,"Francesco M. Marincola; MD (CC) |Richard M Siegel; MD, PhD (NIAMS)","1. Crompton JG, Narayanan M, Cuddapah S, Roychoudhuri R, Ji Y, Yang W, Patel SJ, Sukumar M, Palmer DC, Peng W, Wang E, Marincola FM, Klebanoff CA, Zhao K, Tsang JS, Gattinoni L, Restifo NP (2016). Lineage relationship of CD8(+) T cell subsets is revealed by progressive changes in the epigenetic landscape. Cell Mol Immunol  13, 502-13.   https://doi.org/10.1038/cmi.2015.32",https://intramural.nih.gov/search/searchview.taf?ipid=94206
480,BC011591-03,"October 01, 2015 -  September 30, 2016",Contribution of Y-specific Genes to Bladder Cancer,Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Iawen  Hsu,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94203
481,BC011592-03,"October 01, 2015 -  September 30, 2016",Evaluation of Protein Kinase D1 in Bladder Cancer as a possible oncogene,Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Thomas  Sanford,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94204
482,BC011593-03,"October 01, 2015 -  September 30, 2016",Investigation of Epigenetic Modifiers in Bladder Cancer,Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Qingdi Q Li|Leonard  Neckers; PhD,NULL,NULL,NULL,"1. Li QQ, Hao JJ, Zhang Z, Hsu I, Liu Y, Tao Z, Lewi K, Metwalli AR, Agarwal PK (2016). Histone deacetylase inhibitor-induced cell death in bladder cancer is associated with chromatin modification and modifying protein expression: A proteomic approach. Int J Oncol  48, 2591-607.   https://doi.org/10.3892/ijo.2016.3478",https://intramural.nih.gov/search/searchview.taf?ipid=94205
483,BC011594-03,"October 01, 2015 -  September 30, 2016",Targeting the MET pathway in urothelial carcinoma,Andrea Borghese Apolo|IRP Faculty Profile,NULL,"Genitourinary Malignancies Branch, NCI",NULL,NULL,Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Donald P Bottaro; PhD (Urologic Oncology Branch)|Mark  Raffeld; MD (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94202
484,BC011620-02,"October 01, 2015 -  September 30, 2016",Selenium in Health and its incorporation into Protein as Selenocysteine,Dolph Lee Hatfield; PhD|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Bradley A Carlson|Petra Akiko Tsuji,"Ulrich  Schweizer (Neuroscience Research Center and, Charit-Universittsmedizin Berlin)|Marcus  Conrad (Institute of Clinical Molecular Biology and Tumor Genetics)|Byeong Jae  Lee (Seoul National University)|Vadim  Gladyshev (Brigham and Womenâ€™s Hospital and Harvard Medical School)|Michael  Howard (University of Utah)",Harold  Seifried; PhD (Nutritional Science Research Group),NULL,"1. Carlson B (2016) Selenocysteine tRNA[Ser]Sec mouse models for elucidating roles of selenoproteins in health and development, in Selenium: Its molecular biology and role in human health, in press.|2. Carlson B, Hartman J, Tsuji P (2016) The 15 kDa Selenoprotein: Insights into its regulation and function, in Selenium: Its molecular biology and role in human health, in press.|3. Carlson B, Lee B, Tsuji P, Tobe R, Park J, Schweizer U, Gladyshev V, Hatfield D (2016) Selenocysteine tRNA[Ser]Sec: From nonsense suppressor tRNA to the quintessential constituent in selenoprotein biosynthesis, in Selenium: Its Molecular Biology and Role in Human Health, in press.|4. Carlson B, Tobe R, Tsuji P, Yoo M, Feigenbaum L, Tessarollo L, Lee B, Schweizer U, Gladyshev V, Hatfield D (2015) Selenocysteine tRNA[Ser]Sec: The central component of selenoprotein biosynthesis, in Diversity of Selenium Functions in Health and Disease. , pp. 350.|5. Hatfield D, Carlson B, Gladyshev V (2016) Pathways in de novo biosynthesis of selenocysteine and cysteine in eukaryotes, in Selenium: Its molecular biology and role in human health, in press.|6. Hatfield D, Carlson B, Tsuji P, Tobe R, Gladyshev V (2016) Selenium and Cancer, in Molecular, Genetic, and Nutritional Aspects of Major and Trace Minerals, in press.|7. Tsuji P, Lee B, Carlson B, Hatfield D (2016) Interplay of selenoproteins and different antioxidant systems in various cancers, in Selenium: Its Molecular Biology and Role in Human Health, in press.|8. Bang J, Huh JH, Na JW, Lu Q, Carlson BA, Tobe R, Tsuji PA, Gladyshev VN, Hatfield DL, Lee BJ (2015). Cell Proliferation and Motility Are Inhibited by G1 Phase Arrest in 15-kDa Selenoprotein-Deficient Chang Liver Cells. Mol Cells  38, 457-65.   https://doi.org/10.14348/molcells.2015.0007|9. Bang J, Jang M, Huh JH, Na JW, Shim M, Carlson BA, Tobe R, Tsuji PA, Gladyshev VN, Hatfield DL, Lee BJ (2015) Deficiency of the 15-kDa selenoprotein led to cytoskeleton remodeling and non-apoptotic membrane blebbing through a RhoA/ROCK pathway. Biochem Biophys Res Commun 456:884-90|10. Carlson BA, Tobe R, Yefremova E, Tsuji PA, Hoffmann VJ, Schweizer U, Gladyshev VN, Hatfield DL, Conrad M (2016). Glutathione peroxidase 4 and vitamin E cooperatively prevent hepatocellular degeneration. Redox Biol  9, 22-31.   https://doi.org/10.1016/j.redox.2016.05.003|11. Hatfield DL (2016). Redox Pioneer: Professor Vadim N. Gladyshev. Antioxid Redox Signal  25, 1-9.   https://doi.org/10.1089/ars.2015.6625|12. Schoenmakers E, Carlson B, Agostini M, Moran C, Rajanayagam O, Bochukova E, Tobe R, Peat R, Gevers E, Muntoni F, Guicheney P, Schoenmakers N, Farooqi S, Lyons G, Hatfield D, Chatterjee K (2016). Mutation in human selenocysteine transfer RNA selectively disrupts selenoprotein synthesis. J Clin Invest  126, 992-6.   https://doi.org/10.1172/JCI84747|13. Tobe R, Carlson BA, Tsuji PA, Lee BJ, Gladyshev VN, Hatfield DL (2015). Differences in Redox Regulatory Systems in Human Lung and Liver Tumors Suggest Different Avenues for Therapy. Cancers (Basel)  7, 2262-76.   https://doi.org/10.3390/cancers7040889|14. Tsuji PA, Carlson BA, Anderson CB, Seifried HE, Hatfield DL, Howard MT (2015). Dietary Selenium Levels Affect Selenoprotein Expression and Support the Interferon-γ and IL-6 Immune Response Pathways in Mice. Nutrients  7, 6529-49.   https://doi.org/10.3390/nu7085297|15. Tsuji PA, Carlson BA, Yoo MH, Naranjo-Suarez S, Xu XM, He Y, Asaki E, Seifried HE, Reinhold WC, Davis CD, Gladyshev VN, Hatfield DL (2015). The 15kDa selenoprotein and thioredoxin reductase 1 promote colon cancer by different pathways. PLoS One  10, e0124487.   https://doi.org/10.1371/journal.pone.0124487|16. Turanov AA, Everley RA, Hybsier S, Renko K, Schomburg L, Gygi SP, Hatfield DL, Gladyshev VN (2015). Regulation of Selenocysteine Content of Human Selenoprotein P by Dietary Selenium and Insertion of Cysteine in Place of Selenocysteine. PLoS One  10, e0140353.   https://doi.org/10.1371/journal.pone.0140353",https://intramural.nih.gov/search/searchview.taf?ipid=94264
485,BC011627-02,"October 01, 2015 -  September 30, 2016",Myosin VI: a new ubiquitin receptor,Kylie Janice Walters|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",NULL,Simona  Polo (University of Milan)|Aaron  Ehlinger (University of Minnesota),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94259
486,BC011628-02,"October 01, 2015 -  September 30, 2016",A novel pathway to clear cells of misfolded proteins,Kylie Janice Walters|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",NULL,NULL,NULL,NULL,"1. Liu F, Koepp DM, Walters KJ (2015). Artificial targeting of misfolded cytosolic proteins to endoplasmic reticulum as a mechanism for clearance. Sci Rep  5, 12088.   https://doi.org/10.1038/srep12088",https://intramural.nih.gov/search/searchview.taf?ipid=94260
487,BC011630-02,"October 01, 2015 -  September 30, 2016",Metabolomic Profiling of Esophageal Cancers,Robert Taylor Ripley; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Colleen Donahue Bond|Deborah Rae Surman|David  Schrump; MD|Udayan  Guha,NULL,Leonard  Neckers; PhD (Urologic Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94261
488,BC011631-02,"October 01, 2015 -  September 30, 2016",Synergy of Bile Acid and Cigarette Smoke on Esophageal Cancer Progression,Robert Taylor Ripley; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Yuan  Xu; PhD|David  Schrump; MD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94262
489,BC011632-02,"October 01, 2015 -  September 30, 2016",Metabolic and p53 Targets of Cellular Respiration of Esophageal Cancer,Robert Taylor Ripley; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Kate Elizabeth Brown|David  Schrump; MD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94255
490,BC011633-02,"October 01, 2015 -  September 30, 2016",T cell Development and Regeneration,"Avinash  Bhandoola; MD, PhD|IRP Faculty Profile",NULL,"Laboratory Of Genome Integrity, NCI",Andre A Nussenzweig; PhD,David  Allman (University of Pennsylvania)|Golnaz  Vahedi,NULL,NULL,"1. Bryson JL, Bhandoola A (2015). Editorial: Ephs, ephrins, and early T cell development. J Leukoc Biol  98, 877-9.   https://doi.org/10.1189/jlb.1CE0315-132R|2. Califano D, Cho JJ, Uddin MN, Lorentsen KJ, Yang Q, Bhandoola A, Li H, Avram D (2015). Transcription Factor Bcl11b Controls Identity and Function of Mature Type 2 Innate Lymphoid Cells. Immunity  43, 354-68.   https://doi.org/10.1016/j.immuni.2015.07.005|3. De Obaldia ME, Bhandoola A (2015). Transcriptional regulation of innate and adaptive lymphocyte lineages. Annu Rev Immunol  33, 607-42.   https://doi.org/10.1146/annurev-immunol-032414-112032|4. Yang Q, Li F, Harly C, Xing S, Ye L, Xia X, Wang H, Wang X, Yu S, Zhou X, Cam M, Xue HH, Bhandoola A (2015). TCF-1 upregulation identifies early innate lymphoid progenitors in the bone marrow. Nat Immunol  16, 1044-50.   https://doi.org/10.1038/ni.3248",https://intramural.nih.gov/search/searchview.taf?ipid=94254
491,BC011637-02,"October 01, 2015 -  September 30, 2016",BRD4 is a HAT,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Devaiah Nanjappa Ballachanda|Chanelle Monet Case Borden,NULL,Daoud M Meerzaman (Cancer Informatics Branch)|Qingrong  Chen (Cancer Informatics Branch),Keiko  Ozato; PhD (NICHD) |Jinfang  Zhu; PhD (NIAID) |Anup  Dey; PhD (NICHD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94257
492,BC011640-02,"October 01, 2015 -  September 30, 2016",Exploring the Therapeutic Potential of Stem Cell Biology in Gliomas,Mark Richard Gilbert; MD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Susie  Ahn|Aiguo  Li|Virginia W Rodriguez|Hua  Song|Wei  Zhang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94269
493,BC011643-02,"October 01, 2015 -  September 30, 2016",Rare Central Nervous System Cancers Initiative,Mark Richard Gilbert; MD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Susie  Ahn|Terri Sue Armstrong; PhD|Lisa Marie Boris|Nancy B Garren|Deric Minwoo Park|Christine  Laing|Show all 8,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch)|Andra Valentina Krauze (Radiation Oncology Branch)|Deedee Kay Smart (Radiation Oncology Branch)|Christopher Ryan Heery; MD (Laboratory of Tumor Immunology and Biology)|Rosandra N Kaplan (Pediatric Oncology Branch)|Cari Meinhold Kitahara (Radiation Epidemiology Branch),"John D Heiss; MD (NINDS) |Kareem Amir Zaghloul; MD, PhD (NINDS) |Elizabeth A Erickson (NHGRI) |Prashant  Chittiboina; MD (NINDS) |Zhengping  Zhuang; MD, PhD (NINDS) |Robert Sean Wildin; MD (NHGRI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94268
494,BC011646-02,"October 01, 2015 -  September 30, 2016",Role of long non-coding RNAs in p53 signaling,Ashish Kumar Lal|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",NULL,NULL,Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)|Stefan  Ambs (Laboratory of Human Carcinogenesis)|Curtis  Harris; MD (Laboratory of Human Carcinogenesis),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94279
495,BC011647-02,"October 01, 2015 -  September 30, 2016",Identifying New Glioma-Associated Tumor Suppressors  Oncogenes,Mark Richard Gilbert; MD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Susie  Ahn|Shuyu  Hao|Jinkyu  Jung|Aiguo  Li|Virginia W Rodriguez|Yu-Ting  Su|Show all 8,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94278
496,BC011648-02,"October 01, 2015 -  September 30, 2016",Targeting Genetic and Metabolic Alterations in Distinct Subtypes of RCC,"Ramaprasad  Srinivasan; MD, PhD|IRP Faculty Profile",NULL,"Urologic Oncology Branch, NCI",Amit Lodha  Dharm Chand Jain|Julia C Friend; PA|Roma  Pahwa|Donald P Bottaro; PhD|Leonard  Neckers; PhD|Adam R Metwalli,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|John Walter Glod (Pediatric Oncology Branch)|Heidi H Kong (Dermatology Branch)|Edward W Cowen (Dermatology Branch)|Joanna H Shih (Biostatistics Branch)","Karel  Pacak; MD, PhD (NICHD) |Pamela  Stratton; MD (NINDS) |Wadih Michel Zein; MD (NEI) |Ashkan A Malayeri (CC) |Clara Chi Chen; MD (CC)","1. Srnivasan R, Linehan W (2015) Treatment of Advanced Renal Cell Carcinoma, in Campbell-Walsh Urology, 11th ed, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=94277
497,BC011649-02,"October 01, 2015 -  September 30, 2016",The Hippo Pathway in Human Gliomas,Jayne M Stommel|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Alan Surya Halim|Diane Marie Kambach|Kevin A Camphausen; MD,Keith  Ligon (Dana-Farber Cancer Institute)|Cameron  Brennan (Memorial Sloan-Kettering Cancer Center),Natasha  Caplen (Cancer Genetics Branch)|Ettore  Appella; MD (Chemical Immunology Section)|Eric  Batchelor; PhD (Laboratory of Pathology)|Ji  Luo (Laboratory of Cancer Biology and Genetics)|Rosandra N Kaplan (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94276
498,BC011650-02,"October 01, 2015 -  September 30, 2016",Genomic characterization of breast cancer in high risk subsets of breast cancer,"Stanley  Lipkowitz; MD, PhD|IRP Faculty Profile",NULL,"Womens Malignancies Branch, NCI",Patricia  Steeg; PhD,Hai  Hu (Windber Research Institute)|Kangmin  Zhu|Jeremy  Perkins,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94274
499,BC011651-02,"October 01, 2015 -  September 30, 2016",Laboratory and Clinical studies on T-cells recognizing NSCLC,"James Chung-Yin Yang; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",NULL,NULL,Udayan  Guha (Thoracic & Oncologic Surgery Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94275
500,BC011652-02,"October 01, 2015 -  September 30, 2016",Mesothelin-targeted immunotoxins in Pancreatic Cancer,Christine Campo Alewine|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Danielle  Arons|Salma E El-Behaedi|Rebekah Claire Landsman|Michael W Rudloff|Xianyu  Zhang; MS,NULL,Syed Perwez  Hussain (Molecular Genetics and Carcinogenesis Section)|Ira H Pastan; MD (Molecular Biology Section)|David J Fitzgerald; PhD (Biotherapy Section)|Serguei V Kozlov (Office of the Director)|William D Figg; PharmD (Genitourinary Malignancies Branch)|Raffit  Hassan (Thoracic & Oncologic Surgery Branch),NULL,"1. Alewine C, Hassan R, Pastan I (2015). Advances in anticancer immunotoxin therapy. Oncologist  20, 176-85.   https://doi.org/10.1634/theoncologist.2014-0358|2. Hassan R, Alewine C, Pastan I (2016). New Life for Immunotoxin Cancer Therapy. Clin Cancer Res  22, 1055-8.   https://doi.org/10.1158/1078-0432.CCR-15-1623",https://intramural.nih.gov/search/searchview.taf?ipid=94273
501,BC011654-02,"October 01, 2015 -  September 30, 2016",TEDDI-R in PCNSL,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Louis  Staudt; MD,NULL,"Elaine S Jaffe; MD (Laboratory of Pathology)|Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94272
502,BC011655-02,"October 01, 2015 -  September 30, 2016",Targeting protein-DNA interactions in prokaryotic systems,Federico  Bernal|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Sterling Robert Alan Payne,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94250
503,BC011657-02,"October 01, 2015 -  September 30, 2016",microRNA regulatory networks in thoracic cancers,Chuong Dinh Hoang|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Nisan  Bhattacharyya; PhD|Anand  Singh; PhD|Li  Zhang; PhD|David  Schrump; MD,NULL,"Margaret  Cam; PhD (Office of the Director)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Markku Martti Miettinen (Laboratory of Pathology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94252
504,BC011659-02,"October 01, 2015 -  September 30, 2016",Deciphering the efficacy of posttransplant cyclophosphamide in haplo transplant,Christopher George Kanakry|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Lucas Paul Wachsmuth,NULL,NULL,NULL,"1. Kanakry CG, Coffey DG, Towlerton AM, Vulic A, Storer BE, Chou J, Yeung CC, Gocke CD, Robins HS, O'Donnell PV, Luznik L, Warren EH (2016). Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide. JCI Insight  1.   https://doi.org/10.1172/jci.insight.86252|2. Kanakry CG, Fuchs EJ, Luznik L (2016). Modern approaches to HLA-haploidentical blood or marrow transplantation. Nat Rev Clin Oncol  13, 10-24.   https://doi.org/10.1038/nrclinonc.2015.128",https://intramural.nih.gov/search/searchview.taf?ipid=94247
505,BC011660-02,"October 01, 2015 -  September 30, 2016",Development of fully-human anti-CD30 chimeric antigen receptors,James N Kochenderfer|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Melissa Ann Pegues; PhD|Victoria  Shi|Ronald E Gress; MD|Frances  Hakim; PhD,NULL,NULL,David F Stroncek; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94248
506,BC011666-02,"October 01, 2015 -  September 30, 2016",Synthetically Accessible Virtual Inventory (SAVI),Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Yuri  Pevzner,"Wolf-Dietrich  Ihlenfeldt (Xemistry GmbH)|Peter  Ertl (Novartis)|Martin  Ott (Lhasa Limited)|Philip  Judson (Lhasa Limited)|Alex  Sukharevsky (LHASA, LLC)|Alan  Long (LHASA, LLC)|Show all 9",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94243
507,BC011669-02,"October 01, 2015 -  September 30, 2016",NCI X-ray free electron laser (XFEL) initiative,Yun Xing M Wang|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94242
508,BC011670-02,"October 01, 2015 -  September 30, 2016",Role of the microbiota in regulating the mononuclear phagocyte system,Silvana Romina Goldszmid|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Romina Elizabeth Araya|Aliyah Nicole Gaines|Sayeh  Gorjifard|Shafiuddin  Siddiqui|Giorgio  Trinchieri,Marilia  Seelaender (University of Sao Paulo)|Eliane  Piaggio (Institut Curie),NULL,Robert Alan Seder; MD (NIAID),"1. Gorjifard S, Goldszmid S (2016) Microbiota - myeloid cells crosstalk beyond the gut. Journal of Leukocyte Biology, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=94241
509,BC011672-01,"-  September 30, 2016",Clinical Protocols in the Cancer Signaling Networks Section,Udayan  Guha|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Constance M Cultraro|Tapan Kumar Maity|Nina Gabrielle Monkash|Abhilash  Venugopalan|Xu  Zhang|David  Schrump; MD,NULL,"Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Javed  Khan; MD (Cancer Genetics Branch)|David Erwin Kleiner; MD, PhD (Laboratory of Pathology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97576
510,BC011679-01,"-  September 30, 2016",Mechanisms driving evolution of aggressive prostate cancer,Adam G Sowalsky|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Sean Thomas Hennigan|Shana Y Trostel|Elizabeth Darlene Walton|Huihui  Ye|Nichelle Chantil Whitlock; PhD,NULL,Hisataka  Kobayashi (Molecular Imaging Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97577
511,BC011680-01,"-  September 30, 2016",Early detection of prostate cancer using circulating tumor DNA,Adam G Sowalsky|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Sean Thomas Hennigan|Shana Y Trostel|Elizabeth Darlene Walton|Huihui  Ye,Steven  Balk (Beth Israel Deaconess Medical Center)|Glenn  Bubley (Beth Israel Deaconess Medical Center)|Huihui  Ye (Laboratory Of Genitourinary Cancer Pathogenesis),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97578
512,BC011681-01,"-  September 30, 2016",Dynamics and Genetics of HIV Proviruses before and during Antiretroviral Therapy,Mary  Kearney,Frank  Maldarelli,"Host Virus Interaction Branch, NCI",Michael Javier Bale|Valerie F Boltz|Wei  Shao; PhD|Jonathan E Spindler|Ann P Wiegand,"Zandrea  Ambrose (University of Pittsburgh)|John  Coffin (Tufts University)|Steven  Deeks (San Francisco General Hospital, University of California, San Francisco)|Jonathan  Li (Harvard University)|John W Mellors|Sarah E Palmer",Stephen H Hughes; PhD (Retroviral Replication Laboratory)|Jeffrey D Lifson; MD (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97579
513,BC011682-01,"-  September 30, 2016",Molecular mechanisms of membrane remodeling,"Roberto  Weigert; MSc Chemistry, PhD|IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI",Yun  Chen; PhD|Olivia Jo-Ann Harding|Akiko  Shitara,Douglas  Brooks (University of South Australia)|Peter  Gunning (University of New South Wales)|Alexander  Sorkin (Univeristy of Pittsburgh)|Marino  Zerial (Max Planck Institute),NULL,"Irwin Monroe Arias; BS, MD (CC) |Kelly G Ten Hagen; BS, PhD (NIDCR)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97632
514,BC011684-01,"-  September 30, 2016",Investigation on the biology of IDH mutant glioma,Chun Zhang  Yang; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Victor Andres Arrieta|Yang  Liu,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97581
515,BC011685-01,"-  September 30, 2016",Brain Interstitium Temozolomide Concentration Pre and Post Regadenoson,Sadhana  Jackson|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Mark Richard Gilbert; MD,NULL,Christine M Bryla (Office Of The Clinical Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97582
516,BC011686-01,"-  September 30, 2016",BBB Permeability in Preclinical Models,Sadhana  Jackson|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97583
517,BC011687-01,"-  September 30, 2016",Dysregulation of Antigen Presenting Cell Function in Cancer,Paul A Roche; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Joanna Marta Bandola-Simon; PhD|Even  Walseng,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97584
518,BC011688-01,"-  September 30, 2016",In vivo function of BRD4,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Anne G M Gegonne Bosselut|Jie  Mu|Chanelle Monet Case Borden,NULL,Qingrong  Chen (Cancer Informatics Branch)|Daoud M Meerzaman (Cancer Informatics Branch)|Xuguang C Tai (Lymphocyte Development Section),Anup  Dey; PhD (NICHD) |Keiko  Ozato; PhD (NICHD) |Jinfang  Zhu; PhD (NIAID),"1. Devaiah BN, Case-Borden C, Gegonne A, Hsu CH, Chen Q, Meerzaman D, Dey A, Ozato K, Singer DS (2016). BRD4 is a histone acetyltransferase that evicts nucleosomes from chromatin. Nat Struct Mol Biol  23, 540-8.   https://doi.org/10.1038/nsmb.3228",https://intramural.nih.gov/search/searchview.taf?ipid=97586
519,BC011690-01,"-  September 30, 2016",Novel Tumor Suppressing Kinases in Cancer,John Fickes Brognard; MS|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",NULL,Tony C Hunter|Crispin  Miller (CRUK Manchester Institute)|Alexandra  Newton (University of California at San Diego)|Jon  Read (Astrazeneca)|Owen  Sansom (CRUK Beatson Institute),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97589
520,BC011691-01,"-  September 30, 2016",Oncogenic Kinases in Cancer,John Fickes Brognard; MS|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",NULL,Caroline  Dive (CRUK Manchester Institute)|Richard  Marais (CRUK Manchester Institute)|Crispin  Miller (CRUK Manchester Institute),NULL,NULL,"1. Antal CE, Hudson AM, Kang E, Zanca C, Wirth C, Stephenson NL, Trotter EW, Gallegos LL, Miller CJ, Furnari FB, Hunter T, Brognard J, Newton AC (2015). Cancer-associated protein kinase C mutations reveal kinase's role as tumor suppressor. Cell  160, 489-502.   https://doi.org/10.1016/j.cell.2015.01.001",https://intramural.nih.gov/search/searchview.taf?ipid=97590
521,BC011692-01,"-  September 30, 2016",COP Laboratory,Amy Kathleen Leblanc; DVM,Thomas A Misteli; PhD,"Pediatric Oncology Branch, NCI",Christina  Mazcko|Ling  Ren|Christine Kim Tran Hoang,Pete  Dickinson (University of California)|Louis  Stancato (NCI)|Tanja  Zabka (Genentech),"Mark Richard Gilbert; MD (Neuro-Oncology Branch)|Lee Jay Helman; MD (Pediatric Oncology Branch)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Robert Mark Simpson; DVM, PhD (Laboratory of Cancer Biology and Genetics)|Lawrence R Sternberg (Office Of The Director)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97587
522,BC011695-01,"-  September 30, 2016",Understand metabolic reprogramming in IDH1 mutant glioma,Chun Zhang  Yang; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Wendy Diana Bautista Guzman|Yanxin  Lu|Seog In  Moon|Yang  Liu|Mioara  Larion; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97588
523,BC011696-01,"-  September 30, 2016",Comparative Brain Tumor Consortium,Amy Kathleen Leblanc; DVM,Thomas A Misteli; PhD,"Pediatric Oncology Branch, NCI",Christina  Mazcko,"Ken  Aldape (NABTC, NABTC)|Timothy  Bentley (Purdue University)|Beth  Boudreau (Texas A&M University)|Matthew  Breen; PhD (Veterinary Medicine, North Carolina State University)|Pete  Dickinson (University of California)|Timothy  Fan (Veterinary Clinical Medicine, University of Illinois)|Show all 17","Mark Richard Gilbert; MD (Neuro-Oncology Branch)|Robert Mark Simpson; DVM, PhD (Laboratory of Cancer Biology and Genetics)",Kara Nichole Corps (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97591
524,BC011697-01,"-  September 30, 2016",Effects of Antiretroviral Therapy on Transcriptional Activity of HIV Proviruses,Mary  Kearney,Frank  Maldarelli,"Host Virus Interaction Branch, NCI",William Richard McManus|Andrew Timothy Rajendra Musick|Victoria Karena Musick|Wei  Shao; PhD|Jonathan E Spindler|Ann P Wiegand,"Zandrea  Ambrose (University of Pittsburgh)|John  Coffin (Tufts University)|Steven  Deeks (San Francisco General Hospital, University of California, San Francisco)|Jonathan  Li (Harvard University)|David M Margolis|John W Mellors",Stephen H Hughes; PhD (Retroviral Replication Laboratory),NULL,"1. Kearney MF, Anderson EM, Coomer C, Smith L, Shao W, Johnson N, Kline C, Spindler J, Mellors JW, Coffin JM, Ambrose Z (2015). Well-mixed plasma and tissue viral populations in RT-SHIV-infected macaques implies a lack of viral replication in the tissues during antiretroviral therapy. Retrovirology  12, 93.   https://doi.org/10.1186/s12977-015-0212-2",https://intramural.nih.gov/search/searchview.taf?ipid=97592
525,BC011698-01,"-  September 30, 2016",Impact of Interventions on Clonally Expanded Proviruses and Their RNA Expression,Mary  Kearney,Frank  Maldarelli,"Host Virus Interaction Branch, NCI",Wei  Shao; PhD|Jonathan E Spindler,David M Margolis|John W Mellors,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97556
526,BC011699-01,"-  September 30, 2016",Ultrasensitive Single-Genome Sequencing to Study HIV Transmission and Evolution,Mary  Kearney,Frank  Maldarelli,"Host Virus Interaction Branch, NCI",Michael Javier Bale|Valerie F Boltz|Wei  Shao; PhD,"John  Coffin (Tufts University)|Mark  Cotton (Stellenbosch University)|Richard  Haubrich (University of California, San Diego)|Michael  Hughes (U.S. Environmental Protection Agency)|Shahin  Lockman (Harvard University)|James  McIntyre (University of Witwatersrand)|Show all 8",Eric O Freed; PhD (HIV Drug Resistance Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97593
527,BC011700-01,"-  September 30, 2016",Patient Oriented Research in Viral Malignancies and HIV-associated Cancers,Thomas S Uldrick|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI",Priscila Hermont Goncalves; MD|Griffin Benjamin Shoemaker|Robert  Yarchoan; MD|Joseph M Ziegelbauer,Martin A Cheever|Nicholas  Chomont (University of Montreal)|Sharon  Lewin (University of Melbourne)|Anisa  Mosam (University of KwaZulu-Natal)|Mark Niccolo Polizzotto; MD|Rafick  Sekaly; PhD (Vaccine & Gene Therapy Institute),"Deborah E Citrin (Radiation Oncology Branch)|Frank  Maldarelli (Host Virus Interaction Branch)|Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Giovanna  Tosato; PhD (Laboratory of Cellular Oncology)|Denise  Whitby (Office Of The Director)",Mark  Connors; MD (NIAID) |Irini  Sereti; MD (NIAID),"1. Hu D, Wang V, Yang M, Abdullah S, Davis DA, Uldrick TS, Polizzotto MN, Veeranna RP, Pittaluga S, Tosato G, Yarchoan R (2016). Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interleukin-6 by X-Box Binding Protein 1. J Virol  90, 368-78.   https://doi.org/10.1128/JVI.01192-15|2. Polizzotto MN, Millo C, Uldrick TS, Aleman K, Whatley M, Wyvill KM, O'Mahony D, Marshall V, Whitby D, Maass-Moreno R, Steinberg SM, Little RF, Yarchoan R (2015). 18F-fluorodeoxyglucose Positron Emission Tomography in Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease: Correlation With Activity, Severity, Inflammatory and Virologic Parameters. J Infect Dis  212, 1250-60.   https://doi.org/10.1093/infdis/jiv204|3. Polizzotto MN, Uldrick TS, Wyvill KM, Aleman K, Marshall V, Wang V, Whitby D, Pittaluga S, Jaffe ES, Millo C, Tosato G, Little RF, Steinberg SM, Sereti I, Yarchoan R (2016). Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS). Clin Infect Dis  62, 730-738.   https://doi.org/10.1093/cid/civ996|4. Sissolak G, Seftel M, Uldrick T, Esterhuizen T, Mohamed N, Kotze D (2016) Burkitt lymphoma and B-cell lymphoma unclassifiable with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma in patients with HIV: Outcomes in a South African public hospital. J Global Oncol, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=97594
528,BC011701-01,"-  September 30, 2016",Metabolic characterization of FH- and SDH-deficient RCC cell lines,Jeffrey Arnold Moscow,NULL,"Urologic Oncology Branch, NCI","Rony  Panarsky; PhD, BPHARM|William Marston Linehan; MD",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97595
529,BC011704-01,"-  September 30, 2016",Discovery of genes required for expression or activity of fusion oncogenes,Natasha  Caplen|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Sara Lynn Haddock|Konrad  Huppi; MD, PhD|Tamara L Jones|Neha  Kalla|Suntae  Kim|Carla Maya Neckles; PhD|Show all 9",Patrick  Grohar|Amanda  Hummon|Philip L Lorenzi,Lee Jay Helman; MD (Pediatric Oncology Branch)|John Stephen Schneekloth (Chemical Biology Laboratory),Madhu A Lal (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97597
530,BC011707-01,"-  September 30, 2016",The effect of therapeutics on mutated IDH1 cell lines and mice tumor models,Mioara  Larion; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Sriya Sravani Movva,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97598
531,BC011708-01,"-  September 30, 2016",Targeted and untargeted metabolomics in IDH1 mutated xenografts in mice,Mioara  Larion; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Tyrone Maurice Dowdy|Adrian  Lita,NULL,Kylie Janice Walters (Structural Biophysics Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97599
532,BC011709-01,"-  September 30, 2016","Metabolite profiling of patients blood, urine, cerebrospinal fluid and tissue",Mioara  Larion; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Tyrone Maurice Dowdy|Adrian  Lita|Mark Richard Gilbert; MD|Amber Jin Giles|Sadhana  Jackson|Deric Minwoo Park|Show all 7,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97600
533,BC011710-01,"-  September 30, 2016",In vivo and in vitro metabolic flux analysis in preclinical mouse models,Mioara  Larion; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Tyrone Maurice Dowdy|Adrian  Lita,NULL,Murali  Krishna; PhD (Radiation Biology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97601
534,BC011711-01,"-  September 30, 2016",Develop RAMAN imaging to visualize metabolism in cell lines and tissue,Mioara  Larion; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI","Adrian  Lita|Amber Jin Giles|Deric Minwoo Park|Jing  Wu; MD, PhD",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97602
535,BC011713-01,"-  September 30, 2016",Mechanisms of resistance to Androgen Receptor inhibition in prostate cancer,David James Vanderweele|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Melissa Amber Babcook; MD Candidate, PhD|Yen Thi Minh  Nguyen|Jose Antonio Rodriguez-Nieves; PhD|Kathleen  Kelly; PhD",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97603
536,BC011714-01,"-  September 30, 2016",Brain Tumor Immunotherapy,Mark Richard Gilbert; MD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Orieta  Celiku|Caitlin Marie Reid|Amber Jin Giles|Vinh Quang Au|Marsha-Kay Norissa Deanna Hutchinson|Heather Marie Sonneman|Show all 7,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97604
537,BC011715-01,"-  September 30, 2016",T cell receptor proximal signaling,Jonathan D Ashwell; MD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Debjani  Dutta; PhD|Paul  Mittelstadt; PhD|Maria Letizia  Giardino Torchia,NULL,Lawrence Elliot Samelson; MD (Laboratory of Cellular and Molecular Biology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97605
538,BC011717-01,"-  September 30, 2016",Structural studies of biomolecules related to cancer and HIV-AIDS,Hiroshi  Matsuo; PhD,Joel Patrick Schneider; PhD,"Basic Research Laboratory, NCI",Tapan  Kanai|Atanu  Maiti; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97607
539,BC011718-01,"-  September 30, 2016",Breast cancer aggressiveness in young patients,Patricia  Steeg; PhD|IRP Faculty Profile,NULL,"Womens Malignancies Branch, NCI",Alex Man Lai Wu,NULL,Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)|Li  Yang; PhD (Laboratory of Cancer Biology and Genetics),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97608
540,BC011719-01,"-  September 30, 2016",Multiregion sequencing of localized prostate cancer,David James Vanderweele|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",NULL,Satoru  Miyano (University of Tokyo Institute of Medical Science)|Hidewaki  Nakagawa (RIKEN Center for Integrative Medical Sciences)|Gladell  paner (University of Chicago),Margaret  Cam; PhD (Office of the Director)|Richard Phillip Finney (Cancer Informatics Branch)|David Lee Wheeler (Laboratory Of Biochemistry & Molecular Biology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97609
541,BC011720-01,"-  September 30, 2016","Gag Trafficking, Assembly, and Release",Eric O Freed; PhD|IRP Faculty Profile,NULL,"HIV Drug Resistance Program, NCI",Sherimay  Ablan|Melissa Victoria Fernandez; PhD|Justin Allan Kaplan|James Kiprotich Kirui|Nishani  Kuruppu|Mariia  Novikova; PhD|Show all 12,"Asim  Debnath (Lindsley F. Kimball Research Institute of the New York Blood Center)|James  Hurley (University of California, Berkeley)|Brett  Lindenbach (Yale University)|Matias  Ostrowski (University of Buenos Aires)|Christos  Petropoulos (Monogram Biosciences)|Gali  Prag|Show all 10",Wei-Shau  Hu; PhD (Retroviral Replication Laboratory)|Vineet Narain KewalRamani; PhD (Basic Research Laboratory)|Bruce Allen Shapiro; PhD (Gene Regulation and Chromosome Biology Laboratory),Juan S Bonifacino; PhD (NICHD) |Jennifer A Lippincott Schwartz; PhD (NICHD) |Yihong  Ye (NIDDK),"1. Freed EO (2015). HIV-1 assembly, release and maturation. Nat Rev Microbiol  13, 484-96.   https://doi.org/10.1038/nrmicro3490",https://intramural.nih.gov/search/searchview.taf?ipid=97610
542,BC011721-01,"-  September 30, 2016",Envelope Glycoprotein Incorporation,Eric O Freed; PhD|IRP Faculty Profile,NULL,"HIV Drug Resistance Program, NCI",Sherimay  Ablan|Melissa Victoria Fernandez; PhD|Justin Allan Kaplan|Nishani  Kuruppu|Mariia  Novikova; PhD|Maya Danielle Wivell Swiderski|Show all 11,"Eric  Barklis (University of Oregon)|Simon  Cocklin (Drexel University)|Shan-Lu  Liu (University of Missouri)|Michael  Summers (University of Maryland, Baltimore County)",Sriram  Subramaniam; PhD (Laboratory of Cell Biology),NULL,"1. Tedbury PR, Freed EO (2015). HIV-1 gag: an emerging target for antiretroviral therapy. Curr Top Microbiol Immunol  389, 171-201.   https://doi.org/10.1007/82_2015_436|2. Tedbury PR, Mercredi PY, Gaines CR, Summers MF, Freed EO (2015). Elucidating the mechanism by which compensatory mutations rescue an HIV-1 matrix mutant defective for gag membrane targeting and envelope glycoprotein incorporation. J Mol Biol  427, 1413-1427.   https://doi.org/10.1016/j.jmb.2015.01.018",https://intramural.nih.gov/search/searchview.taf?ipid=97612
543,BC011722-01,"-  September 30, 2016",Genomic characterization and development of therapies for Rhabdomyosarcoma,John Frederick Shern|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Christina Marie Murphy,NULL,Javed  Khan; MD (Cancer Genetics Branch),NULL,"1. Chen L, Shern JF, Wei JS, Yohe ME, Song YK, Hurd L, Liao H, Catchpoole D, Skapek SX, Barr FG, Hawkins DS, Khan J (2015). Clonality and evolutionary history of rhabdomyosarcoma. PLoS Genet  11, e1005075.   https://doi.org/10.1371/journal.pgen.1005075",https://intramural.nih.gov/search/searchview.taf?ipid=97611
544,BC011725-01,"-  September 30, 2016",Metabolic basis of chronic graft-versus-host disease,Nataliya Prokopenko Buxbaum|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Natella  Maglakelidze|Brittany Ursula Oliver|Don Eugene Farthing,NULL,Murali  Krishna; PhD (Radiation Biology Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Daniel  Crooks (Urologic Oncology Branch)|William Marston Linehan; MD (Urologic Oncology Branch)|James B Mitchell; PhD (Radiation Biology Branch)|Carole  Sourbier (Urologic Oncology Branch),"Hellmut  Merkle; MS, PHD (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97614
545,BC011726-01,"-  September 30, 2016",Phenotypic variability within isogenic population of lymphocytes,Gregoire Yves Altan-Bonnet|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Amir  Erez; PhD|Alon  Oyler Yaniv,Jackie  Bromberg (Memorial Sloan Kettering Cancer Center)|Guillermo  Cecchi (I.B.M.)|Paul  Franois (McGill University)|Oleg  Krichevsky (Ben Gurion University)|Lia  Palomba (Memorial Sloan Kettering),NULL,NULL,"1. Franois P, Bonnet G (2016) The Case for Absolute Ligand Discrimination: Modeling Information Processing and Decision by Immune T Cells Journal of Statistical Physics 162:1130–1152",https://intramural.nih.gov/search/searchview.taf?ipid=97615
546,BC011727-01,"-  September 30, 2016",In vivo cell kinetics and imaging of chronic graft-versus-host-disease,Nataliya Prokopenko Buxbaum|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Don Eugene Farthing|Natella  Maglakelidze|Brittany Ursula Oliver,NULL,"Andrea Christine Bohrer (Laboratory of Immune Cell Biology)|Remy J Bosselut; MD, PhD (Laboratory of Immune Cell Biology)",Yasmine  Belkaid; PhD (NIAID) |Nicolas  Bouladoux; PhD (NIAID) |Michael  Eckhaus; DVM (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97616
547,BC011728-01,"-  September 30, 2016",Cell-cell communications create robust collective immunological responses,Gregoire Yves Altan-Bonnet|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Marion Veronique Guerin|David Matthew Johnson|Jennifer Erin Oyler-Yaniv,Oleg  Krichevsky (Ben Gurion University)|Laurent  Lauvau (Albert Einstein College of Medicine),NULL,"Ronald N Germain; MD, PhD (NIAID)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97617
548,BC011730-01,"-  September 30, 2016",Studies on drug resistance in HIV-related Kaposis sarcoma,Michael Marc Gottesman; MD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Robert W Robey|Fatima Ghazanfar Ali-Rahmani,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97619
549,BC011732-01,"-  September 30, 2016",Discovery of combination therapy for KRAS mutant cancer,Ji  Luo|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Shinjen  Lin,NULL,NULL,Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97621
550,BC011733-01,"-  September 30, 2016",Mechanism of anchorage independent growth driven by the KRAS oncogene,Ji  Luo|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Junqiu  Yue; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97622
551,BC011734-01,"-  September 30, 2016",Genomic dissection of tumor heterogeneity and progression,John Frederick Shern|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Tom  Fountaine|Haiyan  Lei|Carly Meyer Sayers|Brigitte  Widemann; MD,NULL,"Douglas Russell Stewart; BA, MD (Clinical Genetics Branch)",NULL,"1. Long AH, Haso WM, Shern JF, Wanhainen KM, Murgai M, Ingaramo M, Smith JP, Walker AJ, Kohler ME, Venkateshwara VR, Kaplan RN, Patterson GH, Fry TJ, Orentas RJ, Mackall CL (2015). 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors. Nat Med  21, 581-90.   https://doi.org/10.1038/nm.3838|2. Shern JF, Yohe ME, Khan J (2015). Pediatric Rhabdomyosarcoma. Crit Rev Oncog  20, 227-43.   https://doi.org/10.1615/critrevoncog.2015013800",https://intramural.nih.gov/search/searchview.taf?ipid=97623
552,BC011736-01,"-  September 30, 2016",Preclinical Development of Therapeutics in Murine Models of Lung Cancer,Shyam K Sharan|IRP Faculty Profile,NULL,"Office of the Director, NCI",Baktiar Omer Karim,NULL,Peter L Choyke; MD (Molecular Imaging Program)|Udayan  Guha (Thoracic & Oncologic Surgery Branch)|Hisataka  Kobayashi (Molecular Imaging Program),Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97625
553,BC011737-01,"-  September 30, 2016","Validation of, and therapeutic evaluation in ovarian cancer GEM models",Shyam K Sharan|IRP Faculty Profile,NULL,"Office of the Director, NCI",Baktiar Omer Karim,NULL,Yves  Pommier; PhD (Developmental Therapeutics Branch)|Robert  Shoemaker (Chemopreventive Agent Development Research Group),Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97626
554,BC011738-01,"-  September 30, 2016",Preclinical GEM and GDA Models of Primary and Metastatic Melanoma,Shyam K Sharan|IRP Faculty Profile,NULL,"Office of the Director, NCI",Baktiar Omer Karim,"Robert  Hollingsworth (MedImmune)|Les  Stewart (Solaran Rx, Inc.)",Chi-Ping  Day (Laboratory of Cancer Biology and Genetics)|Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97627
555,BC011739-01,"-  September 30, 2016",Development and Preclinical Application of Pancreatic Adenocarcinoma Models,Shyam K Sharan|IRP Faculty Profile,NULL,"Office of the Director, NCI",Baktiar Omer Karim,"Ruihong  Chen (K-Gen, Inc.)|David  Frost (AbbVie)|Leaf  Huang (University of North Carolina)|Guillermina Gigi  Lozano (MD Anderson)|Frank  McCormick (UCSF School of Medicine)|Peppi  Prasit (Inception 2, Inc.)",Christine Campo Alewine (Laboratory of Molecular Biology)|Jonathan D Ashwell; MD (Laboratory of Immune Cell Biology)|James Halpern Doroshow (Office of the Director)|Ira H Pastan; MD (Molecular Biology Section)|Udo  Rudloff (Thoracic & Oncologic Surgery Branch)|Bradley D St Croix (Mouse Cancer Genetics Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97628
556,BC011740-01,"-  September 30, 2016",Inhibitors of Viral Membrane Fusion,Federico  Bernal|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Merissa Lynnea Baxter|Sterling Robert Alan Payne|Amanda Lee Whiting,NULL,Eric  Batchelor; PhD (Laboratory of Pathology),Peter  Jahrling (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97629
557,BC011741-01,"-  September 30, 2016",Targeting Metabolic Pathways in Bladder Cancer,Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Akhil  Wali|Leonard  Neckers; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97630
558,BC011742-01,"-  September 30, 2016",Natural History Study of the Complications Associated with Allogeneic HCT,Juan Carlos Gea-Banacloche; MD,NULL,"Experimental Transplantation and Immunology Branch, NCI","Daniel H Fowler|Ronald E Gress; MD|Dennis D Hickstein|Steven  Pavletic; MD, MS",NULL,Terry J Fry (Pediatric Oncology Branch)|Nirali Niranjan Shah (Pediatric Oncology Branch),Alessandra  Brofferio (NHLBI) |Jeffrey  Cohen; MD (NIAID) |Lesia Kizyma Dropulic (NIAID) |Theo  Heller; MD (NIDDK) |Steven M Holland; MD (NIAID) |Theresa Donohue Jerussi (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97631
559,BC011743-01,"-  September 30, 2016",NIH Chronic GVHD Study Group,"Steven  Pavletic; MD, MS|IRP Faculty Profile",NULL,"Experimental Transplantation and Immunology Branch, NCI",Lauren Mary Curtis|Licia Rita Masuch|Filip  Pirsl,"Nelson J Chao|Kenneth  Cooke (Johns Hopkins University)|Alexandra  Filipovich; MD (Pediatrics, Division of Hematology/Oncology, Cincinnati Children's Hospital Medical Center, University of Cincinnati Medical Center)|Hildegard  Greinix (Medizinische Universitat Graz)|Mary  Horawitz (Medical College of Wisconsin)|Madan  Jagasia (Vanderbilt-Ingram Cancer Center)|Show all 12","Edward W Cowen (Dermatology Branch)|David Erwin Kleiner; MD, PhD (Laboratory of Pathology)|Daoud M Meerzaman (Cancer Informatics Branch)|Sandra  Mitchell (Outcomes Research Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)",Rachel Jessica Bishop; MD (NEI) |Ann M Cohen-Berger; MD (CC) |Manuel B Datiles; MD (NEI) |Theo  Heller; MD (NIDDK) |Galen O Joe (CC) |Harry Lewis Malech; MD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97633
560,CO020003-08,"October 01, 2015 -  September 30, 2016",Office of Cancer Genomics,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"National Cancer Institute, NCI",NULL,NULL,Daniela S Gerhard  (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94282
561,CP000101-12,"October 01, 2015 -  September 30, 2016",Human Studies of Diet and Nutrition,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI",NULL,"Terryl  Hartman (Penn State University)|David  Baer (BHNRC, USDA)|Joanne  Dorgan; PhD (NCI)|Jerry  Combs (USDA)|Meryl  Wastney (Metabolic Modeling Services)",Ruth  Pfeiffer; PhD (Biostatistics Branch)|Somdat  Mahabir (Analytic Epidemiology Research Branch)|Blossom  Patterson (Biometry Research Group),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94324
562,CP000112-12,"October 01, 2015 -  September 30, 2016",Nutrition Intervention Trials in Linxian China,"Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile  | |Sanford Martin Dawsey; MD|IRP Faculty Profile  |Philip  Taylor; MD, ScD",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI

Genetic Epidemiology Branch, NCI",Nan  Hu|Neal David Freedman|Alisa  Goldstein; PhD|Paula L Hyland|Gwen  Murphy,"You-Lin  Qiao (Cancer Institute of the Chinese Academy of Science)|Wen-Qiang  Wei (Cancer Institute, Chinese Academy of Medical Sciences)",Kai  Yu (Biostatistics Branch),NULL,"1. Murphy G, Freedman ND, Michel A, Fan JH, Taylor PR, Pawlita M, Qiao YL, Zhang H, Yu K, Abnet CC, Dawsey SM (2015). Prospective study of Helicobacter pylori antigens and gastric noncardia cancer risk in the nutrition intervention trial cohort. Int J Cancer  137, 1938-46.   https://doi.org/10.1002/ijc.29543|2. Wang JB, Dawsey SM, Fan JH, Freedman ND, Tang ZZ, Ding T, Hu N, Wang LM, Wang CY, Su H, Qiao YL, Goldstein AM, Taylor PR, Abnet CC (2015). Common genetic variants related to vitamin D status are not associated with esophageal squamous cell carcinoma risk in China. Cancer Epidemiol  39, 157-9.   https://doi.org/10.1016/j.canep.2014.12.013|3. Wang JB, Fan JH, Dawsey SM, Sinha R, Freedman ND, Taylor PR, Qiao YL, Abnet CC (2016). Dietary components and risk of total, cancer and cardiovascular disease mortality in the Linxian Nutrition Intervention Trials cohort in China. Sci Rep  6, 22619.   https://doi.org/10.1038/srep22619|4. Wang SM, Fan JH, Jia MM, Yang Z, Zhang YQ, Qiao YL, Taylor PR (2016). Body mass index and long-term risk of death from esophageal squamous cell carcinoma in a Chinese population. Thorac Cancer  7, 387-92.   https://doi.org/10.1111/1759-7714.12340",https://intramural.nih.gov/search/searchview.taf?ipid=94323
563,CP000176-12,"October 01, 2015 -  September 30, 2016",Biologic Specimen Bank for Early Lung Cancer Markers in Chinese Tin Miners,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI","Neil Edward Caporaso; MS, MD|Nan  Hu|Guoqin  Yu",You-Lin  Qiao (Cancer Institute of the Chinese Academy of Science)|George M Weinstock|Jie  He (CICAMS)|Bert R Vogelstein,"Christian Cormac Abnet; PhD, MPH (Hormonal and Reproductive Epidemiology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94325
564,CP000185-12,"October 01, 2015 -  September 30, 2016",Upper Gastrointestinal Cancer Studies,"Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile  | |Neal David Freedman|IRP Faculty Profile  |Philip  Taylor; MD, ScD| | |Sanford Martin Dawsey; MD|IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI

Genetic Epidemiology Branch, NCI",Gwen  Murphy|Arash  Etemadi|Nan  Hu,"Paolo  Boffetta (International Agency for Research on Cancer)|Paul  Brennan (International Agency for Research on Cancer, Lyon, France)|Renato  Fagundes|David  Fleischer (Mayo Clinic (Scottsdale))|Ning  Lu (Cancer Institute, Chinese Academy of Medical Sciences)|Reza  Malekzadeh (Digestive Disease Research Center, Tehran University of Medical Sciences)|Show all 11",NULL,NULL,"1. Abnet CC, Corley DA, Freedman ND, Kamangar F (2015). Diet and upper gastrointestinal malignancies. Gastroenterology  148, 1234-1243.e4.   https://doi.org/10.1053/j.gastro.2015.02.007|2. Couch G, Redman JE, Wernisch L, Newton R, Malhotra S, Dawsey SM, Lao-Sirieix P, Fitzgerald RC (2016). The Discovery and Validation of Biomarkers for the Diagnosis of Esophageal Squamous Dysplasia and Squamous Cell Carcinoma. Cancer Prev Res (Phila)  9, 558-66.   https://doi.org/10.1158/1940-6207.CAPR-15-0379|3. Drahos J, Schwameis K, Orzolek LD, Hao H, Birner P, Taylor PR, Pfeiffer RM, Schoppmann SF, Cook MB (2016). MicroRNA Profiles of Barrett's Esophagus and Esophageal Adenocarcinoma: Differences in Glandular Non-native Epithelium. Cancer Epidemiol Biomarkers Prev  25, 429-37.   https://doi.org/10.1158/1055-9965.EPI-15-0161|4. Eichelberger L, Murphy G, Etemadi A, Abnet CC, Islami F, Shakeri R, Malekzadeh R, Dawsey SM (2015). Risk of gastric cancer by water source: evidence from the Golestan case-control study. PLoS One  10, e0128491.   https://doi.org/10.1371/journal.pone.0128491|5. Golozar A, Etemadi A, Kamangar F, Fazeltabar Malekshah A, Islami F, Nasrollahzadeh D, Abedi-Ardekani B, Khoshnia M, Pourshams A, Semnani S, Marjani HA, Shakeri R, Sotoudeh M, Brennan P, Taylor P, Boffetta P, Abnet C, Dawsey S, Malekzadeh R (2016). Food preparation methods, drinking water source, and esophageal squamous cell carcinoma in the high-risk area of Golestan, Northeast Iran. Eur J Cancer Prev  25, 123-9.   https://doi.org/10.1097/CEJ.0000000000000156|6. He S, Bergman J, Zhang Y, Weusten B, Xue L, Qin X, Dou L, Liu Y, Fleischer D, Lu N, Dawsey SM, Wang GQ (2015). Endoscopic radiofrequency ablation for early esophageal squamous cell neoplasia: report of safety and effectiveness from a large prospective trial. Endoscopy  47, 398-408.   https://doi.org/10.1055/s-0034-1391285|7. Hu N, Wang Z, Song X, Wei L, Kim BS, Freedman ND, Baek J, Burdette L, Chang J, Chung C, Dawsey SM, Ding T, Gao YT, Giffen C, Han Y, Hong M, Huang J, Kim HS, Koh WP, Liao LM, Mao YM, Qiao YL, Shu XO, Tan W, Wang C, et al. [16 more authors] (2016) Genome-wide association study of gastric adenocarcinoma in Asia: a comparison of associations between cardia and non-cardia tumours. Gut 65:1611-8|8. Lin S, Freedman N, Shi J, Gail M, Vogtmann E, Yu G, KlepacCeraj V, Paster B, Dye B, Wang G, Wei W, Fan J, Qiao Y, Dawsey S, Abnet C (2015) Beta-diversity metrics of the upper digestive tract microbiome are associated with body mass index. Obesity (Silver Spring, Md.) 23:862-9|9. Mwachiro MM, Burgert SL, Lando J, Chepkwony R, Bett C, Bosire C, Abnet CC, Githanga J, Waweru W, Giffen CA, Murphy G, White RE, Topazian MD, Dawsey SM (2016). Esophageal Squamous Dysplasia is Common in Asymptomatic Kenyans: A Prospective, Community-Based, Cross-Sectional Study. Am J Gastroenterol  111, 500-7.   https://doi.org/10.1038/ajg.2016.26|10. Shakeri R, Malekzadeh R, Nasrollahzadeh D, Pawlita M, Pawilta M, Murphy G, Islami F, Sotoudeh M, Michel A, Etemadi A, Waterboer T, Poustchi H, Brennan P, Boffetta P, Dawsey SM, Kamangar F, Abnet CC (2015). Multiplex H. pylori Serology and Risk of Gastric Cardia and Noncardia Adenocarcinomas. Cancer Res  75, 4876-83.   https://doi.org/10.1158/0008-5472.CAN-15-0556|11. Sinha R, Abnet CC, White O, Knight R, Huttenhower C (2015). The microbiome quality control project: baseline study design and future directions. Genome Biol  16, 276.   https://doi.org/10.1186/s13059-015-0841-8|12. Topazian H, Cira M, Dawsey SM, Kibachio J, Kocholla L, Wangai M, Welch J, Williams MJ, Duncan K, Galassi A (2016). Joining Forces to Overcome Cancer: The Kenya Cancer Research and Control Stakeholder Program. J Cancer Policy  7, 36-41.   https://doi.org/10.1016/j.jcpo.2015.12.001|13. Vogtmann E, Corley DA, Almers LM, Cardwell CR, Murray LJ, Abnet CC (2015). Oral Bisphosphonate Exposure and the Risk of Upper Gastrointestinal Cancers. PLoS One  10, e0140180.   https://doi.org/10.1371/journal.pone.0140180|14. Vogtmann E, Graubard B, Loftfield E, Chaturvedi A, Dye BA, Abnet CC, Freedman ND (2017). Contemporary impact of tobacco use on periodontal disease in the USA. Tob Control  26, 237-238.   https://doi.org/10.1136/tobaccocontrol-2015-052750",https://intramural.nih.gov/search/searchview.taf?ipid=94326
565,CP004410-40,"October 01, 2015 -  September 30, 2016",Family Studies,"Neil Edward Caporaso; MS, MD|IRP Faculty Profile  |Lynn Rachel Goldin; PhD| | |Alisa  Goldstein; PhD|IRP Faculty Profile  | |Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile  | |Xiaohong Rose Yang; PhD|IRP Faculty Profile  | |Margaret Anne Tucker|IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI

Human Genetics Program, NCI",Mary Louise McMaster; MD,Janis  Beach (Information Management Systems)|Donato  Calista (Bufalini Hospital)|Florence  Demenais (Institut National de la Sante et de la Recherche Medicale)|Michael  Kelley (Duke University Medical Center)|Jeannette  Korczak (Karmanos Cancer Institute)|Yvonne  Reid (American Type Culture Collection)|Show all 11,"Gladys M. Glenn; MD, PhD (Clinical Genetics Branch)|June  Peters (Clinical Genetics Branch)|Kenneth H Kraemer; MD (Dermatology Branch)","Jeffery P Struewing; MS, MD (NHGRI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94298
566,CP005782-22,"October 01, 2015 -  September 30, 2016",Epidemiology of Oncogenic Viruses,"Thomas R O'Brien; BA, MPH, MD|IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,Ruth  Pfeiffer; PhD (Biostatistics Branch)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics)|Neal David Freedman (Hormonal and Reproductive Epidemiology Branch),Barbara  Rehermann; MD (NIDDK) |Raymond  Donnelly (OD),"1. Kuniholm M, O'Brien T, ProkuninaOlsson L, Augenbraun M, Plankey M, Karim R, Sarkar M, French A, Pierce C, Strickler H, Anastos K (2016) Association of Hepatitis C Virus Infection with CD4CD8 Ratio in HIV-Positive Women JAIDS 72:162-70|2. O'Brien TR, Pfeiffer RM, Paquin A, Lang Kuhs KA, Chen S, Bonkovsky HL, Edlin BR, Howell CD, Kirk GD, Kuniholm MH, Morgan TR, Strickler HD, Thomas DL, Prokunina-Olsson L (2015). Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance. J Hepatol  63, 1103-10.   https://doi.org/10.1016/j.jhep.2015.06.035",https://intramural.nih.gov/search/searchview.taf?ipid=94297
567,CP005803-22,"October 01, 2015 -  September 30, 2016",Genetic Epidemiology,"Neil Edward Caporaso; MS, MD|IRP Faculty Profile  |Lynn Rachel Goldin; PhD| | |Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile  | |Margaret Anne Tucker|IRP Faculty Profile  | |Xiaohong Rose Yang; PhD|IRP Faculty Profile  | |Alisa  Goldstein; PhD|IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI

Human Genetics Program, NCI",Mary Louise McMaster; MD|Dilys  Parry; PhD,"Tim  Bishop (Institute for Cancer Research)|Florence  Demenais (Institut National de la Sante et de la Recherche Medicale)|Jorgen  Olsen (Danish Cancer Society)|Lene  Mellemkjaer (Danish Cancer Society)|Kari  Hemminki; PhD (Department of Biosciences, Karolinska Institute)|Donato  Calista (Bufalini Hospital)","Mitchell Henry Gail; PhD, MD (Biostatistics Branch)|Ruth  Pfeiffer; PhD (Biostatistics Branch)|Ola Anders Landgren (Lymphoid Malignancies Branch)|Mark E Sherman; MD (Breast and Gynecologic Cancer Research Group)",NULL,"1. Li M, Tse LA, Chan WC, Kwok CH, Leung SL, Wu C, Yu WC, Yu IT, Yu CH, Wang F, Sung H, Yang XR (2016). Evaluation of breast cancer risk associated with tea consumption by menopausal and estrogen receptor status among Chinese women in Hong Kong. Cancer Epidemiol  40, 73-8.   https://doi.org/10.1016/j.canep.2015.11.013|2. Sung H, Rosenberg PS, Chen WQ, Hartman M, Lim WY, Chia KS, Wai-Kong Mang O, Tse L, Anderson WF, Yang XR (2016). The impact of breast cancer-specific birth cohort effects among younger and older Chinese populations. Int J Cancer  139, 527-34.   https://doi.org/10.1002/ijc.30095",https://intramural.nih.gov/search/searchview.taf?ipid=94296
568,CP005804-22,"October 01, 2015 -  September 30, 2016",Pharmacogenetic Studies,"Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile  | |Neil Edward Caporaso; MS, MD|IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI",Andrea  Baccarelli|Andrew Wells Bergen|Alisa  Goldstein; PhD|Lynn Rachel Goldin; PhD,Janis  Beach (Information Management Systems)|Maria  Landi (DCEG),Margaret Anne Tucker (Human Genetics Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94295
569,CP010119-21,"October 01, 2015 -  September 30, 2016",Studies of Occupational Cancer (Pesticides),"Jonathan Nicholas Hofmann|IRP Faculty Profile  | |Stella  Koutros|IRP Faculty Profile  | |Mary Helen Ward; MS, PhD|IRP Faculty Profile  | |Laura Elizabeth Beane Freeman|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Gabriella  Andreotti|Debra  Silverman; ScD, ScM|Nathaniel C Rothman; MD",Lisbeth  Lopez-Carrillo (Mexican National Institute of Public Health)|Andrew  Olshan (University of North Carolina)|Sandra  Petralia (Roche Laboratories)|Dennis  Weisenburger (University of Nebraska Medical Center)|Jane  Hoppin (North Carolina State University),NULL,NULL,"1. Bonner MR, Freeman LE, Hoppin JA, Koutros S, Sandler DP, Lynch CF, Hines CJ, Thomas K, Blair A, Alavanja MC (2017). Occupational Exposure to Pesticides and the Incidence of Lung Cancer in the Agricultural Health Study. Environ Health Perspect  125, 544-551.   https://doi.org/10.1289/EHP456|2. Campbell PT, Newton CC, Freedman ND, Koshiol J, Alavanja MC, Beane Freeman LE, Buring JE, Chan AT, Chong DQ, Datta M, Gaudet MM, Gaziano JM, Giovannucci EL, Graubard BI, Hollenbeck AR, King L, Lee IM, Linet MS, Palmer JR, Petrick JL, Poynter JN, Purdue MP, Robien K, Rosenberg L, Sahasrabuddhe VV, et al. [8 more authors] (2016) Body Mass Index, Waist Circumference, Diabetes, and Risk of Liver Cancer for U.S. Adults. Cancer Res 76:6076-6083|3. Hofmann JN, Beane Freeman LE, Lynch CF, Andreotti G, Thomas KW, Sandler DP, Savage SA, Alavanja MC (2015). The Biomarkers of Exposure and Effect in Agriculture (BEEA) Study: Rationale, Design, Methods, and Participant Characteristics. J Toxicol Environ Health A  78, 1338-47.   https://doi.org/10.1080/15287394.2015.1091414|4. Hoppin JA, Umbach DM, Long S, London SJ, Henneberger PK, Blair A, Alavanja M, Freeman LE, Sandler DP (2017). Pesticides are Associated with Allergic and Non-Allergic Wheeze among Male Farmers. Environ Health Perspect  125, 535-543.   https://doi.org/10.1289/EHP315|5. Koutros S, Silverman DT, Alavanja MC, Andreotti G, Lerro CC, Heltshe S, Lynch CF, Sandler DP, Blair A, Beane Freeman LE (2016). Occupational exposure to pesticides and bladder cancer risk. Int J Epidemiol  45, 792-805.   https://doi.org/10.1093/ije/dyv195|6. Tual S, Silverman DT, Koutros S, Blair A, Sandler DP, Lebailly P, Andreotti G, Hoppin JA, Freeman LE (2016). Use of Dieselized Farm Equipment and Incident Lung Cancer: Findings from the Agricultural Health Study Cohort. Environ Health Perspect  124, 611-8.   https://doi.org/10.1289/ehp.1409238|7. Zirkle KW, Nolan BT, Jones RR, Weyer PJ, Ward MH, Wheeler DC (2016). Assessing the relationship between groundwater nitrate and animal feeding operations in Iowa (USA). Sci Total Environ  566-567, 1062-1068.   https://doi.org/10.1016/j.scitotenv.2016.05.130",https://intramural.nih.gov/search/searchview.taf?ipid=94290
570,CP010120-21,"October 01, 2015 -  September 30, 2016",Studies of Occupational Cancer,"Michael  Alavanja; PhD| | |Nathaniel C Rothman; MD|IRP Faculty Profile  | |Debra  Silverman; ScD, ScM|IRP Faculty Profile  | |Qing  Lan|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris|Joanne S Colt|Bu Tian  Ji|Mary Helen Ward; MS, PhD|Aaron E Blair; PhD, MPH|Patricia S Stewart; PhD|Show all 13",Paolo  Boffetta (International Agency for Research on Cancer)|Leon  Burmeister (University of Iowa)|Larwence  Figgs (St. Louis University)|Daniel  Lackland (Medical University of South Carolina)|J.  Nichols (Medical University of South Carolina)|Dennis  Zaebst (National Institute for Occupational Safety and Health)|Show all 21,"Jay  Lubin; PhD (Biostatistics Branch)|Louise  Brinton; PhD (Office of the Director)|Montserrat  Garcia-Closas; MD, PhD (Office of the Director)","Dale  Sandler; PhD (NIEHS) |Jane  Hoppin; ScD (NIEHS) |Freya  Kamel; PhD, MPH (NIEHS)","1. Daniels RD, Bertke S, Dahm MM, Yiin JH, Kubale TL, Hales TR, Baris D, Zahm SH, Beaumont JJ, Waters KM, Pinkerton LE (2015). Exposure-response relationships for select cancer and non-cancer health outcomes in a cohort of U.S. firefighters from San Francisco, Chicago and Philadelphia (1950-2009). Occup Environ Med  72, 699-706.   https://doi.org/10.1136/oemed-2014-102671",https://intramural.nih.gov/search/searchview.taf?ipid=94292
571,CP010121-21,"October 01, 2015 -  September 30, 2016",Molecular Epidemiology Studies of Occupational and Environmental Exposures,"Qing  Lan|IRP Faculty Profile  | |Debra  Silverman; ScD, ScM|IRP Faculty Profile  | |Nathaniel C Rothman; MD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Mary Helen Ward; MS, PhD|Michael  Alavanja; PhD|Kenneth  Cantor; PhD|Aaron E Blair; PhD, MPH|Min  Shen|Lifang  Hou|Show all 8","Stephen  Rappaport (School of Public Health, University of California)|Martyn  Smith (University of California at Berkeley)|Wei  Zheng (Vanderbilt University Medical Center)|John  Tessari (Colorado State University)|Xiao  Shu (Vanderbilt)|Robert  Branch (University of Pittsburgh)|Show all 13",NULL,NULL,"1. Wang TW, Vermeulen RC, Hu W, Liu G, Xiao X, Alekseyev Y, Xu J, Reiss B, Steiling K, Downward GS, Silverman DT, Wei F, Wu G, Li J, Lenburg ME, Rothman N, Spira A, Lan Q (2015). Gene-expression profiling of buccal epithelium among non-smoking women exposed to household air pollution from smoky coal. Carcinogenesis  36, 1494-501.   https://doi.org/10.1093/carcin/bgv150",https://intramural.nih.gov/search/searchview.taf?ipid=94293
572,CP010122-21,"October 01, 2015 -  September 30, 2016",Occupational Exposure Assessment,Melissa Charmaine Friesen|IRP Faculty Profile,NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris|Mary Helen Ward; MS, PhD|Michael  Alavanja; PhD|Kenneth  Cantor; PhD|Aaron E Blair; PhD, MPH|Qing  Lan|Show all 14",NULL,NULL,NULL,"1. Friesen MC, Wheeler DC, Vermeulen R, Locke SJ, Zaebst DD, Koutros S, Pronk A, Colt JS, Baris D, Karagas MR, Malats N, Schwenn M, Johnson A, Armenti KR, Rothman N, Stewart PA, Kogevinas M, Silverman DT (2016). Combining Decision Rules from Classification Tree Models and Expert Assessment to Estimate Occupational Exposure to Diesel Exhaust for a Case-Control Study. Ann Occup Hyg  60, 467-78.   https://doi.org/10.1093/annhyg/mev095|2. Russ DE, Ho KY, Colt JS, Armenti KR, Baris D, Chow WH, Davis F, Johnson A, Purdue MP, Karagas MR, Schwartz K, Schwenn M, Silverman DT, Johnson CA, Friesen MC (2016). Computer-based coding of free-text job descriptions to efficiently identify occupations in epidemiological studies. Occup Environ Med  73, 417-24.   https://doi.org/10.1136/oemed-2015-103152",https://intramural.nih.gov/search/searchview.taf?ipid=94291
573,CP010123-21,"October 01, 2015 -  September 30, 2016",Occupational and Environmental Determinants of Cancer among Women and Minorities,"Michael  Alavanja; PhD| | |Melissa Charmaine Friesen|IRP Faculty Profile  | |Qing  Lan|IRP Faculty Profile  | |Mark  Purdue|IRP Faculty Profile  | |Nathaniel C Rothman; MD|IRP Faculty Profile  | |Debra  Silverman; ScD, ScM|IRP Faculty Profile  | |Mary Helen Ward; MS, PhD|IRP Faculty Profile  | |Laura Elizabeth Beane Freeman|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris|Aaron E Blair; PhD, MPH|Bu Tian  Ji|Joanne S Colt",NULL,"Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)|Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Martha S Linet; PhD (Radiation Epidemiology Branch)",NULL,"1. Costas L, Lambert BH, Birmann BM, Moysich KB, De Roos AJ, Hofmann JN, Baris D, Wang SS, Camp NJ, Tricot G, Atanackovic D, Brennan P, Cocco P, Nieters A, Becker N, Maynadié M, Foretová L, Boffetta P, Staines A, Brown EE, de Sanjosé S (2016). A Pooled Analysis of Reproductive Factors, Exogenous Hormone Use, and Risk of Multiple Myeloma among Women in the International Multiple Myeloma Consortium. Cancer Epidemiol Biomarkers Prev  25, 217-21.   https://doi.org/10.1158/1055-9965.EPI-15-0953|2. Dai Y, Niu Y, Duan H, Bassig BA, Ye M, Zhang X, Meng T, Bin P, Jia X, Shen M, Zhang R, Hu W, Yang X, Vermeulen R, Silverman D, Rothman N, Lan Q, Yu S, Zheng Y (2016). Effects of occupational exposure to carbon black on peripheral white blood cell counts and lymphocyte subsets. Environ Mol Mutagen  57, 615-622.   https://doi.org/10.1002/em.22036|3. Kim C, Seow WJ, Shu XO, Bassig BA, Rothman N, Chen BE, Xiang YB, Hosgood HD, Ji BT, Hu W, Wen C, Chow WH, Cai Q, Yang G, Gao YT, Zheng W, Lan Q (2016). Cooking Coal Use and All-Cause and Cause-Specific Mortality in a Prospective Cohort Study of Women in Shanghai, China. Environ Health Perspect  124, 1384-9.   https://doi.org/10.1289/EHP236|4. Schinasi LH, Brown EE, Camp NJ, Wang SS, Hofmann JN, Chiu BC, Miligi L, Beane Freeman LE, de Sanjose S, Bernstein L, Monnereau A, Clavel J, Tricot GJ, Atanackovic D, Cocco P, Orsi L, Dosman JA, McLaughlin JR, Purdue MP, Cozen W, Spinelli JJ, de Roos AJ (2016). Multiple myeloma and family history of lymphohaematopoietic cancers: Results from the International Multiple Myeloma Consortium. Br J Haematol  175, 87-101.   https://doi.org/10.1111/bjh.14199|5. Seow WJ, Downward GS, Wei H, Rothman N, Reiss B, Xu J, Bassig BA, Li J, He J, Hosgood HD, Wu G, Chapman RS, Tian L, Wei F, Caporaso NE, Vermeulen R, Lan Q (2016). Indoor concentrations of nitrogen dioxide and sulfur dioxide from burning solid fuels for cooking and heating in Yunnan Province, China. Indoor Air  26, 776-83.   https://doi.org/10.1111/ina.12251|6. Wang XM, Bassig BA, Wen JJ, Li GD, Liu ZB, Yao WX, Hu W, Wang Y, Li JM, Wang XD, Gan MZ, Wang CS, Xu G, Rothman N, Lan Q, Xu CG (2016). Clinical analysis of 1629 newly diagnosed malignant lymphomas in current residents of Sichuan province, China. Hematol Oncol  34, 193-199.   https://doi.org/10.1002/hon.2202|7. Wu SH, Shu XO, Milne G, Xiang YB, Zhang X, Cai Q, Fazio S, Linton MF, Chen H, Purdue M, Rothman N, Gao YT, Zheng W, Yang G (2015). Uric acid correlates to oxidation and inflammation in opposite directions in women. Biomarkers  20, 225-31.   https://doi.org/10.3109/1354750X.2015.1068852",https://intramural.nih.gov/search/searchview.taf?ipid=94294
574,CP010124-21,"October 01, 2015 -  September 30, 2016",Human papillomavirus (HPV) infection and cervical and anal cancers,Mark  Schiffman; MD|IRP Faculty Profile  | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",Julia  Gage|Clara  Bodelon,Robert  Burk (Albert Einstein College of Medicine)|Michael  Gold MD (Vanderbilt University)|Patti  Gravitt (Johns Hopkins University)|Martha  Hutchinson (Brown University)|David  Scott (Kaiser Permanente)|Joan  Walker MD (University of Oklahoma Health Sciences Center)|Show all 27,Mark E Sherman; MD (Breast and Gynecologic Cancer Research Group)|Hormuzdiar Aspandiar Katki; MS (Biostatistics Branch)|Joshua Neil Sampson (Biostatistics Branch)|Vikrant Vasant Sahasrabuddhe (Breast and Gynecologic Cancer Research Group)|Hannah  Yang (Office of the Director)|Douglas  Lowy; MD (Office Of The Director),NULL,"1. Bodelon C, Vinokurova S, Sampson JN, den Boon JA, Walker JL, Horswill MA, Korthauer K, Schiffman M, Sherman ME, Zuna RE, Mitchell J, Zhang X, Boland JF, Chaturvedi AK, Dunn ST, Newton MA, Ahlquist P, Wang SS, Wentzensen N (2016). Chromosomal copy number alterations and HPV integration in cervical precancer and invasive cancer. Carcinogenesis  37, 188-196.   https://doi.org/10.1093/carcin/bgv171|2. Hildesheim A, Gonzalez P, Kreimer AR, Wacholder S, Schussler J, Rodriguez AC, Porras C, Schiffman M, Sidawy M, Schiller JT, Lowy DR, Herrero R, Costa Rica HPV Vaccine Trial (CVT) Group (2016). Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment. Am J Obstet Gynecol  215, 212.e1-212.e15.   https://doi.org/10.1016/j.ajog.2016.02.021|3. Liu AH, Gold MA, Schiffman M, Smith KM, Zuna RE, Dunn ST, Gage JC, Walker JL, Wentzensen N (2016). Comparison of Colposcopic Impression Based on Live Colposcopy and Evaluation of Static Digital Images. J Low Genit Tract Dis  20, 154-61.   https://doi.org/10.1097/LGT.0000000000000194|4. Schiffman M, Yu K, Zuna R, Terence Dunn S, Zhang H, Walker J, Gold M, Hyun N, Rydzak G, Katki HA, Wentzensen N (2017). Proof-of-principle study of a novel cervical screening and triage strategy: Computer-analyzed cytology to decide which HPV-positive women are likely to have ≥CIN2. Int J Cancer  140, 718-725.   https://doi.org/10.1002/ijc.30456|5. Wentzensen N, Fetterman B, Castle PE, Schiffman M, Wood SN, Stiemerling E, Tokugawa D, Bodelon C, Poitras N, Lorey T, Kinney W (2015). p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women. J Natl Cancer Inst  107, djv257.   https://doi.org/10.1093/jnci/djv257|6. Xu L, Verdoodt F, Wentzensen N, Bergeron C, Arbyn M (2016). Triage of ASC-H: A meta-analysis of the accuracy of high-risk HPV testing and other markers to detect cervical precancer. Cancer Cytopathol  124, 261-72.   https://doi.org/10.1002/cncy.21661",https://intramural.nih.gov/search/searchview.taf?ipid=94286
575,CP010125-21,"October 01, 2015 -  September 30, 2016",Cancer Risk and Environmental Exposures,"Mary Helen Ward; MS, PhD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Rena Rae Jones|Joanne S Colt|Debra  Silverman; ScD, ScM|Michael  Alavanja; PhD|Nathaniel C Rothman; MD|Aaron E Blair; PhD, MPH|Show all 11","James  Cerhan (Mayo Clinic)|Charles  Lynch (University of Iowa)|R William  Field (University of Iowa)|Manolis  Kogevinas|John W Brock (CDC)|Alexander  Parker (Mayo Clinic, Rochestor, NM)|Show all 28",Jay  Lubin; PhD (Biostatistics Branch)|Maki  Inoue Choi (Hormonal and Reproductive Epidemiology Branch),Lawrence Stuart Engel; PhD (NIEHS),"1. Baris D, Waddell R, Beane Freeman LE, Schwenn M, Colt JS, Ayotte JD, Ward MH, Nuckols J, Schned A, Jackson B, Clerkin C, Rothman N, Moore LE, Taylor A, Robinson G, Hosain GM, Armenti KR, McCoy R, Samanic C, Hoover RN, Fraumeni JF, Johnson A, Karagas MR, Silverman DT (2016). Elevated Bladder Cancer in Northern New England: The Role of Drinking Water and Arsenic. J Natl Cancer Inst  108.   https://doi.org/10.1093/jnci/djw099|2. Deziel NC, Nuckols JR, Jones RR, Graubard BI, De Roos AJ, Pronk A, Gourley C, Colt JS, Ward MH (2017). Comparison of industrial emissions and carpet dust concentrations of polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans in a multi-center U.S. study. Sci Total Environ  580, 1276-1286.   https://doi.org/10.1016/j.scitotenv.2016.12.090|3. Gunier RB, Nuckols JR, Whitehead TP, Colt JS, Deziel NC, Metayer C, Reynolds P, Ward MH (2016). Temporal Trends of Insecticide Concentrations in Carpet Dust in California from 2001 to 2006. Environ Sci Technol  50, 7761-9.   https://doi.org/10.1021/acs.est.6b00252|4. Inoue-Choi M, Sinha R, Gierach GL, Ward MH (2016). Red and processed meat, nitrite, and heme iron intakes and postmenopausal breast cancer risk in the NIH-AARP Diet and Health Study. Int J Cancer  138, 1609-18.   https://doi.org/10.1002/ijc.29901|5. Inoue-Choi M, Virk-Baker MK, Aschebrook-Kilfoy B, Cross AJ, Subar AF, Thompson FE, Sinha R, Ward MH (2016). Development and calibration of a dietary nitrate and nitrite database in the NIH-AARP Diet and Health Study. Public Health Nutr  19, 1934-43.   https://doi.org/10.1017/S1368980015003407|6. Inoue-Choi M, Weyer PJ, Jones RR, Booth BJ, Cantor KP, Robien K, Ward MH (2016). Atrazine in public water supplies and risk of ovarian cancer among postmenopausal women in the Iowa Women's Health Study. Occup Environ Med  73, 582-7.   https://doi.org/10.1136/oemed-2016-103575|7. Jones RR, Weyer PJ, DellaValle CT, Inoue-Choi M, Anderson KE, Cantor KP, Krasner S, Robien K, Freeman LE, Silverman DT, Ward MH (2016). Nitrate from Drinking Water and Diet and Bladder Cancer Among Postmenopausal Women in Iowa. Environ Health Perspect  124, 1751-1758.   https://doi.org/10.1289/EHP191",https://intramural.nih.gov/search/searchview.taf?ipid=94299
576,CP010126-21,"October 01, 2015 -  September 30, 2016",Hormone-Related Cancers,"Louise  Brinton; PhD| | |Michael Blaise Cook|IRP Faculty Profile  | |Montserrat  Garcia-Closas; MD, PhD|IRP Faculty Profile  | |Katherine Ann McGlynn; PhD|IRP Faculty Profile  | |Britton Lindsay Trabert|IRP Faculty Profile  | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  | |Gretchen L Gierach|IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI

Clinical Genetics Branch, NCI

Office of the Director, NCI","Roni T Falk|Hannah  Yang|Stephen J Chanock; MD, PhD",David  Alberts (University of Arizona Cancer Center)|Douglas  Bauer (University of California at San Francisco)|Ralph  Coates (Centers for Disease Control and Prevention)|Joanne  Dorgan; PhD (NCI)|Kathleen  Egan (Harvard University)|R Loren  Erickson (Department of Defense)|Show all 11,"Mark E Sherman; MD (Breast and Gynecologic Cancer Research Group)|Barry Ira Graubard; PhD (Biostatistics Branch)|William Frederick Anderson (Biostatistics Branch)|Aaron E Blair; PhD, MPH (Occupational and Environmental Epidemiology Branch)","Jeffery P Struewing; MS, MD (NHGRI) |Matthew P. Longnecker; MD, ScD (NIEHS)","1. Abubakar M, Howat WJ, Daley F, Zabaglo L, McDuffus LA, Blows F, Coulson P, Raza Ali H, Benitez J, Milne R, Brenner H, Stegmaier C, Mannermaa A, Chang-Claude J, Rudolph A, Sinn P, Couch FJ, Tollenaar RA, Devilee P, Figueroa J, Sherman ME, Lissowska J, Hewitt S, Eccles D, Hooning MJ, et al. [18 more authors] (2016). High-throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium. J Pathol Clin Res  2, 138-53.   https://doi.org/10.1002/cjp2.42|2. Amankwah EK, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Aben KK, Anton-Culver H, Antonenkova N, Bruinsma F, Bandera EV, Bean YT, Beckmann MW, Bisogna M, Bjorge L, Bogdanova N, Brinton LA, Brooks-Wilson A, Bunker CH, Butzow R, Campbell IG, Carty K, Chen Z, Chen YA, Chang-Claude J, Georgia Chenevix-Trench on behalf of the AOCS management group, et al. [132 more authors] (2015). Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk. Genet Epidemiol  39, 689-97.   https://doi.org/10.1002/gepi.21921|3. Bodelon C, Heaphy CM, Meeker AK, Geller B, Vacek PM, Weaver DL, Chicoine RE, Shepherd JA, Mahmoudzadeh AP, Patel DA, Brinton LA, Sherman ME, Gierach GL (2015). Leukocyte telomere length and its association with mammographic density and proliferative diagnosis among women undergoing diagnostic image-guided breast biopsy. BMC Cancer  15, 823.   https://doi.org/10.1186/s12885-015-1860-2|4. Brinton LA, Trabert B, Anderson GL, Falk RT, Felix AS, Fuhrman BJ, Gass ML, Kuller LH, Pfeiffer RM, Rohan TE, Strickler HD, Xu X, Wentzensen N (2016). Serum Estrogens and Estrogen Metabolites and Endometrial Cancer Risk among Postmenopausal Women. Cancer Epidemiol Biomarkers Prev  25, 1081-9.   https://doi.org/10.1158/1055-9965.EPI-16-0225|5. Chen MM, O'Mara TA, Thompson DJ, Painter JN, Australian National Endometrial Cancer Study Group (ANECS), Attia J, Black A, Brinton L, Chanock S, Chen C, Cheng TH, Cook LS, Crous-Bou M, Doherty J, Friedenreich CM, Garcia-Closas M, Gaudet MM, Gorman M, Haiman C, Hankinson SE, Hartge P, Henderson BE, Hodgson S, Holliday EG, Horn-Ross PL, Hunter DJ, National Study Of Endometrial Cancer Genetics Group (NSECG), et al. [38 more authors] (2016). GWAS meta-analysis of 16 852 women identifies new susceptibility locus for endometrial cancer. Hum Mol Genet  25, 2612-2620.   https://doi.org/10.1093/hmg/ddw092|6. Dallal CM, Brinton LA, Matthews CE, Pfeiffer RM, Hartman TJ, Lissowska J, Falk RT, Garcia-Closas M, Xu X, Veenstra TD, Gierach GL (2016). Association of Active and Sedentary Behaviors with Postmenopausal Estrogen Metabolism. Med Sci Sports Exerc  48, 439-48.   https://doi.org/10.1249/MSS.0000000000000790|7. Day FR, Ruth KS, Thompson DJ, Lunetta KL, Pervjakova N, Chasman DI, Stolk L, Finucane HK, Sulem P, Bulik-Sullivan B, Esko T, Johnson AD, Elks CE, Franceschini N, He C, Altmaier E, Brody JA, Franke LL, Huffman JE, Keller MF, McArdle PF, Nutile T, Porcu E, Robino A, Rose LM, PRACTICAL consortium, kConFab Investigators, AOCS Investigators, Generation Scotland, EPIC-InterAct Consortium, LifeLines Cohort Study, et al. [216 more authors] (2015). Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair. Nat Genet  47, 1294-1303.   https://doi.org/10.1038/ng.3412|8. Earp M, Winham SJ, Larson N, Permuth JB, Sicotte H, Chien J, Anton-Culver H, Bandera EV, Berchuck A, Cook LS, Cramer D, Doherty JA, Goodman MT, Levine DA, Monteiro AN, Ness RB, Pearce CL, Rossing MA, Tworoger SS, Wentzensen N, Bisogna M, Brinton L, Brooks-Wilson A, Carney ME, Cunningham JM, et al. [29 more authors] (2016). A targeted genetic association study of epithelial ovarian cancer susceptibility. Oncotarget  7, 7381-9.   https://doi.org/10.18632/oncotarget.7121|9. Felix AS, Scott McMeekin D, Mutch D, Walker JL, Creasman WT, Cohn DE, Ali S, Moore RG, Downs LS, Ioffe OB, Park KJ, Sherman ME, Brinton LA (2015). Associations between etiologic factors and mortality after endometrial cancer diagnosis: the NRG Oncology/Gynecologic Oncology Group 210 trial. Gynecol Oncol  139, 70-6.   https://doi.org/10.1016/j.ygyno.2015.08.022|10. Ghazarian AA, Trabert B, Graubard BI, Schwartz SM, Altekruse SF, McGlynn KA (2015). Incidence of testicular germ cell tumors among US men by census region. Cancer  121, 4181-9.   https://doi.org/10.1002/cncr.29643|11. Gierach GL, Patel DA, Pfeiffer RM, Figueroa JD, Linville L, Papathomas D, Johnson JM, Chicoine RE, Herschorn SD, Shepherd JA, Wang J, Malkov S, Vacek PM, Weaver DL, Fan B, Mahmoudzadeh AP, Palakal M, Xiang J, Oh H, Horne HN, Sprague BL, Hewitt SM, Brinton LA, Sherman ME (2016). Relationship of Terminal Duct Lobular Unit Involution of the Breast with Area and Volume Mammographic Densities. Cancer Prev Res (Phila)  9, 149-58.   https://doi.org/10.1158/1940-6207.CAPR-15-0282|12. Guo X, Long J, Zeng C, Michailidou K, Ghoussaini M, Bolla MK, Wang Q, Milne RL, Shu XO, Cai Q, Beesley J, Kar SP, Andrulis IL, Anton-Culver H, Arndt V, Beckmann MW, Beeghly-Fadiel A, Benitez J, Blot W, Bogdanova N, Bojesen SE, Brauch H, Brenner H, Brinton L, Broeks A, kConFab Investigators, et al. [89 more authors] (2015). Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk. Cancer Epidemiol Biomarkers Prev  24, 1680-91.   https://doi.org/10.1158/1055-9965.EPI-15-0363|13. Hampras SS, Sucheston-Campbell LE, Cannioto R, Chang-Claude J, Modugno F, Dörk T, Hillemanns P, Preus L, Knutson KL, Wallace PK, Hong CC, Friel G, Davis W, Nesline M, Pearce CL, Kelemen LE, Goodman MT, Bandera EV, Terry KL, Schoof N, Eng KH, Clay A, Singh PK, Joseph JM, Aben KK, et al. [145 more authors] (2016). Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. Oncotarget  7, 69097-69110.   https://doi.org/10.18632/oncotarget.10215|14. Horne HN, Sherman ME, Pfeiffer RM, Figueroa JD, Khodr ZG, Falk RT, Pollak M, Patel DA, Palakal MM, Linville L, Papathomas D, Geller B, Vacek PM, Weaver DL, Chicoine R, Shepherd J, Mahmoudzadeh AP, Wang J, Fan B, Malkov S, Herschorn S, Hewitt SM, Brinton LA, Gierach GL (2016). Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease. Breast Cancer Res  18, 24.   https://doi.org/10.1186/s13058-016-0678-4|15. Jim HS, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Chen Z, Chen AY, Permuth-Wey J, Aben KK, Anton-Culver H, Antonenkova N, Bruinsma F, Bandera EV, Bean YT, Beckmann MW, Bisogna M, Bjorge L, Bogdanova N, Brinton LA, Brooks-Wilson A, Bunker CH, Butzow R, Campbell IG, Carty K, Georgia Chenevix-Trench on behalf of the AOCS management group 95,96, et al. [130 more authors] (2015). Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC). J Genet Genome Res  2.   https://doi.org/10.23937/2378-3648/1410017|16. Kar SP, Tyrer JP, Li Q, Lawrenson K, Aben KK, Anton-Culver H, Antonenkova N, Chenevix-Trench G, Australian Cancer Study, Australian Ovarian Cancer Study Group, Baker H, Bandera EV, Bean YT, Beckmann MW, Berchuck A, Bisogna M, Bjørge L, Bogdanova N, Brinton L, Brooks-Wilson A, Butzow R, Campbell I, Carty K, Chang-Claude J, Chen YA, Chen Z, Cook LS, et al. [128 more authors] (2015). Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk. Cancer Epidemiol Biomarkers Prev  24, 1574-84.   https://doi.org/10.1158/1055-9965.EPI-14-1270|17. Lawrenson K, Iversen ES, Tyrer J, Weber RP, Concannon P, Hazelett DJ, Li Q, Marks JR, Berchuck A, Lee JM, Aben KK, Anton-Culver H, Antonenkova N, Australian Cancer Study (Ovarian Cancer), Australian Ovarian Cancer Study Group, Bandera EV, Bean Y, Beckmann MW, Bisogna M, Bjorge L, Bogdanova N, Brinton LA, Brooks-Wilson A, Bruinsma F, Butzow R, Campbell IG, Carty K, et al. [131 more authors] (2015). Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer. Carcinogenesis  36, 1341-53.   https://doi.org/10.1093/carcin/bgv138|18. Lawrenson K, Li Q, Kar S, Seo JH, Tyrer J, Spindler TJ, Lee J, Chen Y, Karst A, Drapkin R, Aben KK, Anton-Culver H, Antonenkova N, Australian Ovarian Cancer Study Group, Baker H, Bandera EV, Bean Y, Beckmann MW, Berchuck A, Bisogna M, Bjorge L, Bogdanova N, Brinton LA, Brooks-Wilson A, Bruinsma F, Butzow R, et al. [138 more authors] (2015). Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer. Nat Commun  6, 8234.   https://doi.org/10.1038/ncomms9234|19. Lee AW, Templeman C, Stram DA, Beesley J, Tyrer J, Berchuck A, Pharoah PP, Chenevix-Trench G, Pearce CL, Ovarian Cancer Association Consortium (2016). Evidence of a genetic link between endometriosis and ovarian cancer. Fertil Steril  105, 35-43.e1-10.   https://doi.org/10.1016/j.fertnstert.2015.09.023|20. Merritt MA, Strickler HD, Einstein MH, Yang HP, Sherman ME, Wentzensen N, Brouwer-Visser J, Cossio MJ, Whitney KD, Yu H, Gunter MJ, Huang GS (2016). Insulin/IGF and sex hormone axes in human endometrium and associations with endometrial cancer risk factors. Cancer Causes Control  27, 737-48.   https://doi.org/10.1007/s10552-016-0751-4|21. Mullooly M, Pfeiffer RM, Nyante SJ, Heckman-Stoddard BM, Perloff M, Jatoi I, Brinton LA, Aiello Bowles EJ, Hoover RN, Glass A, Berrington de Gonzalez A, Sherman ME, Gierach GL (2016). Mammographic Density as a Biosensor of Tamoxifen Effectiveness in Adjuvant Endocrine Treatment of Breast Cancer: Opportunities and Implications. J Clin Oncol  34, 2093-7.   https://doi.org/10.1200/JCO.2015.64.4492|22. Murphy J, Sherman ME, Browne EP, Caballero AI, Punska EC, Pfeiffer RM, Yang HP, Lee M, Yang H, Gierach GL, Arcaro KF (2016). Potential of breastmilk analysis to inform early events in breast carcinogenesis: rationale and considerations. Breast Cancer Res Treat  157, 13-22.   https://doi.org/10.1007/s10549-016-3796-x|23. Nyante SJ, Sherman ME, Pfeiffer RM, Berrington de Gonzalez A, Brinton LA, Bowles EJ, Hoover RN, Glass A, Gierach GL (2016). Longitudinal Change in Mammographic Density among ER-Positive Breast Cancer Patients Using Tamoxifen. Cancer Epidemiol Biomarkers Prev  25, 212-6.   https://doi.org/10.1158/1055-9965.EPI-15-0412|24. Oh H, Bodelon C, Palakal M, Chatterjee N, Sherman ME, Linville L, Geller BM, Vacek PM, Weaver DL, Chicoine RE, Papathomas D, Patel DA, Xiang J, Clare SE, Visscher DW, Mies C, Hewitt SM, Brinton LA, Storniolo AM, He C, Garcia-Closas M, Chanock SJ, Gierach GL, Figueroa JD (2016). Ages at menarche- and menopause-related genetic variants in relation to terminal duct lobular unit involution in normal breast tissue. Breast Cancer Res Treat  158, 341-50.   https://doi.org/10.1007/s10549-016-3859-z|25. Oh H, Khodr ZG, Sherman ME, Palakal M, Pfeiffer RM, Linville L, Geller BM, Vacek PM, Weaver DL, Chicoine RE, Falk RT, Horne HN, Papathomas D, Patel DA, Xiang J, Xu X, Veenstra T, Hewitt SM, Shepherd JA, Brinton LA, Figueroa JD, Gierach GL (2016). Relation of Serum Estrogen Metabolites with Terminal Duct Lobular Unit Involution Among Women Undergoing Diagnostic Image-Guided Breast Biopsy. Horm Cancer  7, 305-315.   https://doi.org/10.1007/s12672-016-0265-2|26. Permuth JB, Pirie A, Ann Chen Y, Lin HY, Reid BM, Chen Z, Monteiro A, Dennis J, Mendoza-Fandino G, AOCS Study Group, Australian Cancer Study (Ovarian Cancer), Anton-Culver H, Bandera EV, Bisogna M, Brinton L, Brooks-Wilson A, Carney ME, Chenevix-Trench G, Cook LS, Cramer DW, Cunningham JM, Cybulski C, D'Aloisio AA, Anne Doherty J, Earp M, Edwards RP, Fridley BL, Ovarian Cancer Association Consortium, et al. [52 more authors] (2016). Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk. Hum Mol Genet  25, 3600-3612.   https://doi.org/10.1093/hmg/ddw196|27. Prescott J, Setiawan VW, Wentzensen N, Schumacher F, Yu H, Delahanty R, Bernstein L, Chanock SJ, Chen C, Cook LS, Friedenreich C, Garcia-Closas M, Haiman CA, Le Marchand L, Liang X, Lissowska J, Lu L, Magliocco AM, Olson SH, Risch HA, Shu XO, Ursin G, Yang HP, Kraft P, De Vivo I (2015). Body Mass Index Genetic Risk Score and Endometrial Cancer Risk. PLoS One  10, e0143256.   https://doi.org/10.1371/journal.pone.0143256|28. Stang A, Kowall B, Rusner C, Trabert B, Bray F, Schüz J, McGlynn KA, Kuss O (2016). A novel method for identifying settings for well-motivated ecologic studies of cancer. Int J Cancer  138, 1887-93.   https://doi.org/10.1002/ijc.29931|29. Steeves JA, Fitzhugh EC, Bradwin G, McGlynn KA, Platz EA, Joshu CE (2016). Cross-sectional association between physical activity and serum testosterone levels in US men: results from NHANES 1999-2004. Andrology  4, 465-72.   https://doi.org/10.1111/andr.12169|30. Trabert B, Brinton LA, Anderson GL, Pfeiffer RM, Falk RT, Strickler HD, Sliesoraitis S, Kuller LH, Gass ML, Fuhrman BJ, Xu X, Wentzensen N (2016). Circulating Estrogens and Postmenopausal Ovarian Cancer Risk in the Women's Health Initiative Observational Study. Cancer Epidemiol Biomarkers Prev  25, 648-56.   https://doi.org/10.1158/1055-9965.EPI-15-1272-T|31. Trabert B, Falk RT, Stanczyk FZ, McGlynn KA, Brinton LA, Xu X (2015). Reproducibility of an assay to measure serum progesterone metabolites that may be related to breast cancer risk using liquid chromatography-tandem mass spectrometry. Horm Mol Biol Clin Investig  23, 79-84.   https://doi.org/10.1515/hmbci-2015-0026|32. Trabert B, Xu X, Falk RT, Guillemette C, Stanczyk FZ, McGlynn KA (2016). Assay reproducibility of serum androgen measurements using liquid chromatography-tandem mass spectrometry. J Steroid Biochem Mol Biol  155, 56-62.   https://doi.org/10.1016/j.jsbmb.2015.09.032|33. Usset JL, Raghavan R, Tyrer JP, McGuire V, Sieh W, Webb P, Chang-Claude J, Rudolph A, Anton-Culver H, Berchuck A, Brinton L, Cunningham JM, DeFazio A, Doherty JA, Edwards RP, Gayther SA, Gentry-Maharaj A, Goodman MT, Høgdall E, Jensen A, Johnatty SE, Kiemeney LA, Kjaer SK, Larson MC, Lurie G, Ovarian Cancer Association Consortium and the Australian Cancer Study, et al. [24 more authors] (2016). Assessment of Multifactor Gene-Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors. Cancer Epidemiol Biomarkers Prev  25, 780-90.   https://doi.org/10.1158/1055-9965.EPI-15-1039|34. Winham SJ, Pirie A, Chen YA, Larson MC, Fogarty ZC, Earp MA, Anton-Culver H, Bandera EV, Cramer D, Doherty JA, Goodman MT, Gronwald J, Karlan BY, Kjaer SK, Levine DA, Menon U, Ness RB, Pearce CL, Pejovic T, Rossing MA, Wentzensen N, Bean YT, Bisogna M, Brinton LA, Carney ME, Australian Ovarian Cancer Study Group, et al. [42 more authors] (2016). Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer. Cancer Epidemiol Biomarkers Prev  25, 446-54.   https://doi.org/10.1158/1055-9965.EPI-15-0240|35. Yang HP, Meeker A, Guido R, Gunter MJ, Huang GS, Luhn P, d'Ambrosio L, Wentzensen N, Sherman ME (2015). PTEN expression in benign human endometrial tissue and cancer in relation to endometrial cancer risk factors. Cancer Causes Control  26, 1729-36.   https://doi.org/10.1007/s10552-015-0666-5|36. Yang HP, Murphy KR, Pfeiffer RM, George N, Garcia-Closas M, Lissowska J, Brinton LA, Wentzensen N (2016). Lifetime Number of Ovulatory Cycles and Risks of Ovarian and Endometrial Cancer Among Postmenopausal Women. Am J Epidemiol  183, 800-14.   https://doi.org/10.1093/aje/kwv308",https://intramural.nih.gov/search/searchview.taf?ipid=94300
577,CP010127-21,"October 01, 2015 -  September 30, 2016",Etiologic Studies of Diet and Cancer,Eric Andrew Engels; PhD|IRP Faculty Profile  | |Katherine Ann McGlynn; PhD|IRP Faculty Profile  | |Rashmi P Sinha; PhD|IRP Faculty Profile  | |Neal David Freedman|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Chen W, Wang JB, Abnet CC, Dawsey SM, Fan JH, Yin LY, Yin J, Taylor PR, Qiao YL, Freedman ND (2015). Association between C-reactive protein, incident liver cancer, and chronic liver disease mortality in the Linxian Nutrition Intervention Trials: a nested case-control study. Cancer Epidemiol Biomarkers Prev  24, 386-92.   https://doi.org/10.1158/1055-9965.EPI-14-1038|2. Murphy G, Dawsey SM, Engels EA, Ricker W, Parsons R, Etemadi A, Lin SW, Abnet CC, Freedman ND (2015). Cancer Risk After Pernicious Anemia in the US Elderly Population. Clin Gastroenterol Hepatol  13, 2282-9.e1-4.   https://doi.org/10.1016/j.cgh.2015.05.040|3. Sinha R, Vogtmann E, Chen J, Amir A, Shi J, Sampson J, Flores R, Knight R, Chia N (2016). Fecal Microbiome in Epidemiologic Studies-Response. Cancer Epidemiol Biomarkers Prev  25, 870-1.   https://doi.org/10.1158/1055-9965.EPI-16-0161",https://intramural.nih.gov/search/searchview.taf?ipid=94318
578,CP010128-21,"October 01, 2015 -  September 30, 2016",Therapeutic and Diagnostic Factors as Related to Cancer Risk,Louise  Brinton; PhD| | |Gretchen L Gierach|IRP Faculty Profile  | |Katherine Ann McGlynn; PhD|IRP Faculty Profile  |Vikrant Vasant Sahasrabuddhe| | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  | |Britton Lindsay Trabert|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI

Clinical Genetics Branch, NCI

Office of the Director, NCI

Breast and Gynecologic Cancer Research Group, NCI",Roni T Falk,Lenore  Buckley (Virginia Commonwealth University)|Theodore  Colton (Boston University School of Public Health)|Olga  Dvorkina (SUNY Health Sciences Center)|Susanne  Kruger-Kjaer (Danish Cancer Registry)|Emmet  Lamb (Stanford University)|Lene  Mellemkjaer (Danish Cancer Society)|Show all 10,NULL,NULL,"1. Brinton LA, Moghissi KS, Scoccia B, Lamb EJ, Trabert B, Niwa S, Ruggieri D, Westhoff CL (2015). Effects of fertility drugs on cancers other than breast and gynecologic malignancies. Fertil Steril  104, 980-988.   https://doi.org/10.1016/j.fertnstert.2015.06.045|2. Reigstad MM, Larsen IK, Myklebust TÅ, Robsahm TE, Oldereid NB, Brinton LA, Storeng R (2016). Risk of Cancer in Children Conceived by Assisted Reproductive Technology. Pediatrics  137, e20152061.   https://doi.org/10.1542/peds.2015-2061",https://intramural.nih.gov/search/searchview.taf?ipid=94301
579,CP010131-21,"October 01, 2015 -  September 30, 2016",Studies of Populations Exposed to Therapeutic Medical Radiation and Other Agents,"Amy  de Gonzalez|IRP Faculty Profile  | |Choonsik  Lee|IRP Faculty Profile  | |Martha S Linet; PhD|IRP Faculty Profile  | |Mark Peter Little|IRP Faculty Profile  | |Kiyohiko  Mabuchi; MD, DPhil|IRP Faculty Profile  | |Lindsay Mcomber Morton|IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI",Rochelle E Curtis|Ruth Anne Kleinerman; MPH|Michele M Doody; MS|Alice  Sigurdson; PhD|Steven L Simon|Maureen Cusack Hatch; MD|Show all 12,David  Abramson (New York Presbyterian Hospital)|Michael  Andersson (Danish Cancer Society)|Mary  Gospodarowicz (Princess Margaret Hospital)|Eric  Holowaty (Cancer Care Ontario)|Ann  Mertens (University of Minnesota)|Joseph  Neglia (University of Minnesota)|Show all 24,Margaret Anne Tucker (Human Genetics Program)|Preetha  Rajaraman (Center For Global Health)|Jay  Lubin; PhD (Biostatistics Branch),NULL,"1. Chodick G, Sigurdson AJ, Kleinerman RA, Sklar CA, Leisenring W, Mertens AC, Stovall M, Smith SA, Weathers RE, Veiga LH, Robison LL, Inskip PD (2016). The Risk of Cataract among Survivors of Childhood and Adolescent Cancer: A Report from the Childhood Cancer Survivor Study. Radiat Res  185, 366-74.   https://doi.org/10.1667/RR14276.1|2. Freedman DM, Pfeiffer RM (2016). Associations Between Parkinson Disease and Cancer in US Asian Americans. JAMA Oncol  2, 1093-4.   https://doi.org/10.1001/jamaoncol.2016.0729|3. Freedman DM, Wu J, Chen H, Engels EA, Enewold LR, Freedman ND, Goedert JJ, Kuncl RW, Gail MH, Pfeiffer RM (2016). Associations between cancer and Parkinson's disease in U.S. elderly adults. Int J Epidemiol  45, 741-51.   https://doi.org/10.1093/ije/dyw016|4. Friedman DN, Chou JF, Oeffinger KC, Kleinerman RA, Ford JS, Sklar CA, Li Y, McCabe MS, Robison LL, Marr BP, Abramson DH, Dunkel IJ (2016). Chronic medical conditions in adult survivors of retinoblastoma: Results of the Retinoblastoma Survivor Study. Cancer  122, 773-81.   https://doi.org/10.1002/cncr.29704|5. Hauptmann M, Fossa SD, Stovall M, van Leeuwen FE, Johannesen TB, Rajaraman P, Gilbert ES, Smith SA, Weathers RE, Aleman BM, Andersson M, Curtis RE, Dores GM, Fraumeni JF, Hall P, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Lynch CF, Pukkala E, Storm HH, Vaalavirta L, van den Belt-Dusebout AW, et al. [2 more authors] (2015). Increased stomach cancer risk following radiotherapy for testicular cancer. Br J Cancer  112, 44-51.   https://doi.org/10.1038/bjc.2014.552|6. Inskip PD, Sigurdson AJ, Veiga L, Bhatti P, Ronckers C, Rajaraman P, Boukheris H, Stovall M, Smith S, Hammond S, Henderson TO, Watt TC, Mertens AC, Leisenring W, Stratton K, Whitton J, Donaldson SS, Armstrong GT, Robison LL, Neglia JP (2016). Radiation-Related New Primary Solid Cancers in the Childhood Cancer Survivor Study: Comparative Radiation Dose Response and Modification of Treatment Effects. Int J Radiat Oncol Biol Phys  94, 800-7.   https://doi.org/10.1016/j.ijrobp.2015.11.046|7. Lam CJ, Curtis RE, Dores GM, Engels EA, Caporaso NE, Polliack A, Warren JL, Young HA, Levine PH, Elmi AF, Fraumeni JF, Tucker MA, Morton LM (2016). Risk factors for second acute myeloid leukemia/myelodysplastic syndrome among survivors of non-Hodgkin lymphoma. Leukemia  30, 1187-90.   https://doi.org/10.1038/leu.2015.248|8. Newhauser WD, Berrington de Gonzalez A, Schulte R, Lee C (2016). A Review of Radiotherapy-Induced Late Effects Research after Advanced Technology Treatments. Front Oncol  6, 13.   https://doi.org/10.3389/fonc.2016.00013|9. Srour SA, Devesa SS, Morton LM, Check DP, Curtis RE, Linet MS, Dores GM (2016). Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001-12. Br J Haematol  174, 382-96.   https://doi.org/10.1111/bjh.14061",https://intramural.nih.gov/search/searchview.taf?ipid=94302
580,CP010132-21,"October 01, 2015 -  September 30, 2016",Studies of Populations Exposed to Environmental Sources of Radiation,"Amy  de Gonzalez|IRP Faculty Profile  | |Choonsik  Lee|IRP Faculty Profile  | |Martha S Linet; PhD|IRP Faculty Profile  | |Mark Peter Little|IRP Faculty Profile  | |Kiyohiko  Mabuchi; MD, DPhil|IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI",Maureen Cusack Hatch; MD|Daryl  Freedman|Alice  Sigurdson; PhD|Steven L Simon,Boris  Gusev (Kazakh Institute for Radiation Medicine and Ecology)|Terry  Hartman (Pennsylvania State University)|Alex  Romanukha (National Institute for Standards and Technology)|N.  Shilnikova (Biophysics Institute-Branch 1)|Alexander  Sekerbaev (Kazakhstan Research Institute of Radiation Medicine and Ecology)|Mykola  Tronko (Research Institute of Endocrinology and Metabolism)|Show all 10,NULL,NULL,"1. Drozdovitch V, Minenko V, Golovanov I, Khrutchinsky A, Kukhta T, Kutsen S, Luckyanov N, Ostroumova E, Trofimik S, Voillequé P, Simon SL, Bouville A (2015). Thyroid Dose Estimates for a Cohort of Belarusian Children Exposed to (131)I from the Chernobyl Accident: Assessment of Uncertainties. Radiat Res  184, 203-18.   https://doi.org/10.1667/rr13791.1|2. Finch SC, Dyagil I, Reiss RF, Gudzenko N, Babkina N, Lyubarets T, Bebeshko V, Romanenko A, Chumak VV, Bouville A, Hatch M, Little MP, Bazyka D, Zablotska LB (2017). Clinical characteristics of chronic lymphocytic leukemia occurring in chornobyl cleanup workers. Hematol Oncol  35, 215-224.   https://doi.org/10.1002/hon.2278|3. Hatch M, Ostroumova E, Brenner A, Federenko Z, Gorokh Y, Zvinchuk O, Shpak V, Tereschenko V, Tronko M, Mabuchi K (2015). Non-thyroid cancer in Northern Ukraine in the post-Chernobyl period: Short report. Cancer Epidemiol  39, 279-83.   https://doi.org/10.1016/j.canep.2015.02.002|4. Little MP (2016). Radiation and circulatory disease. Mutat Res  770, 299-318.   https://doi.org/10.1016/j.mrrev.2016.07.008|5. Little MP, Hendry JH (2017). Mathematical models of tissue stem and transit target cell divisions and the risk of radiation- or smoking-associated cancer. PLoS Comput Biol  13, e1005391.   https://doi.org/10.1371/journal.pcbi.1005391|6. Little MP, Kwon D, Zablotska LB, Brenner AV, Cahoon EK, Rozhko AV, Polyanskaya ON, Minenko VF, Golovanov I, Bouville A, Drozdovitch V (2015). Impact of Uncertainties in Exposure Assessment on Thyroid Cancer Risk among Persons in Belarus Exposed as Children or Adolescents Due to the Chernobyl Accident. PLoS One  10, e0139826.   https://doi.org/10.1371/journal.pone.0139826|7. Zablotska LB, Nadyrov EA, Polyanskaya ON, McConnell RJ, O'Kane P, Lubin J, Hatch M, Little MP, Brenner AV, Veyalkin IV, Yauseyenka VV, Bouville A, Drozdovitch VV, Minenko VF, Demidchik YE, Mabuchi K, Rozhko AV (2015). Risk of thyroid follicular adenoma among children and adolescents in Belarus exposed to iodine-131 after the Chornobyl accident. Am J Epidemiol  182, 781-90.   https://doi.org/10.1093/aje/kwv127|8. Zablotska LB, Nadyrov EA, Rozhko AV, Gong Z, Polyanskaya ON, McConnell RJ, O'Kane P, Brenner AV, Little MP, Ostroumova E, Bouville A, Drozdovitch V, Minenko V, Demidchik Y, Nerovnya A, Yauseyenka V, Savasteeva I, Nikonovich S, Mabuchi K, Hatch M (2015). Analysis of thyroid malignant pathologic findings identified during 3 rounds of screening (1997-2008) of a cohort of children and adolescents from belarus exposed to radioiodines after the Chernobyl accident. Cancer  121, 457-66.   https://doi.org/10.1002/cncr.29073",https://intramural.nih.gov/search/searchview.taf?ipid=94287
581,CP010133-21,"October 01, 2015 -  September 30, 2016",Studies of Populations Exposed to Occupational Sources of Radiation,"Martha S Linet; PhD|IRP Faculty Profile  | |Mark Peter Little|IRP Faculty Profile  | |Kiyohiko  Mabuchi; MD, DPhil|IRP Faculty Profile  | |Cari Meinhold Kitahara|IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI",Michele M Doody; MS|Daryl  Freedman|Maureen Cusack Hatch; MD|Peter D Inskip; ScD|Alice  Sigurdson; PhD|Steven L Simon|Show all 8,Bruce  Alexander (University of Minnesota)|Terry  Hartman (Pennsylvania State University)|Juozas  Kurtinaitis (Lithuanian Cancer Registry)|Dale  Preston (Hirosoft)|S.  Salomaa (Finnish Center for Radiation and Nuclear Safety)|N.  Shilnikova (Biophysics Institute-Branch 1)|Show all 16,NULL,NULL,"1. Chumak V, Drozdovitch V, Kryuchkov V, Bakhanova E, Babkina N, Bazyka D, Gudzenko N, Hatch M, Trotsuk N, Zablotska L, Golovanov I, Luckyanov N, Voillequé P, Bouville A (2015). Dosimetry Support of the Ukrainian-American Case-control Study of Leukemia and Related Disorders Among Chornobyl Cleanup Workers. Health Phys  109, 296-301.   https://doi.org/10.1097/HP.0000000000000341|2. Finch SC, Dyagil I, Reiss RF, Gudzenko N, Babkina N, Lyubarets T, Bebeshko V, Romanenko A, Chumak VV, Bouville A, Hatch M, Little MP, Bazyka D, Zablotska LB (2017). Clinical characteristics of chronic lymphocytic leukemia occurring in chornobyl cleanup workers. Hematol Oncol  35, 215-224.   https://doi.org/10.1002/hon.2278|3. Gudzenko N, Hatch M, Bazyka D, Dyagil I, Reiss RF, Brenner A, Chumak V, Babkina N, Zablotska LB, Mabuchi K (2015). Non-radiation risk factors for leukemia: A case-control study among chornobyl cleanup workers in Ukraine. Environ Res  142, 72-6.   https://doi.org/10.1016/j.envres.2015.06.019|4. Michal Freedman D, Kitahara CM, Linet MS, Alexander BH, Neta G, Little MP, Cahoon EK (2015). Ambient temperature and risk of first primary basal cell carcinoma: A nationwide United States cohort study. J Photochem Photobiol B  148, 284-289.   https://doi.org/10.1016/j.jphotobiol.2015.04.025|5. Sun Z, Inskip PD, Wang J, Kwon D, Zhao Y, Zhang L, Wang Q, Fan S (2016). Solid cancer incidence among Chinese medical diagnostic x-ray workers, 1950-1995: Estimation of radiation-related risks. Int J Cancer  138, 2875-83.   https://doi.org/10.1002/ijc.30036|6. Van Dyke ME, Drozdovitch V, Doody MM, Lim H, Bolus NE, Simon SL, Alexander BH, Kitahara CM (2016). Historical Patterns in the Types of Procedures Performed and Radiation Safety Practices Used in Nuclear Medicine From 1945-2009. Health Phys  111, 37-46.   https://doi.org/10.1097/HP.0000000000000519",https://intramural.nih.gov/search/searchview.taf?ipid=94303
582,CP010134-21,"October 01, 2015 -  September 30, 2016",Studies of Atomic Bomb Survivors,"Amy  de Gonzalez|IRP Faculty Profile  | |Kiyohiko  Mabuchi; MD, DPhil|IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI",Alina V Brenner,"Dale  Preston (Hirosoft)|Kazunori  Kodama (Radiation Effects Research Foundation, Japan)|Kyoji  Furukawa; PhD|Kotaro  Ozasa (Radiation Effects Research Foundation)|Yuko  Hirai (Genetics, Radiation Effects Research Foundation)|Nori  Nakamwa (Radiation Effects Research Foundation)|Show all 9",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94328
583,CP010135-21,"October 01, 2015 -  September 30, 2016",Studies of Non-Ionizing Radiation-Related Cancer,Cari Meinhold Kitahara|IRP Faculty Profile  | |Mark Peter Little|IRP Faculty Profile,Martha S Linet; PhD,"Radiation Epidemiology Branch, NCI",Alina V Brenner|Alice  Sigurdson; PhD|Rochelle E Curtis,Peter  Black (Brigham and Women's Hospital & Dana Farber Cancer Center)|W.  Bleyer (Children's Cancer Group)|Howard  Fine (NYU Langone Medical Center)|Jay  Loeffler (Massachusetts General Hospital)|Bruce  Alexander (University of Minnesota)|Ann  Mertens (University of Minnesota)|Show all 13,Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)|Preetha  Rajaraman (Center For Global Health)|Gila I Neta (Office of the Director)|Susan Shaw Devesa (Biostatistics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94304
584,CP010136-21,"October 01, 2015 -  September 30, 2016",Cancer Risk in Human Populations,"Debra  Silverman; ScD, ScM|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Bu Tian  Ji|Dalsu  Baris|Joanne S Colt|Mary Helen Ward; MS, PhD|Joseph B Coble|Claudine M Samanic|Show all 11",NULL,Mark  Schiffman; MD (Clinical Genetics Branch),NULL,"1. Andreotti G, Katz M, Hoering A, Van Ness B, Crowley J, Morgan G, Hoover RN, Baris D, Durie B (2016). Risk of multiple myeloma in a case-spouse study. Leuk Lymphoma  57, 1450-9.   https://doi.org/10.3109/10428194.2015.1094693|2. Hofmann J, Birmann B, Teras L, Wang Y, Albanes D, Baris D, Colditz G, De Roos A, Giles G, Morton L, Hosgood D, Lan Q, Landgren O, Dong L, Pfeiffer R, Rothman N, Oshinsky SJ, Pollak M, Neuhouser M, Purdue M (2015) A pooled investigation of circulating adiponectin levels and risk of multiple myeloma Cancer Research 75:Abstract 934|3. Hofmann JN, Birmann BM, Teras LR, Pfeiffer RM, Wang Y, Albanes D, Baris D, Colditz GA, De Roos AJ, Giles GG, Hosgood HD, Lan Q, Landgren O, Liao LM, Rothman N, Weinstein SJ, Pollak MN, Neuhouser ML, Purdue MP (2016). Low Levels of Circulating Adiponectin Are Associated with Multiple Myeloma Risk in Overweight and Obese Individuals. Cancer Res  76, 1935-41.   https://doi.org/10.1158/0008-5472.CAN-15-2406|4. Karami S, Daughtery SE, Schwartz K, Davis FG, Ruterbusch JJ, Wacholder S, Graubard BI, Berndt SI, Hofmann JN, Purdue MP, Moore LE, Colt JS (2016). Analgesic use and risk of renal cell carcinoma: A case-control, cohort and meta-analytic assessment. Int J Cancer  139, 584-92.   https://doi.org/10.1002/ijc.30108|5. Kuijpers E, Bekker C, Fransman W, Brouwer D, Tromp P, Vlaanderen J, Godderis L, Hoet P, Lan Q, Silverman D, Vermeulen R, Pronk A (2016). Occupational Exposure to Multi-Walled Carbon Nanotubes During Commercial Production Synthesis and Handling. Ann Occup Hyg  60, 305-17.   https://doi.org/10.1093/annhyg/mev082|6. Schwartz K, Ruterbusch JJ, Colt JS, Miller DC, Chow WH, Purdue MP (2016). Racial disparities in overall survival among renal cell carcinoma patients with young age and small tumors. Cancer Med  5, 200-8.   https://doi.org/10.1002/cam4.578",https://intramural.nih.gov/search/searchview.taf?ipid=94305
585,CP010142-18,"October 01, 2015 -  September 30, 2016",Genetic Modifiers of Cancer Risk,"Sonja  Berndt|IRP Faculty Profile  | |Stephen J Chanock; MD, PhD|IRP Faculty Profile  | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Mark H Greene; MD|IRP Faculty Profile  | |Hormuzdiar Aspandiar Katki; MS|IRP Faculty Profile  |Jennifer T Loud| | |Lisa  Mirabello|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Philip Samuel Rosenberg; PhD|IRP Faculty Profile  | |Douglas Russell Stewart; BA, MD|IRP Faculty Profile  | |Sharon Ann Savage|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Biostatistics Branch, NCI

Genetic Epidemiology Branch, NCI

Clinical Genetics Branch, NCI

Office of the Director, NCI",Anand  Pathak|Rebecca  Troisi|Meredith  Yeager,Joseph  Constantino (National Surgical Adjuvant Breast & Bowel Project Statistical Center)|Larry  Wickerham (NSABP Group Headquarters)|Norman  Wolmark (National Surgical Adjuvant Breast and Bowel Project)|Phuong L Mai,"Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94306
586,CP010144-18,"October 01, 2015 -  September 30, 2016",Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,"Blanche P Alter|IRP Faculty Profile  |Bari Jane Ballew| |Rosamma M Decastro; NP| | |Shahinaz M Gadalla|IRP Faculty Profile  | |Mark H Greene; MD|IRP Faculty Profile  |Payal Premchand Khincha| |Jennifer T Loud| |Lisa James McReynolds| | |Lisa  Mirabello|IRP Faculty Profile  |Alexander  Pemov| |June  Peters| | |Philip Samuel Rosenberg; PhD|IRP Faculty Profile  | |Douglas Russell Stewart; BA, MD|IRP Faculty Profile  |Jennifer Louise Young| | |Sharon Ann Savage|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Genetic Epidemiology Branch, NCI

Clinical Genetics Branch, NCI","Mitchell Henry Gail; PhD, MD|Neelam K Giri; MD|Renee C Bremer|Hormuzdiar Aspandiar Katki; MS|Mary Louise McMaster; MD",David  Alberts (University of Arizona Cancer Center)|Tim  Bishop (Institute for Cancer Research)|Robert  Brodsky (Johns Hopkins University School of Medicine)|Joseph  Califano (Johns Hopkins University School of Medicine)|Peter  Durie (Toronto Hospital for Sick Children)|M.  Elghetany (University of Texas)|Show all 50,"Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)|Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Katherine Ann McGlynn; PhD (Hormonal and Reproductive Epidemiology Branch)|Mark E Sherman; MD (Breast and Gynecologic Cancer Research Group)|Margaret Anne Tucker (Human Genetics Program)|Stephen J Chanock; MD, PhD (Office of the Director)",Pamela  Stratton; MD (NINDS),"1. Dewan R, Pemov A, Dutra AS, Pak ED, Edwards NA, Ray-Chaudhury A, Hansen NF, Chandrasekharappa SC, Mullikin JC, Asthagiri AR, NISC Comparative Sequencing Program, Heiss JD, Stewart DR, Germanwala AV (2017). First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation. BMC Cancer  17, 127.   https://doi.org/10.1186/s12885-017-3127-6|2. Gadalla SM, Pfeiffer RM, Kristinsson SY, Björkholm M, Landgren O, Greene MH (2016). Brain tumors in patients with myotonic dystrophy: a population-based study. Eur J Neurol  23, 542-7.   https://doi.org/10.1111/ene.12886|3. Khincha PP, Savage SA (2016). Neonatal manifestations of inherited bone marrow failure syndromes. Semin Fetal Neonatal Med  21, 57-65.   https://doi.org/10.1016/j.siny.2015.12.003|4. Meeks HD, Song H, Michailidou K, Bolla MK, Dennis J, Wang Q, Barrowdale D, Frost D, EMBRACE, McGuffog L, Ellis S, Feng B, Buys SS, Hopper JL, Southey MC, Tesoriero A, kConFab Investigators, James PA, Bruinsma F, Campbell IG, Australia Ovarian Cancer Study Group, Broeks A, Schmidt MK, Hogervorst FB, HEBON, Beckman MW, Fasching PA, Fletcher O, Johnson N, GEMO Study Collaborators, OCGN, PRostate cancer AssoCiation group To Investigate Cancer Associated aLterations in the genome, et al. [228 more authors] (2016). BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. J Natl Cancer Inst  108.   https://doi.org/10.1093/jnci/djv315|5. Pathak A, Seipel K, Pemov A, Dewan R, Brown C, Ravichandran S, Luke BT, Malasky M, Suman S, Yeager M, NCI DCEG Cancer Genomics Research Laboratory, NCI DCEG Cancer Sequencing Working Group, Gatti RA, Caporaso NE, Mulvihill JJ, Goldin LR, Pabst T, McMaster ML, Stewart DR (2016). Whole exome sequencing reveals a C-terminal germline variant in CEBPA-associated acute myeloid leukemia: 45-year follow up of a large family. Haematologica  101, 846-52.   https://doi.org/10.3324/haematol.2015.130799|6. Rebbeck TR, Friebel TM, Mitra N, Wan F, Chen S, Andrulis IL, Apostolou P, Arnold N, Arun BK, Barrowdale D, Benitez J, Berger R, Berthet P, Borg A, Buys SS, Caldes T, Carter J, Chiquette J, Claes KB, Couch FJ, Cybulski C, Daly MB, de la Hoya M, Diez O, Domchek SM, EMBRACE, HEBON, et al. [78 more authors] (2016). Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women. Breast Cancer Res  18, 112.   https://doi.org/10.1186/s13058-016-0768-3",https://intramural.nih.gov/search/searchview.taf?ipid=94307
587,CP010145-17,"October 01, 2015 -  September 30, 2016",Intervention Trials in Persons at Increased Genetic Risk of Cancer,"Mitchell Henry Gail; PhD, MD|IRP Faculty Profile  | |Mark H Greene; MD|IRP Faculty Profile  |Jennifer T Loud| |Mark E Sherman; MD| | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  | |Sharon Ann Savage|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Clinical Genetics Branch, NCI

Breast and Gynecologic Cancer Research Group, NCI",June  Peters,David  Alberts (University of Arizona Cancer Center)|Steven  Skates (Massachusetts General Hospital)|Marion  Piedmonte (GOG Statistical and Data Center)|Martee  Hensley (Memorial Sloan-Kettering Cancer Center)|Austin  Miller (GOG Statistical and Data Center)|Karen  Lu (MD Anderson Cancer Center)|Show all 15,Margaret Anne Tucker (Human Genetics Program)|Lori M Minasian (Office of the Director)|Richard P Moser (Science Of Research & Technology Branch),Paul Kj Han (NHGRI) |Gustavo Javier Rodriguez (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94308
588,CP010150-17,"October 01, 2015 -  September 30, 2016","Infections, immunity, and inflammation in cancer",Eric Andrew Engels; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",Meredith Sarah Shiels|Anil Kumar Chaturvedi|Jill Elizabeth Koshiol,NULL,Ruth  Pfeiffer; PhD (Biostatistics Branch)|Lindsay Mcomber Morton (Radiation Epidemiology Branch)|Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)|James Jerome Goedert; MD (Hormonal and Reproductive Epidemiology Branch)|Neal David Freedman (Hormonal and Reproductive Epidemiology Branch)|Joseph  Fraumeni; MD (Office of the Director),NULL,"1. Agerbaek MØ, Pereira MA, Clausen TM, Pehrson C, Oo HZ, Spliid C, Rich JR, Fung V, Nkrumah F, Neequaye J, Biggar RJ, Reynolds SJ, Tosato G, Pullarkat ST, Ayers LW, Theander TG, Daugaard M, Bhatia K, Nielsen MA, Mbulaiteye SM, Salanti A (2017). Burkitt lymphoma expresses oncofetal chondroitin sulfate without being a reservoir for placental malaria sequestration. Int J Cancer  140, 1597-1608.   https://doi.org/10.1002/ijc.30575|2. Arron ST, Raymond AK, Yanik EL, Castenson D, McCulloch CE, Clarke CA, Paddock LE, Niu X, Engels EA (2016). Melanoma Outcomes in Transplant Recipients With Pretransplant Melanoma. Dermatol Surg  42, 157-66.   https://doi.org/10.1097/DSS.0000000000000602|3. Camargo MC, Kim KM, Matsuo K, Torres J, Liao LM, Morgan DR, Michel A, Waterboer T, Zabaleta J, Dominguez RL, Yatabe Y, Kim S, Rocha-Guevara ER, Lissowska J, Pawlita M, Rabkin CS (2016). Anti-Helicobacter pylori Antibody Profiles in Epstein-Barr virus (EBV)-Positive and EBV-Negative Gastric Cancer. Helicobacter  21, 153-7.   https://doi.org/10.1111/hel.12249|4. Coghill AE, Shiels MS, Rycroft RK, Copeland G, Finch JL, Hakenewerth AM, Pawlish KS, Engels EA (2016). Rectal squamous cell carcinoma in immunosuppressed populations: is this a distinct entity from anal cancer? AIDS  30, 105-12.   https://doi.org/10.1097/QAD.0000000000000873|5. Goedert JJ, Hosgood HD, Biggar RJ, Strickler HD, Rabkin CS (2016). Screening for Cancer in Persons Living with HIV Infection. Trends Cancer  2, 416-428.   https://doi.org/10.1016/j.trecan.2016.06.007|6. Kalil RS, Lynch CF, Engels EA (2015). Risk of cancer in retransplants compared to primary kidney transplants in the United States. Clin Transplant  29, 944-50.   https://doi.org/10.1111/ctr.12601|7. Lam CJ, Curtis RE, Dores GM, Engels EA, Caporaso NE, Polliack A, Warren JL, Young HA, Levine PH, Elmi AF, Fraumeni JF, Tucker MA, Morton LM (2016). Risk factors for second acute myeloid leukemia/myelodysplastic syndrome among survivors of non-Hodgkin lymphoma. Leukemia  30, 1187-90.   https://doi.org/10.1038/leu.2015.248|8. Pine SR, Mechanic LE, Enewold L, Bowman ED, Ryan BM, Cote ML, Wenzlaff AS, Loffredo CA, Olivo-Marston S, Chaturvedi A, Caporaso NE, Schwartz AG, Harris CC (2016). Differential Serum Cytokine Levels and Risk of Lung Cancer Between African and European Americans. Cancer Epidemiol Biomarkers Prev  25, 488-97.   https://doi.org/10.1158/1055-9965.EPI-15-0378|9. Robbins HA, Clarke CA, Arron ST, Tatalovich Z, Kahn AR, Hernandez BY, Paddock L, Yanik EL, Lynch CF, Kasiske BL, Snyder J, Engels EA (2015). Melanoma Risk and Survival among Organ Transplant Recipients. J Invest Dermatol  135, 2657-2665.   https://doi.org/10.1038/jid.2015.312|10. Shiels MS, Copeland G, Goodman MT, Harrell J, Lynch CF, Pawlish K, Pfeiffer RM, Engels EA (2015). Cancer stage at diagnosis in patients infected with the human immunodeficiency virus and transplant recipients. Cancer  121, 2063-71.   https://doi.org/10.1002/cncr.29324|11. Shiels MS, Pfeiffer RM, Besson C, Clarke CA, Morton LM, Nogueira L, Pawlish K, Yanik EL, Suneja G, Engels EA (2016). Trends in primary central nervous system lymphoma incidence and survival in the U.S. Br J Haematol  174, 417-24.   https://doi.org/10.1111/bjh.14073|12. Shiels MS, Robbins HA, Engels EA (2016). Younger age at cancer diagnosis may be driven by age structure of the HCV population. J Hepatol  64, 516-517.   https://doi.org/10.1016/j.jhep.2015.09.026|13. Yanik EL, Achenbach CJ, Gopal S, Coghill AE, Cole SR, Eron JJ, Moore RD, Mathews WC, Drozd DR, Hamdan A, Ballestas ME, Engels EA (2016). Changes in Clinical Context for Kaposi's Sarcoma and Non-Hodgkin Lymphoma Among People With HIV Infection in the United States. J Clin Oncol  34, 3276-83.   https://doi.org/10.1200/JCO.2016.67.6999|14. Yanik EL, Chinnakotla S, Gustafson SK, Snyder JJ, Israni AK, Segev DL, Engels EA (2016). Effects of maintenance immunosuppression with sirolimus after liver transplant for hepatocellular carcinoma. Liver Transpl  22, 627-34.   https://doi.org/10.1002/lt.24395|15. Yanik EL, Katki HA, Engels EA (2016). Cancer risk among the HIV-infected elderly in the United States. AIDS  30, 1663-8.   https://doi.org/10.1097/QAD.0000000000001077",https://intramural.nih.gov/search/searchview.taf?ipid=94309
589,CP010152-17,"October 01, 2015 -  September 30, 2016",PLCO Trial Etiologic and Early Marker Study,"Neal David Freedman|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI",Amanda  Black,"Mona  Fouad (University of Alabama, Birmingham)|Paul  Kvale (Extramural PLCO)|David T Crawford|Lance  Yokochi (Pacific Health Research Institute)|Doug  Reding (Marshfield Clinic Research Foundation)|Timothy R. Church; PhD (Environ & Occup Health, University of Minnesota School of Public Health)|Show all 11",Wen-Yi  Huang (Occupational and Environmental Epidemiology Branch)|Christine Dorothy Berg (Office of the Director),NULL,"1. Loftfield E, Freedman ND, Graubard BI, Guertin KA, Black A, Huang WY, Shebl FM, Mayne ST, Sinha R (2015). Association of Coffee Consumption With Overall and Cause-Specific Mortality in a Large US Prospective Cohort Study. Am J Epidemiol  182, 1010-22.   https://doi.org/10.1093/aje/kwv146|2. Travis RC, Appleby PN, Martin RM, Holly JMP, Albanes D, Black A, Bueno-de-Mesquita HBA, Chan JM, Chen C, Chirlaque MD, Cook MB, Deschasaux M, Donovan JL, Ferrucci L, Galan P, Giles GG, Giovannucci EL, Gunter MJ, Habel LA, Hamdy FC, Helzlsouer KJ, Hercberg S, Hoover RN, Janssen JAMJL, Kaaks R, et al. [26 more authors] (2016). A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk. Cancer Res  76, 2288-2300.   https://doi.org/10.1158/0008-5472.CAN-15-1551",https://intramural.nih.gov/search/searchview.taf?ipid=94310
590,CP010158-16,"October 01, 2015 -  September 30, 2016",Studies of Rare Cancers,Katherine Ann McGlynn; PhD|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",NULL,"Yu-Tang  Gao (Shanghai Cancer Institute)|Evelyene  Lennette (Virolab, Inc.)|Lene  Mellemkjaer (Danish Cancer Society)|Jorgen  Olsen (Danish Cancer Society)|Asif  Rashid (MD Anderson Cancer Center)|Juergen  Reichardt (University of Southern California)|Show all 12",NULL,NULL,"1. Gelband H, Chen CJ, Chen W, Franceschi S, Hall SA, London WT, McGlynn KA, Wild CP (2016) Liver Cancer, in Cancer: Disease Control Priorities, Third Edition (Volume 3). Gelband H, Jha P, Sankaranarayanan R, Horton S, eds.  The International Bank for Reconstruction and Development / The World Bank (Washington (DC)). , pp.|2. Hagberg KW, Sahasrabuddhe VV, McGlynn KA, Jick SS (2016). Does Angiotensin-Converting Enzyme Inhibitor and β-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the U.K. Clinical Practice Research Datalink. Pharmacotherapy  36, 187-95.   https://doi.org/10.1002/phar.1704|3. Lin J, Carter CA, McGlynn KA, Zahm SH, Nations JA, Anderson WF, Shriver CD, Zhu K (2015). A Prognostic Model to Predict Mortality among Non-Small-Cell Lung Cancer Patients in the U.S. Military Health System. J Thorac Oncol  10, 1694-702.   https://doi.org/10.1097/JTO.0000000000000691|4. Makarova-Rusher OV, Altekruse SF, McNeel TS, Ulahannan S, Duffy AG, Graubard BI, Greten TF, McGlynn KA (2016). Population attributable fractions of risk factors for hepatocellular carcinoma in the United States. Cancer  122, 1757-65.   https://doi.org/10.1002/cncr.29971|5. McGlynn KA, Hagberg K, Chen J, Braunlin M, Graubard BI, Suneja N, Jick S, Sahasrabuddhe VV (2016). Menopausal hormone therapy use and risk of primary liver cancer in the clinical practice research datalink. Int J Cancer  138, 2146-53.   https://doi.org/10.1002/ijc.29960|6. Petrick JL, Braunlin M, Laversanne M, Valery PC, Bray F, McGlynn KA (2016). International trends in liver cancer incidence, overall and by histologic subtype, 1978-2007. Int J Cancer  139, 1534-45.   https://doi.org/10.1002/ijc.30211|7. Petrick JL, Freedman ND, Demuth J, Yang B, Van Den Eeden SK, Engel LS, McGlynn KA (2016). Obesity, diabetes, serum glucose, and risk of primary liver cancer by birth cohort, race/ethnicity, and sex: Multiphasic health checkup study. Cancer Epidemiol  42, 140-6.   https://doi.org/10.1016/j.canep.2016.04.009|8. Schinkel JK, Shao S, Zahm SH, McGlynn KA, Shriver CD, Zhu K (2016). Overall and recurrence-free survival among black and white bladder cancer patients in an equal-access health system. Cancer Epidemiol  42, 154-8.   https://doi.org/10.1016/j.canep.2016.04.012|9. Yang B, Hagberg KW, Chen J, Sahasrabuddhe VV, Graubard BI, Jick S, McGlynn KA (2016). Associations of antibiotic use with risk of primary liver cancer in the Clinical Practice Research Datalink. Br J Cancer  115, 85-9.   https://doi.org/10.1038/bjc.2016.148|10. Yang B, Petrick JL, Chen J, Hagberg KW, Sahasrabuddhe VV, Graubard BI, Jick S, McGlynn KA (2016). Associations of NSAID and paracetamol use with risk of primary liver cancer in the Clinical Practice Research Datalink. Cancer Epidemiol  43, 105-11.   https://doi.org/10.1016/j.canep.2016.06.009",https://intramural.nih.gov/search/searchview.taf?ipid=94311
591,CP010167-16,"October 01, 2015 -  September 30, 2016",General Studies of Epidemiology,"Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",Rebecca  Troisi,Chester  Douglass (Harvard School of Dentistry)|Patricia  Hartge; ScD (NCI),Sharon Ann Savage (Clinical Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94312
592,CP010168-16,"October 01, 2015 -  September 30, 2016",Early Life Exposures and Subsequent Cancer Risk,"Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",Rebecca  Troisi,"Ervin  Adam (Baylor College of Medicine)|Elizabeth  Hatch (Boston University)|Arthur  Herbst (University of Chicago)|Julie  Palmer (Boston University)|Stanley  Robboy; MD (Pathology and Obstetrics & Gynecology, Duke University Medical Center)|William  Strohsnitter (University of Massachusetts)|Show all 11",NULL,NULL,"1. Troisi R, Hatch EE, Palmer JR, Titus L, Robboy SJ, Strohsnitter WC, Herbst AL, Adam E, Hyer M, Hoover RN (2016). Prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tract. Am J Obstet Gynecol  215, 322.e1-8.   https://doi.org/10.1016/j.ajog.2016.03.007",https://intramural.nih.gov/search/searchview.taf?ipid=94313
593,CP010169-15,"October 01, 2015 -  September 30, 2016","Nutrition, Metabolism, and Cancer","Stephen J Chanock; MD, PhD|IRP Faculty Profile  | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Regina Gale Ziegler; PhD, MPH|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Epidemiology and Biostatistics Program, NCI

Office of the Director, NCI","Louise  Brinton; PhD|Mitchell Henry Gail; PhD, MD|Gloria L Gridley|Patricia  Hartge; ScD|Hormuzdiar Aspandiar Katki; MS|Catherine G Schairer","Lawrence  Kolonel (University of Hawaii)|Abraham  Nomura (School of Public Health, University of Hawaii)|Emanuel  Petricoin III (Food and Drug Administration)|Malcolm  Pike (University of Southern California)|Michael  Pollak (McGill University)|Frank  Stanczyk (University of Southern California)|Show all 11",Demetrius  Albanes; MD (Hormonal and Reproductive Epidemiology Branch)|Roni T Falk (Hormonal and Reproductive Epidemiology Branch)|Richard  Hayes; PhD (Occupational and Environmental Epidemiology Branch)|Peter D Inskip; ScD (Radiation Epidemiology Branch)|Martha S Linet; PhD (Radiation Epidemiology Branch)|Katherine Ann McGlynn; PhD (Hormonal and Reproductive Epidemiology Branch),NULL,"1. Berrigan D, Troiano RP, Graubard BI (2016). BMI and mortality: the limits of epidemiological evidence. Lancet  388, 734-6.   https://doi.org/10.1016/S0140-6736(16)30949-7|2. Colli LM, Machiela MJ, Myers TA, Jessop L, Yu K, Chanock SJ (2016). Burden of Nonsynonymous Mutations among TCGA Cancers and Candidate Immune Checkpoint Inhibitor Responses. Cancer Res  76, 3767-72.   https://doi.org/10.1158/0008-5472.CAN-16-0170|3. Kant AK, Graubard BI (2017). A prospective study of water intake and subsequent risk of all-cause mortality in a national cohort. Am J Clin Nutr  105, 212-220.   https://doi.org/10.3945/ajcn.116.143826|4. Moore SC, Matthews CE, Ou Shu X, Yu K, Gail MH, Xu X, Ji BT, Chow WH, Cai Q, Li H, Yang G, Ruggieri D, Boyd-Morin J, Rothman N, Hoover RN, Gao YT, Zheng W, Ziegler RG (2016). Endogenous Estrogens, Estrogen Metabolites, and Breast Cancer Risk in Postmenopausal Chinese Women. J Natl Cancer Inst  108.   https://doi.org/10.1093/jnci/djw103|5. Zanetti KA, Wang Z, Aldrich M, Amos CI, Blot WJ, Bowman ED, Burdette L, Cai Q, Caporaso N, Chung CC, Gillanders EM, Haiman CA, Hansen HM, Henderson BE, Kolonel LN, Marchand LL, Li S, McNeill LH, Ryan BM, Schwartz AG, Sison JD, Spitz MR, Tucker M, Wenzlaff AS, Wiencke JK, et al. [17 more authors] (2016). Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population. Lung Cancer  98, 33-42.   https://doi.org/10.1016/j.lungcan.2016.05.008",https://intramural.nih.gov/search/searchview.taf?ipid=94316
594,CP010170-16,"October 01, 2015 -  September 30, 2016",Multidisciplinary Studies of Hematopoietic Malignancies,Martha S Linet; PhD|IRP Faculty Profile  | |Mark Peter Little|IRP Faculty Profile  | |Nathaniel C Rothman; MD|IRP Faculty Profile  | |Lindsay Mcomber Morton|IRP Faculty Profile,NULL,"Occupational and Environmental Epidemiology Branch, NCI

Radiation Epidemiology Branch, NCI","Joanne S Colt|Aaron E Blair; PhD, MPH|Mary Helen Ward; MS, PhD","Wendy  Cozen (Norris Comprehensive Cancer Center)|Scott  Davis (Fred Hutchinson Cancer Research Center)|Richard  Severson (Barbara Karmanos Cancer Institute)|James  Cerhan (Mayo Clinic)|Anneclaire  De Roos (University of Washington, Seattle, WA)|Maryjean  Schenk (Barbara Karmanos Cancer Institute)",Sophia S Wang; PhD (Infection & Immunoepidemiology Branch)|Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)|Gloria L Gridley (Biostatistics Branch),NULL,"1. Czarnota J, Gennings C, Colt JS, De Roos AJ, Cerhan JR, Severson RK, Hartge P, Ward MH, Wheeler DC (2015). Analysis of Environmental Chemical Mixtures and Non-Hodgkin Lymphoma Risk in the NCI-SEER NHL Study. Environ Health Perspect  123, 965-70.   https://doi.org/10.1289/ehp.1408630|2. Deziel NC, Nuckols JR, Jones RR, Graubard BI, De Roos AJ, Pronk A, Gourley C, Colt JS, Ward MH (2017). Comparison of industrial emissions and carpet dust concentrations of polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans in a multi-center U.S. study. Sci Total Environ  580, 1276-1286.   https://doi.org/10.1016/j.scitotenv.2016.12.090|3. Paltiel O, Tikellis G, Linet M, Golding J, Lemeshow S, Phillips G, Lamb K, Stoltenberg C, Håberg SE, Strøm M, Granstrøm C, Northstone K, Klebanoff M, Ponsonby AL, Milne E, Pedersen M, Kogevinas M, Ha E, Dwyer T, International Childhood Cancer Cohort Consortium (2015). Birthweight and Childhood Cancer: Preliminary Findings from the International Childhood Cancer Cohort Consortium (I4C). Paediatr Perinat Epidemiol  29, 335-45.   https://doi.org/10.1111/ppe.12193|4. Stenehjem JS, Kjærheim K, Bråtveit M, Samuelsen SO, Barone-Adesi F, Rothman N, Lan Q, Grimsrud TK (2015). Benzene exposure and risk of lymphohaematopoietic cancers in 25 000 offshore oil industry workers. Br J Cancer  112, 1603-12.   https://doi.org/10.1038/bjc.2015.108",https://intramural.nih.gov/search/searchview.taf?ipid=94314
595,CP010176-16,"October 01, 2015 -  September 30, 2016",Epidemiology and Natural History of Cancer-Associated Viruses,"Eric Andrew Engels; PhD|IRP Faculty Profile  |James Jerome Goedert; MD| | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Thomas R O'Brien; BA, MPH, MD|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Philip Samuel Rosenberg; PhD|IRP Faculty Profile  | |Sam  Mbulaiteye|IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI

Biostatistics Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI",Charles  Rabkin|Anil Kumar Chaturvedi,"M  Eyster (Pennsylvania State University)|Angelos  Hatzakis (University of Athens Medical School)|Michael  Lederman; MD (Case Western Reserve University)|Nino  Romano (University of Palermo)|Cloe  Thio (Dept of Medicine, Johns Hopkins University School of Medicine)|David  Thomas (Johns Hopkins University)|Show all 7","Stephen J Chanock; MD, PhD (Office of the Director)|Denise  Whitby (Office Of The Director)",NULL,"1. Godbole SV, Nandy K, Gauniyal M, Nalawade P, Sane S, Koyande S, Toyama J, Hegde A, Virgo P, Bhatia K, Paranjape RS, Risbud AR, Mbulaiteye SM, Mitsuyasu RT (2016). HIV and cancer registry linkage identifies a substantial burden of cancers in persons with HIV in India. Medicine (Baltimore)  95, e4850.   https://doi.org/10.1097/MD.0000000000004850|2. Lei H, Li T, Li B, Tsai S, Biggar RJ, Nkrumah F, Neequaye J, Gutierrez M, Epelman S, Mbulaiteye SM, Bhatia K, Lo SC (2015). Epstein-Barr virus from Burkitt Lymphoma biopsies from Africa and South America share novel LMP-1 promoter and gene variations. Sci Rep  5, 16706.   https://doi.org/10.1038/srep16706|3. Maziarz M, Kinyera T, Otim I, Kagwa P, Nabalende H, Legason ID, Ogwang MD, Kirimunda S, Emmanuel B, Reynolds SJ, Kerchan P, Joloba MM, Bergen AW, Bhatia K, Talisuna AO, Biggar RJ, Goedert JJ, Pfeiffer RM, Mbulaiteye SM (2017). Age and geographic patterns of Plasmodium falciparum malaria infection in a representative sample of children living in Burkitt lymphoma-endemic areas of northern Uganda. Malar J  16, 124.   https://doi.org/10.1186/s12936-017-1778-z|4. Nash SD, Katamba A, Mafigiri DK, Mbulaiteye SM, Sethi AK (2016). Sex-related alcohol expectancies and high-risk sexual behaviour among drinking adults in Kampala, Uganda. Glob Public Health  11, 449-62.   https://doi.org/10.1080/17441692.2015.1068824",https://intramural.nih.gov/search/searchview.taf?ipid=94315
596,CP010180-15,"October 01, 2015 -  September 30, 2016",Prostate Cancer Studies,Michael Blaise Cook|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Sabah  Quraishi|Lisa Wey-Lan Chu,Chu  Chen (University of Washington)|Yu-Tang  Gao (Shanghai Cancer Institute)|Juergen  Reichardt (University of Southern California)|Frank  Stanczyk (University of Southern California)|Paul  Levine (George Washington U)|Streamson  Chua (Columbia University)|Show all 15,Richard  Hayes; PhD (Occupational and Environmental Epidemiology Branch),NULL,"1. Yeboah ED, Hsing AW, Mante S, Mensah JE, Kyei MY, Yarney J, Vanderpuye V, Beecham K, Tettey Y, Biritwum RB, Adjei AA, Gyasi R, Asante K, Ampadu KN, Klufio GO, Gepi-Attee S, Owoo C, Kwami D, Ahiaku, Pandra R, Cook MB (2016). MANAGEMENT OF PROSTATE CANCER IN ACCRA, GHANA. J West Afr Coll Surg  6, 31-65.",https://intramural.nih.gov/search/searchview.taf?ipid=94329
597,CP010181-14,"October 01, 2015 -  September 30, 2016",Methods for Epidemiology Studies,"Mitchell Henry Gail; PhD, MD|IRP Faculty Profile  | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Hormuzdiar Aspandiar Katki; MS|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Philip Samuel Rosenberg; PhD|IRP Faculty Profile  | |Joshua Neil Sampson|IRP Faculty Profile  | |Jianxin  Shi|IRP Faculty Profile  | |Sholom  Wacholder; PhD|IRP Faculty Profile  | |Kai  Yu|IRP Faculty Profile  |Nilanjan  Chatterjee",NULL,"Biostatistics Branch, NCI",Junmo  Nam,"Efstathia  Bura (The George Washington University, Washington, DC)|Raymond  Carroll (Texas A&M University)|Laure  El Ghormli (GW Biostat)|Katherine  Flegal (Centers for Disease Control and Prevention)|Kari  Hemminki; PhD (Department of Biosciences, Karolinska Institute)|Cathy  Kronin (DCCPS, NCI, Rockville, MD)|Show all 13","Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)|Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)|Sam  Mbulaiteye (Infection & Immunoepidemiology Branch)|Stephen J Chanock; MD, PhD (Office of the Director)|Maria Teresa Pia Landi; MD, PhD (Genetic Epidemiology Branch)|Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)",NULL,"1. Boca SM, Pfeiffer RM, Sampson JN (2017). Multivariate meta-analysis with an increasing number of parameters. Biom J  59, 496-510.   https://doi.org/10.1002/bimj.201600013|2. Boonstra PS, Mukherjee B, Gruber SB, Ahn J, Schmit SL, Chatterjee N (2016). Tests for Gene-Environment Interactions and Joint Effects With Exposure Misclassification. Am J Epidemiol  183, 237-47.   https://doi.org/10.1093/aje/kwv198|3. Castle PE, Katki HA (2016). Screening: A risk-based framework to decide who benefits from screening. Nat Rev Clin Oncol  13, 531-2.   https://doi.org/10.1038/nrclinonc.2016.101|4. Chatterjee N, Chen YH, Maas P, Carroll RJ (2016). Constrained Maximum Likelihood Estimation for Model Calibration Using Summary-level Information from External Big Data Sources. J Am Stat Assoc  111, 107-117.   https://doi.org/10.1080/01621459.2015.1123157|5. Gail MH, Wu J, Wang M, Yaun SS, Cook NR, Eliassen AH, McCullough ML, Yu K, Zeleniuch-Jacquotte A, Smith-Warner SA, Ziegler RG, Carroll RJ (2016). Calibration and seasonal adjustment for matched case-control studies of vitamin D and cancer. Stat Med  35, 2133-48.   https://doi.org/10.1002/sim.6856|6. Hua X, Hyland PL, Huang J, Song L, Zhu B, Caporaso NE, Landi MT, Chatterjee N, Shi J (2016). MEGSA: A Powerful and Flexible Framework for Analyzing Mutual Exclusivity of Tumor Mutations. Am J Hum Genet  98, 442-455.   https://doi.org/10.1016/j.ajhg.2015.12.021|7. Lubin JH, Albanes D, Hoppin JA, Chen H, Lerro CC, Weinstein SJ, Sandler DP, Beane Freeman LE (2017). Greater Coronary Heart Disease Risk With Lower Intensity and Longer Duration Smoking Compared With Higher Intensity and Shorter Duration Smoking: Congruent Results Across Diverse Cohorts. Nicotine Tob Res  19, 817-825.   https://doi.org/10.1093/ntr/ntw290|8. Lubin JH, Couper D, Lutsey PL, Woodward M, Yatsuya H, Huxley RR (2016). Risk of Cardiovascular Disease from Cumulative Cigarette Use and the Impact of Smoking Intensity. Epidemiology  27, 395-404.   https://doi.org/10.1097/EDE.0000000000000437|9. Wu SP, Pfeiffer RM, Ahn IE, Mailankody S, Sonneveld P, van Duin M, Munshi NC, Walker BA, Morgan G, Landgren O (2016). Impact of Genes Highly Correlated with MMSET Myeloma on the Survival of Non-MMSET Myeloma Patients. Clin Cancer Res  22, 4039-44.   https://doi.org/10.1158/1078-0432.CCR-15-2366|10. Zhang H, Wu CO, Yang Y, Berndt SI, Chanock SJ, Yu K (2018). A multi-locus genetic association test for a dichotomous trait and its secondary phenotype. Stat Methods Med Res  27, 1464-1475.   https://doi.org/10.1177/0962280216662071",https://intramural.nih.gov/search/searchview.taf?ipid=94289
598,CP010182-14,"October 01, 2015 -  September 30, 2016",Epidemiologic Field Studies,"Barry Ira Graubard; PhD|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Mitchell Henry Gail; PhD, MD|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI",Catherine G Schairer,Wei-Cheng  You (Beijing Institute for Cancer Research)|Susan  Sturgeon (University of Massachusetts)|Paul  Levine (George Washington U)|Lian  Zhang|Amr  Soliman (M.D. Anderson Cancer Center)|Donghui  Li (M.D. Anderson Cancer Center)|Show all 7,"Joseph  Fraumeni; MD (Office of the Director)|Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94319
599,CP010183-14,"October 01, 2015 -  September 30, 2016",Descriptive Studies and Record Linkage,Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  |William Frederick Anderson,NULL,"Biostatistics Branch, NCI

Clinical Genetics Branch, NCI","Nilanjan  Chatterjee|Mitchell Henry Gail; PhD, MD|Ruth  Pfeiffer; PhD|Philip Samuel Rosenberg; PhD|Catherine G Schairer|Sholom  Wacholder; PhD",Susan Shaw Devesa (NCI)|Ismail  Jatoi (US Army)|Ahmedin  Jemal (American Cancer Society)|Niels  Kroman (Danish Breast Cancer Group)|Timothy R Rebbeck|Rebecca B Siegel|Show all 9,"Louise  Brinton; PhD (Office of the Director)|Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)|Anil Kumar Chaturvedi (Infection & Immunoepidemiology Branch)|Michael Blaise Cook (Hormonal and Reproductive Epidemiology Branch)|Rochelle E Curtis (Radiation Epidemiology Branch)|Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)",NULL,"1. Karami S, Colt JS, Stewart PA, Schwartz K, Davis FG, Ruterbusch JJ, Chow WH, Wacholder S, Graubard BI, Purdue MP, Moore LE (2016). A case-control study of occupational sunlight exposure and renal cancer risk. Int J Cancer  138, 1626-33.   https://doi.org/10.1002/ijc.29902|2. Sung H, Rosenberg PS, Chen WQ, Hartman M, Lim WY, Chia KS, Wai-Kong Mang O, Tse L, Anderson WF, Yang XR (2016). The impact of breast cancer-specific birth cohort effects among younger and older Chinese populations. Int J Cancer  139, 527-34.   https://doi.org/10.1002/ijc.30095",https://intramural.nih.gov/search/searchview.taf?ipid=94288
600,CP010184-14,"October 01, 2015 -  September 30, 2016",Consultation and Collaboration,Sholom  Wacholder; PhD|IRP Faculty Profile  | |Barry Ira Graubard; PhD|IRP Faculty Profile,NULL,"Biostatistics Branch, NCI","Nilanjan  Chatterjee|Junmo  Nam|Mitchell Henry Gail; PhD, MD|Ruth  Pfeiffer; PhD|Hormuzdiar Aspandiar Katki; MS|Joshua Neil Sampson|Show all 8",Eleuterio  Bravo-Otero (University of Puerto Rico)|David  Brenner (Columbia University)|Robert  Burk (Albert Einstein College of Medicine)|Julianne  Byrne (Washington Children's hospital)|David  Camann (Southwest Research Institute)|Scott  Davis (Fred Hutchinson Cancer Research Center)|Show all 78,"Regina Gale Ziegler; PhD, MPH (Epidemiology and Biostatistics Program)|Michele M Doody; MS (Radiation Epidemiology Branch)|Roni T Falk (Hormonal and Reproductive Epidemiology Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Joanne S Colt (Occupational and Environmental Epidemiology Branch)|Wen-Yi  Huang (Occupational and Environmental Epidemiology Branch)",Harvey J Alter; MD (CC) |Jane  Hoppin; ScD (NIEHS) |Joni L Rutter (OD) |Dale  Sandler; PhD (NIEHS) |Clarice  Weinberg; PhD (NIEHS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94321
601,CP010185-14,"October 01, 2015 -  September 30, 2016",Biodefense Project,Choonsik  Lee|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI",Alice  Sigurdson; PhD|Vladimir  Drozdovitch|Steven L Simon|Amy  de Gonzalez|Andre  Bouville,"Harold  Beck (DOE Environmental Measurements Laboratory (retired))|Victor  Kryuchkov (Institute of Biophysics)|Sergey  Shinkarev (Moscow Institute of Biophysics)|Sergey  Sholom (URPI)|Eduardo  Yukihara (Oklahoma State University)|Nikolai  Talerko (Scientific Center of Radiation Medicine, Ukraine)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94320
602,CP010187-12,"October 01, 2015 -  September 30, 2016",Cancer Genetic Markers of Susceptibility,"Stephen J Chanock; MD, PhD|IRP Faculty Profile  | |Mark  Purdue|IRP Faculty Profile  | |Nathaniel C Rothman; MD|IRP Faculty Profile  | |Margaret Anne Tucker|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI

Human Genetics Program, NCI

Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94327
603,CP010188-12,"October 01, 2015 -  September 30, 2016",Risk prediction methods,"Barry Ira Graubard; PhD|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Hormuzdiar Aspandiar Katki; MS|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Mitchell Henry Gail; PhD, MD|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Epidemiology and Biostatistics Program, NCI",Catherine G Schairer|Nilanjan  Chatterjee,Garnet  Anderson (WHI Clinical Coordinating Center)|Heather  Feigelson (American Cancer Society)|David  Hunter (Harvard School of Public Health)|Mateo  Banegas (University of Washington)|Stephanie Ann Kovalchik|Ju-Hyun  Park,"Demetrius  Albanes; MD (Hormonal and Reproductive Epidemiology Branch)|Yikyung  Park (Hormonal and Reproductive Epidemiology Branch)|Thomas R O'Brien; BA, MPH, MD (Infection & Immunoepidemiology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94322
604,CP010190-11,"October 01, 2015 -  September 30, 2016",Genetic Epidemiology of Telomere Maintenance and Cancer Etiology,Shahinaz M Gadalla|IRP Faculty Profile  |Payal Premchand Khincha| | |Sharon Ann Savage|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",Lisa James McReynolds|Neelam K Giri; MD|Blanche P Alter,"Immaculata  DeVivo (Harvard Medical School)|Steven  Artandi (Stanford University)|Judy  Wong (University of British Columbia)|Alison  Bertuch; MD, PhD (Pediatrics, Baylor College of Medicine)|Davide  Ruggero (University of California San Francisco)|Catherine  Keegan (University of Michigan)|Show all 10",Lisa  Mirabello (Genetic Epidemiology Branch),NULL,"1. Savage SA (2016) Dyskeratosis Congenita, in GeneReviews(®). Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K, eds.  University of Washington, Seattle (Seattle (WA)). , pp.|2. Burris AM, Ballew BJ, Kentosh JB, Turner CE, Norton SA, NCI DCEG Cancer Genomics Research Laboratory, NCI DCEG Cancer Sequencing Working Group, Giri N, Alter BP, Nellan A, Gamper C, Hartman KR, Savage SA (2016). Hoyeraal-Hreidarsson Syndrome due to PARN Mutations: Fourteen Years of Follow-Up. Pediatr Neurol  56, 62-68.e1.   https://doi.org/10.1016/j.pediatrneurol.2015.12.005|3. Gadalla SM, Khincha PP, Katki HA, Giri N, Wong JY, Spellman S, Yanovski JA, Han JC, De Vivo I, Alter BP, Savage SA (2016). The limitations of qPCR telomere length measurement in diagnosing dyskeratosis congenita. Mol Genet Genomic Med  4, 475-9.   https://doi.org/10.1002/mgg3.220|4. Jones M, Bisht K, Savage SA, Nandakumar J, Keegan CE, Maillard I (2016). The shelterin complex and hematopoiesis. J Clin Invest  126, 1621-9.   https://doi.org/10.1172/JCI84547",https://intramural.nih.gov/search/searchview.taf?ipid=94330
605,CP010193-10,"October 01, 2015 -  September 30, 2016",Whole Genome Scan in the Pancreatic Cancer Cohort Consortium (PanScan),"Laufey Thora Amundadottir|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Rachael Zoe Solomon|IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI

Laboratory Translational Genomics, NCI",NULL,"Charles  Fuchs (Harvard)|Alan  Arslan (NYU)|Eric  Jacobs (American Cancer Society)|H  Bueno-de-Mesquita (Dept of Chronic Dis Epidemiology, Natl Inst for Pub Health and the Environ)|Wei  Zheng (Vanderbilt University Medical Center)|Andrea  LaCroix (Fred Hutchinson Cancer Research Center)|Show all 17",Geoffrey Scott Tobias (Office of the Director)|Kai  Yu (Biostatistics Branch)|Amy  Hutchinson (Office of the Director),NULL,"1. Arem H, Yu K, Xiong X, Moy K, Freedman ND, Mayne ST, Albanes D, Arslan AA, Austin M, Bamlet WR, Beane-Freeman L, Bracci P, Canzian F, Cotterchio M, Duell EJ, Gallinger S, Giles GG, Goggins M, Goodman PJ, Hartge P, Hassan M, Helzlsouer K, Henderson B, Holly EA, Hoover R, et al. [27 more authors] (2015). Vitamin D metabolic pathway genes and pancreatic cancer risk. PLoS One  10, e0117574.   https://doi.org/10.1371/journal.pone.0117574|2. Childs EJ, Mocci E, Campa D, Bracci PM, Gallinger S, Goggins M, Li D, Neale RE, Olson SH, Scelo G, Amundadottir LT, Bamlet WR, Bijlsma MF, Blackford A, Borges M, Brennan P, Brenner H, Bueno-de-Mesquita HB, Canzian F, Capurso G, Cavestro GM, Chaffee KG, Chanock SJ, Cleary SP, Cotterchio M, et al. [37 more authors] (2015). Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. Nat Genet  47, 911-6.   https://doi.org/10.1038/ng.3341|3. Stolzenberg-Solomon RZ, Amundadottir LT (2015). Epidemiology and Inherited Predisposition for Sporadic Pancreatic Adenocarcinoma. Hematol Oncol Clin North Am  29, 619-40.   https://doi.org/10.1016/j.hoc.2015.04.009",https://intramural.nih.gov/search/searchview.taf?ipid=94331
606,CP010195-10,"October 01, 2015 -  September 30, 2016","Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study","Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile  | |Neal David Freedman|IRP Faculty Profile  | |Rashmi P Sinha; PhD|IRP Faculty Profile  | |Rachael Zoe Solomon|IRP Faculty Profile  | |Demetrius  Albanes; MD|IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Stephanie Joan Weinstein|Alison Marian Mondul|Jacqueline M Major; MS|Michael Blaise Cook,David  Hunter (Harvard School of Public Health)|Brian  Henderson (University of Southern California)|Elio  Riboli (International Agency for Research on Cancer)|Peter  Kraft|Tim  Key (Oxford University)|Laurence N Kolonel|Show all 26,"Stephen J Chanock; MD, PhD (Office of the Director)|Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)|Qing  Lan (Occupational and Environmental Epidemiology Branch)|Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)|Maria Teresa Pia Landi; MD, PhD (Genetic Epidemiology Branch)|Philip  Taylor; MD, ScD (Genetic Epidemiology Branch)",NULL,"1. Anic GM, Albanes D, Rohrmann S, Kanarek N, Nelson WG, Bradwin G, Rifai N, McGlynn KA, Platz EA, Mondul AM (2016). Association between serum 25-hydroxyvitamin D and serum sex steroid hormones among men in NHANES. Clin Endocrinol (Oxf)  85, 258-66.   https://doi.org/10.1111/cen.13062|2. Miranti EH, Freedman ND, Weinstein SJ, Abnet CC, Selhub J, Murphy G, Diaw L, Männistö S, Taylor PR, Albanes D, Stolzenberg-Solomon RZ (2016). Prospective study of serum cysteine and cysteinylglycine and cancer of the head and neck, esophagus, and stomach in a cohort of male smokers. Am J Clin Nutr  104, 686-93.   https://doi.org/10.3945/ajcn.115.125799|3. Mondul A, Mancina RM, Merlo A, Dongiovanni P, Rametta R, Montalcini T, Valenti L, Albanes D, Romeo S (2015). PNPLA3 I148M Variant Influences Circulating Retinol in Adults with Nonalcoholic Fatty Liver Disease or Obesity. J Nutr  145, 1687-91.   https://doi.org/10.3945/jn.115.210633|4. Mondul AM, Moore SC, Weinstein SJ, Karoly ED, Sampson JN, Albanes D (2015). Metabolomic analysis of prostate cancer risk in a prospective cohort: The alpha-tocolpherol, beta-carotene cancer prevention (ATBC) study. Int J Cancer  137, 2124-32.   https://doi.org/10.1002/ijc.29576|5. Mondul AM, Weinstein SJ, Albanes D (2017). Vitamins, metabolomics, and prostate cancer. World J Urol  35, 883-893.   https://doi.org/10.1007/s00345-016-1878-3|6. Mondul AM, Weinstein SJ, Moy KA, Männistö S, Albanes D (2016). Circulating 25-Hydroxyvitamin D and Prostate Cancer Survival. Cancer Epidemiol Biomarkers Prev  25, 665-9.   https://doi.org/10.1158/1055-9965.EPI-15-0991",https://intramural.nih.gov/search/searchview.taf?ipid=94332
607,CP010196-10,"October 01, 2015 -  September 30, 2016",Prospective Studies of Diet and Cancer in the AARP Cohort,Charles E Matthews|IRP Faculty Profile  | |Rashmi P Sinha; PhD|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI","Yikyung  Park|Rachael Zoe Solomon|Neal David Freedman|Steven  Moore|Christian Cormac Abnet; PhD, MPH",NULL,Louise  Brinton; PhD (Office of the Director),NULL,"1. Arem H, Pfeiffer RM, Engels EA, Alfano CM, Hollenbeck A, Park Y, Matthews CE (2015). Pre- and postdiagnosis physical activity, television viewing, and mortality among patients with colorectal cancer in the National Institutes of Health-AARP Diet and Health Study. J Clin Oncol  33, 180-8.   https://doi.org/10.1200/JCO.2014.58.1355|2. Arnold M, Freisling H, Stolzenberg-Solomon R, Kee F, O'Doherty MG, Ordóñez-Mena JM, Wilsgaard T, May AM, Bueno-de-Mesquita HB, Tjønneland A, Orfanos P, Trichopoulou A, Boffetta P, Bray F, Jenab M, Soerjomataram I, CHANCES consortium (2016). Overweight duration in older adults and cancer risk: a study of cohorts in Europe and the United States. Eur J Epidemiol  31, 893-904.   https://doi.org/10.1007/s10654-016-0169-z|3. Felix AS, Bunch K, Yang HP, Arem H, Trabert B, Gierach GL, Park Y, Lowery WJ, Brinton LA (2015). Menopausal hormone therapy and mortality among women diagnosed with ovarian cancer in the NIH-AARP Diet and Health Study. Gynecol Oncol Rep  13, 13-7.   https://doi.org/10.1016/j.gore.2015.04.007|4. Freedman ND, Abnet CC, Caporaso NE, Fraumeni JF, Murphy G, Hartge P, Hollenbeck AR, Park Y, Shiels MS, Silverman DT (2016). Impact of changing US cigarette smoking patterns on incident cancer: risks of 20 smoking-related cancers among the women and men of the NIH-AARP cohort. Int J Epidemiol  45, 846-56.   https://doi.org/10.1093/ije/dyv175|5. Gu F, Xiao Q, Chu LW, Yu K, Matthews CE, Hsing AW, Caporaso NE (2016). Sleep Duration and Cancer in the NIH-AARP Diet and Health Study Cohort. PLoS One  11, e0161561.   https://doi.org/10.1371/journal.pone.0161561|6. Guertin KA, Freedman ND, Loftfield E, Graubard BI, Caporaso NE, Sinha R (2016). Coffee consumption and incidence of lung cancer in the NIH-AARP Diet and Health Study. Int J Epidemiol  45, 929-39.   https://doi.org/10.1093/ije/dyv104|7. Guertin KA, Freedman ND, Loftfield E, Stolzenberg-Solomon RZ, Graubard BI, Sinha R (2015). A prospective study of coffee intake and pancreatic cancer: results from the NIH-AARP Diet and Health Study. Br J Cancer  113, 1081-5.   https://doi.org/10.1038/bjc.2015.235|8. Jiao L, Stolzenberg-Solomon R, Zimmerman TP, Duan Z, Chen L, Kahle L, Risch A, Subar AF, Cross AJ, Hollenbeck A, Vlassara H, Striker G, Sinha R (2015). Dietary consumption of advanced glycation end products and pancreatic cancer in the prospective NIH-AARP Diet and Health Study. Am J Clin Nutr  101, 126-34.   https://doi.org/10.3945/ajcn.114.098061|9. Kabat GC, Matthews CE, Kamensky V, Hollenbeck AR, Rohan TE (2015). Adherence to cancer prevention guidelines and cancer incidence, cancer mortality, and total mortality: a prospective cohort study. Am J Clin Nutr  101, 558-69.   https://doi.org/10.3945/ajcn.114.094854|10. Keadle SK, Arem H, Moore SC, Sampson JN, Matthews CE (2015). Impact of changes in television viewing time and physical activity on longevity: a prospective cohort study. Int J Behav Nutr Phys Act  12, 156.   https://doi.org/10.1186/s12966-015-0315-0|11. McGuire V, Hartge P, Liao LM, Sinha R, Bernstein L, Canchola AJ, Anderson GL, Stefanick ML, Whittemore AS (2016). Parity and Oral Contraceptive Use in Relation to Ovarian Cancer Risk in Older Women. Cancer Epidemiol Biomarkers Prev  25, 1059-63.   https://doi.org/10.1158/1055-9965.EPI-16-0011|12. Taunk P, Hecht E, Stolzenberg-Solomon R (2016). Are meat and heme iron intake associated with pancreatic cancer? Results from the NIH-AARP diet and health cohort. Int J Cancer  138, 2172-89.   https://doi.org/10.1002/ijc.29964|13. Thurston GD, Ahn J, Cromar KR, Shao Y, Reynolds HR, Jerrett M, Lim CC, Shanley R, Park Y, Hayes RB (2016). Ambient Particulate Matter Air Pollution Exposure and Mortality in the NIH-AARP Diet and Health Cohort. Environ Health Perspect  124, 484-90.   https://doi.org/10.1289/ehp.1509676|14. Wu K, Spiegelman D, Hou T, Albanes D, Allen NE, Berndt SI, van den Brandt PA, Giles GG, Giovannucci E, Alexandra Goldbohm R, Goodman GG, Goodman PJ, Håkansson N, Inoue M, Key TJ, Kolonel LN, Männistö S, McCullough ML, Neuhouser ML, Park Y, Platz EA, Schenk JM, Sinha R, Stampfer MJ, Stevens VL, et al. [6 more authors] (2016). Associations between unprocessed red and processed meat, poultry, seafood and egg intake and the risk of prostate cancer: A pooled analysis of 15 prospective cohort studies. Int J Cancer  138, 2368-82.   https://doi.org/10.1002/ijc.29973",https://intramural.nih.gov/search/searchview.taf?ipid=94338
608,CP010197-10,"October 01, 2015 -  September 30, 2016","Physical Activity, Energy Balance, and Cancer",Charles E Matthews|IRP Faculty Profile  | |Rashmi P Sinha; PhD|IRP Faculty Profile  | |Rachael Zoe Solomon|IRP Faculty Profile  | |Demetrius  Albanes; MD|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Steven  Moore,NULL,NULL,NULL,"1. Gennuso KP, Matthews CE, Colbert LH (2015). Reliability and Validity of 2 Self-Report Measures to Assess Sedentary Behavior in Older Adults. J Phys Act Health  12, 727-32.   https://doi.org/10.1123/jpah.2013-0546|2. Glenn KR, Slaughter JC, Fowke JH, Buchowski MS, Matthews CE, Signorello LB, Blot WJ, Lipworth L (2015). Physical activity, sedentary behavior and all-cause mortality among blacks and whites with diabetes. Ann Epidemiol  25, 649-55.   https://doi.org/10.1016/j.annepidem.2015.04.006|3. Keadle SK, Moore SC, Sampson JN, Xiao Q, Albanes D, Matthews CE (2015). Causes of Death Associated With Prolonged TV Viewing: NIH-AARP Diet and Health Study. Am J Prev Med  49, 811-21.   https://doi.org/10.1016/j.amepre.2015.05.023|4. Matthews CE, Moore SC, Sampson J, Blair A, Xiao Q, Keadle SK, Hollenbeck A, Park Y (2015). Mortality Benefits for Replacing Sitting Time with Different Physical Activities. Med Sci Sports Exerc  47, 1833-40.   https://doi.org/10.1249/MSS.0000000000000621|5. Sampson JN, Matthews CE, Freedman L, Carroll RJ, Kipnis V (2016). Methods to Assess Measurement Error in Questionnaires of Sedentary Behavior. J Appl Stat  43, 1706-1721.   https://doi.org/10.1080/02664763.2015.1117593|6. Starling AP, Engel LS, Calafat AM, Koutros S, Satagopan JM, Yang G, Matthews CE, Cai Q, Buckley JP, Ji BT, Cai H, Chow WH, Zheng W, Gao YT, Rothman N, Xiang YB, Shu XO (2015). Predictors and long-term reproducibility of urinary phthalate metabolites in middle-aged men and women living in urban Shanghai. Environ Int  84, 94-106.   https://doi.org/10.1016/j.envint.2015.07.003|7. Warren Andersen S, Zheng W, Sonderman J, Shu XO, Matthews CE, Yu D, Steinwandel M, McLaughlin JK, Hargreaves MK, Blot WJ (2016). Combined Impact of Health Behaviors on Mortality in Low-Income Americans. Am J Prev Med  51, 344-55.   https://doi.org/10.1016/j.amepre.2016.03.018|8. Xiao Q, Moore SC, Keadle SK, Xiang YB, Zheng W, Peters TM, Leitzmann MF, Ji BT, Sampson JN, Shu XO, Matthews CE (2016). Objectively measured physical activity and plasma metabolomics in the Shanghai Physical Activity Study. Int J Epidemiol  45, 1433-1444.   https://doi.org/10.1093/ije/dyw033|9. Xiao Q, Signorello LB, Brinton LA, Cohen SS, Blot WJ, Matthews CE (2016). Sleep duration and breast cancer risk among black and white women. Sleep Med  20, 25-9.   https://doi.org/10.1016/j.sleep.2015.11.010",https://intramural.nih.gov/search/searchview.taf?ipid=94333
609,CP010198-10,"October 01, 2015 -  September 30, 2016",Lower Gastrointestinal Cancer Studies,Rashmi P Sinha; PhD|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Gwen  Murphy,NULL,NULL,NULL,"1. Flores R, Shi J, Yu G, Ma B, Ravel J, Goedert JJ, Sinha R (2015). Collection media and delayed freezing effects on microbial composition of human stool. Microbiome  3, 33.   https://doi.org/10.1186/s40168-015-0092-7|2. Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ (2016). Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One  11, e0152126.   https://doi.org/10.1371/journal.pone.0152126|3. Sinha R, Chen J, Amir A, Vogtmann E, Shi J, Inman KS, Flores R, Sampson J, Knight R, Chia N (2016). Collecting Fecal Samples for Microbiome Analyses in Epidemiology Studies. Cancer Epidemiol Biomarkers Prev  25, 407-16.   https://doi.org/10.1158/1055-9965.EPI-15-0951|4. Sinha R, Vogtmann E, Chen J, Amir A, Shi J, Sampson J, Flores R, Knight R, Chia N (2016). Fecal Microbiome in Epidemiologic Studies-Response. Cancer Epidemiol Biomarkers Prev  25, 870-1.   https://doi.org/10.1158/1055-9965.EPI-16-0161|5. Vogtmann E, Hua X, Zeller G, Sunagawa S, Voigt AY, Hercog R, Goedert JJ, Shi J, Bork P, Sinha R (2016). Colorectal Cancer and the Human Gut Microbiome: Reproducibility with Whole-Genome Shotgun Sequencing. PLoS One  11, e0155362.   https://doi.org/10.1371/journal.pone.0155362",https://intramural.nih.gov/search/searchview.taf?ipid=94334
610,CP010199-10,"October 01, 2015 -  September 30, 2016",Methods for Etiologic Studies of Diet and Cancer,Rashmi P Sinha; PhD|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Charles E Matthews,NULL,Amy F Subar (Risk Factor Assessment Branch)|Victor  Kipnis (Biometry Research Group)|Frances E Thompson (Risk Factor Assessment Branch)|Douglas N Midthune (Biometry Research Group)|Laurence  Freedman (Biometry Research Group)|Richard P Troiano (Risk Factor Assessment Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94335
611,CP010200-09,"October 01, 2015 -  September 30, 2016",GEI - Genome-Wide Association Studies,"Stephen J Chanock; MD, PhD|IRP Faculty Profile  |Nilanjan  Chatterjee| | |Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile  | |Margaret Anne Tucker|IRP Faculty Profile  | |Neil Edward Caporaso; MS, MD|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Genetic Epidemiology Branch, NCI

Human Genetics Program, NCI

Office of the Director, NCI",NULL,NULL,Mark  Purdue (Occupational and Environmental Epidemiology Branch),NULL,"1. Karami S, Han Y, Pande M, Cheng I, Rudd J, Pierce BL, Nutter EL, Schumacher FR, Kote-Jarai Z, Lindstrom S, Witte JS, Fang S, Han J, Kraft P, Hunter DJ, Song F, Hung RJ, McKay J, Gruber SB, Chanock SJ, Risch A, Shen H, Haiman CA, Boardman L, Ulrich CM, et al. [49 more authors] (2016) Telomere structure and maintenance gene variants and risk of five cancer types. Int J Cancer 139:2655-2670",https://intramural.nih.gov/search/searchview.taf?ipid=94337
612,CP010201-07,"October 01, 2015 -  September 30, 2016",Laboratory of Translational Genomics,Michael  Dean; PhD|IRP Faculty Profile,NULL,"Laboratory Translational Genomics, NCI",Laufey Thora Amundadottir|Liudmila  Prokunina-Olsson; PhD|Kevin Michael Brown,NULL,NULL,NULL,"1. Amundadottir LT (2016). Pancreatic Cancer Genetics. Int J Biol Sci  12, 314-25.   https://doi.org/10.7150/ijbs.15001|2. Paquin A, Onabajo OO, Tang W, Prokunina-Olsson L (2016). Comparative Functional Analysis of 12 Mammalian IFN-λ4 Orthologs. J Interferon Cytokine Res  36, 30-6.   https://doi.org/10.1089/jir.2015.0096",https://intramural.nih.gov/search/searchview.taf?ipid=94342
613,CP010202-08,"October 01, 2015 -  September 30, 2016","Biochemical, molecular, and dietary studies for pancreatic cancer within PLCO",Rachael Zoe Solomon|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",NULL,Brietta M Oaks|K  Dodd (DCCPS/NCI),"Cari Meinhold Kitahara (Radiation Epidemiology Branch)|Debra  Silverman; ScD, ScM (Occupational and Environmental Epidemiology Branch)|Richard  Hayes; PhD (Occupational and Environmental Epidemiology Branch)",NULL,"1. Stolzenberg-Solomon RZ, Newton CC, Silverman DT, Pollak M, Nogueira LM, Weinstein SJ, Albanes D, Männistö S, Jacobs EJ (2015). Circulating Leptin and Risk of Pancreatic Cancer: A Pooled Analysis From 3 Cohorts. Am J Epidemiol  182, 187-97.   https://doi.org/10.1093/aje/kwv041",https://intramural.nih.gov/search/searchview.taf?ipid=94285
614,CP010206-07,"October 01, 2015 -  September 30, 2016","Human Papillomavirus (HPV) Natural History, Genomics and Risk Assessment",Mark  Schiffman; MD|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",Mark H Greene; MD|Nicolas Albert Hermann Wentzensen|Julia  Gage,Robert  Burk (Albert Einstein College of Medicine)|Rodney D Long|Attila  Lorincz (Digene)|Walter  Kinney (Kaiser Permanente Northern California)|Tina  Raine-Bennett (Kaiser Permanente Northern California)|Cosette  Wheeler (University of New Mexico)|Show all 11,Sholom  Wacholder; PhD (Biostatistics Branch)|Hormuzdiar Aspandiar Katki; MS (Biostatistics Branch)|Kai  Yu (Biostatistics Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Lisa  Mirabello (Genetic Epidemiology Branch)|Meredith  Yeager (Office of the Director),NULL,"1. Gage JC, Hunt WC, Schiffman M, Katki HA, Cheung LC, Cuzick J, Myers O, Castle PE, Wheeler CM, New Mexico HPV Pap Registry Steering Committee (2016). Risk Stratification Using Human Papillomavirus Testing among Women with Equivocally Abnormal Cytology: Results from a State-Wide Surveillance Program. Cancer Epidemiol Biomarkers Prev  25, 36-42.   https://doi.org/10.1158/1055-9965.EPI-15-0669|2. Schiffman M, Vaughan LM, Raine-Bennett TR, Castle PE, Katki HA, Gage JC, Fetterman B, Befano B, Wentzensen N (2015). A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results. Gynecol Oncol  138, 573-8.   https://doi.org/10.1016/j.ygyno.2015.06.040",https://intramural.nih.gov/search/searchview.taf?ipid=94343
615,CP010207-07,"October 01, 2015 -  September 30, 2016",PLCO EEMS and Extended Follow Up,"Neal David Freedman|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI",Amanda  Black,NULL,Philip  Prorok (Office of the Director)|Paul F Pinsky (Early Detection Research Group),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94344
616,CP010209-07,"October 01, 2015 -  September 30, 2016",HPV and cancer at multiple anatomic sites,Aimee Rebecca Kreimer|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Lang Kuhs KA, Anantharaman D, Waterboer T, Johansson M, Brennan P, Michel A, Willhauck-Fleckenstein M, Purdue MP, Holcátová I, Ahrens W, Lagiou P, Polesel J, Simonato L, Merletti F, Healy CM, Kjaerheim K, Conway DI, Macfarlane TV, Thomson P, Castellsagué X, Znaor A, Black A, Huang WY, Krogh V, Trichopoulou A, et al. [11 more authors] (2015). Human Papillomavirus 16 E6 Antibodies in Individuals without Diagnosed Cancer: A Pooled Analysis. Cancer Epidemiol Biomarkers Prev  24, 683-9.   https://doi.org/10.1158/1055-9965.EPI-14-1217|2. Shiels MS, Kreimer AR, Coghill AE, Darragh TM, Devesa SS (2015). Anal Cancer Incidence in the United States, 1977-2011: Distinct Patterns by Histology and Behavior. Cancer Epidemiol Biomarkers Prev  24, 1548-56.   https://doi.org/10.1158/1055-9965.EPI-15-0044",https://intramural.nih.gov/search/searchview.taf?ipid=94346
617,CP010210-07,"October 01, 2015 -  September 30, 2016","HPV, cervical neoplasia, and vaccination",Mark  Schiffman; MD|IRP Faculty Profile  | |Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI

Clinical Genetics Branch, NCI",Mahboobeh  Safaeian|Aimee Rebecca Kreimer,L  Pinto (SAIC-NCI)|Mary  Carrington (SAIC Frederick),"Douglas  Lowy; MD (Office Of The Director)|John  Schiller; PhD (Laboratory of Cellular Oncology)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Sholom  Wacholder; PhD (Biostatistics Branch)|Hormuzdiar Aspandiar Katki; MS (Biostatistics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94347
618,CP010211-07,"October 01, 2015 -  September 30, 2016",Viral and Host Factors Associated with NPC,Alisa  Goldstein; PhD|IRP Faculty Profile  | |Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI

Genetic Epidemiology Branch, NCI",Cindy M Chang|Kelly Jen-Yi Yu,Chen-Jen  Chen (Academia Sinica in Taiwan)|ChenPing  Wang (National Taiwan University),"Mary  Carrington; MS, PhD (Cancer Inflammation Program)|Ruth  Pfeiffer; PhD (Biostatistics Branch)|Kai  Yu (Biostatistics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94348
619,CP010212-07,"October 01, 2015 -  September 30, 2016",Molecular mechanisms of infection-related cancer,Charles  Rabkin|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Breyer BN, Huang WY, Rabkin CS, Alderete JF, Pakpahan R, Beason TS, Kenfield SA, Mabie J, Ragard L, Wolin KY, Grubb RL, Andriole GL, Sutcliffe S (2016). Sexually transmitted infections, benign prostatic hyperplasia and lower urinary tract symptom-related outcomes: results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. BJU Int  117, 145-54.   https://doi.org/10.1111/bju.13050|2. Camargo MC, Kim KM, Matsuo K, Torres J, Liao LM, Morgan DR, Michel A, Waterboer T, Zabaleta J, Dominguez RL, Yatabe Y, Kim S, Rocha-Guevara ER, Lissowska J, Pawlita M, Rabkin CS (2016). Anti-Helicobacter pylori Antibody Profiles in Epstein-Barr virus (EBV)-Positive and EBV-Negative Gastric Cancer. Helicobacter  21, 153-7.   https://doi.org/10.1111/hel.12249|3. Camargo MC, Rabkin CS, Appel N, Hollenbeck AR (2015). Variable association of height with gastric cancer by anatomical subsite. Cancer Causes Control  26, 1361.   https://doi.org/10.1007/s10552-015-0616-2",https://intramural.nih.gov/search/searchview.taf?ipid=94349
620,CP010213-07,"October 01, 2015 -  September 30, 2016",Studies of Head and Neck Cancers,Anil Kumar Chaturvedi|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94350
621,CP010214-07,"October 01, 2015 -  September 30, 2016",Microbes and Human Malignancies,Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,"Jacques  Ravel; PhD (Microbial Genomics, The Institute for Genomic Research (TIGR))|Jeffrey  Gordon (WUSTL)|Wendy  Cozen (Norris Comprehensive Cancer Center)|Heather  Feigelson (American Cancer Society)|Dominique  Costagliola (INSERM, U943)|Nino  Romano (University of Palermo)|Show all 9",Barbara J Fuhrman (Hormonal and Reproductive Epidemiology Branch)|Roberto  Flores (Nutritional Science Research Group),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94351
622,CP010215-07,"October 01, 2015 -  September 30, 2016",Human microbiome and cancer,Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94352
623,CP010216-07,"October 01, 2015 -  September 30, 2016",Immune responses to HPV infection and HPV vaccination,Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Kemp T, Ken Matsui , Gloriana Shelton , Mahboobeh Safaiean , Pinto L (2015) A comparative study of two different assay kits for the detection of secreted alkaline phosphatase in HPV antibody neutralization assays Hum Vacc  Immuthr 11:337-46",https://intramural.nih.gov/search/searchview.taf?ipid=94353
624,CP010217-06,"October 01, 2015 -  September 30, 2016",HPV Vaccine Trial,Hormuzdiar Aspandiar Katki; MS|IRP Faculty Profile  | |Aimee Rebecca Kreimer|IRP Faculty Profile  |Ligia  Pinto| |Mahboobeh  Safaeian| | |Mark  Schiffman; MD|IRP Faculty Profile  | |Sholom  Wacholder; PhD|IRP Faculty Profile  | |Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI

Biostatistics Branch, NCI

Clinical Genetics Branch, NCI",Nicolas Albert Hermann Wentzensen|Anil Kumar Chaturvedi|Felipe A Castro,Rolando  Herrero (IARC)|Douglas  Lowy; MD (NCI)|Ana-Cecilia  Rodriguez (Proyecto Epidemiologico Guanacaste)|John  Schiller; PhD (NCI)|Diane  Solomon; PhD (NCI)|Wim  Quint (Delft Diagnostic Laboratory),NULL,NULL,"1. Beachler DC, Gonzales FA, Kobrin SC, Kreimer AR (2016). HPV vaccination initiation after the routine-recommended ages of 11-12 in the United States. Papillomavirus Res  2, 11-16.   https://doi.org/10.1016/j.pvr.2015.12.001|2. Hildesheim A, Gonzalez P, Kreimer AR, Wacholder S, Schussler J, Rodriguez AC, Porras C, Schiffman M, Sidawy M, Schiller JT, Lowy DR, Herrero R, Costa Rica HPV Vaccine Trial (CVT) Group (2016). Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment. Am J Obstet Gynecol  215, 212.e1-212.e15.   https://doi.org/10.1016/j.ajog.2016.02.021|3. Talarico S, Safaeian M, Gonzalez P, Hildesheim A, Herrero R, Porras C, Cortes B, Larson A, Fang FC, Salama NR (2016). Quantitative Detection and Genotyping of Helicobacter pylori from Stool using Droplet Digital PCR Reveals Variation in Bacterial Loads that Correlates with cagA Virulence Gene Carriage. Helicobacter  21, 325-33.   https://doi.org/10.1111/hel.12289",https://intramural.nih.gov/search/searchview.taf?ipid=94354
625,CP010218-06,"October 01, 2015 -  September 30, 2016",Etiology of Biliary Tract Cancer,Jill Elizabeth Koshiol|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",Felipe A Castro,NULL,Gabriella  Andreotti (Occupational and Environmental Epidemiology Branch),NULL,"1. Espinoza JA, Bizama C, García P, Ferreccio C, Javle M, Miquel JF, Koshiol J, Roa JC (2016). The inflammatory inception of gallbladder cancer. Biochim Biophys Acta  1865, 245-54.   https://doi.org/10.1016/j.bbcan.2016.03.004|2. Ferreccio C, Roa JC, Bambs C, Vives A, Corvalán AH, Cortés S, Foerster C, Acevedo J, Huidobro A, Passi A, Toro P, Covacevich Y, de la Cruz R, Koshiol J, Olivares M, Miquel JF, Cruz F, Silva R, Quest AF, Kogan MJ, Castro PF, Lavandero S (2016). Study protocol for the Maule Cohort (MAUCO) of chronic diseases, Chile 2014-2024. BMC Public Health  16, 122.   https://doi.org/10.1186/s12889-015-2454-2|3. Koshiol J, Castro F, Kemp TJ, Gao YT, Roa JC, Wang B, Nogueira L, Araya JC, Shen MC, Rashid A, Hsing AW, Hildesheim A, Ferreccio C, Pfeiffer RM, Pinto LA (2016). Association of inflammatory and other immune markers with gallbladder cancer: Results from two independent case-control studies. Cytokine  83, 217-225.   https://doi.org/10.1016/j.cyto.2016.05.003",https://intramural.nih.gov/search/searchview.taf?ipid=94355
626,CP010219-06,"October 01, 2015 -  September 30, 2016",Studies of other risk factors for radiosensitive tumors,Amy  de Gonzalez|IRP Faculty Profile  | |Martha S Linet; PhD|IRP Faculty Profile  | |Cari Meinhold Kitahara|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Braganza MZ, Potischman N, Park Y, Thompson FE, Hollenbeck AR, Kitahara CM (2015). Adolescent and mid-life diet and subsequent risk of thyroid cancer in the NIH-AARP diet and health study. Int J Cancer  137, 2413-23.   https://doi.org/10.1002/ijc.29600|2. Gaudet MM, Kitahara CM, Newton CC, Bernstein L, Reynolds P, Weiderpass E, Kreimer AR, Yang G, Adami HO, Alavanja MC, Beane Freeman LE, Boeing H, Buring J, Chaturvedi A, Chen Y, D'Aloisio AA, Freedman M, Gao YT, Gaziano JM, Giles GG, Håkansson N, Huang WY, Lee IM, Linet MS, MacInnis RJ, et al. [18 more authors] (2015). Anthropometry and head and neck cancer:a pooled analysis of cohort data. Int J Epidemiol  44, 673-81.   https://doi.org/10.1093/ije/dyv059|3. Moore SC, Lee IM, Weiderpass E, Campbell PT, Sampson JN, Kitahara CM, Keadle SK, Arem H, Berrington de Gonzalez A, Hartge P, Adami HO, Blair CK, Borch KB, Boyd E, Check DP, Fournier A, Freedman ND, Gunter M, Johannson M, Khaw KT, Linet MS, Orsini N, Park Y, Riboli E, Robien K, et al. [7 more authors] (2016). Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults. JAMA Intern Med  176, 816-25.   https://doi.org/10.1001/jamainternmed.2016.1548",https://intramural.nih.gov/search/searchview.taf?ipid=94356
627,CP010220-06,"October 01, 2015 -  September 30, 2016",Barretts Esophagus,"Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile  | |Sanford Martin Dawsey; MD|IRP Faculty Profile  | |Neal David Freedman|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  |Philip  Taylor; MD, ScD| | |Michael Blaise Cook|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI

Genetic Epidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Drahos J, Li L, Jick SS, Cook MB (2016). Metabolic syndrome in relation to Barrett's esophagus and esophageal adenocarcinoma: Results from a large population-based case-control study in the Clinical Practice Research Datalink. Cancer Epidemiol  42, 9-14.   https://doi.org/10.1016/j.canep.2016.02.008|2. Drahos J, Xiao Q, Risch HA, Freedman ND, Abnet CC, Anderson LA, Bernstein L, Brown L, Chow WH, Gammon MD, Kamangar F, Liao LM, Murray LJ, Ward MH, Ye W, Wu AH, Vaughan TL, Whiteman DC, Cook MB (2016). Age-specific risk factor profiles of adenocarcinomas of the esophagus: A pooled analysis from the international BEACON consortium. Int J Cancer  138, 55-64.   https://doi.org/10.1002/ijc.29688|3. Ek WE, Lagergren K, Cook M, Wu AH, Abnet CC, Levine D, Chow WH, Bernstein L, Risch HA, Shaheen NJ, Bird NC, Corley DA, Hardie LJ, Fitzgerald RC, Gammon MD, Romero Y, Liu G, Ye W, Vaughan TL, MacGregor S, Whiteman DC, Westberg L, Lagergren J (2016). Polymorphisms in genes in the androgen pathway and risk of Barrett's esophagus and esophageal adenocarcinoma. Int J Cancer  138, 1146-52.   https://doi.org/10.1002/ijc.29863|4. Petrick JL, Nguyen T, Cook MB (2016). Temporal trends of esophageal disorders by age in the Cerner Health Facts database. Ann Epidemiol  26, 151-154.e4.   https://doi.org/10.1016/j.annepidem.2015.11.004",https://intramural.nih.gov/search/searchview.taf?ipid=94357
628,CP010221-06,"October 01, 2015 -  September 30, 2016",Etiologic Studies of Prostate Cancer,"Sonja  Berndt|IRP Faculty Profile  | |Stephen J Chanock; MD, PhD|IRP Faculty Profile  | |Demetrius  Albanes; MD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI

Office of the Director, NCI",Alison Marian Mondul|Stephanie Joan Weinstein|Jacqueline M Major; MS|Mark  Purdue|Meredith  Yeager|Zhaoming  Wang,"David  Hunter (Harvard School of Public Health)|Peter  Kraft|Brian  Henderson (University of Southern California)|Laurence N Kolonel|Susan  Gapstur (American Cancer Society)|Margie  Wright; PhD (Queensland Institute of Medical Research, Brisbane, Australia)|Show all 7","Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Kevin  Jacobs (Laboratory Translational Genomics)|Joanne Lee Watters (Clinical & Translational Epidemiology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94358
629,CP010222-06,"October 01, 2015 -  September 30, 2016",Studies of Populations Exposed to Diagnostic Medical Radiation,Cari Meinhold Kitahara|IRP Faculty Profile  | |Choonsik  Lee|IRP Faculty Profile  | |Mark Peter Little|IRP Faculty Profile  | |Amy  de Gonzalez|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI","Rochelle E Curtis|Ruth Anne Kleinerman; MPH|Michele M Doody; MS|Alice  Sigurdson; PhD|Steven L Simon|Kiyohiko  Mabuchi; MD, DPhil|Show all 12",David  Abramson (New York Presbyterian Hospital)|Johanna  Seddon (Massachusetts Eye and Ear Infirmary)|Marilyn  Stovall (The University of Texas MD Anderson Cancer Center)|Neal Andrew Naito|Ritsu  Sakata; PhD|Eve  Roman (University of York)|Show all 14,Margaret Anne Tucker (Human Genetics Program)|Preetha  Rajaraman (Center For Global Health)|Jay  Lubin; PhD (Biostatistics Branch),NULL,"1. Berrington de Gonzalez A, Kleinerman RA (2015). CT Scanning: Is the Contrast Material Enhancing the Radiation Dose and Cancer Risk as Well as the Image? Radiology  275, 627-9.   https://doi.org/10.1148/radiol.2015150605|2. Berrington de Gonzalez A, Salotti JA, McHugh K, Little MP, Harbron RW, Lee C, Ntowe E, Braganza MZ, Parker L, Rajaraman P, Stiller C, Stewart DR, Craft AW, Pearce MS (2016). Relationship between paediatric CT scans and subsequent risk of leukaemia and brain tumours: assessment of the impact of underlying conditions. Br J Cancer  114, 388-94.   https://doi.org/10.1038/bjc.2015.415|3. Chodick G, Levin M, Kleinerman RA, Shwarz M, Shalev V, Ashkenazi S, Horev G (2015). Differences in characteristics of pediatric patients undergoing computed tomography between hospitals and primary care settings: implications for assessing cancer follow-up studies. Isr J Health Policy Res  4, 33.   https://doi.org/10.1186/s13584-015-0031-x|4. Lamart S, Simon SL, Bouville A, Moroz BE, Lee C (2016). S values for 131I based on the ICRP adult voxel phantoms. Radiat Prot Dosimetry  168, 92-110.   https://doi.org/10.1093/rpd/ncv016|5. Lee C, Pearce MS, Salotti JA, Harbron RW, Little MP, McHugh K, Chapple CL, Berrington de Gonzalez A (2016). Reduction in radiation doses from paediatric CT scans in Great Britain. Br J Radiol  89, 20150305.   https://doi.org/10.1259/bjr.20150305|6. Romanyukha A, Folio L, Lamart S, Simon SL, Lee C (2016). BODY SIZE-SPECIFIC EFFECTIVE DOSE CONVERSION COEFFICIENTS FOR CT SCANS. Radiat Prot Dosimetry  172, 428-437.   https://doi.org/10.1093/rpd/ncv511",https://intramural.nih.gov/search/searchview.taf?ipid=94359
630,CP010224-05,"October 01, 2015 -  September 30, 2016",Esophageal cancer genetic project,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI",Nan  Hu|Alisa  Goldstein; PhD|Paula L Hyland,"TI  Ding (DEPT OF THORACIC SURGERY, SCHI)|LiDong  Wang (Zhengzhou Medical University)|DongXin  Lin (CICAMS)|Wei  Zheng (Vanderbilt University)|XiaoOu  Shu (Vanderbilt University)|JianMin  Yuan (University of Pittsburgh)","Christian Cormac Abnet; PhD, MPH (Hormonal and Reproductive Epidemiology Branch)|Sanford Martin Dawsey; MD (Hormonal and Reproductive Epidemiology Branch)|Neal David Freedman (Hormonal and Reproductive Epidemiology Branch)",NULL,"1. Hu N, Kadota M, Liu H, Abnet CC, Su H, Wu H, Freedman ND, Yang HH, Wang C, Yan C, Wang L, Gere S, Hutchinson A, Song G, Wang Y, Ding T, Qiao YL, Koshiol J, Dawsey SM, Giffen C, Goldstein AM, Taylor PR, Lee MP (2016). Genomic Landscape of Somatic Alterations in Esophageal Squamous Cell Carcinoma and Gastric Cancer. Cancer Res  76, 1714-23.   https://doi.org/10.1158/0008-5472.CAN-15-0338",https://intramural.nih.gov/search/searchview.taf?ipid=94361
631,CP010225-05,"October 01, 2015 -  September 30, 2016",Barretts esophagus early detection project,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI",Nan  Hu|Paula L Hyland,Ming  Zhou (SAIC)|Patrick  Young (WRNMMC),"Melissa  Rotunno (Clinical and Genetic Epidemiology Research Branch)|Ruth  Pfeiffer; PhD (Biostatistics Branch)|Sanford Martin Dawsey; MD (Hormonal and Reproductive Epidemiology Branch)|Christian Cormac Abnet; PhD, MPH (Hormonal and Reproductive Epidemiology Branch)|Michael Blaise Cook (Hormonal and Reproductive Epidemiology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94362
632,CP010227-02,"October 01, 2015 -  September 30, 2016",Laboratory of Genetic Susceptibility,"Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",NULL,"Chris  Amos (Dartmouth University)|Smita  Bhatia (University of Alabama School of Medicine)|Paul  Brennan (International Agency for Research on Cancer, Lyon, France)|James  Cerhan (Mayo Clinic)|Fergus  Couch; PhD (Dept of Laboratory Medicine & Pathology, Mayo Clinic)|Olivier  Delattre (Institut Curie, Paris, France)|Show all 20","Leandro Machado Colli (Laboratory Of Genetic Susceptibility)|Lea  Jessop (Laboratory Of Genetic Susceptibility)|Roelof  Koster (Laboratory Of Genetic Susceptibility)|Mitchell John Machiela; PhD (Laboratory Of Genetic Susceptibility)|Timothy A Myers (Laboratory Of Genetic Susceptibility)|Mary  Carrington; MS, PhD (Cancer Inflammation Program)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94364
633,CP010228-01,"-  September 30, 2016",Human Papillomavirus (HPV) Genomics Project,Mark  Schiffman; MD|IRP Faculty Profile  | |Lisa  Mirabello|IRP Faculty Profile,NULL,"Genetic Epidemiology Branch, NCI

Clinical Genetics Branch, NCI",Nicolas Albert Hermann Wentzensen|Yanzi  Xiao,NULL,Meredith  Yeager (Office of the Director)|Joseph  Boland (Office of the Director)|Kai  Yu (Biostatistics Branch)|Bin  Zhu (Biostatistics Branch),NULL,"1. Mirabello L, Yeager M, Cullen M, Boland JF, Chen Z, Wentzensen N, Zhang X, Yu K, Yang Q, Mitchell J, Roberson D, Bass S, Xiao Y, Burdett L, Raine-Bennett T, Lorey T, Castle PE, Burk RD, Schiffman M (2016). HPV16 Sublineage Associations With Histology-Specific Cancer Risk Using HPV Whole-Genome Sequences in 3200 Women. J Natl Cancer Inst  108.   https://doi.org/10.1093/jnci/djw100",https://intramural.nih.gov/search/searchview.taf?ipid=97196
634,SC000550-36,"October 01, 2015 -  September 30, 2016",Lymphoma Disease Discovery and Definition,Elaine S Jaffe; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Tapan Mahendra Bhavsar|Theresa M Davies Hill|Caoimhe Mary Egan; MD|Maryknoll Mawanay Palisoc|Stefania  Pittaluga|Laura Marie Wake|Show all 9,"Elias  Campo (University of Barcelona)|Wing  Chan (Pathology, University of Nebraska)|Falko  Fend|Randy  Gascoyne (British Columbia Cancer Center)|Leticia  Quintanilla-Martinez (Pathology, Technical University of Munich)|Lisa  Rimsza (University of Arizona Cancer Center)|Show all 8","Kieron Michael Dunleavy (Lymphoid Malignancies Branch)|Louis  Staudt; MD (Lymphoid Malignancies Branch)|Thomas S Uldrick (HIV and AIDS Malignancy Branch)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|George W Wright (Computational & Systems Biology Branch)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)",NULL,"1. Alikhan M, Song JY, Sohani AR, Moroch J, Plonquet A, Duffield AS, Borowitz MJ, Jiang L, Bueso-Ramos C, Inamdar K, Menon MP, Gurbuxani S, Chan E, Smith SM, Nicolae A, Jaffe ES, Gaulard P, Venkataraman G (2016). Peripheral T-cell lymphomas of follicular helper T-cell type frequently display an aberrant CD3(-/dim)CD4(+) population by flow cytometry: an important clue to the diagnosis of a Hodgkin lymphoma mimic. Mod Pathol  29, 1173-82.   https://doi.org/10.1038/modpathol.2016.113|2. Bates SE, Eisch R, Ling A, Rosing D, Turner M, Pittaluga S, Prince HM, Kirschbaum MH, Allen SL, Zain J, Geskin LJ, Joske D, Popplewell L, Cowen EW, Jaffe ES, Nichols J, Kennedy S, Steinberg SM, Liewehr DJ, Showe LC, Steakley C, Wright J, Fojo T, Litman T, Piekarz RL (2015). Romidepsin in peripheral and cutaneous T-cell lymphoma: mechanistic implications from clinical and correlative data. Br J Haematol  170, 96-109.   https://doi.org/10.1111/bjh.13400|3. Brown RJ, Chan JL, Jaffe ES, Cochran E, DePaoli AM, Gautier JF, Goujard C, Vigouroux C, Gorden P (2016). Lymphoma in acquired generalized lipodystrophy. Leuk Lymphoma  57, 45-50.   https://doi.org/10.3109/10428194.2015.1040015|4. Cohen JI, Niemela JE, Stoddard JL, Pittaluga S, Heslop H, Jaffe ES, Dowdell K (2015). Late-onset severe chronic active EBV in a patient for five years with mutations in STXBP2 (MUNC18-2) and PRF1 (perforin 1). J Clin Immunol  35, 445-8.   https://doi.org/10.1007/s10875-015-0168-y|5. Ganapathi KA, Jobanputra V, Iwamoto F, Jain P, Chen J, Cascione L, Nahum O, Levy B, Xie Y, Khattar P, Hoehn D, Bertoni F, Murty VV, Pittaluga S, Jaffe ES, Alobeid B, Mansukhani MM, Bhagat G (2016). The genetic landscape of dural marginal zone lymphomas. Oncotarget  7, 43052-43061.   https://doi.org/10.18632/oncotarget.9678|6. Gong S, Auer I, Duggal R, Pittaluga S, Raffeld M, Jaffe ES (2015). Epstein-Barr virus-associated inflammatory pseudotumor presenting as a colonic mass. Hum Pathol  46, 1956-61.   https://doi.org/10.1016/j.humpath.2015.08.011|7. Gratzinger D, Jaffe ES (2016). Mucocutaneous ulcer: a mimic of EBV + diffuse large B cell lymphoma in the immunodeficiency setting. Leuk Lymphoma  57, 1982-3.   https://doi.org/10.3109/10428194.2016.1166492|8. Jain S, Chen J, Nicolae A, Wang H, Shin DM, Adkins EB, Sproule TJ, Leeth CM, Sakai T, Kovalchuk AL, Raffeld M, Ward JM, Rehg JE, Waldmann TA, Jaffe ES, Roopenian DC, Morse HC (2015). IL-21-driven neoplasms in SJL mice mimic some key features of human angioimmunoblastic T-cell lymphoma. Am J Pathol  185, 3102-14.   https://doi.org/10.1016/j.ajpath.2015.07.021|9. Kanemitsu M, John D, Lim A, Jaffe ES, Aoki J (2015). Clonal Epstein-Barr virus-positive mucocutaneous ulcer mimicking a mature B-cell lymphoma in a patient with mycophenolate-induced immune suppression. Leuk Lymphoma  56, 1908-10.   https://doi.org/10.3109/10428194.2014.982646|10. Laurent C, Fabiani B, Do C, Tchernonog E, Cartron G, Gravelle P, Amara N, Malot S, Palisoc MM, Copie-Bergman C, Glehen AT, Copin MC, Brousset P, Pittaluga S, Jaffe ES, Coppo P (2016). Immune-checkpoint expression in Epstein-Barr virus positive and negative plasmablastic lymphoma: a clinical and pathological study in 82 patients. Haematologica  101, 976-84.   https://doi.org/10.3324/haematol.2016.141978|11. Lee YS, Filie A, Arthur D, Fojo AT, Jaffe ES (2015). Breast implant-associated anaplastic large cell lymphoma in a patient with Li-Fraumeni syndrome. Histopathology  67, 925-7.   https://doi.org/10.1111/his.12737|12. Menon MP, Nicolae A, Meeker H, Raffeld M, Xi L, Jegalian AG, Miller DC, Pittaluga S, Jaffe ES (2015). Primary CNS T-cell Lymphomas: A Clinical, Morphologic, Immunophenotypic, and Molecular Analysis. Am J Surg Pathol  39, 1719-1729.   https://doi.org/10.1097/PAS.0000000000000503|13. Nicolae A, Pittaluga S, Abdullah S, Steinberg SM, Pham TA, Davies-Hill T, Xi L, Raffeld M, Jaffe ES (2015). EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment. Blood  126, 863-72.   https://doi.org/10.1182/blood-2015-02-630632|14. Roschewski M, Dunleavy K, Pittaluga S, Moorhead M, Pepin F, Kong K, Shovlin M, Jaffe ES, Staudt LM, Lai C, Steinberg SM, Chen CC, Zheng J, Willis TD, Faham M, Wilson WH (2015). Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study. Lancet Oncol  16, 541-9.   https://doi.org/10.1016/S1470-2045(15)70106-3|15. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES (2016). The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood  127, 2375-90.   https://doi.org/10.1182/blood-2016-01-643569|16. Wang HW, Pittaluga S, Jaffe ES (2016). Multicentric Castleman disease: Where are we now? Semin Diagn Pathol  33, 294-306.   https://doi.org/10.1053/j.semdp.2016.05.006|17. Xiao W, Chen WW, Sorbara L, Davies-Hill T, Pittaluga S, Raffeld M, Jaffe ES (2016). Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion. Hum Pathol  55, 108-116.   https://doi.org/10.1016/j.humpath.2016.04.019|18. Xie Y, Pittaluga S, Jaffe ES (2015). The histological classification of diffuse large B-cell lymphomas. Semin Hematol  52, 57-66.   https://doi.org/10.1053/j.seminhematol.2015.01.006",https://intramural.nih.gov/search/searchview.taf?ipid=94375
635,SC000892-33,"October 01, 2015 -  September 30, 2016",Molecular Biology of the Metastatic Phenotype,Patricia  Steeg; PhD|IRP Faculty Profile,NULL,"Womens Malignancies Branch, NCI",Danielle Laurene Brooks|Emily  Hua|Imran  Khan; PhD,NULL,Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Udayan  Guha (Thoracic & Oncologic Surgery Branch),NULL,"1. Zimmer AS, Steeg PS (2015). Meaningful prevention of breast cancer metastasis: candidate therapeutics, preclinical validation, and clinical trial concerns. J Mol Med (Berl)  93, 13-29.   https://doi.org/10.1007/s00109-014-1226-2",https://intramural.nih.gov/search/searchview.taf?ipid=94377
636,SC003669-27,"October 01, 2015 -  September 30, 2016",Regulation of Cutaneous Accessory Cell Activity in Health and Disease,Mark  Udey; MD,NULL,"Dermatology Branch, NCI",NULL,Keisuke  Nagao (Keio University Schiool of Medicine)|Adam  Glick; PhD (NCI),NULL,Maria Irene Morasso; PhD (NIAMS) |Ulrich K Siebenlist; PhD (NIAID),"1. Ouchi T, Nakato G, Udey MC (2016). EpCAM Expressed by Murine Epidermal Langerhans Cells Modulates Immunization to an Epicutaneously Applied Protein Antigen. J Invest Dermatol  136, 1627-1635.   https://doi.org/10.1016/j.jid.2016.04.005|2. Yamada K, Uchiyama A, Uehara A, Perera B, Ogino S, Yokoyama Y, Takeuchi Y, Udey MC, Ishikawa O, Motegi S (2016). MFG-E8 Drives Melanoma Growth by Stimulating Mesenchymal Stromal Cell-Induced Angiogenesis and M2 Polarization of Tumor-Associated Macrophages. Cancer Res  76, 4283-92.   https://doi.org/10.1158/0008-5472.CAN-15-2812",https://intramural.nih.gov/search/searchview.taf?ipid=94378
637,SC004002-47,"October 01, 2015 -  September 30, 2016",IL-2:IL-15 cytokine receptor: implications for cancer therapy and vaccine,"Thomas Alexander Waldmann; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI","Yuquan  Lin|Juergen R Mueller; PhD|Masao  Nakagawa|Sunny Tianyi Ouyang|Michael N Petrus|Mei  Zhang; MD, PhD|Show all 7",Sandor  Damjanovich MD (University of Debrecen)|Richard  Bamford; PhD|Georgy  Vamosi (University of Debrecen),NULL,NULL,"1. Mitra S, Ring AM, Amarnath S, Spangler JB, Li P, Ju W, Fischer S, Oh J, Spolski R, Weiskopf K, Kohrt H, Foley JE, Rajagopalan S, Long EO, Fowler DH, Waldmann TA, Garcia KC, Leonard WJ (2015). Interleukin-2 activity can be fine tuned with engineered receptor signaling clamps. Immunity  42, 826-38.   https://doi.org/10.1016/j.immuni.2015.04.018|2. Sharma K, Janik JE, O'Mahony D, Stewart D, Pittaluga S, Stetler-Stevenson M, Jaffe ES, Raffeld M, Fleisher TA, Lee CC, Steinberg SM, Waldmann TA, Morris JC (2017). Phase II Study of Alemtuzumab (CAMPATH-1) in Patients with HTLV-1-Associated Adult T-cell Leukemia/lymphoma. Clin Cancer Res  23, 35-42.   https://doi.org/10.1158/1078-0432.CCR-16-1022|3. Zhang M, Mathews Griner LA, Ju W, Duveau DY, Guha R, Petrus MN, Wen B, Maeda M, Shinn P, Ferrer M, Conlon KD, Bamford RN, O'Shea JJ, Thomas CJ, Waldmann TA (2015). Selective targeting of JAK/STAT signaling is potentiated by Bcl-xL blockade in IL-2-dependent adult T-cell leukemia. Proc Natl Acad Sci U S A  112, 12480-5.   https://doi.org/10.1073/pnas.1516208112",https://intramural.nih.gov/search/searchview.taf?ipid=94379
638,SC004020-39,"October 01, 2015 -  September 30, 2016","Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS","Jay Arthur Berzofsky; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Rolf  Billeskov|Anja Constanze Bloom|Katharine Tyler Clark|Blake Francis Frey|Shingo  Kato; MD, PhD|Shweta Santosh Kulkarni|Show all 19","Guido  Forni (Clinical and Biological Sciences, University of Turin)|Steven  Ledbetter (Genzyme Corp.)|Scott  Lonning (Gene Therapy, Genzyme Corp.)|Dale  Godfrey (Immunolgy, University of Melbourne)|Wayne M. Yokoyama; MD (Rheumatology Division, Washington University)|Yoran  Reiter (Immunology, Technion-Israel Institue of Technology)|Show all 33","William Marston Linehan; MD (Urologic Oncology Branch)|Ira H Pastan; MD (Molecular Biology Section)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Dennis M Klinman; MD, PhD (Cancer Inflammation Program)|David J Venzon; PhD (Biostatistics and Data Management Section)|Hisataka  Kobayashi (Molecular Imaging Program)","Brian  Kelsall; MD (NIAID) |David Harvey Margulies; MD, PhD (NIAID) |Warren  Strober; MD (NIAID) |Patricia  Earl; PhD (NIAID) |Raj K Puri (OD) |Warren J Leonard; MD (NHLBI)","1. Berzofsky J, Wood L, Terabe M (2015) Strategies for improving vaccines to elicit T cells to treat cancer, in Developments in T cell based cancer immunotherapies, in press.|2. Terabe M, Berzofsky J (2015) NKT cells in tumor immunity, in Encyclopedia of Immunobiology, in press.|3. Kapanadze T, Medina-Echeverz J, Gamrekelashvili J, Weiss JM, Wiltrout RH, Kapoor V, Hawk N, Terabe M, Berzofsky JA, Manns MP, Wang E, Marincola FM, Korangy F, Greten TF (2015). Tumor-induced CD11b(+) Gr-1(+) myeloid-derived suppressor cells exacerbate immune-mediated hepatitis in mice in a CD40-dependent manner. Eur J Immunol  45, 1148-58.   https://doi.org/10.1002/eji.201445093|4. Lacouture ME, Morris JC, Lawrence DP, Tan AR, Olencki TE, Shapiro GI, Dezube BJ, Berzofsky JA, Hsu FJ, Guitart J (2015). Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor β by the monoclonal antibody fresolimumab (GC1008). Cancer Immunol Immunother  64, 437-46.   https://doi.org/10.1007/s00262-015-1653-0|5. Parchment R, Voth A, Doroshow J, Berzofsky J (2016) Immuno-pharmacodynamics (Immuno-PD) for evaluating mechanism of action and developing immunotherapy combinations. Seminars in Oncology, in press.|6. Wang Y, Sui Y, Kato S, Hogg AE, Steel JC, Morris JC, Berzofsky JA (2015). Vaginal type-II mucosa is an inductive site for primary CD8⁺ T-cell mucosal immunity. Nat Commun  6, 6100.   https://doi.org/10.1038/ncomms7100|7. Wood L, Fojo A, Roberson B, Hughes M, Dahut W, Gulley J, Madan R, Arlen P, Sabatino M, Stroncek D, Castiello L, Trepel J, Lee M, Parnes H, Steinberg S, Terabe M, Wilkerson J, Pastan I, Berzofsky J (2016) TARP Vaccination is Associated with Slowing in PSA Velocity and Decreasing Tumor Growth Rates in Patients with Stage D0 Prostate Cancer. OncoImmunology, in press.|8. Wood LV, Fojo A, Roberson BD, Hughes MS, Dahut W, Gulley JL, Madan RA, Arlen PM, Sabatino M, Stroncek DF, Castiello L, Trepel JB, Lee MJ, Parnes HL, Steinberg SM, Terabe M, Wilkerson J, Pastan I, Berzofsky JA (2016). TARP vaccination is associated with slowing in PSA velocity and decreasing tumor growth rates in patients with Stage D0 prostate cancer. Oncoimmunology  5, e1197459.   https://doi.org/10.1080/2162402X.2016.1197459",https://intramural.nih.gov/search/searchview.taf?ipid=94380
639,SC006321-37,"October 01, 2015 -  September 30, 2016",Modulation of Therapeutic Response,James B Mitchell; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Rajani  Choudhuri|John Andrew Cook; PhD|Janet W Gamson|Askale Y Mathias|Chandrasek N. Nagineni; PhD|Sarwat  Naz; PhD|Show all 8,NULL,Deborah E Citrin (Radiation Oncology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch),"Carter  Van Waes; MD, PhD (NIDCD)","1. Eytan DF, Snow GE, Carlson S, Derakhshan A, Saleh A, Schiltz S, Cheng H, Mohan S, Cornelius S, Coupar J, Sowers AL, Hernandez L, Mitchell JB, Annunziata CM, Chen Z, Van Waes C (2016). SMAC Mimetic Birinapant plus Radiation Eradicates Human Head and Neck Cancers with Genomic Amplifications of Cell Death Genes FADD and BIRC2. Cancer Res  76, 5442-5454.   https://doi.org/10.1158/0008-5472.CAN-15-3317|2. Leiker AJ, DeGraff W, Choudhuri R, Sowers AL, Thetford A, Cook JA, Van Waes C, Mitchell JB (2015). Radiation Enhancement of Head and Neck Squamous Cell Carcinoma by the Dual PI3K/mTOR Inhibitor PF-05212384. Clin Cancer Res  21, 2792-801.   https://doi.org/10.1158/1078-0432.CCR-14-3279|3. Wojtkowiak JW, Cornnell HC, Matsumoto S, Saito K, Takakusagi Y, Dutta P, Kim M, Zhang X, Leos R, Bailey KM, Martinez G, Lloyd MC, Weber C, Mitchell JB, Lynch RM, Baker AF, Gatenby RA, Rejniak KA, Hart C, Krishna MC, Gillies RJ (2015). Pyruvate sensitizes pancreatic tumors to hypoxia-activated prodrug TH-302. Cancer Metab  3, 2.   https://doi.org/10.1186/s40170-014-0026-z",https://intramural.nih.gov/search/searchview.taf?ipid=94381
640,SC006330-36,"October 01, 2015 -  September 30, 2016",Radiation Field Modeling and Computerized Treatment Planning,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",NULL,"Thomas  Fearon (Radiology, Children's National Medical Center)|Chang-Ming  Ma (Radiation Oncology Department, Fox Chase Cancer Center)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94370
641,SC006353-34,"October 01, 2015 -  September 30, 2016",Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy,Martin W Brechbiel; PhD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",NULL,Andrew  Scott (Ludwig Institute for Cancer Research)|Marty  Pomper (Johns Hopkins),NULL,NULL,"1. Banerjee SR, Foss CA, Pullambhatla M, Wang Y, Srinivasan S, Hobbs RF, Baidoo KE, Brechbiel MW, Nimmagadda S, Mease RC, Sgouros G, Pomper MG (2015). Preclinical evaluation of 86Y-labeled inhibitors of prostate-specific membrane antigen for dosimetry estimates. J Nucl Med  56, 628-34.   https://doi.org/10.2967/jnumed.114.149062|2. Baum RP, Kulkarni HR, Müller D, Satz S, Danthi N, Kim YS, Brechbiel MW (2015). First-In-Human Study Demonstrating Tumor-Angiogenesis by PET/CT Imaging with (68)Ga-NODAGA-THERANOST, a High-Affinity Peptidomimetic for αvβ3 Integrin Receptor Targeting. Cancer Biother Radiopharm  30, 152-9.   https://doi.org/10.1089/cbr.2014.1747|3. Ciprotti M, Tebbutt NC, Lee FT, Lee ST, Gan HK, McKee DC, O'Keefe GJ, Gong SJ, Chong G, Hopkins W, Chappell B, Scott FE, Brechbiel MW, Tse AN, Jansen M, Matsumura M, Kotsuma M, Watanabe R, Venhaus R, Beckman RA, Greenberg J, Scott AM (2015). Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer. J Clin Oncol  33, 2609-16.   https://doi.org/10.1200/JCO.2014.60.4256|4. Milenic DE, Baidoo KE, Brechbiel MW (2015). Bench to Bedside: Stability Studies of GMP Produced Trastuzumab-TCMC in Support of a Clinical Trial. Pharmaceuticals (Basel)  8, 435-54.   https://doi.org/10.3390/ph8030435|5. Milenic DE, Baidoo KE, Kim YS, Brechbiel MW (2015). Evaluation of cetuximab as a candidate for targeted α-particle radiation therapy of HER1-positive disseminated intraperitoneal disease. MAbs  7, 255-64.   https://doi.org/10.4161/19420862.2014.985160|6. Milenic DE, Molinolo AA, Solivella MS, Banaga E, Torgue J, Besnainou S, Brechbiel MW, Baidoo KE (2015). Toxicological Studies of 212Pb Intravenously or Intraperitoneally Injected into Mice for a Phase 1 Trial. Pharmaceuticals (Basel)  8, 416-34.   https://doi.org/10.3390/ph8030416|7. Yong K, Brechbiel M (2015). Application of 212Pb for Targeted α-particle Therapy (TAT): Pre-clinical and Mechanistic Understanding through to Clinical Translation. AIMS Med Sci  2, 228-245.   https://doi.org/10.3934/medsci.2015.3.228|8. Yong KJ, Milenic DE, Baidoo KE, Brechbiel MW (2016). Mechanisms of Cell Killing Response from Low Linear Energy Transfer (LET) Radiation Originating from (177)Lu Radioimmunotherapy Targeting Disseminated Intraperitoneal Tumor Xenografts. Int J Mol Sci  17.   https://doi.org/10.3390/ijms17050736",https://intramural.nih.gov/search/searchview.taf?ipid=94382
642,SC006387-29,"October 01, 2015 -  September 30, 2016",Nitroxides as Protectors Against Oxidative Stress,James B Mitchell; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Rajani  Choudhuri|John Andrew Cook; PhD|Janet W Gamson|Askale Y Mathias|Chandrasek N. Nagineni; PhD|Sarwat  Naz; PhD|Show all 8,NULL,Frank Jess Gonzalez; PhD (Laboratory of Metabolism),Tracey Ann Rouault; MD (NICHD),"1. Kagiya G, Ogawa R, Choudhuri R, Cook JA, Hatashita M, Tanaka Y, Koda K, Yamashita K, Kubo M, Kawakami F, Mitchell JB (2015). Selective enhancement of hypoxic cell killing by tempol-regulated suicide gene expression. Oncol Rep  34, 1065-73.   https://doi.org/10.3892/or.2015.4020",https://intramural.nih.gov/search/searchview.taf?ipid=94383
643,SC006538-23,"October 01, 2015 -  September 30, 2016",Development of Angiogenesis Inhibitors,William D Figg; PharmD|IRP Faculty Profile,NULL,"Genitourinary Malignancies Branch, NCI","Shaunna Leigh Beedie|Cindy Huong-Bich Chau|Douglas K Price|James L Gulley; MD, PhD|William Laurence Dahut; MD|Ravi  Madan|Show all 7","Christopher  Schofield (University of Oxford)|Brent R Copp; PhD (Chemistry, University of Auckland)|Neil  Vargesson; PhD (University of Aberdeen)","Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Howard  Parnes (Prostate and Urologic Cancer Research Group)|Tawnya Carlene McKee; BA, PhD (Diagnostic Biomarkers and Technology Branch)|David J Venzon; PhD (Biostatistics and Data Management Section)|Ismail Baris Turkbey (Molecular Imaging Program)|Tim Friedrich Greten (Thoracic & Oncologic Surgery Branch)",Fatima Hafiz Karzai; MD (NIMHD) |Nigel H Greig; PhD (NIA),"1. Chau C, Figg W (2015) Pharmacology of Cancer Biotherapeutics: Angiogenesis Agents, in Cancer: Principles and Practice of Oncology, 10th Ed. , pp. 290-299.|2. Beedie SL, Peer CJ, Pisle S, Gardner ER, Mahony C, Barnett S, Ambrozak A, Gütschow M, Chau CH, Vargesson N, Figg WD (2015). Anticancer Properties of a Novel Class of Tetrafluorinated Thalidomide Analogues. Mol Cancer Ther  14, 2228-37.   https://doi.org/10.1158/1535-7163.MCT-15-0320|3. Chau CH, O'Keefe BR, Figg WD (2016). The canSAR data hub for drug discovery. Lancet Oncol  17, 286.   https://doi.org/10.1016/S1470-2045(16)00095-4|4. Fernandez EV, Reece KM, Ley AM, Troutman SM, Sissung TM, Price DK, Chau CH, Figg WD (2015). Dual targeting of the androgen receptor and hypoxia-inducible factor 1α pathways synergistically inhibits castration-resistant prostate cancer cells. Mol Pharmacol  87, 1006-12.   https://doi.org/10.1124/mol.114.097477|5. Ley AM, Chau CH, Figg WD (2015). Structural studies reveal thalidomide's mechanism of action and clinical effects: crystal clear or clearly complexed? Cancer Biol Ther  16, 19-20.   https://doi.org/10.4161/15384047.2014.972828|6. Madan RA, Karzai FH, Ning YM, Adesunloye BA, Huang X, Harold N, Couvillon A, Chun G, Cordes L, Sissung T, Beedie SL, Dawson NA, Theoret MR, McLeod DG, Rosner I, Trepel JB, Lee MJ, Tomita Y, Lee S, Chen C, Steinberg SM, Arlen PM, Gulley JL, Figg WD, Dahut WL (2016). Phase II trial of docetaxel, bevacizumab, lenalidomide and prednisone in patients with metastatic castration-resistant prostate cancer. BJU Int  118, 590-7.   https://doi.org/10.1111/bju.13412",https://intramural.nih.gov/search/searchview.taf?ipid=94384
644,SC006663-27,"October 01, 2015 -  September 30, 2016",Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer,David  Danforth,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",NULL,NULL,"Armando  Filie (Laboratory of Pathology)|Karl Thomas Ried; MD (Cancer Genetics Branch)|Mark H Greene; MD (Clinical Genetics Branch)|Maria  Merino; PhD (Laboratory of Pathology)|David Erwin Kleiner; MD, PhD (Laboratory of Pathology)|Sheila Ann Prindiville (Office Of The Director)",NULL,"1. Danforth D (2016) Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer. Breast Cancer:Basic and Clinical Research, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=94386
645,SC006737-25,"October 01, 2015 -  September 30, 2016",Development of Novel Therapies for HIV Infection,Robert  Yarchoan; MD|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI",David A Davis; MD|Hiroaki  Mitsuya,NULL,"George N Pavlakis; MD, PhD (Vaccine Branch)|Eric O Freed; PhD (HIV Drug Resistance Program)|Marjorie  Robert-Guroff; PhD (Vaccine Branch)|Stephen H Hughes; PhD (Retroviral Replication Laboratory)|Frank  Maldarelli (Host Virus Interaction Branch)",Paul T Wingfield; PhD (NIAMS),"1. Yarchoan R (2015) HIV and KSHV-Related Cancers: Diseases at the Crossroads of Virology, Immunology, and Cell Biology Microbe 10:157-162",https://intramural.nih.gov/search/searchview.taf?ipid=94388
646,SC006738-25,"October 01, 2015 -  September 30, 2016",Development of Antiviral Therapy of HIV-1 Infection,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI",Robert  Yarchoan; MD,"Arun  Ghosh|Yasuhiro  Koh (Kumamoto University School of Medicine)|Masayuki  Amano (Kumamoto University School of Medicine)|Eiichi  Kodama (Kyoto University)|Irene  Weber (Department of Biology, Georgia State University)|Anderson  Karen (Yale University School of Medicine)|Show all 9",NULL,Paul T Wingfield; PhD (NIAMS),"1. Amano M, Tojo Y, Salcedo-Gómez PM, Parham GL, Nyalapatla PR, Das D, Ghosh AK, Mitsuya H (2015). A novel tricyclic ligand-containing nonpeptidic HIV-1 protease inhibitor, GRL-0739, effectively inhibits the replication of multidrug-resistant HIV-1 variants and has a desirable central nervous system penetration property in vitro. Antimicrob Agents Chemother  59, 2625-35.   https://doi.org/10.1128/AAC.04757-14|2. Aoki M, Hayashi H, Yedidi RS, Martyr CD, Takamatsu Y, Aoki-Ogata H, Nakamura T, Nakata H, Das D, Yamagata Y, Ghosh AK, Mitsuya H (2015). C-5-Modified Tetrahydropyrano-Tetrahydofuran-Derived Protease Inhibitors (PIs) Exert Potent Inhibition of the Replication of HIV-1 Variants Highly Resistant to Various PIs, including Darunavir. J Virol  90, 2180-94.   https://doi.org/10.1128/JVI.01829-15|3. Das D, Maeda K, Hayashi Y, Gavande N, Desai DV, Chang SB, Ghosh AK, Mitsuya H (2015). Insights into the mechanism of inhibition of CXCR4: identification of Piperidinylethanamine analogs as anti-HIV-1 inhibitors. Antimicrob Agents Chemother  59, 1895-904.   https://doi.org/10.1128/AAC.04654-14|4. Ghosh AK, Martyr CD, Kassekert LA, Nyalapatla PR, Steffey M, Agniswamy J, Wang YF, Weber IT, Amano M, Mitsuya H (2015) Design, synthesis, biological evaluation and X-ray structural studies of HIV-1 protease inhibitors containing substituted fused-tetrahydropyranyl tetrahydrofuran as P2-ligands. Org Biomol Chem 13:11607-21|5. Ghosh AK, Martyr CD, Osswald HL, Sheri VR, Kassekert LA, Chen S, Agniswamy J, Wang YF, Hayashi H, Aoki M, Weber IT, Mitsuya H (2015). Design of HIV-1 Protease Inhibitors with Amino-bis-tetrahydrofuran Derivatives as P2-Ligands to Enhance Backbone-Binding Interactions: Synthesis, Biological Evaluation, and Protein-Ligand X-ray Studies. J Med Chem  58, 6994-7006.   https://doi.org/10.1021/acs.jmedchem.5b00900|6. Ghosh AK, Osswald HL, Glauninger K, Agniswamy J, Wang YF, Hayashi H, Aoki M, Weber IT, Mitsuya H (2016). Probing Lipophilic Adamantyl Group as the P1-Ligand for HIV-1 Protease Inhibitors: Design, Synthesis, Protein X-ray Structural Studies, and Biological Evaluation. J Med Chem  59, 6826-37.   https://doi.org/10.1021/acs.jmedchem.6b00639|7. Ghosh AK, Takayama J, Kassekert LA, Ella-Menye JR, Yashchuk S, Agniswamy J, Wang YF, Aoki M, Amano M, Weber IT, Mitsuya H (2015). Structure-based design, synthesis, X-ray studies, and biological evaluation of novel HIV-1 protease inhibitors containing isophthalamide-derived P2-ligands. Bioorg Med Chem Lett  25, 4903-4909.   https://doi.org/10.1016/j.bmcl.2015.05.052|8. Ghosh AK, Yashchuk S, Mizuno A, Chakraborty N, Agniswamy J, Wang YF, Aoki M, Gomez PM, Amano M, Weber IT, Mitsuya H (2015). Design of gem-difluoro-bis-tetrahydrofuran as P2 ligand for HIV-1 protease inhibitors to improve brain penetration: synthesis, X-ray studies, and biological evaluation. ChemMedChem  10, 107-15.   https://doi.org/10.1002/cmdc.201402358|9. Ghosh AK, Yu X, Osswald HL, Agniswamy J, Wang YF, Amano M, Weber IT, Mitsuya H (2015). Structure-based design of potent HIV-1 protease inhibitors with modified P1-biphenyl ligands: synthesis, biological evaluation, and enzyme-inhibitor X-ray structural studies. J Med Chem  58, 5334-43.   https://doi.org/10.1021/acs.jmedchem.5b00676",https://intramural.nih.gov/search/searchview.taf?ipid=94371
647,SC006741-24,"October 01, 2015 -  September 30, 2016",Lymphoma Studies,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,NULL,"Louis  Staudt; MD (Lymphoid Malignancies Branch)|Elaine S Jaffe; MD (Laboratory of Pathology)|Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology)","Adrian U Wiestner; MD, PhD (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94372
648,SC006891-28,"October 01, 2015 -  September 30, 2016",Clinical Studies in Pediatric Solid Tumors,Lee Jay Helman; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Fernanda  Arnaldez|Christine Marie Heske|Brigitte  Widemann; MD,Katherine  Janeway (Dana Farber Cancer Institute)|Alberto  Pappo (St Jude Children's Research Hospital),"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Jonathan Keith Killian (Cancer Genetics Branch)","Constantine Argyrios Stratakis; MD, DSc (NICHD)","1. Pappo AS, Furman WL, Schultz KA, Ferrari A, Helman L, Krailo MD (2015). Rare Tumors in Children: Progress Through Collaboration. J Clin Oncol  33, 3047-54.   https://doi.org/10.1200/JCO.2014.59.3632|2. Wan X, Yeung C, Heske C, Mendoza A, Helman LJ (2015). IGF-1R Inhibition Activates a YES/SFK Bypass Resistance Pathway: Rational Basis for Co-Targeting IGF-1R and Yes/SFK Kinase in Rhabdomyosarcoma. Neoplasia  17, 358-66.   https://doi.org/10.1016/j.neo.2015.03.001",https://intramural.nih.gov/search/searchview.taf?ipid=94389
649,SC006892-28,"October 01, 2015 -  September 30, 2016",Molecular Biology of Pediatric Tumors,Lee Jay Helman; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Fernanda  Arnaldez|Joshua Tanner Baumgart,Katherine  Janeway (Dana Farber Cancer Institute)|Alberto  Pappo (St Jude Children's Research Hospital),"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Jonathan Keith Killian (Cancer Genetics Branch)|Louis  Staudt; MD (Lymphoid Malignancies Branch)|Natasha  Caplen (Cancer Genetics Branch)|Leonard  Neckers; PhD (Urologic Oncology Branch)","Constantine Argyrios Stratakis; MD, DSc (NICHD) |Karel  Pacak; MD, PhD (NICHD)","1. Boikos SA, Xekouki P, Fumagalli E, Faucz FR, Raygada M, Szarek E, Ball E, Kim SY, Miettinen M, Helman LJ, Carney JA, Pacak K, Stratakis CA (2016). Carney triad can be (rarely) associated with germline succinate dehydrogenase defects. Eur J Hum Genet  24, 569-73.   https://doi.org/10.1038/ejhg.2015.142|2. Osgood CL, Maloney N, Kidd CG, Kitchen-Goosen S, Segars L, Gebregiorgis M, Woldemichael GM, He M, Sankar S, Lessnick SL, Kang M, Smith M, Turner L, Madaj ZB, Winn ME, Núñez LE, González-Sabín J, Helman LJ, Morís F, Grohar PJ (2016). Identification of Mithramycin Analogues with Improved Targeting of the EWS-FLI1 Transcription Factor. Clin Cancer Res  22, 4105-18.   https://doi.org/10.1158/1078-0432.CCR-15-2624|3. Pappo AS, Furman WL, Schultz KA, Ferrari A, Helman L, Krailo MD (2015). Rare Tumors in Children: Progress Through Collaboration. J Clin Oncol  33, 3047-54.   https://doi.org/10.1200/JCO.2014.59.3632|4. Wan X, Yeung C, Heske C, Mendoza A, Helman LJ (2015). IGF-1R Inhibition Activates a YES/SFK Bypass Resistance Pathway: Rational Basis for Co-Targeting IGF-1R and Yes/SFK Kinase in Rhabdomyosarcoma. Neoplasia  17, 358-66.   https://doi.org/10.1016/j.neo.2015.03.001",https://intramural.nih.gov/search/searchview.taf?ipid=94390
650,SC007263-24,"October 01, 2015 -  September 30, 2016",TRAIL-induced Cell Death in Breast Cancer Cells,"Stanley  Lipkowitz; MD, PhD|IRP Faculty Profile",NULL,"Womens Malignancies Branch, NCI",Samuel Fredrick Gilbert; MPH|Yoshimi Endo Greer|Celia Shoily Islam|David Sam Kotlyar; MD|Donna M Voeller,Mauricio A Cuello|Sandra M Swain; MD|David  Tice (MedImmune),"Natasha  Caplen (Cancer Genetics Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Anand S Merchant (Office of the Director)",Markus  Hafner (NIAMS) |Madhu A Lal (NCATS),"1. Dine JL, O'Sullivan CC, Voeller D, Greer YE, Chavez KJ, Conway CM, Sinclair S, Stone B, Amiri-Kordestani L, Merchant AS, Hewitt SM, Steinberg SM, Swain SM, Lipkowitz S (2016). The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl. Breast Cancer Res Treat  155, 235-51.   https://doi.org/10.1007/s10549-015-3673-z",https://intramural.nih.gov/search/searchview.taf?ipid=94391
651,SC007281-23,"October 01, 2015 -  September 30, 2016",Nitric Oxide as a Modifier of Oxidative Stress,David Anderson Wink|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",NULL,NULL,Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Stefan  Ambs (Laboratory of Human Carcinogenesis)|Terry  Moody; PhD (Office of the Director)|James B Mitchell; PhD (Radiation Biology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94392
652,SC009144-32,"October 01, 2015 -  September 30, 2016",Mechanisms of transcription factor integration at the c-myc promoter,David  Levens; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Laura  Baranello|Fedor Edmundovich Kouzine|Zuqin  Nie; PhD|Suzanne Laurie Sanford|Lipeng  Wu|Ying  Zheng,NULL,"Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Louis  Staudt; MD (Lymphoid Malignancies Branch)",Keji  Zhao; PhD (NHLBI) |Rafael Cristian Casellas; PhD (NIAMS) |Teresa M Przytycka (NLM),"1. Baranello L, Wojtowicz D, Cui K, Devaiah BN, Chung HJ, Chan-Salis KY, Guha R, Wilson K, Zhang X, Zhang H, Piotrowski J, Thomas CJ, Singer DS, Pugh BF, Pommier Y, Przytycka TM, Kouzine F, Lewis BA, Zhao K, Levens D (2016). RNA Polymerase II Regulates Topoisomerase 1 Activity to Favor Efficient Transcription. Cell  165, 357-71.   https://doi.org/10.1016/j.cell.2016.02.036|2. Guo L, Zaysteva O, Nie Z, Mitchell NC, Amanda Lee JE, Ware T, Parsons L, Luwor R, Poortinga G, Hannan RD, Levens DL, Quinn LM (2016). Defining the essential function of FBP/KSRP proteins: Drosophila Psi interacts with the mediator complex to modulate MYC transcription and tissue growth. Nucleic Acids Res  44, 7646-58.   https://doi.org/10.1093/nar/gkw461|3. Jin W, Tang Q, Wan M, Cui K, Zhang Y, Ren G, Ni B, Sklar J, Przytycka TM, Childs R, Levens D, Zhao K (2015). Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples. Nature  528, 142-6.   https://doi.org/10.1038/nature15740",https://intramural.nih.gov/search/searchview.taf?ipid=94393
653,SC009172-28,"October 01, 2015 -  September 30, 2016",Cellular Interactions with Thrombospondin,David D Roberts; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Rajdeep  Banerjee|Sukhbir  Kaur|Laurence  Lamy|Elizabeth Chase Lessey-Morillon; PhD|Anthony Lee Schwartz; PhD|John M Sipes|Show all 11,NULL,"David Anderson Wink (Cancer Inflammation Program)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Susan H Garfield (Laboratory of Cancer Biology and Genetics)",Abdel G Elkahloun; PhD (NHGRI) |Chengyu  Liu; PhD (NHLBI) |Satya P Singh; PhD (NIAID),"1. Miller TW, Soto-Pantoja DR, Schwartz AL, Sipes JM, DeGraff WG, Ridnour LA, Wink DA, Roberts DD (2015). CD47 Receptor Globally Regulates Metabolic Pathways That Control Resistance to Ionizing Radiation. J Biol Chem  290, 24858-74.   https://doi.org/10.1074/jbc.M115.665752|2. Stein EV, Miller TW, Ivins-O'Keefe K, Kaur S, Roberts DD (2016). Secreted Thrombospondin-1 Regulates Macrophage Interleukin-1β Production and Activation through CD47. Sci Rep  6, 19684.   https://doi.org/10.1038/srep19684",https://intramural.nih.gov/search/searchview.taf?ipid=94367
654,SC009173-28,"October 01, 2015 -  September 30, 2016",Host Colonization and Vascular Dissemination of Candida albicans,David D Roberts; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",John M Sipes,NULL,NULL,Martin J Lizak; PhD (NINDS) |Jeeva P Munasinghe (NINDS) |Michail S Lionakis (NIAID),"1. Navarathna DH, Roberts DD, Munasinghe J, Lizak MJ (2016). Imaging Candida Infections in the Host. Methods Mol Biol  1356, 69-78.   https://doi.org/10.1007/978-1-4939-3052-4_6",https://intramural.nih.gov/search/searchview.taf?ipid=94368
655,SC009174-28,"October 01, 2015 -  September 30, 2016",Roles of Glycoconjugates and Redox Signaling in Tumor Biology,David D Roberts; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Anthony Lee Schwartz; PhD|John M Sipes|David Ricardo Soto Pantoja; PhD,Jeff  Isenberg (University of Pittsburgh)|Lijuan  Zhang (Ocean University)|Douglas  Thomas (University of Illinois at Chicago),David Anderson Wink (Cancer Inflammation Program),NULL,"1. Miller TW, Soto-Pantoja DR, Schwartz AL, Sipes JM, DeGraff WG, Ridnour LA, Wink DA, Roberts DD (2015). CD47 Receptor Globally Regulates Metabolic Pathways That Control Resistance to Ionizing Radiation. J Biol Chem  290, 24858-74.   https://doi.org/10.1074/jbc.M115.665752|2. Thomas DD, Heinecke JL, Ridnour LA, Cheng RY, Kesarwala AH, Switzer CH, McVicar DW, Roberts DD, Glynn S, Fukuto JM, Wink DA, Miranda KM (2015). Signaling and stress: The redox landscape in NOS2 biology. Free Radic Biol Med  87, 204-25.   https://doi.org/10.1016/j.freeradbiomed.2015.06.002",https://intramural.nih.gov/search/searchview.taf?ipid=94366
656,SC009179-28,"October 01, 2015 -  September 30, 2016","The Role of TIMPs in Cell Growth, Tumor Progression and Metastasis","William G Stetler-Stevenson; MD, PhD|IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI",Ananda  Chowdhury; PhD|Sandra  Jensen-Taubman|Sarvesh  Kumar|David  Peeney; PhD,NULL,"Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)",NULL,"1. Dunn DM, Woodford MR, Truman AW, Jensen SM, Schulman J, Caza T, Remillard TC, Loiselle D, Wolfgeher D, Blagg BS, Franco L, Haystead TA, Daturpalli S, Mayer MP, Trepel JB, Morgan RM, Prodromou C, Kron SJ, Panaretou B, Stetler-Stevenson WG, Landas SK, Neckers L, Bratslavsky G, Bourboulia D, Mollapour M (2015). c-Abl Mediated Tyrosine Phosphorylation of Aha1 Activates Its Co-chaperone Function in Cancer Cells. Cell Rep  12, 1006-18.   https://doi.org/10.1016/j.celrep.2015.07.004|2. Kumar S, Malhotra S, Prasad AK, Van der Eycken EV, Bracke ME, Stetler-Stevenson WG, Parmar VS, Ghosh B (2015). Anti-inflammatory and antioxidant properties of Piper species: a perspective from screening to molecular mechanisms. Curr Top Med Chem  15, 886-93.   https://doi.org/10.2174/1568026615666150220120651",https://intramural.nih.gov/search/searchview.taf?ipid=94394
657,SC009389-23,"October 01, 2015 -  September 30, 2016",A Mitogen-induced G Protein-coupled Receptor,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Juanjuan  Yin,NULL,Sheueyann  Cheng; PhD (Gene Regulation Section)|Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94395
658,SC010051-21,"October 01, 2015 -  September 30, 2016",Metal Chelate Conjugated Dendrimer Constructs for Diagnosis and Therapy,Martin W Brechbiel; PhD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",NULL,NULL,NULL,Lacy Henry Bryant (CC) |Daniel  Appella; PhD (NIDDK),"1. Kim YS, Zhou Y, Bryant H, Milenic DE, Baidoo KE, Lewis BK, Frank JA, Brechbiel MW (2015). Synthesis and characterization of gadolinium-Peptidomimetic complex as an αvβ3 integrin targeted MR contrast agent. Bioorg Med Chem Lett  25, 2056-9.   https://doi.org/10.1016/j.bmcl.2015.03.092",https://intramural.nih.gov/search/searchview.taf?ipid=94396
659,SC010074-21,"October 01, 2015 -  September 30, 2016",Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction,Leonard  Neckers; PhD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",NULL,"YunJin  Jung (Pusan National University)|Brian  Blagg (Chemistry, University of Kansas)|David  Toft (Cell Biology, Mayo Clinic)|Larry  Karnitz (Mayo Clinic)|Robert  Cotter (Johns Hopkins University)|Neal  Rosen (Medicine, Memorial Sloan Kettering Cancer Center)|Show all 12",NULL,NULL,"1. Lu Y, Xu W, Ji J, Feng D, Sourbier C, Yang Y, Qu J, Zeng Z, Wang C, Chang X, Chen Y, Mishra A, Xu M, Lee MJ, Lee S, Trepel J, Linehan WM, Wang X, Yang Y, Neckers L (2015). Alternative splicing of the cell fate determinant Numb in hepatocellular carcinoma. Hepatology  62, 1122-31.   https://doi.org/10.1002/hep.27923|2. Prince TL, Kijima T, Tatokoro M, Lee S, Tsutsumi S, Yim K, Rivas C, Alarcon S, Schwartz H, Khamit-Kush K, Scroggins BT, Beebe K, Trepel JB, Neckers L (2015). Client Proteins and Small Molecule Inhibitors Display Distinct Binding Preferences for Constitutive and Stress-Induced HSP90 Isoforms and Their Conformationally Restricted Mutants. PLoS One  10, e0141786.   https://doi.org/10.1371/journal.pone.0141786|3. Sattin S, Tao J, Vettoretti G, Moroni E, Pennati M, Lopergolo A, Morelli L, Bugatti A, Zuehlke A, Moses M, Prince T, Kijima T, Beebe K, Rusnati M, Neckers L, Zaffaroni N, Agard DA, Bernardi A, Colombo G (2015). Activation of Hsp90 Enzymatic Activity and Conformational Dynamics through Rationally Designed Allosteric Ligands. Chemistry  21, 13598-608.   https://doi.org/10.1002/chem.201502211|4. Schwartz H, Scroggins B, Zuehlke A, Kijima T, Beebe K, Mishra A, Neckers L, Prince T (2015). Combined HSP90 and kinase inhibitor therapy: Insights from The Cancer Genome Atlas. Cell Stress Chaperones  20, 729-41.   https://doi.org/10.1007/s12192-015-0604-1|5. Zuehlke AD, Beebe K, Neckers L, Prince T (2015). Regulation and function of the human HSP90AA1 gene. Gene  570, 8-16.   https://doi.org/10.1016/j.gene.2015.06.018",https://intramural.nih.gov/search/searchview.taf?ipid=94397
660,SC010093-20,"October 01, 2015 -  September 30, 2016",Epigenetic Therapy for Thoracic Malignanceis,David  Schrump; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Colleen Donahue Bond|Julie A Hong|Mahadev  Rao|Mary R Zhang,"Nasser  Altorki (Thoracic Surgery, Cornell University Medical Center)|Xinmin  Li (Functional Genomics, University of Chicago)|Sacha  Ghnatic (Ludwig Cancer Inst)",William D Figg; PharmD (Genitourinary Malignancies Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94374
661,SC010098-14,"October 01, 2015 -  September 30, 2016",The Evaluation of Novel Therapeutics for Genitourinary Malignancies,William Laurence Dahut; MD|IRP Faculty Profile,NULL,"Genitourinary Malignancies Branch, NCI",Philip M Arlen; MD|Anna C Couvillon; NP|Ravi  Madan,Phil  Kantoff (DFCI)|Joseph  KIm (Yale),"William Marston Linehan; MD (Urologic Oncology Branch)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Peter L Choyke; MD (Molecular Imaging Program)|Deborah E Citrin (Radiation Oncology Branch)",NULL,"1. Madan RA, Gulley JL, Dahut WL (2016). Radium-223 in prostate cancer: emitting the right signals. Lancet Oncol  17, 1186-7.   https://doi.org/10.1016/S1470-2045(16)30248-0",https://intramural.nih.gov/search/searchview.taf?ipid=94415
662,SC010282-19,"October 01, 2015 -  September 30, 2016",Cytogenetic Studies of B-cell Chronic Lymphocytic Leukemia (B-CLL),Diane Carol Arthur; MD,Frederic Glenn Barr,"Laboratory of Pathology, NCI","Maryalice  Stetler-Stevenson; MD, PhD",NULL,"Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)","Gerald Ernest Marti (NHLBI) |Adrian U Wiestner; MD, PhD (NHLBI) |Mohammed Zulfiqar Farooqui; DO (NHLBI)","1. Farooqui MZ, Valdez J, Martyr S, Aue G, Saba N, Niemann CU, Herman SE, Tian X, Marti G, Soto S, Hughes TE, Jones J, Lipsky A, Pittaluga S, Stetler-Stevenson M, Yuan C, Lee YS, Pedersen LB, Geisler CH, Calvo KR, Arthur DC, Maric I, Childs R, Young NS, Wiestner A (2015). Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial. Lancet Oncol  16, 169-76.   https://doi.org/10.1016/S1470-2045(14)71182-9",https://intramural.nih.gov/search/searchview.taf?ipid=94398
663,SC010288-19,"October 01, 2015 -  September 30, 2016",Th1-Th2 and Tc1-Tc2 T Cell Subsets in Transplantation Therapy,Daniel H Fowler,NULL,"Experimental Transplantation and Immunology Branch, NCI","Ronald E Gress; MD|Steven  Pavletic; MD, MS|Frances  Hakim; PhD","Carl  June (University of Penn)|Bruce  Levine (Abramson Family Cancer Research Center, University of Pennsylvania)|Robert  Korngold (Cancer Center, Hackensack University)|Scott  Rowley (Hackensack University)|David  Vesole (Georgetown University)",NULL,David F Stroncek; MD (CC) |Hanh M Khuu; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94399
664,SC010354-17,"October 01, 2015 -  September 30, 2016",Clinical Development of Novel Drugs for Children with Refractory Cancers,Brigitte  Widemann; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Diana Louise Bradford|Diane  Cole|Eva  Dombi|Nalini M Jayaprakash|Robert F Murphy|Lee Jay Helman; MD,"John  Perentesis (Pediatric Oncology, Cincinnati Children's Hospital)|AeRang  Kim (Children's National Medical Center)","Karlyne M Reilly; BS, PhD (Office of the Director)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|William Marston Linehan; MD (Urologic Oncology Branch)|Alice Pinting Chen (Office of the Director)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Kieron Michael Dunleavy (Lymphoid Malignancies Branch)",NULL,"1. Kim A, Widemann BC, Krailo M, Jayaprakash N, Fox E, Weigel B, Blaney SM (2015). Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group. Pediatr Blood Cancer  62, 1562-6.   https://doi.org/10.1002/pbc.25548|2. Lodish M, Gkourogianni A, Bornstein E, Sinaii N, Fox E, Chuk M, Marcus L, Akshintala S, Balis F, Widemann B, Stratakis CA (2015). Patterns of thyroid hormone levels in pediatric medullary thyroid carcinoma patients on vandetanib therapy. Int J Pediatr Endocrinol  2015, 3.   https://doi.org/10.1186/1687-9856-2015-3|3. Stieglitz E, Ward AF, Gerbing RB, Alonzo TA, Arceci RJ, Liu YL, Emanuel PD, Widemann BC, Cheng JW, Jayaprakash N, Balis FM, Castleberry RP, Bunin NJ, Loh ML, Cooper TM (2015). Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology Group. Pediatr Blood Cancer  62, 629-36.   https://doi.org/10.1002/pbc.25342|4. Widemann BC (2015). Practical considerations for the administration of glucarpidase in high-dose methotrexate (HDMTX) induced renal dysfunction. Pediatr Blood Cancer  62, 1512-3.   https://doi.org/10.1002/pbc.25577",https://intramural.nih.gov/search/searchview.taf?ipid=94400
665,SC010355-17,"October 01, 2015 -  September 30, 2016",Angiogenesis and Tumor Growth,Giovanna  Tosato; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",NULL,Maria  Cid (Univ. of Barcelona Medical School)|Catherine  Porcher (Oxford Univ)|Amparo  Acher-Palmer (University of Frankfurt)|Shushang  Wang (Univ. Texas Southwestern Med Center)|Elena  Pasquale (Burnham Inst),Elaine S Jaffe; MD (Laboratory of Pathology)|David A Davis; MD (HIV and AIDS Malignancy Branch)|Stefania  Pittaluga (Laboratory of Pathology)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Ira  Daar; PhD (Cancer and Developmental Biology Laboratory),Manfred  Boehm; MD (NHLBI) |Yosuke  Mukoyama; PhD (NHLBI),"1. Chen II, Caprioli A, Ohnuki H, Kwak H, Porcher C, Tosato G (2016). EphrinB2 regulates the emergence of a hemogenic endothelium from the aorta. Sci Rep  6, 27195.   https://doi.org/10.1038/srep27195|2. Salvucci O, Ohnuki H, Maric D, Hou X, Li X, Yoon SO, Segarra M, Eberhart CG, Acker-Palmer A, Tosato G (2015). EphrinB2 controls vessel pruning through STAT1-JNK3 signalling. Nat Commun  6, 6576.   https://doi.org/10.1038/ncomms7576",https://intramural.nih.gov/search/searchview.taf?ipid=94401
666,SC010356-17,"October 01, 2015 -  September 30, 2016",A Role for KSHV in the Pathogenesis of Malignancies,Giovanna  Tosato; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",NULL,Frederick  Wang (Harvard Univ)|Stefan  Rose-John (Univ. of Kiel),Elaine S Jaffe; MD (Laboratory of Pathology)|David A Davis; MD (HIV and AIDS Malignancy Branch)|Stefania  Pittaluga (Laboratory of Pathology)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Thomas S Uldrick (HIV and AIDS Malignancy Branch),Manfred  Boehm; MD (NHLBI),"1. Espígol-Frigolé G, Planas-Rigol E, Ohnuki H, Salvucci O, Kwak H, Ravichandran S, Luke B, Cid MC, Tosato G (2016). Identification of IL-23p19 as an endothelial proinflammatory peptide that promotes gp130-STAT3 signaling. Sci Signal  9, ra28.   https://doi.org/10.1126/scisignal.aad2357",https://intramural.nih.gov/search/searchview.taf?ipid=94402
667,SC010357-17,"October 01, 2015 -  September 30, 2016",Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses,"Zhi Ming  Zheng; MD, PhD|IRP Faculty Profile",NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",NULL,"Craig  Meyers (Microbiology and Immunology, Penn State University College of Medicine)|Louise T Chow|Xing  Xie (Zhejiang University)|Thomas  Tuschl (Rockefeller University)",Michael John Kruhlak; PhD (Experimental Immunology Branch),Jun  Zhu; PhD (NHLBI),"1. Ajiro M, Jia R, Wang RH, Deng CX, Zheng ZM (2015). Adapted Resistance to the Knockdown Effect of shRNA-Derived Srsf3 siRNAs in Mouse Littermates. Int J Biol Sci  11, 1248-56.   https://doi.org/10.7150/ijbs.13011|2. Ajiro M, Zheng ZM (2015). E6^E7, a novel splice isoform protein of human papillomavirus 16, stabilizes viral E6 and E7 oncoproteins via HSP90 and GRP78. MBio  6, e02068-14.   https://doi.org/10.1128/mBio.02068-14|3. Ajiro M, Zheng ZM (2015). Vemurafenib-resistant BRAF selects alternative branch points different from its wild-type BRAF in intron 8 for RNA splicing. Cell Biosci  5, 70.   https://doi.org/10.1186/s13578-015-0061-7|4. Majerciak V, Pripuzova N, Chan C, Temkin N, Specht SI, Zheng ZM (2015). Stability of structured Kaposi's sarcoma-associated herpesvirus ORF57 protein is regulated by protein phosphorylation and homodimerization. J Virol  89, 3256-74.   https://doi.org/10.1128/JVI.03721-14|5. Majerciak V, Zheng ZM (2015). KSHV ORF57, a protein of many faces. Viruses  7, 604-33.   https://doi.org/10.3390/v7020604|6. Massimelli MJ, Majerciak V, Kang JG, Liewehr DJ, Steinberg SM, Zheng ZM (2015). Multiple regions of Kaposi's sarcoma-associated herpesvirus ORF59 RNA are required for its expression mediated by viral ORF57 and cellular RBM15. Viruses  7, 496-510.   https://doi.org/10.3390/v7020496",https://intramural.nih.gov/search/searchview.taf?ipid=94403
668,SC010366-16,"October 01, 2015 -  September 30, 2016",Identification of Genes for Predicting Prognosis in Pediatric Cancers,Javed  Khan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",NULL,"John  Maris (Pharmacology, Children's Hospital of Philadelphia)|Peter  Ambros (Children’s Cancer Research Institute)|Daniel  Catchpoole (The Children's Hospital at Westmead)|Robert  Seeger (Division of Pediatric Hematology-Oncology, Children's Hospital of Los Angeles)",Carol J Thiele (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94404
669,SC010372-16,"October 01, 2015 -  September 30, 2016",Molecular Profiling of Patients Undergoing Radiotherapy,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94405
670,SC010373-16,"October 01, 2015 -  September 30, 2016",The Synergy Between Radiotherapy and Molecularly Targeted Agents,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",NULL,NULL,NULL,NULL,"1. Gordon IK, Lu J, Graves CA, Huntoon K, Frerich JM, Hanson RH, Wang X, Hong CS, Ho W, Feldman MJ, Ikejiri B, Bisht K, Chen XS, Tandle A, Yang C, Arscott WT, Ye D, Heiss JD, Lonser RR, Camphausen K, Zhuang Z (2015). Protein Phosphatase 2A Inhibition with LB100 Enhances Radiation-Induced Mitotic Catastrophe and Tumor Growth Delay in Glioblastoma. Mol Cancer Ther  14, 1540-1547.   https://doi.org/10.1158/1535-7163.MCT-14-0614|2. Maachani UB, Kramp T, Hanson R, Zhao S, Celiku O, Shankavaram U, Colombo R, Caplen NJ, Camphausen K, Tandle A (2015). Targeting MPS1 Enhances Radiosensitization of Human Glioblastoma by Modulating DNA Repair Proteins. Mol Cancer Res  13, 852-62.   https://doi.org/10.1158/1541-7786.MCR-14-0462-T|3. Maachani UB, Tandle A, Shankavaram U, Kramp T, Camphausen K (2016). Modulation of miR-21 signaling by MPS1 in human glioblastoma. Oncotarget  7, 52912-52927.   https://doi.org/10.18632/oncotarget.4143|4. Tandle A, Camphausen K (2016). Mitotic Protein Kinase 1: Role in Spindle Assembly Checkpoint Revisited. J Cancer Clin Trials  1.",https://intramural.nih.gov/search/searchview.taf?ipid=94406
671,SC010375-16,"October 01, 2015 -  September 30, 2016",TAF7: A Check-point Regulator in Transcription Initiation,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Dan  Cheng|Anne G M Gegonne Bosselut,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94407
672,SC010376-16,"October 01, 2015 -  September 30, 2016","TNF Signaling, Cell Death and Cancer",Zhenggang  Liu; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Zhenyu  Cai|Swati Suresh Choksi|Jonathan  Jang|Chamila Charthuranga Kadigamuwa|Qing  Xu; MD|Anling  Zhang,"Xuemin  Zhang|Brian  Rowan (School of Medicine, Tulane University)|Jennifer  Yu (Cleveland Clinic)",NULL,Richard James Youle; PhD (NINDS) |Chengyu  Liu; PhD (NHLBI),"1. Cai Z, Zhang A, Choksi S, Li T, Zhang X, Liu Z (2016) Activation of cell surface protease promotes necroptosis, inflammation and cell migration. Cell research, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=94408
673,SC010378-16,"October 01, 2015 -  September 30, 2016",Activation of Proto-Oncogenes by Chromosomal Translocation,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Trevor Stephen Barlowe|Yang-Jo  Chung|Joseph  Dufraine; PhD|Liat Hava Goldberg-Cooks|Subhadip  Kundu|Masahiro  Onozawa|Show all 9,"Trang  Hoang (U. Montreal)|Adolfo  Ferrando (Genetics, Columbia U.)",David  Levens; PhD (Laboratory of Pathology),NULL,"1. Cui Y, Onozawa M, Garber HR, Samsel L, Wang Z, McCoy JP, Burkett S, Wu X, Aplan PD, Mackall CL (2015). Thymic expression of a T-cell receptor targeting a tumor-associated antigen coexpressed in the thymus induces T-ALL. Blood  125, 2958-67.   https://doi.org/10.1182/blood-2014-10-609271|2. Fry TJ, Aplan PD (2015). A robust in vivo model for B cell precursor acute lymphoblastic leukemia. J Clin Invest  125, 3427-9.   https://doi.org/10.1172/JCI83799",https://intramural.nih.gov/search/searchview.taf?ipid=94409
674,SC010379-16,"October 01, 2015 -  September 30, 2016",Mechanisms of Chromosomal Translocation,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Liat Hava Goldberg-Cooks|Masahiro  Onozawa|Mianmian  Yin|Zhenhua  Zhang,NULL,NULL,NULL,"1. Onozawa M, Goldberg L, Aplan PD (2015). Landscape of insertion polymorphisms in the human genome. Genome Biol Evol  7, 960-8.   https://doi.org/10.1093/gbe/evv043",https://intramural.nih.gov/search/searchview.taf?ipid=94410
675,SC010384-16,"October 01, 2015 -  September 30, 2016",Hematopoietic Stem Cell Gene Therapy for Leukocyte Adhesion Deficiency,Dennis D Hickstein|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Thomas R Bauer,David  Russell (University of Washington)|Punam  Malik,NULL,Harry Lewis Malech; MD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94411
676,BC010906-09,"October 01, 2015 -  September 30, 2016",Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy,"Thomas Alexander Waldmann; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Nancy  Beltran|Bonita R Bryant|Kevin Charles Conlon|Sigrid Priscilla Dubois|Cathryn C Lee|Liyanage P Perera; PhD|Show all 11,"Nicole  Urquhart (Dept of, University of the West Indies)|Joseph  Murray (Department of Gastroenterology, Mayo Clinic)|Jeffrey  Miller (University of Minnesota)","Jason L Yovandich (Biological Resources Branch)|Stephen  Creekmore; PhD (Biological Resources Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",NULL,"1. Parra M, Liu X, Derrick SC, Yang A, Molina-Cruz A, Barillas-Mury C, Zheng H, Thao Pham P, Sedegah M, Belmonte A, Litilit DD, Waldmann TA, Kumar S, Morris SL, Perera LP (2015). Co-expression of Interleukin-15 Enhances the Protective Immune Responses Induced by Immunization with a Murine Malaria MVA-Based Vaccine Encoding the Circumsporozoite Protein. PLoS One  10, e0141141.   https://doi.org/10.1371/journal.pone.0141141|2. Pilipow K, Roberto A, Roederer M, Waldmann TA, Mavilio D, Lugli E (2015). IL15 and T-cell Stemness in T-cell-Based Cancer Immunotherapy. Cancer Res  75, 5187-5193.   https://doi.org/10.1158/0008-5472.CAN-15-1498|3. Waldmann TA (2015). The shared and contrasting roles of IL2 and IL15 in the life and death of normal and neoplastic lymphocytes: implications for cancer therapy. Cancer Immunol Res  3, 219-27.   https://doi.org/10.1158/2326-6066.CIR-15-0009|4. Yu H, Sui Y, Wang Y, Sato N, Frey B, Xia Z, Waldmann TA, Berzofsky J (2015). Interleukin-15 Constrains Mucosal T Helper 17 Cell Generation: Influence of Mononuclear Phagocytes. PLoS One  10, e0143001.   https://doi.org/10.1371/journal.pone.0143001",https://intramural.nih.gov/search/searchview.taf?ipid=93934
677,BC009255-42,"October 01, 2015 -  September 30, 2016",Application of Flow Cytometry to Cell Biology,Susan  Sharrow,Alfred  Singer; MD,"Experimental Immunology Branch, NCI",Anthony J Adams|Assiatu Jalloh Crossman|Lawrence G Granger|Donald G Plugge,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93616
678,BC010469-14,"October 01, 2015 -  September 30, 2016",Molecular Targets Laboratory,James  McMahon; PhD,NULL,"Molecular Targets Laboratory, NCI",Emad  Darvishi|Curtis  Henrich|Ancy Dimpy Nalli|Tanya R Johnson|Emily Ann Smith|Anthony  Wamiru|Show all 9,"Peter  Seeberger (Chemistry, MIT/)|David  Craik (Institute for Molecular Bioscience, Univ. of Queensland)|Patrick  Cummings (Masters Program development, Johns Hopkins University)|Ihsan  Calis (Natural product diversity librarires, Hacteppe University)|Johnny  Easmon (HDAC Inhibitors, University of Innsbruck)|Yutaka  Takebe (National Institute of Infectious Diseases)|Show all 9",Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|William Marston Linehan; MD (Urologic Oncology Branch)|Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)|Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory)|Robert Andrew Byrd (Structural Biophysics Laboratory)|Jonathan S Wiest; PhD (Office of the Director),Michael P Bray (NIAID),"1. O'Keefe BR, Murad AM, Vianna GR, Ramessar K, Saucedo CJ, Wilson J, Buckheit KW, da Cunha NB, Araújo AC, Lacorte CC, Madeira L, McMahon JB, Rech EL (2015). Engineering soya bean seeds as a scalable platform to produce cyanovirin-N, a non-ARV microbicide against HIV. Plant Biotechnol J  13, 884-92.   https://doi.org/10.1111/pbi.12309",https://intramural.nih.gov/search/searchview.taf?ipid=93743
679,BC010517-14,"October 01, 2015 -  September 30, 2016",Large Databases of Small Molecules - Drug Development Tool and Public Resource,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Hitesh Jayantilal Patel; PhD|Yuri  Pevzner,Wolf-Dietrich  Ihlenfeldt (Xemistry GmbH)|Ann  Richard (EPA)|Stephen  Boyer|Lawrence  Callahan (FDA)|Eugene  Demchuk (CDC)|Antony  Williams|Show all 11,NULL,"Christopher P Austin; AB, MD (NCATS) |Evan  Bolton; PhD (NLM) |Igor V Filippov (NLM)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93746
680,BC010548-14,"October 01, 2015 -  September 30, 2016",Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents,William D Figg; PharmD|IRP Faculty Profile,NULL,"Office Of The Clinical Director, NCI",Julie Katherine Barnes|Cody John Peer|Keith Thomas Schmidt,NULL,"Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|Anish  Thomas; MD (Thoracic & Oncologic Surgery Branch)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|James Halpern Doroshow (Developmental Therapeutics Branch)|Tim Friedrich Greten (Thoracic & Oncologic Surgery Branch)",NULL,"1. Goey AK, Sissung TM, Peer CJ, Trepel JB, Lee MJ, Tomita Y, Ehrlich S, Bryla C, Balasubramaniam S, Piekarz R, Steinberg SM, Bates SE, Figg WD (2016). Effects of UGT1A1 genotype on the pharmacokinetics, pharmacodynamics, and toxicities of belinostat administered by 48-hour continuous infusion in patients with cancer. J Clin Pharmacol  56, 461-73.   https://doi.org/10.1002/jcph.625|2. Peer CJ, Goey AK, Sissung TM, Erlich S, Lee MJ, Tomita Y, Trepel JB, Piekarz R, Balasubramaniam S, Bates SE, Figg WD (2016). UGT1A1 genotype-dependent dose adjustment of belinostat in patients with advanced cancers using population pharmacokinetic modeling and simulation. J Clin Pharmacol  56, 450-60.   https://doi.org/10.1002/jcph.627",https://intramural.nih.gov/search/searchview.taf?ipid=93843
681,BC010639-13,"October 01, 2015 -  September 30, 2016",In Silico Screening for Cancer Targets,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Megan L Peach|John Stephen Schneekloth|Jordan Leslie Meier; PhD|Jeffrey  Gildersleeve,Iwona Elzbieta Weidlich|Julieta  Comin (University of Buenos Aires),"Donald P Bottaro; PhD (Urologic Oncology Branch)|Kyung  Lee; PhD (Chemistry Section)|Peter  Blumberg; PhD (Laboratory of Cancer Biology and Genetics)|David D Roberts; PhD (Laboratory of Pathology)|Sergey G Tarasov (Structural Biophysics Laboratory)|Kevin  Gardner; MD, PhD (Cancer Genetics Branch)","Paul P. Liu; MD, PhD (NHGRI)","1. Montgomery DC, Sorum AW, Guasch L, Nicklaus MC, Meier JL (2015). Metabolic Regulation of Histone Acetyltransferases by Endogenous Acyl-CoA Cofactors. Chem Biol  22, 1030-1039.   https://doi.org/10.1016/j.chembiol.2015.06.015|2. Shrimp JH, Sorum AW, Garlick JM, Guasch L, Nicklaus MC, Meier JL (2016). Characterizing the Covalent Targets of a Small Molecule Inhibitor of the Lysine Acetyltransferase P300. ACS Med Chem Lett  7, 151-5.   https://doi.org/10.1021/acsmedchemlett.5b00385",https://intramural.nih.gov/search/searchview.taf?ipid=93761
682,BC010685-12,"October 01, 2015 -  September 30, 2016",Postmortem Pathology,"David Erwin Kleiner; MD, PhD",Frederic Glenn Barr,"Laboratory of Pathology, NCI",Willie J Young|Mohammad Javed Mahboob|Sarah Paige Young,NULL,Udayan  Guha (Thoracic & Oncologic Surgery Branch)|Andrea Borghese Apolo (Genitourinary Malignancies Branch)|Mark Richard Gilbert; MD (Neuro-Oncology Branch),"Theo  Heller; MD (NIDDK) |Steven M Holland; MD (NIAID) |Kenneth  Olivier; MD, MPH (NHLBI)","1. Kleiner DE, Makhlouf HR (2016). Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children. Clin Liver Dis  20, 293-312.   https://doi.org/10.1016/j.cld.2015.10.011",https://intramural.nih.gov/search/searchview.taf?ipid=93779
683,BC010687-12,"October 01, 2015 -  September 30, 2016",Histology Core Laboratory,Joseph  Chinquee,Frederic Glenn Barr,"Laboratory of Pathology, NCI",Tashanda Renee Ashford|Terrica Shuntay Johnson|Helen G Lynch|Mohammad Javed Mahboob|Michael Kanwolo Newford|Claire D Roque|Show all 7,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93781
684,BC010858-10,"October 01, 2015 -  September 30, 2016",CCR Confocal Microscopy Core,Susan H Garfield,Glenn  Merlino; PhD,"Laboratory of Cancer Biology and Genetics, NCI",Langston  Lim|Poonam  Mannan,NULL,Sukhbir  Kaur (Laboratory of Pathology),Kevin G Chen; MD (NINDS),"1. Chen RJ, Zhang G, Garfield SH, Shi YJ, Chen KG, Robey PG, Leapman RD (2015). Variations in Glycogen Synthesis in Human Pluripotent Stem Cells with Altered Pluripotent States. PLoS One  10, e0142554.   https://doi.org/10.1371/journal.pone.0142554",https://intramural.nih.gov/search/searchview.taf?ipid=93849
685,BC010903-09,"October 01, 2015 -  September 30, 2016",Transgenic Core Facility,Deborah A Swing,Lino  Tessarollo,"Mouse Cancer Genetics Program, NCI",NULL,NULL,NULL,NULL,"1. Basheer WA, Harris BS, Mentrup HL, Abreha M, Thames EL, Lea JB, Swing DA, Copeland NG, Jenkins NA, Price RL, Matesic LE (2015). Cardiomyocyte-specific overexpression of the ubiquitin ligase Wwp1 contributes to reduction in Connexin 43 and arrhythmogenesis. J Mol Cell Cardiol  88, 1-13.   https://doi.org/10.1016/j.yjmcc.2015.09.004|2. Herriges JC, Verheyden JM, Zhang Z, Sui P, Zhang Y, Anderson MJ, Swing DA, Zhang Y, Lewandoski M, Sun X (2015). FGF-Regulated ETV Transcription Factors Control FGF-SHH Feedback Loop in Lung Branching. Dev Cell  35, 322-32.   https://doi.org/10.1016/j.devcel.2015.10.006|3. Jiang J, Zhu Q, Gendron TF, Saberi S, McAlonis-Downes M, Seelman A, Stauffer JE, Jafar-Nejad P, Drenner K, Schulte D, Chun S, Sun S, Ling SC, Myers B, Engelhardt J, Katz M, Baughn M, Platoshyn O, Marsala M, Watt A, Heyser CJ, Ard MC, De Muynck L, Daughrity LM, Swing DA, et al. [16 more authors] (2016). Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs. Neuron  90, 535-50.   https://doi.org/10.1016/j.neuron.2016.04.006|4. Posokhova E, Shukla A, Seaman S, Volate S, Hilton MB, Wu B, Morris H, Swing DA, Zhou M, Zudaire E, Rubin JS, St Croix B (2015). GPR124 functions as a WNT7-specific coactivator of canonical β-catenin signaling. Cell Rep  10, 123-30.   https://doi.org/10.1016/j.celrep.2014.12.020|5. Vitre B, Holland AJ, Kulukian A, Shoshani O, Hirai M, Wang Y, Maldonado M, Cho T, Boubaker J, Swing DA, Tessarollo L, Evans SM, Fuchs E, Cleveland DW (2015) Chronic centrosome amplification without tumorigenesis. Proc Natl Acad Sci U S A 112:E6321-30",https://intramural.nih.gov/search/searchview.taf?ipid=93925
686,BC010905-09,"October 01, 2015 -  September 30, 2016",Surgery Branch Cell Prep Core,John R Wunderlich,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI","Nicholas Phillip Restifo; MD|Paul  Robbins|Udai S Kammula|James Chung-Yin Yang; MD, PhD|Richard  Sherry; MD|Donald E White|Show all 15",NULL,Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Christian S Hinrichs (Experimental Transplantation and Immunology Branch)|David  Schrump; MD (Thoracic & Oncologic Surgery Branch)|Robert Taylor Ripley; MD (Thoracic & Oncologic Surgery Branch)|Marybeth S Hughes (Thoracic & Oncologic Surgery Branch)|Mark  Raffeld; MD (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93942
687,BC010915-09,"October 01, 2015 -  September 30, 2016",EIB Microscopy Core Facility,Michael John Kruhlak; PhD,Alfred  Singer; MD,"Experimental Immunology Branch, NCI",Paul A Roche; PhD|Dinah  Singer; PhD|Vanja  Lazarevic|Damian  Kovalovsky; PhD|Jung-Hyun  Park|Richard J Hodes; MD,NULL,"Zhi Ming  Zheng; MD, PhD (Gene Regulation and Chromosome Biology Laboratory)|Louis  Staudt; MD (Lymphoid Malignancies Branch)|Mark  Udey; MD (Dermatology Branch)|Joseph M Ziegelbauer (HIV and AIDS Malignancy Branch)|Philipp  Oberdoerffer (Laboratory of Receptor Biology and Gene Expression)|Carol J Thiele (Pediatric Oncology Branch)","Elissa P Lei; BS, PhD (NIDDK) |Richard D Leapman; PhD (NIBIB) |Rafael Cristian Casellas; PhD (NIAMS) |Jeffrey Burnett Kopp; MD (NIDDK) |Myung Hee  Park; PhD (NIDCR) |Hira  Nakhasi (OD)","1. Bhattacharya P, Dey R, Dagur PK, Kruhlak M, Ismail N, Debrabant A, Joshi AB, Akue A, Kukuruga M, Takeda K, Selvapandiyan A, McCoy JP, Nakhasi HL (2015). Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice. Infect Immun  83, 3800-15.   https://doi.org/10.1128/IAI.00184-15|2. Kaul S, Mittal SK, Feigenbaum L, Kruhlak MJ, Roche PA (2015). Expression of the SNARE protein SNAP-23 is essential for cell survival. PLoS One  10, e0118311.   https://doi.org/10.1371/journal.pone.0118311|3. Sharma NR, Wang X, Majerciak V, Ajiro M, Kruhlak M, Meyers C, Zheng ZM (2016). Cell Type- and Tissue Context-dependent Nuclear Distribution of Human Ago2. J Biol Chem  291, 2302-9.   https://doi.org/10.1074/jbc.C115.695049",https://intramural.nih.gov/search/searchview.taf?ipid=93958
688,BC010934-09,"October 01, 2015 -  September 30, 2016",Immune reconstitution following autologous and allogeneic stem cell transplant,Frances  Hakim; PhD,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI","Shayla M Duncan|Jeremy J Rose|Xiao Y Yan|Monica M Cho|Steven  Pavletic; MD, MS|Daniel H Fowler|Show all 12",NULL,Edward W Cowen (Dermatology Branch)|Kristin  Baird (Pediatric Oncology Branch),David F Stroncek; MD (CC) |Ping  Jin (CC) |Arya  Biragyn; PhD (NIA),"1. Amarnath S, Foley JE, Farthing DE, Gress RE, Laurence A, Eckhaus MA, Métais JY, Rose JJ, Hakim FT, Felizardo TC, Cheng AV, Robey PG, Stroncek DE, Sabatino M, Battiwalla M, Ito S, Fowler DH, Barrett AJ (2015). Bone marrow-derived mesenchymal stromal cells harness purinergenic signaling to tolerize human Th1 cells in vivo. Stem Cells  33, 1200-12.   https://doi.org/10.1002/stem.1934|2. Hakim FT, Memon S, Jin P, Imanguli MM, Wang H, Rehman N, Yan XY, Rose J, Mays JW, Dhamala S, Kapoor V, Telford W, Dickinson J, Davis S, Halverson D, Naik HB, Baird K, Fowler D, Stroncek D, Cowen EW, Pavletic SZ, Gress RE (2016). Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease. J Immunol  197, 3490-3503.   https://doi.org/10.4049/jimmunol.1601054|3. Mossoba ME, Halverson DC, Kurlander R, Schuver BB, Carpenter A, Hansen B, Steinberg SM, Ali SA, Tageja N, Hakim FT, Gea-Banacloche J, Sportes C, Hardy NM, Hickstein DD, Pavletic SZ, Khuu H, Sabatini M, Stroncek D, Levine BL, June CH, Mariotti J, Rixe O, Fojo AT, Bishop MR, Gress RE, et al. [1 more author] (2015). High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses. Clin Cancer Res  21, 4312-20.   https://doi.org/10.1158/1078-0432.CCR-15-0340|4. Paczesny S, Hakim FT, Pidala J, Cooke KR, Lathrop J, Griffith LM, Hansen J, Jagasia M, Miklos D, Pavletic S, Parkman R, Russek-Cohen E, Flowers ME, Lee S, Martin P, Vogelsang G, Walton M, Schultz KR (2015). National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report. Biol Blood Marrow Transplant  21, 780-92.   https://doi.org/10.1016/j.bbmt.2015.01.003|5. Pirsl F, Curtis LM, Steinberg SM, Tella SH, Katić M, Dobbin M, Hsu J, Hakim FT, Mays JW, Im AP, Pulanić D, Mitchell SA, Baruffaldi J, Masuch L, Halverson DC, Gress RE, Barsony J, Pavletic SZ (2016). Characterization and Risk Factor Analysis of Osteoporosis in a Large Cohort of Patients with Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant  22, 1517-1524.   https://doi.org/10.1016/j.bbmt.2016.04.012",https://intramural.nih.gov/search/searchview.taf?ipid=93890
689,BC010936-09,"October 01, 2015 -  September 30, 2016",CCR VB FACS CORE,Katherine M McKinnon,"Jay Arthur Berzofsky; MD, PhD","Vaccine Branch, NCI",Sophia Nadine Brown|Marjorie  Robert-Guroff; PhD|Genoveffa  Franchini; MD|Masaki  Terabe|Monica  Vaccari|Yongjun  Sui|Show all 12,Kent  Weinhold (DUMC)|Cliburn  Chan (Duke University)|Marcin  Moniuszko|Jason  Warfal (FDA),Thomas A Misteli; PhD (Laboratory of Receptor Biology and Gene Expression)|Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|Lyuba  Varticovski (Laboratory of Receptor Biology and Gene Expression)|Charles  Vinson; PhD (Nucleic Acids Section)|Cynthia  Masison (Office of the Director)|Stuart H Yuspa; MD (Laboratory of Cancer Biology and Genetics),Lois Jean Patterson (OD) |Myong-Hee  Sung (NIA),"1. Blackburn MJ, Zhong-Min M, Caccuri F, McKinnon K, Schifanella L, Guan Y, Gorini G, Venzon D, Fenizia C, Binello N, Gordon SN, Miller CJ, Franchini G, Vaccari M (2015). Regulatory and Helper Follicular T Cells and Antibody Avidity to Simian Immunodeficiency Virus Glycoprotein 120. J Immunol  195, 3227-36.   https://doi.org/10.4049/jimmunol.1402699|2. Demberg T, Mohanram V, Musich T, Brocca-Cofano E, McKinnon KM, Venzon D, Robert-Guroff M (2015). Loss of marginal zone B-cells in SHIVSF162P4 challenged rhesus macaques despite control of viremia to low or undetectable levels in chronic infection. Virology  484, 323-33.   https://doi.org/10.1016/j.virol.2015.06.022",https://intramural.nih.gov/search/searchview.taf?ipid=93974
690,BC010937-09,"October 01, 2015 -  September 30, 2016",Novel Targets for Vaccine Therapy,Claudia Mercedes Palena|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Justin Michael David; PhD|Charli Lynn Dominguez|Kristen Koenig McCampbell|Soham  Sen|Jeffrey  Schlom; PhD|James W Hodge; PhD,"Fiorella  Guadagni (Pathology, Regina Elena Cancer Institute)|Mario  Roselli (Oncology, Tor Vergata)","James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Markku Martti Miettinen (Laboratory of Pathology)",Marc  Ferrer-Alegre (NCATS),"1. Gabitzsch ES, Tsang KY, Palena C, David JM, Fantini M, Kwilas A, Rice AE, Latchman Y, Hodge JW, Gulley JL, Madan RA, Heery CR, Balint JP, Jones FR, Schlom J (2015). The generation and analyses of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic. Oncotarget  6, 31344-59.   https://doi.org/10.18632/oncotarget.5181|2. Hamilton DH, Fernando RI, Schlom J, Palena C (2015). Aberrant expression of the embryonic transcription factor brachyury in human tumors detected with a novel rabbit monoclonal antibody. Oncotarget  6, 4853-62.   https://doi.org/10.18632/oncotarget.3086|3. Palena C, Hamilton DH (2015). Immune Targeting of Tumor Epithelial-Mesenchymal Transition via Brachyury-Based Vaccines. Adv Cancer Res  128, 69-93.   https://doi.org/10.1016/bs.acr.2015.04.001",https://intramural.nih.gov/search/searchview.taf?ipid=93985
691,BC010947-09,"October 01, 2015 -  September 30, 2016",Laboratory of Genitourinary Cancer Pathogenesis Microscopy Core Facility,Ross G Lake,Kathleen  Kelly; PhD,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Zhenggang  Liu; PhD|Adam G Sowalsky,NULL,Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics)|Electron  Kebebew; MD (Endocrine Oncology Branch)|Kandice Danielle Tanner; PhD (Laboratory of Cell Biology)|Philip Jeffrey Tofilon (Radiation Oncology Branch),"Theodore B Usdin; MD, PhD (NIMH)","1. Agarwal S, Hynes PG, Tillman HS, Lake R, Abou-Kheir WG, Fang L, Casey OM, Ameri AH, Martin PL, Yin JJ, Iaquinta PJ, Karthaus WR, Clevers HC, Sawyers CL, Kelly K (2015). Identification of Different Classes of Luminal Progenitor Cells within Prostate Tumors. Cell Rep  13, 2147-58.   https://doi.org/10.1016/j.celrep.2015.10.077",https://intramural.nih.gov/search/searchview.taf?ipid=93937
692,BC010948-09,"October 01, 2015 -  September 30, 2016",DNA Sequencing and FACS Core Facilities,Paul  Robbins,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",NULL,Cyrille  Cohen|David  Haussler (Howard Hughes Medical Institute)|Yardena  Samuel (Weizmann Institute of Science)|Benoit  Van den Eynde (Ludwig Institute for Cancer Research),NULL,NULL,"1. Prickett T, Crystal J, Cohen C, Pasetto A, Parkhurst M, Gartner J, Yao X, Wang R, Gros A, ElGamil M, Li Y, TrebskaMcGowan K, Rosenberg S, Robbins P (2016) Durable complete regression in a patient with metastatic melanoma following adoptive transfer of autologous T cells recognizing 10 mutated tumor antigens. Cancer Immunology Research, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=93894
693,BC010953-09,"October 01, 2015 -  September 30, 2016",Molecular Pathology Research for Cancer Diagnostics and Biomarkers,"Robert Mark Simpson; DVM, PhD|IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI",Jennifer B Dwyer|John  Hickerson|Shelley B Hoover|Munish  Puri|Bih-Rong  Wei|Beverly  Mock; PhD|Show all 10,Glen  Esplin (Univsity of Utah)|brandon  gallas (Food and Drug Administration)|Charles Harrison Castle Halsey (LABORATORY CANCER BIOLOGY & GENETICS),"Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Michael Marc Gottesman; MD (Laboratory of Cell Biology)|Lee Jay Helman; MD (Pediatric Oncology Branch)|Udayan  Guha (Thoracic & Oncologic Surgery Branch)|Xin Wei Wang; PhD (Molecular Genetics and Carcinogenesis Section)|Natasha  Caplen (Cancer Genetics Branch)",NULL,"1. Cataisson C, Michalowski AM, Shibuya K, Ryscavage A, Klosterman M, Wright L, Dubois W, Liu F, Zhuang A, Rodrigues KB, Hoover S, Dwyer J, Simpson MR, Merlino G, Yuspa SH (2016). MET signaling in keratinocytes activates EGFR and initiates squamous carcinogenesis. Sci Signal  9, ra62.   https://doi.org/10.1126/scisignal.aaf5106|2. Chang KE, Wei BR, Madigan JP, Hall MD, Simpson RM, Zhuang Z, Gottesman MM (2015). The protein phosphatase 2A inhibitor LB100 sensitizes ovarian carcinoma cells to cisplatin-mediated cytotoxicity. Mol Cancer Ther  14, 90-100.   https://doi.org/10.1158/1535-7163.MCT-14-0496|3. Kumar JS, Wei BR, Madigan JP, Simpson RM, Hall MD, Gottesman MM (2016). Bioluminescent imaging of ABCG2 efflux activity at the blood-placenta barrier. Sci Rep  6, 20418.   https://doi.org/10.1038/srep20418|4. Roessler S, Lin G, Forgues M, Budhu A, Hoover S, Simpson RM, Wu X, He P, Qin LX, Tang ZY, Ye QH, Wang XW (2015). Integrative genomic and transcriptomic characterization of matched primary and metastatic liver and colorectal carcinoma. Int J Biol Sci  11, 88-98.   https://doi.org/10.7150/ijbs.10583|5. Yu B, Swatkoski S, Holly A, Lee LC, Giroux V, Lee CS, Hsu D, Smith JL, Yuen G, Yue J, Ann DK, Simpson RM, Creighton CJ, Figg WD, Gucek M, Luo J (2015). Oncogenesis driven by the Ras/Raf pathway requires the SUMO E2 ligase Ubc9. Proc Natl Acad Sci U S A  112, E1724-33.   https://doi.org/10.1073/pnas.1415569112",https://intramural.nih.gov/search/searchview.taf?ipid=93907
694,BC010965-09,"October 01, 2015 -  September 30, 2016",CCR Biophysics Resource Core,Sergey G Tarasov,Robert Andrew Byrd,"Structural Biophysics Laboratory, NCI",NULL,NULL,Alan  Rein; PhD (Retroviral Replication Laboratory)|Stuart F J Le Grice; PhD (Basic Research Laboratory)|David S Waugh; PhD (Protein Engineering Section)|Xinhua  Ji; PhD (Biomolecular Structure Section)|Joost J Oppenheim; MD (Cancer Inflammation Program)|Dimiter Stanchev Dimitrov; PhD (Cancer Inflammation Program),Stephen H Leppla; PhD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93926
695,BC010978-09,"October 01, 2015 -  September 30, 2016",Confocal Core for the Laboratory of Cellular and Molecular Biology,Valarie  Barr; PhD,Lawrence Elliot Samelson; MD,"Laboratory of Cellular and Molecular Biology, NCI","Paul A Randazzo; MD, PhD|Carole A Parent; PhD|Ying  Zhang",Wolfgang  Losert (University of Maryland)|Stephen  Bunnell (Tufts University School of Medicine)|Robert  Rottapel (University of Toronto),"Jonathan D Ashwell; MD (Laboratory of Immune Cell Biology)|Stanley  Lipkowitz; MD, PhD (Womens Malignancies Branch)","Paul E Love; MD, PhD (NICHD)","1. Balagopalan L, Kortum RL, Coussens NP, Barr VA, Samelson LE (2015). The linker for activation of T cells (LAT) signaling hub: from signaling complexes to microclusters. J Biol Chem  290, 26422-9.   https://doi.org/10.1074/jbc.R115.665869",https://intramural.nih.gov/search/searchview.taf?ipid=93861
696,BC010981-09,"October 01, 2015 -  September 30, 2016",Biomarker investigations for Clinical Trials,Liang  Cao,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",Zhigang  Kang|Yunkai  Yu,NULL,"Alice Pinting Chen (Office of the Director)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|William D Figg; PharmD (Genitourinary Malignancies Branch)|Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)|Tim Friedrich Greten (Thoracic & Oncologic Surgery Branch)|Jung-Min  Lee (Womens Malignancies Branch)",NULL,"1. Karzai FH, Apolo AB, Cao L, Madan RA, Adelberg DE, Parnes H, McLeod DG, Harold N, Peer C, Yu Y, Tomita Y, Lee MJ, Lee S, Trepel JB, Gulley JL, Figg WD, Dahut WL (2015). A phase I study of TRC105 anti-endoglin (CD105) antibody in metastatic castration-resistant prostate cancer. BJU Int  116, 546-55.   https://doi.org/10.1111/bju.12986",https://intramural.nih.gov/search/searchview.taf?ipid=93870
697,BC010989-09,"October 01, 2015 -  September 30, 2016",Clinical production of viral vectors for cancer gene therapy,Steven A Feldman,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI","Ornela  Dervishaj|Isaac Roland Kriley; MD|Nikolaos  Zacharakis; PhD|James Chung-Yin Yang; MD, PhD|Nicholas Phillip Restifo; MD",Dirk  Jager (University Medical Center Heidelberg)|Gary T Lee|Marc  Better (KITE Pharma),Ira H Pastan; MD (Molecular Biology Section)|James N Kochenderfer (Experimental Transplantation and Immunology Branch),Joseph  Shiloach; PhD (NIDDK) |Harry Lewis Malech; MD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93881
698,BC010991-09,"October 01, 2015 -  September 30, 2016",Radiation Oncology Branch - Microarray Facility,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93868
699,BC011016-09,"October 01, 2015 -  September 30, 2016",Protein Production,Joseph Edward Tropea,Alexander  Wlodawer; PhD,"Macromolecular Crystallography Laboratory, NCI",NULL,"Jozsef  Tozser|Robert  Ulrich (Molecular Immunology, USAMRIID)|Honggao  Yan|Vaclav  Veverka (Institute of Organic Chemistry and Biochemistry of the ASCR, v.v.i.)",Xinhua  Ji; PhD (Biomolecular Structure Section)|David S Waugh; PhD (Protein Engineering Section)|Donald L Court; PhD (Molecular Control and Genetics Section)|Zbigniew  Dauter (Synchrotron Radiation Research Section)|John Stephen Schneekloth (Chemical Biology Laboratory)|Ding Jun Jin (Gene Regulation and Chromosome Biology Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93927
700,BC011021-08,"October 01, 2015 -  September 30, 2016",Basic Research Support for the CCR,Thomas A Misteli; PhD|IRP Faculty Profile,NULL,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93605
701,BC011029-09,"October 01, 2015 -  September 30, 2016",Preclinical development and clinical monitoring of adoptive immune therapy,Frances  Hakim; PhD,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",Monica M Cho|Vicki  Fellowes|Jeremy J Rose|Xiao Y Yan|Daniel H Fowler|James N Kochenderfer|Show all 8,NULL,NULL,NULL,"1. Ali SA, Shi V, Maric I, Wang M, Stroncek DF, Rose JJ, Brudno JN, Stetler-Stevenson M, Feldman SA, Hansen BG, Fellowes VS, Hakim FT, Gress RE, Kochenderfer JN (2016). T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma. Blood  128, 1688-700.   https://doi.org/10.1182/blood-2016-04-711903|2. Mossoba ME, Halverson DC, Kurlander R, Schuver BB, Carpenter A, Hansen B, Steinberg SM, Ali SA, Tageja N, Hakim FT, Gea-Banacloche J, Sportes C, Hardy NM, Hickstein DD, Pavletic SZ, Khuu H, Sabatini M, Stroncek D, Levine BL, June CH, Mariotti J, Rixe O, Fojo AT, Bishop MR, Gress RE, et al. [1 more author] (2015). High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses. Clin Cancer Res  21, 4312-20.   https://doi.org/10.1158/1078-0432.CCR-15-0340",https://intramural.nih.gov/search/searchview.taf?ipid=93891
702,BC011030-09,"October 01, 2015 -  September 30, 2016",The Antigen Targeting Core,Maria  Parkhurst,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",Nicholas Phillip Restifo; MD|Steven A Feldman|Paul  Robbins,NULL,NULL,Michael  Norcross (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93986
703,BC011040-09,"October 01, 2015 -  September 30, 2016",Molecular Profiling of Clinical Specimens,Daniel C Edelman,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",Sven  Bilke|Leslie Ann Brents|Jonathan Keith Killian|Yu Jin  Lee|David  Petersen|Marbin A Pineda|Show all 13,NULL,William Marston Linehan; MD (Urologic Oncology Branch)|Lee Jay Helman; MD (Pediatric Oncology Branch)|Miriam Christine Poirier; PhD (Laboratory of Cancer Biology and Genetics)|Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Laufey Thora Amundadottir (Laboratory Translational Genomics)|Xiaohong Rose Yang; PhD (Genetic Epidemiology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93879
704,BC011041-09,"October 01, 2015 -  September 30, 2016",Technical Development of Molecular Profiling Technologies,Daniel C Edelman,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",Sven  Bilke|Jonathan Keith Killian|David  Petersen|Marbin A Pineda|Jennifer  Walling|Yonghong  Wang,NULL,Andrea Borghese Apolo (Genitourinary Malignancies Branch),NULL,"1. Stevenson HS, Wang Y, Muller R, Edelman DC (2015). Long-term stability of total RNA in RNAstable® as evaluated by expression microarray. Biopreserv Biobank  13, 114-22.   https://doi.org/10.1089/bio.2014.0068",https://intramural.nih.gov/search/searchview.taf?ipid=93880
705,BC011042-09,"October 01, 2015 -  September 30, 2016",Global changes in specific histone modifications in cancer,David  Levens; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Russell William Bandle|Hye-Jung  Chung|Elaine S Jaffe; MD,NULL,Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|Louis  Staudt; MD (Lymphoid Malignancies Branch),Keji  Zhao; PhD (NHLBI) |Katherine Rainsford Calvo (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93960
706,BC011044-09,"October 01, 2015 -  September 30, 2016",Tissue Processing-Sequencing Facility,Cathy  Vocke; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI",Robert A Worrell,William  Kaelin (Dana-Farber Cancer Institute)|Paul T Spellman|James  Brugarolas (University of Texas Southwestern Medical Center)|Maria  Czyzyk-Krzeska (University of Cincinnati),"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|James Chung-Yin Yang; MD, PhD (Surgery Branch)|Maria  Merino; PhD (Laboratory of Pathology)|Karl Thomas Ried; MD (Cancer Genetics Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Peter L Choyke; MD (Molecular Imaging Program)","Karel  Pacak; MD, PhD (NICHD) |Richard  Childs; MD (NHLBI) |Joel  Moss; MD, PhD (NHLBI) |Jeffrey Burnett Kopp; MD (NIDDK) |Leslie Glenn Biesecker; MD (NHGRI) |Robert S Munford (NIAID)","1. Fei SS, Mitchell AD, Heskett MB, Vocke CD, Ricketts CJ, Peto M, Wang NJ, Sönmez K, Linehan WM, Spellman PT (2016). Patient-specific factors influence somatic variation patterns in von Hippel-Lindau disease renal tumours. Nat Commun  7, 11588.   https://doi.org/10.1038/ncomms11588|2. Lang M, Vocke C, Merino M, Schmidt L, Linehan W (2015) Mitochondrial DNA mutations distinguish bilateral multifocal renal oncocytomas from familial Birt-Hogg-Dube tumors. Modern Path, in press.|3. Sidana A, Walton-Diaz A, Truong H, Siddiqui MM, Miao N, Shih J, Mannes A, Bratslavsky G, Linehan WM, Metwalli AR (2016). Postoperative elevation in creatine kinase and its impact on renal function in patients undergoing complex partial nephrectomy. Int Urol Nephrol  48, 1047-1053.   https://doi.org/10.1007/s11255-016-1284-1",https://intramural.nih.gov/search/searchview.taf?ipid=93932
707,BC011047-09,"October 01, 2015 -  September 30, 2016",Animal Model and Genotyping Core Support Facility,Wendy Dianne Du Bois De Vroylande,Glenn  Merlino; PhD,"Laboratory of Cancer Biology and Genetics, NCI",Mario A Anzano|William Tyler Beals|Marta  Custer|Maudeline  Etienne|Anthony W Vieira|Susan  Walters|Show all 12,NULL,"James B Mitchell; PhD (Radiation Biology Branch)|Konrad  Huppi; MD, PhD (Cancer Genetics Branch)|David  Levens; PhD (Laboratory of Pathology)|Philipp  Oberdoerffer (Laboratory of Receptor Biology and Gene Expression)|Suman Kumar Vodnala (Surgery Branch)","Pamela Lee Schwartzberg; MD, PhD (NHGRI) |Rafael Cristian Casellas; PhD (NIAMS) |Herbert Carpenter Morse; MD (NIAID) |Neal S Young; MD (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93876
708,BC011048-09,"October 01, 2015 -  September 30, 2016",Preclinical Development of Novel Targeted Therapeutics Against Pediatric Sarcoma,Liang  Cao,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",Zhigang  Kang,NULL,Lee Jay Helman; MD (Pediatric Oncology Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch),NULL,"1. Kang Z, Goldstein SD, Yu Y, Meltzer PS, Loeb DM, Cao L (2015). Caspase-8 expression is predictive of tumour response to death receptor 5 agonist antibody in Ewing's sarcoma. Br J Cancer  113, 894-901.   https://doi.org/10.1038/bjc.2015.298|2. Tang SW, Bilke S, Cao L, Murai J, Sousa FG, Yamade M, Rajapakse V, Varma S, Helman LJ, Khan J, Meltzer PS, Pommier Y (2015). SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma. Clin Cancer Res  21, 4184-93.   https://doi.org/10.1158/1078-0432.CCR-14-2112",https://intramural.nih.gov/search/searchview.taf?ipid=93871
709,BC011052-09,"October 01, 2015 -  September 30, 2016",Cytopathology Core,Armando  Filie|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Giorgi  Berulava|Keith R Brosky|Tangi Y Howard|Dana K Erickson|May Ester Owens|Mark J Roth|Show all 8,NULL,Raffit  Hassan (Thoracic & Oncologic Surgery Branch),Monica C Skarulis; MD (NIDDK),"1. Danforth DN, Warner AC, Wangsa D, Ried T, Duelli D, Filie AC, Prindiville SA (2015). An Improved Breast Epithelial Sampling Method for Molecular Profiling and Biomarker Analysis in Women at Risk for Breast Cancer. Breast Cancer (Auckl)  9, 31-40.   https://doi.org/10.4137/BCBCR.S23577|2. Rosenberg AZ, Armani MD, Fetsch PA, Xi L, Pham TT, Raffeld M, Chen Y, O'Flaherty N, Stussman R, Blackler AR, Du Q, Hanson JC, Roth MJ, Filie AC, Roh MH, Emmert-Buck MR, Hipp JD, Tangrea MA (2016). High-Throughput Microdissection for Next-Generation Sequencing. PLoS One  11, e0151775.   https://doi.org/10.1371/journal.pone.0151775",https://intramural.nih.gov/search/searchview.taf?ipid=93882
710,BC011075-09,"October 01, 2015 -  September 30, 2016",Molecular Modeling of the Human P-glycoprotein Transporter Protein,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,Suresh V Ambudkar; PhD (Transport Biochemistry Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93877
711,BC011077-09,"October 01, 2015 -  September 30, 2016",Molecular Modeling of Interactions Regulating the Activity of the p53 Protein,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,Ettore  Appella; MD (Chemical Immunology Section)|Hanqiao  Feng (Laboratory Of Biochemistry & Molecular Biology)|Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology),Daniel  Appella; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93878
712,BC011079-09,"October 01, 2015 -  September 30, 2016",Molecular Diagnostics Core Laboratory,Mark  Raffeld; MD,Frederic Glenn Barr,"Laboratory of Pathology, NCI",Elaine S Jaffe; MD|Stefania  Pittaluga|Armando  Filie,"Leticia  Quintanilla-Martinez (Pathology, Technical University of Munich)|Giuseppe  Giaccone; MD|Michael  Tangrea|Philippe  Trougouboff (Emek Medical Center)","Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|Raffit  Hassan (Thoracic & Oncologic Surgery Branch)|Udai S Kammula (Surgery Branch)|Nicholas Phillip Restifo; MD (Surgery Branch)",Steven M Holland; MD (NIAID) |Amy D Klion; MD (NIAID) |Jeffrey  Baron; MD (NICHD) |Herbert Carpenter Morse; MD (NIAID),"1. Gong S, Auer I, Duggal R, Pittaluga S, Raffeld M, Jaffe ES (2015). Epstein-Barr virus-associated inflammatory pseudotumor presenting as a colonic mass. Hum Pathol  46, 1956-61.   https://doi.org/10.1016/j.humpath.2015.08.011|2. Hsu AP, Pittaluga S, Martinez B, Rump AP, Raffeld M, Uzel G, Puck JM, Freeman AF, Holland SM (2015). IL2RG reversion event in a common lymphoid progenitor leads to delayed diagnosis and milder phenotype. J Clin Immunol  35, 449-53.   https://doi.org/10.1007/s10875-015-0174-0|3. Jain S, Chen J, Nicolae A, Wang H, Shin DM, Adkins EB, Sproule TJ, Leeth CM, Sakai T, Kovalchuk AL, Raffeld M, Ward JM, Rehg JE, Waldmann TA, Jaffe ES, Roopenian DC, Morse HC (2015). IL-21-driven neoplasms in SJL mice mimic some key features of human angioimmunoblastic T-cell lymphoma. Am J Pathol  185, 3102-14.   https://doi.org/10.1016/j.ajpath.2015.07.021|4. McDermott DH, Gao JL, Liu Q, Siwicki M, Martens C, Jacobs P, Velez D, Yim E, Bryke CR, Hsu N, Dai Z, Marquesen MM, Stregevsky E, Kwatemaa N, Theobald N, Long Priel DA, Pittaluga S, Raffeld MA, Calvo KR, Maric I, Desmond R, Holmes KL, Kuhns DB, Balabanian K, Bachelerie F, et al. [3 more authors] (2015). Chromothriptic cure of WHIM syndrome. Cell  160, 686-699.   https://doi.org/10.1016/j.cell.2015.01.014|5. Nicolae A, Pittaluga S, Abdullah S, Steinberg SM, Pham TA, Davies-Hill T, Xi L, Raffeld M, Jaffe ES (2015). EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment. Blood  126, 863-72.   https://doi.org/10.1182/blood-2015-02-630632|6. Shalabi H, Angiolillo A, Vezina G, Rubenstein JL, Pittaluga S, Raffeld M, Marcus L (2015). Prolonged Complete Response in a Pediatric Patient With Primary Peripheral T-Cell Lymphoma of the Central Nervous System. Pediatr Hematol Oncol  32, 529-34.   https://doi.org/10.3109/08880018.2015.1074325",https://intramural.nih.gov/search/searchview.taf?ipid=93992
713,BC011093-09,"October 01, 2015 -  September 30, 2016",Flow Cytometric Detection of Malignant Cells in Body Fluids,"Maryalice  Stetler-Stevenson; MD, PhD",Frederic Glenn Barr,"Laboratory of Pathology, NCI",Gregory A Jasper|Catharine S Mccoy|Dalia Abdel-Raouf Salem|Linda Shonk Weaver|Constance M Yuan,NULL,"Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Daniel H Fowler (Experimental Transplantation and Immunology Branch)|Thomas S Uldrick (HIV and AIDS Malignancy Branch)",NULL,"1. Kranick SM, Goncalves PH, Stetler-Stevenson M, Aleman K, Polizzotto MN, Little RF, Yarchoan R, Uldrick TS (2015). Paradoxical central nervous system immune reconstitution syndrome in acquired immunodeficiency syndrome-related primary central nervous system lymphoma. Haematologica  100, e21-4.   https://doi.org/10.3324/haematol.2014.114736|2. Kreitman RJ, Stetler-Stevenson M, Jaffe ES, Conlon KC, Steinberg SM, Wilson W, Waldmann TA, Pastan I (2016). Complete Remissions of Adult T-cell Leukemia with Anti-CD25 Recombinant Immunotoxin LMB-2 and Chemotherapy to Block Immunogenicity. Clin Cancer Res  22, 310-8.   https://doi.org/10.1158/1078-0432.CCR-15-1412",https://intramural.nih.gov/search/searchview.taf?ipid=93923
714,BC011104-09,"October 01, 2015 -  September 30, 2016",Flow Cytometric Evaluation of Biomarkers,"Maryalice  Stetler-Stevenson; MD, PhD",Frederic Glenn Barr,"Laboratory of Pathology, NCI",Gregory A Jasper|Catharine S Mccoy|Dalia Abdel-Raouf Salem|Linda Shonk Weaver|Constance M Yuan,NULL,"Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Ira H Pastan; MD (Molecular Biology Section)|Terry J Fry (Pediatric Oncology Branch)|Daniel W Lee (Pediatric Oncology Branch)|Raffit  Hassan (Thoracic & Oncologic Surgery Branch)|James N Kochenderfer (Experimental Transplantation and Immunology Branch)","Adrian U Wiestner; MD, PhD (NHLBI)","1. Farooqui MZ, Valdez J, Martyr S, Aue G, Saba N, Niemann CU, Herman SE, Tian X, Marti G, Soto S, Hughes TE, Jones J, Lipsky A, Pittaluga S, Stetler-Stevenson M, Yuan C, Lee YS, Pedersen LB, Geisler CH, Calvo KR, Arthur DC, Maric I, Childs R, Young NS, Wiestner A (2015). Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial. Lancet Oncol  16, 169-76.   https://doi.org/10.1016/S1470-2045(14)71182-9|2. Niemann CU, Herman SE, Maric I, Gomez-Rodriguez J, Biancotto A, Chang BY, Martyr S, Stetler-Stevenson M, Yuan CM, Calvo KR, Braylan RC, Valdez J, Lee YS, Wong DH, Jones J, Sun C, Marti GE, Farooqui MZ, Wiestner A (2016). Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib--Findings from an Investigator-Initiated Phase II Study. Clin Cancer Res  22, 1572-82.   https://doi.org/10.1158/1078-0432.CCR-15-1965|3. Sun C, Tian X, Lee YS, Gunti S, Lipsky A, Herman SE, Salem D, Stetler-Stevenson M, Yuan C, Kardava L, Moir S, Maric I, Valdez J, Soto S, Marti GE, Farooqui MZ, Notkins AL, Wiestner A, Aue G (2015). Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib. Blood  126, 2213-9.   https://doi.org/10.1182/blood-2015-04-639203",https://intramural.nih.gov/search/searchview.taf?ipid=93922
715,BC011138-09,"October 01, 2015 -  September 30, 2016",ETIB FACS Core Facility,William G Telford,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93990
716,BC011139-09,"October 01, 2015 -  September 30, 2016",Application of novel laser technology for flow cytometric analysis,William G Telford,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",NULL,"Vladislav  Verkhusha; PhD (Albert Einstein College of Medicine, Jack and Pearl Resnick Campus)|Awtar  Krishan (University of Miami School of Medicine)|Fetah  Benabid (University of Limoges)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93991
717,BC011236-08,"October 01, 2015 -  September 30, 2016",CCR-Frederick Flow Cytometry Core,Kathleen  Noer,Giorgio  Trinchieri,"Cancer Inflammation Program, NCI",Melissa K Gregory|Roberta M Matthai,NULL,NULL,NULL,"1. Thirthagiri E, Klarmann KD, Shukla AK, Southon E, Biswas K, Martin BK, North SL, Magidson V, Burkett S, Haines DC, Noer K, Matthai R, Tessarollo L, Loncarek J, Keller JR, Sharan SK (2016). BRCA2 minor transcript lacking exons 4-7 supports viability in mice and may account for survival of humans with a pathogenic biallelic mutation. Hum Mol Genet  25, 1934-1945.   https://doi.org/10.1093/hmg/ddw066",https://intramural.nih.gov/search/searchview.taf?ipid=94024
718,BC011237-08,"October 01, 2015 -  September 30, 2016",CIP Genetics and Microbiome Core,Colm  Ohuigin,Giorgio  Trinchieri,"Cancer Inflammation Program, NCI","Ying  Qi|Vishal Vijayan Thovarai|Wuxing  Yuan|Husen  Zhang|Mary  Carrington; MS, PhD|Daniel  McVicar; PhD|Show all 7",Effie  Petersdorf (Fred Hutchinson)|Robert  Lanford (Texas Biomedical Research Institute),Michael  Dean; PhD (Laboratory Translational Genomics),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94025
719,BC011265-07,"October 01, 2015 -  September 30, 2016",Gene Targeting Facility,Lino  Tessarollo|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Jodi L Becker|Mary Ellen  Palko|Susan W Reid|Francesco  Tomassoni Ardori; PhD|Bradley D St Croix|Dolph Lee Hatfield; PhD,NULL,"Mark  Udey; MD (Dermatology Branch)|Jairaj K Acharya; MBBS, PhD (Cancer and Developmental Biology Laboratory)|Howard A Young; PhD (Cancer Inflammation Program)|David  Levens; PhD (Laboratory of Pathology)|Terence P Yamaguchi; PhD (Cell Signaling in Vertebrate Development Section)",Ola Mae Zack Howard (CSR),"1. Ajima R, Bisson JA, Helt JC, Nakaya MA, Habas R, Tessarollo L, He X, Morrisey EE, Yamaguchi TP, Cohen ED (2015). DAAM1 and DAAM2 are co-required for myocardial maturation and sarcomere assembly. Dev Biol  408, 126-39.   https://doi.org/10.1016/j.ydbio.2015.10.003|2. Deng T, Zhu ZI, Zhang S, Postnikov Y, Huang D, Horsch M, Furusawa T, Beckers J, Rozman J, Klingenspor M, Amarie O, Graw J, Rathkolb B, Wolf E, Adler T, Busch DH, Gailus-Durner V, Fuchs H, Hrabě de Angelis M, van der Velde A, Tessarollo L, Ovcherenko I, Landsman D, Bustin M (2015). Functional compensation among HMGN variants modulates the DNase I hypersensitive sites at enhancers. Genome Res  25, 1295-308.   https://doi.org/10.1101/gr.192229.115|3. Hasumi H, Baba M, Hasumi Y, Lang M, Huang Y, Oh HF, Matsuo M, Merino MJ, Yao M, Ito Y, Furuya M, Iribe Y, Kodama T, Southon E, Tessarollo L, Nagashima K, Haines DC, Linehan WM, Schmidt LS (2015). Folliculin-interacting proteins Fnip1 and Fnip2 play critical roles in kidney tumor suppression in cooperation with Flcn. Proc Natl Acad Sci U S A  112, E1624-31.   https://doi.org/10.1073/pnas.1419502112|4. Mahdi Y, Xu XM, Carlson BA, Fradejas N, Günter P, Braun D, Southon E, Tessarollo L, Hatfield DL, Schweizer U (2015). Expression of Selenoproteins Is Maintained in Mice Carrying Mutations in SECp43, the tRNA Selenocysteine 1 Associated Protein (Trnau1ap). PLoS One  10, e0127349.   https://doi.org/10.1371/journal.pone.0127349|5. Manna S, Kim JK, Baugé C, Cam M, Zhao Y, Shetty J, Vacchio MS, Castro E, Tran B, Tessarollo L, Bosselut R (2015). Histone H3 Lysine 27 demethylases Jmjd3 and Utx are required for T-cell differentiation. Nat Commun  6, 8152.   https://doi.org/10.1038/ncomms9152|6. Schliehe C, Flynn EK, Vilagos B, Richson U, Swaminanthan S, Bosnjak B, Bauer L, Kandasamy RK, Griesshammer IM, Kosack L, Schmitz F, Litvak V, Sissons J, Lercher A, Bhattacharya A, Khamina K, Trivett AL, Tessarollo L, Mesteri I, Hladik A, Merkler D, Kubicek S, Knapp S, Epstein MM, Symer DE, et al. [2 more authors] (2015). The methyltransferase Setdb2 mediates virus-induced susceptibility to bacterial superinfection. Nat Immunol  16, 67-74.   https://doi.org/10.1038/ni.3046|7. Zheng M, Zhang H, Dill DL, Clark JD, Tu S, Yablonovitch AL, Tan MH, Zhang R, Rujescu D, Wu M, Tessarollo L, Vieira W, Gottesman MM, Deng S, Eberlin LS, Zare RN, Billard JM, Gillet JP, Li JB, Peltz G (2015). The role of Abcb5 alleles in susceptibility to haloperidol-induced toxicity in mice and humans. PLoS Med  12, e1001782.   https://doi.org/10.1371/journal.pmed.1001782",https://intramural.nih.gov/search/searchview.taf?ipid=94046
720,BC011309-07,"October 01, 2015 -  September 30, 2016",DNA Extraction Service,Jeffrey A Hammer; MS,Alfred  Singer; MD,"Molecular Regulation Section, NCI",NULL,NULL,Dinah  Singer; PhD (Experimental Immunology Branch)|Paul A Roche; PhD (Experimental Immunology Branch)|Richard J Hodes; MD (Experimental Immunology Branch)|Jung-Hyun  Park (Experimental Immunology Branch)|Vanja  Lazarevic (Experimental Immunology Branch)|Damian  Kovalovsky; PhD (Experimental Immunology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94066
721,BC011310-07,"October 01, 2015 -  September 30, 2016",Hollow Fiber Production of Monoclonal Antibodies,Jeffrey A Hammer; MS,Alfred  Singer; MD,"Molecular Regulation Section, NCI",NULL,NULL,Dinah  Singer; PhD (Experimental Immunology Branch)|Jung-Hyun  Park (Experimental Immunology Branch)|Vanja  Lazarevic (Experimental Immunology Branch)|Damian  Kovalovsky; PhD (Experimental Immunology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94067
722,BC011331-07,"October 01, 2015 -  September 30, 2016",CCR Sequencing Facility,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94079
723,BC011380-06,"October 01, 2015 -  September 30, 2016",Multivalent Inhibition of Membrane Receptors,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,Ettore  Appella; MD (Chemical Immunology Section),Daniel  Appella; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94097
724,BC011392-06,"October 01, 2015 -  September 30, 2016",Center for Cancer Research Genetics Core,Janelle  Cortner,Thomas A Misteli; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94105
725,BC011428-05,"October 01, 2015 -  September 30, 2016","CCR, LGI, Flow Cytometry Core Facility",Ferenc  Livak,Andre A Nussenzweig; PhD,"Laboratory Of Genome Integrity, NCI",Subhadra  Banerjee|Teresa Saumei Hawley|Caiyi  Li|Karen Marie Wolcott,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94158
726,BC011430-05,"October 01, 2015 -  September 30, 2016",CPTR - Mass Spectrometry Unit,Lisa Marie Jenkins,Suresh V Ambudkar; PhD,"Pigment Cell Biology Section, NCI",NULL,NULL,"Paul A Randazzo; MD, PhD (Laboratory of Cellular and Molecular Biology)|Michael Marc Gottesman; MD (Laboratory of Cell Biology)|Ettore  Appella; MD (Chemical Immunology Section)|Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Michael  Maurizi; PhD (Biochemistry of Proteins Section)|Jonathan D Ashwell; MD (Laboratory of Immune Cell Biology)",NULL,"1. Appella E, Jenkins LM, Guengerich FP (2015). Introduction to thematic series: protein interactions, structures, and networks. J Biol Chem  290, 26393-4.   https://doi.org/10.1074/jbc.R115.690370|2. Jones T, Cardozo T, Abell L, Hsieh M, Jenkins L, Jha S, Hinton D (2016) Visualizing the phage T4 activated transcription complex of DNA and E. coli RNA polymerase. Nucleic Acids Research, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=94138
727,BC011434-05,"October 01, 2015 -  September 30, 2016","Nano-scale proteomic analysis: development, implementation, and applications",Jinqiu  Chen,Peter  Blumberg; PhD,"Laboratory of Cancer Biology and Genetics, NCI",Xiaoling  Luo|Lalage  Wakefield; PhD|Beverly  Mock; PhD|Stuart H Yuspa; MD|Ji  Luo|Jeffrey E Green; MD,NULL,"Javed  Khan; MD (Cancer Genetics Branch)|Udayan  Guha (Thoracic & Oncologic Surgery Branch)|Stanley  Lipkowitz; MD, PhD (Womens Malignancies Branch)|Ettore  Appella; MD (Chemical Immunology Section)|Thomas A Misteli; PhD (Laboratory of Receptor Biology and Gene Expression)|Christina M Annunziata (Womens Malignancies Branch)",NULL,"1. Chen JQ, Wakefield LM, Goldstein DJ (2015). Capillary nano-immunoassays: advancing quantitative proteomics analysis, biomarker assessment, and molecular diagnostics. J Transl Med  13, 182.   https://doi.org/10.1186/s12967-015-0537-6|2. Holkova B, Zingone A, Kmieciak M, Bose P, Badros AZ, Voorhees PM, Baz R, Korde N, Lin HY, Chen JQ, Herrmann M, Xi L, Raffeld M, Zhao X, Wan W, Tombes MB, Shrader E, Weir-Wiggins C, Sankala H, Hogan KT, Doyle A, Annunziata CM, Wellons M, Roberts JD, Sullivan D, et al. [2 more authors] (2016). A Phase II Trial of AZD6244 (Selumetinib, ARRY-142886), an Oral MEK1/2 Inhibitor, in Relapsed/Refractory Multiple Myeloma. Clin Cancer Res  22, 1067-75.   https://doi.org/10.1158/1078-0432.CCR-15-1076",https://intramural.nih.gov/search/searchview.taf?ipid=94144
728,BC011475-04,"October 01, 2015 -  September 30, 2016",Genomics and Bioinformatics Group web site development and maintenance,William Curtis Reinhold,Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",Margot  Sunshine|Sudhir  Varma,NULL,NULL,NULL,"1. Reinhold WC, Sunshine M, Varma S, Doroshow JH, Pommier Y (2015). Using CellMiner 1.6 for Systems Pharmacology and Genomic Analysis of the NCI-60. Clin Cancer Res  21, 3841-52.   https://doi.org/10.1158/1078-0432.CCR-15-0335",https://intramural.nih.gov/search/searchview.taf?ipid=94171
729,BC011497-04,"October 01, 2015 -  September 30, 2016",RNA sequencing (RNA-Seq) of the NCI-60,William Curtis Reinhold,Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",Margot  Sunshine|Sudhir  Varma|James Halpern Doroshow,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94169
730,BC011499-04,"October 01, 2015 -  September 30, 2016",DNA methylation data and its web-based tool for the NCI-60,William Curtis Reinhold,Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",James Halpern Doroshow,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94168
731,BC011509-04,"October 01, 2015 -  September 30, 2016",Comparison of molecular factors to drug activities,William Curtis Reinhold,Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",Margot  Sunshine|Sudhir  Varma|James Halpern Doroshow,Jacques  Robert (DEVELOPMENTAL THERAPEUTICS BRANCH)|Fabricio Garmus Sousa (LABORATORY MOLECULAR PHARMACOLOGY),"David Jay Goldstein (Office of the Director)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"1. Reinhold WC, Sunshine M, Varma S, Doroshow JH, Pommier Y (2015). Using CellMiner 1.6 for Systems Pharmacology and Genomic Analysis of the NCI-60. Clin Cancer Res  21, 3841-52.   https://doi.org/10.1158/1078-0432.CCR-15-0335|2. Sousa FG, Matuo R, Tang SW, Rajapakse VN, Luna A, Sander C, Varma S, Simon PH, Doroshow JH, Reinhold WC, Pommier Y (2015) Alterations of DNA repair genes in the NCI-60 cell lines and their predictive value for anticancer drug activity. DNA Repair (Amst) 28:107-15",https://intramural.nih.gov/search/searchview.taf?ipid=94170
732,BC011515-04,"October 01, 2015 -  September 30, 2016",Chemical Synthesis Core,Joel Patrick Schneider; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Gary T Pauly,NULL,Eric O Freed; PhD (HIV Drug Resistance Program)|Stephen H Hughes; PhD (Retroviral Replication Laboratory),NULL,"1. Urano E, Ablan SD, Mandt R, Pauly GT, Sigano DM, Schneider JP, Martin DE, Nitz TJ, Wild CT, Freed EO (2016). Alkyl Amine Bevirimat Derivatives Are Potent and Broadly Active HIV-1 Maturation Inhibitors. Antimicrob Agents Chemother  60, 190-7.   https://doi.org/10.1128/AAC.02121-15",https://intramural.nih.gov/search/searchview.taf?ipid=94181
733,BC011531-04,"October 01, 2015 -  September 30, 2016",High Throughput Screening of Agents in Bladder Cancer Cell Lines,Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Louis Spencer Krane|Reema Sunil Railkar|Thomas  Sanford,NULL,Andrea Borghese Apolo (Genitourinary Malignancies Branch),Craig Joseph Thomas (NCATS) |Marc  Ferrer-Alegre (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94189
734,BC011532-04,"October 01, 2015 -  September 30, 2016",CCR Collaborative Bioinformatics Resource,David Jay Goldstein,Thomas A Misteli; PhD,"Office of the Director, NCI",Margaret  Cam; PhD|Fathi  Elloumi|Richard Phillip Finney|Peter C Fitzgerald|Parthav A Jailwala|Bong-Hyun  Kim|Show all 14,NULL,"Frank Jess Gonzalez; PhD (Laboratory of Metabolism)|Robert  Callahan; PhD (Basic Research Laboratory)|Udai S Kammula (Surgery Branch)|Cheryl Ann Winkler (Basic Research Laboratory)|Remy J Bosselut; MD, PhD (Laboratory of Immune Cell Biology)|Dennis D Hickstein (Experimental Transplantation and Immunology Branch)",NULL,"1. Dine JL, O'Sullivan CC, Voeller D, Greer YE, Chavez KJ, Conway CM, Sinclair S, Stone B, Amiri-Kordestani L, Merchant AS, Hewitt SM, Steinberg SM, Swain SM, Lipkowitz S (2016). The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl. Breast Cancer Res Treat  155, 235-51.   https://doi.org/10.1007/s10549-015-3673-z|2. He X, Tillo D, Vierstra J, Syed KS, Deng C, Ray GJ, Stamatoyannopoulos J, FitzGerald PC, Vinson C (2015). Methylated Cytosines Mutate to Transcription Factor Binding Sites that Drive Tetrapod Evolution. Genome Biol Evol  7, 3155-69.   https://doi.org/10.1093/gbe/evv205|3. Rothermel LD, Sabesan AC, Stephens DJ, Chandran SS, Paria BC, Srivastava AK, Somerville R, Wunderlich JR, Lee CC, Xi L, Pham TH, Raffeld M, Jailwala P, Kasoji M, Kammula US (2016). Identification of an Immunogenic Subset of Metastatic Uveal Melanoma. Clin Cancer Res  22, 2237-49.   https://doi.org/10.1158/1078-0432.CCR-15-2294",https://intramural.nih.gov/search/searchview.taf?ipid=94199
735,BC011535-03,"October 01, 2015 -  September 30, 2016",SAXS Core,Yun Xing M Wang|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",NULL,NULL,Alan  Rein; PhD (Retroviral Replication Laboratory)|Xinhua  Ji; PhD (Biomolecular Structure Section),Adrian Riu Ferre-D'Amare (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94239
736,BC011567-03,"October 01, 2015 -  September 30, 2016",HiTIF Microscopy Core Facility,Gianluca  Pegoraro,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",Prabhakar R Gudla; PhD|Laurent L Ozbun|Thomas A Misteli; PhD|Daniel Robert Larson; PhD|Philipp  Oberdoerffer,NULL,Andre A Nussenzweig; PhD (Laboratory Of Genome Integrity)|Carol J Thiele (Pediatric Oncology Branch)|Kathleen  Kelly; PhD (Laboratory Of Genitourinary Cancer Pathogenesis)|Munira A Basrai; PhD (Cancer Genetics Branch),"Mary C Dasso; BA, PhD (NICHD) |Iain  Fraser (NIAID) |Madhu A Lal (NCATS)","1. Burman B, Misteli T, Pegoraro G (2015). Quantitative detection of rare interphase chromosome breaks and translocations by high-throughput imaging. Genome Biol  16, 146.   https://doi.org/10.1186/s13059-015-0718-x|2. Burman B, Zhang ZZ, Pegoraro G, Lieb JD, Misteli T (2015). Histone modifications predispose genome regions to breakage and translocation. Genes Dev  29, 1393-402.   https://doi.org/10.1101/gad.262170.115|3. Ji X, Dadon DB, Powell BE, Fan ZP, Borges-Rivera D, Shachar S, Weintraub AS, Hnisz D, Pegoraro G, Lee TI, Misteli T, Jaenisch R, Young RA (2016). 3D Chromosome Regulatory Landscape of Human Pluripotent Cells. Cell Stem Cell  18, 262-75.   https://doi.org/10.1016/j.stem.2015.11.007|4. Kubben N, Zhang W, Wang L, Voss TC, Yang J, Qu J, Liu GH, Misteli T (2016). Repression of the Antioxidant NRF2 Pathway in Premature Aging. Cell  165, 1361-1374.   https://doi.org/10.1016/j.cell.2016.05.017|5. Pegoraro G, Misteli T (2016). High-throughput Imaging as a versatile and unbiased discovery tool. Methods  96, 1-2.   https://doi.org/10.1016/j.ymeth.2016.01.003|6. Roukos V, Pegoraro G, Voss TC, Misteli T (2015). Cell cycle staging of individual cells by fluorescence microscopy. Nat Protoc  10, 334-48.   https://doi.org/10.1038/nprot.2015.016|7. Shachar S, Pegoraro G, Misteli T (2015). HIPMap: A High-Throughput Imaging Method for Mapping Spatial Gene Positions. Cold Spring Harb Symp Quant Biol  80, 73-81.   https://doi.org/10.1101/sqb.2015.80.027417|8. Shachar S, Voss TC, Pegoraro G, Sciascia N, Misteli T (2015). Identification of Gene Positioning Factors Using High-Throughput Imaging Mapping. Cell  162, 911-23.   https://doi.org/10.1016/j.cell.2015.07.035|9. Zong D, Callén E, Pegoraro G, Lukas C, Lukas J, Nussenzweig A (2015). Ectopic expression of RNF168 and 53BP1 increases mutagenic but not physiological non-homologous end joining. Nucleic Acids Res  43, 4950-61.   https://doi.org/10.1093/nar/gkv336",https://intramural.nih.gov/search/searchview.taf?ipid=94218
737,BC011569-03,"October 01, 2015 -  September 30, 2016",Cell Production Core Facility,Robert P Somerville,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",Carol Marie Bryant|Zulmarie  Franco; MSc|Mary B Ganges|Michelle  Pelletier|Tangying  Lu|Azam V Nahvi|Show all 9,NULL,Christian S Hinrichs (Experimental Transplantation and Immunology Branch)|James N Kochenderfer (Experimental Transplantation and Immunology Branch),NULL,"1. Benz BA, Nandadasa S, Takeuchi M, Grady RC, Takeuchi H, LoPilato RK, Kakuda S, Somerville RPT, Apte SS, Haltiwanger RS, Holdener BC (2016). Genetic and biochemical evidence that gastrulation defects in Pofut2 mutants result from defects in ADAMTS9 secretion. Dev Biol  416, 111-122.   https://doi.org/10.1016/j.ydbio.2016.05.038|2. Brudno JN, Somerville RP, Shi V, Rose JJ, Halverson DC, Fowler DH, Gea-Banacloche JC, Pavletic SZ, Hickstein DD, Lu TL, Feldman SA, Iwamoto AT, Kurlander R, Maric I, Goy A, Hansen BG, Wilder JS, Blacklock-Schuver B, Hakim FT, Rosenberg SA, Gress RE, Kochenderfer JN (2016). Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease. J Clin Oncol  34, 1112-21.   https://doi.org/10.1200/JCO.2015.64.5929|3. Goff SL, Dudley ME, Citrin DE, Somerville RP, Wunderlich JR, Danforth DN, Zlott DA, Yang JC, Sherry RM, Kammula US, Klebanoff CA, Hughes MS, Restifo NP, Langhan MM, Shelton TE, Lu L, Kwong ML, Ilyas S, Klemen ND, Payabyab EC, Morton KE, Toomey MA, Steinberg SM, White DE, Rosenberg SA (2016). Randomized, Prospective Evaluation Comparing Intensity of Lymphodepletion Before Adoptive Transfer of Tumor-Infiltrating Lymphocytes for Patients With Metastatic Melanoma. J Clin Oncol  34, 2389-97.   https://doi.org/10.1200/JCO.2016.66.7220|4. Kochenderfer JN, Dudley ME, Kassim SH, Somerville RP, Carpenter RO, Stetler-Stevenson M, Yang JC, Phan GQ, Hughes MS, Sherry RM, Raffeld M, Feldman S, Lu L, Li YF, Ngo LT, Goy A, Feldman T, Spaner DE, Wang ML, Chen CC, Kranick SM, Nath A, Nathan DA, Morton KE, Toomey MA, et al. [1 more author] (2015). Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor. J Clin Oncol  33, 540-9.   https://doi.org/10.1200/JCO.2014.56.2025",https://intramural.nih.gov/search/searchview.taf?ipid=94216
738,BC011571-03,"October 01, 2015 -  September 30, 2016",Transcription factor mobility,Tatiana  Karpova,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94210
739,BC011574-03,"October 01, 2015 -  September 30, 2016",LRBGE Optical Microscopy Core,Tatiana  Karpova,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",NULL,"Keith  Wilkinson; PhD (Biochemistry, Emory University)|John S Choy","Munira A Basrai; PhD (Cancer Genetics Branch)|Genoveffa  Franchini; MD (Vaccine Branch)|Vladimir L Larionov; PhD, DSc (Developmental Therapeutics Branch)|Kyung  Lee; PhD (Chemistry Section)|Karl Thomas Ried; MD (Cancer Genetics Branch)|Marjorie  Robert-Guroff; PhD (Vaccine Branch)","Marta Liliana Catalfamo; PhD (NIAID) |Edward  Giniger; BS, MS, PHD (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94213
740,BC011596-03,"October 01, 2015 -  September 30, 2016",CCR Dedicated Cores at the ATRF,Janelle  Cortner,Thomas A Misteli; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94201
741,BC011622-02,"October 01, 2015 -  September 30, 2016",Development of novel molecular or phenotypic databases,William Curtis Reinhold,Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",Margot  Sunshine|Sudhir  Varma|James Halpern Doroshow,"Manel  Esteller (Cancer Epigenetics Laboratory, Spanish National Cancer Center)|Mathew  Garnett (Wellcome Trust Sanger Institute)|Aebersold  Ruedi (Institute of Biotechnology at the Swiss Federal Institute of Technology)","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Kirk R Gustafson; PhD (Molecular Targets Laboratory)",NULL,"1. Luna A, Rajapakse VN, Sousa FG, Gao J, Schultz N, Varma S, Reinhold W, Sander C, Pommier Y (2016). rcellminer: exploring molecular profiles and drug response of the NCI-60 cell lines in R. Bioinformatics  32, 1272-4.   https://doi.org/10.1093/bioinformatics/btv701|2. Nogales V, Reinhold WC, Varma S, Martinez-Cardus A, Moutinho C, Moran S, Heyn H, Sebio A, Barnadas A, Pommier Y, Esteller M (2016). Epigenetic inactivation of the putative DNA/RNA helicase SLFN11 in human cancer confers resistance to platinum drugs. Oncotarget  7, 3084-97.   https://doi.org/10.18632/oncotarget.6413|3. Reinhold WC, Sunshine M, Varma S, Doroshow JH, Pommier Y (2015). Using CellMiner 1.6 for Systems Pharmacology and Genomic Analysis of the NCI-60. Clin Cancer Res  21, 3841-52.   https://doi.org/10.1158/1078-0432.CCR-15-0335",https://intramural.nih.gov/search/searchview.taf?ipid=94265
742,BC011623-02,"October 01, 2015 -  September 30, 2016",CCR Genomics Core,Elizabeth A Conner,Javed  Khan; MD,"Cancer Genetics Branch, NCI",Valery  Bliskovsky; PhD|Steven W Shema|Qin  Wei,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94263
743,BC011638-02,"October 01, 2015 -  September 30, 2016",Experimental Pathology Laboratory (EPL),"Stephen M Hewitt; MD, PhD",Frederic Glenn Barr,"Laboratory of Pathology, NCI",Elaine S Jaffe; MD,NULL,NULL,NULL,"1. Braunschweig T, Chung JY, Choi CH, Cho H, Chen QR, Xie R, Perry C, Khan J, Hewitt SM (2015). Assessment of a panel of tumor markers for the differential diagnosis of benign and malignant effusions by well-based reverse phase protein array. Diagn Pathol  10, 53.   https://doi.org/10.1186/s13000-015-0290-4|2. Choi CH, Chung JY, Kim JH, Kim BG, Hewitt SM (2016). Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patients. J Transl Med  14, 124.   https://doi.org/10.1186/s12967-016-0874-0|3. Perry C, Chung JY, Ylaya K, Choi CH, Simpson A, Matsumoto KT, Smith WA, Hewitt SM (2016). A Buffered Alcohol-Based Fixative for Histomorphologic and Molecular Applications. J Histochem Cytochem  64, 425-40.   https://doi.org/10.1369/0022155416649579",https://intramural.nih.gov/search/searchview.taf?ipid=94258
744,BC011641-02,"October 01, 2015 -  September 30, 2016",Pre-clinical Translational Research Facility,Mark Richard Gilbert; MD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI","Rolanda  Bailey|Dionne  Davis|Hua  Song|Jing  Wu; MD, PhD|Wei  Zhang",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94270
745,BC011724-01,"-  September 30, 2016",Effects of Cytosine Modifications on Transcription Factor Binding,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,Charles  Vinson; PhD (Nucleic Acids Section),NULL,"1. Syed K, HE X, Holzberg T, Wang J, Upadhyay S, Durell S, Mukherjee S, Weirauch M, Rose R, Vinson C (2016) 5-hydroxymethylcytosine in E-Box motifs ACATGTG and ACACGTG increases DNA-binding of the B-HLH transcription factor TCF4 but not USF1. Integr Biol, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=97613
746,BC011731-01,"-  September 30, 2016",Tissue Procurement  Processing Facility and Biorepository,Joseph  Chinquee,Frederic Glenn Barr,"Laboratory of Pathology, NCI",Neil J Hardegen|Mohammad Javed Mahboob|Sarah Paige Young,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97620
747,CO020007-08,"October 01, 2015 -  September 30, 2016",NCI-Frederick Support and Technical Services,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"National Cancer Institute, NCI",NULL,NULL,Craig W Reynolds  (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94284
748,CP010178-15,"October 01, 2015 -  September 30, 2016",Cancer Genomics Research Laboratory,"Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",Meredith  Yeager|Tabassum  Bandey|Ian K Barrow|Michael  Beerman|Merideth  Brown|Laura Ann Burdett|Show all 24,NULL,Gilles F Thomas (Laboratory Translational Genomics)|Xiang  Deng (Radiation Oncology Branch)|Kashif  Haque (Office Of The Director)|Kevin  Jacobs (Laboratory Translational Genomics)|Calvin  Ott (Office Of The Director)|Liqun  Qi (Biorepositories & Biospecimen Research Branch),Jun  Lu (NIEHS),"1. Machiela MJ, Zhou W, Caporaso N, Dean M, Gapstur SM, Goldin L, Stevens VL, Yeager M, Chanock SJ (2016). Mosaic 13q14 deletions in peripheral leukocytes of non-hematologic cancer cases and healthy controls. J Hum Genet  61, 411-8.   https://doi.org/10.1038/jhg.2015.166|2. Zanetti KA, Wang Z, Aldrich M, Amos CI, Blot WJ, Bowman ED, Burdette L, Cai Q, Caporaso N, Chung CC, Gillanders EM, Haiman CA, Hansen HM, Henderson BE, Kolonel LN, Marchand LL, Li S, McNeill LH, Ryan BM, Schwartz AG, Sison JD, Spitz MR, Tucker M, Wenzlaff AS, Wiencke JK, et al. [17 more authors] (2016). Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population. Lung Cancer  98, 33-42.   https://doi.org/10.1016/j.lungcan.2016.05.008|3. Zhou W, Machiela MJ, Freedman ND, Rothman N, Malats N, Dagnall C, Caporaso N, Teras LT, Gaudet MM, Gapstur SM, Stevens VL, Jacobs KB, Sampson J, Albanes D, Weinstein S, Virtamo J, Berndt S, Hoover RN, Black A, Silverman D, Figueroa J, Garcia-Closas M, Real FX, Earl J, Marenne G, et al. [13 more authors] (2016). Mosaic loss of chromosome Y is associated with common variation near TCL1A. Nat Genet  48, 563-8.   https://doi.org/10.1038/ng.3545",https://intramural.nih.gov/search/searchview.taf?ipid=94317
749,CP010192-09,"October 01, 2015 -  September 30, 2016","Biorepository Processing, Storage, and Research","Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",Karen E Berliner|Marianne  Henderson,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94336
750,CP010203-08,"October 01, 2015 -  September 30, 2016",Applied Molecular Pathology Laboratory,Margaret Anne Tucker|IRP Faculty Profile,NULL,"Human Genetics Program, NCI",NULL,NULL,"Mark E Sherman; MD (Breast and Gynecologic Cancer Research Group)|Karen E Berliner (Office of the Director)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94339
751,CP010223-05,"October 01, 2015 -  September 30, 2016",Endogenous Hormone Measurement Production Assay Infrastructure at the FNLCR,"Louise  Brinton; PhD| | |Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI

Office of the Director, NCI","Marianne  Henderson|Regina Gale Ziegler; PhD, MPH",Timothy  Veenstra (SAIC)|Xia  Xu (SAIC frederick),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94360
752,CP010226-03,"October 01, 2015 -  September 30, 2016",Cohort and Biobank Development,"Amy  de Gonzalez|IRP Faculty Profile  | |Katherine Ann McGlynn; PhD|IRP Faculty Profile  | |Mark  Purdue|IRP Faculty Profile  | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Radiation Epidemiology Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI

Clinical Genetics Branch, NCI",Hannah  Yang|Amanda  Black|Catherine G Schairer,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94363
753,SC006536-23,"October 01, 2015 -  September 30, 2016",Sample Processing and Analytical Methods Development for New Anticancer Agents,William D Figg; PharmD|IRP Faculty Profile,NULL,"Office Of The Clinical Director, NCI",Julie Katherine Barnes|Paula A Carter|David Kyle Doan|Merrill E Goldsmith|Trung C Pham|Diana  Roame|Show all 8,NULL,Brigitte  Widemann; MD (Pediatric Oncology Branch)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|David  Schrump; MD (Thoracic & Oncologic Surgery Branch)|Christina M Annunziata (Womens Malignancies Branch)|Andrea Borghese Apolo (Genitourinary Malignancies Branch)|William Laurence Dahut; MD (Genitourinary Malignancies Branch),NULL,"1. Akshintala S, Marcus L, Warren KE, Murphy RF, Sissung TM, Srivastava A, Goodspeed WJ, Goodwin A, Brewer CC, Zalewski C, King KA, Kim A, Figg WD, Widemann BC (2015). Phase 1 trial and pharmacokinetic study of the oral platinum analog satraplatin in children and young adults with refractory solid tumors including brain tumors. Pediatr Blood Cancer  62, 603-10.   https://doi.org/10.1002/pbc.25344|2. Peer C, Ronner P, Rodgers L, McCully C, Warren K, Figg W (2016) Quantitation of Temozolomide in Nonhuman Primate Fluids by Isocratic Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry to Study Brain Tissue Penetration following Intranasal or Intravenous Delivery Separations (formerly Chromatography) 3:4",https://intramural.nih.gov/search/searchview.taf?ipid=94413
754,SC006537-23,"October 01, 2015 -  September 30, 2016",Using Clinical Pharmacology Principles to Develop New Anticancer Therapies,William D Figg; PharmD|IRP Faculty Profile,NULL,"Office Of The Clinical Director, NCI",Julie Katherine Barnes|Andrew Kiem Goey|Alesia J Holly|Cody John Peer|Keith Thomas Schmidt|Tristan  Sissung|Show all 7,Michael  Pacanowski (FDA)|C  Landgren (Memorial Sloan Kettering Cancer Center),Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Heidi H Kong (Dermatology Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Howard  Parnes (Prostate and Urologic Cancer Research Group)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|Richard Lawrence Piekarz (Investigational Drug Branch),Fatima Hafiz Karzai; MD (NIMHD),"1. Thomas A, Bates S, Figg W, Pommier Y (2015) DNA Topoisomerase Targeting Drugs, in Holland-Frei Cancer Medicine, 9th Ed, in press.|2. Akshintala S, Marcus L, Warren KE, Murphy RF, Sissung TM, Srivastava A, Goodspeed WJ, Goodwin A, Brewer CC, Zalewski C, King KA, Kim A, Figg WD, Widemann BC (2015). Phase 1 trial and pharmacokinetic study of the oral platinum analog satraplatin in children and young adults with refractory solid tumors including brain tumors. Pediatr Blood Cancer  62, 603-10.   https://doi.org/10.1002/pbc.25344|3. Goey AK, Sissung TM, Peer CJ, Trepel JB, Lee MJ, Tomita Y, Ehrlich S, Bryla C, Balasubramaniam S, Piekarz R, Steinberg SM, Bates SE, Figg WD (2016). Effects of UGT1A1 genotype on the pharmacokinetics, pharmacodynamics, and toxicities of belinostat administered by 48-hour continuous infusion in patients with cancer. J Clin Pharmacol  56, 461-73.   https://doi.org/10.1002/jcph.625|4. Massey PR, Prasad V, Figg WD, Fojo T (2015). Multiplying therapies and reducing toxicity in metastatic melanoma. Cancer Biol Ther  16, 1014-8.   https://doi.org/10.1080/15384047.2015.1046650|5. Okoli TC, Peer CJ, Dunleavy K, Figg WD (2015). Targeted PI3Kδ inhibition by the small molecule idelalisib as a novel therapy in indolent non-Hodgkin lymphoma. Cancer Biol Ther  16, 204-6.   https://doi.org/10.1080/15384047.2014.1002369|6. Peer C, Ronner P, Rodgers L, McCully C, Warren K, Figg W (2016) Quantitation of Temozolomide in Nonhuman Primate Fluids by Isocratic Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry to Study Brain Tissue Penetration following Intranasal or Intravenous Delivery Separations (formerly Chromatography) 3:4|7. Schmidt KT, Chau CH, Price DK, Figg WD (2016). Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment. J Clin Pharmacol  56, 1484-1499.   https://doi.org/10.1002/jcph.765|8. Strauss J, Alewine C, Figg WD, Duffy A (2016). Targeting the microenvironment of pancreatic cancer: overcoming treatment barriers and improving local immune responses. Clin Transl Oncol  18, 653-9.   https://doi.org/10.1007/s12094-015-1459-8|9. Strauss J, Figg WD (2015). Epigenetic approaches to overcoming chemotherapy resistance. Lancet Oncol  16, 1013-1015.   https://doi.org/10.1016/S1470-2045(15)00231-4",https://intramural.nih.gov/search/searchview.taf?ipid=94414
755,SC006743-23,"October 01, 2015 -  September 30, 2016",Signal Transduction Events and the Regulation of Cell Growth,Jane Beth Trepel,Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",Min Jung Lee|Sunmin T Lee|Nadereh  Nasr|David B Rekhtman|Saori  Tomita|Yusuke  Tomita|Show all 7,"Jay  Bradner (Chemical Biology Program, Broad Institute)|Marc  Cox (University of Texas at El Paso)|Shiv  Srivastava (Urology, CPDR, USUHS)|Christophe  Nicot (-, University of Kansas Medical Center)|Luke  Whitesell (Pediatrics, University of Arizona)","Leonard  Neckers; PhD (Urologic Oncology Branch)|William Marston Linehan; MD (Urologic Oncology Branch)|Donald P Bottaro; PhD (Urologic Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Lauren V Wood; MD (Vaccine Branch)","Karel  Pacak; MD, PhD (NICHD)","1. Gharwan H, Tomita Y, Lee M, Thomas A, Berman A, Giaccone G, Trepel J, Rajan A (2015) Alterations of immune cell subsets in thymoma-associated steroid-refractory minimal change disease. Oncol Lett, in press.|2. Gharwan H, Tomita Y, Lee MJ, Thomas A, Berman A, Giaccone G, Trepel J, Rajan A (2015). Alterations of immune cell subsets in relapsed, thymoma-associated minimal change disease: A case report. Oncol Lett  10, 1155-1158.   https://doi.org/10.3892/ol.2015.3325|3. Lee HS, Lee NC, Kouprina N, Kim JH, Kagansky A, Bates S, Trepel JB, Pommier Y, Sackett D, Larionov V (2016). Effects of Anticancer Drugs on Chromosome Instability and New Clinical Implications for Tumor-Suppressing Therapies. Cancer Res  76, 902-11.   https://doi.org/10.1158/0008-5472.CAN-15-1617",https://intramural.nih.gov/search/searchview.taf?ipid=94412
756,SC009372-25,"October 01, 2015 -  September 30, 2016",Flow Cytometric Analysis of Benign and Malignant Tumors,"Maryalice  Stetler-Stevenson; MD, PhD",Frederic Glenn Barr,"Laboratory of Pathology, NCI",Kathryn Elizabeth Fulda|Gregory A Jasper|Catharine S Mccoy|Dalia Abdel-Raouf Salem|Drake Anthony Scott|Linda Shonk Weaver|Show all 7,NULL,"Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Ira H Pastan; MD (Molecular Biology Section)|Daniel H Fowler (Experimental Transplantation and Immunology Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|Thomas S Uldrick (HIV and AIDS Malignancy Branch)|Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)","Adrian U Wiestner; MD, PhD (NHLBI)","1. Farooqui MZ, Valdez J, Martyr S, Aue G, Saba N, Niemann CU, Herman SE, Tian X, Marti G, Soto S, Hughes TE, Jones J, Lipsky A, Pittaluga S, Stetler-Stevenson M, Yuan C, Lee YS, Pedersen LB, Geisler CH, Calvo KR, Arthur DC, Maric I, Childs R, Young NS, Wiestner A (2015). Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial. Lancet Oncol  16, 169-76.   https://doi.org/10.1016/S1470-2045(14)71182-9|2. Kranick SM, Goncalves PH, Stetler-Stevenson M, Aleman K, Polizzotto MN, Little RF, Yarchoan R, Uldrick TS (2015). Paradoxical central nervous system immune reconstitution syndrome in acquired immunodeficiency syndrome-related primary central nervous system lymphoma. Haematologica  100, e21-4.   https://doi.org/10.3324/haematol.2014.114736|3. Kreitman RJ, Stetler-Stevenson M, Jaffe ES, Conlon KC, Steinberg SM, Wilson W, Waldmann TA, Pastan I (2016). Complete Remissions of Adult T-cell Leukemia with Anti-CD25 Recombinant Immunotoxin LMB-2 and Chemotherapy to Block Immunogenicity. Clin Cancer Res  22, 310-8.   https://doi.org/10.1158/1078-0432.CCR-15-1412|4. Manasanch EE, Salem DA, Yuan CM, Tageja N, Bhutani M, Kwok M, Kazandjian D, Carter G, Steinberg SM, Zuchlinski D, Mulquin M, Calvo K, Maric I, Roschewski M, Korde N, Braylan R, Landgren O, Stetler-Stevenson M (2015). Flow cytometric sensitivity and characteristics of plasma cells in patients with multiple myeloma or its precursor disease: influence of biopsy site and anticoagulation method. Leuk Lymphoma  56, 1416-24.   https://doi.org/10.3109/10428194.2014.955020|5. Sun C, Tian X, Lee YS, Gunti S, Lipsky A, Herman SE, Salem D, Stetler-Stevenson M, Yuan C, Kardava L, Moir S, Maric I, Valdez J, Soto S, Marti GE, Farooqui MZ, Notkins AL, Wiestner A, Aue G (2015). Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib. Blood  126, 2213-9.   https://doi.org/10.1182/blood-2015-04-639203",https://intramural.nih.gov/search/searchview.taf?ipid=94373
757,BC010686-12,"October 01, 2015 -  September 30, 2016",Clinical Operations for Laboratory of Pathology,Joseph  Chinquee,Frederic Glenn Barr,"Laboratory of Pathology, NCI",Earle J Barnes|Arthur Alan Crump|Neil J Hardegen|Kayla A O'Donnell|Silke  Williams,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93780
758,BC010694-12,"October 01, 2015 -  September 30, 2016",Clinical Cancer Cytogenetics,Diane Carol Arthur; MD,Frederic Glenn Barr,"Laboratory of Pathology, NCI","Elaine S Jaffe; MD|Stefania  Pittaluga|Maryalice  Stetler-Stevenson; MD, PhD",NULL,"Blanche P Alter (Clinical Genetics Branch)|Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)|Neelam K Giri; MD (Clinical Genetics Branch)|Sharon Ann Savage (Clinical Genetics Branch)|Daniel H Fowler (Experimental Transplantation and Immunology Branch)","Gerald Ernest Marti (NHLBI) |Adrian U Wiestner; MD, PhD (NHLBI) |Irina  Maric; MD (CC) |Katherine Rainsford Calvo (CC) |Mohammed Zulfiqar Farooqui; DO (NHLBI) |Steven M Holland; MD (NIAID)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93767
759,BC010882-09,"October 01, 2015 -  September 30, 2016",Center for Cancer Research Clinical Trials Support,"Caryn  Steakley; BA, BSN, MSW",William Laurence Dahut; MD,"Office Of The Clinical Director, NCI",Deborah Anne Grady|Lisa R King|Susan G Mcmullen|Elizabeth A Ness|Martha B Shaw,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93919
760,BC010963-09,"October 01, 2015 -  September 30, 2016",ETIB Clinical Research Core,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Megan Irene Kenyon|Lauren R Skeffington,"Andrew  Pecora (Cancer Center, Hackensack University)|Robert  Korngold (Cancer Center, Hackensack University)|Scott  Rowley (Hackensack University)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93886
761,BC010987-09,"October 01, 2015 -  September 30, 2016",Center for Cancer Research Patient Travel,"Caryn  Steakley; BA, BSN, MSW",William Laurence Dahut; MD,"Office Of The Clinical Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93920
762,BC010990-09,"October 01, 2015 -  September 30, 2016",Radiation Oncology Branch - Radiation Clinic,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93869
763,BC011022-08,"October 01, 2015 -  September 30, 2016",Clinical Research Support for the CCR,Thomas A Misteli; PhD|IRP Faculty Profile,NULL,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93606
764,BC011089-09,"October 01, 2015 -  September 30, 2016",Clinical Nursing and Data Management Core,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Donald P Bottaro; PhD,NULL,Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)|Bradford J Wood; MD (Office of the Director),"Emily Y Chew; MD (NEI) |Karel  Pacak; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93963
765,BC011092-09,"October 01, 2015 -  September 30, 2016",Urologic Oncology Branch Consult Core,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",NULL,NULL,Maria  Merino; PhD (Laboratory of Pathology),"Karel  Pacak; MD, PhD (NICHD) |Pamela  Stratton; MD (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93964
766,BC011242-08,"October 01, 2015 -  September 30, 2016",Center for Interventional Oncology,Bradford J Wood; MD|IRP Faculty Profile,NULL,"Office of the Director, NCI",NULL,Mark  Dewhirst (Duke)|Russel  Taylor (Johns Hopkins University)|Emad  Boctor (Johns Hopkins University)|Umar  Mahmood (Harvard / Massachusetts General Hospital)|Luigi  Solbiati (Busto Arsizio)|Thierry  de Bare (Institut de Cancrologie Gustave Roussy)|Show all 23,"Peter A Pinto; MD (Urologic Oncology Branch)|William Marston Linehan; MD (Urologic Oncology Branch)|Deborah E Citrin (Radiation Oncology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)","Elliot Brian Levy (CC) |Karel  Pacak; MD, PhD (NICHD) |Karen T Adams (NICHD) |Karun  Sharma (CC) |David Alan Bluemke; MD, PhD (CC) |Andrew J Mannes; MD (CC)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94043
767,BC011291-07,"October 01, 2015 -  September 30, 2016",General Surgical Pathology,Markku Martti Miettinen|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",NULL,NULL,Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Claudia Mercedes Palena (Laboratory of Tumor Immunology and Biology)|Christopher Ryan Heery; MD (Laboratory of Tumor Immunology and Biology)|Raffit  Hassan (Thoracic & Oncologic Surgery Branch)|David  Schrump; MD (Thoracic & Oncologic Surgery Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94054
768,BC011317-07,"October 01, 2015 -  September 30, 2016",Dermatology Consultation Service,Edward W Cowen|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",Olanda M Hathaway,NULL,NULL,"Raphaela  Goldbach-Mansky; MD, MHS (NIAMS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94072
769,BC011517-04,"October 01, 2015 -  September 30, 2016",Pediatric Oncology Branch Behavioral Science Core,John Walter Glod,Brigitte  Widemann; MD,"Pediatric Oncology Branch, NCI",NULL,Leonard  Wexler (Memorial Sloan Kettering Cancer Center)|David  Jacobson (CNMC)|Wendy  Lichtenthal (MSKCC)|Jimmie  Holland (MSKCC)|Aziza  Shad (Georgetown),NULL,Maryland  Pao; MD (NIMH),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94178
770,BC011534-03,"October 01, 2015 -  September 30, 2016",EOB Clinical Core,Electron  Kebebew; MD|IRP Faculty Profile,NULL,"Endocrine Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94240
771,BC011540-03,"October 01, 2015 -  September 30, 2016",Thoracic and Gastrointestinal Oncology Branch Medical Clinical Core,Raffit  Hassan|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",NULL,NULL,Ira H Pastan; MD (Molecular Biology Section)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Peter L Choyke; MD (Molecular Imaging Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94238
772,BC011541-03,"October 01, 2015 -  September 30, 2016",TGIB Surgical Consultative Services,David  Schrump; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Colleen Donahue Bond|Marybeth S Hughes|Janice Marie Pappas|Lance Rodgers Redding|Yvonne  Shutack|Jeremy Lee Davis; MD|Show all 9,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94237
773,BC011543-03,"October 01, 2015 -  September 30, 2016",Medical Oncology Service Clinical Core,"James L Gulley; MD, PhD|IRP Faculty Profile",NULL,"Office Of The Clinical Director, NCI",Candis  Morrison|Tonette D Vinson|Gloria L Jackson|Robert Lee Alderman; PA-C|Janet A Edds|Jeannette Christine Nashed|Show all 8,NULL,Ravi  Madan (Genitourinary Malignancies Branch)|Christina M Annunziata (Womens Malignancies Branch)|Austin Gerard Duffy (Thoracic & Oncologic Surgery Branch)|Kieron Michael Dunleavy (Lymphoid Malignancies Branch)|Mark Jason Roschewski (Lymphoid Malignancies Branch)|Anish  Thomas; MD (Thoracic & Oncologic Surgery Branch),Diane  Aker (CC) |Ekene  Monyei (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94235
774,BC011578-03,"October 01, 2015 -  September 30, 2016",Clinical management of patients on immunotherapy protocols,Christopher Austin Klebanoff,NULL,"Surgery Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94214
775,BC011642-02,"October 01, 2015 -  September 30, 2016",Brain Tumor Clinical and Clinical Research Program,Mark Richard Gilbert; MD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Lisa Marie Boris|Kiera M Caffee|Nancy B Garren|Deric Minwoo Park|Surabhi  Ranjan|Christine  Laing|Show all 11,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch)|Andra Valentina Krauze (Radiation Oncology Branch)|Deedee Kay Smart (Radiation Oncology Branch),"John Anthony Butman; MD, PhD (CC) |John D Heiss; MD (NINDS) |Kareem Amir Zaghloul; MD, PhD (NINDS) |Edjah K Nduom (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94267
776,BC011683-01,"-  September 30, 2016",Medical Oncology HIV-AIDS Clinical Research,"James L Gulley; MD, PhD|IRP Faculty Profile",NULL,"Office Of The Clinical Director, NCI",Candis  Morrison|Tonette D Vinson,NULL,Mark Jason Roschewski (Lymphoid Malignancies Branch)|Priscila Hermont Goncalves; MD (HIV and AIDS Malignancy Branch)|Thomas S Uldrick (HIV and AIDS Malignancy Branch)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch),Diane  Aker (CC) |Deborah A Kolakowski (CC) |Ekene  Monyei (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97580
777,BC011716-01,"-  September 30, 2016",CCR Research Nursing,"Caryn  Steakley; BA, BSN, MSW",William Laurence Dahut; MD,"Office Of The Clinical Director, NCI",Joan  Aaron|Karen O Aleman|Deborah E Allen|Melissa Maria Amaya|Christine L Atallah|Sonia Elisa Bellfield|Show all 78,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97606
778,BC011729-01,"-  September 30, 2016",Chronic graft-versus-host disease in children and young adults,Nataliya Prokopenko Buxbaum|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Brittany Ursula Oliver,NULL,NULL,"Maya Beth Lodish (NICHD) |Jacqueline W Mays; DDS, PhD (NIDCR) |Ninet  Sinaii (CC)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97618
779,SC006329-36,"October 01, 2015 -  September 30, 2016",Clinical Radiation Physics Service,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",Deborah E Citrin|Deedee Kay Smart,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94369
780,SC007202-33,"October 01, 2015 -  September 30, 2016",Biostatistics and Data Management Section,Seth M Steinberg; PhD|IRP Faculty Profile,NULL,"Biostatistics and Data Management Section, NCI",David J Liewehr|David J Venzon; PhD,NULL,"Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|James Chung-Yin Yang; MD, PhD (Surgery Branch)|Marjorie  Robert-Guroff; PhD (Vaccine Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94365
781,BC010843-10,"October 01, 2015 -  September 30, 2016",Medical Oncology Fellowship Program,Marijo  Bilusic,"James L Gulley; MD, PhD","Genitourinary Malignancies Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93814
782,BC011023-09,"October 01, 2015 -  September 30, 2016",Clinical Fellowship Training Program,Peter A Pinto; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",NULL,NULL,Peter L Choyke; MD (Molecular Imaging Program)|Bradford J Wood; MD (Office of the Director)|Maria  Merino; PhD (Laboratory of Pathology),NULL,"1. Sidana A, Walton-Diaz A, Truong H, Siddiqui MM, Miao N, Shih J, Mannes A, Bratslavsky G, Linehan WM, Metwalli AR (2016). Postoperative elevation in creatine kinase and its impact on renal function in patients undergoing complex partial nephrectomy. Int Urol Nephrol  48, 1047-1053.   https://doi.org/10.1007/s11255-016-1284-1",https://intramural.nih.gov/search/searchview.taf?ipid=93987
783,BC011241-08,"October 01, 2015 -  September 30, 2016",Hematopathology Fellowship,Elaine S Jaffe; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Tapan Mahendra Bhavsar|Theresa M Davies Hill|Nancy Ellen Diener|Caoimhe Mary Egan; MD|Michael Edward Kallen|Froilan Tolentino Orille|Show all 15,Donald  Karcher (George Washington University Medical Center)|Michael  Borowitz (Johns Hopkins Medical School),NULL,Irina  Maric; MD (CC) |Katherine Rainsford Calvo (CC) |Raul Cipriano Braylan; MD (CC),"1. Gong S, Auer I, Duggal R, Pittaluga S, Raffeld M, Jaffe ES (2015). Epstein-Barr virus-associated inflammatory pseudotumor presenting as a colonic mass. Hum Pathol  46, 1956-61.   https://doi.org/10.1016/j.humpath.2015.08.011|2. Lee YS, Filie A, Arthur D, Fojo AT, Jaffe ES (2015). Breast implant-associated anaplastic large cell lymphoma in a patient with Li-Fraumeni syndrome. Histopathology  67, 925-7.   https://doi.org/10.1111/his.12737|3. Menon MP, Nicolae A, Meeker H, Raffeld M, Xi L, Jegalian AG, Miller DC, Pittaluga S, Jaffe ES (2015). Primary CNS T-cell Lymphomas: A Clinical, Morphologic, Immunophenotypic, and Molecular Analysis. Am J Surg Pathol  39, 1719-1729.   https://doi.org/10.1097/PAS.0000000000000503|4. Wang HW, Pittaluga S, Jaffe ES (2016). Multicentric Castleman disease: Where are we now? Semin Diagn Pathol  33, 294-306.   https://doi.org/10.1053/j.semdp.2016.05.006|5. Xiao W, Chen WW, Sorbara L, Davies-Hill T, Pittaluga S, Raffeld M, Jaffe ES (2016). Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion. Hum Pathol  55, 108-116.   https://doi.org/10.1016/j.humpath.2016.04.019|6. Xie Y, Pittaluga S, Jaffe ES (2015). The histological classification of diffuse large B-cell lymphomas. Semin Hematol  52, 57-66.   https://doi.org/10.1053/j.seminhematol.2015.01.006",https://intramural.nih.gov/search/searchview.taf?ipid=94016
784,BC011384-06,"October 01, 2015 -  September 30, 2016",Anatomic Pathology Residency Program,Frederic Glenn Barr|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Michael  Allgaeuer|Selena Tomeka Brantley|Kelly Maureen Brenan-Rothschild|Gregory Thomas Brown|Mary Veronica Eid|Alessio  Giubellino|Show all 11,NULL,NULL,NULL,"1. Giubellino A, Lara K, Martucci V, Huynh T, Agarwal P, Pacak K, Merino MJ (2015). Urinary Bladder Paragangliomas: How Immunohistochemistry Can Assist to Identify Patients With SDHB Germline and Somatic Mutations. Am J Surg Pathol  39, 1488-92.   https://doi.org/10.1097/PAS.0000000000000534",https://intramural.nih.gov/search/searchview.taf?ipid=94101
785,BC011516-04,"October 01, 2015 -  September 30, 2016",Pediatric Oncology Branch Clinical Care and Education,John Walter Glod,Brigitte  Widemann; MD,"Pediatric Oncology Branch, NCI","Alissa Caitlin Baker|Lingling  Chen|Gordon James Cohen; MD, MPH|Sherri L Depollar|Joanne A Derdak|Tom  Fountaine|Show all 25",Donald  Small (Johns Hopkins University School of Medicine)|James  Cassella (Johns Hopkins University School of Medicine)|Stacey  Cooper (Johns Hopkins),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94177
786,BC011542-03,"October 01, 2015 -  September 30, 2016",TGIB Surgical Oncology Fellowship Program,David  Schrump; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Zachary John Brown; DO|Adam Charles Cerise; MD|David Juan-De Chen; MD|Jeremy Lee Davis; MD|Robert Langland Eil|Lisa  Gesumaria|Show all 24,NULL,NULL,NULL,"1. Feingold PL, Quadri HS, Steinberg SM, Malech HL, Gallin JI, Zerbe CS, Zarember KA, Marciano BE, Holland SM, Schrump DS, Ripley RT (2016). Thoracic Surgery in Chronic Granulomatous Disease: a 25-Year Single-Institution Experience. J Clin Immunol  36, 677-83.   https://doi.org/10.1007/s10875-016-0319-9|2. Straughan DM, Kerkar S, Azoury SC, Reardon ES, Schrump DS (2015). Pulmonary mucosa-associated lymphoma in a patient with von Hippel-Lindau disease. J Surg Case Rep  2015.   https://doi.org/10.1093/jscr/rjv080",https://intramural.nih.gov/search/searchview.taf?ipid=94236
787,BC011653-02,"October 01, 2015 -  September 30, 2016",Clinical Support,Christine Campo Alewine|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",NULL,NULL,Raffit  Hassan (Thoracic & Oncologic Surgery Branch)|Anish  Thomas; MD (Thoracic & Oncologic Surgery Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94271
788,BC011656-02,"October 01, 2015 -  September 30, 2016",EOB Clinical and Research Fellowship Training Program,Electron  Kebebew; MD|IRP Faculty Profile,NULL,"Endocrine Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94251
789,SC000853-63,"October 01, 2015 -  September 30, 2016",Translational Surgical Pathology,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Mark  Raffeld; MD,NULL,"Peter L Choyke; MD (Molecular Imaging Program)|Peter A Pinto; MD (Urologic Oncology Branch)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Ramaprasad  Srinivasan; MD, PhD (Urologic Oncology Branch)|Brigitte  Widemann; MD (Pediatric Oncology Branch)","Karel  Pacak; MD, PhD (NICHD)","1. Karageorgiadis AS, Papadakis GZ, Biro J, Keil MF, Lyssikatos C, Quezado MM, Merino M, Schrump DS, Kebebew E, Patronas NJ, Hunter MK, Alwazeer MR, Karaviti LP, Balazs AE, Lodish MB, Stratakis CA (2015). Ectopic adrenocorticotropic hormone and corticotropin-releasing hormone co-secreting tumors in children and adolescents causing cushing syndrome: a diagnostic dilemma and how to solve it. J Clin Endocrinol Metab  100, 141-8.   https://doi.org/10.1210/jc.2014-2945|2. Lang M, Vocke CD, Merino MJ, Schmidt LS, Linehan WM (2015). Mitochondrial DNA mutations distinguish bilateral multifocal renal oncocytomas from familial Birt-Hogg-Dubé tumors. Mod Pathol  28, 1458-69.   https://doi.org/10.1038/modpathol.2015.101|3. Logan JK, Rais-Bahrami S, Merino MJ, Pinto PA (2015). Upgrading prostate cancer following proton beam therapy. Urol Ann  7, 262-4.   https://doi.org/10.4103/0974-7796.152944|4. Muller BG, Shih JH, Sankineni S, Marko J, Rais-Bahrami S, George AK, de la Rosette JJ, Merino MJ, Wood BJ, Pinto P, Choyke PL, Turkbey B (2015). Prostate Cancer: Interobserver Agreement and Accuracy with the Revised Prostate Imaging Reporting and Data System at Multiparametric MR Imaging. Radiology  277, 741-50.   https://doi.org/10.1148/radiol.2015142818",https://intramural.nih.gov/search/searchview.taf?ipid=94376
790,BC010856-10,"October 01, 2015 -  September 30, 2016",Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research,Mary C Custer,Thomas A Misteli; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93848
791,BC010931-09,"October 01, 2015 -  September 30, 2016",Comparative Biomedical Scientist Training Program,"Robert Mark Simpson; DVM, PhD|IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI","Jennifer B Dwyer|Eugene Joseph Ehrhart; DVM, PhD, DACVP|John  Hickerson|Shelley B Hoover|Matti  Kiupel; PhD|Tyler John Peat|Show all 14","Siba  Samal; PhD (Virginia-Maryland Regional College of Vet Med, University of Maryland)|Matti  Kiupel; PhD","Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Jonathan S Wiest; PhD (Office of the Director)|Lee Jay Helman; MD (Pediatric Oncology Branch)|Natasha  Caplen (Cancer Genetics Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Scott K Durum; PhD (Cancer Inflammation Program)",NULL,"1. Wei BR, Michael HT, Halsey CH, Peer CJ, Adhikari A, Dwyer JE, Hoover SB, El Meskini R, Kozlov S, Weaver Ohler Z, Figg WD, Merlino G, Simpson RM (2016). Synergistic targeted inhibition of MEK and dual PI3K/mTOR diminishes viability and inhibits tumor growth of canine melanoma underscoring its utility as a preclinical model for human mucosal melanoma. Pigment Cell Melanoma Res  29, 643-655.   https://doi.org/10.1111/pcmr.12512",https://intramural.nih.gov/search/searchview.taf?ipid=93906
792,BC011689-01,"-  September 30, 2016",Comparative Oncology Trials Consortium,Amy Kathleen Leblanc; DVM,Thomas A Misteli; PhD,"Pediatric Oncology Branch, NCI",Christina  Mazcko|Ling  Ren|Christine Kim Tran Hoang,"Lisa  Barber (Veterinary Medicine, Tufts University)|Antonella  Borgatti (University of Minnesota)|Jenna Leigh Burton|Mike  Childress (Purdue University College of Veterinary Medicine)|Katie  Curran (Oregon State University)|E  Ehrhart (Colorado State University)|Show all 37",James Halpern Doroshow (Developmental Therapeutics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97585
793,BC011735-01,"-  September 30, 2016",Development of Novel Preclinical Animal Models - CAPR Infrastructure,Shyam K Sharan|IRP Faculty Profile,NULL,"Office of the Director, NCI",Baktiar Omer Karim,NULL,Christine Campo Alewine (Laboratory of Molecular Biology)|Peter L Choyke; MD (Molecular Imaging Program)|Chi-Ping  Day (Laboratory of Cancer Biology and Genetics)|James Halpern Doroshow (Office of the Director)|Udayan  Guha (Thoracic & Oncologic Surgery Branch)|Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics),Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=97624
794,BC011235-08,"October 01, 2015 -  September 30, 2016",Support of NCI CCR Clinical Research and Bioinformatics,Jason Edward Levine,Thomas A Misteli; PhD,"Office of the Director, NCI",Ravi Sankar Srinivas Dinavahi|Ming  Ji|Christian Jose Mambrin|Richard J Moon|Rohit  Paul|James  Waters,NULL,William D Figg; PharmD (Genitourinary Malignancies Branch)|Mark Richard Gilbert; MD (Neuro-Oncology Branch)|Electron  Kebebew; MD (Endocrine Oncology Branch)|Heidi H Kong (Dermatology Branch)|Stacia Martin Peron; PhD (Pediatric Oncology Branch)|Brigitte  Widemann; MD (Pediatric Oncology Branch),Jon W McKeeby (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94031
795,BC011445-05,"October 01, 2015 -  September 30, 2016",Mathematical Modeling of cell colony growth and DNA Replication.,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",Yinon  Shafrir|Kandice Danielle Tanner; PhD,NULL,Mirit I Aladjem; PhD (Developmental Therapeutics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94132
796,BC011703-01,"-  September 30, 2016","Integrated analyses of genetics, epigenetics, and gene expression",Maxwell P Lee; PhD,Glenn  Merlino; PhD,"Laboratory of Cancer Biology and Genetics, NCI",Huaitian  Liu|Howard H Yang|Jeffrey E Green; MD|Jing  Huang|Kent W Hunter; PhD|Beverly  Mock; PhD|Show all 9,NULL,"Kevin  Gardner; MD, PhD (Cancer Genetics Branch)|Alisa  Goldstein; PhD (Genetic Epidemiology Branch)|Ronald  Lubet (Chemopreventive Agent Development Research Group)|Karl Thomas Ried; MD (Cancer Genetics Branch)|Mark E Sherman; MD (Breast and Gynecologic Cancer Research Group)|Robert  Shoemaker (Chemopreventive Agent Development Research Group)",NULL,"1. Bai L, Yang HH, Hu Y, Shukla A, Ha NH, Doran A, Faraji F, Goldberger N, Lee MP, Keane T, Hunter KW (2016). An Integrated Genome-Wide Systems Genetics Screen for Breast Cancer Metastasis Susceptibility Genes. PLoS Genet  12, e1005989.   https://doi.org/10.1371/journal.pgen.1005989|2. Faraji F, Hu Y, Yang HH, Lee MP, Winkler GS, Hafner M, Hunter KW (2016). Post-transcriptional Control of Tumor Cell Autonomous Metastatic Potential by CCR4-NOT Deadenylase CNOT7. PLoS Genet  12, e1005820.   https://doi.org/10.1371/journal.pgen.1005820|3. He Y, de Castro LF, Shin MH, Dubois W, Yang HH, Jiang S, Mishra PJ, Ren L, Gou H, Lal A, Khanna C, Merlino G, Lee M, Robey PG, Huang J (2015). p53 loss increases the osteogenic differentiation of bone marrow stromal cells. Stem Cells  33, 1304-19.   https://doi.org/10.1002/stem.1925",https://intramural.nih.gov/search/searchview.taf?ipid=97596
797,CO020005-08,"October 01, 2015 -  September 30, 2016",National Cancer Informatics Program (NCIP),Douglas  Lowy; MD|IRP Faculty Profile,NULL,"Office Of The Director, NCI",Anthony Robert Kerlavage|Warren Alden Kibbe,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94283
798,CP010205-08,"October 01, 2015 -  September 30, 2016",Scientific Computing,"Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",Marianne  Henderson|Karen E Berliner|Alyssa Marie Voss|Louise  Brinton; PhD,NULL,"Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Margaret Anne Tucker (Human Genetics Program)|Nilanjan  Chatterjee (Biostatistics Branch)|Mark H Greene; MD (Clinical Genetics Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Debra  Silverman; ScD, ScM (Occupational and Environmental Epidemiology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94341
799,BC011234-08,"October 01, 2015 -  September 30, 2016",CCR New Space Activation,Darren W Henderson,Thomas A Misteli; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94011
800,CO020002-08,"October 01, 2015 -  September 30, 2016",Space and Facilities Management,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"National Cancer Institute, NCI",NULL,NULL,NULL,Jean P Khoshbin (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94281
801,BC011133-08,"October 01, 2015 -  September 30, 2016",CCR Office of Training and Education,Jonathan S Wiest; PhD,NULL,"Office of the Director, NCI",Viola D Black|Terry  Moody; PhD|Mary L Velthuis|Ravi  Dhar; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93608
802,BC011285-07,"October 01, 2015 -  September 30, 2016",CCR Education and Outreach,Melissa A Bronez,Thomas A Misteli; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94051
803,BC011365-04,"October 01, 2015 -  September 30, 2016","Cancer, Genetics, and Signaling Training Program",Janelle  Cortner,Thomas A Misteli; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93604
804,CP010204-08,"October 01, 2015 -  September 30, 2016","Communications, Education and Outreach","Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",Catherine B McClave|Jennifer K Loukissas|Alyssa Marie Voss|Jackie Ann Lavigne|Wendy  Schneider-Levinson|Victoria Anne McCallum,NULL,Kristin O Kiser (Office of Education),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94340
805,CP010208-07,"October 01, 2015 -  September 30, 2016",Special Studies Institutional Review Board Support,"Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",Catherine G Schairer|Catherine B McClave,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94345
806,BC010857-10,"October 01, 2015 -  September 30, 2016",Science and Technology Resources,David Jay Goldstein,Thomas A Misteli; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=93850
807,BC011193-08,"October 01, 2015 -  September 30, 2016",Office of Policy and Intellectual Property,Eric A Hale,Thomas A Misteli; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94010
808,CO020001-08,"October 01, 2015 -  September 30, 2016",Technology Transfer Center,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"National Cancer Institute, NCI",Karen M Maurey,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=94280
